<MIFFile 10.0> # Generated by FrameMaker 10.0.2.419
# Options:
#    Paragraph Text
#    Paragraph Tags
#    Paragraph Formats
#    Font Information
#    Markers
#    Anchored Frames
#    Tables
#    Graphics and TextRect Layout
#    Master Page Items
#    Condition Catalog
#    Table Catalogs
#    Font Catalog
#    Paragraph Catalog
#    Document Template
#    Document Dictionary
#    Variables
#
<Units Umm>
<CharUnits CUpt>
<ColorCatalog 
 <Color 
  <ColorTag `Black'>
  <ColorCyan  0.000000>
  <ColorMagenta  0.000000>
  <ColorYellow  0.000000>
  <ColorBlack  100.000000>
  <ColorAttribute ColorIsBlack>
  <ColorAttribute ColorIsReserved>
 > # end of Color
 <Color 
  <ColorTag `White'>
  <ColorCyan  0.000000>
  <ColorMagenta  0.000000>
  <ColorYellow  0.000000>
  <ColorBlack  0.000000>
  <ColorAttribute ColorIsWhite>
  <ColorAttribute ColorIsReserved>
 > # end of Color
 <Color 
  <ColorTag `Red'>
  <ColorCyan  0.000000>
  <ColorMagenta  100.000000>
  <ColorYellow  100.000000>
  <ColorBlack  0.000000>
  <ColorAttribute ColorIsRed>
  <ColorAttribute ColorIsReserved>
 > # end of Color
 <Color 
  <ColorTag `Green'>
  <ColorCyan  100.000000>
  <ColorMagenta  0.000000>
  <ColorYellow  100.000000>
  <ColorBlack  0.000000>
  <ColorAttribute ColorIsGreen>
  <ColorAttribute ColorIsReserved>
 > # end of Color
 <Color 
  <ColorTag `Blue'>
  <ColorCyan  100.000000>
  <ColorMagenta  100.000000>
  <ColorYellow  0.000000>
  <ColorBlack  0.000000>
  <ColorAttribute ColorIsBlue>
  <ColorAttribute ColorIsReserved>
 > # end of Color
 <Color 
  <ColorTag `Cyan'>
  <ColorCyan  100.000000>
  <ColorMagenta  0.000000>
  <ColorYellow  0.000000>
  <ColorBlack  0.000000>
  <ColorAttribute ColorIsCyan>
  <ColorAttribute ColorIsReserved>
 > # end of Color
 <Color 
  <ColorTag `Magenta'>
  <ColorCyan  0.000000>
  <ColorMagenta  100.000000>
  <ColorYellow  0.000000>
  <ColorBlack  0.000000>
  <ColorAttribute ColorIsMagenta>
  <ColorAttribute ColorIsReserved>
 > # end of Color
 <Color 
  <ColorTag `Yellow'>
  <ColorCyan  0.000000>
  <ColorMagenta  0.000000>
  <ColorYellow  100.000000>
  <ColorBlack  0.000000>
  <ColorAttribute ColorIsYellow>
  <ColorAttribute ColorIsReserved>
 > # end of Color
 <Color 
  <ColorTag `Svart 35%'>
  <ColorCyan  0.000000>
  <ColorMagenta  0.000000>
  <ColorYellow  0.000000>
  <ColorBlack  35.000000>
 > # end of Color
 <Color 
  <ColorTag `[Registration]'>
  <ColorCyan  100.000000>
  <ColorMagenta  100.000000>
  <ColorYellow  100.000000>
  <ColorBlack  100.000000>
 > # end of Color
 <Color 
  <ColorTag `PICT Color 2'>
  <ColorCyan  0.000000>
  <ColorMagenta  0.000000>
  <ColorYellow  0.000000>
  <ColorBlack  100.000000>
 > # end of Color
 <Color 
  <ColorTag `PANTONE Rubine Red CVC'>
  <ColorCyan  0.000000>
  <ColorMagenta  99.998474>
  <ColorYellow  14.999390>
  <ColorBlack  0.000000>
  <ColorLibraryFamilyName `PANTONE® Coated'>
  <ColorLibraryInkName `PANTONE Rubine Red CVC'>
 > # end of Color
 <Color 
  <ColorTag `Dark Grey'>
  <ColorCyan  0.000000>
  <ColorMagenta  0.000000>
  <ColorYellow  0.000000>
  <ColorBlack  60.000000>
  <ColorAttribute ColorIsDarkGrey>
  <ColorAttribute ColorIsReserved>
 > # end of Color
 <Color 
  <ColorTag `Pale Green'>
  <ColorCyan  26.000000>
  <ColorMagenta  0.000000>
  <ColorYellow  60.000000>
  <ColorBlack  0.000000>
  <ColorAttribute ColorIsPaleGreen>
  <ColorAttribute ColorIsReserved>
 > # end of Color
 <Color 
  <ColorTag `Forest Green'>
  <ColorCyan  41.000000>
  <ColorMagenta  0.000000>
  <ColorYellow  41.000000>
  <ColorBlack  46.000000>
  <ColorAttribute ColorIsForestGreen>
  <ColorAttribute ColorIsReserved>
 > # end of Color
 <Color 
  <ColorTag `Royal Blue'>
  <ColorCyan  93.000000>
  <ColorMagenta  46.000000>
  <ColorYellow  0.000000>
  <ColorBlack  0.000000>
  <ColorAttribute ColorIsRoyalBlue>
  <ColorAttribute ColorIsReserved>
 > # end of Color
 <Color 
  <ColorTag `Mauve'>
  <ColorCyan  40.000000>
  <ColorMagenta  60.000000>
  <ColorYellow  0.000000>
  <ColorBlack  0.000000>
  <ColorAttribute ColorIsMauve>
  <ColorAttribute ColorIsReserved>
 > # end of Color
 <Color 
  <ColorTag `Light Salmon'>
  <ColorCyan  0.000000>
  <ColorMagenta  40.000000>
  <ColorYellow  60.000000>
  <ColorBlack  0.000000>
  <ColorAttribute ColorIsLightSalmon>
  <ColorAttribute ColorIsReserved>
 > # end of Color
 <Color 
  <ColorTag `Olive'>
  <ColorCyan  0.000000>
  <ColorMagenta  0.000000>
  <ColorYellow  40.000000>
  <ColorBlack  60.000000>
  <ColorAttribute ColorIsDarkYellow>
  <ColorAttribute ColorIsReserved>
 > # end of Color
 <Color 
  <ColorTag `Salmon'>
  <ColorCyan  0.000000>
  <ColorMagenta  57.000000>
  <ColorYellow  76.000000>
  <ColorBlack  0.000000>
  <ColorAttribute ColorIsSalmon>
  <ColorAttribute ColorIsReserved>
 > # end of Color
 <Color 
  <ColorTag `PANTONE 7488'>
  <ColorCyan  42.999268>
  <ColorMagenta  0.000000>
  <ColorYellow  78.997803>
  <ColorBlack  0.000000>
  <ColorLibraryFamilyName `PANTONE® Coated'>
  <ColorLibraryInkName `PANTONE 375 CVC'>
 > # end of Color
 <Color 
  <ColorTag `Akut'>
  <ColorCyan  100.000000>
  <ColorMagenta  72.000000>
  <ColorYellow  0.000000>
  <ColorBlack  46.000000>
 > # end of Color
 <Color 
  <ColorTag `Akut_Text'>
  <ColorCyan  100.000000>
  <ColorMagenta  72.000000>
  <ColorYellow  0.000000>
  <ColorBlack  46.000000>
 > # end of Color
 <Color 
  <ColorTag `Color8'>
  <ColorCyan  35.686264>
  <ColorMagenta  19.607834>
  <ColorYellow  0.000000>
  <ColorBlack  43.137238>
 > # end of Color
 <Color 
  <ColorTag `Color9'>
  <ColorCyan  43.137253>
  <ColorMagenta  23.529404>
  <ColorYellow  0.000000>
  <ColorBlack  25.882339>
 > # end of Color
> # end of ColorCatalog
<ConditionCatalog 
 <Condition 
  <CTag `Comment'>
  <CState CShown>
  <CStyle CUnderline>
  <CSeparation 2>
  <CColor `Red'>
 > # end of Condition
 <Condition 
  <CTag `FM8_SYSTEM_HIDEELEMENT'>
  <CState CHidden>
  <CStyle CAsIs>
  <CSeparation 8>
  <CColor `Dark Grey'>
 > # end of Condition
 <Condition 
  <CTag `FM8_TRACK_CHANGES_ADDED'>
  <CState CShown>
  <CStyle CUnderline>
  <CSeparation 10>
  <CColor `Forest Green'>
  <CAndCondition >
 > # end of Condition
 <Condition 
  <CTag `FM8_TRACK_CHANGES_DELETED'>
  <CState CShown>
  <CStyle CStrike>
  <CSeparation 2>
  <CColor `Red'>
  <CAndCondition >
 > # end of Condition
> # end of ConditionCatalog
<BoolCondCatalog 
  <BoolCond 
  <BoolCondTag `Conditional Expression'>
  <BoolCondExprName `Default Expression'>
  <BoolCondExpr `"Comment"'>
  <BoolCondState `Inactive'>
 > # end of BoolCond
> # end of BoolCondCatalog
<DefAttrValuesCatalog 
> # end of DefAttrValuesCatalog
<AttrCondExprCatalog 
> # end of AttrCondExprCatalog
<CombinedFontCatalog 
> # end of CombinedFontCatalog
<PgfCatalog 
 <Pgf 
  <PgfTag `AvsnittsRub'>
  <PgfUseNextTag No>
  <PgfNextTag `'>
  <PgfAlignment Right>
  <PgfFIndent  0.0 mm>
  <PgfLIndent  0.0 mm>
  <PgfRIndent  0.0 mm>
  <PgfFIndentRelative No>
  <PgfFIndentOffset  0.0 mm>
  <PgfTopSeparator `'>
  <PgfTopSepAtIndent No>
  <PgfTopSepOffset  0.0 mm>
  <PgfBotSeparator `'>
  <PgfBotSepAtIndent No>
  <PgfBotSepOffset  0.0 mm>
  <PgfPlacement Anywhere>
  <PgfPlacementStyle Normal>
  <PgfRunInDefaultPunct `. '>
  <PgfSpBefore  0.0 pt>
  <PgfSpAfter  0.0 pt>
  <PgfWithPrev No>
  <PgfWithNext No>
  <PgfBlockSize 1>
  <PgfFont 
   <FTag `'>
   <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
   <FFamily `Frutiger LT Std 45 Light'>
   <FVar `Regular'>
   <FWeight `Bold'>
   <FAngle `Regular'>
   <FPostScriptName `FrutigerLTStd-Bold'>
   <FEncoding `FrameRoman'>
   <FSize  7.0 pt>
   <FUnderlining FNoUnderlining>
   <FOverline No>
   <FStrike No>
   <FChangeBar No>
   <FOutline No>
   <FShadow No>
   <FPairKern Yes>
   <FTsume No>
   <FCase FAsTyped>
   <FPosition FNormal>
   <FDX  0.0%>
   <FDY  0.0%>
   <FDW  0.0%>
   <FStretch  100.0%>
   <FLanguage Swedish>
   <FLocked No>
   <FSeparation 0>
   <FColor `Black'>
   <FBackgroundColor NoColor>
  > # end of PgfFont
  <PgfLineSpacing Fixed>
  <PgfLeading  1.7 pt>
  <PgfAutoNum No>
  <PgfNumTabs 0>
  <PgfHyphenate Yes>
  <HyphenMaxLines 2>
  <HyphenMinPrefix 2>
  <HyphenMinSuffix 2>
  <HyphenMinWord 5>
  <PgfLetterSpace No>
  <PgfMinWordSpace 75>
  <PgfOptWordSpace 100>
  <PgfMaxWordSpace 125>
  <PgfMinJRomanLetterSpace 0>
  <PgfOptJRomanLetterSpace 25>
  <PgfMaxJRomanLetterSpace 50>
  <PgfMinJLetterSpace 0>
  <PgfOptJLetterSpace 0>
  <PgfMaxJLetterSpace 10>
  <PgfYakumonoType Floating>
  <PgfAcrobatLevel 1>
  <PgfPDFStructureLevel 26>
  <PgfLanguage Swedish>
  <PgfCellAlignment Top>
  <PgfCellMargins  0.0 pt 0.0 pt 0.0 pt 0.0 pt>
  <PgfCellLMarginFixed No>
  <PgfCellTMarginFixed No>
  <PgfCellRMarginFixed No>
  <PgfCellBMarginFixed No>
  <PgfLocked No>
 > # end of Pgf
 <Pgf 
  <PgfTag `Bröd'>
  <PgfUseNextTag Yes>
  <PgfNextTag `BrödIn'>
  <PgfAlignment LeftRight>
  <PgfFIndent  0.0 mm>
  <PgfLIndent  0.0 mm>
  <PgfRIndent  0.0 mm>
  <PgfFIndentRelative No>
  <PgfFIndentOffset  0.0 mm>
  <PgfTopSeparator `'>
  <PgfTopSepAtIndent No>
  <PgfTopSepOffset  0.0 mm>
  <PgfBotSeparator `'>
  <PgfBotSepAtIndent No>
  <PgfBotSepOffset  0.0 mm>
  <PgfPlacement Anywhere>
  <PgfPlacementStyle Normal>
  <PgfRunInDefaultPunct `'>
  <PgfSpBefore  0.0 pt>
  <PgfSpAfter  0.0 pt>
  <PgfWithPrev No>
  <PgfWithNext No>
  <PgfBlockSize 2>
  <PgfFont 
   <FTag `'>
   <FPlatformName `W.NewCenturySchlbk LT Std.R.400'>
   <FFamily `NewCenturySchlbk LT Std'>
   <FVar `Regular'>
   <FWeight `Regular'>
   <FAngle `Regular'>
   <FPostScriptName `NewCenturySchlbkLTStd-Roman'>
   <FEncoding `FrameRoman'>
   <FSize  9.0 pt>
   <FUnderlining FNoUnderlining>
   <FOverline No>
   <FStrike No>
   <FChangeBar No>
   <FOutline No>
   <FShadow No>
   <FPairKern Yes>
   <FTsume No>
   <FCase FAsTyped>
   <FPosition FNormal>
   <FDX  0.0%>
   <FDY  0.0%>
   <FDW  0.0%>
   <FStretch  100.0%>
   <FLanguage Swedish>
   <FLocked No>
   <FSeparation 0>
   <FColor `Black'>
   <FBackgroundColor NoColor>
  > # end of PgfFont
  <PgfLineSpacing Fixed>
  <PgfLeading  1.7 pt>
  <PgfAutoNum No>
  <PgfNumTabs 0>
  <PgfHyphenate Yes>
  <HyphenMaxLines 4>
  <HyphenMinPrefix 2>
  <HyphenMinSuffix 2>
  <HyphenMinWord 5>
  <PgfLetterSpace No>
  <PgfMinWordSpace 75>
  <PgfOptWordSpace 100>
  <PgfMaxWordSpace 125>
  <PgfMinJRomanLetterSpace 0>
  <PgfOptJRomanLetterSpace 25>
  <PgfMaxJRomanLetterSpace 50>
  <PgfMinJLetterSpace 0>
  <PgfOptJLetterSpace 0>
  <PgfMaxJLetterSpace 10>
  <PgfYakumonoType Floating>
  <PgfAcrobatLevel 0>
  <PgfPDFStructureLevel 26>
  <PgfLanguage Swedish>
  <PgfCellAlignment Top>
  <PgfCellMargins  0.0 pt 0.0 pt 0.0 pt 0.0 pt>
  <PgfCellLMarginFixed No>
  <PgfCellTMarginFixed No>
  <PgfCellRMarginFixed No>
  <PgfCellBMarginFixed No>
  <PgfLocked No>
 > # end of Pgf
 <Pgf 
  <PgfTag `BrödIn'>
  <PgfUseNextTag No>
  <PgfNextTag `'>
  <PgfAlignment LeftRight>
  <PgfFIndent  3.0 mm>
  <PgfLIndent  0.0 mm>
  <PgfRIndent  0.0 mm>
  <PgfFIndentRelative No>
  <PgfFIndentOffset  0.0 mm>
  <PgfTopSeparator `'>
  <PgfTopSepAtIndent No>
  <PgfTopSepOffset  0.0 mm>
  <PgfBotSeparator `'>
  <PgfBotSepAtIndent No>
  <PgfBotSepOffset  0.0 mm>
  <PgfPlacement Anywhere>
  <PgfPlacementStyle Normal>
  <PgfRunInDefaultPunct `'>
  <PgfSpBefore  0.0 pt>
  <PgfSpAfter  0.0 pt>
  <PgfWithPrev No>
  <PgfWithNext No>
  <PgfBlockSize 2>
  <PgfFont 
   <FTag `'>
   <FPlatformName `W.NewCenturySchlbk LT Std.R.400'>
   <FFamily `NewCenturySchlbk LT Std'>
   <FVar `Regular'>
   <FWeight `Regular'>
   <FAngle `Regular'>
   <FPostScriptName `NewCenturySchlbkLTStd-Roman'>
   <FEncoding `FrameRoman'>
   <FSize  9.0 pt>
   <FUnderlining FNoUnderlining>
   <FOverline No>
   <FStrike No>
   <FChangeBar No>
   <FOutline No>
   <FShadow No>
   <FPairKern Yes>
   <FTsume No>
   <FCase FAsTyped>
   <FPosition FNormal>
   <FDX  0.0%>
   <FDY  0.0%>
   <FDW  0.0%>
   <FStretch  100.0%>
   <FLanguage Swedish>
   <FLocked No>
   <FSeparation 0>
   <FColor `Black'>
   <FBackgroundColor NoColor>
  > # end of PgfFont
  <PgfLineSpacing Fixed>
  <PgfLeading  1.7 pt>
  <PgfAutoNum No>
  <PgfNumTabs 0>
  <PgfHyphenate Yes>
  <HyphenMaxLines 4>
  <HyphenMinPrefix 2>
  <HyphenMinSuffix 2>
  <HyphenMinWord 5>
  <PgfLetterSpace No>
  <PgfMinWordSpace 75>
  <PgfOptWordSpace 100>
  <PgfMaxWordSpace 125>
  <PgfMinJRomanLetterSpace 0>
  <PgfOptJRomanLetterSpace 25>
  <PgfMaxJRomanLetterSpace 50>
  <PgfMinJLetterSpace 0>
  <PgfOptJLetterSpace 0>
  <PgfMaxJLetterSpace 10>
  <PgfYakumonoType Floating>
  <PgfAcrobatLevel 0>
  <PgfPDFStructureLevel 26>
  <PgfLanguage Swedish>
  <PgfCellAlignment Top>
  <PgfCellMargins  0.0 pt 0.0 pt 0.0 pt 0.0 pt>
  <PgfCellLMarginFixed No>
  <PgfCellTMarginFixed No>
  <PgfCellRMarginFixed No>
  <PgfCellBMarginFixed No>
  <PgfLocked No>
 > # end of Pgf
 <Pgf 
  <PgfTag `BrödNr1'>
  <PgfUseNextTag No>
  <PgfNextTag `'>
  <PgfAlignment Left>
  <PgfFIndent  0.0 mm>
  <PgfLIndent  5.0 mm>
  <PgfRIndent  0.0 mm>
  <PgfFIndentRelative No>
  <PgfFIndentOffset  0.0 mm>
  <PgfTopSeparator `'>
  <PgfTopSepAtIndent No>
  <PgfTopSepOffset  0.0 mm>
  <PgfBotSeparator `'>
  <PgfBotSepAtIndent No>
  <PgfBotSepOffset  0.0 mm>
  <PgfPlacement Anywhere>
  <PgfPlacementStyle Normal>
  <PgfRunInDefaultPunct `'>
  <PgfSpBefore  5.35 pt>
  <PgfSpAfter  0.0 pt>
  <PgfWithPrev No>
  <PgfWithNext No>
  <PgfBlockSize 2>
  <PgfFont 
   <FTag `'>
   <FPlatformName `W.NewCenturySchlbk LT Std.R.400'>
   <FFamily `NewCenturySchlbk LT Std'>
   <FVar `Regular'>
   <FWeight `Regular'>
   <FAngle `Regular'>
   <FPostScriptName `NewCenturySchlbkLTStd-Roman'>
   <FEncoding `FrameRoman'>
   <FSize  9.0 pt>
   <FUnderlining FNoUnderlining>
   <FOverline No>
   <FStrike No>
   <FChangeBar No>
   <FOutline No>
   <FShadow No>
   <FPairKern Yes>
   <FTsume No>
   <FCase FAsTyped>
   <FPosition FNormal>
   <FDX  0.0%>
   <FDY  0.0%>
   <FDW  0.0%>
   <FStretch  100.0%>
   <FLanguage Swedish>
   <FLocked No>
   <FSeparation 0>
   <FColor `Black'>
   <FBackgroundColor NoColor>
  > # end of PgfFont
  <PgfLineSpacing Fixed>
  <PgfLeading  1.7 pt>
  <PgfAutoNum Yes>
  <PgfNumFormat `B:<n=1\>.\\t'>
  <PgfNumberFont `'>
  <PgfNumAtEnd No>
  <PgfNumTabs 1>
  <TabStop 
   <TSX  5.0 mm>
   <TSType Left>
   <TSLeaderStr ` '>
  > # end of TabStop
  <PgfHyphenate Yes>
  <HyphenMaxLines 4>
  <HyphenMinPrefix 2>
  <HyphenMinSuffix 2>
  <HyphenMinWord 5>
  <PgfLetterSpace No>
  <PgfMinWordSpace 75>
  <PgfOptWordSpace 100>
  <PgfMaxWordSpace 125>
  <PgfMinJRomanLetterSpace 0>
  <PgfOptJRomanLetterSpace 25>
  <PgfMaxJRomanLetterSpace 50>
  <PgfMinJLetterSpace 0>
  <PgfOptJLetterSpace 0>
  <PgfMaxJLetterSpace 10>
  <PgfYakumonoType Floating>
  <PgfAcrobatLevel 0>
  <PgfPDFStructureLevel 21>
  <PgfLanguage Swedish>
  <PgfCellAlignment Top>
  <PgfCellMargins  0.0 pt 0.0 pt 0.0 pt 0.0 pt>
  <PgfCellLMarginFixed No>
  <PgfCellTMarginFixed No>
  <PgfCellRMarginFixed No>
  <PgfCellBMarginFixed No>
  <PgfLocked No>
 > # end of Pgf
 <Pgf 
  <PgfTag `BrödNr1EfterRubrik'>
  <PgfUseNextTag No>
  <PgfNextTag `'>
  <PgfAlignment Left>
  <PgfFIndent  0.0 mm>
  <PgfLIndent  5.0 mm>
  <PgfRIndent  0.0 mm>
  <PgfFIndentRelative No>
  <PgfFIndentOffset  0.0 mm>
  <PgfTopSeparator `'>
  <PgfTopSepAtIndent No>
  <PgfTopSepOffset  0.0 mm>
  <PgfBotSeparator `'>
  <PgfBotSepAtIndent No>
  <PgfBotSepOffset  0.0 mm>
  <PgfPlacement Anywhere>
  <PgfPlacementStyle Normal>
  <PgfRunInDefaultPunct `'>
  <PgfSpBefore  2.0 pt>
  <PgfSpAfter  0.0 pt>
  <PgfWithPrev No>
  <PgfWithNext No>
  <PgfBlockSize 2>
  <PgfFont 
   <FTag `'>
   <FPlatformName `W.NewCenturySchlbk LT Std.R.400'>
   <FFamily `NewCenturySchlbk LT Std'>
   <FVar `Regular'>
   <FWeight `Regular'>
   <FAngle `Regular'>
   <FPostScriptName `NewCenturySchlbkLTStd-Roman'>
   <FEncoding `FrameRoman'>
   <FSize  9.0 pt>
   <FUnderlining FNoUnderlining>
   <FOverline No>
   <FStrike No>
   <FChangeBar No>
   <FOutline No>
   <FShadow No>
   <FPairKern Yes>
   <FTsume No>
   <FCase FAsTyped>
   <FPosition FNormal>
   <FDX  0.0%>
   <FDY  0.0%>
   <FDW  0.0%>
   <FStretch  100.0%>
   <FLanguage Swedish>
   <FLocked No>
   <FSeparation 0>
   <FColor `Black'>
   <FBackgroundColor NoColor>
  > # end of PgfFont
  <PgfLineSpacing Fixed>
  <PgfLeading  1.7 pt>
  <PgfAutoNum Yes>
  <PgfNumFormat `B:<n=1\>.\\t'>
  <PgfNumberFont `'>
  <PgfNumAtEnd No>
  <PgfNumTabs 1>
  <TabStop 
   <TSX  5.0 mm>
   <TSType Left>
   <TSLeaderStr ` '>
  > # end of TabStop
  <PgfHyphenate Yes>
  <HyphenMaxLines 4>
  <HyphenMinPrefix 2>
  <HyphenMinSuffix 2>
  <HyphenMinWord 5>
  <PgfLetterSpace No>
  <PgfMinWordSpace 75>
  <PgfOptWordSpace 100>
  <PgfMaxWordSpace 125>
  <PgfMinJRomanLetterSpace 0>
  <PgfOptJRomanLetterSpace 25>
  <PgfMaxJRomanLetterSpace 50>
  <PgfMinJLetterSpace 0>
  <PgfOptJLetterSpace 0>
  <PgfMaxJLetterSpace 10>
  <PgfYakumonoType Floating>
  <PgfAcrobatLevel 0>
  <PgfPDFStructureLevel 0>
  <PgfLanguage Swedish>
  <PgfCellAlignment Top>
  <PgfCellMargins  0.0 pt 0.0 pt 0.0 pt 0.0 pt>
  <PgfCellLMarginFixed No>
  <PgfCellTMarginFixed No>
  <PgfCellRMarginFixed No>
  <PgfCellBMarginFixed No>
  <PgfLocked No>
 > # end of Pgf
 <Pgf 
  <PgfTag `BrödNrForts'>
  <PgfUseNextTag No>
  <PgfNextTag `'>
  <PgfAlignment Left>
  <PgfFIndent  0.0 mm>
  <PgfLIndent  5.0 mm>
  <PgfRIndent  0.0 mm>
  <PgfFIndentRelative No>
  <PgfFIndentOffset  0.0 mm>
  <PgfTopSeparator `'>
  <PgfTopSepAtIndent No>
  <PgfTopSepOffset  0.0 mm>
  <PgfBotSeparator `'>
  <PgfBotSepAtIndent No>
  <PgfBotSepOffset  0.0 mm>
  <PgfPlacement Anywhere>
  <PgfPlacementStyle Normal>
  <PgfRunInDefaultPunct `'>
  <PgfSpBefore  5.35 pt>
  <PgfSpAfter  0.0 pt>
  <PgfWithPrev No>
  <PgfWithNext No>
  <PgfBlockSize 2>
  <PgfFont 
   <FTag `'>
   <FPlatformName `W.NewCenturySchlbk LT Std.R.400'>
   <FFamily `NewCenturySchlbk LT Std'>
   <FVar `Regular'>
   <FWeight `Regular'>
   <FAngle `Regular'>
   <FPostScriptName `NewCenturySchlbkLTStd-Roman'>
   <FEncoding `FrameRoman'>
   <FSize  9.0 pt>
   <FUnderlining FNoUnderlining>
   <FOverline No>
   <FStrike No>
   <FChangeBar No>
   <FOutline No>
   <FShadow No>
   <FPairKern Yes>
   <FTsume No>
   <FCase FAsTyped>
   <FPosition FNormal>
   <FDX  0.0%>
   <FDY  0.0%>
   <FDW  0.0%>
   <FStretch  100.0%>
   <FLanguage Swedish>
   <FLocked No>
   <FSeparation 0>
   <FColor `Black'>
   <FBackgroundColor NoColor>
  > # end of PgfFont
  <PgfLineSpacing Fixed>
  <PgfLeading  1.7 pt>
  <PgfAutoNum Yes>
  <PgfNumFormat `B:<n+\>.\\t'>
  <PgfNumberFont `'>
  <PgfNumAtEnd No>
  <PgfNumTabs 1>
  <TabStop 
   <TSX  5.0 mm>
   <TSType Left>
   <TSLeaderStr ` '>
  > # end of TabStop
  <PgfHyphenate Yes>
  <HyphenMaxLines 2>
  <HyphenMinPrefix 2>
  <HyphenMinSuffix 2>
  <HyphenMinWord 5>
  <PgfLetterSpace No>
  <PgfMinWordSpace 75>
  <PgfOptWordSpace 100>
  <PgfMaxWordSpace 125>
  <PgfMinJRomanLetterSpace 0>
  <PgfOptJRomanLetterSpace 25>
  <PgfMaxJRomanLetterSpace 50>
  <PgfMinJLetterSpace 0>
  <PgfOptJLetterSpace 0>
  <PgfMaxJLetterSpace 10>
  <PgfYakumonoType Floating>
  <PgfAcrobatLevel 0>
  <PgfPDFStructureLevel 21>
  <PgfLanguage Swedish>
  <PgfCellAlignment Top>
  <PgfCellMargins  0.0 pt 0.0 pt 0.0 pt 0.0 pt>
  <PgfCellLMarginFixed No>
  <PgfCellTMarginFixed No>
  <PgfCellRMarginFixed No>
  <PgfCellBMarginFixed No>
  <PgfLocked No>
 > # end of Pgf
 <Pgf 
  <PgfTag `BrödNrFortsSista'>
  <PgfUseNextTag No>
  <PgfNextTag `'>
  <PgfAlignment Left>
  <PgfFIndent  0.0 mm>
  <PgfLIndent  5.0 mm>
  <PgfRIndent  0.0 mm>
  <PgfFIndentRelative No>
  <PgfFIndentOffset  0.0 mm>
  <PgfTopSeparator `'>
  <PgfTopSepAtIndent No>
  <PgfTopSepOffset  0.0 mm>
  <PgfBotSeparator `'>
  <PgfBotSepAtIndent No>
  <PgfBotSepOffset  0.0 mm>
  <PgfPlacement Anywhere>
  <PgfPlacementStyle Normal>
  <PgfRunInDefaultPunct `'>
  <PgfSpBefore  5.35 pt>
  <PgfSpAfter  5.35 pt>
  <PgfWithPrev No>
  <PgfWithNext No>
  <PgfBlockSize 2>
  <PgfFont 
   <FTag `'>
   <FPlatformName `W.NewCenturySchlbk LT Std.R.400'>
   <FFamily `NewCenturySchlbk LT Std'>
   <FVar `Regular'>
   <FWeight `Regular'>
   <FAngle `Regular'>
   <FPostScriptName `NewCenturySchlbkLTStd-Roman'>
   <FEncoding `FrameRoman'>
   <FSize  9.0 pt>
   <FUnderlining FNoUnderlining>
   <FOverline No>
   <FStrike No>
   <FChangeBar No>
   <FOutline No>
   <FShadow No>
   <FPairKern Yes>
   <FTsume No>
   <FCase FAsTyped>
   <FPosition FNormal>
   <FDX  0.0%>
   <FDY  0.0%>
   <FDW  0.0%>
   <FStretch  100.0%>
   <FLanguage Swedish>
   <FLocked No>
   <FSeparation 0>
   <FColor `Black'>
   <FBackgroundColor NoColor>
  > # end of PgfFont
  <PgfLineSpacing Fixed>
  <PgfLeading  1.7 pt>
  <PgfAutoNum Yes>
  <PgfNumFormat `B:<n+\>.\\t'>
  <PgfNumberFont `'>
  <PgfNumAtEnd No>
  <PgfNumTabs 1>
  <TabStop 
   <TSX  5.0 mm>
   <TSType Left>
   <TSLeaderStr ` '>
  > # end of TabStop
  <PgfHyphenate Yes>
  <HyphenMaxLines 2>
  <HyphenMinPrefix 2>
  <HyphenMinSuffix 2>
  <HyphenMinWord 5>
  <PgfLetterSpace No>
  <PgfMinWordSpace 75>
  <PgfOptWordSpace 100>
  <PgfMaxWordSpace 125>
  <PgfMinJRomanLetterSpace 0>
  <PgfOptJRomanLetterSpace 25>
  <PgfMaxJRomanLetterSpace 50>
  <PgfMinJLetterSpace 0>
  <PgfOptJLetterSpace 0>
  <PgfMaxJLetterSpace 10>
  <PgfYakumonoType Floating>
  <PgfAcrobatLevel 0>
  <PgfPDFStructureLevel 21>
  <PgfLanguage Swedish>
  <PgfCellAlignment Top>
  <PgfCellMargins  0.0 pt 0.0 pt 0.0 pt 0.0 pt>
  <PgfCellLMarginFixed No>
  <PgfCellTMarginFixed No>
  <PgfCellRMarginFixed No>
  <PgfCellBMarginFixed No>
  <PgfLocked No>
 > # end of Pgf
 <Pgf 
  <PgfTag `BrödPunkt'>
  <PgfUseNextTag No>
  <PgfNextTag `'>
  <PgfAlignment Left>
  <PgfFIndent  0.0 mm>
  <PgfLIndent  5.0 mm>
  <PgfRIndent  0.0 mm>
  <PgfFIndentRelative No>
  <PgfFIndentOffset  0.0 mm>
  <PgfTopSeparator `'>
  <PgfTopSepAtIndent No>
  <PgfTopSepOffset  0.0 mm>
  <PgfBotSeparator `'>
  <PgfBotSepAtIndent No>
  <PgfBotSepOffset  0.0 mm>
  <PgfPlacement Anywhere>
  <PgfPlacementStyle Normal>
  <PgfRunInDefaultPunct `'>
  <PgfSpBefore  5.35 pt>
  <PgfSpAfter  0.0 pt>
  <PgfWithPrev No>
  <PgfWithNext No>
  <PgfBlockSize 2>
  <PgfFont 
   <FTag `'>
   <FPlatformName `W.NewCenturySchlbk LT Std.R.400'>
   <FFamily `NewCenturySchlbk LT Std'>
   <FVar `Regular'>
   <FWeight `Regular'>
   <FAngle `Regular'>
   <FPostScriptName `NewCenturySchlbkLTStd-Roman'>
   <FEncoding `FrameRoman'>
   <FSize  9.0 pt>
   <FUnderlining FNoUnderlining>
   <FOverline No>
   <FStrike No>
   <FChangeBar No>
   <FOutline No>
   <FShadow No>
   <FPairKern Yes>
   <FTsume No>
   <FCase FAsTyped>
   <FPosition FNormal>
   <FDX  0.0%>
   <FDY  0.0%>
   <FDW  0.0%>
   <FStretch  100.0%>
   <FLanguage Swedish>
   <FLocked No>
   <FSeparation 0>
   <FColor `Black'>
   <FBackgroundColor NoColor>
  > # end of PgfFont
  <PgfLineSpacing Fixed>
  <PgfLeading  1.7 pt>
  <PgfAutoNum Yes>
  <PgfNumFormat `•\\t'>
  <PgfNumberFont `'>
  <PgfNumAtEnd No>
  <PgfNumTabs 1>
  <TabStop 
   <TSX  5.0 mm>
   <TSType Left>
   <TSLeaderStr ` '>
  > # end of TabStop
  <PgfHyphenate Yes>
  <HyphenMaxLines 2>
  <HyphenMinPrefix 2>
  <HyphenMinSuffix 2>
  <HyphenMinWord 5>
  <PgfLetterSpace No>
  <PgfMinWordSpace 75>
  <PgfOptWordSpace 100>
  <PgfMaxWordSpace 125>
  <PgfMinJRomanLetterSpace 0>
  <PgfOptJRomanLetterSpace 25>
  <PgfMaxJRomanLetterSpace 50>
  <PgfMinJLetterSpace 0>
  <PgfOptJLetterSpace 0>
  <PgfMaxJLetterSpace 10>
  <PgfYakumonoType Floating>
  <PgfAcrobatLevel 0>
  <PgfPDFStructureLevel 26>
  <PgfLanguage Swedish>
  <PgfCellAlignment Top>
  <PgfCellMargins  0.0 pt 0.0 pt 0.0 pt 0.0 pt>
  <PgfCellLMarginFixed No>
  <PgfCellTMarginFixed No>
  <PgfCellRMarginFixed No>
  <PgfCellBMarginFixed No>
  <PgfLocked No>
 > # end of Pgf
 <Pgf 
  <PgfTag `BrödPunktEfterRubrik'>
  <PgfUseNextTag No>
  <PgfNextTag `'>
  <PgfAlignment Left>
  <PgfFIndent  0.0 mm>
  <PgfLIndent  5.0 mm>
  <PgfRIndent  0.0 mm>
  <PgfFIndentRelative No>
  <PgfFIndentOffset  0.0 mm>
  <PgfTopSeparator `'>
  <PgfTopSepAtIndent No>
  <PgfTopSepOffset  0.0 mm>
  <PgfBotSeparator `'>
  <PgfBotSepAtIndent No>
  <PgfBotSepOffset  0.0 mm>
  <PgfPlacement Anywhere>
  <PgfPlacementStyle Normal>
  <PgfRunInDefaultPunct `'>
  <PgfSpBefore  5.35 pt>
  <PgfSpAfter  0.0 pt>
  <PgfWithPrev No>
  <PgfWithNext No>
  <PgfBlockSize 2>
  <PgfFont 
   <FTag `'>
   <FPlatformName `W.NewCenturySchlbk LT Std.R.400'>
   <FFamily `NewCenturySchlbk LT Std'>
   <FVar `Regular'>
   <FWeight `Regular'>
   <FAngle `Regular'>
   <FPostScriptName `NewCenturySchlbkLTStd-Roman'>
   <FEncoding `FrameRoman'>
   <FSize  9.0 pt>
   <FUnderlining FNoUnderlining>
   <FOverline No>
   <FStrike No>
   <FChangeBar No>
   <FOutline No>
   <FShadow No>
   <FPairKern Yes>
   <FTsume No>
   <FCase FAsTyped>
   <FPosition FNormal>
   <FDX  0.0%>
   <FDY  0.0%>
   <FDW  0.0%>
   <FStretch  100.0%>
   <FLanguage Swedish>
   <FLocked No>
   <FSeparation 0>
   <FColor `Black'>
   <FBackgroundColor NoColor>
  > # end of PgfFont
  <PgfLineSpacing Fixed>
  <PgfLeading  1.7 pt>
  <PgfAutoNum Yes>
  <PgfNumFormat `•\\t'>
  <PgfNumberFont `'>
  <PgfNumAtEnd No>
  <PgfNumTabs 1>
  <TabStop 
   <TSX  5.0 mm>
   <TSType Left>
   <TSLeaderStr ` '>
  > # end of TabStop
  <PgfHyphenate Yes>
  <HyphenMaxLines 2>
  <HyphenMinPrefix 2>
  <HyphenMinSuffix 2>
  <HyphenMinWord 5>
  <PgfLetterSpace No>
  <PgfMinWordSpace 75>
  <PgfOptWordSpace 100>
  <PgfMaxWordSpace 125>
  <PgfMinJRomanLetterSpace 0>
  <PgfOptJRomanLetterSpace 25>
  <PgfMaxJRomanLetterSpace 50>
  <PgfMinJLetterSpace 0>
  <PgfOptJLetterSpace 0>
  <PgfMaxJLetterSpace 10>
  <PgfYakumonoType Floating>
  <PgfAcrobatLevel 0>
  <PgfPDFStructureLevel 0>
  <PgfLanguage Swedish>
  <PgfCellAlignment Top>
  <PgfCellMargins  0.0 pt 0.0 pt 0.0 pt 0.0 pt>
  <PgfCellLMarginFixed No>
  <PgfCellTMarginFixed No>
  <PgfCellRMarginFixed No>
  <PgfCellBMarginFixed No>
  <PgfLocked No>
 > # end of Pgf
 <Pgf 
  <PgfTag `BrödPunktSista'>
  <PgfUseNextTag No>
  <PgfNextTag `'>
  <PgfAlignment Left>
  <PgfFIndent  0.0 mm>
  <PgfLIndent  5.0 mm>
  <PgfRIndent  0.0 mm>
  <PgfFIndentRelative No>
  <PgfFIndentOffset  0.0 mm>
  <PgfTopSeparator `'>
  <PgfTopSepAtIndent No>
  <PgfTopSepOffset  0.0 mm>
  <PgfBotSeparator `'>
  <PgfBotSepAtIndent No>
  <PgfBotSepOffset  0.0 mm>
  <PgfPlacement Anywhere>
  <PgfPlacementStyle Normal>
  <PgfRunInDefaultPunct `'>
  <PgfSpBefore  5.35 pt>
  <PgfSpAfter  5.35 pt>
  <PgfWithPrev No>
  <PgfWithNext No>
  <PgfBlockSize 2>
  <PgfFont 
   <FTag `'>
   <FPlatformName `W.NewCenturySchlbk LT Std.R.400'>
   <FFamily `NewCenturySchlbk LT Std'>
   <FVar `Regular'>
   <FWeight `Regular'>
   <FAngle `Regular'>
   <FPostScriptName `NewCenturySchlbkLTStd-Roman'>
   <FEncoding `FrameRoman'>
   <FSize  9.0 pt>
   <FUnderlining FNoUnderlining>
   <FOverline No>
   <FStrike No>
   <FChangeBar No>
   <FOutline No>
   <FShadow No>
   <FPairKern Yes>
   <FTsume No>
   <FCase FAsTyped>
   <FPosition FNormal>
   <FDX  0.0%>
   <FDY  0.0%>
   <FDW  0.0%>
   <FStretch  100.0%>
   <FLanguage Swedish>
   <FLocked No>
   <FSeparation 0>
   <FColor `Black'>
   <FBackgroundColor NoColor>
  > # end of PgfFont
  <PgfLineSpacing Fixed>
  <PgfLeading  1.7 pt>
  <PgfAutoNum Yes>
  <PgfNumFormat `•\\t'>
  <PgfNumberFont `'>
  <PgfNumAtEnd No>
  <PgfNumTabs 1>
  <TabStop 
   <TSX  5.0 mm>
   <TSType Left>
   <TSLeaderStr ` '>
  > # end of TabStop
  <PgfHyphenate Yes>
  <HyphenMaxLines 2>
  <HyphenMinPrefix 2>
  <HyphenMinSuffix 2>
  <HyphenMinWord 5>
  <PgfLetterSpace No>
  <PgfMinWordSpace 75>
  <PgfOptWordSpace 100>
  <PgfMaxWordSpace 125>
  <PgfMinJRomanLetterSpace 0>
  <PgfOptJRomanLetterSpace 25>
  <PgfMaxJRomanLetterSpace 50>
  <PgfMinJLetterSpace 0>
  <PgfOptJLetterSpace 0>
  <PgfMaxJLetterSpace 10>
  <PgfYakumonoType Floating>
  <PgfAcrobatLevel 0>
  <PgfPDFStructureLevel 26>
  <PgfLanguage Swedish>
  <PgfCellAlignment Top>
  <PgfCellMargins  0.0 pt 0.0 pt 0.0 pt 0.0 pt>
  <PgfCellLMarginFixed No>
  <PgfCellTMarginFixed No>
  <PgfCellRMarginFixed No>
  <PgfCellBMarginFixed No>
  <PgfLocked No>
 > # end of Pgf
 <Pgf 
  <PgfTag `FaktaRub1'>
  <PgfUseNextTag Yes>
  <PgfNextTag `FaktaText'>
  <PgfAlignment Left>
  <PgfFIndent  3.0 mm>
  <PgfLIndent  3.0 mm>
  <PgfRIndent  3.0 mm>
  <PgfFIndentRelative No>
  <PgfFIndentOffset  0.0 mm>
  <PgfTopSeparator `'>
  <PgfTopSepAtIndent No>
  <PgfTopSepOffset  0.0 mm>
  <PgfBotSeparator `'>
  <PgfBotSepAtIndent No>
  <PgfBotSepOffset  0.0 mm>
  <PgfPlacement Anywhere>
  <PgfPlacementStyle Normal>
  <PgfRunInDefaultPunct `'>
  <PgfSpBefore  5.0 pt>
  <PgfSpAfter  1.0 pt>
  <PgfWithPrev No>
  <PgfWithNext No>
  <PgfBlockSize 2>
  <PgfFont 
   <FTag `'>
   <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
   <FFamily `Frutiger LT Std 45 Light'>
   <FVar `Regular'>
   <FWeight `Bold'>
   <FAngle `Regular'>
   <FPostScriptName `FrutigerLTStd-Bold'>
   <FEncoding `FrameRoman'>
   <FSize  8.0 pt>
   <FUnderlining FNoUnderlining>
   <FOverline No>
   <FStrike No>
   <FChangeBar No>
   <FOutline No>
   <FShadow No>
   <FPairKern Yes>
   <FTsume No>
   <FCase FAsTyped>
   <FPosition FNormal>
   <FDX  0.0%>
   <FDY  0.0%>
   <FDW  0.0%>
   <FStretch  100.0%>
   <FLanguage Swedish>
   <FLocked No>
   <FSeparation 0>
   <FColor `Black'>
   <FBackgroundColor NoColor>
  > # end of PgfFont
  <PgfLineSpacing Fixed>
  <PgfLeading  2.0 pt>
  <PgfAutoNum No>
  <PgfNumTabs 0>
  <PgfHyphenate Yes>
  <HyphenMaxLines 2>
  <HyphenMinPrefix 2>
  <HyphenMinSuffix 2>
  <HyphenMinWord 5>
  <PgfLetterSpace No>
  <PgfMinWordSpace 75>
  <PgfOptWordSpace 100>
  <PgfMaxWordSpace 125>
  <PgfMinJRomanLetterSpace 0>
  <PgfOptJRomanLetterSpace 25>
  <PgfMaxJRomanLetterSpace 50>
  <PgfMinJLetterSpace 0>
  <PgfOptJLetterSpace 0>
  <PgfMaxJLetterSpace 10>
  <PgfYakumonoType Floating>
  <PgfAcrobatLevel 0>
  <PgfPDFStructureLevel 0>
  <PgfLanguage Swedish>
  <PgfCellAlignment Top>
  <PgfCellMargins  0.0 pt 0.0 pt 0.0 pt 0.0 pt>
  <PgfCellLMarginFixed No>
  <PgfCellTMarginFixed No>
  <PgfCellRMarginFixed No>
  <PgfCellBMarginFixed No>
  <PgfLocked No>
 > # end of Pgf
 <Pgf 
  <PgfTag `FaktaRub2'>
  <PgfUseNextTag No>
  <PgfNextTag `'>
  <PgfAlignment Left>
  <PgfFIndent  3.0 mm>
  <PgfLIndent  3.0 mm>
  <PgfRIndent  3.0 mm>
  <PgfFIndentRelative No>
  <PgfFIndentOffset  0.0 mm>
  <PgfTopSeparator `'>
  <PgfTopSepAtIndent No>
  <PgfTopSepOffset  0.0 mm>
  <PgfBotSeparator `'>
  <PgfBotSepAtIndent No>
  <PgfBotSepOffset  0.0 mm>
  <PgfPlacement Anywhere>
  <PgfPlacementStyle Normal>
  <PgfRunInDefaultPunct `'>
  <PgfSpBefore  3.0 pt>
  <PgfSpAfter  0.0 pt>
  <PgfWithPrev No>
  <PgfWithNext No>
  <PgfBlockSize 2>
  <PgfFont 
   <FTag `'>
   <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
   <FFamily `Frutiger LT Std 45 Light'>
   <FVar `Regular'>
   <FWeight `Bold'>
   <FAngle `Regular'>
   <FPostScriptName `FrutigerLTStd-Bold'>
   <FEncoding `FrameRoman'>
   <FSize  7.0 pt>
   <FUnderlining FNoUnderlining>
   <FOverline No>
   <FStrike No>
   <FChangeBar No>
   <FOutline No>
   <FShadow No>
   <FPairKern Yes>
   <FTsume No>
   <FCase FAsTyped>
   <FPosition FNormal>
   <FDX  0.0%>
   <FDY  0.0%>
   <FDW  0.0%>
   <FStretch  100.0%>
   <FLanguage Swedish>
   <FLocked No>
   <FSeparation 0>
   <FColor `Black'>
   <FBackgroundColor NoColor>
  > # end of PgfFont
  <PgfLineSpacing Fixed>
  <PgfLeading  3.0 pt>
  <PgfAutoNum No>
  <PgfNumTabs 0>
  <PgfHyphenate Yes>
  <HyphenMaxLines 2>
  <HyphenMinPrefix 2>
  <HyphenMinSuffix 2>
  <HyphenMinWord 5>
  <PgfLetterSpace No>
  <PgfMinWordSpace 75>
  <PgfOptWordSpace 100>
  <PgfMaxWordSpace 125>
  <PgfMinJRomanLetterSpace 0>
  <PgfOptJRomanLetterSpace 25>
  <PgfMaxJRomanLetterSpace 50>
  <PgfMinJLetterSpace 0>
  <PgfOptJLetterSpace 0>
  <PgfMaxJLetterSpace 10>
  <PgfYakumonoType Floating>
  <PgfAcrobatLevel 0>
  <PgfPDFStructureLevel 26>
  <PgfLanguage Swedish>
  <PgfCellAlignment Top>
  <PgfCellMargins  0.0 pt 0.0 pt 0.0 pt 0.0 pt>
  <PgfCellLMarginFixed No>
  <PgfCellTMarginFixed No>
  <PgfCellRMarginFixed No>
  <PgfCellBMarginFixed No>
  <PgfLocked No>
 > # end of Pgf
 <Pgf 
  <PgfTag `FaktaText'>
  <PgfUseNextTag Yes>
  <PgfNextTag `RefTextNrForts'>
  <PgfAlignment Left>
  <PgfFIndent  3.0 mm>
  <PgfLIndent  3.0 mm>
  <PgfRIndent  3.0 mm>
  <PgfFIndentRelative No>
  <PgfFIndentOffset  0.0 mm>
  <PgfTopSeparator `'>
  <PgfTopSepAtIndent No>
  <PgfTopSepOffset  0.0 mm>
  <PgfBotSeparator `'>
  <PgfBotSepAtIndent No>
  <PgfBotSepOffset  0.0 mm>
  <PgfPlacement Anywhere>
  <PgfPlacementStyle Normal>
  <PgfRunInDefaultPunct `'>
  <PgfSpBefore  0.0 pt>
  <PgfSpAfter  0.0 pt>
  <PgfWithPrev No>
  <PgfWithNext No>
  <PgfBlockSize 2>
  <PgfFont 
   <FTag `'>
   <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
   <FFamily `Frutiger LT Std 55 Roman'>
   <FVar `Regular'>
   <FWeight `Regular'>
   <FAngle `Regular'>
   <FPostScriptName `FrutigerLTStd-Roman'>
   <FEncoding `FrameRoman'>
   <FSize  7.0 pt>
   <FUnderlining FNoUnderlining>
   <FOverline No>
   <FStrike No>
   <FChangeBar No>
   <FOutline No>
   <FShadow No>
   <FPairKern Yes>
   <FTsume No>
   <FCase FAsTyped>
   <FPosition FNormal>
   <FDX  0.0%>
   <FDY  0.0%>
   <FDW  0.0%>
   <FStretch  100.0%>
   <FLanguage Swedish>
   <FLocked No>
   <FSeparation 0>
   <FColor `Black'>
   <FBackgroundColor NoColor>
  > # end of PgfFont
  <PgfLineSpacing Fixed>
  <PgfLeading  3.0 pt>
  <PgfAutoNum No>
  <PgfNumTabs 0>
  <PgfHyphenate Yes>
  <HyphenMaxLines 2>
  <HyphenMinPrefix 2>
  <HyphenMinSuffix 2>
  <HyphenMinWord 5>
  <PgfLetterSpace No>
  <PgfMinWordSpace 75>
  <PgfOptWordSpace 100>
  <PgfMaxWordSpace 125>
  <PgfMinJRomanLetterSpace 0>
  <PgfOptJRomanLetterSpace 25>
  <PgfMaxJRomanLetterSpace 50>
  <PgfMinJLetterSpace 0>
  <PgfOptJLetterSpace 0>
  <PgfMaxJLetterSpace 10>
  <PgfYakumonoType Floating>
  <PgfAcrobatLevel 0>
  <PgfPDFStructureLevel 26>
  <PgfLanguage Swedish>
  <PgfCellAlignment Top>
  <PgfCellMargins  0.0 pt 0.0 pt 0.0 pt 0.0 pt>
  <PgfCellLMarginFixed No>
  <PgfCellTMarginFixed No>
  <PgfCellRMarginFixed No>
  <PgfCellBMarginFixed No>
  <PgfLocked No>
 > # end of Pgf
 <Pgf 
  <PgfTag `FaktaTextIn'>
  <PgfUseNextTag No>
  <PgfNextTag `'>
  <PgfAlignment Left>
  <PgfFIndent  5.0 mm>
  <PgfLIndent  3.0 mm>
  <PgfRIndent  3.0 mm>
  <PgfFIndentRelative No>
  <PgfFIndentOffset  0.0 mm>
  <PgfTopSeparator `'>
  <PgfTopSepAtIndent No>
  <PgfTopSepOffset  0.0 mm>
  <PgfBotSeparator `'>
  <PgfBotSepAtIndent No>
  <PgfBotSepOffset  0.0 mm>
  <PgfPlacement Anywhere>
  <PgfPlacementStyle Normal>
  <PgfRunInDefaultPunct `'>
  <PgfSpBefore  0.0 pt>
  <PgfSpAfter  0.0 pt>
  <PgfWithPrev No>
  <PgfWithNext No>
  <PgfBlockSize 2>
  <PgfFont 
   <FTag `'>
   <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
   <FFamily `Frutiger LT Std 55 Roman'>
   <FVar `Regular'>
   <FWeight `Regular'>
   <FAngle `Regular'>
   <FPostScriptName `FrutigerLTStd-Roman'>
   <FEncoding `FrameRoman'>
   <FSize  7.0 pt>
   <FUnderlining FNoUnderlining>
   <FOverline No>
   <FStrike No>
   <FChangeBar No>
   <FOutline No>
   <FShadow No>
   <FPairKern Yes>
   <FTsume No>
   <FCase FAsTyped>
   <FPosition FNormal>
   <FDX  0.0%>
   <FDY  0.0%>
   <FDW  0.0%>
   <FStretch  100.0%>
   <FLanguage Swedish>
   <FLocked No>
   <FSeparation 0>
   <FColor `Black'>
   <FBackgroundColor NoColor>
  > # end of PgfFont
  <PgfLineSpacing Fixed>
  <PgfLeading  3.0 pt>
  <PgfAutoNum No>
  <PgfNumTabs 0>
  <PgfHyphenate Yes>
  <HyphenMaxLines 2>
  <HyphenMinPrefix 2>
  <HyphenMinSuffix 2>
  <HyphenMinWord 5>
  <PgfLetterSpace No>
  <PgfMinWordSpace 75>
  <PgfOptWordSpace 100>
  <PgfMaxWordSpace 125>
  <PgfMinJRomanLetterSpace 0>
  <PgfOptJRomanLetterSpace 25>
  <PgfMaxJRomanLetterSpace 50>
  <PgfMinJLetterSpace 0>
  <PgfOptJLetterSpace 0>
  <PgfMaxJLetterSpace 10>
  <PgfYakumonoType Floating>
  <PgfAcrobatLevel 0>
  <PgfPDFStructureLevel 26>
  <PgfLanguage Swedish>
  <PgfCellAlignment Top>
  <PgfCellMargins  0.0 pt 0.0 pt 0.0 pt 0.0 pt>
  <PgfCellLMarginFixed No>
  <PgfCellTMarginFixed No>
  <PgfCellRMarginFixed No>
  <PgfCellBMarginFixed No>
  <PgfLocked No>
 > # end of Pgf
 <Pgf 
  <PgfTag `FaktaTextNr1'>
  <PgfUseNextTag No>
  <PgfNextTag `'>
  <PgfAlignment Left>
  <PgfFIndent  3.0 mm>
  <PgfLIndent  6.5 mm>
  <PgfRIndent  3.0 mm>
  <PgfFIndentRelative No>
  <PgfFIndentOffset  0.0 mm>
  <PgfTopSeparator `'>
  <PgfTopSepAtIndent No>
  <PgfTopSepOffset  0.0 mm>
  <PgfBotSeparator `'>
  <PgfBotSepAtIndent No>
  <PgfBotSepOffset  0.0 mm>
  <PgfPlacement Anywhere>
  <PgfPlacementStyle Normal>
  <PgfRunInDefaultPunct `'>
  <PgfSpBefore  0.0 pt>
  <PgfSpAfter  0.0 pt>
  <PgfWithPrev No>
  <PgfWithNext No>
  <PgfBlockSize 2>
  <PgfFont 
   <FTag `'>
   <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
   <FFamily `Frutiger LT Std 55 Roman'>
   <FVar `Regular'>
   <FWeight `Regular'>
   <FAngle `Regular'>
   <FPostScriptName `FrutigerLTStd-Roman'>
   <FEncoding `FrameRoman'>
   <FSize  7.0 pt>
   <FUnderlining FNoUnderlining>
   <FOverline No>
   <FStrike No>
   <FChangeBar No>
   <FOutline No>
   <FShadow No>
   <FPairKern Yes>
   <FTsume No>
   <FCase FAsTyped>
   <FPosition FNormal>
   <FDX  0.0%>
   <FDY  0.0%>
   <FDW  0.0%>
   <FStretch  100.0%>
   <FLanguage Swedish>
   <FLocked No>
   <FSeparation 0>
   <FColor `Black'>
   <FBackgroundColor NoColor>
  > # end of PgfFont
  <PgfLineSpacing Fixed>
  <PgfLeading  3.0 pt>
  <PgfAutoNum Yes>
  <PgfNumFormat `H:<n=1\>.\\t'>
  <PgfNumberFont `'>
  <PgfNumAtEnd No>
  <PgfNumTabs 1>
  <TabStop 
   <TSX  6.5 mm>
   <TSType Left>
   <TSLeaderStr ` '>
  > # end of TabStop
  <PgfHyphenate Yes>
  <HyphenMaxLines 2>
  <HyphenMinPrefix 2>
  <HyphenMinSuffix 2>
  <HyphenMinWord 5>
  <PgfLetterSpace No>
  <PgfMinWordSpace 75>
  <PgfOptWordSpace 100>
  <PgfMaxWordSpace 125>
  <PgfMinJRomanLetterSpace 0>
  <PgfOptJRomanLetterSpace 25>
  <PgfMaxJRomanLetterSpace 50>
  <PgfMinJLetterSpace 0>
  <PgfOptJLetterSpace 0>
  <PgfMaxJLetterSpace 10>
  <PgfYakumonoType Floating>
  <PgfAcrobatLevel 0>
  <PgfPDFStructureLevel 25>
  <PgfLanguage Swedish>
  <PgfCellAlignment Top>
  <PgfCellMargins  0.0 pt 0.0 pt 0.0 pt 0.0 pt>
  <PgfCellLMarginFixed No>
  <PgfCellTMarginFixed No>
  <PgfCellRMarginFixed No>
  <PgfCellBMarginFixed No>
  <PgfLocked No>
 > # end of Pgf
 <Pgf 
  <PgfTag `FaktaTextNrForts'>
  <PgfUseNextTag No>
  <PgfNextTag `'>
  <PgfAlignment Left>
  <PgfFIndent  3.0 mm>
  <PgfLIndent  6.5 mm>
  <PgfRIndent  3.0 mm>
  <PgfFIndentRelative No>
  <PgfFIndentOffset  0.0 mm>
  <PgfTopSeparator `'>
  <PgfTopSepAtIndent No>
  <PgfTopSepOffset  0.0 mm>
  <PgfBotSeparator `'>
  <PgfBotSepAtIndent No>
  <PgfBotSepOffset  0.0 mm>
  <PgfPlacement Anywhere>
  <PgfPlacementStyle Normal>
  <PgfRunInDefaultPunct `'>
  <PgfSpBefore  0.0 pt>
  <PgfSpAfter  0.0 pt>
  <PgfWithPrev No>
  <PgfWithNext No>
  <PgfBlockSize 2>
  <PgfFont 
   <FTag `'>
   <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
   <FFamily `Frutiger LT Std 55 Roman'>
   <FVar `Regular'>
   <FWeight `Regular'>
   <FAngle `Regular'>
   <FPostScriptName `FrutigerLTStd-Roman'>
   <FEncoding `FrameRoman'>
   <FSize  7.0 pt>
   <FUnderlining FNoUnderlining>
   <FOverline No>
   <FStrike No>
   <FChangeBar No>
   <FOutline No>
   <FShadow No>
   <FPairKern Yes>
   <FTsume No>
   <FCase FAsTyped>
   <FPosition FNormal>
   <FDX  0.0%>
   <FDY  0.0%>
   <FDW  0.0%>
   <FStretch  100.0%>
   <FLanguage Swedish>
   <FLocked No>
   <FSeparation 0>
   <FColor `Black'>
   <FBackgroundColor NoColor>
  > # end of PgfFont
  <PgfLineSpacing Fixed>
  <PgfLeading  3.0 pt>
  <PgfAutoNum Yes>
  <PgfNumFormat `H:<n+\>.\\t'>
  <PgfNumberFont `'>
  <PgfNumAtEnd No>
  <PgfNumTabs 1>
  <TabStop 
   <TSX  6.5 mm>
   <TSType Left>
   <TSLeaderStr ` '>
  > # end of TabStop
  <PgfHyphenate Yes>
  <HyphenMaxLines 2>
  <HyphenMinPrefix 2>
  <HyphenMinSuffix 2>
  <HyphenMinWord 5>
  <PgfLetterSpace No>
  <PgfMinWordSpace 75>
  <PgfOptWordSpace 100>
  <PgfMaxWordSpace 125>
  <PgfMinJRomanLetterSpace 0>
  <PgfOptJRomanLetterSpace 25>
  <PgfMaxJRomanLetterSpace 50>
  <PgfMinJLetterSpace 0>
  <PgfOptJLetterSpace 0>
  <PgfMaxJLetterSpace 10>
  <PgfYakumonoType Floating>
  <PgfAcrobatLevel 0>
  <PgfPDFStructureLevel 25>
  <PgfLanguage Swedish>
  <PgfCellAlignment Top>
  <PgfCellMargins  0.0 pt 0.0 pt 0.0 pt 0.0 pt>
  <PgfCellLMarginFixed No>
  <PgfCellTMarginFixed No>
  <PgfCellRMarginFixed No>
  <PgfCellBMarginFixed No>
  <PgfLocked No>
 > # end of Pgf
 <Pgf 
  <PgfTag `FaktaTextPunkt'>
  <PgfUseNextTag No>
  <PgfNextTag `'>
  <PgfAlignment Left>
  <PgfFIndent  3.0 mm>
  <PgfLIndent  5.5 mm>
  <PgfRIndent  3.0 mm>
  <PgfFIndentRelative No>
  <PgfFIndentOffset  0.0 mm>
  <PgfTopSeparator `'>
  <PgfTopSepAtIndent No>
  <PgfTopSepOffset  0.0 mm>
  <PgfBotSeparator `'>
  <PgfBotSepAtIndent No>
  <PgfBotSepOffset  0.0 mm>
  <PgfPlacement Anywhere>
  <PgfPlacementStyle Normal>
  <PgfRunInDefaultPunct `'>
  <PgfSpBefore  0.0 pt>
  <PgfSpAfter  0.0 pt>
  <PgfWithPrev No>
  <PgfWithNext No>
  <PgfBlockSize 2>
  <PgfFont 
   <FTag `'>
   <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
   <FFamily `Frutiger LT Std 55 Roman'>
   <FVar `Regular'>
   <FWeight `Regular'>
   <FAngle `Regular'>
   <FPostScriptName `FrutigerLTStd-Roman'>
   <FEncoding `FrameRoman'>
   <FSize  7.0 pt>
   <FUnderlining FNoUnderlining>
   <FOverline No>
   <FStrike No>
   <FChangeBar No>
   <FOutline No>
   <FShadow No>
   <FPairKern Yes>
   <FTsume No>
   <FCase FAsTyped>
   <FPosition FNormal>
   <FDX  0.0%>
   <FDY  0.0%>
   <FDW  0.0%>
   <FStretch  100.0%>
   <FLanguage Swedish>
   <FLocked No>
   <FSeparation 0>
   <FColor `Black'>
   <FBackgroundColor NoColor>
  > # end of PgfFont
  <PgfLineSpacing Fixed>
  <PgfLeading  3.0 pt>
  <PgfAutoNum Yes>
  <PgfNumFormat `•\\t'>
  <PgfNumberFont `'>
  <PgfNumAtEnd No>
  <PgfNumTabs 1>
  <TabStop 
   <TSX  5.5 mm>
   <TSType Left>
   <TSLeaderStr ` '>
  > # end of TabStop
  <PgfHyphenate Yes>
  <HyphenMaxLines 2>
  <HyphenMinPrefix 2>
  <HyphenMinSuffix 2>
  <HyphenMinWord 5>
  <PgfLetterSpace No>
  <PgfMinWordSpace 75>
  <PgfOptWordSpace 100>
  <PgfMaxWordSpace 125>
  <PgfMinJRomanLetterSpace 0>
  <PgfOptJRomanLetterSpace 25>
  <PgfMaxJRomanLetterSpace 50>
  <PgfMinJLetterSpace 0>
  <PgfOptJLetterSpace 0>
  <PgfMaxJLetterSpace 10>
  <PgfYakumonoType Floating>
  <PgfAcrobatLevel 0>
  <PgfPDFStructureLevel 26>
  <PgfLanguage Swedish>
  <PgfCellAlignment Top>
  <PgfCellMargins  0.0 pt 0.0 pt 0.0 pt 0.0 pt>
  <PgfCellLMarginFixed No>
  <PgfCellTMarginFixed No>
  <PgfCellRMarginFixed No>
  <PgfCellBMarginFixed No>
  <PgfLocked No>
 > # end of Pgf
 <Pgf 
  <PgfTag `FigurIns'>
  <PgfUseNextTag No>
  <PgfNextTag `'>
  <PgfAlignment LeftRight>
  <PgfFIndent  3.0 mm>
  <PgfLIndent  0.0 mm>
  <PgfRIndent  0.0 mm>
  <PgfFIndentRelative No>
  <PgfFIndentOffset  0.0 mm>
  <PgfTopSeparator `'>
  <PgfTopSepAtIndent No>
  <PgfTopSepOffset  0.0 mm>
  <PgfBotSeparator `Tjock_Tunn'>
  <PgfBotSepAtIndent No>
  <PgfBotSepOffset  0.0 mm>
  <PgfPlacement Anywhere>
  <PgfPlacementStyle Normal>
  <PgfRunInDefaultPunct `'>
  <PgfSpBefore  0.0 pt>
  <PgfSpAfter  0.0 pt>
  <PgfWithPrev No>
  <PgfWithNext Yes>
  <PgfBlockSize 2>
  <PgfFont 
   <FTag `'>
   <FPlatformName `W.NewCenturySchlbk LT Std.R.400'>
   <FFamily `NewCenturySchlbk LT Std'>
   <FVar `Regular'>
   <FWeight `Regular'>
   <FAngle `Regular'>
   <FPostScriptName `NewCenturySchlbkLTStd-Roman'>
   <FEncoding `FrameRoman'>
   <FSize  9.0 pt>
   <FUnderlining FNoUnderlining>
   <FOverline No>
   <FStrike No>
   <FChangeBar No>
   <FOutline No>
   <FShadow No>
   <FPairKern Yes>
   <FTsume No>
   <FCase FAsTyped>
   <FPosition FNormal>
   <FDX  0.0%>
   <FDY  0.0%>
   <FDW  0.0%>
   <FStretch  100.0%>
   <FLanguage Swedish>
   <FLocked No>
   <FSeparation 0>
   <FColor `Black'>
   <FBackgroundColor NoColor>
  > # end of PgfFont
  <PgfLineSpacing Fixed>
  <PgfLeading  1.7 pt>
  <PgfAutoNum No>
  <PgfNumTabs 0>
  <PgfHyphenate Yes>
  <HyphenMaxLines 2>
  <HyphenMinPrefix 2>
  <HyphenMinSuffix 2>
  <HyphenMinWord 5>
  <PgfLetterSpace No>
  <PgfMinWordSpace 75>
  <PgfOptWordSpace 100>
  <PgfMaxWordSpace 125>
  <PgfMinJRomanLetterSpace 0>
  <PgfOptJRomanLetterSpace 25>
  <PgfMaxJRomanLetterSpace 50>
  <PgfMinJLetterSpace 0>
  <PgfOptJLetterSpace 0>
  <PgfMaxJLetterSpace 10>
  <PgfYakumonoType Floating>
  <PgfAcrobatLevel 0>
  <PgfPDFStructureLevel 16>
  <PgfLanguage Swedish>
  <PgfCellAlignment Top>
  <PgfCellMargins  0.0 pt 0.0 pt 0.0 pt 0.0 pt>
  <PgfCellLMarginFixed No>
  <PgfCellTMarginFixed No>
  <PgfCellRMarginFixed No>
  <PgfCellBMarginFixed No>
  <PgfLocked No>
 > # end of Pgf
 <Pgf 
  <PgfTag `FigurNr'>
  <PgfUseNextTag No>
  <PgfNextTag `'>
  <PgfAlignment LeftRight>
  <PgfFIndent  2.82223 mm>
  <PgfLIndent  2.82223 mm>
  <PgfRIndent  2.82223 mm>
  <PgfFIndentRelative No>
  <PgfFIndentOffset  0.0 mm>
  <PgfTopSeparator `Tunn_Tjock'>
  <PgfTopSepAtIndent No>
  <PgfTopSepOffset  0.0 mm>
  <PgfBotSeparator `'>
  <PgfBotSepAtIndent No>
  <PgfBotSepOffset  0.0 mm>
  <PgfPlacement Anywhere>
  <PgfPlacementStyle StraddleNormalOnly>
  <PgfRunInDefaultPunct `'>
  <PgfSpBefore  0.0 pt>
  <PgfSpAfter  0.0 pt>
  <PgfWithPrev No>
  <PgfWithNext No>
  <PgfBlockSize 2>
  <PgfFont 
   <FTag `'>
   <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
   <FFamily `Frutiger LT Std 55 Roman'>
   <FVar `Regular'>
   <FWeight `Regular'>
   <FAngle `Regular'>
   <FPostScriptName `FrutigerLTStd-Roman'>
   <FEncoding `FrameRoman'>
   <FSize  8.0 pt>
   <FUnderlining FNoUnderlining>
   <FOverline No>
   <FStrike No>
   <FChangeBar No>
   <FOutline No>
   <FShadow No>
   <FPairKern Yes>
   <FTsume No>
   <FCase FAsTyped>
   <FPosition FNormal>
   <FDX  0.0%>
   <FDY  0.0%>
   <FDW  0.0%>
   <FStretch  100.0%>
   <FLanguage Swedish>
   <FLocked No>
   <FSeparation 0>
   <FColor `Black'>
   <FBackgroundColor NoColor>
  > # end of PgfFont
  <PgfLineSpacing Fixed>
  <PgfLeading  2.0 pt>
  <PgfAutoNum Yes>
  <PgfNumFormat `F:Figur <n+\>. '>
  <PgfNumberFont `FigTabFet'>
  <PgfNumAtEnd No>
  <PgfNumTabs 0>
  <PgfHyphenate Yes>
  <HyphenMaxLines 2>
  <HyphenMinPrefix 2>
  <HyphenMinSuffix 2>
  <HyphenMinWord 5>
  <PgfLetterSpace No>
  <PgfMinWordSpace 75>
  <PgfOptWordSpace 100>
  <PgfMaxWordSpace 125>
  <PgfMinJRomanLetterSpace 0>
  <PgfOptJRomanLetterSpace 25>
  <PgfMaxJRomanLetterSpace 50>
  <PgfMinJLetterSpace 0>
  <PgfOptJLetterSpace 0>
  <PgfMaxJLetterSpace 10>
  <PgfYakumonoType Floating>
  <PgfAcrobatLevel 0>
  <PgfPDFStructureLevel 0>
  <PgfLanguage Swedish>
  <PgfCellAlignment Top>
  <PgfCellMargins  0.0 pt 0.0 pt 0.0 pt 0.0 pt>
  <PgfCellLMarginFixed No>
  <PgfCellTMarginFixed No>
  <PgfCellRMarginFixed No>
  <PgfCellBMarginFixed No>
  <PgfLocked No>
 > # end of Pgf
 <Pgf 
  <PgfTag `Footnote'>
  <PgfUseNextTag No>
  <PgfNextTag `'>
  <PgfAlignment Left>
  <PgfFIndent  2.82223 mm>
  <PgfLIndent  2.82223 mm>
  <PgfRIndent  2.82223 mm>
  <PgfFIndentRelative No>
  <PgfFIndentOffset  0.0 mm>
  <PgfTopSeparator `'>
  <PgfTopSepAtIndent No>
  <PgfTopSepOffset  0.0 mm>
  <PgfBotSeparator `'>
  <PgfBotSepAtIndent No>
  <PgfBotSepOffset  0.0 mm>
  <PgfPlacement Anywhere>
  <PgfPlacementStyle Normal>
  <PgfRunInDefaultPunct `. '>
  <PgfSpBefore  0.0 pt>
  <PgfSpAfter  0.0 pt>
  <PgfWithPrev No>
  <PgfWithNext No>
  <PgfBlockSize 1>
  <PgfFont 
   <FTag `'>
   <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
   <FFamily `Frutiger LT Std 55 Roman'>
   <FVar `Regular'>
   <FWeight `Regular'>
   <FAngle `Regular'>
   <FPostScriptName `FrutigerLTStd-Roman'>
   <FEncoding `FrameRoman'>
   <FSize  6.0 pt>
   <FUnderlining FNoUnderlining>
   <FOverline No>
   <FStrike No>
   <FChangeBar No>
   <FOutline No>
   <FShadow No>
   <FPairKern Yes>
   <FTsume No>
   <FCase FAsTyped>
   <FPosition FNormal>
   <FDX  0.0%>
   <FDY  0.0%>
   <FDW  0.0%>
   <FStretch  100.0%>
   <FLanguage Swedish>
   <FLocked No>
   <FSeparation 0>
   <FColor `Black'>
   <FBackgroundColor NoColor>
  > # end of PgfFont
  <PgfLineSpacing Fixed>
  <PgfLeading  2.0 pt>
  <PgfAutoNum No>
  <PgfNumTabs 0>
  <PgfHyphenate Yes>
  <HyphenMaxLines 2>
  <HyphenMinPrefix 2>
  <HyphenMinSuffix 2>
  <HyphenMinWord 5>
  <PgfLetterSpace No>
  <PgfMinWordSpace 75>
  <PgfOptWordSpace 100>
  <PgfMaxWordSpace 125>
  <PgfMinJRomanLetterSpace 0>
  <PgfOptJRomanLetterSpace 25>
  <PgfMaxJRomanLetterSpace 50>
  <PgfMinJLetterSpace 0>
  <PgfOptJLetterSpace 0>
  <PgfMaxJLetterSpace 10>
  <PgfYakumonoType Floating>
  <PgfAcrobatLevel 0>
  <PgfPDFStructureLevel 6>
  <PgfLanguage Swedish>
  <PgfCellAlignment Top>
  <PgfCellMargins  0.0 pt 0.0 pt 0.0 pt 0.0 pt>
  <PgfCellLMarginFixed No>
  <PgfCellTMarginFixed No>
  <PgfCellRMarginFixed No>
  <PgfCellBMarginFixed No>
  <PgfLocked No>
 > # end of Pgf
 <Pgf 
  <PgfTag `ForVidareLasning'>
  <PgfUseNextTag Yes>
  <PgfNextTag `RefTextNrForts'>
  <PgfAlignment Left>
  <PgfFIndent  0.0 mm>
  <PgfLIndent  0.0 mm>
  <PgfRIndent  0.0 mm>
  <PgfFIndentRelative No>
  <PgfFIndentOffset  0.0 mm>
  <PgfTopSeparator `'>
  <PgfTopSepAtIndent No>
  <PgfTopSepOffset  0.0 mm>
  <PgfBotSeparator `'>
  <PgfBotSepAtIndent No>
  <PgfBotSepOffset  0.0 mm>
  <PgfPlacement Anywhere>
  <PgfPlacementStyle Normal>
  <PgfRunInDefaultPunct `'>
  <PgfSpBefore  5.0 pt>
  <PgfSpAfter  1.0 pt>
  <PgfWithPrev No>
  <PgfWithNext No>
  <PgfBlockSize 2>
  <PgfFont 
   <FTag `'>
   <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
   <FFamily `Frutiger LT Std 45 Light'>
   <FVar `Regular'>
   <FWeight `Bold'>
   <FAngle `Regular'>
   <FPostScriptName `FrutigerLTStd-Bold'>
   <FEncoding `FrameRoman'>
   <FSize  8.0 pt>
   <FUnderlining FNoUnderlining>
   <FOverline No>
   <FStrike No>
   <FChangeBar No>
   <FOutline No>
   <FShadow No>
   <FPairKern Yes>
   <FTsume No>
   <FCase FAsTyped>
   <FPosition FNormal>
   <FDX  0.0%>
   <FDY  0.0%>
   <FDW  0.0%>
   <FStretch  100.0%>
   <FLanguage Swedish>
   <FLocked No>
   <FSeparation 0>
   <FColor `Black'>
   <FBackgroundColor NoColor>
  > # end of PgfFont
  <PgfLineSpacing Fixed>
  <PgfLeading  2.0 pt>
  <PgfAutoNum Yes>
  <PgfNumFormat `För vidare läsning'>
  <PgfNumberFont `'>
  <PgfNumAtEnd No>
  <PgfNumTabs 0>
  <PgfHyphenate Yes>
  <HyphenMaxLines 2>
  <HyphenMinPrefix 2>
  <HyphenMinSuffix 2>
  <HyphenMinWord 5>
  <PgfLetterSpace No>
  <PgfMinWordSpace 75>
  <PgfOptWordSpace 100>
  <PgfMaxWordSpace 125>
  <PgfMinJRomanLetterSpace 0>
  <PgfOptJRomanLetterSpace 25>
  <PgfMaxJRomanLetterSpace 50>
  <PgfMinJLetterSpace 0>
  <PgfOptJLetterSpace 0>
  <PgfMaxJLetterSpace 10>
  <PgfYakumonoType Floating>
  <PgfAcrobatLevel 0>
  <PgfPDFStructureLevel 0>
  <PgfLanguage Swedish>
  <PgfCellAlignment Top>
  <PgfCellMargins  0.0 pt 0.0 pt 0.0 pt 0.0 pt>
  <PgfCellLMarginFixed No>
  <PgfCellTMarginFixed No>
  <PgfCellRMarginFixed No>
  <PgfCellBMarginFixed No>
  <PgfLocked No>
 > # end of Pgf
 <Pgf 
  <PgfTag `Författare'>
  <PgfUseNextTag Yes>
  <PgfNextTag `Inledning'>
  <PgfAlignment Center>
  <PgfFIndent  0.0 mm>
  <PgfLIndent  0.0 mm>
  <PgfRIndent  0.0 mm>
  <PgfFIndentRelative No>
  <PgfFIndentOffset  0.0 mm>
  <PgfTopSeparator `'>
  <PgfTopSepAtIndent No>
  <PgfTopSepOffset  0.0 mm>
  <PgfBotSeparator `'>
  <PgfBotSepAtIndent No>
  <PgfBotSepOffset  0.0 mm>
  <PgfPlacement Anywhere>
  <PgfPlacementStyle Normal>
  <PgfRunInDefaultPunct `'>
  <PgfSpBefore  0.0 pt>
  <PgfSpAfter  0.0 pt>
  <PgfWithPrev No>
  <PgfWithNext No>
  <PgfBlockSize 2>
  <PgfFont 
   <FTag `'>
   <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
   <FFamily `Frutiger LT Std 55 Roman'>
   <FVar `Regular'>
   <FWeight `Regular'>
   <FAngle `Regular'>
   <FPostScriptName `FrutigerLTStd-Roman'>
   <FEncoding `FrameRoman'>
   <FSize  10.0 pt>
   <FUnderlining FNoUnderlining>
   <FOverline No>
   <FStrike No>
   <FChangeBar No>
   <FOutline No>
   <FShadow No>
   <FPairKern Yes>
   <FTsume No>
   <FCase FAsTyped>
   <FPosition FNormal>
   <FDX  0.0%>
   <FDY  0.0%>
   <FDW  0.0%>
   <FStretch  100.0%>
   <FLanguage Swedish>
   <FLocked No>
   <FSeparation 0>
   <FColor `Black'>
   <FBackgroundColor NoColor>
  > # end of PgfFont
  <PgfLineSpacing Fixed>
  <PgfLeading  2.0 pt>
  <PgfAutoNum No>
  <PgfNumTabs 0>
  <PgfHyphenate Yes>
  <HyphenMaxLines 2>
  <HyphenMinPrefix 2>
  <HyphenMinSuffix 2>
  <HyphenMinWord 5>
  <PgfLetterSpace No>
  <PgfMinWordSpace 75>
  <PgfOptWordSpace 100>
  <PgfMaxWordSpace 125>
  <PgfMinJRomanLetterSpace 0>
  <PgfOptJRomanLetterSpace 25>
  <PgfMaxJRomanLetterSpace 50>
  <PgfMinJLetterSpace 0>
  <PgfOptJLetterSpace 0>
  <PgfMaxJLetterSpace 10>
  <PgfYakumonoType Floating>
  <PgfAcrobatLevel 0>
  <PgfPDFStructureLevel 12>
  <PgfLanguage Swedish>
  <PgfCellAlignment Top>
  <PgfCellMargins  0.0 pt 0.0 pt 0.0 pt 0.0 pt>
  <PgfCellLMarginFixed No>
  <PgfCellTMarginFixed No>
  <PgfCellRMarginFixed No>
  <PgfCellBMarginFixed No>
  <PgfLocked No>
 > # end of Pgf
 <Pgf 
  <PgfTag `Ingress'>
  <PgfUseNextTag Yes>
  <PgfNextTag `Bröd'>
  <PgfAlignment LeftRight>
  <PgfFIndent  0.0 mm>
  <PgfLIndent  0.0 mm>
  <PgfRIndent  0.0 mm>
  <PgfFIndentRelative No>
  <PgfFIndentOffset  0.0 mm>
  <PgfTopSeparator `'>
  <PgfTopSepAtIndent No>
  <PgfTopSepOffset  0.0 mm>
  <PgfBotSeparator `'>
  <PgfBotSepAtIndent No>
  <PgfBotSepOffset  0.0 mm>
  <PgfPlacement Anywhere>
  <PgfPlacementStyle Normal>
  <PgfRunInDefaultPunct `'>
  <PgfSpBefore  0.0 pt>
  <PgfSpAfter  0.0 pt>
  <PgfWithPrev No>
  <PgfWithNext No>
  <PgfBlockSize 2>
  <PgfFont 
   <FTag `'>
   <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
   <FFamily `Frutiger LT Std 45 Light'>
   <FVar `Regular'>
   <FWeight `Bold'>
   <FAngle `Regular'>
   <FPostScriptName `FrutigerLTStd-Bold'>
   <FEncoding `FrameRoman'>
   <FSize  9.0 pt>
   <FUnderlining FNoUnderlining>
   <FOverline No>
   <FStrike No>
   <FChangeBar No>
   <FOutline No>
   <FShadow No>
   <FPairKern Yes>
   <FTsume No>
   <FCase FAsTyped>
   <FPosition FNormal>
   <FDX  0.0%>
   <FDY  0.0%>
   <FDW  0.0%>
   <FStretch  100.0%>
   <FLanguage Swedish>
   <FLocked No>
   <FSeparation 0>
   <FColor `Black'>
   <FBackgroundColor NoColor>
  > # end of PgfFont
  <PgfLineSpacing Fixed>
  <PgfLeading  1.7 pt>
  <PgfAutoNum No>
  <PgfNumTabs 0>
  <PgfHyphenate Yes>
  <HyphenMaxLines 2>
  <HyphenMinPrefix 2>
  <HyphenMinSuffix 2>
  <HyphenMinWord 5>
  <PgfLetterSpace No>
  <PgfMinWordSpace 75>
  <PgfOptWordSpace 100>
  <PgfMaxWordSpace 125>
  <PgfMinJRomanLetterSpace 0>
  <PgfOptJRomanLetterSpace 25>
  <PgfMaxJRomanLetterSpace 50>
  <PgfMinJLetterSpace 0>
  <PgfOptJLetterSpace 0>
  <PgfMaxJLetterSpace 10>
  <PgfYakumonoType Floating>
  <PgfAcrobatLevel 0>
  <PgfPDFStructureLevel 26>
  <PgfLanguage Swedish>
  <PgfCellAlignment Top>
  <PgfCellMargins  0.0 pt 0.0 pt 0.0 pt 0.0 pt>
  <PgfCellLMarginFixed No>
  <PgfCellTMarginFixed No>
  <PgfCellRMarginFixed No>
  <PgfCellBMarginFixed No>
  <PgfLocked No>
 > # end of Pgf
 <Pgf 
  <PgfTag `Inledning'>
  <PgfUseNextTag Yes>
  <PgfNextTag `Ingress'>
  <PgfAlignment Center>
  <PgfFIndent  0.0 mm>
  <PgfLIndent  0.0 mm>
  <PgfRIndent  0.0 mm>
  <PgfFIndentRelative No>
  <PgfFIndentOffset  0.0 mm>
  <PgfTopSeparator `Tjock_Tunn'>
  <PgfTopSepAtIndent No>
  <PgfTopSepOffset  0.0 mm>
  <PgfBotSeparator `Tunn_Tjock'>
  <PgfBotSepAtIndent No>
  <PgfBotSepOffset  0.0 mm>
  <PgfPlacement ColumnTop>
  <PgfPlacementStyle Normal>
  <PgfRunInDefaultPunct `'>
  <PgfSpBefore  0.0 pt>
  <PgfSpAfter  0.0 pt>
  <PgfWithPrev No>
  <PgfWithNext No>
  <PgfBlockSize 2>
  <PgfFont 
   <FTag `'>
   <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
   <FFamily `Frutiger LT Std 45 Light'>
   <FVar `Regular'>
   <FWeight `Bold'>
   <FAngle `Regular'>
   <FPostScriptName `FrutigerLTStd-Bold'>
   <FEncoding `FrameRoman'>
   <FSize  10.0 pt>
   <FUnderlining FNoUnderlining>
   <FOverline No>
   <FStrike No>
   <FChangeBar No>
   <FOutline No>
   <FShadow No>
   <FPairKern Yes>
   <FTsume No>
   <FCase FAsTyped>
   <FPosition FNormal>
   <FDX  0.0%>
   <FDY  0.0%>
   <FDW  0.0%>
   <FStretch  100.0%>
   <FLanguage Swedish>
   <FLocked No>
   <FSeparation 0>
   <FColor `Black'>
   <FBackgroundColor NoColor>
  > # end of PgfFont
  <PgfLineSpacing Fixed>
  <PgfLeading  2.0 pt>
  <PgfAutoNum Yes>
  <PgfNumFormat `Inledning'>
  <PgfNumberFont `'>
  <PgfNumAtEnd No>
  <PgfNumTabs 0>
  <PgfHyphenate Yes>
  <HyphenMaxLines 2>
  <HyphenMinPrefix 2>
  <HyphenMinSuffix 2>
  <HyphenMinWord 5>
  <PgfLetterSpace No>
  <PgfMinWordSpace 75>
  <PgfOptWordSpace 100>
  <PgfMaxWordSpace 125>
  <PgfMinJRomanLetterSpace 0>
  <PgfOptJRomanLetterSpace 25>
  <PgfMaxJRomanLetterSpace 50>
  <PgfMinJLetterSpace 0>
  <PgfOptJLetterSpace 0>
  <PgfMaxJLetterSpace 10>
  <PgfYakumonoType Floating>
  <PgfAcrobatLevel 0>
  <PgfPDFStructureLevel 4>
  <PgfLanguage Swedish>
  <PgfCellAlignment Top>
  <PgfCellMargins  0.0 pt 0.0 pt 0.0 pt 0.0 pt>
  <PgfCellLMarginFixed No>
  <PgfCellTMarginFixed No>
  <PgfCellRMarginFixed No>
  <PgfCellBMarginFixed No>
  <PgfLocked No>
 > # end of Pgf
 <Pgf 
  <PgfTag `KapRub'>
  <PgfUseNextTag Yes>
  <PgfNextTag `Författare'>
  <PgfAlignment Center>
  <PgfFIndent  0.0 mm>
  <PgfLIndent  0.0 mm>
  <PgfRIndent  0.0 mm>
  <PgfFIndentRelative No>
  <PgfFIndentOffset  0.0 mm>
  <PgfTopSeparator `'>
  <PgfTopSepAtIndent No>
  <PgfTopSepOffset  0.0 mm>
  <PgfBotSeparator `'>
  <PgfBotSepAtIndent No>
  <PgfBotSepOffset  0.0 mm>
  <PgfPlacement ColumnTop>
  <PgfPlacementStyle Normal>
  <PgfRunInDefaultPunct `'>
  <PgfSpBefore  0.0 pt>
  <PgfSpAfter  6.0 pt>
  <PgfWithPrev No>
  <PgfWithNext No>
  <PgfBlockSize 2>
  <PgfFont 
   <FTag `'>
   <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
   <FFamily `Frutiger LT Std 45 Light'>
   <FVar `Regular'>
   <FWeight `Bold'>
   <FAngle `Regular'>
   <FPostScriptName `FrutigerLTStd-Bold'>
   <FEncoding `FrameRoman'>
   <FSize  20.0 pt>
   <FUnderlining FNoUnderlining>
   <FOverline No>
   <FStrike No>
   <FChangeBar No>
   <FOutline No>
   <FShadow No>
   <FPairKern Yes>
   <FTsume No>
   <FCase FAsTyped>
   <FPosition FNormal>
   <FDX  0.0%>
   <FDY  0.0%>
   <FDW  0.0%>
   <FStretch  100.0%>
   <FLanguage Swedish>
   <FLocked No>
   <FSeparation 5>
   <FColor `Akut_Text'>
   <FBackgroundColor NoColor>
  > # end of PgfFont
  <PgfLineSpacing Fixed>
  <PgfLeading  2.0 pt>
  <PgfAutoNum No>
  <PgfNumTabs 0>
  <PgfHyphenate Yes>
  <HyphenMaxLines 2>
  <HyphenMinPrefix 2>
  <HyphenMinSuffix 2>
  <HyphenMinWord 5>
  <PgfLetterSpace No>
  <PgfMinWordSpace 75>
  <PgfOptWordSpace 100>
  <PgfMaxWordSpace 125>
  <PgfMinJRomanLetterSpace 0>
  <PgfOptJRomanLetterSpace 25>
  <PgfMaxJRomanLetterSpace 50>
  <PgfMinJLetterSpace 0>
  <PgfOptJLetterSpace 0>
  <PgfMaxJLetterSpace 10>
  <PgfYakumonoType Floating>
  <PgfAcrobatLevel 2>
  <PgfPDFStructureLevel 2>
  <PgfLanguage Swedish>
  <PgfCellAlignment Top>
  <PgfCellMargins  0.0 pt 0.0 pt 0.0 pt 0.0 pt>
  <PgfCellLMarginFixed No>
  <PgfCellTMarginFixed No>
  <PgfCellRMarginFixed No>
  <PgfCellBMarginFixed No>
  <PgfLocked No>
 > # end of Pgf
 <Pgf 
  <PgfTag `Preparat'>
  <PgfUseNextTag No>
  <PgfNextTag `'>
  <PgfAlignment Center>
  <PgfFIndent  3.0 mm>
  <PgfLIndent  0.0 mm>
  <PgfRIndent  0.0 mm>
  <PgfFIndentRelative No>
  <PgfFIndentOffset  0.0 mm>
  <PgfTopSeparator `Tjock_Tunn'>
  <PgfTopSepAtIndent No>
  <PgfTopSepOffset  0.0 mm>
  <PgfBotSeparator `'>
  <PgfBotSepAtIndent No>
  <PgfBotSepOffset  0.0 mm>
  <PgfPlacement ColumnTop>
  <PgfPlacementStyle Normal>
  <PgfRunInDefaultPunct `'>
  <PgfSpBefore  11.0 pt>
  <PgfSpAfter  10.5 pt>
  <PgfWithPrev No>
  <PgfWithNext Yes>
  <PgfBlockSize 2>
  <PgfFont 
   <FTag `'>
   <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
   <FFamily `Frutiger LT Std 45 Light'>
   <FVar `Regular'>
   <FWeight `Bold'>
   <FAngle `Regular'>
   <FPostScriptName `FrutigerLTStd-Bold'>
   <FEncoding `FrameRoman'>
   <FSize  10.0 pt>
   <FUnderlining FNoUnderlining>
   <FOverline No>
   <FStrike No>
   <FChangeBar No>
   <FOutline No>
   <FShadow No>
   <FPairKern Yes>
   <FTsume No>
   <FCase FAsTyped>
   <FPosition FNormal>
   <FDX  0.0%>
   <FDY  0.0%>
   <FDW  0.0%>
   <FStretch  100.0%>
   <FLanguage Swedish>
   <FLocked No>
   <FSeparation 0>
   <FColor `Black'>
   <FBackgroundColor NoColor>
  > # end of PgfFont
  <PgfLineSpacing Fixed>
  <PgfLeading  -3.0 pt>
  <PgfAutoNum Yes>
  <PgfNumFormat `Preparat'>
  <PgfNumberFont `'>
  <PgfNumAtEnd No>
  <PgfNumTabs 0>
  <PgfHyphenate Yes>
  <HyphenMaxLines 2>
  <HyphenMinPrefix 2>
  <HyphenMinSuffix 2>
  <HyphenMinWord 5>
  <PgfLetterSpace No>
  <PgfMinWordSpace 75>
  <PgfOptWordSpace 100>
  <PgfMaxWordSpace 125>
  <PgfMinJRomanLetterSpace 0>
  <PgfOptJRomanLetterSpace 25>
  <PgfMaxJRomanLetterSpace 50>
  <PgfMinJLetterSpace 0>
  <PgfOptJLetterSpace 0>
  <PgfMaxJLetterSpace 10>
  <PgfYakumonoType Floating>
  <PgfAcrobatLevel 0>
  <PgfPDFStructureLevel 3>
  <PgfLanguage Swedish>
  <PgfCellAlignment Top>
  <PgfCellMargins  0.0 pt 0.0 pt 0.0 pt 0.0 pt>
  <PgfCellLMarginFixed No>
  <PgfCellTMarginFixed No>
  <PgfCellRMarginFixed No>
  <PgfCellBMarginFixed No>
  <PgfLocked No>
 > # end of Pgf
 <Pgf 
  <PgfTag `PrepBröd'>
  <PgfUseNextTag No>
  <PgfNextTag `'>
  <PgfAlignment Left>
  <PgfFIndent  3.0 mm>
  <PgfLIndent  3.0 mm>
  <PgfRIndent  3.0 mm>
  <PgfFIndentRelative No>
  <PgfFIndentOffset  0.0 mm>
  <PgfTopSeparator `'>
  <PgfTopSepAtIndent No>
  <PgfTopSepOffset  0.0 mm>
  <PgfBotSeparator `'>
  <PgfBotSepAtIndent No>
  <PgfBotSepOffset  0.0 mm>
  <PgfPlacement Anywhere>
  <PgfPlacementStyle Normal>
  <PgfRunInDefaultPunct `'>
  <PgfSpBefore  0.0 pt>
  <PgfSpAfter  0.0 pt>
  <PgfWithPrev No>
  <PgfWithNext No>
  <PgfBlockSize 2>
  <PgfFont 
   <FTag `'>
   <FPlatformName `W.NewCenturySchlbk LT Std.R.400'>
   <FFamily `NewCenturySchlbk LT Std'>
   <FVar `Regular'>
   <FWeight `Regular'>
   <FAngle `Regular'>
   <FPostScriptName `NewCenturySchlbkLTStd-Roman'>
   <FEncoding `FrameRoman'>
   <FSize  8.0 pt>
   <FUnderlining FNoUnderlining>
   <FOverline No>
   <FStrike No>
   <FChangeBar No>
   <FOutline No>
   <FShadow No>
   <FPairKern Yes>
   <FTsume No>
   <FCase FAsTyped>
   <FPosition FNormal>
   <FDX  0.0%>
   <FDY  0.0%>
   <FDW  0.0%>
   <FStretch  100.0%>
   <FLanguage Swedish>
   <FLocked No>
   <FSeparation 0>
   <FColor `Black'>
   <FBackgroundColor NoColor>
  > # end of PgfFont
  <PgfLineSpacing Fixed>
  <PgfLeading  2.7 pt>
  <PgfAutoNum No>
  <PgfNumTabs 0>
  <PgfHyphenate Yes>
  <HyphenMaxLines 4>
  <HyphenMinPrefix 2>
  <HyphenMinSuffix 2>
  <HyphenMinWord 5>
  <PgfLetterSpace No>
  <PgfMinWordSpace 75>
  <PgfOptWordSpace 100>
  <PgfMaxWordSpace 125>
  <PgfMinJRomanLetterSpace 0>
  <PgfOptJRomanLetterSpace 25>
  <PgfMaxJRomanLetterSpace 50>
  <PgfMinJLetterSpace 0>
  <PgfOptJLetterSpace 0>
  <PgfMaxJLetterSpace 10>
  <PgfYakumonoType Floating>
  <PgfAcrobatLevel 0>
  <PgfPDFStructureLevel 0>
  <PgfLanguage Swedish>
  <PgfCellAlignment Top>
  <PgfCellMargins  0.0 pt 0.0 pt 0.0 pt 0.0 pt>
  <PgfCellLMarginFixed No>
  <PgfCellTMarginFixed No>
  <PgfCellRMarginFixed No>
  <PgfCellBMarginFixed No>
  <PgfLocked No>
 > # end of Pgf
 <Pgf 
  <PgfTag `PrepBrödIndrag'>
  <PgfUseNextTag No>
  <PgfNextTag `'>
  <PgfAlignment Left>
  <PgfFIndent  6.0 mm>
  <PgfLIndent  3.0 mm>
  <PgfRIndent  3.0 mm>
  <PgfFIndentRelative No>
  <PgfFIndentOffset  0.0 mm>
  <PgfTopSeparator `'>
  <PgfTopSepAtIndent No>
  <PgfTopSepOffset  0.0 mm>
  <PgfBotSeparator `'>
  <PgfBotSepAtIndent No>
  <PgfBotSepOffset  0.0 mm>
  <PgfPlacement Anywhere>
  <PgfPlacementStyle Normal>
  <PgfRunInDefaultPunct `'>
  <PgfSpBefore  0.0 pt>
  <PgfSpAfter  0.0 pt>
  <PgfWithPrev No>
  <PgfWithNext No>
  <PgfBlockSize 2>
  <PgfFont 
   <FTag `'>
   <FPlatformName `W.NewCenturySchlbk LT Std.R.400'>
   <FFamily `NewCenturySchlbk LT Std'>
   <FVar `Regular'>
   <FWeight `Regular'>
   <FAngle `Regular'>
   <FPostScriptName `NewCenturySchlbkLTStd-Roman'>
   <FEncoding `FrameRoman'>
   <FSize  8.0 pt>
   <FUnderlining FNoUnderlining>
   <FOverline No>
   <FStrike No>
   <FChangeBar No>
   <FOutline No>
   <FShadow No>
   <FPairKern Yes>
   <FTsume No>
   <FCase FAsTyped>
   <FPosition FNormal>
   <FDX  0.0%>
   <FDY  0.0%>
   <FDW  0.0%>
   <FStretch  100.0%>
   <FLanguage Swedish>
   <FLocked No>
   <FSeparation 0>
   <FColor `Black'>
   <FBackgroundColor NoColor>
  > # end of PgfFont
  <PgfLineSpacing Fixed>
  <PgfLeading  2.7 pt>
  <PgfAutoNum No>
  <PgfNumTabs 0>
  <PgfHyphenate Yes>
  <HyphenMaxLines 2>
  <HyphenMinPrefix 2>
  <HyphenMinSuffix 2>
  <HyphenMinWord 5>
  <PgfLetterSpace No>
  <PgfMinWordSpace 75>
  <PgfOptWordSpace 100>
  <PgfMaxWordSpace 125>
  <PgfMinJRomanLetterSpace 0>
  <PgfOptJRomanLetterSpace 25>
  <PgfMaxJRomanLetterSpace 50>
  <PgfMinJLetterSpace 0>
  <PgfOptJLetterSpace 0>
  <PgfMaxJLetterSpace 10>
  <PgfYakumonoType Floating>
  <PgfAcrobatLevel 0>
  <PgfPDFStructureLevel 0>
  <PgfLanguage Swedish>
  <PgfCellAlignment Top>
  <PgfCellMargins  0.0 pt 0.0 pt 0.0 pt 0.0 pt>
  <PgfCellLMarginFixed No>
  <PgfCellTMarginFixed No>
  <PgfCellRMarginFixed No>
  <PgfCellBMarginFixed No>
  <PgfLocked No>
 > # end of Pgf
 <Pgf 
  <PgfTag `PrepRub'>
  <PgfUseNextTag No>
  <PgfNextTag `'>
  <PgfAlignment Center>
  <PgfFIndent  0.0 mm>
  <PgfLIndent  0.0 mm>
  <PgfRIndent  0.0 mm>
  <PgfFIndentRelative No>
  <PgfFIndentOffset  0.0 mm>
  <PgfTopSeparator `'>
  <PgfTopSepAtIndent No>
  <PgfTopSepOffset  0.0 mm>
  <PgfBotSeparator `'>
  <PgfBotSepAtIndent No>
  <PgfBotSepOffset  0.0 mm>
  <PgfPlacement Anywhere>
  <PgfPlacementStyle Normal>
  <PgfRunInDefaultPunct `'>
  <PgfSpBefore  0.0 pt>
  <PgfSpAfter  6.0 pt>
  <PgfWithPrev No>
  <PgfWithNext Yes>
  <PgfBlockSize 2>
  <PgfFont 
   <FTag `'>
   <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
   <FFamily `Frutiger LT Std 55 Roman'>
   <FVar `Regular'>
   <FWeight `Regular'>
   <FAngle `Regular'>
   <FPostScriptName `FrutigerLTStd-Roman'>
   <FEncoding `FrameRoman'>
   <FSize  10.0 pt>
   <FUnderlining FNoUnderlining>
   <FOverline No>
   <FStrike No>
   <FChangeBar No>
   <FOutline No>
   <FShadow No>
   <FPairKern Yes>
   <FTsume No>
   <FCase FAsTyped>
   <FPosition FNormal>
   <FDX  0.0%>
   <FDY  0.0%>
   <FDW  0.0%>
   <FStretch  100.0%>
   <FLanguage Swedish>
   <FLocked No>
   <FSeparation 0>
   <FColor `Black'>
   <FBackgroundColor NoColor>
  > # end of PgfFont
  <PgfLineSpacing Fixed>
  <PgfLeading  0.7 pt>
  <PgfAutoNum No>
  <PgfNumTabs 0>
  <PgfHyphenate Yes>
  <HyphenMaxLines 2>
  <HyphenMinPrefix 2>
  <HyphenMinSuffix 2>
  <HyphenMinWord 5>
  <PgfLetterSpace No>
  <PgfMinWordSpace 75>
  <PgfOptWordSpace 100>
  <PgfMaxWordSpace 125>
  <PgfMinJRomanLetterSpace 0>
  <PgfOptJRomanLetterSpace 25>
  <PgfMaxJRomanLetterSpace 50>
  <PgfMinJLetterSpace 0>
  <PgfOptJLetterSpace 0>
  <PgfMaxJLetterSpace 10>
  <PgfYakumonoType Floating>
  <PgfAcrobatLevel 0>
  <PgfPDFStructureLevel 8>
  <PgfLanguage Swedish>
  <PgfCellAlignment Top>
  <PgfCellMargins  0.0 pt 0.0 pt 0.0 pt 0.0 pt>
  <PgfCellLMarginFixed No>
  <PgfCellTMarginFixed No>
  <PgfCellRMarginFixed No>
  <PgfCellBMarginFixed No>
  <PgfLocked No>
 > # end of Pgf
 <Pgf 
  <PgfTag `PrepRub2'>
  <PgfUseNextTag No>
  <PgfNextTag `'>
  <PgfAlignment Left>
  <PgfFIndent  2.82223 mm>
  <PgfLIndent  2.82223 mm>
  <PgfRIndent  2.82223 mm>
  <PgfFIndentRelative No>
  <PgfFIndentOffset  0.0 mm>
  <PgfTopSeparator `'>
  <PgfTopSepAtIndent No>
  <PgfTopSepOffset  0.0 mm>
  <PgfBotSeparator `'>
  <PgfBotSepAtIndent No>
  <PgfBotSepOffset  0.0 mm>
  <PgfPlacement Anywhere>
  <PgfPlacementStyle Normal>
  <PgfRunInDefaultPunct `'>
  <PgfSpBefore  7.0 pt>
  <PgfSpAfter  0.0 pt>
  <PgfWithPrev No>
  <PgfWithNext Yes>
  <PgfBlockSize 2>
  <PgfFont 
   <FTag `'>
   <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
   <FFamily `Frutiger LT Std 45 Light'>
   <FVar `Regular'>
   <FWeight `Bold'>
   <FAngle `Regular'>
   <FPostScriptName `FrutigerLTStd-Bold'>
   <FEncoding `FrameRoman'>
   <FSize  7.0 pt>
   <FUnderlining FNoUnderlining>
   <FOverline No>
   <FStrike No>
   <FChangeBar No>
   <FOutline No>
   <FShadow No>
   <FPairKern Yes>
   <FTsume No>
   <FCase FAsTyped>
   <FPosition FNormal>
   <FDX  0.0%>
   <FDY  0.0%>
   <FDW  0.0%>
   <FStretch  100.0%>
   <FLanguage Swedish>
   <FLocked No>
   <FSeparation 0>
   <FColor `Black'>
   <FBackgroundColor NoColor>
  > # end of PgfFont
  <PgfLineSpacing Fixed>
  <PgfLeading  2.0 pt>
  <PgfAutoNum No>
  <PgfNumTabs 0>
  <PgfHyphenate Yes>
  <HyphenMaxLines 2>
  <HyphenMinPrefix 2>
  <HyphenMinSuffix 2>
  <HyphenMinWord 5>
  <PgfLetterSpace No>
  <PgfMinWordSpace 75>
  <PgfOptWordSpace 100>
  <PgfMaxWordSpace 125>
  <PgfMinJRomanLetterSpace 0>
  <PgfOptJRomanLetterSpace 25>
  <PgfMaxJRomanLetterSpace 50>
  <PgfMinJLetterSpace 0>
  <PgfOptJLetterSpace 0>
  <PgfMaxJLetterSpace 10>
  <PgfYakumonoType Floating>
  <PgfAcrobatLevel 0>
  <PgfPDFStructureLevel 17>
  <PgfLanguage Swedish>
  <PgfCellAlignment Top>
  <PgfCellMargins  0.0 pt 0.0 pt 0.0 pt 0.0 pt>
  <PgfCellLMarginFixed No>
  <PgfCellTMarginFixed No>
  <PgfCellRMarginFixed No>
  <PgfCellBMarginFixed No>
  <PgfLocked No>
 > # end of Pgf
 <Pgf 
  <PgfTag `PrepRub2_Linje'>
  <PgfUseNextTag No>
  <PgfNextTag `'>
  <PgfAlignment Left>
  <PgfFIndent  2.82223 mm>
  <PgfLIndent  2.82223 mm>
  <PgfRIndent  2.82223 mm>
  <PgfFIndentRelative No>
  <PgfFIndentOffset  0.0 mm>
  <PgfTopSeparator `PreparatLinje'>
  <PgfTopSepAtIndent No>
  <PgfTopSepOffset  0.0 mm>
  <PgfBotSeparator `'>
  <PgfBotSepAtIndent No>
  <PgfBotSepOffset  0.0 mm>
  <PgfPlacement Anywhere>
  <PgfPlacementStyle Normal>
  <PgfRunInDefaultPunct `'>
  <PgfSpBefore  3.0 pt>
  <PgfSpAfter  0.0 pt>
  <PgfWithPrev No>
  <PgfWithNext Yes>
  <PgfBlockSize 2>
  <PgfFont 
   <FTag `'>
   <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
   <FFamily `Frutiger LT Std 45 Light'>
   <FVar `Regular'>
   <FWeight `Bold'>
   <FAngle `Regular'>
   <FPostScriptName `FrutigerLTStd-Bold'>
   <FEncoding `FrameRoman'>
   <FSize  7.0 pt>
   <FUnderlining FNoUnderlining>
   <FOverline No>
   <FStrike No>
   <FChangeBar No>
   <FOutline No>
   <FShadow No>
   <FPairKern Yes>
   <FTsume No>
   <FCase FAsTyped>
   <FPosition FNormal>
   <FDX  0.0%>
   <FDY  0.0%>
   <FDW  0.0%>
   <FStretch  100.0%>
   <FLanguage Swedish>
   <FLocked No>
   <FSeparation 0>
   <FColor `Black'>
   <FBackgroundColor NoColor>
  > # end of PgfFont
  <PgfLineSpacing Fixed>
  <PgfLeading  2.0 pt>
  <PgfAutoNum No>
  <PgfNumTabs 0>
  <PgfHyphenate Yes>
  <HyphenMaxLines 2>
  <HyphenMinPrefix 2>
  <HyphenMinSuffix 2>
  <HyphenMinWord 5>
  <PgfLetterSpace No>
  <PgfMinWordSpace 75>
  <PgfOptWordSpace 100>
  <PgfMaxWordSpace 125>
  <PgfMinJRomanLetterSpace 0>
  <PgfOptJRomanLetterSpace 25>
  <PgfMaxJRomanLetterSpace 50>
  <PgfMinJLetterSpace 0>
  <PgfOptJLetterSpace 0>
  <PgfMaxJLetterSpace 10>
  <PgfYakumonoType Floating>
  <PgfAcrobatLevel 0>
  <PgfPDFStructureLevel 17>
  <PgfLanguage Swedish>
  <PgfCellAlignment Top>
  <PgfCellMargins  0.0 pt 0.0 pt 0.0 pt 0.0 pt>
  <PgfCellLMarginFixed No>
  <PgfCellTMarginFixed No>
  <PgfCellRMarginFixed No>
  <PgfCellBMarginFixed No>
  <PgfLocked No>
 > # end of Pgf
 <Pgf 
  <PgfTag `PrepRub_Linje'>
  <PgfUseNextTag No>
  <PgfNextTag `'>
  <PgfAlignment Center>
  <PgfFIndent  0.0 mm>
  <PgfLIndent  0.0 mm>
  <PgfRIndent  0.0 mm>
  <PgfFIndentRelative No>
  <PgfFIndentOffset  0.0 mm>
  <PgfTopSeparator `PreparatLinje'>
  <PgfTopSepAtIndent No>
  <PgfTopSepOffset  0.0 mm>
  <PgfBotSeparator `'>
  <PgfBotSepAtIndent No>
  <PgfBotSepOffset  0.0 mm>
  <PgfPlacement Anywhere>
  <PgfPlacementStyle Normal>
  <PgfRunInDefaultPunct `'>
  <PgfSpBefore  3.0 pt>
  <PgfSpAfter  6.0 pt>
  <PgfWithPrev No>
  <PgfWithNext Yes>
  <PgfBlockSize 2>
  <PgfFont 
   <FTag `'>
   <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
   <FFamily `Frutiger LT Std 55 Roman'>
   <FVar `Regular'>
   <FWeight `Regular'>
   <FAngle `Regular'>
   <FPostScriptName `FrutigerLTStd-Roman'>
   <FEncoding `FrameRoman'>
   <FSize  10.0 pt>
   <FUnderlining FNoUnderlining>
   <FOverline No>
   <FStrike No>
   <FChangeBar No>
   <FOutline No>
   <FShadow No>
   <FPairKern Yes>
   <FTsume No>
   <FCase FAsTyped>
   <FPosition FNormal>
   <FDX  0.0%>
   <FDY  0.0%>
   <FDW  0.0%>
   <FStretch  100.0%>
   <FLanguage Swedish>
   <FLocked No>
   <FSeparation 0>
   <FColor `Black'>
   <FBackgroundColor NoColor>
  > # end of PgfFont
  <PgfLineSpacing Fixed>
  <PgfLeading  0.7 pt>
  <PgfAutoNum No>
  <PgfNumTabs 0>
  <PgfHyphenate Yes>
  <HyphenMaxLines 2>
  <HyphenMinPrefix 2>
  <HyphenMinSuffix 2>
  <HyphenMinWord 5>
  <PgfLetterSpace No>
  <PgfMinWordSpace 75>
  <PgfOptWordSpace 100>
  <PgfMaxWordSpace 125>
  <PgfMinJRomanLetterSpace 0>
  <PgfOptJRomanLetterSpace 25>
  <PgfMaxJRomanLetterSpace 50>
  <PgfMinJLetterSpace 0>
  <PgfOptJLetterSpace 0>
  <PgfMaxJLetterSpace 10>
  <PgfYakumonoType Floating>
  <PgfAcrobatLevel 0>
  <PgfPDFStructureLevel 8>
  <PgfLanguage Swedish>
  <PgfCellAlignment Top>
  <PgfCellMargins  0.0 pt 0.0 pt 0.0 pt 0.0 pt>
  <PgfCellLMarginFixed No>
  <PgfCellTMarginFixed No>
  <PgfCellRMarginFixed No>
  <PgfCellBMarginFixed No>
  <PgfLocked No>
 > # end of Pgf
 <Pgf 
  <PgfTag `PrepSubst'>
  <PgfUseNextTag No>
  <PgfNextTag `'>
  <PgfAlignment Left>
  <PgfFIndent  2.82223 mm>
  <PgfLIndent  2.82223 mm>
  <PgfRIndent  2.82223 mm>
  <PgfFIndentRelative No>
  <PgfFIndentOffset  0.0 mm>
  <PgfTopSeparator `'>
  <PgfTopSepAtIndent No>
  <PgfTopSepOffset  0.0 mm>
  <PgfBotSeparator `'>
  <PgfBotSepAtIndent No>
  <PgfBotSepOffset  0.0 mm>
  <PgfPlacement Anywhere>
  <PgfPlacementStyle Normal>
  <PgfRunInDefaultPunct `'>
  <PgfSpBefore  0.0 pt>
  <PgfSpAfter  0.0 pt>
  <PgfWithPrev No>
  <PgfWithNext Yes>
  <PgfBlockSize 2>
  <PgfFont 
   <FTag `'>
   <FPlatformName `W.Frutiger LT Std 55 Roman.I.400'>
   <FFamily `Frutiger LT Std 55 Roman'>
   <FVar `Regular'>
   <FWeight `Regular'>
   <FAngle `Italic'>
   <FPostScriptName `FrutigerLTStd-Italic'>
   <FEncoding `FrameRoman'>
   <FSize  7.0 pt>
   <FUnderlining FNoUnderlining>
   <FOverline No>
   <FStrike No>
   <FChangeBar No>
   <FOutline No>
   <FShadow No>
   <FPairKern Yes>
   <FTsume No>
   <FCase FAsTyped>
   <FPosition FNormal>
   <FDX  0.0%>
   <FDY  0.0%>
   <FDW  0.0%>
   <FStretch  100.0%>
   <FLanguage Swedish>
   <FLocked No>
   <FSeparation 0>
   <FColor `Black'>
   <FBackgroundColor NoColor>
  > # end of PgfFont
  <PgfLineSpacing Fixed>
  <PgfLeading  2.0 pt>
  <PgfAutoNum No>
  <PgfNumTabs 0>
  <PgfHyphenate Yes>
  <HyphenMaxLines 2>
  <HyphenMinPrefix 2>
  <HyphenMinSuffix 2>
  <HyphenMinWord 5>
  <PgfLetterSpace No>
  <PgfMinWordSpace 75>
  <PgfOptWordSpace 100>
  <PgfMaxWordSpace 125>
  <PgfMinJRomanLetterSpace 0>
  <PgfOptJRomanLetterSpace 25>
  <PgfMaxJRomanLetterSpace 50>
  <PgfMinJLetterSpace 0>
  <PgfOptJLetterSpace 0>
  <PgfMaxJLetterSpace 10>
  <PgfYakumonoType Floating>
  <PgfAcrobatLevel 0>
  <PgfPDFStructureLevel 18>
  <PgfLanguage Swedish>
  <PgfCellAlignment Top>
  <PgfCellMargins  0.0 pt 0.0 pt 0.0 pt 0.0 pt>
  <PgfCellLMarginFixed No>
  <PgfCellTMarginFixed No>
  <PgfCellRMarginFixed No>
  <PgfCellBMarginFixed No>
  <PgfLocked No>
 > # end of Pgf
 <Pgf 
  <PgfTag `PrepVara'>
  <PgfUseNextTag No>
  <PgfNextTag `'>
  <PgfAlignment Left>
  <PgfFIndent  5.64445 mm>
  <PgfLIndent  5.64445 mm>
  <PgfRIndent  2.82223 mm>
  <PgfFIndentRelative No>
  <PgfFIndentOffset  0.0 mm>
  <PgfTopSeparator `'>
  <PgfTopSepAtIndent No>
  <PgfTopSepOffset  0.0 mm>
  <PgfBotSeparator `'>
  <PgfBotSepAtIndent No>
  <PgfBotSepOffset  0.0 mm>
  <PgfPlacement Anywhere>
  <PgfPlacementStyle Normal>
  <PgfRunInDefaultPunct `'>
  <PgfSpBefore  0.0 pt>
  <PgfSpAfter  0.0 pt>
  <PgfWithPrev No>
  <PgfWithNext No>
  <PgfBlockSize 2>
  <PgfFont 
   <FTag `'>
   <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
   <FFamily `Frutiger LT Std 55 Roman'>
   <FVar `Regular'>
   <FWeight `Regular'>
   <FAngle `Regular'>
   <FPostScriptName `FrutigerLTStd-Roman'>
   <FEncoding `FrameRoman'>
   <FSize  7.0 pt>
   <FUnderlining FNoUnderlining>
   <FOverline No>
   <FStrike No>
   <FChangeBar No>
   <FOutline No>
   <FShadow No>
   <FPairKern Yes>
   <FTsume No>
   <FCase FAsTyped>
   <FPosition FNormal>
   <FDX  0.0%>
   <FDY  0.0%>
   <FDW  0.0%>
   <FStretch  100.0%>
   <FLanguage Swedish>
   <FLocked No>
   <FSeparation 0>
   <FColor `Black'>
   <FBackgroundColor NoColor>
  > # end of PgfFont
  <PgfLineSpacing Fixed>
  <PgfLeading  2.0 pt>
  <PgfAutoNum No>
  <PgfNumTabs 0>
  <PgfHyphenate Yes>
  <HyphenMaxLines 2>
  <HyphenMinPrefix 2>
  <HyphenMinSuffix 2>
  <HyphenMinWord 5>
  <PgfLetterSpace No>
  <PgfMinWordSpace 75>
  <PgfOptWordSpace 100>
  <PgfMaxWordSpace 125>
  <PgfMinJRomanLetterSpace 0>
  <PgfOptJRomanLetterSpace 25>
  <PgfMaxJRomanLetterSpace 50>
  <PgfMinJLetterSpace 0>
  <PgfOptJLetterSpace 0>
  <PgfMaxJLetterSpace 10>
  <PgfYakumonoType Floating>
  <PgfAcrobatLevel 0>
  <PgfPDFStructureLevel 26>
  <PgfLanguage Swedish>
  <PgfCellAlignment Top>
  <PgfCellMargins  0.0 pt 0.0 pt 0.0 pt 0.0 pt>
  <PgfCellLMarginFixed No>
  <PgfCellTMarginFixed No>
  <PgfCellRMarginFixed No>
  <PgfCellBMarginFixed No>
  <PgfLocked No>
 > # end of Pgf
 <Pgf 
  <PgfTag `RefRub'>
  <PgfUseNextTag Yes>
  <PgfNextTag `RefTextNr1'>
  <PgfAlignment Center>
  <PgfFIndent  0.0 mm>
  <PgfLIndent  0.0 mm>
  <PgfRIndent  0.0 mm>
  <PgfFIndentRelative No>
  <PgfFIndentOffset  0.0 mm>
  <PgfTopSeparator `Tjock_Tunn'>
  <PgfTopSepAtIndent No>
  <PgfTopSepOffset  0.0 mm>
  <PgfBotSeparator `Tunn_Tjock'>
  <PgfBotSepAtIndent No>
  <PgfBotSepOffset  0.0 mm>
  <PgfPlacement PageTop>
  <PgfPlacementStyle Normal>
  <PgfRunInDefaultPunct `'>
  <PgfSpBefore  0.0 pt>
  <PgfSpAfter  5.0 pt>
  <PgfWithPrev No>
  <PgfWithNext No>
  <PgfBlockSize 2>
  <PgfFont 
   <FTag `'>
   <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
   <FFamily `Frutiger LT Std 45 Light'>
   <FVar `Regular'>
   <FWeight `Bold'>
   <FAngle `Regular'>
   <FPostScriptName `FrutigerLTStd-Bold'>
   <FEncoding `FrameRoman'>
   <FSize  10.0 pt>
   <FUnderlining FNoUnderlining>
   <FOverline No>
   <FStrike No>
   <FChangeBar No>
   <FOutline No>
   <FShadow No>
   <FPairKern Yes>
   <FTsume No>
   <FCase FAsTyped>
   <FPosition FNormal>
   <FDX  0.0%>
   <FDY  0.0%>
   <FDW  0.0%>
   <FStretch  100.0%>
   <FLanguage Swedish>
   <FLocked No>
   <FSeparation 0>
   <FColor `Black'>
   <FBackgroundColor NoColor>
  > # end of PgfFont
  <PgfLineSpacing Fixed>
  <PgfLeading  -3.0 pt>
  <PgfAutoNum Yes>
  <PgfNumFormat `Referenser'>
  <PgfNumberFont `'>
  <PgfNumAtEnd No>
  <PgfNumTabs 0>
  <PgfHyphenate Yes>
  <HyphenMaxLines 2>
  <HyphenMinPrefix 2>
  <HyphenMinSuffix 2>
  <HyphenMinWord 5>
  <PgfLetterSpace No>
  <PgfMinWordSpace 75>
  <PgfOptWordSpace 100>
  <PgfMaxWordSpace 125>
  <PgfMinJRomanLetterSpace 0>
  <PgfOptJRomanLetterSpace 25>
  <PgfMaxJRomanLetterSpace 50>
  <PgfMinJLetterSpace 0>
  <PgfOptJLetterSpace 0>
  <PgfMaxJLetterSpace 10>
  <PgfYakumonoType Floating>
  <PgfAcrobatLevel 0>
  <PgfPDFStructureLevel 1>
  <PgfLanguage Swedish>
  <PgfCellAlignment Top>
  <PgfCellMargins  0.0 pt 0.0 pt 0.0 pt 0.0 pt>
  <PgfCellLMarginFixed No>
  <PgfCellTMarginFixed No>
  <PgfCellRMarginFixed No>
  <PgfCellBMarginFixed No>
  <PgfLocked No>
 > # end of Pgf
 <Pgf 
  <PgfTag `RefTextNr1'>
  <PgfUseNextTag Yes>
  <PgfNextTag `RefTextNrForts'>
  <PgfAlignment Left>
  <PgfFIndent  0.0 mm>
  <PgfLIndent  3.5 mm>
  <PgfRIndent  0.0 mm>
  <PgfFIndentRelative No>
  <PgfFIndentOffset  0.0 mm>
  <PgfTopSeparator `'>
  <PgfTopSepAtIndent No>
  <PgfTopSepOffset  0.0 mm>
  <PgfBotSeparator `'>
  <PgfBotSepAtIndent No>
  <PgfBotSepOffset  0.0 mm>
  <PgfPlacement Anywhere>
  <PgfPlacementStyle Normal>
  <PgfRunInDefaultPunct `'>
  <PgfSpBefore  0.0 pt>
  <PgfSpAfter  0.0 pt>
  <PgfWithPrev No>
  <PgfWithNext No>
  <PgfBlockSize 2>
  <PgfFont 
   <FTag `'>
   <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
   <FFamily `Frutiger LT Std 55 Roman'>
   <FVar `Regular'>
   <FWeight `Regular'>
   <FAngle `Regular'>
   <FPostScriptName `FrutigerLTStd-Roman'>
   <FEncoding `FrameRoman'>
   <FSize  7.5 pt>
   <FUnderlining FNoUnderlining>
   <FOverline No>
   <FStrike No>
   <FChangeBar No>
   <FOutline No>
   <FShadow No>
   <FPairKern Yes>
   <FTsume No>
   <FCase FAsTyped>
   <FPosition FNormal>
   <FDX  0.0%>
   <FDY  0.0%>
   <FDW  0.0%>
   <FStretch  100.0%>
   <FLanguage Swedish>
   <FLocked No>
   <FSeparation 0>
   <FColor `Black'>
   <FBackgroundColor NoColor>
  > # end of PgfFont
  <PgfLineSpacing Fixed>
  <PgfLeading  3.2 pt>
  <PgfAutoNum Yes>
  <PgfNumFormat `R:<n=1\>.\\t'>
  <PgfNumberFont `'>
  <PgfNumAtEnd No>
  <PgfNumTabs 1>
  <TabStop 
   <TSX  3.5 mm>
   <TSType Left>
   <TSLeaderStr ` '>
  > # end of TabStop
  <PgfHyphenate Yes>
  <HyphenMaxLines 2>
  <HyphenMinPrefix 2>
  <HyphenMinSuffix 2>
  <HyphenMinWord 5>
  <PgfLetterSpace No>
  <PgfMinWordSpace 75>
  <PgfOptWordSpace 100>
  <PgfMaxWordSpace 125>
  <PgfMinJRomanLetterSpace 0>
  <PgfOptJRomanLetterSpace 25>
  <PgfMaxJRomanLetterSpace 50>
  <PgfMinJLetterSpace 0>
  <PgfOptJLetterSpace 0>
  <PgfMaxJLetterSpace 10>
  <PgfYakumonoType Floating>
  <PgfAcrobatLevel 0>
  <PgfPDFStructureLevel 24>
  <PgfLanguage Swedish>
  <PgfCellAlignment Top>
  <PgfCellMargins  0.0 pt 0.0 pt 0.0 pt 0.0 pt>
  <PgfCellLMarginFixed No>
  <PgfCellTMarginFixed No>
  <PgfCellRMarginFixed No>
  <PgfCellBMarginFixed No>
  <PgfLocked No>
 > # end of Pgf
 <Pgf 
  <PgfTag `RefTextNrForts'>
  <PgfUseNextTag No>
  <PgfNextTag `'>
  <PgfAlignment Left>
  <PgfFIndent  0.0 mm>
  <PgfLIndent  3.5 mm>
  <PgfRIndent  0.0 mm>
  <PgfFIndentRelative No>
  <PgfFIndentOffset  0.0 mm>
  <PgfTopSeparator `'>
  <PgfTopSepAtIndent No>
  <PgfTopSepOffset  0.0 mm>
  <PgfBotSeparator `'>
  <PgfBotSepAtIndent No>
  <PgfBotSepOffset  0.0 mm>
  <PgfPlacement Anywhere>
  <PgfPlacementStyle Normal>
  <PgfRunInDefaultPunct `'>
  <PgfSpBefore  0.0 pt>
  <PgfSpAfter  0.0 pt>
  <PgfWithPrev No>
  <PgfWithNext No>
  <PgfBlockSize 2>
  <PgfFont 
   <FTag `'>
   <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
   <FFamily `Frutiger LT Std 55 Roman'>
   <FVar `Regular'>
   <FWeight `Regular'>
   <FAngle `Regular'>
   <FPostScriptName `FrutigerLTStd-Roman'>
   <FEncoding `FrameRoman'>
   <FSize  7.5 pt>
   <FUnderlining FNoUnderlining>
   <FOverline No>
   <FStrike No>
   <FChangeBar No>
   <FOutline No>
   <FShadow No>
   <FPairKern Yes>
   <FTsume No>
   <FCase FAsTyped>
   <FPosition FNormal>
   <FDX  0.0%>
   <FDY  0.0%>
   <FDW  0.0%>
   <FStretch  100.0%>
   <FLanguage Swedish>
   <FLocked No>
   <FSeparation 0>
   <FColor `Black'>
   <FBackgroundColor NoColor>
  > # end of PgfFont
  <PgfLineSpacing Fixed>
  <PgfLeading  3.2 pt>
  <PgfAutoNum Yes>
  <PgfNumFormat `R:<n+\>.\\t'>
  <PgfNumberFont `'>
  <PgfNumAtEnd No>
  <PgfNumTabs 1>
  <TabStop 
   <TSX  3.5 mm>
   <TSType Left>
   <TSLeaderStr ` '>
  > # end of TabStop
  <PgfHyphenate Yes>
  <HyphenMaxLines 2>
  <HyphenMinPrefix 2>
  <HyphenMinSuffix 2>
  <HyphenMinWord 5>
  <PgfLetterSpace No>
  <PgfMinWordSpace 75>
  <PgfOptWordSpace 100>
  <PgfMaxWordSpace 125>
  <PgfMinJRomanLetterSpace 0>
  <PgfOptJRomanLetterSpace 25>
  <PgfMaxJRomanLetterSpace 50>
  <PgfMinJLetterSpace 0>
  <PgfOptJLetterSpace 0>
  <PgfMaxJLetterSpace 10>
  <PgfYakumonoType Floating>
  <PgfAcrobatLevel 0>
  <PgfPDFStructureLevel 24>
  <PgfLanguage Swedish>
  <PgfCellAlignment Top>
  <PgfCellMargins  0.0 pt 0.0 pt 0.0 pt 0.0 pt>
  <PgfCellLMarginFixed No>
  <PgfCellTMarginFixed No>
  <PgfCellRMarginFixed No>
  <PgfCellBMarginFixed No>
  <PgfLocked No>
 > # end of Pgf
 <Pgf 
  <PgfTag `Rub1'>
  <PgfUseNextTag No>
  <PgfNextTag `'>
  <PgfAlignment Center>
  <PgfFIndent  0.0 mm>
  <PgfLIndent  0.0 mm>
  <PgfRIndent  0.0 mm>
  <PgfFIndentRelative No>
  <PgfFIndentOffset  0.0 mm>
  <PgfTopSeparator `'>
  <PgfTopSepAtIndent No>
  <PgfTopSepOffset  0.0 mm>
  <PgfBotSeparator `'>
  <PgfBotSepAtIndent No>
  <PgfBotSepOffset  0.0 mm>
  <PgfPlacement Anywhere>
  <PgfPlacementStyle Normal>
  <PgfRunInDefaultPunct `'>
  <PgfSpBefore  18.4 pt>
  <PgfSpAfter  3.0 pt>
  <PgfWithPrev No>
  <PgfWithNext Yes>
  <PgfBlockSize 2>
  <PgfFont 
   <FTag `'>
   <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
   <FFamily `Frutiger LT Std 45 Light'>
   <FVar `Regular'>
   <FWeight `Bold'>
   <FAngle `Regular'>
   <FPostScriptName `FrutigerLTStd-Bold'>
   <FEncoding `FrameRoman'>
   <FSize  10.1 pt>
   <FUnderlining FNoUnderlining>
   <FOverline No>
   <FStrike No>
   <FChangeBar No>
   <FOutline No>
   <FShadow No>
   <FPairKern Yes>
   <FTsume No>
   <FCase FAsTyped>
   <FPosition FNormal>
   <FDX  0.0%>
   <FDY  0.0%>
   <FDW  0.0%>
   <FStretch  100.0%>
   <FLanguage Swedish>
   <FLocked No>
   <FSeparation 0>
   <FColor `Black'>
   <FBackgroundColor NoColor>
  > # end of PgfFont
  <PgfLineSpacing Fixed>
  <PgfLeading  0.6 pt>
  <PgfAutoNum No>
  <PgfNumTabs 0>
  <PgfHyphenate Yes>
  <HyphenMaxLines 2>
  <HyphenMinPrefix 2>
  <HyphenMinSuffix 2>
  <HyphenMinWord 5>
  <PgfLetterSpace No>
  <PgfMinWordSpace 75>
  <PgfOptWordSpace 100>
  <PgfMaxWordSpace 125>
  <PgfMinJRomanLetterSpace 0>
  <PgfOptJRomanLetterSpace 25>
  <PgfMaxJRomanLetterSpace 50>
  <PgfMinJLetterSpace 0>
  <PgfOptJLetterSpace 0>
  <PgfMaxJLetterSpace 10>
  <PgfYakumonoType Floating>
  <PgfAcrobatLevel 3>
  <PgfPDFStructureLevel 7>
  <PgfLanguage Swedish>
  <PgfCellAlignment Top>
  <PgfCellMargins  0.0 pt 0.0 pt 0.0 pt 0.0 pt>
  <PgfCellLMarginFixed No>
  <PgfCellTMarginFixed No>
  <PgfCellRMarginFixed No>
  <PgfCellBMarginFixed No>
  <PgfLocked No>
 > # end of Pgf
 <Pgf 
  <PgfTag `Rub2'>
  <PgfUseNextTag No>
  <PgfNextTag `'>
  <PgfAlignment Center>
  <PgfFIndent  0.0 mm>
  <PgfLIndent  0.0 mm>
  <PgfRIndent  0.0 mm>
  <PgfFIndentRelative No>
  <PgfFIndentOffset  0.0 mm>
  <PgfTopSeparator `'>
  <PgfTopSepAtIndent No>
  <PgfTopSepOffset  0.0 mm>
  <PgfBotSeparator `'>
  <PgfBotSepAtIndent No>
  <PgfBotSepOffset  0.0 mm>
  <PgfPlacement Anywhere>
  <PgfPlacementStyle Normal>
  <PgfRunInDefaultPunct `'>
  <PgfSpBefore  10.7 pt>
  <PgfSpAfter  0.0 pt>
  <PgfWithPrev No>
  <PgfWithNext Yes>
  <PgfBlockSize 2>
  <PgfFont 
   <FTag `'>
   <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
   <FFamily `Frutiger LT Std 45 Light'>
   <FVar `Regular'>
   <FWeight `Bold'>
   <FAngle `Regular'>
   <FPostScriptName `FrutigerLTStd-Bold'>
   <FEncoding `FrameRoman'>
   <FSize  8.7 pt>
   <FUnderlining FNoUnderlining>
   <FOverline No>
   <FStrike No>
   <FChangeBar No>
   <FOutline No>
   <FShadow No>
   <FPairKern Yes>
   <FTsume No>
   <FCase FAsTyped>
   <FPosition FNormal>
   <FDX  0.0%>
   <FDY  0.0%>
   <FDW  0.0%>
   <FStretch  100.0%>
   <FLanguage Swedish>
   <FLocked No>
   <FSeparation 0>
   <FColor `Black'>
   <FBackgroundColor NoColor>
  > # end of PgfFont
  <PgfLineSpacing Fixed>
  <PgfLeading  2.0 pt>
  <PgfAutoNum No>
  <PgfNumTabs 0>
  <PgfHyphenate Yes>
  <HyphenMaxLines 2>
  <HyphenMinPrefix 2>
  <HyphenMinSuffix 2>
  <HyphenMinWord 5>
  <PgfLetterSpace No>
  <PgfMinWordSpace 75>
  <PgfOptWordSpace 100>
  <PgfMaxWordSpace 125>
  <PgfMinJRomanLetterSpace 0>
  <PgfOptJRomanLetterSpace 25>
  <PgfMaxJRomanLetterSpace 50>
  <PgfMinJLetterSpace 0>
  <PgfOptJLetterSpace 0>
  <PgfMaxJLetterSpace 10>
  <PgfYakumonoType Floating>
  <PgfAcrobatLevel 4>
  <PgfPDFStructureLevel 9>
  <PgfLanguage Swedish>
  <PgfCellAlignment Top>
  <PgfCellMargins  0.0 pt 0.0 pt 0.0 pt 0.0 pt>
  <PgfCellLMarginFixed No>
  <PgfCellTMarginFixed No>
  <PgfCellRMarginFixed No>
  <PgfCellBMarginFixed No>
  <PgfLocked No>
 > # end of Pgf
 <Pgf 
  <PgfTag `Rub2efterRub1'>
  <PgfUseNextTag No>
  <PgfNextTag `'>
  <PgfAlignment Center>
  <PgfFIndent  0.0 mm>
  <PgfLIndent  0.0 mm>
  <PgfRIndent  0.0 mm>
  <PgfFIndentRelative No>
  <PgfFIndentOffset  0.0 mm>
  <PgfTopSeparator `'>
  <PgfTopSepAtIndent No>
  <PgfTopSepOffset  0.0 mm>
  <PgfBotSeparator `'>
  <PgfBotSepAtIndent No>
  <PgfBotSepOffset  0.0 mm>
  <PgfPlacement Anywhere>
  <PgfPlacementStyle Normal>
  <PgfRunInDefaultPunct `'>
  <PgfSpBefore  0.0 pt>
  <PgfSpAfter  0.0 pt>
  <PgfWithPrev No>
  <PgfWithNext Yes>
  <PgfBlockSize 2>
  <PgfFont 
   <FTag `'>
   <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
   <FFamily `Frutiger LT Std 45 Light'>
   <FVar `Regular'>
   <FWeight `Bold'>
   <FAngle `Regular'>
   <FPostScriptName `FrutigerLTStd-Bold'>
   <FEncoding `FrameRoman'>
   <FSize  8.7 pt>
   <FUnderlining FNoUnderlining>
   <FOverline No>
   <FStrike No>
   <FChangeBar No>
   <FOutline No>
   <FShadow No>
   <FPairKern Yes>
   <FTsume No>
   <FCase FAsTyped>
   <FPosition FNormal>
   <FDX  0.0%>
   <FDY  0.0%>
   <FDW  0.0%>
   <FStretch  100.0%>
   <FLanguage Swedish>
   <FLocked No>
   <FSeparation 0>
   <FColor `Black'>
   <FBackgroundColor NoColor>
  > # end of PgfFont
  <PgfLineSpacing Fixed>
  <PgfLeading  2.0 pt>
  <PgfAutoNum No>
  <PgfNumTabs 0>
  <PgfHyphenate Yes>
  <HyphenMaxLines 2>
  <HyphenMinPrefix 2>
  <HyphenMinSuffix 2>
  <HyphenMinWord 5>
  <PgfLetterSpace No>
  <PgfMinWordSpace 75>
  <PgfOptWordSpace 100>
  <PgfMaxWordSpace 125>
  <PgfMinJRomanLetterSpace 0>
  <PgfOptJRomanLetterSpace 25>
  <PgfMaxJRomanLetterSpace 50>
  <PgfMinJLetterSpace 0>
  <PgfOptJLetterSpace 0>
  <PgfMaxJLetterSpace 10>
  <PgfYakumonoType Floating>
  <PgfAcrobatLevel 4>
  <PgfPDFStructureLevel 9>
  <PgfLanguage Swedish>
  <PgfCellAlignment Top>
  <PgfCellMargins  0.0 pt 0.0 pt 0.0 pt 0.0 pt>
  <PgfCellLMarginFixed No>
  <PgfCellTMarginFixed No>
  <PgfCellRMarginFixed No>
  <PgfCellBMarginFixed No>
  <PgfLocked No>
 > # end of Pgf
 <Pgf 
  <PgfTag `Rub3'>
  <PgfUseNextTag No>
  <PgfNextTag `'>
  <PgfAlignment Center>
  <PgfFIndent  0.0 mm>
  <PgfLIndent  0.0 mm>
  <PgfRIndent  0.0 mm>
  <PgfFIndentRelative No>
  <PgfFIndentOffset  0.0 mm>
  <PgfTopSeparator `'>
  <PgfTopSepAtIndent No>
  <PgfTopSepOffset  0.0 mm>
  <PgfBotSeparator `'>
  <PgfBotSepAtIndent No>
  <PgfBotSepOffset  0.0 mm>
  <PgfPlacement Anywhere>
  <PgfPlacementStyle Normal>
  <PgfRunInDefaultPunct `'>
  <PgfSpBefore  10.7 pt>
  <PgfSpAfter  0.0 pt>
  <PgfWithPrev No>
  <PgfWithNext Yes>
  <PgfBlockSize 2>
  <PgfFont 
   <FTag `'>
   <FPlatformName `W.Frutiger LT Std 55 Roman.I.400'>
   <FFamily `Frutiger LT Std 55 Roman'>
   <FVar `Regular'>
   <FWeight `Regular'>
   <FAngle `Italic'>
   <FPostScriptName `FrutigerLTStd-Italic'>
   <FEncoding `FrameRoman'>
   <FSize  8.6 pt>
   <FUnderlining FNoUnderlining>
   <FOverline No>
   <FStrike No>
   <FChangeBar No>
   <FOutline No>
   <FShadow No>
   <FPairKern Yes>
   <FTsume No>
   <FCase FAsTyped>
   <FPosition FNormal>
   <FDX  0.0%>
   <FDY  0.0%>
   <FDW  0.0%>
   <FStretch  100.0%>
   <FLanguage Swedish>
   <FLocked No>
   <FSeparation 0>
   <FColor `Black'>
   <FBackgroundColor NoColor>
  > # end of PgfFont
  <PgfLineSpacing Fixed>
  <PgfLeading  2.1 pt>
  <PgfAutoNum No>
  <PgfNumTabs 0>
  <PgfHyphenate Yes>
  <HyphenMaxLines 2>
  <HyphenMinPrefix 2>
  <HyphenMinSuffix 2>
  <HyphenMinWord 5>
  <PgfLetterSpace No>
  <PgfMinWordSpace 75>
  <PgfOptWordSpace 100>
  <PgfMaxWordSpace 125>
  <PgfMinJRomanLetterSpace 0>
  <PgfOptJRomanLetterSpace 25>
  <PgfMaxJRomanLetterSpace 50>
  <PgfMinJLetterSpace 0>
  <PgfOptJLetterSpace 0>
  <PgfMaxJLetterSpace 10>
  <PgfYakumonoType Floating>
  <PgfAcrobatLevel 0>
  <PgfPDFStructureLevel 10>
  <PgfLanguage Swedish>
  <PgfCellAlignment Top>
  <PgfCellMargins  0.0 pt 0.0 pt 0.0 pt 0.0 pt>
  <PgfCellLMarginFixed No>
  <PgfCellTMarginFixed No>
  <PgfCellRMarginFixed No>
  <PgfCellBMarginFixed No>
  <PgfLocked No>
 > # end of Pgf
 <Pgf 
  <PgfTag `Rub3efterRub2'>
  <PgfUseNextTag No>
  <PgfNextTag `'>
  <PgfAlignment Center>
  <PgfFIndent  0.0 mm>
  <PgfLIndent  0.0 mm>
  <PgfRIndent  0.0 mm>
  <PgfFIndentRelative No>
  <PgfFIndentOffset  0.0 mm>
  <PgfTopSeparator `'>
  <PgfTopSepAtIndent No>
  <PgfTopSepOffset  0.0 mm>
  <PgfBotSeparator `'>
  <PgfBotSepAtIndent No>
  <PgfBotSepOffset  0.0 mm>
  <PgfPlacement Anywhere>
  <PgfPlacementStyle Normal>
  <PgfRunInDefaultPunct `'>
  <PgfSpBefore  0.0 pt>
  <PgfSpAfter  0.0 pt>
  <PgfWithPrev No>
  <PgfWithNext Yes>
  <PgfBlockSize 2>
  <PgfFont 
   <FTag `'>
   <FPlatformName `W.Frutiger LT Std 55 Roman.I.400'>
   <FFamily `Frutiger LT Std 55 Roman'>
   <FVar `Regular'>
   <FWeight `Regular'>
   <FAngle `Italic'>
   <FPostScriptName `FrutigerLTStd-Italic'>
   <FEncoding `FrameRoman'>
   <FSize  8.6 pt>
   <FUnderlining FNoUnderlining>
   <FOverline No>
   <FStrike No>
   <FChangeBar No>
   <FOutline No>
   <FShadow No>
   <FPairKern Yes>
   <FTsume No>
   <FCase FAsTyped>
   <FPosition FNormal>
   <FDX  0.0%>
   <FDY  0.0%>
   <FDW  0.0%>
   <FStretch  100.0%>
   <FLanguage Swedish>
   <FLocked No>
   <FSeparation 0>
   <FColor `Black'>
   <FBackgroundColor NoColor>
  > # end of PgfFont
  <PgfLineSpacing Fixed>
  <PgfLeading  2.1 pt>
  <PgfAutoNum No>
  <PgfNumTabs 0>
  <PgfHyphenate Yes>
  <HyphenMaxLines 2>
  <HyphenMinPrefix 2>
  <HyphenMinSuffix 2>
  <HyphenMinWord 5>
  <PgfLetterSpace No>
  <PgfMinWordSpace 75>
  <PgfOptWordSpace 100>
  <PgfMaxWordSpace 125>
  <PgfMinJRomanLetterSpace 0>
  <PgfOptJRomanLetterSpace 25>
  <PgfMaxJRomanLetterSpace 50>
  <PgfMinJLetterSpace 0>
  <PgfOptJLetterSpace 0>
  <PgfMaxJLetterSpace 10>
  <PgfYakumonoType Floating>
  <PgfAcrobatLevel 0>
  <PgfPDFStructureLevel 10>
  <PgfLanguage Swedish>
  <PgfCellAlignment Top>
  <PgfCellMargins  0.0 pt 0.0 pt 0.0 pt 0.0 pt>
  <PgfCellLMarginFixed No>
  <PgfCellTMarginFixed No>
  <PgfCellRMarginFixed No>
  <PgfCellBMarginFixed No>
  <PgfLocked No>
 > # end of Pgf
 <Pgf 
  <PgfTag `TabellKolRub'>
  <PgfUseNextTag No>
  <PgfNextTag `'>
  <PgfAlignment Left>
  <PgfFIndent  0.0 mm>
  <PgfLIndent  0.0 mm>
  <PgfRIndent  0.0 mm>
  <PgfFIndentRelative No>
  <PgfFIndentOffset  0.0 mm>
  <PgfTopSeparator `'>
  <PgfTopSepAtIndent No>
  <PgfTopSepOffset  0.0 mm>
  <PgfBotSeparator `'>
  <PgfBotSepAtIndent No>
  <PgfBotSepOffset  0.0 mm>
  <PgfPlacement Anywhere>
  <PgfPlacementStyle Normal>
  <PgfRunInDefaultPunct `'>
  <PgfSpBefore  0.0 pt>
  <PgfSpAfter  0.0 pt>
  <PgfWithPrev No>
  <PgfWithNext No>
  <PgfBlockSize 2>
  <PgfFont 
   <FTag `'>
   <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
   <FFamily `Frutiger LT Std 45 Light'>
   <FVar `Regular'>
   <FWeight `Bold'>
   <FAngle `Regular'>
   <FPostScriptName `FrutigerLTStd-Bold'>
   <FEncoding `FrameRoman'>
   <FSize  8.0 pt>
   <FUnderlining FNoUnderlining>
   <FOverline No>
   <FStrike No>
   <FChangeBar No>
   <FOutline No>
   <FShadow No>
   <FPairKern Yes>
   <FTsume No>
   <FCase FAsTyped>
   <FPosition FNormal>
   <FDX  0.0%>
   <FDY  0.0%>
   <FDW  0.0%>
   <FStretch  100.0%>
   <FLanguage Swedish>
   <FLocked No>
   <FSeparation 0>
   <FColor `Black'>
   <FBackgroundColor NoColor>
  > # end of PgfFont
  <PgfLineSpacing Fixed>
  <PgfLeading  2.0 pt>
  <PgfAutoNum No>
  <PgfNumTabs 0>
  <PgfHyphenate Yes>
  <HyphenMaxLines 2>
  <HyphenMinPrefix 2>
  <HyphenMinSuffix 2>
  <HyphenMinWord 5>
  <PgfLetterSpace No>
  <PgfMinWordSpace 75>
  <PgfOptWordSpace 100>
  <PgfMaxWordSpace 125>
  <PgfMinJRomanLetterSpace 0>
  <PgfOptJRomanLetterSpace 25>
  <PgfMaxJRomanLetterSpace 50>
  <PgfMinJLetterSpace 0>
  <PgfOptJLetterSpace 0>
  <PgfMaxJLetterSpace 10>
  <PgfYakumonoType Floating>
  <PgfAcrobatLevel 0>
  <PgfPDFStructureLevel 0>
  <PgfLanguage Swedish>
  <PgfCellAlignment Top>
  <PgfCellMargins  0.0 pt 0.0 pt -5.0 pt 0.0 pt>
  <PgfCellLMarginFixed No>
  <PgfCellTMarginFixed No>
  <PgfCellRMarginFixed No>
  <PgfCellBMarginFixed No>
  <PgfLocked No>
 > # end of Pgf
 <Pgf 
  <PgfTag `TabellLinje'>
  <PgfUseNextTag No>
  <PgfNextTag `'>
  <PgfAlignment LeftRight>
  <PgfFIndent  0.0 mm>
  <PgfLIndent  0.0 mm>
  <PgfRIndent  0.0 mm>
  <PgfFIndentRelative No>
  <PgfFIndentOffset  0.0 mm>
  <PgfTopSeparator `'>
  <PgfTopSepAtIndent No>
  <PgfTopSepOffset  0.0 mm>
  <PgfBotSeparator `'>
  <PgfBotSepAtIndent No>
  <PgfBotSepOffset  0.0 mm>
  <PgfPlacement Anywhere>
  <PgfPlacementStyle Normal>
  <PgfRunInDefaultPunct `'>
  <PgfSpBefore  0.0 pt>
  <PgfSpAfter  0.0 pt>
  <PgfWithPrev No>
  <PgfWithNext No>
  <PgfBlockSize 2>
  <PgfFont 
   <FTag `'>
   <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
   <FFamily `Frutiger LT Std 55 Roman'>
   <FVar `Regular'>
   <FWeight `Regular'>
   <FAngle `Regular'>
   <FPostScriptName `FrutigerLTStd-Roman'>
   <FEncoding `FrameRoman'>
   <FSize  2.0 pt>
   <FUnderlining FNoUnderlining>
   <FOverline No>
   <FStrike No>
   <FChangeBar No>
   <FOutline No>
   <FShadow No>
   <FPairKern Yes>
   <FTsume No>
   <FCase FAsTyped>
   <FPosition FNormal>
   <FDX  0.0%>
   <FDY  0.0%>
   <FDW  0.0%>
   <FStretch  100.0%>
   <FLanguage Swedish>
   <FLocked No>
   <FSeparation 0>
   <FColor `Black'>
   <FBackgroundColor NoColor>
  > # end of PgfFont
  <PgfLineSpacing Fixed>
  <PgfLeading  0.0 pt>
  <PgfAutoNum No>
  <PgfNumTabs 0>
  <PgfHyphenate Yes>
  <HyphenMaxLines 2>
  <HyphenMinPrefix 2>
  <HyphenMinSuffix 2>
  <HyphenMinWord 5>
  <PgfLetterSpace No>
  <PgfMinWordSpace 75>
  <PgfOptWordSpace 100>
  <PgfMaxWordSpace 125>
  <PgfMinJRomanLetterSpace 0>
  <PgfOptJRomanLetterSpace 25>
  <PgfMaxJRomanLetterSpace 50>
  <PgfMinJLetterSpace 0>
  <PgfOptJLetterSpace 0>
  <PgfMaxJLetterSpace 10>
  <PgfYakumonoType Floating>
  <PgfAcrobatLevel 0>
  <PgfPDFStructureLevel 26>
  <PgfLanguage Swedish>
  <PgfCellAlignment Top>
  <PgfCellMargins  -8.504 pt -2.7 pt -8.504 pt -3.0 pt>
  <PgfCellLMarginFixed No>
  <PgfCellTMarginFixed No>
  <PgfCellRMarginFixed No>
  <PgfCellBMarginFixed No>
  <PgfLocked No>
 > # end of Pgf
 <Pgf 
  <PgfTag `TabellRekRub'>
  <PgfUseNextTag No>
  <PgfNextTag `'>
  <PgfAlignment Left>
  <PgfFIndent  2.822 mm>
  <PgfLIndent  2.822 mm>
  <PgfRIndent  0.0 mm>
  <PgfFIndentRelative No>
  <PgfFIndentOffset  0.0 mm>
  <PgfTopSeparator `Tjock_Tunn_Tabellhuvud'>
  <PgfTopSepAtIndent No>
  <PgfTopSepOffset  0.0 mm>
  <PgfBotSeparator `Tunn_Tabellhuvud'>
  <PgfBotSepAtIndent No>
  <PgfBotSepOffset  0.0 mm>
  <PgfPlacement Anywhere>
  <PgfPlacementStyle Normal>
  <PgfRunInDefaultPunct `'>
  <PgfSpBefore  0.0 pt>
  <PgfSpAfter  0.0 pt>
  <PgfWithPrev No>
  <PgfWithNext No>
  <PgfBlockSize 2>
  <PgfFont 
   <FTag `'>
   <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
   <FFamily `Frutiger LT Std 45 Light'>
   <FVar `Regular'>
   <FWeight `Bold'>
   <FAngle `Regular'>
   <FPostScriptName `FrutigerLTStd-Bold'>
   <FEncoding `FrameRoman'>
   <FSize  8.0 pt>
   <FUnderlining FNoUnderlining>
   <FOverline No>
   <FStrike No>
   <FChangeBar No>
   <FOutline No>
   <FShadow No>
   <FPairKern Yes>
   <FTsume No>
   <FCase FAsTyped>
   <FPosition FNormal>
   <FDX  0.0%>
   <FDY  0.0%>
   <FDW  0.0%>
   <FStretch  100.0%>
   <FLanguage Swedish>
   <FLocked No>
   <FSeparation 0>
   <FColor `Black'>
   <FBackgroundColor NoColor>
  > # end of PgfFont
  <PgfLineSpacing Fixed>
  <PgfLeading  2.0 pt>
  <PgfAutoNum Yes>
  <PgfNumFormat `Terapirekommendationer – '>
  <PgfNumberFont `'>
  <PgfNumAtEnd No>
  <PgfNumTabs 0>
  <PgfHyphenate Yes>
  <HyphenMaxLines 2>
  <HyphenMinPrefix 2>
  <HyphenMinSuffix 2>
  <HyphenMinWord 5>
  <PgfLetterSpace No>
  <PgfMinWordSpace 75>
  <PgfOptWordSpace 100>
  <PgfMaxWordSpace 125>
  <PgfMinJRomanLetterSpace 0>
  <PgfOptJRomanLetterSpace 25>
  <PgfMaxJRomanLetterSpace 50>
  <PgfMinJLetterSpace 0>
  <PgfOptJLetterSpace 0>
  <PgfMaxJLetterSpace 10>
  <PgfYakumonoType Floating>
  <PgfAcrobatLevel 0>
  <PgfPDFStructureLevel 26>
  <PgfLanguage Swedish>
  <PgfCellAlignment Top>
  <PgfCellMargins  0.0 pt 0.0 pt 0.0 pt 0.0 pt>
  <PgfCellLMarginFixed No>
  <PgfCellTMarginFixed No>
  <PgfCellRMarginFixed No>
  <PgfCellBMarginFixed No>
  <PgfLocked No>
 > # end of Pgf
 <Pgf 
  <PgfTag `TabellRubrik_1sp'>
  <PgfUseNextTag No>
  <PgfNextTag `'>
  <PgfAlignment Left>
  <PgfFIndent  2.82223 mm>
  <PgfLIndent  2.82223 mm>
  <PgfRIndent  0.0 mm>
  <PgfFIndentRelative No>
  <PgfFIndentOffset  0.0 mm>
  <PgfTopSeparator `'>
  <PgfTopSepAtIndent No>
  <PgfTopSepOffset  0.0 mm>
  <PgfBotSeparator `TabellLinje'>
  <PgfBotSepAtIndent No>
  <PgfBotSepOffset  0.0 mm>
  <PgfPlacement Anywhere>
  <PgfPlacementStyle Normal>
  <PgfRunInDefaultPunct `'>
  <PgfSpBefore  10.7 pt>
  <PgfSpAfter  0.0 pt>
  <PgfWithPrev No>
  <PgfWithNext No>
  <PgfBlockSize 2>
  <PgfFont 
   <FTag `'>
   <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
   <FFamily `Frutiger LT Std 55 Roman'>
   <FVar `Regular'>
   <FWeight `Regular'>
   <FAngle `Regular'>
   <FPostScriptName `FrutigerLTStd-Roman'>
   <FEncoding `FrameRoman'>
   <FSize  8.0 pt>
   <FUnderlining FNoUnderlining>
   <FOverline No>
   <FStrike No>
   <FChangeBar No>
   <FOutline No>
   <FShadow No>
   <FPairKern Yes>
   <FTsume No>
   <FCase FAsTyped>
   <FPosition FNormal>
   <FDX  0.0%>
   <FDY  0.0%>
   <FDW  0.0%>
   <FStretch  100.0%>
   <FLanguage Swedish>
   <FLocked No>
   <FSeparation 0>
   <FColor `Black'>
   <FBackgroundColor NoColor>
  > # end of PgfFont
  <PgfLineSpacing Fixed>
  <PgfLeading  1.0 pt>
  <PgfAutoNum Yes>
  <PgfNumFormat `T:Tabell <n+\>. '>
  <PgfNumberFont `FigTabFet'>
  <PgfNumAtEnd No>
  <PgfNumTabs 0>
  <PgfHyphenate No>
  <HyphenMaxLines 2>
  <HyphenMinPrefix 3>
  <HyphenMinSuffix 3>
  <HyphenMinWord 5>
  <PgfLetterSpace No>
  <PgfMinWordSpace 90>
  <PgfOptWordSpace 100>
  <PgfMaxWordSpace 110>
  <PgfMinJRomanLetterSpace 0>
  <PgfOptJRomanLetterSpace 25>
  <PgfMaxJRomanLetterSpace 50>
  <PgfMinJLetterSpace 0>
  <PgfOptJLetterSpace 0>
  <PgfMaxJLetterSpace 10>
  <PgfYakumonoType Floating>
  <PgfAcrobatLevel 0>
  <PgfPDFStructureLevel 0>
  <PgfLanguage Swedish>
  <PgfCellAlignment Top>
  <PgfCellMargins  0.0 pt 0.0 pt 0.0 pt 0.0 pt>
  <PgfCellLMarginFixed No>
  <PgfCellTMarginFixed No>
  <PgfCellRMarginFixed No>
  <PgfCellBMarginFixed No>
  <PgfLocked No>
 > # end of Pgf
 <Pgf 
  <PgfTag `TabellRubrik_2sp'>
  <PgfUseNextTag No>
  <PgfNextTag `'>
  <PgfAlignment Left>
  <PgfFIndent  2.82223 mm>
  <PgfLIndent  2.82223 mm>
  <PgfRIndent  0.0 mm>
  <PgfFIndentRelative No>
  <PgfFIndentOffset  0.0 mm>
  <PgfTopSeparator `'>
  <PgfTopSepAtIndent No>
  <PgfTopSepOffset  0.0 mm>
  <PgfBotSeparator `TabellLinje'>
  <PgfBotSepAtIndent No>
  <PgfBotSepOffset  0.0 mm>
  <PgfPlacement Anywhere>
  <PgfPlacementStyle StraddleNormalOnly>
  <PgfRunInDefaultPunct `'>
  <PgfSpBefore  10.7 pt>
  <PgfSpAfter  0.0 pt>
  <PgfWithPrev No>
  <PgfWithNext No>
  <PgfBlockSize 2>
  <PgfFont 
   <FTag `'>
   <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
   <FFamily `Frutiger LT Std 55 Roman'>
   <FVar `Regular'>
   <FWeight `Regular'>
   <FAngle `Regular'>
   <FPostScriptName `FrutigerLTStd-Roman'>
   <FEncoding `FrameRoman'>
   <FSize  8.0 pt>
   <FUnderlining FNoUnderlining>
   <FOverline No>
   <FStrike No>
   <FChangeBar No>
   <FOutline No>
   <FShadow No>
   <FPairKern Yes>
   <FTsume No>
   <FCase FAsTyped>
   <FPosition FNormal>
   <FDX  0.0%>
   <FDY  0.0%>
   <FDW  0.0%>
   <FStretch  100.0%>
   <FLanguage Swedish>
   <FLocked No>
   <FSeparation 0>
   <FColor `Black'>
   <FBackgroundColor NoColor>
  > # end of PgfFont
  <PgfLineSpacing Fixed>
  <PgfLeading  1.0 pt>
  <PgfAutoNum Yes>
  <PgfNumFormat `T:Tabell <n+\>. '>
  <PgfNumberFont `FigTabFet'>
  <PgfNumAtEnd No>
  <PgfNumTabs 0>
  <PgfHyphenate No>
  <HyphenMaxLines 2>
  <HyphenMinPrefix 3>
  <HyphenMinSuffix 3>
  <HyphenMinWord 5>
  <PgfLetterSpace No>
  <PgfMinWordSpace 90>
  <PgfOptWordSpace 100>
  <PgfMaxWordSpace 110>
  <PgfMinJRomanLetterSpace 0>
  <PgfOptJRomanLetterSpace 25>
  <PgfMaxJRomanLetterSpace 50>
  <PgfMinJLetterSpace 0>
  <PgfOptJLetterSpace 0>
  <PgfMaxJLetterSpace 10>
  <PgfYakumonoType Floating>
  <PgfAcrobatLevel 0>
  <PgfPDFStructureLevel 0>
  <PgfLanguage Swedish>
  <PgfCellAlignment Top>
  <PgfCellMargins  0.0 pt 0.0 pt 0.0 pt 0.0 pt>
  <PgfCellLMarginFixed No>
  <PgfCellTMarginFixed No>
  <PgfCellRMarginFixed No>
  <PgfCellBMarginFixed No>
  <PgfLocked No>
 > # end of Pgf
 <Pgf 
  <PgfTag `TabellText'>
  <PgfUseNextTag No>
  <PgfNextTag `'>
  <PgfAlignment Left>
  <PgfFIndent  0.0 mm>
  <PgfLIndent  0.0 mm>
  <PgfRIndent  0.0 mm>
  <PgfFIndentRelative No>
  <PgfFIndentOffset  0.0 mm>
  <PgfTopSeparator `'>
  <PgfTopSepAtIndent No>
  <PgfTopSepOffset  0.0 mm>
  <PgfBotSeparator `'>
  <PgfBotSepAtIndent No>
  <PgfBotSepOffset  0.0 mm>
  <PgfPlacement Anywhere>
  <PgfPlacementStyle Normal>
  <PgfRunInDefaultPunct `'>
  <PgfSpBefore  0.0 pt>
  <PgfSpAfter  0.0 pt>
  <PgfWithPrev No>
  <PgfWithNext No>
  <PgfBlockSize 2>
  <PgfFont 
   <FTag `'>
   <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
   <FFamily `Frutiger LT Std 55 Roman'>
   <FVar `Regular'>
   <FWeight `Regular'>
   <FAngle `Regular'>
   <FPostScriptName `FrutigerLTStd-Roman'>
   <FEncoding `FrameRoman'>
   <FSize  7.0 pt>
   <FUnderlining FNoUnderlining>
   <FOverline No>
   <FStrike No>
   <FChangeBar No>
   <FOutline No>
   <FShadow No>
   <FPairKern Yes>
   <FTsume No>
   <FCase FAsTyped>
   <FPosition FNormal>
   <FDX  0.0%>
   <FDY  0.0%>
   <FDW  0.0%>
   <FStretch  100.0%>
   <FLanguage Swedish>
   <FLocked No>
   <FSeparation 0>
   <FColor `Black'>
   <FBackgroundColor NoColor>
  > # end of PgfFont
  <PgfLineSpacing Fixed>
  <PgfLeading  2.0 pt>
  <PgfAutoNum No>
  <PgfNumTabs 0>
  <PgfHyphenate Yes>
  <HyphenMaxLines 2>
  <HyphenMinPrefix 2>
  <HyphenMinSuffix 2>
  <HyphenMinWord 5>
  <PgfLetterSpace No>
  <PgfMinWordSpace 75>
  <PgfOptWordSpace 100>
  <PgfMaxWordSpace 125>
  <PgfMinJRomanLetterSpace 0>
  <PgfOptJRomanLetterSpace 25>
  <PgfMaxJRomanLetterSpace 50>
  <PgfMinJLetterSpace 0>
  <PgfOptJLetterSpace 0>
  <PgfMaxJLetterSpace 10>
  <PgfYakumonoType Floating>
  <PgfAcrobatLevel 0>
  <PgfPDFStructureLevel 0>
  <PgfLanguage Swedish>
  <PgfCellAlignment Top>
  <PgfCellMargins  0.0 pt 0.0 pt 0.0 pt 0.0 pt>
  <PgfCellLMarginFixed No>
  <PgfCellTMarginFixed No>
  <PgfCellRMarginFixed No>
  <PgfCellBMarginFixed No>
  <PgfLocked No>
 > # end of Pgf
 <Pgf 
  <PgfTag `TabellTextFet'>
  <PgfUseNextTag No>
  <PgfNextTag `'>
  <PgfAlignment Left>
  <PgfFIndent  0.0 mm>
  <PgfLIndent  0.0 mm>
  <PgfRIndent  0.0 mm>
  <PgfFIndentRelative No>
  <PgfFIndentOffset  0.0 mm>
  <PgfTopSeparator `'>
  <PgfTopSepAtIndent No>
  <PgfTopSepOffset  0.0 mm>
  <PgfBotSeparator `'>
  <PgfBotSepAtIndent No>
  <PgfBotSepOffset  0.0 mm>
  <PgfPlacement Anywhere>
  <PgfPlacementStyle Normal>
  <PgfRunInDefaultPunct `'>
  <PgfSpBefore  0.0 pt>
  <PgfSpAfter  0.0 pt>
  <PgfWithPrev No>
  <PgfWithNext No>
  <PgfBlockSize 2>
  <PgfFont 
   <FTag `'>
   <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
   <FFamily `Frutiger LT Std 45 Light'>
   <FVar `Regular'>
   <FWeight `Bold'>
   <FAngle `Regular'>
   <FPostScriptName `FrutigerLTStd-Bold'>
   <FEncoding `FrameRoman'>
   <FSize  7.0 pt>
   <FUnderlining FNoUnderlining>
   <FOverline No>
   <FStrike No>
   <FChangeBar No>
   <FOutline No>
   <FShadow No>
   <FPairKern Yes>
   <FTsume No>
   <FCase FAsTyped>
   <FPosition FNormal>
   <FDX  0.0%>
   <FDY  0.0%>
   <FDW  0.0%>
   <FStretch  100.0%>
   <FLanguage Swedish>
   <FLocked No>
   <FSeparation 0>
   <FColor `Black'>
   <FBackgroundColor NoColor>
  > # end of PgfFont
  <PgfLineSpacing Fixed>
  <PgfLeading  2.0 pt>
  <PgfAutoNum No>
  <PgfNumTabs 0>
  <PgfHyphenate Yes>
  <HyphenMaxLines 2>
  <HyphenMinPrefix 2>
  <HyphenMinSuffix 2>
  <HyphenMinWord 5>
  <PgfLetterSpace No>
  <PgfMinWordSpace 75>
  <PgfOptWordSpace 100>
  <PgfMaxWordSpace 125>
  <PgfMinJRomanLetterSpace 0>
  <PgfOptJRomanLetterSpace 25>
  <PgfMaxJRomanLetterSpace 50>
  <PgfMinJLetterSpace 0>
  <PgfOptJLetterSpace 0>
  <PgfMaxJLetterSpace 10>
  <PgfYakumonoType Floating>
  <PgfAcrobatLevel 0>
  <PgfPDFStructureLevel 26>
  <PgfLanguage Swedish>
  <PgfCellAlignment Top>
  <PgfCellMargins  0.0 pt 0.0 pt 0.0 pt 0.0 pt>
  <PgfCellLMarginFixed No>
  <PgfCellTMarginFixed No>
  <PgfCellRMarginFixed No>
  <PgfCellBMarginFixed No>
  <PgfLocked No>
 > # end of Pgf
 <Pgf 
  <PgfTag `TabellTextPunkt'>
  <PgfUseNextTag No>
  <PgfNextTag `'>
  <PgfAlignment Left>
  <PgfFIndent  0.0 mm>
  <PgfLIndent  3.0 mm>
  <PgfRIndent  0.0 mm>
  <PgfFIndentRelative No>
  <PgfFIndentOffset  0.0 mm>
  <PgfTopSeparator `'>
  <PgfTopSepAtIndent No>
  <PgfTopSepOffset  0.0 mm>
  <PgfBotSeparator `'>
  <PgfBotSepAtIndent No>
  <PgfBotSepOffset  0.0 mm>
  <PgfPlacement Anywhere>
  <PgfPlacementStyle Normal>
  <PgfRunInDefaultPunct `'>
  <PgfSpBefore  0.0 pt>
  <PgfSpAfter  0.0 pt>
  <PgfWithPrev No>
  <PgfWithNext No>
  <PgfBlockSize 2>
  <PgfFont 
   <FTag `'>
   <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
   <FFamily `Frutiger LT Std 55 Roman'>
   <FVar `Regular'>
   <FWeight `Regular'>
   <FAngle `Regular'>
   <FPostScriptName `FrutigerLTStd-Roman'>
   <FEncoding `FrameRoman'>
   <FSize  7.0 pt>
   <FUnderlining FNoUnderlining>
   <FOverline No>
   <FStrike No>
   <FChangeBar No>
   <FOutline No>
   <FShadow No>
   <FPairKern Yes>
   <FTsume No>
   <FCase FAsTyped>
   <FPosition FNormal>
   <FDX  0.0%>
   <FDY  0.0%>
   <FDW  0.0%>
   <FStretch  100.0%>
   <FLanguage Swedish>
   <FLocked No>
   <FSeparation 0>
   <FColor `Black'>
   <FBackgroundColor NoColor>
  > # end of PgfFont
  <PgfLineSpacing Fixed>
  <PgfLeading  2.0 pt>
  <PgfAutoNum Yes>
  <PgfNumFormat `•\\t'>
  <PgfNumberFont `'>
  <PgfNumAtEnd No>
  <PgfNumTabs 1>
  <TabStop 
   <TSX  3.0 mm>
   <TSType Left>
   <TSLeaderStr ` '>
  > # end of TabStop
  <PgfHyphenate Yes>
  <HyphenMaxLines 2>
  <HyphenMinPrefix 2>
  <HyphenMinSuffix 2>
  <HyphenMinWord 5>
  <PgfLetterSpace No>
  <PgfMinWordSpace 75>
  <PgfOptWordSpace 100>
  <PgfMaxWordSpace 125>
  <PgfMinJRomanLetterSpace 0>
  <PgfOptJRomanLetterSpace 25>
  <PgfMaxJRomanLetterSpace 50>
  <PgfMinJLetterSpace 0>
  <PgfOptJLetterSpace 0>
  <PgfMaxJLetterSpace 10>
  <PgfYakumonoType Floating>
  <PgfAcrobatLevel 0>
  <PgfPDFStructureLevel 26>
  <PgfLanguage Swedish>
  <PgfCellAlignment Top>
  <PgfCellMargins  0.0 pt 0.0 pt 0.0 pt 0.0 pt>
  <PgfCellLMarginFixed No>
  <PgfCellTMarginFixed No>
  <PgfCellRMarginFixed No>
  <PgfCellBMarginFixed No>
  <PgfLocked No>
 > # end of Pgf
 <Pgf 
  <PgfTag `TableFootnote'>
  <PgfUseNextTag No>
  <PgfNextTag `'>
  <PgfAlignment Left>
  <PgfFIndent  2.82223 mm>
  <PgfLIndent  2.82223 mm>
  <PgfRIndent  2.82223 mm>
  <PgfFIndentRelative No>
  <PgfFIndentOffset  0.0 mm>
  <PgfTopSeparator `'>
  <PgfTopSepAtIndent No>
  <PgfTopSepOffset  0.0 mm>
  <PgfBotSeparator `'>
  <PgfBotSepAtIndent No>
  <PgfBotSepOffset  0.0 mm>
  <PgfPlacement Anywhere>
  <PgfPlacementStyle Normal>
  <PgfRunInDefaultPunct `. '>
  <PgfSpBefore  0.0 pt>
  <PgfSpAfter  0.0 pt>
  <PgfWithPrev No>
  <PgfWithNext No>
  <PgfBlockSize 1>
  <PgfFont 
   <FTag `'>
   <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
   <FFamily `Frutiger LT Std 55 Roman'>
   <FVar `Regular'>
   <FWeight `Regular'>
   <FAngle `Regular'>
   <FPostScriptName `FrutigerLTStd-Roman'>
   <FEncoding `FrameRoman'>
   <FSize  6.0 pt>
   <FUnderlining FNoUnderlining>
   <FOverline No>
   <FStrike No>
   <FChangeBar No>
   <FOutline No>
   <FShadow No>
   <FPairKern Yes>
   <FTsume No>
   <FCase FAsTyped>
   <FPosition FNormal>
   <FDX  0.0%>
   <FDY  0.0%>
   <FDW  0.0%>
   <FStretch  100.0%>
   <FLanguage Swedish>
   <FLocked No>
   <FSeparation 0>
   <FColor `Black'>
   <FBackgroundColor NoColor>
  > # end of PgfFont
  <PgfLineSpacing Fixed>
  <PgfLeading  2.0 pt>
  <PgfAutoNum No>
  <PgfNumTabs 0>
  <PgfHyphenate Yes>
  <HyphenMaxLines 2>
  <HyphenMinPrefix 2>
  <HyphenMinSuffix 2>
  <HyphenMinWord 5>
  <PgfLetterSpace No>
  <PgfMinWordSpace 75>
  <PgfOptWordSpace 100>
  <PgfMaxWordSpace 125>
  <PgfMinJRomanLetterSpace 0>
  <PgfOptJRomanLetterSpace 25>
  <PgfMaxJRomanLetterSpace 50>
  <PgfMinJLetterSpace 0>
  <PgfOptJLetterSpace 0>
  <PgfMaxJLetterSpace 10>
  <PgfYakumonoType Floating>
  <PgfAcrobatLevel 0>
  <PgfPDFStructureLevel 6>
  <PgfLanguage Swedish>
  <PgfCellAlignment Top>
  <PgfCellMargins  0.0 pt 0.0 pt 0.0 pt 0.0 pt>
  <PgfCellLMarginFixed No>
  <PgfCellTMarginFixed No>
  <PgfCellRMarginFixed No>
  <PgfCellBMarginFixed No>
  <PgfLocked No>
 > # end of Pgf
> # end of PgfCatalog
<FontCatalog 
 <Font 
  <FTag `Black'>
  <FLocked No>
  <FSeparation 0>
  <FColor `Black'>
 > # end of Font
 <Font 
  <FTag `Blue'>
  <FLocked No>
  <FSeparation 4>
  <FColor `Blue'>
 > # end of Font
 <Font 
  <FTag `BrödKursiv'>
  <FPlatformName `W.NewCenturySchlbk LT Std.I.400'>
  <FFamily `NewCenturySchlbk LT Std'>
  <FVar `Regular'>
  <FWeight `Regular'>
  <FAngle `Italic'>
  <FPostScriptName `NewCenturySchlbkLTStd-It'>
  <FEncoding `FrameRoman'>
  <FSize  9.0 pt>
  <FUnderlining FNoUnderlining>
  <FOverline No>
  <FStrike No>
  <FChangeBar No>
  <FOutline No>
  <FShadow No>
  <FPairKern Yes>
  <FTsume No>
  <FCase FAsTyped>
  <FPosition FNormal>
  <FDW  0.0%>
  <FStretch  100.0%>
  <FLanguage Swedish>
  <FLocked No>
  <FSeparation 0>
  <FColor `Black'>
 > # end of Font
 <Font 
  <FTag `FaktaFet'>
  <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
  <FFamily `Frutiger LT Std 45 Light'>
  <FVar `Regular'>
  <FWeight `Bold'>
  <FAngle `Regular'>
  <FPostScriptName `FrutigerLTStd-Bold'>
  <FEncoding `FrameRoman'>
  <FSize  7.5 pt>
  <FUnderlining FNoUnderlining>
  <FOverline No>
  <FStrike No>
  <FChangeBar No>
  <FOutline No>
  <FShadow No>
  <FPairKern Yes>
  <FTsume No>
  <FCase FAsTyped>
  <FPosition FNormal>
  <FDW  0.0%>
  <FStretch  100.0%>
  <FLanguage Swedish>
  <FLocked No>
  <FSeparation 0>
  <FColor `Black'>
 > # end of Font
 <Font 
  <FTag `Fet'>
  <FWeight `Bold'>
  <FLocked No>
 > # end of Font
 <Font 
  <FTag `FigTabFet'>
  <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
  <FFamily `Frutiger LT Std 45 Light'>
  <FVar `Regular'>
  <FWeight `Bold'>
  <FAngle `Regular'>
  <FPostScriptName `FrutigerLTStd-Bold'>
  <FEncoding `FrameRoman'>
  <FSize  8.0 pt>
  <FUnderlining FNoUnderlining>
  <FOverline No>
  <FStrike No>
  <FChangeBar No>
  <FOutline No>
  <FShadow No>
  <FPairKern Yes>
  <FTsume No>
  <FCase FAsTyped>
  <FPosition FNormal>
  <FDW  0.0%>
  <FStretch  100.0%>
  <FLanguage Swedish>
  <FLocked No>
  <FSeparation 0>
  <FColor `Black'>
 > # end of Font
 <Font 
  <FTag `LänkSidhuvud'>
  <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
  <FFamily `Frutiger LT Std 45 Light'>
  <FVar `Regular'>
  <FWeight `Bold'>
  <FAngle `Regular'>
  <FPostScriptName `FrutigerLTStd-Bold'>
  <FEncoding `FrameRoman'>
  <FSize  9.0 pt>
  <FUnderlining FNoUnderlining>
  <FOverline No>
  <FStrike No>
  <FChangeBar No>
  <FOutline No>
  <FShadow No>
  <FPairKern Yes>
  <FTsume No>
  <FCase FAsTyped>
  <FPosition FNormal>
  <FDW  0.0%>
  <FStretch  100.0%>
  <FLanguage Swedish>
  <FLocked No>
  <FSeparation 4>
  <FColor `Blue'>
 > # end of Font
 <Font 
  <FTag `Nedsänkt'>
  <FPosition FSubscript>
  <FLocked No>
 > # end of Font
 <Font 
  <FTag `PrepFet'>
  <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
  <FFamily `Frutiger LT Std 45 Light'>
  <FVar `Regular'>
  <FWeight `Bold'>
  <FAngle `Regular'>
  <FPostScriptName `FrutigerLTStd-Bold'>
  <FEncoding `FrameRoman'>
  <FSize  7.0 pt>
  <FUnderlining FNoUnderlining>
  <FOverline No>
  <FStrike No>
  <FChangeBar No>
  <FOutline No>
  <FShadow No>
  <FPairKern Yes>
  <FTsume No>
  <FCase FAsTyped>
  <FPosition FNormal>
  <FDW  0.0%>
  <FStretch  100.0%>
  <FLanguage Swedish>
  <FLocked No>
  <FSeparation 0>
  <FColor `Black'>
 > # end of Font
 <Font 
  <FTag `Ref'>
  <FSize  2.0 pt>
  <FLocked No>
  <FSeparation 1>
  <FColor `White'>
 > # end of Font
 <Font 
  <FTag `Symbol'>
  <FFamily `Symbol'>
  <FWeight `Bolded'>
  <FEncoding `FrameRoman'>
  <FLocked No>
 > # end of Font
 <Font 
  <FTag `TabellFet'>
  <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
  <FFamily `Frutiger LT Std 45 Light'>
  <FVar `Regular'>
  <FWeight `Bold'>
  <FAngle `Regular'>
  <FPostScriptName `FrutigerLTStd-Bold'>
  <FEncoding `FrameRoman'>
  <FSize  7.0 pt>
  <FUnderlining FNoUnderlining>
  <FOverline No>
  <FStrike No>
  <FChangeBar No>
  <FOutline No>
  <FShadow No>
  <FPairKern Yes>
  <FTsume No>
  <FCase FAsTyped>
  <FPosition FNormal>
  <FDW  0.0%>
  <FStretch  100.0%>
  <FLanguage Swedish>
  <FLocked No>
  <FSeparation 0>
  <FColor `Black'>
 > # end of Font
 <Font 
  <FTag `Text i bild'>
  <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
  <FFamily `Frutiger LT Std 55 Roman'>
  <FVar `Regular'>
  <FWeight `Regular'>
  <FAngle `Regular'>
  <FPostScriptName `FrutigerLTStd-Roman'>
  <FEncoding `FrameRoman'>
  <FSize  7.0 pt>
  <FUnderlining FNoUnderlining>
  <FOverline No>
  <FStrike No>
  <FChangeBar No>
  <FOutline No>
  <FShadow No>
  <FPairKern Yes>
  <FTsume No>
  <FCase FAsTyped>
  <FPosition FNormal>
  <FDW  0.0%>
  <FStretch  100.0%>
  <FLanguage Swedish>
  <FLocked No>
  <FSeparation 0>
  <FColor `Black'>
 > # end of Font
 <Font 
  <FTag `Text i bildFet'>
  <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
  <FFamily `Frutiger LT Std 45 Light'>
  <FVar `Regular'>
  <FWeight `Bold'>
  <FAngle `Regular'>
  <FPostScriptName `FrutigerLTStd-Bold'>
  <FEncoding `FrameRoman'>
  <FSize  7.0 pt>
  <FUnderlining FNoUnderlining>
  <FOverline No>
  <FStrike No>
  <FChangeBar No>
  <FOutline No>
  <FShadow No>
  <FPairKern Yes>
  <FTsume No>
  <FCase FAsTyped>
  <FPosition FNormal>
  <FDW  0.0%>
  <FStretch  100.0%>
  <FLanguage Swedish>
  <FLocked No>
  <FSeparation 0>
  <FColor `Black'>
 > # end of Font
 <Font 
  <FTag `Upphöjt'>
  <FPosition FSuperscript>
  <FLocked No>
 > # end of Font
> # end of FontCatalog
<RulingCatalog 
 <Ruling 
  <RulingTag `Thin'>
  <RulingPenWidth  2.0 pt>
  <RulingGap  0.0 pt>
  <RulingSeparation 5>
  <RulingColor `Svart 35%'>
  <RulingPen 0>
  <RulingLines 1>
 > # end of Ruling
 <Ruling 
  <RulingTag `Medium'>
  <RulingPenWidth  2.0 pt>
  <RulingGap  0.0 pt>
  <RulingSeparation 0>
  <RulingColor `Black'>
  <RulingPen 0>
  <RulingLines 1>
 > # end of Ruling
 <Ruling 
  <RulingTag `Double'>
  <RulingPenWidth  0.5 pt>
  <RulingGap  2.0 pt>
  <RulingSeparation 0>
  <RulingColor `Black'>
  <RulingPen 0>
  <RulingLines 2>
 > # end of Ruling
 <Ruling 
  <RulingTag `Thick'>
  <RulingPenWidth  3.0 pt>
  <RulingGap  0.0 pt>
  <RulingSeparation 0>
  <RulingColor `Black'>
  <RulingPen 0>
  <RulingLines 1>
 > # end of Ruling
 <Ruling 
  <RulingTag `Very Thin'>
  <RulingPenWidth  0.25 pt>
  <RulingGap  0.0 pt>
  <RulingSeparation 0>
  <RulingColor `Black'>
  <RulingPen 0>
  <RulingLines 1>
 > # end of Ruling
 <Ruling 
  <RulingTag `Grå tjock'>
  <RulingPenWidth  1.5 pt>
  <RulingGap  0.0 pt>
  <RulingSeparation 5>
  <RulingColor `Svart 35%'>
  <RulingPen 0>
  <RulingLines 1>
 > # end of Ruling
 <Ruling 
  <RulingTag `Grå tunn'>
  <RulingPenWidth  0.5 pt>
  <RulingGap  0.0 pt>
  <RulingSeparation 5>
  <RulingColor `Svart 35%'>
  <RulingPen 0>
  <RulingLines 1>
 > # end of Ruling
 <Ruling 
  <RulingTag `Mycket tunn'>
  <RulingPenWidth  0.25 pt>
  <RulingGap  0.0 pt>
  <RulingSeparation 0>
  <RulingColor `Black'>
  <RulingPen 0>
  <RulingLines 1>
 > # end of Ruling
> # end of RulingCatalog
<TblCatalog 
 <TblFormat 
  <TblTag `Tabell faktaruta'>
  <TblColumn 
   <TblColumnNum 0>
   <TblColumnWidth  63.5 mm>
   <TblColumnH 
    <PgfTag `FaktaRub1'>
    <Pgf 
     <PgfAlignment LeftRight>
     <PgfSpBefore  0.0 pt>
     <PgfSpAfter  0.0 pt>
     <PgfFont 
      <FTag `'>
      <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
      <FFamily `Frutiger LT Std 45 Light'>
      <FVar `Regular'>
      <FWeight `Bold'>
      <FAngle `Regular'>
      <FPostScriptName `FrutigerLTStd-Bold'>
      <FEncoding `FrameRoman'>
      <FSize  7.5 pt>
      <FUnderlining FNoUnderlining>
      <FOverline No>
      <FStrike No>
      <FChangeBar No>
      <FOutline No>
      <FShadow No>
      <FPairKern Yes>
      <FTsume No>
      <FCase FAsTyped>
      <FPosition FNormal>
      <FDX  0.0%>
      <FDY  0.0%>
      <FDW  0.0%>
      <FStretch  100.0%>
      <FLanguage Swedish>
      <FLocked No>
      <FSeparation 0>
      <FColor `Black'>
      <FBackgroundColor NoColor>
     > # end of PgfFont
     <PgfLeading  3.2 pt>
    > # end of Pgf
   > # end of TblColumnH
   <TblColumnBody 
    <PgfTag `FaktaRub1'>
    <Pgf 
     <PgfAlignment LeftRight>
     <PgfSpBefore  0.0 pt>
     <PgfSpAfter  0.0 pt>
     <PgfFont 
      <FTag `'>
      <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
      <FFamily `Frutiger LT Std 45 Light'>
      <FVar `Regular'>
      <FWeight `Bold'>
      <FAngle `Regular'>
      <FPostScriptName `FrutigerLTStd-Bold'>
      <FEncoding `FrameRoman'>
      <FSize  7.5 pt>
      <FUnderlining FNoUnderlining>
      <FOverline No>
      <FStrike No>
      <FChangeBar No>
      <FOutline No>
      <FShadow No>
      <FPairKern Yes>
      <FTsume No>
      <FCase FAsTyped>
      <FPosition FNormal>
      <FDX  0.0%>
      <FDY  0.0%>
      <FDW  0.0%>
      <FStretch  100.0%>
      <FLanguage Swedish>
      <FLocked No>
      <FSeparation 0>
      <FColor `Black'>
      <FBackgroundColor NoColor>
     > # end of PgfFont
     <PgfLeading  3.2 pt>
    > # end of Pgf
   > # end of TblColumnBody
   <TblColumnF 
    <PgfTag `FaktaRub1'>
    <Pgf 
     <PgfAlignment LeftRight>
     <PgfSpBefore  0.0 pt>
     <PgfSpAfter  0.0 pt>
     <PgfFont 
      <FTag `'>
      <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
      <FFamily `Frutiger LT Std 45 Light'>
      <FVar `Regular'>
      <FWeight `Bold'>
      <FAngle `Regular'>
      <FPostScriptName `FrutigerLTStd-Bold'>
      <FEncoding `FrameRoman'>
      <FSize  7.5 pt>
      <FUnderlining FNoUnderlining>
      <FOverline No>
      <FStrike No>
      <FChangeBar No>
      <FOutline No>
      <FShadow No>
      <FPairKern Yes>
      <FTsume No>
      <FCase FAsTyped>
      <FPosition FNormal>
      <FDX  0.0%>
      <FDY  0.0%>
      <FDW  0.0%>
      <FStretch  100.0%>
      <FLanguage Swedish>
      <FLocked No>
      <FSeparation 0>
      <FColor `Black'>
      <FBackgroundColor NoColor>
     > # end of PgfFont
     <PgfLeading  3.2 pt>
    > # end of Pgf
   > # end of TblColumnF
  > # end of TblColumn
  <TblCellMargins  0.0 pt 0.0 pt 0.0 pt 0.0 pt>
  <TblLIndent  0.0 mm>
  <TblRIndent  0.0 mm>
  <TblAlignment Left>
  <TblPlacement Anywhere>
  <TblSpBefore  0.0 pt>
  <TblSpAfter  10.7 pt>
  <TblBlockSize 1>
  <TblHFFill 15>
  <TblHFSeparation 0>
  <TblHFColor `Black'>
  <TblBodyFill 15>
  <TblBodySeparation 0>
  <TblBodyColor `Black'>
  <TblShadeByColumn No>
  <TblLocked No>
  <TblShadePeriod 2>
  <TblXFill 15>
  <TblXSeparation 0>
  <TblXColor `Black'>
  <TblAltShadePeriod 2>
  <TblLRuling `'>
  <TblBRuling `'>
  <TblRRuling `'>
  <TblTRuling `'>
  <TblColumnRuling `'>
  <TblXColumnRuling `'>
  <TblBodyRowRuling `'>
  <TblXRowRuling `'>
  <TblHFRowRuling `'>
  <TblSeparatorRuling `'>
  <TblXColumnNum 1>
  <TblRulingPeriod 2>
  <TblLastBRuling No>
  <TblTitlePlacement None>
  <TblTitlePgf1 
   <Pgf 
    <PgfTag `TableTitle'>
    <PgfUseNextTag No>
    <PgfNextTag `'>
    <PgfAlignment Center>
    <PgfFIndent  0.0 mm>
    <PgfLIndent  0.0 mm>
    <PgfRIndent  0.0 mm>
    <PgfFont 
     <FTag `'>
     <FPlatformName `W.Times New Roman.R.700'>
     <FFamily `Times New Roman'>
     <FVar `Regular'>
     <FWeight `Bold'>
     <FAngle `Regular'>
     <FEncoding `FrameRoman'>
     <FSize  12.0 pt>
     <FUnderlining FNoUnderlining>
     <FOverline No>
     <FStrike No>
     <FChangeBar No>
     <FOutline No>
     <FShadow No>
     <FPairKern Yes>
     <FTsume No>
     <FCase FAsTyped>
     <FPosition FNormal>
     <FDX  0.0%>
     <FDY  0.0%>
     <FDW  0.0%>
     <FStretch  100.0%>
     <FLanguage UKEnglish>
     <FLocked No>
     <FSeparation 0>
     <FColor `Black'>
     <FBackgroundColor NoColor>
    > # end of PgfFont
    <PgfLineSpacing Proportional>
    <PgfLeading  2.0 pt>
    <PgfAutoNum Yes>
    <PgfNumFormat `T:Table <n+\>: '>
    <PgfNumberFont `'>
    <PgfNumAtEnd No>
    <PgfHyphenate No>
    <HyphenMinPrefix 3>
    <HyphenMinSuffix 3>
    <PgfMinWordSpace 90>
    <PgfMaxWordSpace 110>
    <PgfPDFStructureLevel 4>
    <PgfLanguage UKEnglish>
   > # end of Pgf
  > # end of TblTitlePgf1
  <TblTitleGap  3.0 pt>
  <TblInitNumColumns 1>
  <TblInitNumHRows 0>
  <TblInitNumBodyRows 1>
  <TblInitNumFRows 0>
  <TblNumByColumn No>
 > # end of TblFormat
 <TblFormat 
  <TblTag `Tabell smal'>
  <TblColumn 
   <TblColumnNum 0>
   <TblColumnWidth  21.16666 mm>
   <TblColumnH 
    <PgfTag `TabellKolRub'>
    <Pgf 
     <PgfAlignment LeftRight>
     <PgfCellMargins  0.0 pt 0.0 pt 0.0 pt 0.0 pt>
    > # end of Pgf
   > # end of TblColumnH
   <TblColumnBody 
    <PgfTag `TabellText'>
   > # end of TblColumnBody
   <TblColumnF 
    <PgfTag `TabellKolRub'>
    <Pgf 
     <PgfAlignment LeftRight>
     <PgfCellMargins  0.0 pt 0.0 pt 0.0 pt 0.0 pt>
    > # end of Pgf
   > # end of TblColumnF
  > # end of TblColumn
  <TblColumn 
   <TblColumnNum 1>
   <TblColumnWidth  21.16666 mm>
   <TblColumnH 
    <PgfTag `TabellKolRub'>
    <Pgf 
     <PgfAlignment LeftRight>
     <PgfCellMargins  0.0 pt 0.0 pt 0.0 pt 0.0 pt>
    > # end of Pgf
   > # end of TblColumnH
   <TblColumnBody 
    <PgfTag `TabellText'>
   > # end of TblColumnBody
   <TblColumnF 
    <PgfTag `TabellKolRub'>
    <Pgf 
     <PgfAlignment LeftRight>
     <PgfCellMargins  0.0 pt 0.0 pt 0.0 pt 0.0 pt>
    > # end of Pgf
   > # end of TblColumnF
  > # end of TblColumn
  <TblColumn 
   <TblColumnNum 2>
   <TblColumnWidth  21.16666 mm>
   <TblColumnH 
    <PgfTag `TabellKolRub'>
    <Pgf 
     <PgfAlignment LeftRight>
     <PgfCellMargins  0.0 pt 0.0 pt 0.0 pt 0.0 pt>
    > # end of Pgf
   > # end of TblColumnH
   <TblColumnBody 
    <PgfTag `TabellText'>
   > # end of TblColumnBody
   <TblColumnF 
    <PgfTag `TabellKolRub'>
    <Pgf 
     <PgfAlignment LeftRight>
     <PgfCellMargins  0.0 pt 0.0 pt 0.0 pt 0.0 pt>
    > # end of Pgf
   > # end of TblColumnF
  > # end of TblColumn
  <TblCellMargins  8.0 pt 4.0 pt 8.0 pt 2.0 pt>
  <TblLIndent  0.0 mm>
  <TblRIndent  0.0 mm>
  <TblAlignment Left>
  <TblPlacement Anywhere>
  <TblSpBefore  0.0 pt>
  <TblSpAfter  10.7 pt>
  <TblBlockSize 1>
  <TblHFFill 15>
  <TblHFSeparation 0>
  <TblHFColor `Black'>
  <TblBodyFill 15>
  <TblBodySeparation 0>
  <TblBodyColor `Black'>
  <TblShadeByColumn No>
  <TblLocked No>
  <TblShadePeriod 2>
  <TblXFill 15>
  <TblXSeparation 0>
  <TblXColor `Black'>
  <TblAltShadePeriod 2>
  <TblLRuling `'>
  <TblBRuling `Grå tjock'>
  <TblRRuling `'>
  <TblTRuling `'>
  <TblColumnRuling `Grå tunn'>
  <TblXColumnRuling `Grå tunn'>
  <TblBodyRowRuling `Grå tunn'>
  <TblXRowRuling `Grå tunn'>
  <TblHFRowRuling `Thin'>
  <TblSeparatorRuling `Grå tunn'>
  <TblXColumnNum 1>
  <TblRulingPeriod 2>
  <TblLastBRuling No>
  <TblTitlePlacement InHeader>
  <TblTitlePgf1 
   <PgfTag `TabellRubrik_1sp'>
   <Pgf 
    <PgfFont 
     <FTag `'>
     <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
     <FFamily `Frutiger LT Std 45 Light'>
     <FVar `Regular'>
     <FWeight `Bold'>
     <FAngle `Regular'>
     <FPostScriptName `FrutigerLTStd-Bold'>
     <FEncoding `FrameRoman'>
     <FSize  8.0 pt>
     <FUnderlining FNoUnderlining>
     <FOverline No>
     <FStrike No>
     <FChangeBar No>
     <FOutline No>
     <FShadow No>
     <FPairKern Yes>
     <FTsume No>
     <FCase FAsTyped>
     <FPosition FNormal>
     <FDX  0.0%>
     <FDY  0.0%>
     <FDW  0.0%>
     <FStretch  100.0%>
     <FLanguage Swedish>
     <FLocked No>
     <FSeparation 0>
     <FColor `Black'>
     <FBackgroundColor NoColor>
    > # end of PgfFont
    <PgfNumberFont `'>
   > # end of Pgf
  > # end of TblTitlePgf1
  <TblTitleGap  0.0 pt>
  <TblInitNumColumns 3>
  <TblInitNumHRows 1>
  <TblInitNumBodyRows 7>
  <TblInitNumFRows 0>
  <TblNumByColumn No>
 > # end of TblFormat
 <TblFormat 
  <TblTag `Tabell bred'>
  <TblColumn 
   <TblColumnNum 0>
   <TblColumnWidth  44.66666 mm>
   <TblColumnH 
    <PgfTag `TabellKolRub'>
    <Pgf 
     <PgfAlignment LeftRight>
     <PgfCellMargins  0.0 pt 0.0 pt 0.0 pt 0.0 pt>
    > # end of Pgf
   > # end of TblColumnH
   <TblColumnBody 
    <PgfTag `TabellText'>
   > # end of TblColumnBody
   <TblColumnF 
    <PgfTag `TabellKolRub'>
    <Pgf 
     <PgfAlignment LeftRight>
     <PgfCellMargins  0.0 pt 0.0 pt 0.0 pt 0.0 pt>
    > # end of Pgf
   > # end of TblColumnF
  > # end of TblColumn
  <TblColumn 
   <TblColumnNum 1>
   <TblColumnWidth  44.66666 mm>
   <TblColumnH 
    <PgfTag `TabellKolRub'>
    <Pgf 
     <PgfAlignment LeftRight>
     <PgfCellMargins  0.0 pt 0.0 pt 0.0 pt 0.0 pt>
    > # end of Pgf
   > # end of TblColumnH
   <TblColumnBody 
    <PgfTag `TabellText'>
   > # end of TblColumnBody
   <TblColumnF 
    <PgfTag `TabellKolRub'>
    <Pgf 
     <PgfAlignment LeftRight>
     <PgfCellMargins  0.0 pt 0.0 pt 0.0 pt 0.0 pt>
    > # end of Pgf
   > # end of TblColumnF
  > # end of TblColumn
  <TblColumn 
   <TblColumnNum 2>
   <TblColumnWidth  44.66666 mm>
   <TblColumnH 
    <PgfTag `TabellKolRub'>
    <Pgf 
     <PgfAlignment LeftRight>
     <PgfCellMargins  0.0 pt 0.0 pt 0.0 pt 0.0 pt>
    > # end of Pgf
   > # end of TblColumnH
   <TblColumnBody 
    <PgfTag `TabellText'>
   > # end of TblColumnBody
   <TblColumnF 
    <PgfTag `TabellKolRub'>
    <Pgf 
     <PgfAlignment LeftRight>
     <PgfCellMargins  0.0 pt 0.0 pt 0.0 pt 0.0 pt>
    > # end of Pgf
   > # end of TblColumnF
  > # end of TblColumn
  <TblCellMargins  8.0 pt 4.0 pt 8.0 pt 2.0 pt>
  <TblLIndent  0.0 mm>
  <TblRIndent  0.0 mm>
  <TblAlignment Left>
  <TblPlacement Anywhere>
  <TblSpBefore  0.0 pt>
  <TblSpAfter  10.7 pt>
  <TblBlockSize 1>
  <TblHFFill 15>
  <TblHFSeparation 0>
  <TblHFColor `Black'>
  <TblBodyFill 15>
  <TblBodySeparation 0>
  <TblBodyColor `Black'>
  <TblShadeByColumn No>
  <TblLocked No>
  <TblShadePeriod 2>
  <TblXFill 15>
  <TblXSeparation 0>
  <TblXColor `Black'>
  <TblAltShadePeriod 2>
  <TblLRuling `'>
  <TblBRuling `Grå tjock'>
  <TblRRuling `'>
  <TblTRuling `'>
  <TblColumnRuling `Grå tunn'>
  <TblXColumnRuling `Grå tunn'>
  <TblBodyRowRuling `Grå tunn'>
  <TblXRowRuling `Grå tunn'>
  <TblHFRowRuling `Thin'>
  <TblSeparatorRuling `Grå tunn'>
  <TblXColumnNum 1>
  <TblRulingPeriod 2>
  <TblLastBRuling No>
  <TblTitlePlacement InHeader>
  <TblTitlePgf1 
   <PgfTag `TabellRubrik_2sp'>
   <Pgf 
    <PgfFont 
     <FTag `'>
     <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
     <FFamily `Frutiger LT Std 45 Light'>
     <FVar `Regular'>
     <FWeight `Bold'>
     <FAngle `Regular'>
     <FPostScriptName `FrutigerLTStd-Bold'>
     <FEncoding `FrameRoman'>
     <FSize  8.0 pt>
     <FUnderlining FNoUnderlining>
     <FOverline No>
     <FStrike No>
     <FChangeBar No>
     <FOutline No>
     <FShadow No>
     <FPairKern Yes>
     <FTsume No>
     <FCase FAsTyped>
     <FPosition FNormal>
     <FDX  0.0%>
     <FDY  0.0%>
     <FDW  0.0%>
     <FStretch  100.0%>
     <FLanguage Swedish>
     <FLocked No>
     <FSeparation 0>
     <FColor `Black'>
     <FBackgroundColor NoColor>
    > # end of PgfFont
    <PgfNumberFont `'>
   > # end of Pgf
  > # end of TblTitlePgf1
  <TblTitleGap  0.0 pt>
  <TblInitNumColumns 3>
  <TblInitNumHRows 1>
  <TblInitNumBodyRows 7>
  <TblInitNumFRows 0>
  <TblNumByColumn No>
 > # end of TblFormat
 <TblFormat 
  <TblTag `TabellRekBred'>
  <TblColumn 
   <TblColumnNum 0>
   <TblColumnWidth  63.5 mm>
   <TblColumnH 
    <PgfTag `TabellKolRub'>
    <Pgf 
     <PgfAlignment LeftRight>
     <PgfCellMargins  0.0 pt 0.0 pt 0.0 pt 0.0 pt>
    > # end of Pgf
   > # end of TblColumnH
   <TblColumnBody 
    <PgfTag `TabellKolRub'>
    <Pgf 
     <PgfAlignment LeftRight>
     <PgfCellMargins  0.0 pt 0.0 pt 0.0 pt 0.0 pt>
    > # end of Pgf
   > # end of TblColumnBody
   <TblColumnF 
    <PgfTag `TabellKolRub'>
    <Pgf 
     <PgfAlignment LeftRight>
     <PgfCellMargins  0.0 pt 0.0 pt 0.0 pt 0.0 pt>
    > # end of Pgf
   > # end of TblColumnF
  > # end of TblColumn
  <TblColumn 
   <TblColumnNum 1>
   <TblColumnWidth  70.5 mm>
   <TblColumnH 
    <PgfTag `TabellText'>
   > # end of TblColumnH
   <TblColumnBody 
    <PgfTag `TabellText'>
   > # end of TblColumnBody
   <TblColumnF 
    <PgfTag `TabellText'>
   > # end of TblColumnF
  > # end of TblColumn
  <TblCellMargins  8.0 pt 4.0 pt 8.0 pt 2.0 pt>
  <TblLIndent  0.0 mm>
  <TblRIndent  0.0 mm>
  <TblAlignment Left>
  <TblPlacement Anywhere>
  <TblSpBefore  0.0 pt>
  <TblSpAfter  10.7 pt>
  <TblBlockSize 1>
  <TblHFFill 15>
  <TblHFSeparation 0>
  <TblHFColor `Black'>
  <TblBodyFill 15>
  <TblBodySeparation 0>
  <TblBodyColor `Black'>
  <TblShadeByColumn No>
  <TblLocked No>
  <TblShadePeriod 2>
  <TblXFill 15>
  <TblXSeparation 0>
  <TblXColor `Black'>
  <TblAltShadePeriod 2>
  <TblLRuling `'>
  <TblBRuling `Grå tjock'>
  <TblRRuling `'>
  <TblTRuling `'>
  <TblColumnRuling `Grå tunn'>
  <TblXColumnRuling `Grå tunn'>
  <TblBodyRowRuling `Grå tunn'>
  <TblXRowRuling `Grå tunn'>
  <TblHFRowRuling `Thin'>
  <TblSeparatorRuling `Grå tunn'>
  <TblXColumnNum 1>
  <TblRulingPeriod 2>
  <TblLastBRuling No>
  <TblTitlePlacement InHeader>
  <TblTitlePgf1 
   <PgfTag `TabellRekRub'>
   <Pgf 
    <PgfAlignment LeftRight>
   > # end of Pgf
  > # end of TblTitlePgf1
  <TblTitleGap  0.0 pt>
  <TblInitNumColumns 2>
  <TblInitNumHRows 0>
  <TblInitNumBodyRows 8>
  <TblInitNumFRows 0>
  <TblNumByColumn No>
 > # end of TblFormat
 <TblFormat 
  <TblTag `TabellRekSmal'>
  <TblColumn 
   <TblColumnNum 0>
   <TblColumnWidth  63.5 mm>
   <TblColumnH 
    <PgfTag `TabellText'>
   > # end of TblColumnH
   <TblColumnBody 
    <PgfTag `TabellText'>
   > # end of TblColumnBody
   <TblColumnF 
    <PgfTag `TabellText'>
   > # end of TblColumnF
  > # end of TblColumn
  <TblCellMargins  8.0 pt 4.0 pt 8.0 pt 2.0 pt>
  <TblLIndent  0.0 mm>
  <TblRIndent  0.0 mm>
  <TblAlignment Left>
  <TblPlacement Anywhere>
  <TblSpBefore  0.0 pt>
  <TblSpAfter  10.7 pt>
  <TblBlockSize 1>
  <TblHFFill 15>
  <TblHFSeparation 0>
  <TblHFColor `Black'>
  <TblBodyFill 15>
  <TblBodySeparation 0>
  <TblBodyColor `Black'>
  <TblShadeByColumn No>
  <TblLocked No>
  <TblShadePeriod 2>
  <TblXFill 15>
  <TblXSeparation 0>
  <TblXColor `Black'>
  <TblAltShadePeriod 2>
  <TblLRuling `'>
  <TblBRuling `Grå tjock'>
  <TblRRuling `'>
  <TblTRuling `'>
  <TblColumnRuling `Grå tunn'>
  <TblXColumnRuling `Grå tunn'>
  <TblBodyRowRuling `Grå tunn'>
  <TblXRowRuling `Grå tunn'>
  <TblHFRowRuling `Thin'>
  <TblSeparatorRuling `Grå tunn'>
  <TblXColumnNum 1>
  <TblRulingPeriod 2>
  <TblLastBRuling No>
  <TblTitlePlacement InHeader>
  <TblTitlePgf1 
   <PgfTag `TabellRekRub'>
   <Pgf 
    <PgfAlignment LeftRight>
   > # end of Pgf
  > # end of TblTitlePgf1
  <TblTitleGap  0.0 pt>
  <TblInitNumColumns 1>
  <TblInitNumHRows 0>
  <TblInitNumBodyRows 8>
  <TblInitNumFRows 0>
  <TblNumByColumn No>
 > # end of TblFormat
> # end of TblCatalog
<KumihanCatalog 
> # end of KumihanCatalog
<Views 
 <View 
  <ViewNumber 1>
  <ViewCutout `White'>
 > # end of View
 <View 
  <ViewNumber 2>
  <ViewCutout `White'>
  <ViewInvisible `Red'>
  <ViewInvisible `Green'>
  <ViewInvisible `Blue'>
  <ViewInvisible `Cyan'>
  <ViewInvisible `Magenta'>
  <ViewInvisible `Pale Green'>
  <ViewInvisible `Forest Green'>
  <ViewInvisible `Royal Blue'>
  <ViewInvisible `Mauve'>
  <ViewInvisible `Light Salmon'>
  <ViewInvisible `Olive'>
  <ViewInvisible `Salmon'>
 > # end of View
 <View 
  <ViewNumber 3>
  <ViewInvisible `Black'>
  <ViewCutout `White'>
 > # end of View
 <View 
  <ViewNumber 4>
  <ViewCutout `White'>
 > # end of View
 <View 
  <ViewNumber 5>
  <ViewCutout `White'>
 > # end of View
 <View 
  <ViewNumber 6>
  <ViewCutout `White'>
 > # end of View
> # end of Views
<VariableFormats 
 <VariableFormat 
  <VariableName `Page Count'>
  <VariableDef `<$lastpagenum\>'>
 > # end of VariableFormat
 <VariableFormat 
  <VariableName `Current Date (Long)'>
  <VariableDef `<$daynum\> <$monthname\> <$year\>'>
 > # end of VariableFormat
 <VariableFormat 
  <VariableName `Current Date (Short)'>
  <VariableDef `<$daynum\>/<$monthnum\>/<$shortyear\>'>
 > # end of VariableFormat
 <VariableFormat 
  <VariableName `Modification Date (Long)'>
  <VariableDef `<$daynum\> <$monthname\> <$year\> <$hour\>:<$minute00\> <$ampm\>'>
 > # end of VariableFormat
 <VariableFormat 
  <VariableName `Modification Date (Short)'>
  <VariableDef `<$daynum\>/<$monthnum\>/<$shortyear\>'>
 > # end of VariableFormat
 <VariableFormat 
  <VariableName `Creation Date (Long)'>
  <VariableDef `<$daynum\> <$monthname\> <$year\>'>
 > # end of VariableFormat
 <VariableFormat 
  <VariableName `Creation Date (Short)'>
  <VariableDef `<$daynum\>/<$monthnum\>/<$shortyear\>'>
 > # end of VariableFormat
 <VariableFormat 
  <VariableName `Filename (Long)'>
  <VariableDef `<$fullfilename\>'>
 > # end of VariableFormat
 <VariableFormat 
  <VariableName `Filename (Short)'>
  <VariableDef `<$filename\>'>
 > # end of VariableFormat
 <VariableFormat 
  <VariableName `Running H/F 1'>
  <VariableDef `<$paratext[AvsnittsRub]\>'>
 > # end of VariableFormat
 <VariableFormat 
  <VariableName `Running H/F 2'>
  <VariableDef `<$paratext[Heading1]\>'>
 > # end of VariableFormat
 <VariableFormat 
  <VariableName `Current Page #'>
  <VariableDef `<$curpagenum\>'>
 > # end of VariableFormat
 <VariableFormat 
  <VariableName `Running H/F 3'>
  <VariableDef `<$marker1\>'>
 > # end of VariableFormat
 <VariableFormat 
  <VariableName `Running H/F 4'>
  <VariableDef `<$marker2\>'>
 > # end of VariableFormat
 <VariableFormat 
  <VariableName `Table Continuation'>
  <VariableDef ` (Continued)'>
 > # end of VariableFormat
 <VariableFormat 
  <VariableName `Table Sheet'>
  <VariableDef ` (Sheet <$tblsheetnum\> of <$tblsheetcount\>)'>
 > # end of VariableFormat
 <VariableFormat 
  <VariableName `Kapitelnamn'>
  <VariableDef `Trafik, riskfyllt arbete och läkemedel'>
 > # end of VariableFormat
 <VariableFormat 
  <VariableName `Chapter Number'>
  <VariableDef `<$chapnum\>'>
 > # end of VariableFormat
 <VariableFormat 
  <VariableName `Avsnittsnamn'>
  <VariableDef `Läkemedelsanvändning'>
 > # end of VariableFormat
 <VariableFormat 
  <VariableName `Volume Number'>
  <VariableDef `<$volnum\>'>
 > # end of VariableFormat
 <VariableFormat 
  <VariableName `Section Number'>
  <VariableDef `<$sectionnum\>'>
 > # end of VariableFormat
 <VariableFormat 
  <VariableName `Sub Section Number'>
  <VariableDef `<$subsectionnum\>'>
 > # end of VariableFormat
 <VariableFormat 
  <VariableName `Chapter Title Name'>
  <VariableDef `<$chaptertitlename\>'>
 > # end of VariableFormat
 <VariableFormat 
  <VariableName `Running H/F 5'>
  <VariableDef `<$paratext[paratag]\>'>
 > # end of VariableFormat
 <VariableFormat 
  <VariableName `Running H/F 6'>
  <VariableDef `<$paratext[paratag]\>'>
 > # end of VariableFormat
 <VariableFormat 
  <VariableName `Running H/F 7'>
  <VariableDef `<$paratext[paratag]\>'>
 > # end of VariableFormat
 <VariableFormat 
  <VariableName `Running H/F 8'>
  <VariableDef `<$paratext[paratag]\>'>
 > # end of VariableFormat
 <VariableFormat 
  <VariableName `Running H/F 9'>
  <VariableDef `<$paratext[paratag]\>'>
 > # end of VariableFormat
 <VariableFormat 
  <VariableName `Running H/F 10'>
  <VariableDef `<$paratext[paratag]\>'>
 > # end of VariableFormat
 <VariableFormat 
  <VariableName `Running H/F 11'>
  <VariableDef `<$paratext[paratag]\>'>
 > # end of VariableFormat
 <VariableFormat 
  <VariableName `Running H/F 12'>
  <VariableDef `<$paratext[paratag]\>'>
 > # end of VariableFormat
> # end of VariableFormats
<MarkerTypeCatalog 
 <MTypeName `HTML Macro'>
> # end of MarkerTypeCatalog
<XRefFormats 
 <XRefFormat 
  <XRefName `Heading & Page'>
  <XRefDef `“<$paratext\>” on page\x11 <$pagenum\>'>
 > # end of XRefFormat
 <XRefFormat 
  <XRefName `Page'>
  <XRefDef `<Blue\><$pagenum\>'>
 > # end of XRefFormat
 <XRefFormat 
  <XRefName `See Heading & Page'>
  <XRefDef `See “<$paratext\>” on page\x11 <$pagenum\>.'>
 > # end of XRefFormat
 <XRefFormat 
  <XRefName `Table All'>
  <XRefDef `Table\x11 <$paranumonly\>, “<$paratext\>,” on page\x11 <$pagenum\>'>
 > # end of XRefFormat
 <XRefFormat 
  <XRefName `Table Number & Page'>
  <XRefDef `Table\x11 <$paranumonly\> on page\x11 <$pagenum\>'>
 > # end of XRefFormat
 <XRefFormat 
  <XRefName `Ref'>
  <XRefDef `<Ref\> '>
 > # end of XRefFormat
 <XRefFormat 
  <XRefName `ORef'>
  <XRefDef `<Ref\> '>
 > # end of XRefFormat
> # end of XRefFormats
<Document 
 <DViewRect 18 20 923 764 >
 <DWindowRect 0 0 1272 1044 >
 <DViewScale  120.0%>
 <DNextUnique 1089706>
 <DPageSize  170.0 mm 240.0 mm>
 <DMenuBar `'>
 <DVoMenuBar `'>
 <CustomFontFlag No>
 <CustomPgfFlag No>
 <CustomTblFlag No>
 <DStartPage 1313>
 <DPageNumStyle Arabic>
 <ContPageNum Yes>
 <PgfNumbering Restart>
 <VolNumComputeMethod StartNumbering>
 <VolumeNumStart 1>
 <VolumeNumStyle Arabic>
 <VolumeNumText `'>
 <ChapterNumComputeMethod StartNumbering>
 <ChapterNumStart 1>
 <ChapterNumStyle Arabic>
 <ChapterNumText `'>
 <SectionNumComputeMethod StartNumbering>
 <SectionNumStart 1>
 <SectionNumStyle Arabic>
 <SectionNumText `'>
 <SubSectionNumComputeMethod StartNumbering>
 <SubSectionNumStart 1>
 <SubSectionNumStyle Arabic>
 <SubSectionNumText `'>
 <DPagePointStyle Arabic>
 <DTwoSides Yes>
 <DParity FirstRight>
 <DFrozenPages No>
 <DPageRounding MakePageCountEven>
 <DFNoteMaxH  102.00016 mm>
 <FNoteStartNum 1>
 <DFNoteRestart PerPage>
 <DFNoteTag `Footnote'>
 <DFNoteLabels `*†‡'>
 <DFNoteNumStyle Arabic>
 <DFNoteComputeMethod PerPage>
 <DFNoteAnchorPos FNSuperscript>
 <DFNoteNumberPos FNBaseline>
 <DFNoteAnchorPrefix `'>
 <DFNoteAnchorSuffix `'>
 <DFNoteNumberPrefix `'>
 <DFNoteNumberSuffix `. \\t'>
 <DTblFNoteTag `TableFootnote'>
 <DTblFNoteLabels `*†‡'>
 <DTblFNoteNumStyle LCAlpha>
 <DTblFNoteAnchorPos FNSuperscript>
 <DTblFNoteNumberPos FNBaseline>
 <DTblFNoteAnchorPrefix `'>
 <DTblFNoteAnchorSuffix `'>
 <DTblFNoteNumberPrefix `'>
 <DTblFNoteNumberSuffix `. \\t'>
 <DLinebreakChars `-  —/'>
 <DPunctuationChars `:;,.…!?'>
 <DChBarGap  6.00001 mm>
 <DChBarWidth  2.0 pt>
 <DChBarPosition LeftOfCol>
 <DChBarColor `Black'>
 <DAutoChBars No>
 <DShowAllConditions Yes>
 <DDisplayOverrides Yes>
 <DPageScrolling Vertical>
 <DViewOnly No>
 <DViewOnlyXRef GotoBehavior>
 <DViewOnlySelect Yes>
 <DViewOnlyWinBorders Yes>
 <DViewOnlyWinMenubar Yes>
 <DViewOnlyWinPopup Yes>
 <DViewOnlyWinPalette No>
 <DFluid No>
 <DFluidSideheads No>
 <DGridOn No>
 <DPageGrid  10.00002 mm>
 <DSnapGrid  1.0 mm>
 <DSnapRotation  0.25>
 <DRulersOn Yes>
 <DFullRulers Yes>
 <DGraphicsOff No>
 <DCurrentView 1>
 <DBordersOn No>
 <DSymbolsOn No>
 <DLinkBoundariesOn No>
 <DTrackChangesOn No>
 <DTrackChangesPreviewState No>
 <DTrackChangesReviewerName `'>
 <DSmartQuotesOn Yes>
 <DSmartSpacesOn No>
 <DUpdateTextInsetsOnOpen Yes>
 <DUpdateXRefsOnOpen Yes>
 <DLanguage UKEnglish>
 <DSuperscriptSize  66.0%>
 <DSubscriptSize  66.0%>
 <DSmallCapsSize  80.0%>
 <DSuperscriptShift  40.0%>
 <DSubscriptShift  25.0%>
 <DSuperscriptStretch  100.0%>
 <DSubscriptStretch  100.0%>
 <DSmallCapsStretch  100.0%>
 <DRubiSize  50.0%>
 <DRubiOverhang No>
 <DRubiAlignAtLineBounds No>
 <DNarrowRubiSpaceForJapanese Proportional>
 <DWideRubiSpaceForJapanese Proportional>
 <DNarrowRubiSpaceForOther Narrow>
 <DWideRubiSpaceForOther Narrow>
 <DMathAlphaCharFontFamily `Times New Roman'>
 <DMathSmallIntegral  14.0 pt>
 <DMathMediumIntegral  18.0 pt>
 <DMathLargeIntegral  24.0 pt>
 <DMathSmallSigma  14.0 pt>
 <DMathMediumSigma  18.0 pt>
 <DMathLargeSigma  24.0 pt>
 <DMathSmallLevel1  9.0 pt>
 <DMathMediumLevel1  12.0 pt>
 <DMathLargeLevel1  14.0 pt>
 <DMathSmallLevel2  7.0 pt>
 <DMathMediumLevel2  9.0 pt>
 <DMathLargeLevel2  12.0 pt>
 <DMathSmallLevel3  5.0 pt>
 <DMathMediumLevel3  6.0 pt>
 <DMathLargeLevel3  8.0 pt>
 <DMathSmallHoriz  0.0 pt>
 <DMathMediumHoriz  0.0 pt>
 <DMathLargeHoriz  0.0 pt>
 <DMathSmallVert  0.0 pt>
 <DMathMediumVert  0.0 pt>
 <DMathLargeVert  0.0 pt>
 <DMathShowCustom No>
 <DMathFunctions `'>
 <DMathNumbers `'>
 <DMathVariables `EquationVariables'>
 <DMathStrings `'>
 <DMathGreek `'>
 <DMathCatalog >
 <DPrintSkipBlankPages Yes>
 <DPrintSeparations No>
 <DPrintProcessColor `Black'>
 <DNoPrintSepColor `White'>
 <DPrintProcessColor `Cyan'>
 <DPrintProcessColor `Magenta'>
 <DPrintProcessColor `Yellow'>
 <DPrintProcessColor `Svart 35%'>
 <DPrintProcessColor `Pale Green'>
 <DPrintProcessColor `Forest Green'>
 <DPrintProcessColor `Royal Blue'>
 <DPrintProcessColor `Mauve'>
 <DPrintProcessColor `Light Salmon'>
 <DPrintProcessColor `Olive'>
 <DPrintProcessColor `Salmon'>
 <DGenerateAcrobatInfo Yes>
 <DAcrobatParagraphBookmarks Yes>
 <DAcrobatBookmarksIncludeTagNames No>
 <DPDFAllNamedDestinations No>
 <DPDFDestsMarked Yes>
 <DPDFStructure No>
 <DPDFStructureDefined Yes>
 <DPDFBookmarks Yes>
 <DPDFConvertCMYK No>
 <DPDFOpenPage `0'>
 <DPDFFit Page>
 <DPDFZoom  0.0%>
 <DPDFJobOptions `Standard'>
 <DPDFSaveSeparate No>
 <DPDFRegMarks None>
 <DPDFPageSizeSet No>
 <DPDFAllPages Yes>
 <DPDFOpenBookmarkLevel 1>
 <DAcrobatEnableArticleThreads No>
 <PDFDocInfo 
  <Key `Title'>
  <Value `Trafik, riskfyllt arbete och l'>
  <Value `'>
  <Value `kemedel '>
  <Value `'>
  <Value `'>
  <Value ` L'>
  <Value `'>
  <Value `kemedelsboken 2014'>
  <Key `Marked'>
  <Value `True'>
 > # end of PDFDocInfo
 <DocFileInfo 
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
20202020203C786D703A437265617465446174653E303130382D30322D30365430393A34383A33382B30313A30303C2F786D703A437265617465446174653E0A2020202020202020203C786D703A4D6F64696679446174653E303131332D30392D32375431303A33363A31352B30313A30303C2F786D703A4D6F64696679446174653E0A2020202020202020203C786D703A4D65746164617461446174653E303131332D30392D32375431303A33363A31352B30313A30303C2F786D703A4D65746164617461446174653E0A2020202020203C2F7264663A4465736372697074696F6E3E0A2020202020203C7264663A4465736372697074696F6E207264663A61626F75743D22220A202020202020202020202020786D6C6E733A786D705269676874733D22687474703A2F2F6E732E61646F62652E636F6D2F7861702F312E302F7269676874732F223E0A2020202020202020203C786D705269676874733A4D61726B65643E547275653C2F786D705269676874733A4D61726B65643E0A2020202020203C2F7264663A4465736372697074696F6E3E0A2020202020203C7264663A4465736372697074696F6E207264663A61626F75743D22220A202020202020202020202020786D6C6E733A64633D22687474703A2F2F7075726C2E6F72672F64632F656C656D656E74732F312E312F223E0A
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
202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020200A202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020200A202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020200A202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020200A202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020200A2020202020202020202020202020202020202020202020202020202020202020202020202020
20202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020200A202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020200A202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020200A202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020200A202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020200A20202020202020202020202020202020202020202020202020202020202020202020
2020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020200A202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020200A202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020200A202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020200A202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020200A202020202020202020202020202020202020202020202020202020202020
202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020200A202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020200A202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020202020200A2020202020202020202020202020202020202020202020202020200A3C3F787061636B657420656E643D2277223F3E
 > # end of DocFileInfo
> # end of Document
<BookComponent 
 <FileName `<u\><c\>Y2_LMA_TrafikRisk_2013FM10IX.fm'>
 <Unique 0>
 <FileNameSuffix `IX'>
 <DeriveLinks Yes>
 <DeriveType IDX>
 <DeriveTag `Index'>
> # end of BookComponent
<BookComponent 
 <FileName `<u\><c\>Y2_LMA_TrafikRisk_2013FM10TOC.fm'>
 <Unique 0>
 <FileNameSuffix `TOC'>
 <DeriveLinks Yes>
 <DeriveType TOC>
 <DeriveTag `AvsnittsRub'>
 <DeriveTag `KapRub'>
> # end of BookComponent
<InitialAutoNums 
> # end of InitialAutoNums
<Dictionary 
> # end of Dictionary
<AFrames 
 <Frame 
  <ID 1>
  <Unique 1086399>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  6.0 pt>
  <RunaroundType None>
  <Angle  360.0>
  <ShapeRect  145.57909 mm 157.0505 mm 7.12464 mm 5.25187 mm>
  <BRect  145.57909 mm 157.0505 mm 7.12464 mm 5.25187 mm>
  <FrameType RunIntoParagraph>
  <NSOffset  0.0 mm>
  <BLOffset  0.0 mm>
  <AnchorAlign Right>
  <Cropped No>
 > # end of Frame
> # end of AFrames
<Tbls 
 <Tbl 
  <TblID 2>
  <TblFormat 
   <TblTag `Mapping Table'>
   <TblColumn 
    <TblColumnNum 0>
    <TblColumnWidth  25.40005 mm>
    <TblColumnH 
     <Pgf 
      <PgfTag `Body'>
      <PgfFIndent  0.0 mm>
      <PgfLIndent  0.0 mm>
      <PgfTopSeparator `'>
      <PgfBotSeparator `'>
      <PgfRunInDefaultPunct `. '>
      <PgfBlockSize 1>
      <PgfFont 
       <FTag `'>
       <FPlatformName `W.Times New Roman.R.400'>
       <FFamily `Times New Roman'>
       <FVar `Regular'>
       <FWeight `Regular'>
       <FAngle `Regular'>
       <FEncoding `FrameRoman'>
       <FSize  12.0 pt>
       <FUnderlining FNoUnderlining>
       <FOverline No>
       <FStrike No>
       <FChangeBar No>
       <FOutline No>
       <FShadow No>
       <FPairKern No>
       <FTsume No>
       <FCase FAsTyped>
       <FPosition FNormal>
       <FDX  0.0%>
       <FDY  0.0%>
       <FDW  0.0%>
       <FStretch  100.0%>
       <FLanguage UKEnglish>
       <FLocked No>
       <FSeparation 0>
       <FColor `Black'>
       <FBackgroundColor NoColor>
      > # end of PgfFont
      <PgfAutoNum No>
      <PgfPDFStructureLevel 0>
      <PgfLanguage UKEnglish>
     > # end of Pgf
    > # end of TblColumnH
    <TblColumnBody 
    > # end of TblColumnBody
    <TblColumnF 
    > # end of TblColumnF
   > # end of TblColumn
   <TblCellMargins  2.0 pt 2.0 pt 2.0 pt 2.0 pt>
   <TblLIndent  0.0 mm>
   <TblRIndent  0.0 mm>
   <TblAlignment Left>
   <TblPlacement Anywhere>
   <TblSpBefore  6.0 pt>
   <TblSpAfter  6.0 pt>
   <TblBlockSize 1>
   <TblHFFill 15>
   <TblHFSeparation 0>
   <TblHFColor `Black'>
   <TblBodyFill 15>
   <TblBodySeparation 0>
   <TblBodyColor `Black'>
   <TblShadeByColumn No>
   <TblLocked No>
   <TblShadePeriod 4>
   <TblXFill 15>
   <TblXSeparation 0>
   <TblXColor `Black'>
   <TblAltShadePeriod 0>
   <TblLRuling `Thin'>
   <TblBRuling `Thin'>
   <TblRRuling `Thin'>
   <TblTRuling `Thin'>
   <TblColumnRuling `Thin'>
   <TblXColumnRuling `Thin'>
   <TblBodyRowRuling `Thin'>
   <TblXRowRuling `Thin'>
   <TblHFRowRuling `Thin'>
   <TblSeparatorRuling `Double'>
   <TblXColumnNum 1>
   <TblRulingPeriod 4>
   <TblLastBRuling No>
   <TblTitlePlacement InHeader>
   <TblTitlePgf1 
    <Pgf 
     <PgfTag `Mapping Table Title'>
     <PgfPDFStructureLevel 6>
    > # end of Pgf
   > # end of TblTitlePgf1
   <TblTitleGap  4.0 pt>
   <TblInitNumColumns 1>
   <TblInitNumHRows 0>
   <TblInitNumBodyRows 1>
   <TblInitNumFRows 0>
   <TblNumByColumn No>
  > # end of TblFormat
  <TblNumColumns 5>
  <Unique 1086436>
  <TblColumnWidth  50.80009 mm>
  <TblColumnWidth  25.40005 mm>
  <TblColumnWidth  19.05003 mm>
  <TblColumnWidth  15.87503 mm>
  <TblColumnWidth  22.22504 mm>
  <TblTitle 
   <TblTitleContent 
    <Notes 
    > # end of Notes
    <Para 
     <Unique 1086438>
     <Pgf 
      <PgfFont 
       <FTag `'>
       <FPlatformName `W.Times New Roman.R.400'>
       <FFamily `Times New Roman'>
       <FVar `Regular'>
       <FWeight `Regular'>
       <FAngle `Regular'>
       <FEncoding `FrameRoman'>
       <FSize  12.0 pt>
       <FUnderlining FNoUnderlining>
       <FOverline No>
       <FStrike No>
       <FChangeBar No>
       <FOutline No>
       <FShadow No>
       <FPairKern No>
       <FTsume No>
       <FCase FAsTyped>
       <FPosition FNormal>
       <FDX  0.0%>
       <FDY  0.0%>
       <FDW  0.0%>
       <FStretch  100.0%>
       <FLanguage NoLanguage>
       <FLocked No>
       <FSeparation 0>
       <FColor `Black'>
       <FBackgroundColor NoColor>
      > # end of PgfFont
      <PgfLanguage NoLanguage>
     > # end of Pgf
     <ParaLine 
      <Font 
       <FTag `'>
       <FPlatformName `W.Times New Roman.R.400'>
       <FFamily `Times New Roman'>
       <FVar `Regular'>
       <FWeight `Regular'>
       <FAngle `Regular'>
       <FEncoding `FrameRoman'>
       <FSize  12.0 pt>
       <FUnderlining FNoUnderlining>
       <FOverline No>
       <FStrike No>
       <FChangeBar No>
       <FOutline No>
       <FShadow No>
       <FPairKern No>
       <FTsume No>
       <FCase FAsTyped>
       <FPosition FNormal>
       <FDX  0.0%>
       <FDY  0.0%>
       <FDW  0.0%>
       <FStretch  100.0%>
       <FLanguage NoLanguage>
       <FLocked No>
       <FSeparation 0>
       <FColor `Black'>
       <FBackgroundColor NoColor>
      > # end of Font
      <String `HTML Mapping Table'>
     > # end of ParaLine
    > # end of Para
   > # end of TblTitleContent
  > # end of TblTitle
  <TblH 
   <Row 
    <RowMaxHeight  355.60065 mm>
    <RowHeight  5.64445 mm>
    <Cell 
     <CellRows 2>
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086448>
       <Pgf 
        <PgfTag `Mapping Table Cell'>
        <PgfAlignment Left>
        <PgfPDFStructureLevel 6>
       > # end of Pgf
       <ParaLine 
        <String `FrameMaker Source Item'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellColumns 2>
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086450>
       <ParaLine 
        <String `HTML Item'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086452>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellRows 2>
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086454>
       <ParaLine 
        <String `Include '>
       > # end of ParaLine
       <ParaLine 
        <String `Auto#'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellRows 2>
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086456>
       <ParaLine 
        <String `Comments'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
   > # end of Row
   <Row 
    <RowMaxHeight  355.60065 mm>
    <RowHeight  10.58335 mm>
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086458>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086460>
       <ParaLine 
        <String `Element'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086462>
       <ParaLine 
        <String `New Web '>
       > # end of ParaLine
       <ParaLine 
        <String `Page?'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086464>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086466>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
   > # end of Row
  > # end of TblH
  <TblBody 
   <Row 
    <RowMaxHeight  355.60065 mm>
    <RowHeight  5.64445 mm>
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086468>
       <ParaLine 
        <String `P:Body'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086470>
       <ParaLine 
        <String `P'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086472>
       <ParaLine 
        <String `N'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086474>
       <ParaLine 
        <String `N'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086476>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
   > # end of Row
   <Row 
    <RowMaxHeight  355.60065 mm>
    <RowHeight  15.52225 mm>
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086478>
       <ParaLine 
        <String `P:Bulleted'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086480>
       <ParaLine 
        <String `LI'>
       > # end of ParaLine
      > # end of Para
      <Para 
       <Unique 1086481>
       <ParaLine 
        <String `Parent = UL'>
       > # end of ParaLine
      > # end of Para
      <Para 
       <Unique 1086482>
       <ParaLine 
        <String `Depth = 0'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086484>
       <ParaLine 
        <String `N'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086486>
       <ParaLine 
        <String `N'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086488>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
   > # end of Row
   <Row 
    <RowMaxHeight  355.60065 mm>
    <RowHeight  5.64445 mm>
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086490>
       <ParaLine 
        <String `P:CellBody'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086492>
       <ParaLine 
        <String `P'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086494>
       <ParaLine 
        <String `N'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086496>
       <ParaLine 
        <String `N'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086498>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
   > # end of Row
   <Row 
    <RowMaxHeight  355.60065 mm>
    <RowHeight  5.64445 mm>
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086500>
       <ParaLine 
        <String `P:CellHeading'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086502>
       <ParaLine 
        <String `P'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086504>
       <ParaLine 
        <String `N'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086506>
       <ParaLine 
        <String `N'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086508>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
   > # end of Row
   <Row 
    <RowMaxHeight  355.60065 mm>
    <RowHeight  5.64445 mm>
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086510>
       <ParaLine 
        <String `P:Footnote'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086512>
       <ParaLine 
        <String `P'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086514>
       <ParaLine 
        <String `N'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086516>
       <ParaLine 
        <String `N'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086518>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
   > # end of Row
   <Row 
    <RowMaxHeight  355.60065 mm>
    <RowHeight  5.64445 mm>
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086520>
       <ParaLine 
        <String `P:Heading1'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086522>
       <ParaLine 
        <String `H*'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086524>
       <ParaLine 
        <String `N'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086526>
       <ParaLine 
        <String `N'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086528>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
   > # end of Row
   <Row 
    <RowMaxHeight  355.60065 mm>
    <RowHeight  5.64445 mm>
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086530>
       <ParaLine 
        <String `P:Heading2'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086532>
       <ParaLine 
        <String `H*'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086534>
       <ParaLine 
        <String `N'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086536>
       <ParaLine 
        <String `N'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086538>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
   > # end of Row
   <Row 
    <RowMaxHeight  355.60065 mm>
    <RowHeight  5.64445 mm>
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086540>
       <ParaLine 
        <String `P:HeadingRunIn'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086542>
       <ParaLine 
        <String `H*'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086544>
       <ParaLine 
        <String `N'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086546>
       <ParaLine 
        <String `N'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086548>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
   > # end of Row
   <Row 
    <RowMaxHeight  355.60065 mm>
    <RowHeight  15.52225 mm>
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086550>
       <ParaLine 
        <String `P:Indented'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086552>
       <ParaLine 
        <String `P'>
       > # end of ParaLine
      > # end of Para
      <Para 
       <Unique 1086553>
       <ParaLine 
        <String `Parent = UL'>
       > # end of ParaLine
      > # end of Para
      <Para 
       <Unique 1086554>
       <ParaLine 
        <String `Depth = 0'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086556>
       <ParaLine 
        <String `N'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086558>
       <ParaLine 
        <String `N'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086560>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
   > # end of Row
   <Row 
    <RowMaxHeight  355.60065 mm>
    <RowHeight  5.64445 mm>
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086562>
       <ParaLine 
        <String `P:Mapping Table Cell'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086564>
       <ParaLine 
        <String `P'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086566>
       <ParaLine 
        <String `N'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086568>
       <ParaLine 
        <String `N'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086570>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
   > # end of Row
   <Row 
    <RowMaxHeight  355.60065 mm>
    <RowHeight  5.64445 mm>
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086572>
       <ParaLine 
        <String `P:Mapping Table Title'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086574>
       <ParaLine 
        <String `P'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086576>
       <ParaLine 
        <String `N'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086578>
       <ParaLine 
        <String `N'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086580>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
   > # end of Row
   <Row 
    <RowMaxHeight  355.60065 mm>
    <RowHeight  15.52225 mm>
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086582>
       <ParaLine 
        <String `P:Numbered'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086584>
       <ParaLine 
        <String `LI'>
       > # end of ParaLine
      > # end of Para
      <Para 
       <Unique 1086585>
       <ParaLine 
        <String `Parent = OL'>
       > # end of ParaLine
      > # end of Para
      <Para 
       <Unique 1086586>
       <ParaLine 
        <String `Depth = 0'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086588>
       <ParaLine 
        <String `N'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086590>
       <ParaLine 
        <String `N'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086592>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
   > # end of Row
   <Row 
    <RowMaxHeight  355.60065 mm>
    <RowHeight  15.52225 mm>
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086594>
       <ParaLine 
        <String `P:Numbered1'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086596>
       <ParaLine 
        <String `LI'>
       > # end of ParaLine
      > # end of Para
      <Para 
       <Unique 1086597>
       <ParaLine 
        <String `Parent = OL'>
       > # end of ParaLine
      > # end of Para
      <Para 
       <Unique 1086598>
       <ParaLine 
        <String `Depth = 0'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086600>
       <ParaLine 
        <String `N'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086602>
       <ParaLine 
        <String `N'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086604>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
   > # end of Row
   <Row 
    <RowMaxHeight  355.60065 mm>
    <RowHeight  5.64445 mm>
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086606>
       <ParaLine 
        <String `P:TableFootnote'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086608>
       <ParaLine 
        <String `P'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086610>
       <ParaLine 
        <String `N'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086612>
       <ParaLine 
        <String `N'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086614>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
   > # end of Row
   <Row 
    <RowMaxHeight  355.60065 mm>
    <RowHeight  5.64445 mm>
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086616>
       <ParaLine 
        <String `P:TableTitle'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086618>
       <ParaLine 
        <String `H*'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086620>
       <ParaLine 
        <String `N'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086622>
       <ParaLine 
        <String `N'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086624>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
   > # end of Row
   <Row 
    <RowMaxHeight  355.60065 mm>
    <RowHeight  5.64445 mm>
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086626>
       <ParaLine 
        <String `P:Title'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086628>
       <ParaLine 
        <String `H*'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086630>
       <ParaLine 
        <String `N'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086632>
       <ParaLine 
        <String `N'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086634>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
   > # end of Row
   <Row 
    <RowMaxHeight  355.60065 mm>
    <RowHeight  5.64445 mm>
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086636>
       <ParaLine 
        <String `C:Emphasis'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086638>
       <ParaLine 
        <String `EM'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086640>
       <ParaLine 
        <String `N'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086642>
       <ParaLine 
        <String `N'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086644>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
   > # end of Row
   <Row 
    <RowMaxHeight  355.60065 mm>
    <RowHeight  5.64445 mm>
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086646>
       <ParaLine 
        <String `C:EquationVariables'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086648>
       <ParaLine 
        <String `EM'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086650>
       <ParaLine 
        <String `N'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086652>
       <ParaLine 
        <String `N'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086654>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
   > # end of Row
   <Row 
    <RowMaxHeight  355.60065 mm>
    <RowHeight  5.64445 mm>
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086656>
       <ParaLine 
        <String `X:Heading & Page'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086658>
       <ParaLine 
        <String `Heading'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086660>
       <ParaLine 
        <String `N'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086662>
       <ParaLine 
        <String `N'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086664>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
   > # end of Row
   <Row 
    <RowMaxHeight  355.60065 mm>
    <RowHeight  5.64445 mm>
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086666>
       <ParaLine 
        <String `X:Page'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086668>
       <ParaLine 
        <String `Heading'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086670>
       <ParaLine 
        <String `N'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086672>
       <ParaLine 
        <String `N'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086674>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
   > # end of Row
   <Row 
    <RowMaxHeight  355.60065 mm>
    <RowHeight  5.64445 mm>
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086676>
       <ParaLine 
        <String `X:See Heading & Page'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086678>
       <ParaLine 
        <String `See Also'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086680>
       <ParaLine 
        <String `N'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086682>
       <ParaLine 
        <String `N'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086684>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
   > # end of Row
   <Row 
    <RowMaxHeight  355.60065 mm>
    <RowHeight  5.64445 mm>
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086686>
       <ParaLine 
        <String `X:Table All'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086688>
       <ParaLine 
        <String `Table All'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086690>
       <ParaLine 
        <String `N'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086692>
       <ParaLine 
        <String `N'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086694>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
   > # end of Row
   <Row 
    <RowMaxHeight  355.60065 mm>
    <RowHeight  10.58335 mm>
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086696>
       <ParaLine 
        <String `X:Table Number & Page'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086698>
       <ParaLine 
        <String `Table '>
       > # end of ParaLine
       <ParaLine 
        <String `Number'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086700>
       <ParaLine 
        <String `N'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086702>
       <ParaLine 
        <String `N'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086704>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
   > # end of Row
  > # end of TblBody
 > # end of Tbl
 <Tbl 
  <TblID 3>
  <TblFormat 
   <TblTag `Mapping Table'>
   <TblColumn 
    <TblColumnNum 0>
    <TblColumnWidth  25.40005 mm>
    <TblColumnH 
     <Pgf 
      <PgfTag `Body'>
      <PgfAlignment LeftRight>
      <PgfFont 
       <FTag `'>
       <FPlatformName `W.Times New Roman.R.400'>
       <FFamily `Times New Roman'>
       <FVar `Regular'>
       <FWeight `Regular'>
       <FAngle `Regular'>
       <FEncoding `FrameRoman'>
       <FSize  12.0 pt>
       <FUnderlining FNoUnderlining>
       <FOverline No>
       <FStrike No>
       <FChangeBar No>
       <FOutline No>
       <FShadow No>
       <FPairKern No>
       <FTsume No>
       <FCase FAsTyped>
       <FPosition FNormal>
       <FDX  0.0%>
       <FDY  0.0%>
       <FDW  0.0%>
       <FStretch  100.0%>
       <FLanguage UKEnglish>
       <FLocked No>
       <FSeparation 0>
       <FColor `Black'>
       <FBackgroundColor NoColor>
      > # end of PgfFont
      <PgfPDFStructureLevel 0>
      <PgfLanguage UKEnglish>
     > # end of Pgf
    > # end of TblColumnH
    <TblColumnBody 
    > # end of TblColumnBody
    <TblColumnF 
    > # end of TblColumnF
   > # end of TblColumn
   <TblCellMargins  2.0 pt 2.0 pt 2.0 pt 2.0 pt>
   <TblLIndent  0.0 mm>
   <TblRIndent  0.0 mm>
   <TblAlignment Left>
   <TblPlacement Anywhere>
   <TblSpBefore  6.0 pt>
   <TblSpAfter  6.0 pt>
   <TblBlockSize 1>
   <TblHFFill 15>
   <TblHFSeparation 0>
   <TblHFColor `Black'>
   <TblBodyFill 15>
   <TblBodySeparation 0>
   <TblBodyColor `Black'>
   <TblShadeByColumn No>
   <TblLocked No>
   <TblShadePeriod 4>
   <TblXFill 15>
   <TblXSeparation 0>
   <TblXColor `Black'>
   <TblAltShadePeriod 0>
   <TblLRuling `Thin'>
   <TblBRuling `Thin'>
   <TblRRuling `Thin'>
   <TblTRuling `Thin'>
   <TblColumnRuling `Thin'>
   <TblXColumnRuling `Thin'>
   <TblBodyRowRuling `Thin'>
   <TblXRowRuling `Thin'>
   <TblHFRowRuling `Thin'>
   <TblSeparatorRuling `Double'>
   <TblXColumnNum 1>
   <TblRulingPeriod 4>
   <TblLastBRuling No>
   <TblTitlePlacement InHeader>
   <TblTitlePgf1 
    <Pgf 
     <PgfTag `Mapping Table Title'>
     <PgfPDFStructureLevel 6>
    > # end of Pgf
   > # end of TblTitlePgf1
   <TblTitleGap  4.0 pt>
   <TblInitNumColumns 1>
   <TblInitNumHRows 0>
   <TblInitNumBodyRows 1>
   <TblInitNumFRows 0>
   <TblNumByColumn No>
  > # end of TblFormat
  <TblNumColumns 3>
  <Unique 1086705>
  <TblColumnWidth  40.0 mm>
  <TblColumnWidth  44.49988 mm>
  <TblColumnWidth  25.40005 mm>
  <TblTitle 
   <TblTitleContent 
    <Notes 
    > # end of Notes
    <Para 
     <Unique 1086707>
     <Pgf 
      <PgfFont 
       <FTag `'>
       <FPlatformName `W.Times New Roman.R.400'>
       <FFamily `Times New Roman'>
       <FVar `Regular'>
       <FWeight `Regular'>
       <FAngle `Regular'>
       <FEncoding `FrameRoman'>
       <FSize  12.0 pt>
       <FUnderlining FNoUnderlining>
       <FOverline No>
       <FStrike No>
       <FChangeBar No>
       <FOutline No>
       <FShadow No>
       <FPairKern No>
       <FTsume No>
       <FCase FAsTyped>
       <FPosition FNormal>
       <FDX  0.0%>
       <FDY  0.0%>
       <FDW  0.0%>
       <FStretch  100.0%>
       <FLanguage NoLanguage>
       <FLocked No>
       <FSeparation 0>
       <FColor `Black'>
       <FBackgroundColor NoColor>
      > # end of PgfFont
      <PgfLanguage NoLanguage>
     > # end of Pgf
     <ParaLine 
      <String `HTML Options Table'>
     > # end of ParaLine
    > # end of Para
   > # end of TblTitleContent
  > # end of TblTitle
  <TblH 
   <Row 
    <RowMaxHeight  355.60065 mm>
    <RowHeight  5.64445 mm>
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086713>
       <Pgf 
        <PgfTag `Mapping Table Cell'>
        <PgfAlignment Left>
        <PgfPDFStructureLevel 6>
       > # end of Pgf
       <ParaLine 
        <String `Control'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086715>
       <ParaLine 
        <String `Value'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086717>
       <ParaLine 
        <String `Comments'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
   > # end of Row
  > # end of TblH
  <TblBody 
   <Row 
    <RowMaxHeight  355.60065 mm>
    <RowHeight  5.64445 mm>
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086719>
       <ParaLine 
        <String `Image Format'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086721>
       <ParaLine 
        <String `0001IMAGGIF         GIF'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086723>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
   > # end of Row
   <Row 
    <RowMaxHeight  355.60065 mm>
    <RowHeight  10.58335 mm>
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086725>
       <ParaLine 
        <String `Copy Files Imported '>
       > # end of ParaLine
       <ParaLine 
        <String `by Reference'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086727>
       <ParaLine 
        <String `N'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086729>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
   > # end of Row
   <Row 
    <RowMaxHeight  355.60065 mm>
    <RowHeight  5.64445 mm>
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086731>
       <ParaLine 
        <String `Export Encoding'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086733>
       <ParaLine 
        <String `ISO-8859-1'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086735>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
   > # end of Row
   <Row 
    <RowMaxHeight  355.60065 mm>
    <RowHeight  5.64445 mm>
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086737>
       <ParaLine 
        <String `CSS Export Encoding'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086739>
       <ParaLine 
        <String `ISO-8859-1'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086741>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
   > # end of Row
  > # end of TblBody
 > # end of Tbl
 <Tbl 
  <TblID 4>
  <TblFormat 
   <TblTag `Mapping Table'>
   <TblColumn 
    <TblColumnNum 0>
    <TblColumnWidth  25.40005 mm>
    <TblColumnH 
     <Pgf 
      <PgfTag `Body'>
      <PgfAlignment LeftRight>
      <PgfFont 
       <FTag `'>
       <FPlatformName `W.Times New Roman.R.400'>
       <FFamily `Times New Roman'>
       <FVar `Regular'>
       <FWeight `Regular'>
       <FAngle `Regular'>
       <FEncoding `FrameRoman'>
       <FSize  12.0 pt>
       <FUnderlining FNoUnderlining>
       <FOverline No>
       <FStrike No>
       <FChangeBar No>
       <FOutline No>
       <FShadow No>
       <FPairKern No>
       <FTsume No>
       <FCase FAsTyped>
       <FPosition FNormal>
       <FDX  0.0%>
       <FDY  0.0%>
       <FDW  0.0%>
       <FStretch  100.0%>
       <FLanguage UKEnglish>
       <FLocked No>
       <FSeparation 0>
       <FColor `Black'>
       <FBackgroundColor NoColor>
      > # end of PgfFont
      <PgfPDFStructureLevel 0>
      <PgfLanguage UKEnglish>
     > # end of Pgf
    > # end of TblColumnH
    <TblColumnBody 
    > # end of TblColumnBody
    <TblColumnF 
    > # end of TblColumnF
   > # end of TblColumn
   <TblCellMargins  2.0 pt 2.0 pt 2.0 pt 2.0 pt>
   <TblLIndent  0.0 mm>
   <TblRIndent  0.0 mm>
   <TblAlignment Left>
   <TblPlacement Anywhere>
   <TblSpBefore  6.0 pt>
   <TblSpAfter  6.0 pt>
   <TblBlockSize 1>
   <TblHFFill 15>
   <TblHFSeparation 0>
   <TblHFColor `Black'>
   <TblBodyFill 15>
   <TblBodySeparation 0>
   <TblBodyColor `Black'>
   <TblShadeByColumn No>
   <TblLocked No>
   <TblShadePeriod 4>
   <TblXFill 15>
   <TblXSeparation 0>
   <TblXColor `Black'>
   <TblAltShadePeriod 0>
   <TblLRuling `Thin'>
   <TblBRuling `Thin'>
   <TblRRuling `Thin'>
   <TblTRuling `Thin'>
   <TblColumnRuling `Thin'>
   <TblXColumnRuling `Thin'>
   <TblBodyRowRuling `Thin'>
   <TblXRowRuling `Thin'>
   <TblHFRowRuling `Thin'>
   <TblSeparatorRuling `Double'>
   <TblXColumnNum 1>
   <TblRulingPeriod 4>
   <TblLastBRuling No>
   <TblTitlePlacement InHeader>
   <TblTitlePgf1 
    <Pgf 
     <PgfTag `Mapping Table Title'>
     <PgfPDFStructureLevel 6>
    > # end of Pgf
   > # end of TblTitlePgf1
   <TblTitleGap  4.0 pt>
   <TblInitNumColumns 1>
   <TblInitNumHRows 0>
   <TblInitNumBodyRows 1>
   <TblInitNumFRows 0>
   <TblNumByColumn No>
  > # end of TblFormat
  <TblNumColumns 4>
  <Unique 1086742>
  <TblColumnWidth  36.68896 mm>
  <TblColumnWidth  36.68896 mm>
  <TblColumnWidth  36.68896 mm>
  <TblColumnWidth  23.28338 mm>
  <TblTitle 
   <TblTitleContent 
    <Notes 
    > # end of Notes
    <Para 
     <Unique 1086744>
     <Pgf 
      <PgfFont 
       <FTag `'>
       <FPlatformName `W.Times New Roman.R.400'>
       <FFamily `Times New Roman'>
       <FVar `Regular'>
       <FWeight `Regular'>
       <FAngle `Regular'>
       <FEncoding `FrameRoman'>
       <FSize  12.0 pt>
       <FUnderlining FNoUnderlining>
       <FOverline No>
       <FStrike No>
       <FChangeBar No>
       <FOutline No>
       <FShadow No>
       <FPairKern No>
       <FTsume No>
       <FCase FAsTyped>
       <FPosition FNormal>
       <FDX  0.0%>
       <FDY  0.0%>
       <FDW  0.0%>
       <FStretch  100.0%>
       <FLanguage NoLanguage>
       <FLocked No>
       <FSeparation 0>
       <FColor `Black'>
       <FBackgroundColor NoColor>
      > # end of PgfFont
      <PgfLanguage NoLanguage>
     > # end of Pgf
     <ParaLine 
      <String `System Macros'>
     > # end of ParaLine
    > # end of Para
   > # end of TblTitleContent
  > # end of TblTitle
  <TblH 
   <Row 
    <RowMaxHeight  355.60065 mm>
    <RowHeight  5.64445 mm>
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086752>
       <Pgf 
        <PgfTag `Mapping Table Cell'>
        <PgfAlignment Left>
        <PgfPDFStructureLevel 6>
       > # end of Pgf
       <ParaLine 
        <String `Macro Name'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086754>
       <ParaLine 
        <String `Replace With'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086756>
       <ParaLine 
        <String `Head'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086758>
       <ParaLine 
        <String `Comments'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
   > # end of Row
  > # end of TblH
  <TblBody 
   <Row 
    <RowMaxHeight  355.60065 mm>
    <RowHeight  15.52225 mm>
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086760>
       <ParaLine 
        <String `StartOfDoc'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086762>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086764>
       <ParaLine 
        <String `<TITLE\> '>
       > # end of ParaLine
       <ParaLine 
        <String `<$defaulttitle\></'>
       > # end of ParaLine
       <ParaLine 
        <String `TITLE\>'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086766>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
   > # end of Row
   <Row 
    <RowMaxHeight  355.60065 mm>
    <RowHeight  5.64445 mm>
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086768>
       <ParaLine 
        <String `EndOfDoc'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086770>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086772>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086774>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
   > # end of Row
   <Row 
    <RowMaxHeight  355.60065 mm>
    <RowHeight  15.52225 mm>
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086776>
       <ParaLine 
        <String `StartOfSubDoc'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086778>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086780>
       <ParaLine 
        <String `<TITLE\> '>
       > # end of ParaLine
       <ParaLine 
        <String `<$defaulttitle\></'>
       > # end of ParaLine
       <ParaLine 
        <String `TITLE\>'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086782>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
   > # end of Row
   <Row 
    <RowMaxHeight  355.60065 mm>
    <RowHeight  5.64445 mm>
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086784>
       <ParaLine 
        <String `EndOfSubDoc'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086786>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086788>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086790>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
   > # end of Row
   <Row 
    <RowMaxHeight  355.60065 mm>
    <RowHeight  15.52225 mm>
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086792>
       <ParaLine 
        <String `StartOfFirstSubDoc'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086794>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086796>
       <ParaLine 
        <String `<TITLE\> '>
       > # end of ParaLine
       <ParaLine 
        <String `<$defaulttitle\></'>
       > # end of ParaLine
       <ParaLine 
        <String `TITLE\>'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086798>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
   > # end of Row
   <Row 
    <RowMaxHeight  355.60065 mm>
    <RowHeight  5.64445 mm>
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086800>
       <ParaLine 
        <String `EndOfFirstSubDoc'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086802>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086804>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086806>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
   > # end of Row
   <Row 
    <RowMaxHeight  355.60065 mm>
    <RowHeight  15.52225 mm>
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086808>
       <ParaLine 
        <String `StartOfLastSubDoc'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086810>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086812>
       <ParaLine 
        <String `<TITLE\> '>
       > # end of ParaLine
       <ParaLine 
        <String `<$defaulttitle\></'>
       > # end of ParaLine
       <ParaLine 
        <String `TITLE\>'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086814>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
   > # end of Row
   <Row 
    <RowMaxHeight  355.60065 mm>
    <RowHeight  5.64445 mm>
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086816>
       <ParaLine 
        <String `EndOfLastSubDoc'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086818>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086820>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086822>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
   > # end of Row
  > # end of TblBody
 > # end of Tbl
 <Tbl 
  <TblID 5>
  <TblFormat 
   <TblTag `Mapping Table'>
   <TblColumn 
    <TblColumnNum 0>
    <TblColumnWidth  25.40005 mm>
    <TblColumnH 
     <Pgf 
      <PgfTag `Body'>
      <PgfAlignment LeftRight>
      <PgfFont 
       <FTag `'>
       <FPlatformName `W.Times New Roman.R.400'>
       <FFamily `Times New Roman'>
       <FVar `Regular'>
       <FWeight `Regular'>
       <FAngle `Regular'>
       <FEncoding `FrameRoman'>
       <FSize  12.0 pt>
       <FUnderlining FNoUnderlining>
       <FOverline No>
       <FStrike No>
       <FChangeBar No>
       <FOutline No>
       <FShadow No>
       <FPairKern No>
       <FTsume No>
       <FCase FAsTyped>
       <FPosition FNormal>
       <FDX  0.0%>
       <FDY  0.0%>
       <FDW  0.0%>
       <FStretch  100.0%>
       <FLanguage UKEnglish>
       <FLocked No>
       <FSeparation 0>
       <FColor `Black'>
       <FBackgroundColor NoColor>
      > # end of PgfFont
      <PgfPDFStructureLevel 0>
      <PgfLanguage UKEnglish>
     > # end of Pgf
    > # end of TblColumnH
    <TblColumnBody 
    > # end of TblColumnBody
    <TblColumnF 
    > # end of TblColumnF
   > # end of TblColumn
   <TblCellMargins  2.0 pt 2.0 pt 2.0 pt 2.0 pt>
   <TblLIndent  0.0 mm>
   <TblRIndent  0.0 mm>
   <TblAlignment Left>
   <TblPlacement Anywhere>
   <TblSpBefore  6.0 pt>
   <TblSpAfter  6.0 pt>
   <TblBlockSize 1>
   <TblHFFill 15>
   <TblHFSeparation 0>
   <TblHFColor `Black'>
   <TblBodyFill 15>
   <TblBodySeparation 0>
   <TblBodyColor `Black'>
   <TblShadeByColumn No>
   <TblLocked No>
   <TblShadePeriod 4>
   <TblXFill 15>
   <TblXSeparation 0>
   <TblXColor `Black'>
   <TblAltShadePeriod 0>
   <TblLRuling `Thin'>
   <TblBRuling `Thin'>
   <TblRRuling `Thin'>
   <TblTRuling `Thin'>
   <TblColumnRuling `Thin'>
   <TblXColumnRuling `Thin'>
   <TblBodyRowRuling `Thin'>
   <TblXRowRuling `Thin'>
   <TblHFRowRuling `Thin'>
   <TblSeparatorRuling `Double'>
   <TblXColumnNum 1>
   <TblRulingPeriod 4>
   <TblLastBRuling No>
   <TblTitlePlacement InHeader>
   <TblTitlePgf1 
    <Pgf 
     <PgfTag `Mapping Table Title'>
     <PgfPDFStructureLevel 6>
    > # end of Pgf
   > # end of TblTitlePgf1
   <TblTitleGap  4.0 pt>
   <TblInitNumColumns 1>
   <TblInitNumHRows 0>
   <TblInitNumBodyRows 1>
   <TblInitNumFRows 0>
   <TblNumByColumn No>
  > # end of TblFormat
  <TblNumColumns 3>
  <Unique 1086823>
  <TblColumnWidth  50.80009 mm>
  <TblColumnWidth  50.80009 mm>
  <TblColumnWidth  22.22504 mm>
  <TblTitle 
   <TblTitleContent 
    <Notes 
    > # end of Notes
    <Para 
     <Unique 1086825>
     <Pgf 
      <PgfFont 
       <FTag `'>
       <FPlatformName `W.Times New Roman.R.400'>
       <FFamily `Times New Roman'>
       <FVar `Regular'>
       <FWeight `Regular'>
       <FAngle `Regular'>
       <FEncoding `FrameRoman'>
       <FSize  12.0 pt>
       <FUnderlining FNoUnderlining>
       <FOverline No>
       <FStrike No>
       <FChangeBar No>
       <FOutline No>
       <FShadow No>
       <FPairKern No>
       <FTsume No>
       <FCase FAsTyped>
       <FPosition FNormal>
       <FDX  0.0%>
       <FDY  0.0%>
       <FDW  0.0%>
       <FStretch  100.0%>
       <FLanguage NoLanguage>
       <FLocked No>
       <FSeparation 0>
       <FColor `Black'>
       <FBackgroundColor NoColor>
      > # end of PgfFont
      <PgfLanguage NoLanguage>
     > # end of Pgf
     <ParaLine 
      <String `Cross-Reference Macros'>
     > # end of ParaLine
    > # end of Para
   > # end of TblTitleContent
  > # end of TblTitle
  <TblH 
   <Row 
    <RowMaxHeight  355.60065 mm>
    <RowHeight  5.64445 mm>
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086831>
       <Pgf 
        <PgfTag `Mapping Table Cell'>
        <PgfAlignment Left>
        <PgfPDFStructureLevel 6>
       > # end of Pgf
       <ParaLine 
        <String `Macro Name'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086833>
       <ParaLine 
        <String `Replace With'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086835>
       <ParaLine 
        <String `Comments'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
   > # end of Row
  > # end of TblH
  <TblBody 
   <Row 
    <RowMaxHeight  355.60065 mm>
    <RowHeight  5.64445 mm>
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086837>
       <ParaLine 
        <String `Heading'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086839>
       <ParaLine 
        <String `<$paratext\>'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086841>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
   > # end of Row
   <Row 
    <RowMaxHeight  355.60065 mm>
    <RowHeight  5.64445 mm>
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086843>
       <ParaLine 
        <String `See Also'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086845>
       <ParaLine 
        <String `See <$paratext\>.'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086847>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
   > # end of Row
   <Row 
    <RowMaxHeight  355.60065 mm>
    <RowHeight  10.58335 mm>
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086849>
       <ParaLine 
        <String `Table All'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086851>
       <ParaLine 
        <String `Table <$paranumonly\>, '>
       > # end of ParaLine
       <ParaLine 
        <String `<$paratext\>'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086853>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
   > # end of Row
   <Row 
    <RowMaxHeight  355.60065 mm>
    <RowHeight  5.64445 mm>
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086855>
       <ParaLine 
        <String `Table Number'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086857>
       <ParaLine 
        <String `Table <$paranumonly\>'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086859>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
   > # end of Row
  > # end of TblBody
 > # end of Tbl
 <Tbl 
  <TblID 6>
  <TblFormat 
   <TblTag `Mapping Table'>
   <TblColumn 
    <TblColumnNum 0>
    <TblColumnWidth  25.40005 mm>
    <TblColumnH 
     <Pgf 
      <PgfTag `Body'>
      <PgfAlignment LeftRight>
      <PgfFont 
       <FTag `'>
       <FPlatformName `W.Times New Roman.R.400'>
       <FFamily `Times New Roman'>
       <FVar `Regular'>
       <FWeight `Regular'>
       <FAngle `Regular'>
       <FEncoding `FrameRoman'>
       <FSize  12.0 pt>
       <FUnderlining FNoUnderlining>
       <FOverline No>
       <FStrike No>
       <FChangeBar No>
       <FOutline No>
       <FShadow No>
       <FPairKern No>
       <FTsume No>
       <FCase FAsTyped>
       <FPosition FNormal>
       <FDX  0.0%>
       <FDY  0.0%>
       <FDW  0.0%>
       <FStretch  100.0%>
       <FLanguage UKEnglish>
       <FLocked No>
       <FSeparation 0>
       <FColor `Black'>
       <FBackgroundColor NoColor>
      > # end of PgfFont
      <PgfPDFStructureLevel 0>
      <PgfLanguage UKEnglish>
     > # end of Pgf
    > # end of TblColumnH
    <TblColumnBody 
    > # end of TblColumnBody
    <TblColumnF 
    > # end of TblColumnF
   > # end of TblColumn
   <TblCellMargins  2.0 pt 2.0 pt 2.0 pt 2.0 pt>
   <TblLIndent  0.0 mm>
   <TblRIndent  0.0 mm>
   <TblAlignment Left>
   <TblPlacement Anywhere>
   <TblSpBefore  6.0 pt>
   <TblSpAfter  6.0 pt>
   <TblBlockSize 1>
   <TblHFFill 15>
   <TblHFSeparation 0>
   <TblHFColor `Black'>
   <TblBodyFill 15>
   <TblBodySeparation 0>
   <TblBodyColor `Black'>
   <TblShadeByColumn No>
   <TblLocked No>
   <TblShadePeriod 4>
   <TblXFill 15>
   <TblXSeparation 0>
   <TblXColor `Black'>
   <TblAltShadePeriod 0>
   <TblLRuling `Thin'>
   <TblBRuling `Thin'>
   <TblRRuling `Thin'>
   <TblTRuling `Thin'>
   <TblColumnRuling `Thin'>
   <TblXColumnRuling `Thin'>
   <TblBodyRowRuling `Thin'>
   <TblXRowRuling `Thin'>
   <TblHFRowRuling `Thin'>
   <TblSeparatorRuling `Double'>
   <TblXColumnNum 1>
   <TblRulingPeriod 4>
   <TblLastBRuling No>
   <TblTitlePlacement InHeader>
   <TblTitlePgf1 
    <Pgf 
     <PgfTag `Mapping Table Title'>
     <PgfPDFStructureLevel 6>
    > # end of Pgf
   > # end of TblTitlePgf1
   <TblTitleGap  4.0 pt>
   <TblInitNumColumns 1>
   <TblInitNumHRows 0>
   <TblInitNumBodyRows 1>
   <TblInitNumFRows 0>
   <TblNumByColumn No>
  > # end of TblFormat
  <TblNumColumns 4>
  <Unique 1086860>
  <TblColumnWidth  36.68896 mm>
  <TblColumnWidth  36.68896 mm>
  <TblColumnWidth  36.68896 mm>
  <TblColumnWidth  20.10837 mm>
  <TblTitle 
   <TblTitleContent 
    <Notes 
    > # end of Notes
    <Para 
     <Unique 1086862>
     <Pgf 
      <PgfFont 
       <FTag `'>
       <FPlatformName `W.Times New Roman.R.400'>
       <FFamily `Times New Roman'>
       <FVar `Regular'>
       <FWeight `Regular'>
       <FAngle `Regular'>
       <FEncoding `FrameRoman'>
       <FSize  12.0 pt>
       <FUnderlining FNoUnderlining>
       <FOverline No>
       <FStrike No>
       <FChangeBar No>
       <FOutline No>
       <FShadow No>
       <FPairKern No>
       <FTsume No>
       <FCase FAsTyped>
       <FPosition FNormal>
       <FDX  0.0%>
       <FDY  0.0%>
       <FDW  0.0%>
       <FStretch  100.0%>
       <FLanguage NoLanguage>
       <FLocked No>
       <FSeparation 0>
       <FColor `Black'>
       <FBackgroundColor NoColor>
      > # end of PgfFont
      <PgfLanguage NoLanguage>
     > # end of Pgf
     <ParaLine 
      <String `General Macros'>
     > # end of ParaLine
    > # end of Para
   > # end of TblTitleContent
  > # end of TblTitle
  <TblH 
   <Row 
    <RowMaxHeight  355.60065 mm>
    <RowHeight  5.64445 mm>
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086870>
       <Pgf 
        <PgfTag `Mapping Table Cell'>
        <PgfAlignment Left>
        <PgfPDFStructureLevel 6>
       > # end of Pgf
       <ParaLine 
        <String `Macro Name'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086872>
       <ParaLine 
        <String `Replace With'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086874>
       <ParaLine 
        <String `Head'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086876>
       <ParaLine 
        <String `Comments'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
   > # end of Row
  > # end of TblH
  <TblBody 
   <Row 
    <RowMaxHeight  355.60065 mm>
    <RowHeight  5.64445 mm>
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086878>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086880>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086882>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086884>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
   > # end of Row
  > # end of TblBody
 > # end of Tbl
 <Tbl 
  <TblID 7>
  <TblFormat 
   <TblTag `Mapping Table'>
   <TblColumn 
    <TblColumnNum 0>
    <TblColumnWidth  25.40005 mm>
    <TblColumnH 
     <Pgf 
      <PgfTag `Body'>
      <PgfAlignment LeftRight>
      <PgfFont 
       <FTag `'>
       <FPlatformName `W.Times New Roman.R.400'>
       <FFamily `Times New Roman'>
       <FVar `Regular'>
       <FWeight `Regular'>
       <FAngle `Regular'>
       <FEncoding `FrameRoman'>
       <FSize  12.0 pt>
       <FUnderlining FNoUnderlining>
       <FOverline No>
       <FStrike No>
       <FChangeBar No>
       <FOutline No>
       <FShadow No>
       <FPairKern No>
       <FTsume No>
       <FCase FAsTyped>
       <FPosition FNormal>
       <FDX  0.0%>
       <FDY  0.0%>
       <FDW  0.0%>
       <FStretch  100.0%>
       <FLanguage UKEnglish>
       <FLocked No>
       <FSeparation 0>
       <FColor `Black'>
       <FBackgroundColor NoColor>
      > # end of PgfFont
      <PgfPDFStructureLevel 0>
      <PgfLanguage UKEnglish>
     > # end of Pgf
    > # end of TblColumnH
    <TblColumnBody 
    > # end of TblColumnBody
    <TblColumnF 
    > # end of TblColumnF
   > # end of TblColumn
   <TblCellMargins  2.0 pt 2.0 pt 2.0 pt 2.0 pt>
   <TblLIndent  0.0 mm>
   <TblRIndent  0.0 mm>
   <TblAlignment Left>
   <TblPlacement Anywhere>
   <TblSpBefore  6.0 pt>
   <TblSpAfter  6.0 pt>
   <TblBlockSize 1>
   <TblHFFill 15>
   <TblHFSeparation 0>
   <TblHFColor `Black'>
   <TblBodyFill 15>
   <TblBodySeparation 0>
   <TblBodyColor `Black'>
   <TblShadeByColumn No>
   <TblLocked No>
   <TblShadePeriod 4>
   <TblXFill 15>
   <TblXSeparation 0>
   <TblXColor `Black'>
   <TblAltShadePeriod 0>
   <TblLRuling `Thin'>
   <TblBRuling `Thin'>
   <TblRRuling `Thin'>
   <TblTRuling `Thin'>
   <TblColumnRuling `Thin'>
   <TblXColumnRuling `Thin'>
   <TblBodyRowRuling `Thin'>
   <TblXRowRuling `Thin'>
   <TblHFRowRuling `Thin'>
   <TblSeparatorRuling `Double'>
   <TblXColumnNum 1>
   <TblRulingPeriod 4>
   <TblLastBRuling No>
   <TblTitlePlacement InHeader>
   <TblTitlePgf1 
    <Pgf 
     <PgfTag `Mapping Table Title'>
     <PgfPDFStructureLevel 6>
    > # end of Pgf
   > # end of TblTitlePgf1
   <TblTitleGap  4.0 pt>
   <TblInitNumColumns 1>
   <TblInitNumHRows 0>
   <TblInitNumBodyRows 1>
   <TblInitNumFRows 0>
   <TblNumByColumn No>
  > # end of TblFormat
  <TblNumColumns 3>
  <Unique 1086885>
  <TblColumnWidth  25.40005 mm>
  <TblColumnWidth  50.80009 mm>
  <TblColumnWidth  22.22504 mm>
  <TblTitle 
   <TblTitleContent 
    <Notes 
    > # end of Notes
    <Para 
     <Unique 1086887>
     <Pgf 
      <PgfFont 
       <FTag `'>
       <FPlatformName `W.Times New Roman.R.400'>
       <FFamily `Times New Roman'>
       <FVar `Regular'>
       <FWeight `Regular'>
       <FAngle `Regular'>
       <FEncoding `FrameRoman'>
       <FSize  12.0 pt>
       <FUnderlining FNoUnderlining>
       <FOverline No>
       <FStrike No>
       <FChangeBar No>
       <FOutline No>
       <FShadow No>
       <FPairKern No>
       <FTsume No>
       <FCase FAsTyped>
       <FPosition FNormal>
       <FDX  0.0%>
       <FDY  0.0%>
       <FDW  0.0%>
       <FStretch  100.0%>
       <FLanguage NoLanguage>
       <FLocked No>
       <FSeparation 0>
       <FColor `Black'>
       <FBackgroundColor NoColor>
      > # end of PgfFont
      <PgfLanguage NoLanguage>
     > # end of Pgf
     <ParaLine 
      <String `Character Macros'>
     > # end of ParaLine
    > # end of Para
   > # end of TblTitleContent
  > # end of TblTitle
  <TblH 
   <Row 
    <RowMaxHeight  355.60065 mm>
    <RowHeight  5.64445 mm>
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086893>
       <Pgf 
        <PgfTag `Mapping Table Cell'>
        <PgfAlignment Left>
        <PgfPDFStructureLevel 6>
       > # end of Pgf
       <ParaLine 
        <String `Character'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086895>
       <ParaLine 
        <String `Replace With'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086897>
       <ParaLine 
        <String `Comments'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
   > # end of Row
  > # end of TblH
  <TblBody 
   <Row 
    <RowMaxHeight  355.60065 mm>
    <RowHeight  5.64445 mm>
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086899>
       <ParaLine 
        <String `¢'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086901>
       <ParaLine 
        <String `&#162;'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086903>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
   > # end of Row
   <Row 
    <RowMaxHeight  355.60065 mm>
    <RowHeight  5.64445 mm>
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086905>
       <ParaLine 
        <String `©'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086907>
       <ParaLine 
        <String `&#169;'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086909>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
   > # end of Row
   <Row 
    <RowMaxHeight  355.60065 mm>
    <RowHeight  5.64445 mm>
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086911>
       <ParaLine 
        <String `®'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086913>
       <ParaLine 
        <String `&#174;'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086915>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
   > # end of Row
   <Row 
    <RowMaxHeight  355.60065 mm>
    <RowHeight  5.64445 mm>
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086917>
       <ParaLine 
        <String `°'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086919>
       <ParaLine 
        <String `&#176;'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086921>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
   > # end of Row
   <Row 
    <RowMaxHeight  355.60065 mm>
    <RowHeight  5.64445 mm>
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086923>
       <ParaLine 
        <String `—'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086925>
       <ParaLine 
        <String `--'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086927>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
   > # end of Row
   <Row 
    <RowMaxHeight  355.60065 mm>
    <RowHeight  5.64445 mm>
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086929>
       <ParaLine 
        <String `–'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086931>
       <ParaLine 
        <String `-'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086933>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
   > # end of Row
   <Row 
    <RowMaxHeight  355.60065 mm>
    <RowHeight  5.64445 mm>
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086935>
       <ParaLine 
        <String `…'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086937>
       <ParaLine 
        <String `...'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086939>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
   > # end of Row
  > # end of TblBody
 > # end of Tbl
 <Tbl 
  <TblID 8>
  <TblFormat 
   <TblTag `Mapping Table'>
   <TblColumn 
    <TblColumnNum 0>
    <TblColumnWidth  25.40005 mm>
    <TblColumnH 
     <Pgf 
      <PgfTag `Body'>
      <PgfAlignment LeftRight>
      <PgfFont 
       <FTag `'>
       <FPlatformName `W.Times New Roman.R.400'>
       <FFamily `Times New Roman'>
       <FVar `Regular'>
       <FWeight `Regular'>
       <FAngle `Regular'>
       <FEncoding `FrameRoman'>
       <FSize  12.0 pt>
       <FUnderlining FNoUnderlining>
       <FOverline No>
       <FStrike No>
       <FChangeBar No>
       <FOutline No>
       <FShadow No>
       <FPairKern No>
       <FTsume No>
       <FCase FAsTyped>
       <FPosition FNormal>
       <FDX  0.0%>
       <FDY  0.0%>
       <FDW  0.0%>
       <FStretch  100.0%>
       <FLanguage UKEnglish>
       <FLocked No>
       <FSeparation 0>
       <FColor `Black'>
       <FBackgroundColor NoColor>
      > # end of PgfFont
      <PgfPDFStructureLevel 0>
      <PgfLanguage UKEnglish>
     > # end of Pgf
    > # end of TblColumnH
    <TblColumnBody 
    > # end of TblColumnBody
    <TblColumnF 
    > # end of TblColumnF
   > # end of TblColumn
   <TblCellMargins  2.0 pt 2.0 pt 2.0 pt 2.0 pt>
   <TblLIndent  0.0 mm>
   <TblRIndent  0.0 mm>
   <TblAlignment Left>
   <TblPlacement Anywhere>
   <TblSpBefore  6.0 pt>
   <TblSpAfter  6.0 pt>
   <TblBlockSize 1>
   <TblHFFill 15>
   <TblHFSeparation 0>
   <TblHFColor `Black'>
   <TblBodyFill 15>
   <TblBodySeparation 0>
   <TblBodyColor `Black'>
   <TblShadeByColumn No>
   <TblLocked No>
   <TblShadePeriod 4>
   <TblXFill 15>
   <TblXSeparation 0>
   <TblXColor `Black'>
   <TblAltShadePeriod 0>
   <TblLRuling `Thin'>
   <TblBRuling `Thin'>
   <TblRRuling `Thin'>
   <TblTRuling `Thin'>
   <TblColumnRuling `Thin'>
   <TblXColumnRuling `Thin'>
   <TblBodyRowRuling `Thin'>
   <TblXRowRuling `Thin'>
   <TblHFRowRuling `Thin'>
   <TblSeparatorRuling `Double'>
   <TblXColumnNum 1>
   <TblRulingPeriod 4>
   <TblLastBRuling No>
   <TblTitlePlacement InHeader>
   <TblTitlePgf1 
    <Pgf 
     <PgfTag `Mapping Table Title'>
     <PgfPDFStructureLevel 6>
    > # end of Pgf
   > # end of TblTitlePgf1
   <TblTitleGap  4.0 pt>
   <TblInitNumColumns 1>
   <TblInitNumHRows 0>
   <TblInitNumBodyRows 1>
   <TblInitNumFRows 0>
   <TblNumByColumn No>
  > # end of TblFormat
  <TblNumColumns 3>
  <Unique 1086970>
  <TblColumnWidth  38.10007 mm>
  <TblColumnWidth  41.27508 mm>
  <TblColumnWidth  25.40005 mm>
  <TblTitle 
   <TblTitleContent 
    <Notes 
    > # end of Notes
    <Para 
     <Unique 1086972>
     <Pgf 
      <PgfFont 
       <FTag `'>
       <FPlatformName `W.Times New Roman.R.400'>
       <FFamily `Times New Roman'>
       <FVar `Regular'>
       <FWeight `Regular'>
       <FAngle `Regular'>
       <FEncoding `FrameRoman'>
       <FSize  12.0 pt>
       <FUnderlining FNoUnderlining>
       <FOverline No>
       <FStrike No>
       <FChangeBar No>
       <FOutline No>
       <FShadow No>
       <FPairKern No>
       <FTsume No>
       <FCase FAsTyped>
       <FPosition FNormal>
       <FDX  0.0%>
       <FDY  0.0%>
       <FDW  0.0%>
       <FStretch  100.0%>
       <FLanguage NoLanguage>
       <FLocked No>
       <FSeparation 0>
       <FColor `Black'>
       <FBackgroundColor NoColor>
      > # end of PgfFont
      <PgfLanguage NoLanguage>
     > # end of Pgf
     <ParaLine 
      <String `Headings Table'>
     > # end of ParaLine
    > # end of Para
   > # end of TblTitleContent
  > # end of TblTitle
  <TblH 
   <Row 
    <RowMaxHeight  355.60065 mm>
    <RowHeight  5.64445 mm>
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086978>
       <Pgf 
        <PgfTag `Mapping Table Cell'>
        <PgfAlignment Left>
        <PgfPDFStructureLevel 6>
       > # end of Pgf
       <ParaLine 
        <String `Heading Level'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086980>
       <ParaLine 
        <String `Paragraph Format'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086982>
       <ParaLine 
        <String `Comments'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
   > # end of Row
  > # end of TblH
  <TblBody 
   <Row 
    <RowMaxHeight  355.60065 mm>
    <RowHeight  7.76113 mm>
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086984>
       <ParaLine 
        <String `1'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086986>
       <Pgf 
        <PgfFont 
         <FTag `'>
         <FPlatformName `W.Times New Roman.R.700'>
         <FFamily `Times New Roman'>
         <FVar `Regular'>
         <FWeight `Bold'>
         <FAngle `Regular'>
         <FEncoding `FrameRoman'>
         <FSize  18.0 pt>
         <FUnderlining FNoUnderlining>
         <FOverline No>
         <FStrike No>
         <FChangeBar No>
         <FOutline No>
         <FShadow No>
         <FPairKern No>
         <FTsume No>
         <FCase FAsTyped>
         <FPosition FNormal>
         <FDX  0.0%>
         <FDY  0.0%>
         <FDW  0.0%>
         <FStretch  100.0%>
         <FLanguage NoLanguage>
         <FLocked No>
         <FSeparation 0>
         <FColor `Black'>
         <FBackgroundColor NoColor>
        > # end of PgfFont
       > # end of Pgf
       <ParaLine 
        <String `Title'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086988>
       <Pgf 
        <PgfFont 
         <FTag `'>
         <FPlatformName `W.Times New Roman.R.400'>
         <FFamily `Times New Roman'>
         <FVar `Regular'>
         <FWeight `Regular'>
         <FAngle `Regular'>
         <FEncoding `FrameRoman'>
         <FSize  12.0 pt>
         <FUnderlining FNoUnderlining>
         <FOverline No>
         <FStrike No>
         <FChangeBar No>
         <FOutline No>
         <FShadow No>
         <FPairKern No>
         <FTsume No>
         <FCase FAsTyped>
         <FPosition FNormal>
         <FDX  0.0%>
         <FDY  0.0%>
         <FDW  0.0%>
         <FStretch  100.0%>
         <FLanguage NoLanguage>
         <FLocked No>
         <FSeparation 0>
         <FColor `Black'>
         <FBackgroundColor NoColor>
        > # end of PgfFont
       > # end of Pgf
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
   > # end of Row
   <Row 
    <RowMaxHeight  355.60065 mm>
    <RowHeight  6.35 mm>
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086990>
       <ParaLine 
        <String `2'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086992>
       <Pgf 
        <PgfFont 
         <FTag `'>
         <FPlatformName `W.Times New Roman.R.700'>
         <FFamily `Times New Roman'>
         <FVar `Regular'>
         <FWeight `Bold'>
         <FAngle `Regular'>
         <FEncoding `FrameRoman'>
         <FSize  14.0 pt>
         <FUnderlining FNoUnderlining>
         <FOverline No>
         <FStrike No>
         <FChangeBar No>
         <FOutline No>
         <FShadow No>
         <FPairKern No>
         <FTsume No>
         <FCase FAsTyped>
         <FPosition FNormal>
         <FDX  0.0%>
         <FDY  0.0%>
         <FDW  0.0%>
         <FStretch  100.0%>
         <FLanguage NoLanguage>
         <FLocked No>
         <FSeparation 0>
         <FColor `Black'>
         <FBackgroundColor NoColor>
        > # end of PgfFont
       > # end of Pgf
       <ParaLine 
        <String `Heading1'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086994>
       <Pgf 
        <PgfFont 
         <FTag `'>
         <FPlatformName `W.Times New Roman.R.400'>
         <FFamily `Times New Roman'>
         <FVar `Regular'>
         <FWeight `Regular'>
         <FAngle `Regular'>
         <FEncoding `FrameRoman'>
         <FSize  12.0 pt>
         <FUnderlining FNoUnderlining>
         <FOverline No>
         <FStrike No>
         <FChangeBar No>
         <FOutline No>
         <FShadow No>
         <FPairKern No>
         <FTsume No>
         <FCase FAsTyped>
         <FPosition FNormal>
         <FDX  0.0%>
         <FDY  0.0%>
         <FDW  0.0%>
         <FStretch  100.0%>
         <FLanguage NoLanguage>
         <FLocked No>
         <FSeparation 0>
         <FColor `Black'>
         <FBackgroundColor NoColor>
        > # end of PgfFont
       > # end of Pgf
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
   > # end of Row
   <Row 
    <RowMaxHeight  355.60065 mm>
    <RowHeight  5.64445 mm>
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086996>
       <ParaLine 
        <String `3'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086998>
       <Pgf 
        <PgfFont 
         <FTag `'>
         <FPlatformName `W.Times New Roman.R.700'>
         <FFamily `Times New Roman'>
         <FVar `Regular'>
         <FWeight `Bold'>
         <FAngle `Regular'>
         <FEncoding `FrameRoman'>
         <FSize  12.0 pt>
         <FUnderlining FNoUnderlining>
         <FOverline No>
         <FStrike No>
         <FChangeBar No>
         <FOutline No>
         <FShadow No>
         <FPairKern No>
         <FTsume No>
         <FCase FAsTyped>
         <FPosition FNormal>
         <FDX  0.0%>
         <FDY  0.0%>
         <FDW  0.0%>
         <FStretch  100.0%>
         <FLanguage NoLanguage>
         <FLocked No>
         <FSeparation 0>
         <FColor `Black'>
         <FBackgroundColor NoColor>
        > # end of PgfFont
       > # end of Pgf
       <ParaLine 
        <String `Heading2'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1087000>
       <Pgf 
        <PgfFont 
         <FTag `'>
         <FPlatformName `W.Times New Roman.R.400'>
         <FFamily `Times New Roman'>
         <FVar `Regular'>
         <FWeight `Regular'>
         <FAngle `Regular'>
         <FEncoding `FrameRoman'>
         <FSize  12.0 pt>
         <FUnderlining FNoUnderlining>
         <FOverline No>
         <FStrike No>
         <FChangeBar No>
         <FOutline No>
         <FShadow No>
         <FPairKern No>
         <FTsume No>
         <FCase FAsTyped>
         <FPosition FNormal>
         <FDX  0.0%>
         <FDY  0.0%>
         <FDW  0.0%>
         <FStretch  100.0%>
         <FLanguage NoLanguage>
         <FLocked No>
         <FSeparation 0>
         <FColor `Black'>
         <FBackgroundColor NoColor>
        > # end of PgfFont
       > # end of Pgf
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
   > # end of Row
   <Row 
    <RowMaxHeight  355.60065 mm>
    <RowHeight  5.64445 mm>
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1087002>
       <ParaLine 
        <String `4'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1087004>
       <Pgf 
        <PgfFont 
         <FTag `'>
         <FPlatformName `W.Times New Roman.R.700'>
         <FFamily `Times New Roman'>
         <FVar `Regular'>
         <FWeight `Bold'>
         <FAngle `Regular'>
         <FEncoding `FrameRoman'>
         <FSize  12.0 pt>
         <FUnderlining FNoUnderlining>
         <FOverline No>
         <FStrike No>
         <FChangeBar No>
         <FOutline No>
         <FShadow No>
         <FPairKern No>
         <FTsume No>
         <FCase FAsTyped>
         <FPosition FNormal>
         <FDX  0.0%>
         <FDY  0.0%>
         <FDW  0.0%>
         <FStretch  100.0%>
         <FLanguage NoLanguage>
         <FLocked No>
         <FSeparation 0>
         <FColor `Black'>
         <FBackgroundColor NoColor>
        > # end of PgfFont
       > # end of Pgf
       <ParaLine 
        <String `HeadingRunIn'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1087006>
       <Pgf 
        <PgfFont 
         <FTag `'>
         <FPlatformName `W.Times New Roman.R.400'>
         <FFamily `Times New Roman'>
         <FVar `Regular'>
         <FWeight `Regular'>
         <FAngle `Regular'>
         <FEncoding `FrameRoman'>
         <FSize  12.0 pt>
         <FUnderlining FNoUnderlining>
         <FOverline No>
         <FStrike No>
         <FChangeBar No>
         <FOutline No>
         <FShadow No>
         <FPairKern No>
         <FTsume No>
         <FCase FAsTyped>
         <FPosition FNormal>
         <FDX  0.0%>
         <FDY  0.0%>
         <FDW  0.0%>
         <FStretch  100.0%>
         <FLanguage NoLanguage>
         <FLocked No>
         <FSeparation 0>
         <FColor `Black'>
         <FBackgroundColor NoColor>
        > # end of PgfFont
       > # end of Pgf
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
   > # end of Row
   <Row 
    <RowMaxHeight  355.60065 mm>
    <RowHeight  5.64445 mm>
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1087008>
       <ParaLine 
        <String `4'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1087010>
       <Pgf 
        <PgfFont 
         <FTag `'>
         <FPlatformName `W.Times New Roman.R.700'>
         <FFamily `Times New Roman'>
         <FVar `Regular'>
         <FWeight `Bold'>
         <FAngle `Regular'>
         <FEncoding `FrameRoman'>
         <FSize  12.0 pt>
         <FUnderlining FNoUnderlining>
         <FOverline No>
         <FStrike No>
         <FChangeBar No>
         <FOutline No>
         <FShadow No>
         <FPairKern No>
         <FTsume No>
         <FCase FAsTyped>
         <FPosition FNormal>
         <FDX  0.0%>
         <FDY  0.0%>
         <FDW  0.0%>
         <FStretch  100.0%>
         <FLanguage NoLanguage>
         <FLocked No>
         <FSeparation 0>
         <FColor `Black'>
         <FBackgroundColor NoColor>
        > # end of PgfFont
       > # end of Pgf
       <ParaLine 
        <String `TableTitle'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1087012>
       <Pgf 
        <PgfFont 
         <FTag `'>
         <FPlatformName `W.Times New Roman.R.400'>
         <FFamily `Times New Roman'>
         <FVar `Regular'>
         <FWeight `Regular'>
         <FAngle `Regular'>
         <FEncoding `FrameRoman'>
         <FSize  12.0 pt>
         <FUnderlining FNoUnderlining>
         <FOverline No>
         <FStrike No>
         <FChangeBar No>
         <FOutline No>
         <FShadow No>
         <FPairKern No>
         <FTsume No>
         <FCase FAsTyped>
         <FPosition FNormal>
         <FDX  0.0%>
         <FDY  0.0%>
         <FDW  0.0%>
         <FStretch  100.0%>
         <FLanguage NoLanguage>
         <FLocked No>
         <FSeparation 0>
         <FColor `Black'>
         <FBackgroundColor NoColor>
        > # end of PgfFont
       > # end of Pgf
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
   > # end of Row
  > # end of TblBody
 > # end of Tbl
 <Tbl 
  <TblID 9>
  <TblTag `Tabell bred'>
  <TblNumColumns 3>
  <Unique 1031374>
  <TblColumnWidth  44.66666 mm>
  <TblColumnWidth  44.66666 mm>
  <TblColumnWidth  44.66666 mm>
  <TblTitle 
   <TblTitleContent 
    <Notes 
    > # end of Notes
    <Para 
     <Unique 1031436>
     <PgfTag `TabellRubrik_1sp'>
     <PgfNumString `Tabell 1. '>
     <PgfReferenced Yes>
     <ParaLine 
      <Marker 
       <MType 9>
       <MTypeName `Cross-Ref'>
       <MText `98249: TabellRubrik_2sp: Tabell 1. Kognitiva effekter av antiepileptiska läkemedel'>
       <MCurrPage `1329'>
       <Unique 1060191>
      > # end of Marker
      <String `Kognitiva effekter av antiepileptiska läkemedel'>
     > # end of ParaLine
    > # end of Para
   > # end of TblTitleContent
  > # end of TblTitle
  <TblBody 
   <Row 
    <RowMaxHeight  355.60065 mm>
    <RowHeight  4.76251 mm>
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1031448>
       <PgfTag `TabellKolRub'>
       <Pgf 
        <PgfFont 
         <FTag `'>
         <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
         <FFamily `Frutiger LT Std 45 Light'>
         <FVar `Regular'>
         <FWeight `Bold'>
         <FAngle `Regular'>
         <FPostScriptName `FrutigerLTStd-Bold'>
         <FEncoding `FrameRoman'>
         <FSize  7.5 pt>
         <FUnderlining FNoUnderlining>
         <FOverline No>
         <FStrike No>
         <FChangeBar No>
         <FOutline No>
         <FShadow No>
         <FPairKern Yes>
         <FTsume No>
         <FCase FAsTyped>
         <FPosition FNormal>
         <FDX  0.0%>
         <FDY  0.0%>
         <FDW  0.0%>
         <FStretch  100.0%>
         <FLanguage Swedish>
         <FLocked No>
         <FSeparation 0>
         <FColor `Black'>
         <FBackgroundColor NoColor>
        > # end of PgfFont
       > # end of Pgf
       <ParaLine 
        <String `Liten eller ingen effekt'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1031450>
       <PgfTag `TabellKolRub'>
       <Pgf 
        <PgfFont 
         <FTag `'>
         <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
         <FFamily `Frutiger LT Std 45 Light'>
         <FVar `Regular'>
         <FWeight `Bold'>
         <FAngle `Regular'>
         <FPostScriptName `FrutigerLTStd-Bold'>
         <FEncoding `FrameRoman'>
         <FSize  7.5 pt>
         <FUnderlining FNoUnderlining>
         <FOverline No>
         <FStrike No>
         <FChangeBar No>
         <FOutline No>
         <FShadow No>
         <FPairKern Yes>
         <FTsume No>
         <FCase FAsTyped>
         <FPosition FNormal>
         <FDX  0.0%>
         <FDY  0.0%>
         <FDW  0.0%>
         <FStretch  100.0%>
         <FLanguage Swedish>
         <FLocked No>
         <FSeparation 0>
         <FColor `Black'>
         <FBackgroundColor NoColor>
        > # end of PgfFont
       > # end of Pgf
       <PgfReferenced Yes>
       <ParaLine 
        <String `Viss effekt'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1031452>
       <PgfTag `TabellKolRub'>
       <Pgf 
        <PgfFont 
         <FTag `'>
         <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
         <FFamily `Frutiger LT Std 45 Light'>
         <FVar `Regular'>
         <FWeight `Bold'>
         <FAngle `Regular'>
         <FPostScriptName `FrutigerLTStd-Bold'>
         <FEncoding `FrameRoman'>
         <FSize  7.5 pt>
         <FUnderlining FNoUnderlining>
         <FOverline No>
         <FStrike No>
         <FChangeBar No>
         <FOutline No>
         <FShadow No>
         <FPairKern Yes>
         <FTsume No>
         <FCase FAsTyped>
         <FPosition FNormal>
         <FDX  0.0%>
         <FDY  0.0%>
         <FDW  0.0%>
         <FStretch  100.0%>
         <FLanguage Swedish>
         <FLocked No>
         <FSeparation 0>
         <FColor `Black'>
         <FBackgroundColor NoColor>
        > # end of PgfFont
       > # end of Pgf
       <PgfReferenced Yes>
       <ParaLine 
        <String `Potentiellt signifikant effekt'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
   > # end of Row
   <Row 
    <RowMaxHeight  355.60065 mm>
    <RowHeight  4.58611 mm>
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1031454>
       <PgfTag `TabellText'>
       <ParaLine 
        <String `Gabapentin '>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1031456>
       <PgfTag `TabellText'>
       <ParaLine 
        <String `Fenytoin '>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1031458>
       <PgfTag `TabellText'>
       <ParaLine 
        <String `Fenobarbital'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
   > # end of Row
   <Row 
    <RowMaxHeight  355.60065 mm>
    <RowHeight  4.58611 mm>
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1031460>
       <PgfTag `TabellText'>
       <ParaLine 
        <String `Lamotrigin '>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1031462>
       <PgfTag `TabellText'>
       <ParaLine 
        <String `Karbamazepin '>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1031464>
       <PgfTag `TabellText'>
       <PgfReferenced Yes>
       <ParaLine 
        <String `Topiramat'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
   > # end of Row
   <Row 
    <RowMaxHeight  355.60065 mm>
    <RowHeight  4.58611 mm>
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1031466>
       <PgfTag `TabellText'>
       <ParaLine 
        <String `Oxkarbazepin '>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1031468>
       <PgfTag `TabellText'>
       <ParaLine 
        <String `Valproat '>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1031470>
       <PgfTag `TabellText'>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
   > # end of Row
   <Row 
    <RowMaxHeight  355.60065 mm>
    <RowHeight  4.58611 mm>
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1031472>
       <PgfTag `TabellText'>
       <ParaLine 
        <String `Levetiracetam '>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1031474>
       <PgfTag `TabellText'>
       <ParaLine 
        <String `Zonisamid'>
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1031476>
       <PgfTag `TabellText'>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
   > # end of Row
   <Row 
    <RowMaxHeight  355.60065 mm>
    <RowHeight  0.81138 mm>
    <Cell 
     <CellColumns 3>
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1031492>
       <PgfTag `TabellLinje'>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1031494>
       <PgfTag `TabellText'>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1031496>
       <PgfTag `TabellText'>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
   > # end of Row
  > # end of TblBody
 > # end of Tbl
 <Tbl 
  <TblID 10>
  <TblTag `Tabell faktaruta'>
  <TblNumColumns 1>
  <Unique 1086941>
  <TblColumnWidth  63.5 mm>
  <TblBody 
   <Row 
    <RowMaxHeight  355.60065 mm>
    <RowHeight  2.46944 mm>
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086943>
       <PgfTag `FaktaText'>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
   > # end of Row
  > # end of TblBody
 > # end of Tbl
 <Tbl 
  <TblID 11>
  <TblTag `Tabell faktaruta'>
  <TblNumColumns 1>
  <Unique 1086945>
  <TblColumnWidth  63.5 mm>
  <TblBody 
   <Row 
    <RowMaxHeight  355.60065 mm>
    <RowHeight  2.46944 mm>
    <Cell 
     <CellContent 
      <Notes 
      > # end of Notes
      <Para 
       <Unique 1086947>
       <PgfTag `FaktaText'>
       <ParaLine 
       > # end of ParaLine
      > # end of Para
     > # end of CellContent
    > # end of Cell
   > # end of Row
  > # end of TblBody
 > # end of Tbl
> # end of Tbls
<Page 
 <Unique 1085871>
 <PageType LeftMasterPage>
 <PageTag `Left'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <TextRect 
  <ID 12>
  <Unique 1085872>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  6.0 pt>
  <RunaroundType None>
  <ShapeRect  0.0 mm 7.0 mm 17.0 mm 5.0 mm>
  <BRect  0.0 mm 7.0 mm 17.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  10.00002 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <TextRect 
  <ID 13>
  <Unique 1085874>
  <ShapeRect  18.0 mm 225.6 mm 134.0 mm 5.0 mm>
  <BRect  18.0 mm 225.6 mm 134.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  10.00002 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <TextRect 
  <ID 14>
  <Unique 1085876>
  <ShapeRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <BRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <TRNumColumns 2>
  <TRColumnGap  7.0 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <TextRect 
  <ID 15>
  <Unique 1085879>
  <ShapeRect  18.0 mm 7.0 mm 134.0 mm 5.0 mm>
  <BRect  18.0 mm 7.0 mm 134.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  5.00001 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <PolyLine 
  <Unique 1085881>
  <Pen 0>
  <PenWidth  0.5 pt>
  <HeadCap Butt>
  <TailCap Butt>
  <NumPoints 2>
  <Point  85.0 mm 18.0 mm>
  <Point  85.0 mm 220.55 mm>
 > # end of PolyLine
 <TextRect 
  <ID 16>
  <Unique 1085882>
  <GroupID 17>
  <Pen 15>
  <ShapeRect  71.37434 mm 221.71929 mm 11.0 mm 5.0 mm>
  <BRect  71.37434 mm 221.71929 mm 11.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  5.00001 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <TextRect 
  <ID 18>
  <Unique 1085884>
  <GroupID 17>
  <ShapeRect  86.37434 mm 221.71929 mm 15.0 mm 5.0 mm>
  <BRect  86.37434 mm 221.71929 mm 15.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  5.00001 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <Group 
  <ID 17>
  <Unique 1085886>
 > # end of Group
> # end of Page
<Page 
 <Unique 1085906>
 <PageType RightMasterPage>
 <PageTag `Right'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <TextRect 
  <ID 19>
  <Unique 1085907>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  6.0 pt>
  <RunaroundType None>
  <ShapeRect  18.0 mm 7.0 mm 134.0 mm 5.0 mm>
  <BRect  18.0 mm 7.0 mm 134.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  10.00002 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <TextRect 
  <ID 20>
  <Unique 1085909>
  <ShapeRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <BRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <TRNumColumns 2>
  <TRColumnGap  7.0 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <TextRect 
  <ID 21>
  <Unique 1085912>
  <ShapeRect  153.0 mm 7.0 mm 17.0 mm 5.0 mm>
  <BRect  153.0 mm 7.0 mm 17.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  10.00002 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <TextRect 
  <ID 22>
  <Unique 1085914>
  <ShapeRect  18.0 mm 225.6 mm 134.0 mm 5.0 mm>
  <BRect  18.0 mm 225.6 mm 134.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  10.00002 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <PolyLine 
  <Unique 1085916>
  <Pen 0>
  <PenWidth  0.5 pt>
  <HeadCap Butt>
  <TailCap Butt>
  <NumPoints 2>
  <Point  85.0 mm 18.0 mm>
  <Point  85.0 mm 220.55 mm>
 > # end of PolyLine
 <TextRect 
  <ID 23>
  <Unique 1085917>
  <GroupID 24>
  <Pen 15>
  <ShapeRect  71.37434 mm 221.71929 mm 11.0 mm 5.0 mm>
  <BRect  71.37434 mm 221.71929 mm 11.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  5.00001 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <TextRect 
  <ID 25>
  <Unique 1085919>
  <GroupID 24>
  <ShapeRect  86.37434 mm 221.71929 mm 15.0 mm 5.0 mm>
  <BRect  86.37434 mm 221.71929 mm 15.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  5.00001 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <Group 
  <ID 24>
  <Unique 1085921>
 > # end of Group
> # end of Page
<Page 
 <Unique 1085941>
 <PageType OtherMasterPage>
 <PageTag `Första kapitelsida höger'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <TextRect 
  <ID 26>
  <Unique 1085942>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  6.0 pt>
  <RunaroundType None>
  <ShapeRect  18.0 mm 28.0 mm 134.0 mm 47.0 mm>
  <BRect  18.0 mm 28.0 mm 134.0 mm 47.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  7.0 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 27>
 > # end of TextRect
 <TextRect 
  <ID 27>
  <Unique 1085944>
  <ShapeRect  18.0 mm 80.0 mm 134.0 mm 140.55 mm>
  <BRect  18.0 mm 80.0 mm 134.0 mm 140.55 mm>
  <TRNumColumns 2>
  <TRColumnGap  7.0 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <TextRect 
  <ID 28>
  <Unique 1085947>
  <ShapeRect  153.0 mm 7.0 mm 17.0 mm 5.0 mm>
  <BRect  153.0 mm 7.0 mm 17.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  10.00002 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <TextRect 
  <ID 29>
  <Unique 1085949>
  <ShapeRect  18.0 mm 225.6 mm 134.0 mm 5.0 mm>
  <BRect  18.0 mm 225.6 mm 134.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  10.00002 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <PolyLine 
  <Unique 1085951>
  <Pen 0>
  <PenWidth  0.5 pt>
  <HeadCap Butt>
  <TailCap Butt>
  <NumPoints 2>
  <Point  85.0 mm 80.0 mm>
  <Point  85.0 mm 220.55 mm>
 > # end of PolyLine
 <TextRect 
  <ID 30>
  <Unique 1085952>
  <Pen 15>
  <PenWidth  1.0 pt>
  <ShapeRect  18.0 mm 7.0 mm 134.0 mm 5.0 mm>
  <BRect  18.0 mm 7.0 mm 134.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  5.00001 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <TextRect 
  <ID 31>
  <Unique 1085954>
  <GroupID 32>
  <PenWidth  0.5 pt>
  <ShapeRect  71.37434 mm 221.71929 mm 11.0 mm 5.0 mm>
  <BRect  71.37434 mm 221.71929 mm 11.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  5.00001 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <TextRect 
  <ID 33>
  <Unique 1085956>
  <GroupID 32>
  <ShapeRect  86.37434 mm 221.71929 mm 15.0 mm 5.0 mm>
  <BRect  86.37434 mm 221.71929 mm 15.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  5.00001 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <Group 
  <ID 32>
  <Unique 1085958>
 > # end of Group
> # end of Page
<Page 
 <Unique 1085979>
 <PageType OtherMasterPage>
 <PageTag `Första kapitelsida vänster'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <TextRect 
  <ID 34>
  <Unique 1085980>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  6.0 pt>
  <RunaroundType None>
  <ShapeRect  0.0 mm 7.0 mm 17.0 mm 5.0 mm>
  <BRect  0.0 mm 7.0 mm 17.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  10.00002 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <TextRect 
  <ID 35>
  <Unique 1085982>
  <ShapeRect  18.0 mm 225.6 mm 134.0 mm 5.0 mm>
  <BRect  18.0 mm 225.6 mm 134.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  10.00002 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <TextRect 
  <ID 36>
  <Unique 1085984>
  <ShapeRect  18.0 mm 7.0 mm 134.0 mm 5.0 mm>
  <BRect  18.0 mm 7.0 mm 134.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  5.00001 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <TextRect 
  <ID 37>
  <Unique 1085986>
  <ShapeRect  18.0 mm 28.0 mm 134.0 mm 47.0 mm>
  <BRect  18.0 mm 28.0 mm 134.0 mm 47.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  7.0 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 38>
 > # end of TextRect
 <TextRect 
  <ID 38>
  <Unique 1085988>
  <ShapeRect  18.0 mm 80.0 mm 134.0 mm 140.55 mm>
  <BRect  18.0 mm 80.0 mm 134.0 mm 140.55 mm>
  <TRNumColumns 2>
  <TRColumnGap  7.0 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <PolyLine 
  <Unique 1085991>
  <Pen 0>
  <PenWidth  0.5 pt>
  <HeadCap Butt>
  <TailCap Butt>
  <NumPoints 2>
  <Point  85.0 mm 80.0 mm>
  <Point  85.0 mm 220.55 mm>
 > # end of PolyLine
 <TextRect 
  <ID 39>
  <Unique 1085992>
  <GroupID 40>
  <Pen 15>
  <ShapeRect  71.37434 mm 221.71929 mm 11.0 mm 5.0 mm>
  <BRect  71.37434 mm 221.71929 mm 11.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  5.00001 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <TextRect 
  <ID 41>
  <Unique 1085994>
  <GroupID 40>
  <ShapeRect  86.37434 mm 221.71929 mm 15.0 mm 5.0 mm>
  <BRect  86.37434 mm 221.71929 mm 15.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  5.00001 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <Group 
  <ID 40>
  <Unique 1085996>
 > # end of Group
> # end of Page
<Page 
 <Unique 1086017>
 <PageType OtherMasterPage>
 <PageTag `Left utan linje'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <TextRect 
  <ID 42>
  <Unique 1086018>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  6.0 pt>
  <RunaroundType None>
  <ShapeRect  0.0 mm 7.0 mm 17.0 mm 5.0 mm>
  <BRect  0.0 mm 7.0 mm 17.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  10.00002 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <TextRect 
  <ID 43>
  <Unique 1086020>
  <ShapeRect  18.0 mm 225.6 mm 134.0 mm 5.0 mm>
  <BRect  18.0 mm 225.6 mm 134.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  10.00002 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <TextRect 
  <ID 44>
  <Unique 1086022>
  <ShapeRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <BRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <TRNumColumns 2>
  <TRColumnGap  7.0 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <TextRect 
  <ID 45>
  <Unique 1086025>
  <ShapeRect  18.0 mm 7.0 mm 134.0 mm 5.0 mm>
  <BRect  18.0 mm 7.0 mm 134.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  5.00001 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <TextRect 
  <ID 46>
  <Unique 1086027>
  <GroupID 47>
  <PenWidth  0.5 pt>
  <ShapeRect  71.37434 mm 221.71929 mm 11.0 mm 5.0 mm>
  <BRect  71.37434 mm 221.71929 mm 11.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  5.00001 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <TextRect 
  <ID 48>
  <Unique 1086029>
  <GroupID 47>
  <ShapeRect  86.37434 mm 221.71929 mm 15.0 mm 5.0 mm>
  <BRect  86.37434 mm 221.71929 mm 15.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  5.00001 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <Group 
  <ID 47>
  <Unique 1086031>
 > # end of Group
> # end of Page
<Page 
 <Unique 1086051>
 <PageType OtherMasterPage>
 <PageTag `Right utan linje'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <TextRect 
  <ID 49>
  <Unique 1086052>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  6.0 pt>
  <RunaroundType None>
  <ShapeRect  18.0 mm 7.0 mm 134.0 mm 5.0 mm>
  <BRect  18.0 mm 7.0 mm 134.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  10.00002 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <TextRect 
  <ID 50>
  <Unique 1086054>
  <ShapeRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <BRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <TRNumColumns 2>
  <TRColumnGap  7.0 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <TextRect 
  <ID 51>
  <Unique 1086057>
  <ShapeRect  153.0 mm 7.0 mm 17.0 mm 5.0 mm>
  <BRect  153.0 mm 7.0 mm 17.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  10.00002 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <TextRect 
  <ID 52>
  <Unique 1086059>
  <ShapeRect  18.0 mm 225.6 mm 134.0 mm 5.0 mm>
  <BRect  18.0 mm 225.6 mm 134.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  10.00002 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <TextRect 
  <ID 53>
  <Unique 1086061>
  <GroupID 54>
  <PenWidth  0.5 pt>
  <ShapeRect  71.37434 mm 221.71929 mm 11.0 mm 5.0 mm>
  <BRect  71.37434 mm 221.71929 mm 11.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  5.00001 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <TextRect 
  <ID 55>
  <Unique 1086063>
  <GroupID 54>
  <ShapeRect  86.37434 mm 221.71929 mm 15.0 mm 5.0 mm>
  <BRect  86.37434 mm 221.71929 mm 15.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  5.00001 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <Group 
  <ID 54>
  <Unique 1086065>
 > # end of Group
> # end of Page
<Page 
 <Unique 1086085>
 <PageType OtherMasterPage>
 <PageTag `Left liggande'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <TextRect 
  <ID 56>
  <Unique 1086086>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  6.0 pt>
  <RunaroundType None>
  <ShapeRect  0.0 mm 7.0 mm 17.0 mm 5.0 mm>
  <BRect  0.0 mm 7.0 mm 17.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  10.00002 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <TextRect 
  <ID 57>
  <Unique 1086088>
  <ShapeRect  18.0 mm 225.6 mm 134.0 mm 5.0 mm>
  <BRect  18.0 mm 225.6 mm 134.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  10.00002 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <TextRect 
  <ID 58>
  <Unique 1086090>
  <Angle  90.0>
  <ShapeRect  -16.275 mm 52.275 mm 202.55 mm 134.0 mm>
  <BRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <TRNumColumns 1>
  <TRColumnGap  0.0 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <TextRect 
  <ID 59>
  <Unique 1086092>
  <ShapeRect  18.0 mm 7.0 mm 134.0 mm 5.0 mm>
  <BRect  18.0 mm 7.0 mm 134.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  5.00001 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <TextRect 
  <ID 60>
  <Unique 1086094>
  <GroupID 61>
  <PenWidth  0.5 pt>
  <ShapeRect  71.37434 mm 221.71929 mm 11.0 mm 5.0 mm>
  <BRect  71.37434 mm 221.71929 mm 11.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  5.00001 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <TextRect 
  <ID 62>
  <Unique 1086096>
  <GroupID 61>
  <ShapeRect  86.37434 mm 221.71929 mm 15.0 mm 5.0 mm>
  <BRect  86.37434 mm 221.71929 mm 15.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  5.00001 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <Group 
  <ID 61>
  <Unique 1086098>
 > # end of Group
> # end of Page
<Page 
 <Unique 1086118>
 <PageType OtherMasterPage>
 <PageTag `Right liggande'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <TextRect 
  <ID 63>
  <Unique 1086119>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  6.0 pt>
  <RunaroundType None>
  <ShapeRect  18.0 mm 7.0 mm 134.0 mm 5.0 mm>
  <BRect  18.0 mm 7.0 mm 134.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  10.00002 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <TextRect 
  <ID 64>
  <Unique 1086121>
  <ShapeRect  153.0 mm 7.0 mm 17.0 mm 5.0 mm>
  <BRect  153.0 mm 7.0 mm 17.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  10.00002 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <TextRect 
  <ID 65>
  <Unique 1086123>
  <ShapeRect  18.0 mm 225.6 mm 134.0 mm 5.0 mm>
  <BRect  18.0 mm 225.6 mm 134.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  10.00002 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <TextRect 
  <ID 66>
  <Unique 1086125>
  <Angle  90.0>
  <ShapeRect  -16.275 mm 52.275 mm 202.55 mm 134.0 mm>
  <BRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <TRNumColumns 1>
  <TRColumnGap  0.0 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <TextRect 
  <ID 67>
  <Unique 1086127>
  <GroupID 68>
  <PenWidth  0.5 pt>
  <ShapeRect  71.37434 mm 221.71929 mm 11.0 mm 5.0 mm>
  <BRect  71.37434 mm 221.71929 mm 11.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  5.00001 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <TextRect 
  <ID 69>
  <Unique 1086129>
  <GroupID 68>
  <ShapeRect  86.37434 mm 221.71929 mm 15.0 mm 5.0 mm>
  <BRect  86.37434 mm 221.71929 mm 15.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  5.00001 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <Group 
  <ID 68>
  <Unique 1086131>
 > # end of Group
> # end of Page
<Page 
 <Unique 1086151>
 <PageType OtherMasterPage>
 <PageTag `Left preparat'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <TextRect 
  <ID 70>
  <Unique 1086152>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  6.0 pt>
  <RunaroundType None>
  <ShapeRect  0.0 mm 7.0 mm 17.0 mm 5.0 mm>
  <BRect  0.0 mm 7.0 mm 17.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  10.00002 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <TextRect 
  <ID 71>
  <Unique 1086154>
  <ShapeRect  18.0 mm 225.6 mm 134.0 mm 5.0 mm>
  <BRect  18.0 mm 225.6 mm 134.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  10.00002 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <TextRect 
  <ID 72>
  <Unique 1086156>
  <ShapeRect  18.0 mm 18.0 mm 134.0 mm 200.0 mm>
  <BRect  18.0 mm 18.0 mm 134.0 mm 200.0 mm>
  <TRNumColumns 2>
  <TRColumnGap  7.0 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <TextRect 
  <ID 73>
  <Unique 1086159>
  <ShapeRect  18.0 mm 7.0 mm 134.0 mm 5.0 mm>
  <BRect  18.0 mm 7.0 mm 134.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  5.00001 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <PolyLine 
  <Unique 1086161>
  <Pen 0>
  <PenWidth  0.5 pt>
  <HeadCap Butt>
  <TailCap Butt>
  <NumPoints 2>
  <Point  85.0 mm 18.0 mm>
  <Point  85.0 mm 220.55 mm>
 > # end of PolyLine
 <TextRect 
  <ID 74>
  <Unique 1086162>
  <GroupID 75>
  <Pen 15>
  <ShapeRect  71.37434 mm 221.71929 mm 11.0 mm 5.0 mm>
  <BRect  71.37434 mm 221.71929 mm 11.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  5.00001 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <TextRect 
  <ID 76>
  <Unique 1086164>
  <GroupID 75>
  <ShapeRect  86.37434 mm 221.71929 mm 15.0 mm 5.0 mm>
  <BRect  86.37434 mm 221.71929 mm 15.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  5.00001 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <Group 
  <ID 75>
  <Unique 1086166>
 > # end of Group
> # end of Page
<Page 
 <Unique 1086186>
 <PageType OtherMasterPage>
 <PageTag `Right preparat'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <TextRect 
  <ID 77>
  <Unique 1086187>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  6.0 pt>
  <RunaroundType None>
  <ShapeRect  18.0 mm 7.0 mm 134.0 mm 5.0 mm>
  <BRect  18.0 mm 7.0 mm 134.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  10.00002 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <TextRect 
  <ID 78>
  <Unique 1086189>
  <ShapeRect  18.0 mm 18.0 mm 134.0 mm 200.0 mm>
  <BRect  18.0 mm 18.0 mm 134.0 mm 200.0 mm>
  <TRNumColumns 2>
  <TRColumnGap  7.0 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <TextRect 
  <ID 79>
  <Unique 1086192>
  <ShapeRect  153.0 mm 7.0 mm 17.0 mm 5.0 mm>
  <BRect  153.0 mm 7.0 mm 17.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  10.00002 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <TextRect 
  <ID 80>
  <Unique 1086194>
  <ShapeRect  18.0 mm 225.6 mm 134.0 mm 5.0 mm>
  <BRect  18.0 mm 225.6 mm 134.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  10.00002 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <PolyLine 
  <Unique 1086196>
  <Pen 0>
  <PenWidth  0.5 pt>
  <HeadCap Butt>
  <TailCap Butt>
  <NumPoints 2>
  <Point  85.0 mm 18.0 mm>
  <Point  85.0 mm 220.55 mm>
 > # end of PolyLine
 <TextRect 
  <ID 81>
  <Unique 1086197>
  <GroupID 82>
  <Pen 15>
  <ShapeRect  71.37434 mm 221.71929 mm 11.0 mm 5.0 mm>
  <BRect  71.37434 mm 221.71929 mm 11.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  5.00001 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <TextRect 
  <ID 83>
  <Unique 1086199>
  <GroupID 82>
  <ShapeRect  86.37434 mm 221.71929 mm 15.0 mm 5.0 mm>
  <BRect  86.37434 mm 221.71929 mm 15.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  5.00001 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <Group 
  <ID 82>
  <Unique 1086201>
 > # end of Group
> # end of Page
<Page 
 <Unique 1086221>
 <PageType OtherMasterPage>
 <PageTag `Första_Avsnitt'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <TextRect 
  <ID 84>
  <Unique 1086222>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  6.0 pt>
  <RunaroundType None>
  <ShapeRect  18.0 mm 7.0 mm 134.0 mm 3.127 mm>
  <BRect  18.0 mm 7.0 mm 134.0 mm 3.127 mm>
  <TRNumColumns 1>
  <TRColumnGap  10.00002 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 85>
 > # end of TextRect
 <TextRect 
  <ID 86>
  <Unique 1086224>
  <ShapeRect  18.0 mm 10.06917 mm 134.0 mm 1.93083 mm>
  <BRect  18.0 mm 10.06917 mm 134.0 mm 1.93083 mm>
  <TRNumColumns 1>
  <TRColumnGap  10.00002 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <TextRect 
  <ID 85>
  <Unique 1086226>
  <ShapeRect  18.0 mm 28.0 mm 134.0 mm 47.0 mm>
  <BRect  18.0 mm 28.0 mm 134.0 mm 47.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  7.0 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 87>
 > # end of TextRect
 <TextRect 
  <ID 87>
  <Unique 1086228>
  <ShapeRect  18.0 mm 80.0 mm 134.0 mm 140.55 mm>
  <BRect  18.0 mm 80.0 mm 134.0 mm 140.55 mm>
  <TRNumColumns 2>
  <TRColumnGap  7.0 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <TextRect 
  <ID 88>
  <Unique 1086231>
  <ShapeRect  153.0 mm 7.0 mm 17.0 mm 5.0 mm>
  <BRect  153.0 mm 7.0 mm 17.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  10.00002 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <TextRect 
  <ID 89>
  <Unique 1086233>
  <ShapeRect  18.0 mm 225.6 mm 134.0 mm 5.0 mm>
  <BRect  18.0 mm 225.6 mm 134.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  10.00002 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <PolyLine 
  <Unique 1086235>
  <Pen 0>
  <PenWidth  0.5 pt>
  <HeadCap Butt>
  <TailCap Butt>
  <NumPoints 2>
  <Point  85.0 mm 80.0 mm>
  <Point  85.0 mm 220.55 mm>
 > # end of PolyLine
 <TextRect 
  <ID 90>
  <Unique 1086236>
  <GroupID 91>
  <Pen 15>
  <ShapeRect  71.37434 mm 221.71929 mm 11.0 mm 5.0 mm>
  <BRect  71.37434 mm 221.71929 mm 11.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  5.00001 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <TextRect 
  <ID 92>
  <Unique 1086238>
  <GroupID 91>
  <ShapeRect  86.37434 mm 221.71929 mm 15.0 mm 5.0 mm>
  <BRect  86.37434 mm 221.71929 mm 15.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  5.00001 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <Group 
  <ID 91>
  <Unique 1086240>
 > # end of Group
> # end of Page
<Page 
 <Unique 1014927>
 <PageType OtherMasterPage>
 <PageTag `Left preaparat utan linje'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <TextRect 
  <ID 93>
  <Unique 1014928>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  6.0 pt>
  <RunaroundType None>
  <ShapeRect  0.0 mm 7.0 mm 17.0 mm 5.0 mm>
  <BRect  0.0 mm 7.0 mm 17.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  10.00002 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <TextRect 
  <ID 94>
  <Unique 1014930>
  <ShapeRect  18.0 mm 225.6 mm 134.0 mm 5.0 mm>
  <BRect  18.0 mm 225.6 mm 134.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  10.00002 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <TextRect 
  <ID 95>
  <Unique 1014932>
  <ShapeRect  18.0 mm 18.0 mm 134.0 mm 200.0 mm>
  <BRect  18.0 mm 18.0 mm 134.0 mm 200.0 mm>
  <TRNumColumns 2>
  <TRColumnGap  7.0 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <TextRect 
  <ID 96>
  <Unique 1014935>
  <ShapeRect  18.0 mm 7.0 mm 134.0 mm 5.0 mm>
  <BRect  18.0 mm 7.0 mm 134.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  5.00001 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <TextRect 
  <ID 97>
  <Unique 1026842>
  <GroupID 98>
  <PenWidth  0.5 pt>
  <ShapeRect  71.37434 mm 221.71929 mm 11.0 mm 5.0 mm>
  <BRect  71.37434 mm 221.71929 mm 11.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  5.00001 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <TextRect 
  <ID 99>
  <Unique 1026844>
  <GroupID 98>
  <ShapeRect  86.37434 mm 221.71929 mm 15.0 mm 5.0 mm>
  <BRect  86.37434 mm 221.71929 mm 15.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  5.00001 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <Group 
  <ID 98>
  <Unique 1026846>
 > # end of Group
> # end of Page
<Page 
 <Unique 1014952>
 <PageType OtherMasterPage>
 <PageTag `Right preparat utan linje'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <TextRect 
  <ID 100>
  <Unique 1014953>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  6.0 pt>
  <RunaroundType None>
  <ShapeRect  18.0 mm 7.0 mm 134.0 mm 5.0 mm>
  <BRect  18.0 mm 7.0 mm 134.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  10.00002 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <TextRect 
  <ID 101>
  <Unique 1014955>
  <ShapeRect  18.0 mm 18.0 mm 134.0 mm 200.0 mm>
  <BRect  18.0 mm 18.0 mm 134.0 mm 200.0 mm>
  <TRNumColumns 2>
  <TRColumnGap  7.0 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <TextRect 
  <ID 102>
  <Unique 1014958>
  <ShapeRect  153.0 mm 7.0 mm 17.0 mm 5.0 mm>
  <BRect  153.0 mm 7.0 mm 17.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  10.00002 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <TextRect 
  <ID 103>
  <Unique 1014960>
  <ShapeRect  18.0 mm 225.6 mm 134.0 mm 5.0 mm>
  <BRect  18.0 mm 225.6 mm 134.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  10.00002 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <TextRect 
  <ID 104>
  <Unique 1026852>
  <GroupID 105>
  <PenWidth  0.5 pt>
  <ShapeRect  71.37434 mm 221.71929 mm 11.0 mm 5.0 mm>
  <BRect  71.37434 mm 221.71929 mm 11.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  5.00001 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <TextRect 
  <ID 106>
  <Unique 1026854>
  <GroupID 105>
  <ShapeRect  86.37434 mm 221.71929 mm 15.0 mm 5.0 mm>
  <BRect  86.37434 mm 221.71929 mm 15.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  5.00001 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <Group 
  <ID 105>
  <Unique 1026856>
 > # end of Group
> # end of Page
<Page 
 <Unique 1086259>
 <PageType OtherMasterPage>
 <PageTag `Left preparat utan linje'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <TextRect 
  <ID 107>
  <Unique 1086260>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  6.0 pt>
  <RunaroundType None>
  <ShapeRect  0.0 mm 7.0 mm 17.0 mm 5.0 mm>
  <BRect  0.0 mm 7.0 mm 17.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  10.00002 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <TextRect 
  <ID 108>
  <Unique 1086262>
  <ShapeRect  18.0 mm 225.6 mm 134.0 mm 5.0 mm>
  <BRect  18.0 mm 225.6 mm 134.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  10.00002 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <TextRect 
  <ID 109>
  <Unique 1086264>
  <ShapeRect  18.0 mm 18.0 mm 134.0 mm 200.0 mm>
  <BRect  18.0 mm 18.0 mm 134.0 mm 200.0 mm>
  <TRNumColumns 2>
  <TRColumnGap  7.0 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <TextRect 
  <ID 110>
  <Unique 1086267>
  <ShapeRect  18.0 mm 7.0 mm 134.0 mm 5.0 mm>
  <BRect  18.0 mm 7.0 mm 134.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  5.00001 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <TextRect 
  <ID 111>
  <Unique 1086269>
  <GroupID 112>
  <PenWidth  0.5 pt>
  <ShapeRect  71.37434 mm 221.71929 mm 11.0 mm 5.0 mm>
  <BRect  71.37434 mm 221.71929 mm 11.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  5.00001 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <TextRect 
  <ID 113>
  <Unique 1086271>
  <GroupID 112>
  <ShapeRect  86.37434 mm 221.71929 mm 15.0 mm 5.0 mm>
  <BRect  86.37434 mm 221.71929 mm 15.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  5.00001 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <Group 
  <ID 112>
  <Unique 1086273>
 > # end of Group
> # end of Page
<Page 
 <Unique 1086293>
 <PageType OtherMasterPage>
 <PageTag `Right preaparat utan linje'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <TextRect 
  <ID 114>
  <Unique 1086294>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  6.0 pt>
  <RunaroundType None>
  <ShapeRect  18.0 mm 7.0 mm 134.0 mm 5.0 mm>
  <BRect  18.0 mm 7.0 mm 134.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  10.00002 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <TextRect 
  <ID 115>
  <Unique 1086296>
  <ShapeRect  18.0 mm 18.0 mm 134.0 mm 200.0 mm>
  <BRect  18.0 mm 18.0 mm 134.0 mm 200.0 mm>
  <TRNumColumns 2>
  <TRColumnGap  7.0 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <TextRect 
  <ID 116>
  <Unique 1086299>
  <ShapeRect  153.0 mm 7.0 mm 17.0 mm 5.0 mm>
  <BRect  153.0 mm 7.0 mm 17.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  10.00002 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <TextRect 
  <ID 117>
  <Unique 1086301>
  <ShapeRect  18.0 mm 225.6 mm 134.0 mm 5.0 mm>
  <BRect  18.0 mm 225.6 mm 134.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  10.00002 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <TextRect 
  <ID 118>
  <Unique 1086303>
  <GroupID 119>
  <PenWidth  0.5 pt>
  <ShapeRect  71.37434 mm 221.71929 mm 11.0 mm 5.0 mm>
  <BRect  71.37434 mm 221.71929 mm 11.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  5.00001 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <TextRect 
  <ID 120>
  <Unique 1086305>
  <GroupID 119>
  <ShapeRect  86.37434 mm 221.71929 mm 15.0 mm 5.0 mm>
  <BRect  86.37434 mm 221.71929 mm 15.0 mm 5.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  5.00001 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <Group 
  <ID 119>
  <Unique 1086307>
 > # end of Group
> # end of Page
<Page 
 <Unique 1086332>
 <PageType ReferencePage>
 <PageTag `Reference'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <TextRect 
  <ID 121>
  <Unique 1086333>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  6.0 pt>
  <RunaroundType Contour>
  <ShapeRect  18.0 mm 14.65 mm 134.0 mm 26.45857 mm>
  <BRect  18.0 mm 14.65 mm 134.0 mm 26.45857 mm>
  <TRNumColumns 1>
  <TRColumnGap  5.00001 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <Rectangle 
  <Unique 1086335>
  <GroupID 122>
  <Pen 0>
  <PenWidth  1.5 pt>
  <ObTint  3500.0%>
  <RunaroundType None>
  <ShapeRect  18.2 mm 97.40872 mm 63.1 mm 55.0 mm>
  <BRect  18.2 mm 97.40872 mm 63.1 mm 55.0 mm>
 > # end of Rectangle
 <Rectangle 
  <Unique 1086336>
  <GroupID 122>
  <PenWidth  0.5 pt>
  <ObTint  3500.0%>
  <ShapeRect  19.05 mm 98.27964 mm 61.4 mm 53.2 mm>
  <BRect  19.05 mm 98.27964 mm 61.4 mm 53.2 mm>
 > # end of Rectangle
 <TextLine 
  <Unique 1086337>
  <TLOrigin  86.83298 mm 29.0912 mm>
  <TLAlignment Left>
  <Font 
   <FTag `'>
   <FPlatformName `W.Arial.R.700'>
   <FFamily `Arial'>
   <FVar `Regular'>
   <FWeight `Bold'>
   <FAngle `Regular'>
   <FEncoding `FrameRoman'>
   <FSize  12.0 pt>
   <FUnderlining FNoUnderlining>
   <FOverline No>
   <FStrike No>
   <FChangeBar No>
   <FOutline No>
   <FShadow No>
   <FPairKern No>
   <FTsume No>
   <FCase FAsTyped>
   <FPosition FNormal>
   <FDX  0.0%>
   <FDY  0.0%>
   <FDW  0.0%>
   <FStretch  100.0%>
   <FLanguage UKEnglish>
   <FLocked No>
   <FSeparation 0>
   <FColor `Black'>
   <FBackgroundColor NoColor>
  > # end of Font
  <String `Footnote'>
 > # end of TextLine
 <TextLine 
  <Unique 1086338>
  <TLOrigin  18.0 mm 43.00006 mm>
  <TLAlignment Left>
  <String `Tjock_Tunn'>
 > # end of TextLine
 <Frame 
  <Unique 1086339>
  <Pen 15>
  <PenWidth  1.0 pt>
  <Angle  360.0>
  <ShapeRect  86.83298 mm 31.0912 mm 64.0001 mm 5.00001 mm>
  <BRect  86.83298 mm 31.0912 mm 64.0001 mm 5.00001 mm>
  <FrameType NotAnchored>
  <Tag `Footnote'>
  <PolyLine 
   <Unique 1086340>
   <Pen 0>
   <PenWidth  0.5 pt>
   <Separation 5>
   <ObColor `Svart 35%'>
   <HeadCap Square>
   <TailCap Square>
   <NumPoints 2>
   <Point  0.0 mm 2.5 mm>
   <Point  35.0 mm 2.5 mm>
  > # end of PolyLine
 > # end of Frame
 <TextLine 
  <Unique 1086341>
  <Separation 0>
  <ObColor `Black'>
  <TLOrigin  18.0 mm 70.80878 mm>
  <TLAlignment Left>
  <String `Tjock_Tunn_Tabellhuvud'>
 > # end of TextLine
 <Frame 
  <Unique 1086342>
  <Pen 15>
  <PenWidth  1.0 pt>
  <Angle  360.0>
  <ShapeRect  18.0 mm 46.0 mm 134.0 mm 2.99992 mm>
  <BRect  18.0 mm 46.0 mm 134.0 mm 2.99992 mm>
  <FrameType NotAnchored>
  <Tag `Tjock_Tunn'>
  <PolyLine 
   <Unique 1086343>
   <Pen 0>
   <PenWidth  1.5 pt>
   <ObTint  3500.0%>
   <NumPoints 2>
   <Point  0.0 mm 0.37485 mm>
   <Point  134.0 mm 0.37485 mm>
  > # end of PolyLine
  <PolyLine 
   <Unique 1086344>
   <PenWidth  0.5 pt>
   <ObTint  3500.0%>
   <NumPoints 2>
   <Point  0.0 mm 1.11805 mm>
   <Point  134.0 mm 1.11805 mm>
  > # end of PolyLine
 > # end of Frame
 <Frame 
  <Unique 1086345>
  <Pen 15>
  <PenWidth  1.0 pt>
  <Angle  360.0>
  <ShapeRect  18.0 mm 29.97155 mm 64.0001 mm 4.0285 mm>
  <BRect  18.0 mm 29.97155 mm 64.0001 mm 4.0285 mm>
  <FrameType NotAnchored>
  <Tag `TableFootnote'>
  <PolyLine 
   <Unique 1086346>
   <Pen 0>
   <PenWidth  0.5 pt>
   <Separation 5>
   <ObColor `Svart 35%'>
   <NumPoints 2>
   <Point  2.822 mm 2.79377 mm>
   <Point  37.822 mm 2.79377 mm>
  > # end of PolyLine
 > # end of Frame
 <TextLine 
  <Unique 1086347>
  <Separation 0>
  <ObColor `Black'>
  <TLOrigin  18.0 mm 28.00004 mm>
  <TLAlignment Left>
  <String `TableFootnote'>
 > # end of TextLine
 <Frame 
  <Unique 1086348>
  <Pen 15>
  <PenWidth  1.0 pt>
  <Angle  360.0>
  <ShapeRect  18.0 mm 57.00008 mm 134.0 mm 4.07388 mm>
  <BRect  18.0 mm 57.00008 mm 134.0 mm 4.07388 mm>
  <FrameType NotAnchored>
  <Tag `Tunn_Tjock'>
  <PolyLine 
   <Unique 1086349>
   <Pen 0>
   <PenWidth  1.5 pt>
   <ObTint  3500.0%>
   <NumPoints 2>
   <Point  0.0 mm 1.83135 mm>
   <Point  134.0 mm 1.83135 mm>
  > # end of PolyLine
  <PolyLine 
   <Unique 1086350>
   <PenWidth  0.5 pt>
   <ObTint  3500.0%>
   <NumPoints 2>
   <Point  0.0 mm 0.95655 mm>
   <Point  134.0 mm 0.95655 mm>
  > # end of PolyLine
 > # end of Frame
 <TextLine 
  <Unique 1086351>
  <TLOrigin  18.0 mm 54.97668 mm>
  <TLAlignment Left>
  <String `Tunn_Tjock'>
 > # end of TextLine
 <Rectangle 
  <Unique 1086352>
  <GroupID 123>
  <Fill 7>
  <PenWidth  1.5 pt>
  <ObTint  3500.0%>
  <ShapeRect  161.56876 mm 0.0 mm 8.43124 mm 8.43121 mm>
  <BRect  161.56876 mm 0.0 mm 8.43124 mm 8.43121 mm>
 > # end of Rectangle
 <Rectangle 
  <Unique 1086353>
  <GroupID 123>
  <Fill 15>
  <PenWidth  0.5 pt>
  <ObTint  3500.0%>
  <ShapeRect  162.31684 mm 0.82682 mm 6.92414 mm 6.92413 mm>
  <BRect  162.31684 mm 0.82682 mm 6.92414 mm 6.92413 mm>
 > # end of Rectangle
 <TextRect 
  <ID 124>
  <Unique 1086354>
  <GroupID 123>
  <Pen 15>
  <PenWidth  1.5 pt>
  <ObTint  3500.0%>
  <ShapeRect  162.53873 mm 2.97545 mm 6.28391 mm 2.29861 mm>
  <BRect  162.53873 mm 2.97545 mm 6.28391 mm 2.29861 mm>
  <TRNumColumns 1>
  <TRColumnGap  5.00001 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <Group 
  <ID 123>
  <Unique 1086356>
 > # end of Group
 <Rectangle 
  <Unique 1086357>
  <GroupID 125>
  <Pen 0>
  <Fill 7>
  <ObTint  3500.0%>
  <ShapeRect  72.621 mm 97.40872 mm 8.67875 mm 8.67887 mm>
  <BRect  72.621 mm 97.40872 mm 8.67875 mm 8.67887 mm>
 > # end of Rectangle
 <Rectangle 
  <Unique 1086358>
  <GroupID 125>
  <Fill 15>
  <PenWidth  0.5 pt>
  <ObTint  3500.0%>
  <ShapeRect  73.39103 mm 98.02153 mm 7.45083 mm 7.36583 mm>
  <BRect  73.39103 mm 98.02153 mm 7.45083 mm 7.36583 mm>
 > # end of Rectangle
 <TextRect 
  <ID 126>
  <Unique 1086359>
  <GroupID 125>
  <Pen 15>
  <PenWidth  1.5 pt>
  <ObTint  3500.0%>
  <Angle  315.0>
  <ShapeRect  72.25768 mm 102.06029 mm 6.46839 mm 2.36613 mm>
  <BRect  72.25768 mm 102.06029 mm 6.46839 mm 2.36613 mm>
  <TRNumColumns 1>
  <TRColumnGap  5.00001 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <PolyLine 
  <Unique 1086361>
  <GroupID 125>
  <Pen 0>
  <Separation 1>
  <ObColor `White'>
  <NumPoints 2>
  <Point  81.29269 mm 97.40872 mm>
  <Point  81.29269 mm 105.50256 mm>
 > # end of PolyLine
 <PolyLine 
  <Unique 1086362>
  <GroupID 125>
  <NumPoints 2>
  <Point  73.28903 mm 97.40872 mm>
  <Point  81.3 mm 97.40872 mm>
 > # end of PolyLine
 <PolyLine 
  <Unique 1086363>
  <GroupID 125>
  <Separation 5>
  <ObColor `Svart 35%'>
  <NumPoints 2>
  <Point  72.97483 mm 97.4989 mm>
  <Point  81.17694 mm 105.76715 mm>
 > # end of PolyLine
 <Polygon 
  <Unique 1086364>
  <GroupID 125>
  <Pen 15>
  <Fill 7>
  <PenWidth  0.15 pt>
  <Separation 2>
  <ObColor `Red'>
  <NumPoints 3>
  <Point  73.65284 mm 97.80207 mm>
  <Point  81.11079 mm 105.30413 mm>
  <Point  81.11079 mm 97.83515 mm>
 > # end of Polygon
 <Group 
  <ID 125>
  <Unique 1086365>
  <GroupID 122>
 > # end of Group
 <Frame 
  <Unique 1086366>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <Angle  360.0>
  <ShapeRect  18.0 mm 174.40997 mm 134.0 mm 1.98386 mm>
  <BRect  18.0 mm 174.40997 mm 134.0 mm 1.98386 mm>
  <FrameType NotAnchored>
  <Tag `TabellLinje'>
  <PolyLine 
   <Unique 1086367>
   <Pen 0>
   <PenWidth  1.5 pt>
   <ObTint  3500.0%>
   <NumPoints 2>
   <Point  0.0 mm 1.08041 mm>
   <Point  134.0 mm 1.08041 mm>
  > # end of PolyLine
  <PolyLine 
   <Unique 1086368>
   <PenWidth  0.5 pt>
   <ObTint  3500.0%>
   <NumPoints 2>
   <Point  0.0 mm 1.82361 mm>
   <Point  134.0 mm 1.82361 mm>
  > # end of PolyLine
 > # end of Frame
 <Frame 
  <Unique 1086369>
  <Pen 15>
  <Fill 7>
  <Angle  360.0>
  <ShapeRect  18.0 mm 188.73064 mm 134.0 mm 2.02121 mm>
  <BRect  18.0 mm 188.73064 mm 134.0 mm 2.02121 mm>
  <FrameType NotAnchored>
  <Tag `PreparatLinje'>
  <PolyLine 
   <Unique 1086370>
   <Pen 0>
   <ObTint  3500.0%>
   <NumPoints 2>
   <Point  0.0 mm 0.0977 mm>
   <Point  134.0 mm 0.0977 mm>
  > # end of PolyLine
 > # end of Frame
 <TextLine 
  <Unique 1086371>
  <TLOrigin  18.0 mm 184.72713 mm>
  <TLAlignment Left>
  <String `PreparatLinje'>
 > # end of TextLine
 <TextLine 
  <Unique 1086372>
  <TLOrigin  18.0 mm 170.21132 mm>
  <TLAlignment Left>
  <String `TabellLinje'>
 > # end of TextLine
 <PolyLine 
  <Unique 1086373>
  <HeadCap Butt>
  <TailCap Butt>
  <NumPoints 2>
  <Point  85.0 mm 18.0 mm>
  <Point  85.0 mm 220.55 mm>
 > # end of PolyLine
 <TextRect 
  <ID 127>
  <Unique 1086374>
  <Pen 15>
  <Fill 15>
  <ShapeRect  89.58115 mm 157.0505 mm 63.12259 mm 9.44949 mm>
  <BRect  89.58115 mm 157.0505 mm 63.12259 mm 9.44949 mm>
  <TRNumColumns 1>
  <TRColumnGap  5.00001 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <Frame 
  <Unique 1086376>
  <PenWidth  1.0 pt>
  <Angle  360.0>
  <ShapeRect  18.0 mm 73.12 mm 134.0 mm 2.30539 mm>
  <BRect  18.0 mm 73.12 mm 134.0 mm 2.30539 mm>
  <FrameType NotAnchored>
  <Tag `Tjock_Tunn_Tabellhuvud'>
  <PolyLine 
   <Unique 1086377>
   <Pen 0>
   <PenWidth  1.5 pt>
   <ObTint  3500.0%>
   <HeadCap Square>
   <TailCap Square>
   <NumPoints 2>
   <Point  0.0 mm 0.37485 mm>
   <Point  134.0 mm 0.37485 mm>
  > # end of PolyLine
  <PolyLine 
   <Unique 1086378>
   <PenWidth  0.5 pt>
   <ObTint  3500.0%>
   <NumPoints 2>
   <Point  0.0 mm 1.11805 mm>
   <Point  134.0 mm 1.11805 mm>
  > # end of PolyLine
 > # end of Frame
 <Frame 
  <Unique 1086379>
  <Pen 15>
  <PenWidth  1.0 pt>
  <Angle  360.0>
  <ShapeRect  18.0 mm 86.48151 mm 134.0 mm 0.71789 mm>
  <BRect  18.0 mm 86.48151 mm 134.0 mm 0.71789 mm>
  <FrameType NotAnchored>
  <Tag `Tunn_Tabellhuvud'>
  <PolyLine 
   <Unique 1086380>
   <Pen 0>
   <PenWidth  0.5 pt>
   <ObTint  3500.0%>
   <NumPoints 2>
   <Point  0.0 mm 0.61093 mm>
   <Point  134.0 mm 0.61093 mm>
  > # end of PolyLine
 > # end of Frame
 <TextLine 
  <Unique 1086381>
  <TLOrigin  18.0 mm 83.70735 mm>
  <TLAlignment Left>
  <String `Tunn_Tabellhuvud'>
 > # end of TextLine
 <Rectangle 
  <Unique 1086382>
  <GroupID 128>
  <Pen 7>
  <RunaroundGap  0.0 pt>
  <RunaroundType Contour>
  <ShapeRect  88.7 mm 217.55 mm 63.5 mm 3.0 mm>
  <BRect  88.7 mm 217.55 mm 63.5 mm 3.0 mm>
 > # end of Rectangle
 <PolyLine 
  <Unique 1086383>
  <GroupID 129>
  <Pen 0>
  <PenWidth  1.5 pt>
  <ObTint  3500.0%>
  <NumPoints 2>
  <Point  88.92048 mm 220.55 mm>
  <Point  152.01274 mm 220.55 mm>
 > # end of PolyLine
 <PolyLine 
  <Unique 1086384>
  <GroupID 129>
  <PenWidth  0.5 pt>
  <ObTint  3500.0%>
  <NumPoints 2>
  <Point  88.7 mm 219.67521 mm>
  <Point  152.19999 mm 219.67521 mm>
 > # end of PolyLine
 <Group 
  <ID 129>
  <Unique 1086385>
  <GroupID 128>
  <RunaroundType None>
 > # end of Group
 <Group 
  <ID 128>
  <Unique 1086386>
 > # end of Group
 <Rectangle 
  <Unique 1086387>
  <GroupID 130>
  <Pen 7>
  <RunaroundType Contour>
  <ShapeRect  18.0 mm 217.55 mm 63.5 mm 3.0 mm>
  <BRect  18.0 mm 217.55 mm 63.5 mm 3.0 mm>
 > # end of Rectangle
 <PolyLine 
  <Unique 1086388>
  <GroupID 131>
  <Pen 0>
  <PenWidth  1.5 pt>
  <ObTint  3500.0%>
  <NumPoints 2>
  <Point  18.22049 mm 220.55 mm>
  <Point  81.31274 mm 220.55 mm>
 > # end of PolyLine
 <PolyLine 
  <Unique 1086389>
  <GroupID 131>
  <PenWidth  0.5 pt>
  <ObTint  3500.0%>
  <NumPoints 2>
  <Point  18.0 mm 219.67521 mm>
  <Point  81.5 mm 219.67521 mm>
 > # end of PolyLine
 <Group 
  <ID 131>
  <Unique 1086390>
  <GroupID 130>
  <RunaroundType None>
 > # end of Group
 <Group 
  <ID 130>
  <Unique 1086391>
 > # end of Group
 <TextLine 
  <Unique 1086392>
  <RunaroundGap  6.0 pt>
  <TLOrigin  18.70233 mm 215.696 mm>
  <TLAlignment Left>
  <String `Preparat nedtill v-spalt'>
 > # end of TextLine
 <TextLine 
  <Unique 1086393>
  <TLOrigin  88.94007 mm 215.696 mm>
  <TLAlignment Left>
  <String `Preparat nedtill h-spalt'>
 > # end of TextLine
 <Group 
  <ID 122>
  <Unique 1086394>
 > # end of Group
> # end of Page
<Page 
 <Unique 1086405>
 <PageType ReferencePage>
 <PageTag `HTML'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <TextRect 
  <ID 132>
  <Unique 1086406>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  0.0 pt>
  <RunaroundType None>
  <ShapeRect  10.0 mm 74.0 mm 140.0 mm 96.0 mm>
  <BRect  10.0 mm 74.0 mm 140.0 mm 96.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  5.00001 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 133>
 > # end of TextRect
 <TextRect 
  <ID 134>
  <Unique 1086408>
  <RunaroundGap  6.0 pt>
  <RunaroundType Contour>
  <ShapeRect  18.0 mm 14.65 mm 63.5 mm 26.45857 mm>
  <BRect  18.0 mm 14.65 mm 63.5 mm 26.45857 mm>
  <TRNumColumns 1>
  <TRColumnGap  5.00001 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <TextRect 
  <ID 135>
  <Unique 1086410>
  <ShapeRect  88.5 mm 14.65 mm 63.5 mm 26.45857 mm>
  <BRect  88.5 mm 14.65 mm 63.5 mm 26.45857 mm>
  <TRNumColumns 1>
  <TRColumnGap  5.00001 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <Rectangle 
  <Unique 1086412>
  <GroupID 136>
  <Pen 0>
  <PenWidth  1.5 pt>
  <ObTint  3500.0%>
  <RunaroundType None>
  <ShapeRect  18.0 mm 18.0 mm 63.1 mm 55.0 mm>
  <BRect  18.0 mm 18.0 mm 63.1 mm 55.0 mm>
 > # end of Rectangle
 <Rectangle 
  <Unique 1086413>
  <GroupID 136>
  <PenWidth  0.5 pt>
  <ObTint  3500.0%>
  <ShapeRect  18.85 mm 18.87092 mm 61.4 mm 53.2 mm>
  <BRect  18.85 mm 18.87092 mm 61.4 mm 53.2 mm>
 > # end of Rectangle
 <Rectangle 
  <Unique 1086414>
  <GroupID 137>
  <Fill 7>
  <PenWidth  1.5 pt>
  <ObTint  3500.0%>
  <ShapeRect  72.421 mm 18.0 mm 8.67875 mm 8.67887 mm>
  <BRect  72.421 mm 18.0 mm 8.67875 mm 8.67887 mm>
 > # end of Rectangle
 <Rectangle 
  <Unique 1086415>
  <GroupID 137>
  <Fill 15>
  <PenWidth  0.5 pt>
  <ObTint  3500.0%>
  <ShapeRect  73.19103 mm 18.61281 mm 7.45083 mm 7.36583 mm>
  <BRect  73.19103 mm 18.61281 mm 7.45083 mm 7.36583 mm>
 > # end of Rectangle
 <TextRect 
  <ID 138>
  <Unique 1086416>
  <GroupID 137>
  <Pen 15>
  <PenWidth  1.5 pt>
  <ObTint  3500.0%>
  <Angle  315.0>
  <ShapeRect  72.05768 mm 22.65158 mm 6.46839 mm 2.36613 mm>
  <BRect  72.05768 mm 22.65158 mm 6.46839 mm 2.36613 mm>
  <TRNumColumns 1>
  <TRColumnGap  5.00001 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <PolyLine 
  <Unique 1086418>
  <GroupID 137>
  <Pen 0>
  <Separation 1>
  <ObColor `White'>
  <HeadCap Square>
  <TailCap Square>
  <NumPoints 2>
  <Point  81.09269 mm 18.0 mm>
  <Point  81.09269 mm 26.09385 mm>
 > # end of PolyLine
 <PolyLine 
  <Unique 1086419>
  <GroupID 137>
  <NumPoints 2>
  <Point  73.08903 mm 18.0 mm>
  <Point  81.1 mm 18.0 mm>
 > # end of PolyLine
 <PolyLine 
  <Unique 1086420>
  <GroupID 137>
  <Separation 5>
  <ObColor `Svart 35%'>
  <NumPoints 2>
  <Point  72.77483 mm 18.09018 mm>
  <Point  80.97694 mm 26.35843 mm>
 > # end of PolyLine
 <Polygon 
  <Unique 1086421>
  <GroupID 137>
  <Pen 15>
  <Fill 7>
  <PenWidth  0.15 pt>
  <Separation 2>
  <ObColor `Red'>
  <NumPoints 3>
  <Point  73.45284 mm 18.39335 mm>
  <Point  80.91079 mm 25.89541 mm>
  <Point  80.91079 mm 18.42643 mm>
 > # end of Polygon
 <Group 
  <ID 137>
  <Unique 1086422>
  <GroupID 136>
 > # end of Group
 <Group 
  <ID 136>
  <Unique 1086423>
 > # end of Group
 <Rectangle 
  <Unique 1086424>
  <GroupID 139>
  <Pen 0>
  <Fill 15>
  <PenWidth  1.5 pt>
  <Separation 0>
  <ObColor `Black'>
  <ObTint  3500.0%>
  <ShapeRect  88.5 mm 18.0 mm 63.1 mm 55.0 mm>
  <BRect  88.5 mm 18.0 mm 63.1 mm 55.0 mm>
 > # end of Rectangle
 <Rectangle 
  <Unique 1086425>
  <GroupID 139>
  <PenWidth  0.5 pt>
  <ObTint  3500.0%>
  <ShapeRect  89.35 mm 18.87092 mm 61.4 mm 53.2 mm>
  <BRect  89.35 mm 18.87092 mm 61.4 mm 53.2 mm>
 > # end of Rectangle
 <Rectangle 
  <Unique 1086426>
  <GroupID 140>
  <Fill 7>
  <PenWidth  1.5 pt>
  <ObTint  3500.0%>
  <ShapeRect  142.921 mm 18.0 mm 8.67875 mm 8.67887 mm>
  <BRect  142.921 mm 18.0 mm 8.67875 mm 8.67887 mm>
 > # end of Rectangle
 <Rectangle 
  <Unique 1086427>
  <GroupID 140>
  <Fill 15>
  <PenWidth  0.5 pt>
  <ObTint  3500.0%>
  <ShapeRect  143.69103 mm 18.61281 mm 7.45083 mm 7.36583 mm>
  <BRect  143.69103 mm 18.61281 mm 7.45083 mm 7.36583 mm>
 > # end of Rectangle
 <TextRect 
  <ID 141>
  <Unique 1086428>
  <GroupID 140>
  <Pen 15>
  <PenWidth  1.5 pt>
  <ObTint  3500.0%>
  <Angle  315.0>
  <ShapeRect  142.55768 mm 22.65158 mm 6.46839 mm 2.36613 mm>
  <BRect  142.55768 mm 22.65158 mm 6.46839 mm 2.36613 mm>
  <TRNumColumns 1>
  <TRColumnGap  5.00001 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <PolyLine 
  <Unique 1086430>
  <GroupID 140>
  <Pen 0>
  <Separation 1>
  <ObColor `White'>
  <NumPoints 2>
  <Point  151.59269 mm 18.0 mm>
  <Point  151.59269 mm 26.09385 mm>
 > # end of PolyLine
 <PolyLine 
  <Unique 1086431>
  <GroupID 140>
  <NumPoints 2>
  <Point  143.58903 mm 18.0 mm>
  <Point  151.6 mm 18.0 mm>
 > # end of PolyLine
 <PolyLine 
  <Unique 1086432>
  <GroupID 140>
  <Separation 5>
  <ObColor `Svart 35%'>
  <NumPoints 2>
  <Point  143.27483 mm 18.09018 mm>
  <Point  151.47694 mm 26.35843 mm>
 > # end of PolyLine
 <Polygon 
  <Unique 1086433>
  <GroupID 140>
  <Pen 15>
  <Fill 7>
  <PenWidth  0.15 pt>
  <Separation 2>
  <ObColor `Red'>
  <NumPoints 3>
  <Point  143.95284 mm 18.39335 mm>
  <Point  151.41079 mm 25.89541 mm>
  <Point  151.41079 mm 18.42643 mm>
 > # end of Polygon
 <Group 
  <ID 140>
  <Unique 1086434>
  <GroupID 139>
 > # end of Group
 <Group 
  <ID 139>
  <Unique 1086435>
 > # end of Group
> # end of Page
<Page 
 <Unique 1086952>
 <PageType ReferencePage>
 <PageTag `HTML'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <TextRect 
  <ID 133>
  <Unique 1086953>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  0.0 pt>
  <RunaroundType None>
  <ShapeRect  10.0 mm 10.0 mm 140.0 mm 160.0 mm>
  <BRect  10.0 mm 10.0 mm 140.0 mm 160.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  5.00001 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 142>
 > # end of TextRect
> # end of Page
<Page 
 <Unique 1086957>
 <PageType ReferencePage>
 <PageTag `HTML'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <TextRect 
  <ID 142>
  <Unique 1086958>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  0.0 pt>
  <RunaroundType None>
  <ShapeRect  10.0 mm 10.0 mm 140.0 mm 160.0 mm>
  <BRect  10.0 mm 10.0 mm 140.0 mm 160.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  5.00001 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 143>
 > # end of TextRect
> # end of Page
<Page 
 <Unique 1086962>
 <PageType ReferencePage>
 <PageTag `HTML'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <TextRect 
  <ID 143>
  <Unique 1086963>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  0.0 pt>
  <RunaroundType None>
  <ShapeRect  10.0 mm 10.0 mm 140.0 mm 160.0 mm>
  <BRect  10.0 mm 10.0 mm 140.0 mm 160.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  5.00001 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
> # end of Page
<Page 
 <Unique 1086967>
 <PageType ReferencePage>
 <PageTag `Headings'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <TextRect 
  <ID 144>
  <Unique 1086968>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  0.0 pt>
  <RunaroundType None>
  <ShapeRect  10.0 mm 10.0 mm 140.0 mm 160.0 mm>
  <BRect  10.0 mm 10.0 mm 140.0 mm 160.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  5.00001 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
> # end of Page
<Page 
 <Unique 1087016>
 <PageType ReferencePage>
 <PageTag `Ramar'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
> # end of Page
<Page 
 <Unique 996720>
 <PageType BodyPage>
 <PageNum `1313'>
 <PageTag `'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <PageBackground `Första kapitelsida höger'>
 <TextRect 
  <ID 145>
  <Unique 1034380>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  6.0 pt>
  <RunaroundType None>
  <ShapeRect  18.0 mm 28.0 mm 134.0 mm 47.0 mm>
  <BRect  18.0 mm 28.0 mm 134.0 mm 47.0 mm>
  <TRNumColumns 1>
  <TRColumnGap  7.0 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 146>
 > # end of TextRect
 <TextRect 
  <ID 146>
  <Unique 1089514>
  <ShapeRect  18.0 mm 80.0 mm 134.0 mm 140.55 mm>
  <BRect  18.0 mm 80.0 mm 134.0 mm 140.55 mm>
  <TRNumColumns 2>
  <TRColumnGap  7.0 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 147>
 > # end of TextRect
> # end of Page
<Page 
 <Unique 1028164>
 <PageType BodyPage>
 <PageNum `1314'>
 <PageTag `'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <PageBackground `Default'>
 <TextRect 
  <ID 147>
  <Unique 1028167>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  6.0 pt>
  <RunaroundType None>
  <ShapeRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <BRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <TRNumColumns 2>
  <TRColumnGap  7.0 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 148>
 > # end of TextRect
> # end of Page
<Page 
 <Unique 1028172>
 <PageType BodyPage>
 <PageNum `1315'>
 <PageTag `'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <PageBackground `Default'>
 <TextRect 
  <ID 148>
  <Unique 1028175>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  6.0 pt>
  <RunaroundType None>
  <ShapeRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <BRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <TRNumColumns 2>
  <TRColumnGap  7.0 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 149>
 > # end of TextRect
> # end of Page
<Page 
 <Unique 1028180>
 <PageType BodyPage>
 <PageNum `1316'>
 <PageTag `'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <PageBackground `Default'>
 <TextRect 
  <ID 149>
  <Unique 1028183>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  6.0 pt>
  <RunaroundType None>
  <ShapeRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <BRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <TRNumColumns 2>
  <TRColumnGap  7.0 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 150>
 > # end of TextRect
> # end of Page
<Page 
 <Unique 1028188>
 <PageType BodyPage>
 <PageNum `1317'>
 <PageTag `'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <PageBackground `Default'>
 <TextRect 
  <ID 150>
  <Unique 1028191>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  6.0 pt>
  <RunaroundType None>
  <ShapeRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <BRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <TRNumColumns 2>
  <TRColumnGap  7.0 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 151>
 > # end of TextRect
> # end of Page
<Page 
 <Unique 1028196>
 <PageType BodyPage>
 <PageNum `1318'>
 <PageTag `'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <PageBackground `Default'>
 <TextRect 
  <ID 151>
  <Unique 1028199>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  6.0 pt>
  <RunaroundType None>
  <ShapeRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <BRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <TRNumColumns 2>
  <TRColumnGap  7.0 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 152>
 > # end of TextRect
> # end of Page
<Page 
 <Unique 1028204>
 <PageType BodyPage>
 <PageNum `1319'>
 <PageTag `'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <PageBackground `Default'>
 <TextRect 
  <ID 152>
  <Unique 1028207>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  6.0 pt>
  <RunaroundType None>
  <ShapeRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <BRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <TRNumColumns 2>
  <TRColumnGap  7.0 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 153>
 > # end of TextRect
> # end of Page
<Page 
 <Unique 1028212>
 <PageType BodyPage>
 <PageNum `1320'>
 <PageTag `'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <PageBackground `Default'>
 <TextRect 
  <ID 153>
  <Unique 1028215>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  6.0 pt>
  <RunaroundType None>
  <ShapeRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <BRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <TRNumColumns 2>
  <TRColumnGap  7.0 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 154>
 > # end of TextRect
> # end of Page
<Page 
 <Unique 1028220>
 <PageType BodyPage>
 <PageNum `1321'>
 <PageTag `'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <PageBackground `Default'>
 <TextRect 
  <ID 154>
  <Unique 1028223>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  6.0 pt>
  <RunaroundType None>
  <ShapeRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <BRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <TRNumColumns 2>
  <TRColumnGap  7.0 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 155>
 > # end of TextRect
> # end of Page
<Page 
 <Unique 1028228>
 <PageType BodyPage>
 <PageNum `1322'>
 <PageTag `'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <PageBackground `Default'>
 <TextRect 
  <ID 155>
  <Unique 1028231>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  6.0 pt>
  <RunaroundType None>
  <ShapeRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <BRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <TRNumColumns 2>
  <TRColumnGap  7.0 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 156>
 > # end of TextRect
> # end of Page
<Page 
 <Unique 1028236>
 <PageType BodyPage>
 <PageNum `1323'>
 <PageTag `'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <PageBackground `Default'>
 <TextRect 
  <ID 156>
  <Unique 1028239>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  6.0 pt>
  <RunaroundType None>
  <ShapeRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <BRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <TRNumColumns 2>
  <TRColumnGap  7.0 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 157>
 > # end of TextRect
> # end of Page
<Page 
 <Unique 1028244>
 <PageType BodyPage>
 <PageNum `1324'>
 <PageTag `'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <PageBackground `Default'>
 <TextRect 
  <ID 157>
  <Unique 1028247>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  6.0 pt>
  <RunaroundType None>
  <ShapeRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <BRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <TRNumColumns 2>
  <TRColumnGap  7.0 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 158>
 > # end of TextRect
> # end of Page
<Page 
 <Unique 1028252>
 <PageType BodyPage>
 <PageNum `1325'>
 <PageTag `'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <PageBackground `Default'>
 <TextRect 
  <ID 158>
  <Unique 1028255>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  6.0 pt>
  <RunaroundType None>
  <ShapeRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <BRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <TRNumColumns 2>
  <TRColumnGap  7.0 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 159>
 > # end of TextRect
> # end of Page
<Page 
 <Unique 1028260>
 <PageType BodyPage>
 <PageNum `1326'>
 <PageTag `'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <PageBackground `Default'>
 <TextRect 
  <ID 159>
  <Unique 1028263>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  6.0 pt>
  <RunaroundType None>
  <ShapeRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <BRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <TRNumColumns 2>
  <TRColumnGap  7.0 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 160>
 > # end of TextRect
> # end of Page
<Page 
 <Unique 1028268>
 <PageType BodyPage>
 <PageNum `1327'>
 <PageTag `'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <PageBackground `Default'>
 <TextRect 
  <ID 160>
  <Unique 1028271>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  6.0 pt>
  <RunaroundType None>
  <ShapeRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <BRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <TRNumColumns 2>
  <TRColumnGap  7.0 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 161>
 > # end of TextRect
> # end of Page
<Page 
 <Unique 1028276>
 <PageType BodyPage>
 <PageNum `1328'>
 <PageTag `'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <PageBackground `Default'>
 <TextRect 
  <ID 161>
  <Unique 1028279>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  6.0 pt>
  <RunaroundType None>
  <ShapeRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <BRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <TRNumColumns 2>
  <TRColumnGap  7.0 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 162>
 > # end of TextRect
> # end of Page
<Page 
 <Unique 1028284>
 <PageType BodyPage>
 <PageNum `1329'>
 <PageTag `'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <PageBackground `Right utan linje'>
 <TextRect 
  <ID 162>
  <Unique 1028287>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  6.0 pt>
  <RunaroundType None>
  <ShapeRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <BRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <TRNumColumns 2>
  <TRColumnGap  7.0 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 163>
 > # end of TextRect
 <TextRect 
  <ID 164>
  <Unique 1031265>
  <RunaroundType Contour>
  <ShapeRect  18.0 mm 14.65 mm 134.0 mm 33.57169 mm>
  <BRect  18.0 mm 14.65 mm 134.0 mm 33.57169 mm>
  <TRNumColumns 1>
  <TRColumnGap  5.00001 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
 <PolyLine 
  <Unique 1031267>
  <Pen 0>
  <PenWidth  0.5 pt>
  <HeadCap Butt>
  <TailCap Butt>
  <RunaroundType None>
  <NumPoints 2>
  <Point  85.0 mm 51.68204 mm>
  <Point  85.0 mm 220.55 mm>
 > # end of PolyLine
> # end of Page
<Page 
 <Unique 1028292>
 <PageType BodyPage>
 <PageNum `1330'>
 <PageTag `'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <PageBackground `Default'>
 <TextRect 
  <ID 163>
  <Unique 1028295>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  6.0 pt>
  <RunaroundType None>
  <ShapeRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <BRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <TRNumColumns 2>
  <TRColumnGap  7.0 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 165>
 > # end of TextRect
> # end of Page
<Page 
 <Unique 1028300>
 <PageType BodyPage>
 <PageNum `1331'>
 <PageTag `'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <PageBackground `Default'>
 <TextRect 
  <ID 165>
  <Unique 1028303>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  6.0 pt>
  <RunaroundType None>
  <ShapeRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <BRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <TRNumColumns 2>
  <TRColumnGap  7.0 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 166>
 > # end of TextRect
> # end of Page
<Page 
 <Unique 1028308>
 <PageType BodyPage>
 <PageNum `1332'>
 <PageTag `'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <PageBackground `Default'>
 <TextRect 
  <ID 166>
  <Unique 1028311>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  6.0 pt>
  <RunaroundType None>
  <ShapeRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <BRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <TRNumColumns 2>
  <TRColumnGap  7.0 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 167>
 > # end of TextRect
> # end of Page
<Page 
 <Unique 1028316>
 <PageType BodyPage>
 <PageNum `1333'>
 <PageTag `'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <PageBackground `Default'>
 <TextRect 
  <ID 167>
  <Unique 1028319>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  6.0 pt>
  <RunaroundType None>
  <ShapeRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <BRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <TRNumColumns 2>
  <TRColumnGap  7.0 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 168>
 > # end of TextRect
> # end of Page
<Page 
 <Unique 1028324>
 <PageType BodyPage>
 <PageNum `1334'>
 <PageTag `'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <PageBackground `Default'>
 <TextRect 
  <ID 168>
  <Unique 1028327>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  6.0 pt>
  <RunaroundType None>
  <ShapeRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <BRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <TRNumColumns 2>
  <TRColumnGap  7.0 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 169>
 > # end of TextRect
> # end of Page
<Page 
 <Unique 1028332>
 <PageType BodyPage>
 <PageNum `1335'>
 <PageTag `'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <PageBackground `Default'>
 <TextRect 
  <ID 169>
  <Unique 1028335>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  6.0 pt>
  <RunaroundType None>
  <ShapeRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <BRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <TRNumColumns 2>
  <TRColumnGap  7.0 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 170>
 > # end of TextRect
> # end of Page
<Page 
 <Unique 1028340>
 <PageType BodyPage>
 <PageNum `1336'>
 <PageTag `'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <PageBackground `Default'>
 <TextRect 
  <ID 170>
  <Unique 1028343>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  6.0 pt>
  <RunaroundType None>
  <ShapeRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <BRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <TRNumColumns 2>
  <TRColumnGap  7.0 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 171>
 > # end of TextRect
> # end of Page
<Page 
 <Unique 1028348>
 <PageType BodyPage>
 <PageNum `1337'>
 <PageTag `'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <PageBackground `Default'>
 <TextRect 
  <ID 171>
  <Unique 1028351>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  6.0 pt>
  <RunaroundType None>
  <ShapeRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <BRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <TRNumColumns 2>
  <TRColumnGap  7.0 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 172>
 > # end of TextRect
> # end of Page
<Page 
 <Unique 1028356>
 <PageType BodyPage>
 <PageNum `1338'>
 <PageTag `'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <PageBackground `Default'>
 <TextRect 
  <ID 172>
  <Unique 1028359>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  6.0 pt>
  <RunaroundType None>
  <ShapeRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <BRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <TRNumColumns 2>
  <TRColumnGap  7.0 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 173>
 > # end of TextRect
> # end of Page
<Page 
 <Unique 1028364>
 <PageType BodyPage>
 <PageNum `1339'>
 <PageTag `'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <PageBackground `Default'>
 <TextRect 
  <ID 173>
  <Unique 1028367>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  6.0 pt>
  <RunaroundType None>
  <ShapeRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <BRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <TRNumColumns 2>
  <TRColumnGap  7.0 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 174>
 > # end of TextRect
> # end of Page
<Page 
 <Unique 1028372>
 <PageType BodyPage>
 <PageNum `1340'>
 <PageTag `'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <PageBackground `Default'>
 <TextRect 
  <ID 174>
  <Unique 1028375>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  6.0 pt>
  <RunaroundType None>
  <ShapeRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <BRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <TRNumColumns 2>
  <TRColumnGap  7.0 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 175>
 > # end of TextRect
> # end of Page
<Page 
 <Unique 1028380>
 <PageType BodyPage>
 <PageNum `1341'>
 <PageTag `'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <PageBackground `Default'>
 <TextRect 
  <ID 175>
  <Unique 1028383>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  6.0 pt>
  <RunaroundType None>
  <ShapeRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <BRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <TRNumColumns 2>
  <TRColumnGap  7.0 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 176>
 > # end of TextRect
> # end of Page
<Page 
 <Unique 1028388>
 <PageType BodyPage>
 <PageNum `1342'>
 <PageTag `'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <PageBackground `Default'>
 <TextRect 
  <ID 176>
  <Unique 1028391>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  6.0 pt>
  <RunaroundType None>
  <ShapeRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <BRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <TRNumColumns 2>
  <TRColumnGap  7.0 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 177>
 > # end of TextRect
> # end of Page
<Page 
 <Unique 1028396>
 <PageType BodyPage>
 <PageNum `1343'>
 <PageTag `'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <PageBackground `Default'>
 <TextRect 
  <ID 177>
  <Unique 1028399>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  6.0 pt>
  <RunaroundType None>
  <ShapeRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <BRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <TRNumColumns 2>
  <TRColumnGap  7.0 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 178>
 > # end of TextRect
> # end of Page
<Page 
 <Unique 1028404>
 <PageType BodyPage>
 <PageNum `1344'>
 <PageTag `'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <PageBackground `Default'>
 <TextRect 
  <ID 178>
  <Unique 1028407>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  6.0 pt>
  <RunaroundType None>
  <ShapeRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <BRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <TRNumColumns 2>
  <TRColumnGap  7.0 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 179>
 > # end of TextRect
> # end of Page
<Page 
 <Unique 1028412>
 <PageType BodyPage>
 <PageNum `1345'>
 <PageTag `'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <PageBackground `Default'>
 <TextRect 
  <ID 179>
  <Unique 1028415>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  6.0 pt>
  <RunaroundType None>
  <ShapeRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <BRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <TRNumColumns 2>
  <TRColumnGap  7.0 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 180>
 > # end of TextRect
> # end of Page
<Page 
 <Unique 1028420>
 <PageType BodyPage>
 <PageNum `1346'>
 <PageTag `'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <PageBackground `Default'>
 <TextRect 
  <ID 180>
  <Unique 1028423>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  6.0 pt>
  <RunaroundType None>
  <ShapeRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <BRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <TRNumColumns 2>
  <TRColumnGap  7.0 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 181>
 > # end of TextRect
> # end of Page
<Page 
 <Unique 1028428>
 <PageType BodyPage>
 <PageNum `1347'>
 <PageTag `'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <PageBackground `Default'>
 <TextRect 
  <ID 181>
  <Unique 1028431>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  6.0 pt>
  <RunaroundType None>
  <ShapeRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <BRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <TRNumColumns 2>
  <TRColumnGap  7.0 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 182>
 > # end of TextRect
> # end of Page
<Page 
 <Unique 1028436>
 <PageType BodyPage>
 <PageNum `1348'>
 <PageTag `'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <PageBackground `Default'>
 <TextRect 
  <ID 182>
  <Unique 1028439>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  6.0 pt>
  <RunaroundType None>
  <ShapeRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <BRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <TRNumColumns 2>
  <TRColumnGap  7.0 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 183>
 > # end of TextRect
> # end of Page
<Page 
 <Unique 1028444>
 <PageType BodyPage>
 <PageNum `1349'>
 <PageTag `'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <PageBackground `Default'>
 <TextRect 
  <ID 183>
  <Unique 1028447>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  6.0 pt>
  <RunaroundType None>
  <ShapeRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <BRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <TRNumColumns 2>
  <TRColumnGap  7.0 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 184>
 > # end of TextRect
> # end of Page
<Page 
 <Unique 1028452>
 <PageType BodyPage>
 <PageNum `1350'>
 <PageTag `'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <PageBackground `Default'>
 <TextRect 
  <ID 184>
  <Unique 1028455>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  6.0 pt>
  <RunaroundType None>
  <ShapeRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <BRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <TRNumColumns 2>
  <TRColumnGap  7.0 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 185>
 > # end of TextRect
> # end of Page
<Page 
 <Unique 1028460>
 <PageType BodyPage>
 <PageNum `1351'>
 <PageTag `'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <PageBackground `Default'>
 <TextRect 
  <ID 185>
  <Unique 1028463>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  6.0 pt>
  <RunaroundType None>
  <ShapeRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <BRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <TRNumColumns 2>
  <TRColumnGap  7.0 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 186>
 > # end of TextRect
> # end of Page
<Page 
 <Unique 1028468>
 <PageType BodyPage>
 <PageNum `1352'>
 <PageTag `'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <PageBackground `Default'>
 <TextRect 
  <ID 186>
  <Unique 1028471>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  6.0 pt>
  <RunaroundType None>
  <ShapeRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <BRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <TRNumColumns 2>
  <TRColumnGap  7.0 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 187>
 > # end of TextRect
> # end of Page
<Page 
 <Unique 1028476>
 <PageType BodyPage>
 <PageNum `1353'>
 <PageTag `'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <PageBackground `Default'>
 <TextRect 
  <ID 187>
  <Unique 1028479>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  6.0 pt>
  <RunaroundType None>
  <ShapeRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <BRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <TRNumColumns 2>
  <TRColumnGap  7.0 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 188>
 > # end of TextRect
> # end of Page
<Page 
 <Unique 1028484>
 <PageType BodyPage>
 <PageNum `1354'>
 <PageTag `'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <PageBackground `Default'>
 <TextRect 
  <ID 188>
  <Unique 1028487>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  6.0 pt>
  <RunaroundType None>
  <ShapeRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <BRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <TRNumColumns 2>
  <TRColumnGap  7.0 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 189>
 > # end of TextRect
> # end of Page
<Page 
 <Unique 1028492>
 <PageType BodyPage>
 <PageNum `1355'>
 <PageTag `'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <PageBackground `Default'>
 <TextRect 
  <ID 189>
  <Unique 1028495>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  6.0 pt>
  <RunaroundType None>
  <ShapeRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <BRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <TRNumColumns 2>
  <TRColumnGap  7.0 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 190>
 > # end of TextRect
> # end of Page
<Page 
 <Unique 1028500>
 <PageType BodyPage>
 <PageNum `1356'>
 <PageTag `'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <PageBackground `Default'>
 <TextRect 
  <ID 190>
  <Unique 1028503>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  6.0 pt>
  <RunaroundType None>
  <ShapeRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <BRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <TRNumColumns 2>
  <TRColumnGap  7.0 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 191>
 > # end of TextRect
> # end of Page
<Page 
 <Unique 1028508>
 <PageType BodyPage>
 <PageNum `1357'>
 <PageTag `'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <PageBackground `Default'>
 <TextRect 
  <ID 191>
  <Unique 1028511>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  6.0 pt>
  <RunaroundType None>
  <ShapeRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <BRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <TRNumColumns 2>
  <TRColumnGap  7.0 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 192>
 > # end of TextRect
> # end of Page
<Page 
 <Unique 1028516>
 <PageType BodyPage>
 <PageNum `1358'>
 <PageTag `'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <PageBackground `Default'>
 <TextRect 
  <ID 192>
  <Unique 1028519>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  6.0 pt>
  <RunaroundType None>
  <ShapeRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <BRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <TRNumColumns 2>
  <TRColumnGap  7.0 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 193>
 > # end of TextRect
> # end of Page
<Page 
 <Unique 1028524>
 <PageType BodyPage>
 <PageNum `1359'>
 <PageTag `'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <PageBackground `Default'>
 <TextRect 
  <ID 193>
  <Unique 1028527>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  6.0 pt>
  <RunaroundType None>
  <ShapeRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <BRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <TRNumColumns 2>
  <TRColumnGap  7.0 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 194>
 > # end of TextRect
> # end of Page
<Page 
 <Unique 1042772>
 <PageType BodyPage>
 <PageNum `1360'>
 <PageTag `'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <PageBackground `Default'>
 <TextRect 
  <ID 194>
  <Unique 1042775>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  6.0 pt>
  <RunaroundType None>
  <ShapeRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <BRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <TRNumColumns 2>
  <TRColumnGap  7.0 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 195>
 > # end of TextRect
> # end of Page
<Page 
 <Unique 1047107>
 <PageType BodyPage>
 <PageNum `1361'>
 <PageTag `'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <PageBackground `Default'>
 <TextRect 
  <ID 195>
  <Unique 1047110>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  6.0 pt>
  <RunaroundType None>
  <ShapeRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <BRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <TRNumColumns 2>
  <TRColumnGap  7.0 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 196>
 > # end of TextRect
> # end of Page
<Page 
 <Unique 1052280>
 <PageType BodyPage>
 <PageNum `1362'>
 <PageTag `'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <PageBackground `Default'>
 <TextRect 
  <ID 196>
  <Unique 1052283>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  6.0 pt>
  <RunaroundType None>
  <ShapeRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <BRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <TRNumColumns 2>
  <TRColumnGap  7.0 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 197>
 > # end of TextRect
> # end of Page
<Page 
 <Unique 1053812>
 <PageType BodyPage>
 <PageNum `1363'>
 <PageTag `'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <PageBackground `Default'>
 <TextRect 
  <ID 197>
  <Unique 1053815>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  6.0 pt>
  <RunaroundType None>
  <ShapeRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <BRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <TRNumColumns 2>
  <TRColumnGap  7.0 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 198>
 > # end of TextRect
> # end of Page
<Page 
 <Unique 1089527>
 <PageType BodyPage>
 <PageNum `1364'>
 <PageTag `'>
 <PageSize  170.0 mm 240.0 mm>
 <PageOrientation Portrait>
 <PageAngle  0.0>
 <PageBackground `None'>
 <TextRect 
  <ID 198>
  <Unique 1089530>
  <Pen 15>
  <Fill 15>
  <PenWidth  1.0 pt>
  <Separation 0>
  <ObColor `Black'>
  <DashedPattern 
   <DashedStyle Solid>
  > # end of DashedPattern
  <RunaroundGap  6.0 pt>
  <RunaroundType None>
  <ShapeRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <BRect  18.0 mm 18.0 mm 134.0 mm 202.55 mm>
  <TRNumColumns 2>
  <TRColumnGap  7.0 mm>
  <TRColumnBalance No>
  <TRSideheadWidth  30.00005 mm>
  <TRSideheadGap  5.00001 mm>
  <TRSideheadPlacement Left>
  <TRNext 0>
 > # end of TextRect
> # end of Page
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1086035>
  <Pgf 
   <PgfTag `Header'>
   <PgfUseNextTag No>
   <PgfNextTag `'>
   <PgfAlignment Right>
   <PgfFIndent  0.0 mm>
   <PgfLIndent  0.0 mm>
   <PgfRIndent  0.0 mm>
   <PgfFIndentRelative No>
   <PgfFIndentOffset  0.0 mm>
   <PgfTopSeparator `'>
   <PgfTopSepAtIndent No>
   <PgfTopSepOffset  0.0 mm>
   <PgfBotSeparator `'>
   <PgfBotSepAtIndent No>
   <PgfBotSepOffset  0.0 mm>
   <PgfPlacement Anywhere>
   <PgfPlacementStyle Normal>
   <PgfRunInDefaultPunct `. '>
   <PgfSpBefore  0.0 pt>
   <PgfSpAfter  0.0 pt>
   <PgfWithPrev No>
   <PgfWithNext No>
   <PgfBlockSize 1>
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
    <FFamily `Frutiger LT Std 45 Light'>
    <FVar `Regular'>
    <FWeight `Bold'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Bold'>
    <FEncoding `FrameRoman'>
    <FSize  14.5 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  -4.0%>
    <FStretch  100.0%>
    <FLanguage UKEnglish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLineSpacing Fixed>
   <PgfLeading  3.0 pt>
   <PgfAutoNum No>
   <PgfNumTabs 2>
   <TabStop 
    <TSX  67.0 mm>
    <TSType Center>
    <TSLeaderStr ` '>
   > # end of TabStop
   <TabStop 
    <TSX  134.0 mm>
    <TSType Right>
    <TSLeaderStr ` '>
   > # end of TabStop
   <PgfHyphenate Yes>
   <HyphenMaxLines 2>
   <HyphenMinPrefix 2>
   <HyphenMinSuffix 2>
   <HyphenMinWord 5>
   <PgfLetterSpace No>
   <PgfMinWordSpace 75>
   <PgfOptWordSpace 100>
   <PgfMaxWordSpace 125>
   <PgfMinJRomanLetterSpace 0>
   <PgfOptJRomanLetterSpace 25>
   <PgfMaxJRomanLetterSpace 50>
   <PgfMinJLetterSpace 0>
   <PgfOptJLetterSpace 0>
   <PgfMaxJLetterSpace 10>
   <PgfYakumonoType Floating>
   <PgfAcrobatLevel 0>
   <PgfPDFStructureLevel 0>
   <PgfLanguage UKEnglish>
   <PgfCellAlignment Top>
   <PgfCellMargins  0.0 pt 0.0 pt 0.0 pt 0.0 pt>
   <PgfCellLMarginFixed No>
   <PgfCellTMarginFixed No>
   <PgfCellRMarginFixed No>
   <PgfCellBMarginFixed No>
   <PgfLocked No>
  > # end of Pgf
  <ParaLine 
   <TextRectID 42>
   <Variable 
    <VariableName `Current Page #'>
    <Unique 1086033>
   > # end of Variable
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1086036>
  <Pgf 
   <PgfTag `Footer'>
   <PgfAlignment LeftRight>
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
    <FFamily `Frutiger LT Std 55 Roman'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  7.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage UKEnglish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLeading  2.0 pt>
   <PgfPDFStructureLevel 0>
  > # end of Pgf
  <ParaLine 
   <TextRectID 43>
   <String `Läkemedelsverket'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1086037>
  <ParaLine 
   <String `Läkemedelsboken 2014'>
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <TFTag `A'>
 <TFAutoConnect Yes>
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1086038>
  <Pgf 
   <PgfTag `Body'>
   <PgfUseNextTag Yes>
   <PgfNextTag `KapRub'>
   <PgfAlignment Right>
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
    <FFamily `Frutiger LT Std 45 Light'>
    <FVar `Regular'>
    <FWeight `Bold'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Bold'>
    <FEncoding `FrameRoman'>
    <FSize  7.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLeading  1.7 pt>
   <PgfNumTabs 0>
   <PgfPDFStructureLevel 0>
   <PgfLanguage Swedish>
  > # end of Pgf
  <ParaLine 
   <TextRectID 44>
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1086042>
  <Pgf 
   <PgfAlignment Left>
  > # end of Pgf
  <ParaLine 
   <TextRectID 45>
   <Variable 
    <VariableName `Avsnittsnamn'>
    <Unique 1086040>
   > # end of Variable
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1086046>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
    <FFamily `Frutiger LT Std 55 Roman'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  7.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
  > # end of Pgf
  <ParaLine 
   <Variable 
    <VariableName `Kapitelnamn'>
    <Unique 1086044>
   > # end of Variable
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1086069>
  <Pgf 
   <PgfAlignment Right>
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
    <FFamily `Frutiger LT Std 45 Light'>
    <FVar `Regular'>
    <FWeight `Bold'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Bold'>
    <FEncoding `FrameRoman'>
    <FSize  7.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
  > # end of Pgf
  <ParaLine 
   <TextRectID 49>
   <Variable 
    <VariableName `Avsnittsnamn'>
    <Unique 1086067>
   > # end of Variable
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1086073>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
    <FFamily `Frutiger LT Std 55 Roman'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  7.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
  > # end of Pgf
  <ParaLine 
   <Variable 
    <VariableName `Kapitelnamn'>
    <Unique 1086071>
   > # end of Variable
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <TFTag `A'>
 <TFAutoConnect Yes>
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1086074>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
    <FFamily `Frutiger LT Std 45 Light'>
    <FVar `Regular'>
    <FWeight `Bold'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Bold'>
    <FEncoding `FrameRoman'>
    <FSize  7.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
  > # end of Pgf
  <ParaLine 
   <TextRectID 50>
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1086078>
  <Pgf 
   <PgfTag `Header'>
   <PgfUseNextTag No>
   <PgfNextTag `'>
   <PgfAlignment Left>
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
    <FFamily `Frutiger LT Std 45 Light'>
    <FVar `Regular'>
    <FWeight `Bold'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Bold'>
    <FEncoding `FrameRoman'>
    <FSize  14.5 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  -4.0%>
    <FStretch  100.0%>
    <FLanguage UKEnglish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLeading  3.0 pt>
   <PgfNumTabs 2>
   <TabStop 
    <TSX  67.0 mm>
    <TSType Center>
    <TSLeaderStr ` '>
   > # end of TabStop
   <TabStop 
    <TSX  134.0 mm>
    <TSType Right>
    <TSLeaderStr ` '>
   > # end of TabStop
   <PgfPDFStructureLevel 0>
   <PgfLanguage UKEnglish>
  > # end of Pgf
  <ParaLine 
   <TextRectID 51>
   <Variable 
    <VariableName `Current Page #'>
    <Unique 1086076>
   > # end of Variable
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1086079>
  <Pgf 
   <PgfTag `Footer'>
   <PgfAlignment Right>
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
    <FFamily `Frutiger LT Std 55 Roman'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  7.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage UKEnglish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLeading  2.0 pt>
   <PgfPDFStructureLevel 0>
  > # end of Pgf
  <ParaLine 
   <TextRectID 52>
   <String `Läkemedelsverket'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1086080>
  <ParaLine 
   <String `Läkemedelsboken 2014'>
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1086102>
  <Pgf 
   <PgfTag `Header'>
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
    <FFamily `Frutiger LT Std 45 Light'>
    <FVar `Regular'>
    <FWeight `Bold'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Bold'>
    <FEncoding `FrameRoman'>
    <FSize  14.5 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  -4.0%>
    <FStretch  100.0%>
    <FLanguage UKEnglish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLeading  3.0 pt>
   <PgfPDFStructureLevel 0>
  > # end of Pgf
  <ParaLine 
   <TextRectID 56>
   <Variable 
    <VariableName `Current Page #'>
    <Unique 1086100>
   > # end of Variable
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1014965>
  <Pgf 
   <PgfTag `Body'>
   <PgfUseNextTag Yes>
   <PgfNextTag `KapRub'>
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
    <FFamily `Frutiger LT Std 45 Light'>
    <FVar `Regular'>
    <FWeight `Bold'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Bold'>
    <FEncoding `FrameRoman'>
    <FSize  7.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLeading  1.7 pt>
   <PgfNumTabs 0>
   <PgfPDFStructureLevel 0>
   <PgfLanguage Swedish>
  > # end of Pgf
  <ParaLine 
   <TextRectID 100>
   <Variable 
    <VariableName `Avsnittsnamn'>
    <Unique 1014963>
   > # end of Variable
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1014969>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
    <FFamily `Frutiger LT Std 55 Roman'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  7.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
  > # end of Pgf
  <ParaLine 
   <Variable 
    <VariableName `Kapitelnamn'>
    <Unique 1014967>
   > # end of Variable
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <TFTag `A'>
 <TFAutoConnect Yes>
 <Notes 
  <FNote 
   <ID 199>
   <Para 
    <Unique 1087282>
    <PgfTag `Footnote'>
    <Pgf 
     <PgfLIndent  5.5 mm>
     <PgfFont 
      <FTag `'>
      <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
      <FFamily `Frutiger LT Std 55 Roman'>
      <FVar `Regular'>
      <FWeight `Regular'>
      <FAngle `Regular'>
      <FPostScriptName `FrutigerLTStd-Roman'>
      <FEncoding `FrameRoman'>
      <FSize  6.0 pt>
      <FUnderlining FNoUnderlining>
      <FOverline No>
      <FStrike No>
      <FChangeBar No>
      <FOutline No>
      <FShadow No>
      <FPairKern Yes>
      <FTsume No>
      <FCase FAsTyped>
      <FPosition FNormal>
      <FDX  0.0%>
      <FDY  0.0%>
      <FDW  -2.0%>
      <FStretch  100.0%>
      <FLanguage Swedish>
      <FLocked No>
      <FSeparation 0>
      <FColor `Black'>
      <FBackgroundColor NoColor>
     > # end of PgfFont
     <PgfNumTabs 1>
     <TabStop 
      <TSX  5.5 mm>
      <TSType Left>
      <TSLeaderStr ` '>
     > # end of TabStop
    > # end of Pgf
    <PgfReferenced Yes>
    <ParaLine 
     <String `Kapitlet föreligger i den version som ingick i LB 2011–2012, '>
    >
    <ParaLine 
     <Font 
      <FTag `'>
      <FDW  0.0%>
      <FLocked No>
     > # end of Font
     <String `då det var helt nyskrivet. Uppdatering kommer att ske '>
    >
    <ParaLine 
     <String `under 2014.'>
    >
   > # end of Para
  > # end of FNote
  <FNote 
   <ID 200>
   <Para 
    <Unique 1077290>
    <PgfTag `Footnote'>
    <Pgf 
     <PgfLIndent  5.5 mm>
     <PgfNumTabs 1>
     <TabStop 
      <TSX  5.5 mm>
      <TSType Left>
      <TSLeaderStr ` '>
     > # end of TabStop
    > # end of Pgf
    <PgfReferenced Yes>
    <ParaLine 
     <String ` Anordning för att i experimentellt syfte med glukosin'>
     <Char SoftHyphen>
    >
    <ParaLine 
     <String `fusion och insulin under en viss tid erhålla en konstant '>
    >
    <ParaLine 
     <String `(förhöjd) blodglukosnivå. Se även artikeln Norwich KH, '>
    >
    <ParaLine 
     <String `Fluker G, Anthony J, Popescu I, Pagurek B, Hetenyi G Jr. '>
    >
    <ParaLine 
     <String `The development of a glucose clamp. '>
     <Font 
      <FTag `Blue'>
      <FLocked No>
     > # end of Font
     <Marker 
      <MType 8>
      <MTypeName `Hypertext'>
      <MText `message URL http://www.ncbi.nlm.nih.gov/pubmed/1186496'>
      <MCurrPage `1318'>
      <Unique 1087470>
     > # end of Marker
     <String `Metabolism. '>
    >
    <ParaLine 
     <String `1975;24:1221–30'>
     <Font 
      <FTag `'>
      <FLocked No>
     > # end of Font
     <String `.'>
    >
   > # end of Para
  > # end of FNote
  <FNote 
   <ID 201>
   <Para 
    <Unique 1044501>
    <PgfTag `Footnote'>
    <Pgf 
     <PgfLIndent  5.5 mm>
     <PgfNumTabs 1>
     <TabStop 
      <TSX  5.5 mm>
      <TSType Left>
      <TSLeaderStr ` '>
     > # end of TabStop
    > # end of Pgf
    <ParaLine 
     <String ` Med allvarlig hypoglykemi avses att en annan person '>
    >
    <ParaLine 
     <String `har tvingats ingripa för att häva hypoglykemin. Svår hy'>
     <Char SoftHyphen>
    >
    <ParaLine 
     <String `poglykemi i studierna avser oftast en fastställd blodglu'>
     <Char SoftHyphen>
    >
    <ParaLine 
     <String `kosnivå,  2,8 mmol/L, men andra värden kan förekomma.'>
     <Font 
      <FTag `'>
      <FPlatformName `W.Times New Roman.R.400'>
      <FFamily `Times New Roman'>
      <FEncoding `FrameRoman'>
      <FLocked No>
     > # end of Font
    >
   > # end of Para
  > # end of FNote
  <FNote 
   <ID 202>
   <Para 
    <Unique 1079065>
    <PgfTag `Footnote'>
    <Pgf 
     <PgfLIndent  5.5 mm>
     <PgfNumTabs 1>
     <TabStop 
      <TSX  5.5 mm>
      <TSType Left>
      <TSLeaderStr ` '>
     > # end of TabStop
    > # end of Pgf
    <PgfReferenced Yes>
    <ParaLine 
     <String ` MMSE – Minimental State Examination. Svensk version '>
    >
    <ParaLine 
     <String `heter MMT och är ett mått på allmän kognitiv förmåga.'>
     <Font 
      <FTag `'>
      <FPlatformName `W.Times New Roman.R.400'>
      <FFamily `Times New Roman'>
      <FEncoding `FrameRoman'>
      <FLocked No>
     > # end of Font
    >
   > # end of Para
  > # end of FNote
  <FNote 
   <ID 203>
   <Para 
    <Unique 1089268>
    <PgfTag `Footnote'>
    <Pgf 
     <PgfLIndent  5.5 mm>
     <PgfNumTabs 1>
     <TabStop 
      <TSX  5.5 mm>
      <TSType Left>
      <TSLeaderStr ` '>
     > # end of TabStop
    > # end of Pgf
    <PgfReferenced Yes>
    <ParaLine 
     <String `Den europeiska läkemedelsmyndighetens säkerhets'>
     <Char SoftHyphen>
    >
    <ParaLine 
     <String `kommitté PRAC (Pharmacovigilance Risk Assessment '>
    >
    <ParaLine 
     <String `Committee) har påbörjat en granskning av läkemedel '>
    >
    <ParaLine 
     <String `som innehåller zolpidem. Zolpidem används för kort'>
     <Char SoftHyphen>
    >
    <ParaLine 
     <Char DiscHyphen>
     <String `tidsbehandling av sömnlöshet och det finns risk för '>
    >
    <ParaLine 
     <Char DiscHyphen>
     <String `sömnighet och nedsatt '>
     <Char DiscHyphen>
     <String `reaktionsförmåga även dagen '>
    >
    <ParaLine 
     <String `efter intag av läkemedlet. Detta kan öka risken för '>
    >
    <ParaLine 
     <String `olyckor i samband med aktiviteter som kräver skärpt '>
    >
    <ParaLine 
     <String `uppmärksamhet, till exempel bilkörning.'>
     <Char HardReturn>
    >
    <ParaLine 
     <Font 
      <FTag `'>
      <FLocked No>
      <FSeparation 4>
      <FColor `Blue'>
     > # end of Font
     <Marker 
      <MType 8>
      <MTypeName `Hypertext'>
      <MText `message URL http://www.lakemedelsverket.se/Alla-nyheter/Nyheter-2013/Granskning-av-lakemedel-som-innehaller-zolpidem/'>
      <MCurrPage `1335'>
      <Unique 1089329>
     > # end of Marker
     <String `www.lakemedelsverket.se'>
    >
   > # end of Para
  > # end of FNote
 > # end of Notes
 <Para 
  <Unique 1087053>
  <PgfTag `KapRub'>
  <PgfReferenced Yes>
  <ParaLine 
   <TextRectID 145>
   <Marker 
    <MType 9>
    <MTypeName `Cross-Ref'>
    <MText `84972: KapRub: Trafik, riskfyllt arbete och läkemedel'>
    <MCurrPage `1313'>
    <Unique 1087051>
   > # end of Marker
   <String `T'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `trafik:läkemedel;läkemedel:trafik;bilkörning:<$nopage\> se trafik'>
    <MCurrPage `1313'>
    <Unique 1087052>
   > # end of Marker
   <String `rafik, riskfyllt '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `arbete och läkemedel'>
   <Font 
    <FTag `'>
    <FPosition FSuperscript>
    <FLocked No>
   > # end of Font
   <String `1'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1087055>
  <PgfTag `Författare'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Kurt Johansson, Trafikmedicinskt '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Centrum, Karolinska Universitetssjukhuset, Huddinge'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1040226>
  <PgfTag `Inledning'>
  <PgfNumString `Inledning'>
  <ParaLine 
   <TextRectID 146>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1087279>
  <PgfTag `Ingress'>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
    <FFamily `Frutiger LT Std 45 Light'>
    <FVar `Regular'>
    <FWeight `Bold'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Bold'>
    <FEncoding `FrameRoman'>
    <FSize  9.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  -1.0%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <HyphenMaxLines 4>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `Såväl önskad effekt som biverkningar av ett '>
  > # end of ParaLine
  <ParaLine 
   <String `läkemedel kan inverka menligt på lämplig'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `heten att framföra fordon och därmed på '>
  > # end of ParaLine
  <ParaLine 
   <String `olycksrisken eller på att arbeta med riskfyll'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `da verksamheter. Konsekvenserna av den'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `na påverkan kan vara alltifrån olyckor med '>
  > # end of ParaLine
  <ParaLine 
   <String `personskador till döden som yttersta konse'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `kvens. Det är därför av största vikt att för'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `skrivaren är väl förtrogen med trafikvar'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ningstexterna för de läkemedel som ingår i '>
  > # end of ParaLine
  <ParaLine 
   <String `dennes förskrivningsarsenal.'>
   <Font 
    <FTag `'>
    <FLocked No>
    <FSeparation 1>
    <FColor `White'>
   > # end of Font
   <String ` '>
   <FNote 199>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1087283>
  <PgfTag `Ingress'>
  <Pgf 
   <PgfFIndent  3.0 mm>
   <HyphenMaxLines 8>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `Avsikten med detta kapitel är att i första '>
  > # end of ParaLine
  <ParaLine 
   <String `hand ge förskrivaren en fördjupad infor'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `mation om vad som i vetenskaplig littera'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tur är känt om läkemedlens effekter av'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `seende trafikfarlighet (alternativt körför'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `måga eller kognitiva funktioner som är av '>
  > # end of ParaLine
  <ParaLine 
   <String `vikt för trafiksäkerheten) för att han/hon '>
  > # end of ParaLine
  <ParaLine 
   <String `ska vara bättre rustad i sin information till '>
  > # end of ParaLine
  <ParaLine 
   <String `den enskilda patienten. Utöver själva läke'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `medelseffekten finns det flera faktorer att '>
  > # end of ParaLine
  <ParaLine 
   <String `ta med i en bedömning av lämpligheten att '>
  > # end of ParaLine
  <ParaLine 
   <String `köra bil. Sådana faktorer är i första hand '>
  > # end of ParaLine
  <ParaLine 
   <String `grundsjukdomen (och eventuella andra '>
  > # end of ParaLine
  <ParaLine 
   <String `samtidiga sjukdomar) som kan påverka '>
  > # end of ParaLine
  <ParaLine 
   <String `trafiksäkerheten, men även faktorer som '>
  > # end of ParaLine
  <ParaLine 
   <String `påverkar läkemedelsmetabolism, alkohol, '>
  > # end of ParaLine
  <ParaLine 
   <String `stress, dålig sömn, ett besked om livsho'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tande sjukdom etc är exempel på faktorer '>
  > # end of ParaLine
  <ParaLine 
   <String `som kan ingå i bedömningen. Speciellt i '>
  > # end of ParaLine
  <ParaLine 
   <TextRectID 146>
   <String `äldregruppen förekommer ofta multimedi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `cinering, vilket gör bedömningen ännu '>
  > # end of ParaLine
  <ParaLine 
   <String `svårare och det finns ytterst få studier av'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `seende bilkörning och kognitiva funktio'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ner som berör kombinationer av läkemedel '>
  > # end of ParaLine
  <ParaLine 
   <String `(undantag finns när det gäller behandling '>
  > # end of ParaLine
  <ParaLine 
   <String `av diabetes, smärta och epilepsi, där kom'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `bination av två eller flera preparat är van'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ligt). Vid tveksamhet kan det finnas anled'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ning att närmare testa de kognitiva funk'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tionerna med hjälp av en neuropsykolog.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1040255>
  <PgfTag `Ingress'>
  <Pgf 
   <PgfFIndent  3.0 mm>
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
    <FFamily `Frutiger LT Std 45 Light'>
    <FVar `Regular'>
    <FWeight `Bold'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Bold'>
    <FEncoding `FrameRoman'>
    <FSize  9.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  -1.0%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <HyphenMaxLines 4>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `Kapitlet berör endast legalt förskrivna lä'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `kemedel som tas enligt ordination, dvs inte '>
  > # end of ParaLine
  <ParaLine 
   <String `preparat som används vid missbruk eller be'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `roende. Vid missbruk/beroende ska anmä'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `lan göras till körkortsmyndigheten i enlig'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `het med körkortslagens bestämmelse om '>
  > # end of ParaLine
  <ParaLine 
   <String `läkares anmälningsskyldighet (Körkorts'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `lagen, 10 kapitlet 2§) '>
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 1Y2'>
    <MCurrPage `1313'>
    <Unique 1066841>
   > # end of Marker
   <String `(1)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` med referens till de '>
  > # end of ParaLine
  <ParaLine 
   <String `medicinska kraven för körkortsinnehav '>
  > # end of ParaLine
  <ParaLine 
   <String `TSFS 2010:125 '>
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 2Y2'>
    <MCurrPage `1313'>
    <Unique 1066850>
   > # end of Marker
   <String `(2)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Särskilda bestämmelser '>
  > # end of ParaLine
  <ParaLine 
   <String `finns för luftfart (Luftfartsförordningen) '>
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 3Y2'>
    <MCurrPage `1313'>
    <Unique 1066855>
   > # end of Marker
   <String `(3)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` '>
  > # end of ParaLine
  <ParaLine 
   <String `och spårbunden trafik (Banverkets författ'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ningssamling) '>
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 4Y2'>
    <MCurrPage `1313'>
    <Unique 1066860>
   > # end of Marker
   <String `(4)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1040248>
  <PgfTag `Rub1'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Upplägget av kapitlet'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1087319>
  <PgfTag `Bröd'>
  <Pgf 
   <HyphenMaxLines 10>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <Font 
    <FTag `'>
    <FDW  -1.5%>
    <FLocked No>
   > # end of Font
   <String `Under rubriken ”Rekommendationer” tas '>
  > # end of ParaLine
  <ParaLine 
   <String `hänsyn endast till läkemedlens effekter på '>
  > # end of ParaLine
  <ParaLine 
   <String `trafiksäkerhet, kognitiva funktioner och/'>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `eller om aggressivitet/impulsivitet har rap'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `porterats. Hänsyn har inte tagits till andra '>
  > # end of ParaLine
  <ParaLine 
   <String `faktorer, t'>
   <Char HardSpace>
   <String `ex läkemedlens effektivitet, tolera'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `bilitet, övriga biverkningar eller läkemedels'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `kommittéernas rekommendationer, '>
   <Font 
    <FTag `'>
    <FDW  -1.0%>
    <FLocked No>
   > # end of Font
   <String `utan det '>
  > # end of ParaLine
  <ParaLine 
   <String `är en fråga för förskrivaren att göra denna '>
  > # end of ParaLine
  <ParaLine 
   <String `avvägning mot trafikfarlighet för ett läke'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <TextRectID 147>
   <String `medel. En av tankarna bakom '>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `kapitlet är '>
  > # end of ParaLine
  <ParaLine 
   <String `att när den behandlande läkaren ur klinisk '>
  > # end of ParaLine
  <ParaLine 
   <String `synvinkel har två likvärdiga läkemedel att '>
  > # end of ParaLine
  <ParaLine 
   <String `välja mellan ska informationen i kapitlet '>
  > # end of ParaLine
  <ParaLine 
   <String `leda till att det preparat som har minsta ne'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `gativa påverkan på trafiksäkerheten väljs.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1067380>
  <PgfTag `BrödIn'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Då det under senare år skett en ”bredd'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ning” av indikationerna för vissa preparat'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `grupper (exempelvis används antiepilepti'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ka vid smärtbehandling) redovisas substan'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `serna under sin grupptillhörighet (ATC-'>
  > # end of ParaLine
  <ParaLine 
   <String `kod) i Fass i'>
   <Char HardSpace>
   <String `stället för diagnosgrupperat. '>
  > # end of ParaLine
  <ParaLine 
   <String `Efter en allmän översikt av en preparat'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `grupp kommer en sammanfattande bedöm'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ning samt rekommendationer vilka inklu'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `derar litteratur för vidare läsning. Därefter '>
  > # end of ParaLine
  <ParaLine 
   <String `följer en detaljerad genomgång av litteratu'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ren avseende de olika preparaten. För refe'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `renser under rubriken ”Läs vidare” finns '>
  > # end of ParaLine
  <ParaLine 
   <String `länkar till artiklars sammanfattningar i re'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ferenslistan i slutet av kapitlet, medan det '>
  > # end of ParaLine
  <ParaLine 
   <String `för övriga referenser i den mycket omfat'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tande referenslistan saknas sådana.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1067381>
  <PgfTag `BrödIn'>
  <ParaLine 
   <String `Efter referenslistan finns ett Appendix '>
  > # end of ParaLine
  <ParaLine 
   <String `med förkortningar och information om olika '>
  > # end of ParaLine
  <ParaLine 
   <String `tester.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1043784>
  <PgfTag `Rub1'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `R'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `regelverket:läkemedel och trafik;läkemedel:regelverket och trafik'>
    <MCurrPage `1314'>
    <Unique 1058041>
   > # end of Marker
   <String `egelverket om '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `läkemedel och bilkörning'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1044000>
  <PgfTag `Bröd'>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.NewCenturySchlbk LT Std.R.400'>
    <FFamily `NewCenturySchlbk LT Std'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `NewCenturySchlbkLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  9.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  -0.5%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <HyphenMaxLines 10>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <Font 
    <FTag `'>
    <FDW  0.0%>
    <FLocked No>
   > # end of Font
   <String `Läkarens informationsskyldighet angående '>
  > # end of ParaLine
  <ParaLine 
   <String `läkemedels potentiella inverkan på trafik'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `säkerhet eller lämplighet att utföra preci'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `sions- eller riskfyllt arbete är reglerat i Lä'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `kemedelsverkets författningssamling LVFS'>
   <Font 
    <FTag `'>
    <FDW  -1.5%>
    <FLocked No>
   > # end of Font
   <String ` '>
  > # end of ParaLine
  <ParaLine 
   <String `2009:13, '>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `2 kap '>
   <Font 
    <FTag `'>
    <FDW  -1.5%>
    <FLocked No>
   > # end of Font
   <String `15 §  '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 5Y2'>
    <MCurrPage `1314'>
    <Unique 1067348>
   > # end of Marker
   <String `(5): '>
   <Font 
    <FTag `'>
    <FDW  -1.5%>
    <FLocked No>
   > # end of Font
   <String `”'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `Vid förskrivning och '>
  > # end of ParaLine
  <ParaLine 
   <String `utlämnande av läkemedel som kan påverka '>
  > # end of ParaLine
  <ParaLine 
   <String `reaktionsförmågan och därmed förmågan '>
  > # end of ParaLine
  <ParaLine 
   <String `att uppträda som trafikant eller utföra risk'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `fyllt eller precisionskrävande arbete ska för'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `s'>
   <Font 
    <FTag `'>
    <FDW  -1.0%>
    <FLocked No>
   > # end of Font
   <String `krivaren särskilt upplysa patienten om det'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ta.” Det innebär således en ovillkorlig infor'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `mationsskyldighet för förskrivande läkare. '>
  > # end of ParaLine
  <ParaLine 
   <String `Observera att skrivningen trafikant inne'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `bär att informationsplikten inte bara gäller '>
  > # end of ParaLine
  <ParaLine 
   <String `förare av körkortspliktiga fordon utan även '>
  > # end of ParaLine
  <ParaLine 
   <String `mopedister, cyklister, gångtrafikanter och '>
  > # end of ParaLine
  <ParaLine 
   <String `förare av arbetsmaskiner och dylikt.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1079452>
  <PgfTag `BrödIn'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Ansvaret för att inte köra om man är så '>
  > # end of ParaLine
  <ParaLine 
   <String `påverkad av läkemedel att det innebär en '>
  > # end of ParaLine
  <ParaLine 
   <String `trafikfara regleras genom lagen om straff '>
  > # end of ParaLine
  <ParaLine 
   <String `för vissa trafikbrott (Trafikbrottslagen – '>
  > # end of ParaLine
  <ParaLine 
   <String `TBL) 4 § '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 6Y2'>
    <MCurrPage `1314'>
    <Unique 1079453>
   > # end of Marker
   <String `(6)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` där det framgår att en förare '>
  > # end of ParaLine
  <ParaLine 
   <TextRectID 147>
   <String `som är så påverkad av ”annat medel” (än al'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `kohol) att det kan antas att han/hon inte '>
  > # end of ParaLine
  <ParaLine 
   <String `kan framföra ett fordon på ett betryggande '>
  > # end of ParaLine
  <ParaLine 
   <String `sätt, döms för rattfylleri (”drograttfylleri”). '>
  > # end of ParaLine
  <ParaLine 
   <String `Brottet bedöms vanligtvis som grovt, om '>
  > # end of ParaLine
  <ParaLine 
   <String `påverkansgraden motsvarar den som ses '>
  > # end of ParaLine
  <ParaLine 
   <String `vid en alkoholkoncentration i blodet (BAC) '>
  > # end of ParaLine
  <ParaLine 
   <String `av 1,0‰ (eller mer) eller om föraren orsakat '>
  > # end of ParaLine
  <ParaLine 
   <String `en trafikolycka. Vid grovt brott är minimi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `straffet 6 månaders fängelse. Ansvaret vi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `lar således på den enskilde att avgöra hur '>
  > # end of ParaLine
  <ParaLine 
   <String `påverkad man är och det finns alltså inget '>
  > # end of ParaLine
  <ParaLine 
   <String `generellt förbud mot att köra med trafikfar'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `liga läkemedel i kroppen utan det är en be'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `dömningsfråga för föraren i det enskilda '>
  > # end of ParaLine
  <ParaLine 
   <String `fallet. Detta fritar inte på något sätt läka'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ren från dennes informationsskyldighet. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1052092>
  <PgfTag `Rub1'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `V'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `läkemedel:varningstriangeln'>
    <MCurrPage `1314'>
    <Unique 1058046>
   > # end of Marker
   <String `arningstriangeln är avskaffad'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1087353>
  <PgfTag `Bröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Varningstriangeln infördes på 70-talet då '>
  > # end of ParaLine
  <ParaLine 
   <String `det inte fanns bipacksedlar i läkemedelsför'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `packningarna och gav brukaren en varning '>
  > # end of ParaLine
  <ParaLine 
   <String `om att läkemedlet kunde påverka trafiksä'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `kerheten. Tanken var god, men trots var'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ningssignalen visste ca 25% av 500 tillfrå'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `gade äldre bilförare inte vad triangeln stod '>
  > # end of ParaLine
  <ParaLine 
   <String `för. Resterande svar fördelade sig lika mel'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `lan ”Man får inte”, ”Man ska inte” och ”Man '>
  > # end of ParaLine
  <ParaLine 
   <String `bör inte” köra bil (egna opublicerade data). '>
  > # end of ParaLine
  <ParaLine 
   <String `Vissa trafikfarliga läkemedel, speciellt '>
  > # end of ParaLine
  <ParaLine 
   <String `neuro'>
   <Char DiscHyphen>
   <String `leptika (Mallorol (tioridazin), Haldol '>
  > # end of ParaLine
  <ParaLine 
   <String `(haloperidol) och Buronil (melperon)), sak'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `nade dessutom varningstriangel. Det fanns '>
  > # end of ParaLine
  <ParaLine 
   <String `således flera skäl att avskaffa märkningen '>
  > # end of ParaLine
  <ParaLine 
   <String `till förmån för en mer utförlig trafikvar'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ningstext i bipacksedlarna. Se även artikel '>
  > # end of ParaLine
  <ParaLine 
   <String `i Läkartidningen '>
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 7Y2'>
    <MCurrPage `1314'>
    <Unique 1087354>
   > # end of Marker
   <String `(7)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1052310>
  <PgfTag `Rub1'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Trafikvarningstext '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `i '>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `produktresumé:trafikvarning;Fass:trafikvarning'>
    <MCurrPage `1314'>
    <Unique 1058051>
   > # end of Marker
   <String `produktresumé/Fass'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1052419>
  <PgfTag `Bröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `I ett preparats produktresumé, som är god'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `känd av Läkemedelsverket, återfinns infor'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `mation som rör t'>
   <Char HardSpace>
   <String `ex bilkörning under rubri'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ken 4.7 ”Effekter på förmågan att framföra '>
  > # end of ParaLine
  <ParaLine 
   <String `fordon och använda maskiner”. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1053049>
  <PgfTag `BrödIn'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `I Fass finns vanligtvis en rubrik ”Trafik” '>
  > # end of ParaLine
  <ParaLine 
   <String `för varje farmaceutisk specialitet där till'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `verkaren själv avgör vilken information '>
  > # end of ParaLine
  <ParaLine 
   <String `som ska ges. Detta innebär att informatio'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `nen kan skilja sig åt mellan olika tillverka'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `re av samma substans men webbpublice'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <TextRectID 148>
   <String `ringen av Fass verkar ha inneburit att tra'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `fikvarning blivit en obligatorisk rubrik. '>
  > # end of ParaLine
  <ParaLine 
   <String `Skillnaderna är därför inte längre så stora '>
  > # end of ParaLine
  <ParaLine 
   <String `men finns. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054834>
  <PgfTag `BrödIn'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `För en mer översiktlig bild av hur olika '>
  > # end of ParaLine
  <ParaLine 
   <String `länder i EU graderar olika läkemedels tra'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `fikfarlighet hänvisas till ICADTS lista '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 8Y2'>
    <MCurrPage `1315'>
    <Unique 1066888>
   > # end of Marker
   <String `(8)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` '>
  > # end of ParaLine
  <ParaLine 
   <String `(med förklaringar till graderingen '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 9Y2'>
    <MCurrPage `1315'>
    <Unique 1066895>
   > # end of Marker
   <String `(9)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `) eller '>
  > # end of ParaLine
  <ParaLine 
   <String `EU-projektet DRUID '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 10Y2'>
    <MCurrPage `1315'>
    <Unique 1066902>
   > # end of Marker
   <String `(10)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` – alla tillgängliga '>
  > # end of ParaLine
  <ParaLine 
   <String `via Internet. '>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1044064>
  <PgfTag `Rub1'>
  <ParaLine 
   <String `Läkemedels inverkan på vakenhet, '>
  > # end of ParaLine
  <ParaLine 
   <String `sensorik, motorik och kognition'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1029309>
  <PgfTag `Rub2efterRub1'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `T'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `läkemedel:trötthet och trafik;trötthet:läkemedel och trafik'>
    <MCurrPage `1315'>
    <Unique 1058056>
   > # end of Marker
   <String `rötthet'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1077145>
  <PgfTag `Bröd'>
  <ParaLine 
   <String `Trötthet är inte bara en mycket vanligt fö'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `rekommande biverkning av läkemedel utan '>
  > # end of ParaLine
  <ParaLine 
   <String `kan även vara en del av sjukdomsbilden el'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ler som i hypnotikagruppen (se särskilt av'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `snitt) den önskade effekten av läkemedlet '>
  > # end of ParaLine
  <ParaLine 
   <String `men med ”hangover” som innebär en ökad '>
  > # end of ParaLine
  <ParaLine 
   <String `olycksrisk. Det är självklart att trötthet, '>
  > # end of ParaLine
  <ParaLine 
   <String `vare sig symtomet är en biverkning eller '>
  > # end of ParaLine
  <ParaLine 
   <String `sjukdomsrelaterat, ska innebära körförbud. '>
  > # end of ParaLine
  <ParaLine 
   <String `En trafikolycka orsakad av en förares trött'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `het innebär i princip åtal för vårdslöshet i '>
  > # end of ParaLine
  <ParaLine 
   <String `trafik.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1077147>
  <PgfTag `Rub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Y'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `läkemedel:yrsel och trafik;yrsel:läkemedel och trafik'>
    <MCurrPage `1315'>
    <Unique 1077146>
   > # end of Marker
   <String `rsel'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1044123>
  <PgfTag `Bröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Yrsel – i klassisk bemärkelse med känsla av '>
  > # end of ParaLine
  <ParaLine 
   <String `rotation och tillhörande nystagmus, illamå'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ende och kräkningar – som är av den allvar'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `lighetsgrad att den inverkar på körförmå'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `gan är ovanlig som läkemedelsbiverkning. '>
  > # end of ParaLine
  <ParaLine 
   <String `När yrsel förekommer som biverkning är '>
  > # end of ParaLine
  <ParaLine 
   <String `det oftast mer frågan om allmän ostadighet, '>
  > # end of ParaLine
  <ParaLine 
   <String `osäkerhetskänsla etc och har i sig oftast '>
  > # end of ParaLine
  <ParaLine 
   <String `ingen inverkan på körförmågan.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1029343>
  <PgfTag `Rub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `S'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `läkemedel:synen och trafik;trafik:synen och läkemedel;syn:trafik'>
    <MCurrPage `1315'>
    <Unique 1058066>
   > # end of Marker
   <String `ynen'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1078691>
  <PgfTag `Bröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <Font 
    <FTag `'>
    <FDW  -0.25%>
    <FLocked No>
   > # end of Font
   <String `Synen är det sinne bland sensoriska funk'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tioner som för trafiksäkerheten är den i sär'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `klass viktigaste. Vid vissa glaukombehand'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `lingar eftersträvar man en pupillsamman'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `dragning (mios) som samtidigt innebär '>
  > # end of ParaLine
  <ParaLine 
   <String `klart försämrat seende i mörker eller vid då'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `lig (arbetsplats)belysning. Andra läkemedel'>
   <Font 
    <FTag `'>
    <FDW  -0.5%>
    <FLocked No>
   > # end of Font
   <String ` '>
  > # end of ParaLine
  <ParaLine 
   <String `kan förorsaka övergående dimsyn (ögonsal'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `vor). Vissa antiarytmika kan leda till blind'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `het '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 11Y2'>
    <MCurrPage `1315'>
    <Unique 1078692>
   > # end of Marker
   <String `(11,'>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 12Y2'>
    <MCurrPage `1315'>
    <Unique 1078693>
   > # end of Marker
   <String `12)'>
   <Font 
    <FTag `'>
    <FDW  -0.5%>
    <FLocked No>
   > # end of Font
   <String ` och många antiepileptika kan '>
  > # end of ParaLine
  <ParaLine 
   <String `påverka synfunktionen '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 13Y2'>
    <MCurrPage `1315'>
    <Unique 1078694>
   > # end of Marker
   <String `(13)'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FDW  -0.5%>
    <FLocked No>
   > # end of Font
   <String `.'>
   <Font 
    <FTag `'>
    <FDW  -0.5%>
    <FLocked No>
   > # end of Font
   <String ` En nyligen pu'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `blicerad översiktsartikel avseende psykotro'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `pa läkemedel och ögonpåverkan är värd att '>
  > # end of ParaLine
  <ParaLine 
   <TextRectID 148>
   <String `ta del av '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 14Y2'>
    <MCurrPage `1315'>
    <Unique 1078695>
   > # end of Marker
   <String `(14)'>
   <Font 
    <FTag `'>
    <FDW  -0.5%>
    <FLocked No>
   > # end of Font
   <String `. Även antiinflammatoriska lä'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `kemedel kan påverka synen'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 12Y2'>
    <MCurrPage `1315'>
    <Unique 1078696>
   > # end of Marker
   <String `(12,'>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 15Y2'>
    <MCurrPage `1315'>
    <Unique 1078697>
   > # end of Marker
   <String `15)'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
   <String `.'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` Natur'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `läkemedlen är inte att förglömma '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 12Y2'>
    <MCurrPage `1315'>
    <Unique 1078698>
   > # end of Marker
   <String `(12)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Pro'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tonpumpshämmare anses dock inte längre '>
  > # end of ParaLine
  <ParaLine 
   <String `påverka synen '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 16Y2'>
    <MCurrPage `1315'>
    <Unique 1078699>
   > # end of Marker
   <String `(16)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1052662>
  <PgfTag `Rub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `N'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `läkemedel:neuropati och trafik;trafik:neuropati och läkemedel;neuropati:trafik'>
    <MCurrPage `1315'>
    <Unique 1058071>
   > # end of Marker
   <String `europati och '>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `läkemedel:motorik och trafik;motorik:läkemedel och trafik'>
    <MCurrPage `1315'>
    <Unique 1058076>
   > # end of Marker
   <String `motorik'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1067427>
  <PgfTag `Bröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Neuropati och myopati har rapporterats '>
  > # end of ParaLine
  <ParaLine 
   <String `som biverkningar vid statinbehandling och '>
  > # end of ParaLine
  <ParaLine 
   <String `kan ha betydelse för förmågan att hantera '>
  > # end of ParaLine
  <ParaLine 
   <String `pedalerna vid bilkörning. Vid tveksamhet '>
  > # end of ParaLine
  <ParaLine 
   <String `bör bedömning av arbetsterapeut göras '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 17Y2'>
    <MCurrPage `1315'>
    <Unique 1067428>
   > # end of Marker
   <String `(17,'>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 18Y2'>
    <MCurrPage `1315'>
    <Unique 1067429>
   > # end of Marker
   <String `18)'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
   <String `.'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1067402>
  <PgfTag `BrödIn'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Nedsättningar i motoriken i form av '>
  > # end of ParaLine
  <ParaLine 
   <String `extra'>
   <Char DiscHyphen>
   <String `pyramidala symtom är en inte ovanlig '>
  > # end of ParaLine
  <ParaLine 
   <String `biverkning vid neuroleptikamedicinering '>
  > # end of ParaLine
  <ParaLine 
   <String `och har självklart betydelse för förmågan '>
  > # end of ParaLine
  <ParaLine 
   <String `att framföra fordon eller att utföra preci'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `sionsarbete.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1029388>
  <PgfTag `Rub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `K'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `kognitiv påverkan:läkemedel och trafik;trafik:kognitiv påverkan och läkemedel'>
    <MCurrPage `1315'>
    <Unique 1058081>
   > # end of Marker
   <String `ognitiv påverkan'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1087403>
  <PgfTag `Bröd'>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.NewCenturySchlbk LT Std.R.400'>
    <FFamily `NewCenturySchlbk LT Std'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `NewCenturySchlbkLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  9.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  -0.5%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `Kognitiv påverkan ses inte bara vid läkeme'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `delsbehandling som påverkar centrala nerv'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `systemet '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 19Y2'>
    <MCurrPage `1315'>
    <Unique 1087404>
   > # end of Marker
   <String `(19–21)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` utan kan exempelvis även '>
  > # end of ParaLine
  <ParaLine 
   <String `förekomma vid rubbningar i elektrolyt'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `balansen '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 22Y2'>
    <MCurrPage `1315'>
    <Unique 1087405>
   > # end of Marker
   <String `(22)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` som vid diuretikabehandling. '>
  > # end of ParaLine
  <ParaLine 
   <String `Nedsättning i kognitiva funktioner, där bl'>
   <Char HardSpace>
   <String `a '>
  > # end of ParaLine
  <ParaLine 
   <String `reaktionsförmågan ingår, anses idag vara '>
  > # end of ParaLine
  <ParaLine 
   <String `en mycket väsentlig orsak till trafikolyckor, '>
  > # end of ParaLine
  <ParaLine 
   <String `speciellt i äldregruppen. En olycklig följd av '>
  > # end of ParaLine
  <ParaLine 
   <String `läkemedelsinverkan på kognitiva funktio'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ner är att uppmätta effekter varar signifi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `kant längre än självskattning av påverkan '>
  > # end of ParaLine
  <ParaLine 
   <String `visar '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 23Y2'>
    <MCurrPage `1315'>
    <Unique 1087406>
   > # end of Marker
   <String `(23)'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
   <String `,'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` vilket också innebär ett trafiksä'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `kerhetsproblem. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1077170>
  <PgfTag `Rub3'>
  <ParaLine 
   <String `Individuell känslighet'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1077165>
  <PgfTag `Bröd'>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.NewCenturySchlbk LT Std.R.400'>
    <FFamily `NewCenturySchlbk LT Std'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `NewCenturySchlbkLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  9.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  -0.5%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `Vissa patienter är mer känsliga än andra för '>
  > # end of ParaLine
  <ParaLine 
   <String `sidoeffekter av läkemedel, varför det ALL'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `TID måste ske en individuell bedömning '>
  > # end of ParaLine
  <ParaLine 
   <String `även om studierna inte visar på försämring'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ar/nedsättningar i kognitiva funktioner el'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ler körförmåga. En god tumregel kan vara '>
  > # end of ParaLine
  <ParaLine 
   <String `att uppmana patienten att avstå från bilkör'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ning de närmaste dagarna/veckorna efter '>
  > # end of ParaLine
  <ParaLine 
   <String `insättning eller doshöjning av ett läkemedel '>
  > # end of ParaLine
  <ParaLine 
   <String `för att eventuella biverkningar ska visa sig '>
  > # end of ParaLine
  <ParaLine 
   <String `och klinga av.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1027249>
  <PgfTag `Rub1'>
  <PgfReferenced Yes>
  <ParaLine 
   <TextRectID 149>
   <String `M'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `trafik:körtestmetoder;körtestmetoder, läkemedel'>
    <MCurrPage `1316'>
    <Unique 1058086>
   > # end of Marker
   <String `etoder att avgöra '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `läkemedels inverkan på förmågan '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `till säker bilkörning'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1077184>
  <PgfTag `Bröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Ett praktiskt körtest kan vid första anblick'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `en vara det ideala testet för att avgöra i vad '>
  > # end of ParaLine
  <ParaLine 
   <String `mån ett läkemedel inverkar på körförmåga/'>
  > # end of ParaLine
  <ParaLine 
   <String `trafiksäkerhet. Ett sådant körtest kan dock '>
  > # end of ParaLine
  <ParaLine 
   <String `bara vara ett stickprov. Det är nämligen '>
  > # end of ParaLine
  <ParaLine 
   <String `inte alls säkert att det inträffar några kri'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tiska situationer där förarens kognitiva för'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `mågor sätts på prov även om själva färdvä'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `gen är standardiserad. En viss form av '>
  > # end of ParaLine
  <ParaLine 
   <String `standardiserat körtest på motorväg har i '>
  > # end of ParaLine
  <ParaLine 
   <String `brist på bättre ofta använts i just läkeme'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `delsstudier, men är mera ett mått på hur '>
  > # end of ParaLine
  <ParaLine 
   <String `man hanterar fordonet. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1079484>
  <PgfTag `BrödIn'>
  <ParaLine 
   <String `I framför allt Nederländerna använder '>
  > # end of ParaLine
  <ParaLine 
   <String `man sedan många år tillbaka ett praktiskt '>
  > # end of ParaLine
  <ParaLine 
   <String `körtest på motorväg (10 mil) där man konti'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `nuerligt mäter fordonets hastighetsvaria'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tioner och placering (lateralposition) på '>
  > # end of ParaLine
  <ParaLine 
   <String `vägbanan. Resultaten jämförs sedan med '>
  > # end of ParaLine
  <ParaLine 
   <String `vad förare med olika grad av alkoholpåver'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `kan presterar och man kan exempelvis på '>
  > # end of ParaLine
  <ParaLine 
   <String `så sätt avgöra om en förare vinglar mer el'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ler mindre än en alkoholpåverkan motsva'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `rande 0,5‰ BAC, den i Europa vanligaste '>
  > # end of ParaLine
  <ParaLine 
   <String `gränsen för rattfylleri. När man därför i '>
  > # end of ParaLine
  <ParaLine 
   <String `studier säger att ingen signifikant påver'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `kan kan påvisas sker detta oftast i relation '>
  > # end of ParaLine
  <ParaLine 
   <String `till 0,5‰ och inte till 0,2‰, som i Sverige är '>
  > # end of ParaLine
  <ParaLine 
   <String `gränsen för alkoholpåverkan. Ibland kan '>
  > # end of ParaLine
  <ParaLine 
   <String `jämförelse ske mot 0,8‰. Slutsatserna i '>
  > # end of ParaLine
  <ParaLine 
   <String `studierna är därför inte direkt applicerbara '>
  > # end of ParaLine
  <ParaLine 
   <String `på svenska förhållanden mer än i så motto '>
  > # end of ParaLine
  <ParaLine 
   <String `att signifikant påverkan alltid är påverkan '>
  > # end of ParaLine
  <ParaLine 
   <String `i förhållande till svenska gränser. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1077190>
  <PgfTag `BrödIn'>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.NewCenturySchlbk LT Std.R.400'>
    <FFamily `NewCenturySchlbk LT Std'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `NewCenturySchlbkLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  9.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  -0.5%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
  > # end of Pgf
  <ParaLine 
   <String `Studierna är oftast gjorda lege artis med '>
  > # end of ParaLine
  <ParaLine 
   <String `placebokontrollerad, dubbelblind, randomi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `serad cross over-design. Få studier finns '>
  > # end of ParaLine
  <ParaLine 
   <String `med äldre (65 år eller äldre) deltagare och '>
  > # end of ParaLine
  <ParaLine 
   <String `unga försökspersoner är oftast friska och '>
  > # end of ParaLine
  <ParaLine 
   <String `utan den sjukdom läkemedlet avser att be'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `handla. Undantag är studier med neurolep'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tika, migränläkemedel, antiepileptika och '>
  > # end of ParaLine
  <ParaLine 
   <String `diabetesläkemedel. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1078745>
  <PgfTag `BrödIn'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Då körning på väg i påverkat tillstånd '>
  > # end of ParaLine
  <ParaLine 
   <String `innebär en olycksrisk har man exempelvis i '>
  > # end of ParaLine
  <ParaLine 
   <String `Sverige utfört tester i bilsimulator, men '>
  > # end of ParaLine
  <ParaLine 
   <String `denna typ av studier är ovanlig pga höga si'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `mulatorkostnader '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 24Y2'>
    <MCurrPage `1316'>
    <Unique 1078747>
   > # end of Marker
   <String `(24)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Ett annat förfa'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ringssätt kan vara att med samma studie'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `design låta försökspersonerna köra på väg '>
  > # end of ParaLine
  <ParaLine 
   <TextRectID 149>
   <String `tillsammans med en trafikinspektör (eller '>
  > # end of ParaLine
  <ParaLine 
   <String `motsvarande) med utfallet godkänd/under'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `känd.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1082469>
  <PgfTag `BrödIn'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `I studier från framför allt Tyskland och '>
  > # end of ParaLine
  <ParaLine 
   <String `Österrike använder man sig oftast av ett '>
  > # end of ParaLine
  <ParaLine 
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `trafik:kognitivt testbatteri'>
    <MCurrPage `1316'>
    <Unique 1082470>
   > # end of Marker
   <String `kognitivt testbatteri (WTS, se under Tester, '>
  > # end of ParaLine
  <ParaLine 
   <String `s'>
   <Char HardSpace>
   <XRef 
    <XRefName `Page'>
    <XRefSrcText `55866: Rub2: Tester\x0d '>
    <XRefSrcIsElem No>
    <XRefSrcFile `'>
    <XRefLastUpdate  1382866575 931000>
    <XRefSrcElemNonUniqueId `'>
    <XRefAltText `'>
    <XRefApiClient 
     <XRefClientName `'>
     <XRefClientType `'>
    > # end of XRefApiClient
    <Unique 1082475>
   > # end of XRef
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <String `1363'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <XRefEnd >
   <String `) som även används för att avgöra '>
  > # end of ParaLine
  <ParaLine 
   <String `fortsatt körkortsinnehav. Här har man satt '>
  > # end of ParaLine
  <ParaLine 
   <String `gränsen för olämplighet vid den nedre 16:e '>
  > # end of ParaLine
  <ParaLine 
   <String `percentilen i testresultat från en normal'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `population. I andra studier använder man '>
  > # end of ParaLine
  <ParaLine 
   <String `sig av ett testbatteri av '>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `trafik:neuropsykologiska tester'>
    <MCurrPage `1316'>
    <Unique 1082471>
   > # end of Marker
   <String `neuropsykologiska '>
  > # end of ParaLine
  <ParaLine 
   <String `tester, ett för ändamålet sammansatt test'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `batteri, där resultaten jämförs med en kon'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `trollgrupp eller resultat från personer un'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `der viss alkoholpåverkan – vanligtvis 0,5‰. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1087417>
  <PgfTag `BrödIn'>
  <ParaLine 
   <String `Genom registerstudier med samkörning '>
  > # end of ParaLine
  <ParaLine 
   <String `av förskrivnings-/expeditionsregister och '>
  > # end of ParaLine
  <ParaLine 
   <String `olycksregister kan man göra uppskattning'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ar av ett läkemedels trafikfarlighet, vilket '>
  > # end of ParaLine
  <ParaLine 
   <String `bl'>
   <Char HardSpace>
   <String `a har skett i Norge. Nackdelen med den'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `na typ av studier är att man aldrig kan veta '>
  > # end of ParaLine
  <ParaLine 
   <String `i vilken omfattning patienten verkligen tog '>
  > # end of ParaLine
  <ParaLine 
   <String `sitt läkemedel. Metoden ger snarast en un'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `derskattning av riskerna. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1087418>
  <PgfTag `BrödIn'>
  <ParaLine 
   <String `Alla metoderna har sina för- och nack'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `delar, och någon metod som är överlägsen '>
  > # end of ParaLine
  <ParaLine 
   <String `de övriga finns inte.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1027255>
  <PgfTag `Rub2'>
  <Pgf 
   <PgfSpBefore  13.5 pt>
  > # end of Pgf
  <ParaLine 
   <String `Vid osäkerhet om bilkörningslämplighet'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1044220>
  <PgfTag `Bröd'>
  <ParaLine 
   <String `Vid misstanke om kognitiv påverkan av lä'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `kemedel kan neuropsykologisk testning '>
  > # end of ParaLine
  <ParaLine 
   <String `vara aktuell innan patienten tillåts köra '>
  > # end of ParaLine
  <ParaLine 
   <String `bil. Sådana tester kan göras vid trafikmedi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `cinska centrum, enheter eller motsvarande. '>
  > # end of ParaLine
  <ParaLine 
   <String `En testning tar vanligtvis 2–3 timmar och '>
  > # end of ParaLine
  <ParaLine 
   <String `omfattar reaktionsförmåga under olika för'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `utsättningar, uppfattningsförmåga, minne, '>
  > # end of ParaLine
  <ParaLine 
   <String `spatial förmåga, exekutiva funktioner, väg'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `märkeskunskap, UFOV (useful field of '>
  > # end of ParaLine
  <ParaLine 
   <String `view), samt beteendeobservationer inklusi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ve bedömning av omdöme och förmåga till '>
  > # end of ParaLine
  <ParaLine 
   <String `sjukdomsinsikt. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1044287>
  <PgfTag `BrödIn'>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.NewCenturySchlbk LT Std.R.400'>
    <FFamily `NewCenturySchlbk LT Std'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `NewCenturySchlbkLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  9.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  -0.5%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `Det är viktigt att patienten tar sina ordi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `nerade läkemedel inför testningen som van'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ligtvis avslutas med blodprovstagning för '>
  > # end of ParaLine
  <ParaLine 
   <String `att verifiera att läkemedlet verkligen tagits. '>
  > # end of ParaLine
  <ParaLine 
   <String `Att blodprovet tas efter testningen medför '>
  > # end of ParaLine
  <ParaLine 
   <String `att utlåtandet kan relateras till den under '>
  > # end of ParaLine
  <ParaLine 
   <String `testtillfället lägsta läkemedelskoncentratio'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `nen. Ett testutlåtande kan då utmynna i '>
  > # end of ParaLine
  <ParaLine 
   <String `”NN uppvisar i testning ingen kognitiv på'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `verkan vid läkemedelskoncentrationen X”. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1067492>
  <PgfTag `BrödIn'>
  <PgfReferenced Yes>
  <ParaLine 
   <TextRectID 150>
   <String `Neuropsykologiska tester kan inte uppre'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `pas med kortare intervall än 6 månader pga '>
  > # end of ParaLine
  <ParaLine 
   <String `inlärningseffekter. Råd och anvisningar för '>
  > # end of ParaLine
  <ParaLine 
   <String `testning finns i boken ”Kognitiva bedöm'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ningar i körkortsmedicinsk utredning” utgi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ven på Psykologiförlaget, 2003, artikelnum'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `mer 768-001.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1027258>
  <PgfTag `Rub1'>
  <ParaLine 
   <String `Läkemedel och trafik'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1044330>
  <PgfTag `Bröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Genomgången av olika läkemedelssubstan'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ser grundar sig på sökningar i framför allt '>
  > # end of ParaLine
  <ParaLine 
   <String `PubMed med följande sökstrategi: ”aktuellt '>
  > # end of ParaLine
  <ParaLine 
   <String `substansnamn” AND (cognition OR driving '>
  > # end of ParaLine
  <ParaLine 
   <String `OR accident OR automobile OR impair'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ment) och fångar på så sätt upp merparten '>
  > # end of ParaLine
  <ParaLine 
   <String `av vetenskapliga publikationer inom områ'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `det. Det finns dock institutionella rapporter '>
  > # end of ParaLine
  <ParaLine 
   <String `som inte är indexerade och som funnits med '>
  > # end of ParaLine
  <ParaLine 
   <String `i artiklars referenslistor men som varit svå'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ra att få fram. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1067511>
  <PgfTag `BrödIn'>
  <ParaLine 
   <String `Trafikvarningstexterna i Fass kan inne'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `hålla kunskap som framkommit i samband '>
  > # end of ParaLine
  <ParaLine 
   <String `med utprovning av ett läkemedel men som '>
  > # end of ParaLine
  <ParaLine 
   <String `inte publicerats vetenskapligt varför det '>
  > # end of ParaLine
  <ParaLine 
   <String `starkt rekommenderas att även ta del av '>
  > # end of ParaLine
  <ParaLine 
   <String `den texten vid förskrivning.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1087454>
  <PgfTag `BrödIn'>
  <PgfReferenced Yes>
  <ParaLine 
   <Font 
    <FTag `'>
    <FDW  -0.5%>
    <FLocked No>
   > # end of Font
   <String `Många studier är gjorda med i storleks'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ordningen 10–20 individer där man kan '>
  > # end of ParaLine
  <ParaLine 
   <String `ifrågasätta hur pass representativa de är '>
  > # end of ParaLine
  <ParaLine 
   <String `och i vad mån slumpen har lett till signifi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `kanta skillnader. Likaså förekommer det att '>
  > # end of ParaLine
  <ParaLine 
   <String `man gör många olika neuropsykologiska '>
  > # end of ParaLine
  <ParaLine 
   <String `tester i samma försöksomgång där man inte '>
  > # end of ParaLine
  <ParaLine 
   <String `kompenserat för ”multiple testing”. Sådana '>
  > # end of ParaLine
  <ParaLine 
   <String `studier redovisas också eftersom det de facto '>
  > # end of ParaLine
  <ParaLine 
   <String `har konstaterats att individer har påver'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `kats av ett läkemedel på ett sådant sätt att '>
  > # end of ParaLine
  <ParaLine 
   <String `det kan ha betydelse för trafiksäkerheten. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1087459>
  <PgfTag `BrödIn'>
  <ParaLine 
   <String `Det är viktigt att bedömning sker på indi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `vidnivå. Även om ett läkemedel ger signifi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `kant påverkan på gruppnivå kan det finnas '>
  > # end of ParaLine
  <ParaLine 
   <String `enstaka individer som inte blir påverkade '>
  > # end of ParaLine
  <ParaLine 
   <String `liksom det omvända, dvs individpåverkan '>
  > # end of ParaLine
  <ParaLine 
   <String `finns men ingen signifikant påverkan har '>
  > # end of ParaLine
  <ParaLine 
   <String `setts på gruppnivå. Detta kan exemplifieras '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `'>
    <FDW  -0.5%>
    <FLocked No>
   > # end of Font
   <String `med att personer som pga kraftig påverkan '>
  > # end of ParaLine
  <ParaLine 
   <String `av ett läkemedel inte kan genomföra ett kör'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `test exkluderas från beräkningar och resul'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tat. Föreliggande genomgång av litteratu'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ren ger förhoppningsvis ändå ett stöd åt för'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `skrivaren med referenser att fördjupa sig i.'>
   <Font 
    <FTag `'>
    <FDW  -1.0%>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1052810>
  <PgfTag `Rub1'>
  <ParaLine 
   <TextRectID 150>
   <String `Läkemedelsgrupper '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1052830>
  <PgfTag `Rub2efterRub1'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `A04 – '>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `antiemetika:trafik'>
    <MCurrPage `1317'>
    <Unique 1058111>
   > # end of Marker
   <String `antiemetika'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1052834>
  <PgfTag `Rub2efterRub1'>
  <ParaLine 
   <String `Sammanfattning'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1079526>
  <PgfTag `Bröd'>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.NewCenturySchlbk LT Std.R.400'>
    <FFamily `NewCenturySchlbk LT Std'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `NewCenturySchlbkLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  9.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  -1.4%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `Serotoninreceptorantagonister förefaller in'>
   <Char DiscHyphen>
   <String `te '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `'>
    <FDW  0.0%>
    <FLocked No>
   > # end of Font
   <String `påverka körförmågan i negativ riktning '>
  > # end of ParaLine
  <ParaLine 
   <String `medan skopolamin uppvisar klara antiko'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `linerga effekter '>
   <Font 
    <FTag `'>
    <FDW  0.0%>
    <FLocked No>
    <FSeparation 4>
    <FColor `Blue'>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 25Y2'>
    <MCurrPage `1317'>
    <Unique 1081538>
   > # end of Marker
   <String `(25,'>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 26Y2'>
    <MCurrPage `1317'>
    <Unique 1081547>
   > # end of Marker
   <String `26)'>
   <Font 
    <FTag `'>
    <FDW  0.0%>
    <FLocked No>
   > # end of Font
   <String `.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1079527>
  <PgfTag `Rub2'>
  <ParaLine 
   <String `Rekommendationer'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1053014>
  <PgfTag `Bröd'>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.NewCenturySchlbk LT Std.R.400'>
    <FFamily `NewCenturySchlbk LT Std'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `NewCenturySchlbkLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  9.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  -0.5%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <Font 
    <FTag `'>
    <FDW  0.0%>
    <FLocked No>
   > # end of Font
   <String `Serotoninreceptorantagonisterna har vis'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `serligen inte indikationen åksjuka, men ett '>
  > # end of ParaLine
  <ParaLine 
   <String `sådant läkemedel kan vara värt att prova '>
  > # end of ParaLine
  <ParaLine 
   <String `för bilförare som är i behov av åksjukeläke'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `medel eftersom de preparat som har indika'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tionen åksjuka ger negativ inverkan på '>
  > # end of ParaLine
  <ParaLine 
   <String `testresultat och körförmåga. '>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1053015>
  <PgfTag `Rub2'>
  <ParaLine 
   <String `Läs vidare'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1056336>
  <PgfTag `RefTextNr1'>
  <PgfNumString `1.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Transdermal scopolamine: A review of its effects '>
  > # end of ParaLine
  <ParaLine 
   <String `upon motion sickness, psychological performan'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ce and physiological functioning '>
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 25Y2'>
    <MCurrPage `1317'>
    <Unique 1081553>
   > # end of Marker
   <String `(25)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. (En över'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `siktsartikel från 1989.) '>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1056356>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `2.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Scopolamine (hyoscine) for preventing and trea'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `ting motion sickness '>
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 26Y2'>
    <MCurrPage `1317'>
    <Unique 1081560>
   > # end of Marker
   <String `(26).'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` (En Cochrane-översikt '>
  > # end of ParaLine
  <ParaLine 
   <String `från 2009.)'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1056357>
  <PgfTag `Rub2'>
  <ParaLine 
   <String `Enskilda preparat'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1067538>
  <PgfTag `Rub3efterRub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `S'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `SSRI:trafik'>
    <MCurrPage `1317'>
    <Unique 1067537>
   > # end of Marker
   <String `erotoninreceptorantagonister'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1067540>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Serotoninreceptorantagonister ('>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `ondansetron:trafik'>
    <MCurrPage `1317'>
    <Unique 1067539>
   > # end of Marker
   <String `ondanse'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tron, '>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `granisetron:trafik'>
    <MCurrPage `1317'>
    <Unique 1067541>
   > # end of Marker
   <String `granisetron och '>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `tropisetron:trafik'>
    <MCurrPage `1317'>
    <Unique 1067542>
   > # end of Marker
   <String `tropisetron) ger sna'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `rast en förbättring än en försämring av kog'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `nitiva funktioner  '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 27Y2'>
    <MCurrPage `1317'>
    <Unique 1081567>
   > # end of Marker
   <String `(27)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Ondansetron 1 och 4 '>
  > # end of ParaLine
  <ParaLine 
   <String `mg till friska försökspersoner har studerats '>
  > # end of ParaLine
  <ParaLine 
   <String `vid körning på väg och befunnits sakna på'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `verkan – helt jämförbart med placebo '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 28Y2'>
    <MCurrPage `1317'>
    <Unique 1081574>
   > # end of Marker
   <String `(28)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1078802>
  <PgfTag `PrepBröd'>
  <Pgf 
   <PgfFIndent  6.0 mm>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `Yrsel och stört seende rapporterades ofta'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `re med ondansetron (4,2%) än med grani'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `setron (0,6%) '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 29Y2'>
    <MCurrPage `1317'>
    <Unique 1081583>
   > # end of Marker
   <String `(29)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1053023>
  <PgfTag `Rub3efterRub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `A'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `aprepitant:trafik'>
    <MCurrPage `1317'>
    <Unique 1058131>
   > # end of Marker
   <String `prepitant'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1053024>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Aprepitant gavs som en engångsdos, 125 mg, '>
  > # end of ParaLine
  <ParaLine 
   <String `till friska försökspersoner och jämfördes '>
  > # end of ParaLine
  <ParaLine 
   <String `med placebo. Aprepitant gav nedsatt emotio'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `nellt minne och långsammare ansiktsigen'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `känning '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 30Y2'>
    <MCurrPage `1317'>
    <Unique 1067048>
   > # end of Marker
   <String `(30).'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1052844>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `S'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `skopolamin:trafik'>
    <MCurrPage `1317'>
    <Unique 1058140>
   > # end of Marker
   <String `kopolamin'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1067675>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Skopolamin transdermalt (72-timmarsplås'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ter) kan, förutom ackommodationsstörning'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ar och trötthet, ge nedsättningar i inlärning/'>
  > # end of ParaLine
  <ParaLine 
   <String `minne och uppmärksamhet '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 28Y2'>
    <MCurrPage `1317'>
    <Unique 1067676>
   > # end of Marker
   <String `(28,'>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 31Y2'>
    <MCurrPage `1317'>
    <Unique 1067677>
   > # end of Marker
   <String `31,'>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 32Y2'>
    <MCurrPage `1317'>
    <Unique 1081591>
   > # end of Marker
   <String `32).'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054898>
  <PgfTag `Rub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <TextRectID 151>
   <String `A10 –'>
   <Font 
    <FTag `'>
    <FPlatformName `W.NewCenturySchlbk LT Std.R.400'>
    <FFamily `NewCenturySchlbk LT Std'>
    <FWeight `Regular'>
    <FPostScriptName `NewCenturySchlbkLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  9.0 pt>
    <FLocked No>
   > # end of Font
   <String ` '>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `blodglukosnivå:trafik;trafik:blodglukosnivå'>
    <MCurrPage `1318'>
    <Unique 1058145>
   > # end of Marker
   <String `blodglukosnivå och körförmåga '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1077284>
  <PgfTag `Bröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Såväl '>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `hyperglykemi:trafik'>
    <MCurrPage `1318'>
    <Unique 1077281>
   > # end of Marker
   <String `hyperglykemi '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 33Y2'>
    <MCurrPage `1318'>
    <Unique 1077282>
   > # end of Marker
   <String `(33–35)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` som '>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `hypoglykemi:trafik'>
    <MCurrPage `1318'>
    <Unique 1077283>
   > # end of Marker
   <String `hypogly'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `kemi '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 34Y2'>
    <MCurrPage `1318'>
    <Unique 1077285>
   > # end of Marker
   <String `(34–36)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` påverkar kognitiva funktio'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ner som i sin tur är av största betydelse för '>
  > # end of ParaLine
  <ParaLine 
   <String `säkerheten vid bilkörning. Vid hyperglyke'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `mi (blodglukos \>'>
   <Char HardSpace>
   <String `15 mmol/L, både typ 1- och  '>
  > # end of ParaLine
  <ParaLine 
   <String `2-diabetes) ser man vid upprepade mät'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ningar över tiden ofta förlångsamning av '>
  > # end of ParaLine
  <ParaLine 
   <String `hjärnans processhastighet '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 33Y2'>
    <MCurrPage `1318'>
    <Unique 1077286>
   > # end of Marker
   <String `(33,'>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 34Y2'>
    <MCurrPage `1318'>
    <Unique 1081599>
   > # end of Marker
   <String `34),'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` medan '>
  > # end of ParaLine
  <ParaLine 
   <String `en experimentell studie med en mätning vid '>
  > # end of ParaLine
  <ParaLine 
   <String `ett tillfälle i ett test på barn med typ 1-dia'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `betes inte visade någon sådan försämring '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 37Y2'>
    <MCurrPage `1318'>
    <Unique 1077287>
   > # end of Marker
   <String `(37)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Inte heller experiment med clamp'>
   <FNote 200>
   <String `-'>
  > # end of ParaLine
  <ParaLine 
   <String `teknik med flera neuropsykologiska tester '>
  > # end of ParaLine
  <ParaLine 
   <String `visade någon försämring vid 14–21 mmol/L '>
  > # end of ParaLine
  <ParaLine 
   <String `jämfört med värden av blodglukos vid base'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `line = 8,9 mmol/L '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 38Y2'>
    <MCurrPage `1318'>
    <Unique 1077292>
   > # end of Marker
   <String `(38)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Däremot sågs en på'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `taglig försämring vid 2,2 mmol/L. Experi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ment med clamp-teknik vid typ 2-diabetes '>
  > # end of ParaLine
  <ParaLine 
   <String `med baseline-blodglukos 4,5 mmol/L gav en '>
  > # end of ParaLine
  <ParaLine 
   <String `negativ påverkan på processhastighet, min'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ne och uppmärksamhet vid blodglukos på '>
  > # end of ParaLine
  <ParaLine 
   <String `16 mmol/L '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 39Y2'>
    <MCurrPage `1318'>
    <Unique 1077293>
   > # end of Marker
   <String `(39)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1077308>
  <PgfTag `BrödIn'>
  <ParaLine 
   <String `Påverkan vid hyperglykemi är generellt '>
  > # end of ParaLine
  <ParaLine 
   <String `mindre än vid hypoglykemi '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 35Y2'>
    <MCurrPage `1318'>
    <Unique 1077309>
   > # end of Marker
   <String `(35)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` men några '>
  > # end of ParaLine
  <ParaLine 
   <String `studier avseende blodglukos \>'>
   <Char HardSpace>
   <String `22 mmol/L '>
  > # end of ParaLine
  <ParaLine 
   <String `har inte hittats vid litteratursökningen. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1044452>
  <PgfTag `BrödIn'>
  <PgfReferenced Yes>
  <ParaLine 
   <Font 
    <FTag `'>
    <FDW  -0.5%>
    <FLocked No>
   > # end of Font
   <String `Vid körning i en enkel bilsimulator vid typ '>
  > # end of ParaLine
  <ParaLine 
   <String `1-'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `diabetes:trafik;trafik:diabetes'>
    <MCurrPage `1318'>
    <Unique 1058160>
   > # end of Marker
   <String `diabetes konstaterades att körförmågan '>
  > # end of ParaLine
  <ParaLine 
   <String `började försämras redan vid 3,6 mmol/L '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `men att flera förare inte var medvetna om '>
  > # end of ParaLine
  <ParaLine 
   <String `hypoglykemin och därmed inte heller kun'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `de vidta glukoshöjande åtgärder '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 40Y2'>
    <MCurrPage `1318'>
    <Unique 1067118>
   > # end of Marker
   <String `(40)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Re'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `kommendationen var att inte börja köra '>
  > # end of ParaLine
  <ParaLine 
   <String `med blodglukos <'>
   <Char HardSpace>
   <String `4,5 mmol/L och att avbry'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ta körning vid <'>
   <Char HardSpace>
   <String `4,0 mmol/L '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 41Y2'>
    <MCurrPage `1318'>
    <Unique 1067125>
   > # end of Marker
   <String `(41)'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
   <String `.'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1079546>
  <PgfTag `BrödIn'>
  <PgfReferenced Yes>
  <ParaLine 
   <Font 
    <FTag `'>
    <FDW  -1.0%>
    <FLocked No>
   > # end of Font
   <String `I en annan studie fick personer med typ 1-'>
  > # end of ParaLine
  <ParaLine 
   <String `diabetes (n = 37) köra i en mer kvalificerad '>
  > # end of ParaLine
  <ParaLine 
   <String `bilsimulator vid olika blodglukosnivåer och '>
  > # end of ParaLine
  <ParaLine 
   <String `resultaten jämfördes med ”egen” körning vid '>
  > # end of ParaLine
  <ParaLine 
   <String `6 mmol/L. Körförmågan försämrades redan i '>
  > # end of ParaLine
  <ParaLine 
   <String `området 4,0–3,4 mmol/L medan sockerkorri'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `gerande'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` åtgärder vidtogs först vid ≤ 2,8 '>
  > # end of ParaLine
  <ParaLine 
   <String `mmol/L. Författarna rekommenderar att '>
  > # end of ParaLine
  <ParaLine 
   <String `inte börja körning vid blodglukos <'>
   <Char HardSpace>
   <String `4–5 '>
  > # end of ParaLine
  <ParaLine 
   <String `mmol/L utan förebyggande behandling '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 42Y2'>
    <MCurrPage `1318'>
    <Unique 1079547>
   > # end of Marker
   <String `(42)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1067711>
  <PgfTag `BrödIn'>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.NewCenturySchlbk LT Std.R.400'>
    <FFamily `NewCenturySchlbk LT Std'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `NewCenturySchlbkLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  9.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  -0.5%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `Många kör trots hypoglykemi, inte bara '>
  > # end of ParaLine
  <ParaLine 
   <String `vid typ 1-diabetes utan även vid typ 2-diabe'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <TextRectID 151>
   <String `tes '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 43Y2'>
    <MCurrPage `1318'>
    <Unique 1067712>
   > # end of Marker
   <String `(43)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Med BGAT (Blood Glucose Aware'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ness Training) kan man reducera olycksin'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `blandning och episoder med hypoglykemi '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 44Y2'>
    <MCurrPage `1318'>
    <Unique 1067713>
   > # end of Marker
   <String `(44,'>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 45Y2'>
    <MCurrPage `1318'>
    <Unique 1067714>
   > # end of Marker
   <String `45)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Viktigt att komma ihåg är att även '>
  > # end of ParaLine
  <ParaLine 
   <String `efter det att man vidtagit åtgärder mot hy'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `poglykemin och återställt blodglukosnivån '>
  > # end of ParaLine
  <ParaLine 
   <String `finns fortfarande en kognitiv nedsättning '>
  > # end of ParaLine
  <ParaLine 
   <String `trots att hypoglykemisymtomen i övrigt har '>
  > # end of ParaLine
  <ParaLine 
   <String `försvunnit '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 46Y2'>
    <MCurrPage `1318'>
    <Unique 1067715>
   > # end of Marker
   <String `(46)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. För vissa neuropsykologiska '>
  > # end of ParaLine
  <ParaLine 
   <String `tester, t'>
   <Char HardSpace>
   <String `ex valreaktionstid, är det mer än en '>
  > # end of ParaLine
  <ParaLine 
   <String `timmes fördröjning efter restitution av blod'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `glukosnivån '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 47Y2'>
    <MCurrPage `1318'>
    <Unique 1067716>
   > # end of Marker
   <String `(47)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. '>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1027270>
  <PgfTag `Rub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `A10A –'>
   <Font 
    <FTag `'>
    <FPlatformName `W.NewCenturySchlbk LT Std.R.400'>
    <FFamily `NewCenturySchlbk LT Std'>
    <FWeight `Regular'>
    <FPostScriptName `NewCenturySchlbkLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  9.0 pt>
    <FLocked No>
   > # end of Font
   <String ` '>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `insulin:trafik'>
    <MCurrPage `1318'>
    <Unique 1058165>
   > # end of Marker
   <String `insulin och '>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `glukagonanaloger:trafik'>
    <MCurrPage `1318'>
    <Unique 1058170>
   > # end of Marker
   <String `glukagonanaloger '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1027274>
  <PgfTag `Bröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Insulinbehandling innebär alltid en poten'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tiell risk för allvarliga hypoglykemier'>
   <FNote 201>
   <String ` med '>
  > # end of ParaLine
  <ParaLine 
   <String `successiv påverkan på kognitiva funktioner '>
  > # end of ParaLine
  <ParaLine 
   <String `och övergång till insulinkoma. Bilkörning '>
  > # end of ParaLine
  <ParaLine 
   <String `(körkortsinnehav) medges därför endast om '>
  > # end of ParaLine
  <ParaLine 
   <String `sjukdomen är välreglerad (TSFS 2010:125, '>
  > # end of ParaLine
  <ParaLine 
   <String `6 kap)'>
   <Font 
    <FTag `'>
    <FLocked No>
    <FSeparation 4>
    <FColor `Blue'>
   > # end of Font
   <String ` '>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 2Y2'>
    <MCurrPage `1318'>
    <Unique 1081620>
   > # end of Marker
   <String `(2)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1077377>
  <PgfTag `BrödIn'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `I en studie från 2009 noterades att bruk '>
  > # end of ParaLine
  <ParaLine 
   <String `av insulinpump ökar risken med 35% att bli '>
  > # end of ParaLine
  <ParaLine 
   <String `inblandad i ”driving mishaps” jämfört med '>
  > # end of ParaLine
  <ParaLine 
   <String `behandling med insulininjektioner '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 48Y2'>
    <MCurrPage `1318'>
    <Unique 1077378>
   > # end of Marker
   <String `(48)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. '>
  > # end of ParaLine
  <ParaLine 
   <String `Riskökning för en ny incident/kollision sågs '>
  > # end of ParaLine
  <ParaLine 
   <String `även vid förekomst av tidigare kollisioner, '>
  > # end of ParaLine
  <ParaLine 
   <String `svår hypoglykemi och hypoglykemirelate'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `rad ”driving mishap” '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 48Y2'>
    <MCurrPage `1318'>
    <Unique 1077385>
   > # end of Marker
   <String `(48)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Riskökning vid '>
  > # end of ParaLine
  <ParaLine 
   <String `historia av svår hypoglykemi (4 gånger) och '>
  > # end of ParaLine
  <ParaLine 
   <String `hög ålder vid diabetesdiagnos (1,3 gånger) '>
  > # end of ParaLine
  <ParaLine 
   <String `sågs även i en annan studie, som också no'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `terade ett signifikant samband mellan '>
  > # end of ParaLine
  <ParaLine 
   <String `sänkning av HbA'>
   <Font 
    <FTag `'>
    <FPosition FSubscript>
    <FLocked No>
   > # end of Font
   <String `1C'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` och ökad olycksrisk – '>
  > # end of ParaLine
  <ParaLine 
   <String `1,3 gånger per 1% reduktion av HbA'>
   <Font 
    <FTag `'>
    <FPosition FSubscript>
    <FLocked No>
   > # end of Font
   <String `1c'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 49Y2'>
    <MCurrPage `1318'>
    <Unique 1077379>
   > # end of Marker
   <String `(49)'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
   <String `.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1040501>
  <PgfTag `Rub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `A10B – perorala och '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `andra blodglukossänkande medel'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1044802>
  <PgfTag `Bröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Studier om trafiksäkerhet och perorala '>
  > # end of ParaLine
  <ParaLine 
   <String `antidiabetika saknas i stort sett. Den enda '>
  > # end of ParaLine
  <ParaLine 
   <String `funna studien berör äldre medel där kombi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `nationen sulfonylurea och metformin gav '>
  > # end of ParaLine
  <ParaLine 
   <String `en 1,3 (1,0–1,7) gånger ökad olycksrisk '>
  > # end of ParaLine
  <ParaLine 
   <String `medan monoterapi inte var relaterad till '>
  > # end of ParaLine
  <ParaLine 
   <String `någon olycksriskökning '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 50Y2'>
    <MCurrPage `1318'>
    <Unique 1073671>
   > # end of Marker
   <String `(50)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Mot den bak'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `grunden redovisas därför hypoglykemiföre'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `komst eftersom hypoglykemi är relaterad '>
  > # end of ParaLine
  <ParaLine 
   <String `till kognitiv nedsättning och därmed ökad '>
  > # end of ParaLine
  <ParaLine 
   <String `trafiksäkerhetsrisk. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1044807>
  <PgfTag `BrödIn'>
  <PgfReferenced Yes>
  <ParaLine 
   <TextRectID 152>
   <String `I en metaanalys av oönskade effekter vid '>
  > # end of ParaLine
  <ParaLine 
   <String `behandling av typ 2-diabetes sågs en signi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `fikant högre risk (5,3 gånger) för hypoglyke'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `mi vid samtidig behandling med metformin '>
  > # end of ParaLine
  <ParaLine 
   <String `och sulfonylurea '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 51Y2'>
    <MCurrPage `1319'>
    <Unique 1073679>
   > # end of Marker
   <String `(51)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Vid jämförelse över '>
  > # end of ParaLine
  <ParaLine 
   <String `tid mellan 4 olika tilläggspreparat sågs en '>
  > # end of ParaLine
  <ParaLine 
   <String `utjämning av risken efter 15 månaders be'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `handling, där repaglinid initialt hade dubb'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `la risken jämfört med rosiglitazon, pioglita'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `zon och nateglinid '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 52Y2'>
    <MCurrPage `1319'>
    <Unique 1073686>
   > # end of Marker
   <String `(52)'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
   <String `.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1040525>
  <PgfTag `Rub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Sammanfattning'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1087506>
  <PgfTag `Bröd'>
  <ParaLine 
   <String `Framför allt insulinbehandling ökar risken '>
  > # end of ParaLine
  <ParaLine 
   <String `för allvarlig hypoglykemi. I övrigt redovisas '>
  > # end of ParaLine
  <ParaLine 
   <String `oftast patientrapporterade hypoglykemi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `symtom och inte i alla studier fanns möjlig'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `het att verifiera hypoglykemin med mät'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ning av B-/P-glukos. Vanligtvis var hypogly'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `kemi bekräftad vid blodglukos <'>
   <Char HardSpace>
   <String `3,3 mmol/'>
  > # end of ParaLine
  <ParaLine 
   <String `L, ibland <'>
   <Char HardSpace>
   <String `2,2 mmol/L. Svår hypoglykemi '>
  > # end of ParaLine
  <ParaLine 
   <String `förelåg ibland vid blodglukos <'>
   <Char HardSpace>
   <String `2,2 mmol/L, '>
  > # end of ParaLine
  <ParaLine 
   <String `men avvikelser förekommer i studierna. '>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `Ibland avses med svår hypoglykemi att an'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `nan person har behövt hjälpa till för att '>
  > # end of ParaLine
  <ParaLine 
   <String `häva tillståndet.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1079616>
  <PgfTag `BrödIn'>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.NewCenturySchlbk LT Std.R.400'>
    <FFamily `NewCenturySchlbk LT Std'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `NewCenturySchlbkLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  9.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  -0.5%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `Metformin verkar ha en låg hypoglykemi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `frekvens, jämförbar med placebo, medan gli'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `benklamid förefaller ha en klart hög hypo'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `glykemifrekvens. De övriga tilläggsprepara'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ten förefaller ha en liten hypoglykemirisk, '>
  > # end of ParaLine
  <ParaLine 
   <String `jämförbar med placebo, vid samtidig be'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `handling med metformin, medan vid samti'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `dig insulinbehandling ökar hypoglykemi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `risken. Det finns indikationer på att lång'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `verkande medel kan ge ökad risk för äldre '>
  > # end of ParaLine
  <ParaLine 
   <String `personer. GLP-1-receptoragonisterna, fram'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `för allt liraglutid ensamt och i kombination '>
  > # end of ParaLine
  <ParaLine 
   <String `med metformin, förefaller ha en hypoglyke'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `mifrekvens jämförbar med placebo medan '>
  > # end of ParaLine
  <ParaLine 
   <String `frekvensen ökar vid samtidig behandling '>
  > # end of ParaLine
  <ParaLine 
   <String `med metformin + glimepirid '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 53Y2'>
    <MCurrPage `1319'>
    <Unique 1079617>
   > # end of Marker
   <String `(53,'>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 54Y2'>
    <MCurrPage `1319'>
    <Unique 1079618>
   > # end of Marker
   <String `54)'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
   <String `.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1045171>
  <PgfTag `Rub2'>
  <ParaLine 
   <String `Rekommendationer'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.700'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1077399>
  <PgfTag `Bröd'>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.NewCenturySchlbk LT Std.R.400'>
    <FFamily `NewCenturySchlbk LT Std'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `NewCenturySchlbkLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  9.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  -0.5%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
  > # end of Pgf
  <ParaLine 
   <String `Kunskapen hos patienten om hypoglykemi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `symtom är mycket viktig för att kunna und'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `vika bilkörning vid hypoglykemi. Egenmät'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ning av glukos inför bilkörning är att rekom'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `mendera för alla, inte bara för yrkesförare '>
  > # end of ParaLine
  <ParaLine 
   <String `(körkort C, CE, D, DE samt taxi) där egen'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `mätning av glukos inför och under färd nu'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `mera är ett krav.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1078820>
  <PgfTag `BrödIn'>
  <ParaLine 
   <String `Under tiden för upptitrering av ett läke'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `medel eller vid dosjusteringar uppåt bör pa'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <TextRectID 152>
   <String `tienten ha körförbud till dess att utvärde'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ring har skett.'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1067759>
  <PgfTag `BrödIn'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Glibenklamid bör undvikas vid nyinsätt'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ning till bilförare eftersom det finns flera '>
  > # end of ParaLine
  <ParaLine 
   <String `preparat med klart lägre frekvens av hypo'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `glykemier. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1067760>
  <PgfTag `Rub2'>
  <ParaLine 
   <String `Läs vidare'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1040533>
  <PgfTag `RefTextNr1'>
  <PgfNumString `1.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Diabetes and driving – desired data, research '>
  > # end of ParaLine
  <ParaLine 
   <String `methods and their pitfalls, current knowledge, '>
  > # end of ParaLine
  <ParaLine 
   <String `and future research '>
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 55Y2'>
    <MCurrPage `1319'>
    <Unique 1073708>
   > # end of Marker
   <String `(55).'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` (En översiktsartikel från '>
  > # end of ParaLine
  <ParaLine 
   <String `2006.)'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1040534>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `2.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Hypoglycaemia and cognitive function '>
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 36Y2'>
    <MCurrPage `1319'>
    <Unique 1073715>
   > # end of Marker
   <String `(36).'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `(En översiktsartikel från 2005.)'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1040535>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `3.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Risk of hypoglycaemia with oral antidiabetic '>
  > # end of ParaLine
  <ParaLine 
   <String `agents in patients with type 2 diabetes'>
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <String ` '>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 56Y2'>
    <MCurrPage `1319'>
    <Unique 1073722>
   > # end of Marker
   <String `(56).'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `(En översiktsartikel från 2003.)'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1040536>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `4.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Meglitinide analogues for type 2 diabetes melli'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tus '>
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 57Y2'>
    <MCurrPage `1319'>
    <Unique 1073729>
   > # end of Marker
   <String `(57).'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` (Cochrane-översikt från 2007.)'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1040537>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `5.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `A review of efficacy and safety data regarding '>
  > # end of ParaLine
  <ParaLine 
   <String `the use of liraglutide, a once-daily human gluca'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `gon-like peptide 1 analogue, in the treatment of '>
  > # end of ParaLine
  <ParaLine 
   <String `type 2 diabetes mellitus '>
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 58Y2'>
    <MCurrPage `1319'>
    <Unique 1073736>
   > # end of Marker
   <String `(58)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. (En översiktsartikel '>
  > # end of ParaLine
  <ParaLine 
   <String `från 2009.)'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1056360>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `6.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `The safety and tolerability of GLP-1 receptor ago'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `nists in the treatment of type 2-diabetes '>
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 59Y2'>
    <MCurrPage `1319'>
    <Unique 1073743>
   > # end of Marker
   <String `(59)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `(En översiktsartikel från 2010.)'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1087556>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `7.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `The safety and efficacy of liraglutide with or '>
  > # end of ParaLine
  <ParaLine 
   <String `with'>
   <Char DiscHyphen>
   <String `out oral antidiabetic drug therapy in type '>
  > # end of ParaLine
  <ParaLine 
   <String `2'>
   <Char HardSpace>
   <String `diabetes: an overview of the LEAD 1–5 studies '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 60Y2'>
    <MCurrPage `1319'>
    <Unique 1087557>
   > # end of Marker
   <String `(60).'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` (LEAD-översikt från 2009.) '>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1056368>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `8.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Font 
    <FTag `'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <String `Selecting GLP-1 agonists in the management of '>
  > # end of ParaLine
  <ParaLine 
   <String `type 2 diabetes: differential pharmacology and '>
  > # end of ParaLine
  <ParaLine 
   <String `therapeutic benefits of liraglutide and exenatide '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 61Y2'>
    <MCurrPage `1319'>
    <Unique 1073757>
   > # end of Marker
   <String `(61)'>
   <Font 
    <FTag `'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <String `. '>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `(En översiktsartikel från 2010.)'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1056369>
  <PgfTag `Rub2'>
  <ParaLine 
   <String `Enskilda preparat'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1029071>
  <PgfTag `Rub3efterRub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `E'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `exenatid:trafik'>
    <MCurrPage `1319'>
    <Unique 1058215>
   > # end of Marker
   <String `xenatid'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1067843>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Exenatid injicerat i suicidsyfte, 10 gånger '>
  > # end of ParaLine
  <ParaLine 
   <String `ordinerad dos, gav ingen hypoglykemi '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 62Y2'>
    <MCurrPage `1319'>
    <Unique 1073764>
   > # end of Marker
   <String `(62),'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` '>
  > # end of ParaLine
  <ParaLine 
   <String `medan studier av exenatid i kombination '>
  > # end of ParaLine
  <ParaLine 
   <String `med metformin, insulin och/eller sulfonyl'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `urea (SU) gav hypoglykemier hos mellan 5 '>
  > # end of ParaLine
  <ParaLine 
   <String `och 36% beroende på dos (5–10 mikrog) och '>
  > # end of ParaLine
  <ParaLine 
   <String `observationstid '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 63Y2'>
    <MCurrPage `1319'>
    <Unique 1073772>
   > # end of Marker
   <String `(63,'>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 64Y2'>
    <MCurrPage `1319'>
    <Unique 1073777>
   > # end of Marker
   <String `64)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. I en annan studie, '>
  > # end of ParaLine
  <ParaLine 
   <String `över 30 veckor, sågs hypoglykemi hos ca 5% '>
  > # end of ParaLine
  <ParaLine 
   <String `i de olika grupperna som fick antingen '>
  > # end of ParaLine
  <ParaLine 
   <String `5'>
   <Char HardSpace>
   <String `mikrog, 10'>
   <Char HardSpace>
   <String `mikrog exenatid eller placebo '>
  > # end of ParaLine
  <ParaLine 
   <String `som tillägg till metformin '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 65Y2'>
    <MCurrPage `1319'>
    <Unique 1073783>
   > # end of Marker
   <String `(65)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `, dvs ingen '>
  > # end of ParaLine
  <ParaLine 
   <String `skillnad mot placebo. I en studie med exena'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tid som tillägg till metformin eller SU i 9–12 '>
  > # end of ParaLine
  <ParaLine 
   <String `månader rapporterades 3,5% hypoglykemier '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 66Y2'>
    <MCurrPage `1319'>
    <Unique 1073790>
   > # end of Marker
   <String `(66)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. I en nyligen publicerad studie gavs '>
  > # end of ParaLine
  <ParaLine 
   <TextRectID 153>
   <Char DiscHyphen>
   <String `exenatid (långsamt frisatt) 2 mg 1'>
   <Char HardSpace>
   <String `gång/'>
  > # end of ParaLine
  <ParaLine 
   <String `vecka och jämfördes med dagligt tillägg av '>
  > # end of ParaLine
  <ParaLine 
   <String `sitagliptin 100 mg och pioglitazon 45'>
   <Char HardSpace>
   <String `mg till '>
  > # end of ParaLine
  <ParaLine 
   <String `basal terapi med metformin. Hypoglykemi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `frekvensen (lindrig) var 1–3% i alla grupper'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `na '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 67Y2'>
    <MCurrPage `1320'>
    <Unique 1073797>
   > # end of Marker
   <String `(67)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1044861>
  <PgfTag `PrepBröd'>
  <Pgf 
   <PgfFIndent  6.0 mm>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `I ingen av de redovisade studierna sågs '>
  > # end of ParaLine
  <ParaLine 
   <String `svår hypoglykemi. Svår hypoglykemi sågs '>
  > # end of ParaLine
  <ParaLine 
   <String `däremot hos 1,2% vid 10 mikrog x 2 vid kom'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `bination med SU-preparat '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 68Y2'>
    <MCurrPage `1320'>
    <Unique 1073804>
   > # end of Marker
   <String `(68)'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
   <String `.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1029473>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `L'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `liraglutid:trafik'>
    <MCurrPage `1320'>
    <Unique 1058220>
   > # end of Marker
   <String `iraglutid'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1056093>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `I en fas II-studie med liraglutid (10 mikrog/'>
  > # end of ParaLine
  <ParaLine 
   <String `kg kroppsvikt som en engångsdos respektive '>
  > # end of ParaLine
  <ParaLine 
   <String `x 1 i 12 veckor vid typ 2-diabetes) noterades '>
  > # end of ParaLine
  <ParaLine 
   <String `inga hypoglykemier '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 69Y2'>
    <MCurrPage `1320'>
    <Unique 1073812>
   > # end of Marker
   <String `(69)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. I en annan studie '>
  > # end of ParaLine
  <ParaLine 
   <String `med samma förutsättningar noterades 1 hy'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `poglykemi bland 135 deltagare med dose'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ringar mellan 0,045 och 0,75 mg/dag '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 70Y2'>
    <MCurrPage `1320'>
    <Unique 1073823>
   > # end of Marker
   <String `(70)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Li'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `raglutid 0,65, 1,25 och 1,9 mg subkutant '>
  > # end of ParaLine
  <ParaLine 
   <String `jämfördes mot placebo i 14 veckor varunder '>
  > # end of ParaLine
  <ParaLine 
   <String `inga hypoglykemier rapporterades '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 71Y2'>
    <MCurrPage `1320'>
    <Unique 1073830>
   > # end of Marker
   <String `(71)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1045126>
  <PgfTag `PrepBröd'>
  <Pgf 
   <PgfFIndent  6.0 mm>
   <HyphenMaxLines 10>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `Liraglutid 1,2 respektive 1,8 mg x 1 jäm'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `fördes mot glimepirid 8 mg avseende tolera'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `bilitet och biverkningar i LEAD-3-studien '>
  > # end of ParaLine
  <ParaLine 
   <String `(LEAD = Liraglutide Effect and Action in '>
  > # end of ParaLine
  <ParaLine 
   <String `Dia'>
   <Char DiscHyphen>
   <String `betes) '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 72Y2'>
    <MCurrPage `1320'>
    <Unique 1073837>
   > # end of Marker
   <String `(72)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Hypoglykemier förekom 6,5 '>
  > # end of ParaLine
  <ParaLine 
   <String `gånger oftare i glimepiridgruppen '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 72Y2'>
    <MCurrPage `1320'>
    <Unique 1073844>
   > # end of Marker
   <String `(72)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. I stu'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `dien av Nauck (en 26-veckorsstudie med 0,6, '>
  > # end of ParaLine
  <ParaLine 
   <String `1,2 och 1,8 mg liraglutid/dag och placebo, i '>
  > # end of ParaLine
  <ParaLine 
   <String `kombination med metformin) noterades '>
  > # end of ParaLine
  <ParaLine 
   <String `samma incidens av hypoglykemi (<'>
   <Char HardSpace>
   <String `3,1 '>
  > # end of ParaLine
  <ParaLine 
   <String `mmol/'>
   <Char DiscHyphen>
   <String `L) vid behandling med liraglutid som '>
  > # end of ParaLine
  <ParaLine 
   <String `för placebo '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 73Y2'>
    <MCurrPage `1320'>
    <Unique 1073851>
   > # end of Marker
   <String `(73)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. ”Major hypoglycemic event” '>
  > # end of ParaLine
  <ParaLine 
   <String `(där annan person tvingats hjälpa till för att '>
  > # end of ParaLine
  <ParaLine 
   <String `häva hypoglykemin = allvarlig hypoglykemi '>
  > # end of ParaLine
  <ParaLine 
   <String `i trafikmedicinskt hänseende) inträffade i '>
  > # end of ParaLine
  <ParaLine 
   <String `LEAD-studierna 1 och 5. Liraglutid 1,8 mg/'>
  > # end of ParaLine
  <ParaLine 
   <String `dag i kombination med glimepirid orsakade '>
  > # end of ParaLine
  <ParaLine 
   <String `en svår hypoglykemi '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 74Y2'>
    <MCurrPage `1320'>
    <Unique 1073858>
   > # end of Marker
   <String `(74)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1052896>
  <PgfTag `PrepBröd'>
  <Pgf 
   <PgfFIndent  6.0 mm>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `I LEAD-5-studien kompletterades metfor'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `min-/glimepiridbehandlingen för typ 2-dia'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `betes med liraglutid, insulin eller placebo. '>
  > # end of ParaLine
  <ParaLine 
   <String `Här rapporterades 2,2% svåra hypoglyke'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `mier och 27% lindriga hypoglykemier vid '>
  > # end of ParaLine
  <ParaLine 
   <String `kombinationen liraglutid + glimepirid (4 mg '>
  > # end of ParaLine
  <ParaLine 
   <String `x 1) + metformin (1 mg x 2) '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 75Y2'>
    <MCurrPage `1320'>
    <Unique 1073867>
   > # end of Marker
   <String `(75)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Placebo + '>
  > # end of ParaLine
  <ParaLine 
   <String `glimepirid (4 mg x 1) + metformin (1 mg x 2) '>
  > # end of ParaLine
  <ParaLine 
   <String `uppvisade hypoglykemier hos 17%. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1078823>
  <PgfTag `PrepBröd'>
  <Pgf 
   <PgfFIndent  6.0 mm>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `I LEAD-6-studien som publicerades 2009 '>
  > # end of ParaLine
  <ParaLine 
   <String `behandlades ca 230 patienter med typ 2-dia'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `betes med metformin eller SU med 1,8 mg li'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `raglutid/dag och jämfördes med 10 mikrog '>
  > # end of ParaLine
  <ParaLine 
   <TextRectID 153>
   <String `exenatid x 2 under 26 veckor. Hypoglykemi '>
  > # end of ParaLine
  <ParaLine 
   <String `(blodglukos <'>
   <Char HardSpace>
   <String `3,1 mmol/L) förekom i en frek'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `vens av 1,9/patientår mot 2,6 för exenatid'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `gruppen (p = 0,013). För dem som hade met'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `formin var andelen med hypoglykemi 6% för '>
  > # end of ParaLine
  <ParaLine 
   <String `liraglutid mot 11% för exenatid '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 68Y2'>
    <MCurrPage `1320'>
    <Unique 1078824>
   > # end of Marker
   <String `(68)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Två all'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `varliga hypoglykemier förekom i gruppen '>
  > # end of ParaLine
  <ParaLine 
   <String `med exenatid + SU. Att behandling med lira'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `glutid leder till ett mindre antal hypoglyke'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `mier än kombinationer med andra medel '>
  > # end of ParaLine
  <ParaLine 
   <String `framgår även i en annan studie '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 76Y2'>
    <MCurrPage `1320'>
    <Unique 1078825>
   > # end of Marker
   <String `(76)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1045757>
  <PgfTag `PrepBröd'>
  <Pgf 
   <PgfFIndent  6.0 mm>
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.NewCenturySchlbk LT Std.R.400'>
    <FFamily `NewCenturySchlbk LT Std'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `NewCenturySchlbkLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  8.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  -0.5%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `Den enda studien med avvikande resultat '>
  > # end of ParaLine
  <ParaLine 
   <String `– liraglutid 1,8 mg jämfört med placebo som '>
  > # end of ParaLine
  <ParaLine 
   <String `tillägg till metformin + rosiglitazon – rappor'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `terade visserligen om en låg hypoglykemi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `frekvens men signifikant högre än för place'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `bo '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 77Y2'>
    <MCurrPage `1320'>
    <Unique 1073890>
   > # end of Marker
   <String `(77)'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
   <String `.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1045045>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `A'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `akarbos:trafik'>
    <MCurrPage `1320'>
    <Unique 1058225>
   > # end of Marker
   <String `karbos'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1077410>
  <PgfTag `PrepBröd'>
  <Pgf 
   <HyphenMaxLines 6>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `Akarbos som monoterapi ('>
   <Font 
    <FTag `'>
    <FPlatformName `W.Symbol.R.400'>
    <FFamily `Symbol'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
   <String `£'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` 300 mg/dag) i 24 '>
  > # end of ParaLine
  <ParaLine 
   <String `veckor gav huvudsakligen gastrointestinala '>
  > # end of ParaLine
  <ParaLine 
   <String `biverkningar. Inga hypoglykema episoder '>
  > # end of ParaLine
  <ParaLine 
   <String `rapporterades '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 78Y2'>
    <MCurrPage `1320'>
    <Unique 1077411>
   > # end of Marker
   <String `(78)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Likaså finns huvudsak'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ligen intestinala biverkningar rapporterade '>
  > # end of ParaLine
  <ParaLine 
   <String `i en ”post-marketing surveillance study” om'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `fattande 27'>
   <Char HardSpace>
   <String `800 diabetiker behandlade i 12 '>
  > # end of ParaLine
  <ParaLine 
   <String `veckor. Hypoglykemi rapporterades för '>
  > # end of ParaLine
  <ParaLine 
   <String `0,03% av deltagarna med akarbos i monote'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `rapi, 0,03% i kombination med sulfonylurea, '>
  > # end of ParaLine
  <ParaLine 
   <String `0,2% i kombination med metformin och 0,3% '>
  > # end of ParaLine
  <ParaLine 
   <String `i kombination med insulin '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 79Y2'>
    <MCurrPage `1320'>
    <Unique 1077412>
   > # end of Marker
   <String `(79)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1077413>
  <PgfTag `PrepBröd'>
  <Pgf 
   <PgfFIndent  6.0 mm>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `I en cross over-studie med repaglinid eller '>
  > # end of ParaLine
  <ParaLine 
   <String `akarbos som tillägg till metformin + sulfo'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `nylurea sågs ingen hypoglykemi under 12 '>
  > # end of ParaLine
  <ParaLine 
   <String `veckor med akarbos upp till 100 mg x 3 '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 80Y2'>
    <MCurrPage `1320'>
    <Unique 1077414>
   > # end of Marker
   <String `(80)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1029524>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `G'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `glibenklamid:trafik'>
    <MCurrPage `1320'>
    <Unique 1058230>
   > # end of Marker
   <String `libenklamid'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1079637>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Glibenklamid studerades för en jämförelse '>
  > # end of ParaLine
  <ParaLine 
   <String `mellan dosering 1 gång/dag och 2 gånger '>
  > # end of ParaLine
  <ParaLine 
   <String `dagligen varvid 20 respektive 30% drabba'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `des av ”minor hypoglycemic episodes” (av'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `hjälptes av personerna själva). Inga svåra '>
  > # end of ParaLine
  <ParaLine 
   <String `hypoglykemier (<'>
   <Char HardSpace>
   <String `2,8 mmol/L) noterades för '>
  > # end of ParaLine
  <ParaLine 
   <String `de 60 deltagarna under denna 10-månaders'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `studie '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 81Y2'>
    <MCurrPage `1320'>
    <Unique 1079638>
   > # end of Marker
   <String `(81)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1045140>
  <PgfTag `PrepBröd'>
  <Pgf 
   <PgfFIndent  6.0 mm>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `Från en 24-veckorsstudie med glibenkla'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `mid i kombination med metformin rapporte'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `rades att 38% drabbats av hypoglykemi '>
  > # end of ParaLine
  <ParaLine 
   <String `(blodglukos '>
   <Font 
    <FTag `'>
    <FPlatformName `W.Symbol.R.400'>
    <FFamily `Symbol'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
   <String `£'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` 2,8 mmol/L) jämfört med 1% '>
  > # end of ParaLine
  <ParaLine 
   <String `med kombinationen rosiglitazon + metfor'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `min och 4% i glibenklamidgruppen avbröt '>
  > # end of ParaLine
  <ParaLine 
   <String `studien pga hypoglykemier '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 82Y2'>
    <MCurrPage `1320'>
    <Unique 1073925>
   > # end of Marker
   <String `(82).'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1079677>
  <PgfTag `PrepBröd'>
  <Pgf 
   <PgfFIndent  6.0 mm>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <TextRectID 154>
   <String `Svår (allvarlig) hypoglykemi är relaterad '>
  > # end of ParaLine
  <ParaLine 
   <String `till glibenklamid '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 83Y2'>
    <MCurrPage `1321'>
    <Unique 1079678>
   > # end of Marker
   <String `(83)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Frekvensen svår hy'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `poglykemi var i en tysk studie 5,6/1'>
   <Char HardSpace>
   <String `000 per'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `sonår vid behandling med glibenklamid jäm'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `fört med 0,86/1'>
   <Char HardSpace>
   <String `000 personår för glimepirid '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 84Y2'>
    <MCurrPage `1321'>
    <Unique 1079679>
   > # end of Marker
   <String `(84)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1079681>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `G'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `glipizid:trafik'>
    <MCurrPage `1321'>
    <Unique 1079680>
   > # end of Marker
   <String `lipizid'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1055041>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `I en tvåårsstudie (n = ca 580/grupp) med gli'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `pizid (respektive sitagliptin) som tillägg till '>
  > # end of ParaLine
  <ParaLine 
   <String `metformin (≥'>
   <Char HardSpace>
   <String `1'>
   <Char HardSpace>
   <String `500 mg/dag) rapporterade '>
  > # end of ParaLine
  <ParaLine 
   <String `34% i glipizidgruppen att de hade drabbats '>
  > # end of ParaLine
  <ParaLine 
   <String `av hypoglykemi vid sammanlagt 805 tillfäl'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `len. Av de 726 tillfällen där blodglukosnivå'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `erna redovisats var 76% <'>
   <Char HardSpace>
   <String `3,9 mmol/L, 44% '>
  > # end of ParaLine
  <ParaLine 
   <String `<'>
   <Char HardSpace>
   <String `3,3 mmol/L och 8% <'>
   <Char HardSpace>
   <String `2,8 mmol/L. Åttiotre '>
  > # end of ParaLine
  <ParaLine 
   <String `procent av episoderna inträffade under '>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `första studieåret. Arton individer behövde '>
  > # end of ParaLine
  <ParaLine 
   <String `hjälp av en annan person för att häva hypo'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `glykemin och 9 av dessa hade en påtaglig '>
  > # end of ParaLine
  <ParaLine 
   <String `medvetandesänkning '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 85Y2'>
    <MCurrPage `1321'>
    <Unique 1073946>
   > # end of Marker
   <String `(85)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Andra studier '>
  > # end of ParaLine
  <ParaLine 
   <String `har rapporterat hypoglykemiförekomst hos '>
  > # end of ParaLine
  <ParaLine 
   <String `32 respektive 17% av behandlade patienter '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 86Y2'>
    <MCurrPage `1321'>
    <Unique 1073957>
   > # end of Marker
   <String `(86,'>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 87Y2'>
    <MCurrPage `1321'>
    <Unique 1073962>
   > # end of Marker
   <String `87).'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1055042>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `G'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `glimepirid:trafik'>
    <MCurrPage `1321'>
    <Unique 1058240>
   > # end of Marker
   <String `limepirid'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1045432>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Glimepirid (1–8 mg x 1) jämfördes i ett pedi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `atriskt material med metformin (500–1'>
   <Char HardSpace>
   <String `000 '>
  > # end of ParaLine
  <ParaLine 
   <String `mg x 2) under 24 veckor. Hypoglykemi (<'>
   <Char HardSpace>
   <String `2,8 '>
  > # end of ParaLine
  <ParaLine 
   <String `mmol/L) noterades hos 4,9% i glimepirid'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `gruppen mot 4,2% i metformingruppen '>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `(ingen signifikant skillnad). En svår hypo'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `glykemi noterades i vardera gruppen '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 88Y2'>
    <MCurrPage `1321'>
    <Unique 1073970>
   > # end of Marker
   <String `(88)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1055059>
  <PgfTag `PrepBröd'>
  <Pgf 
   <PgfFIndent  6.0 mm>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `I en jämförande studie (12 veckor, typ 2-'>
  > # end of ParaLine
  <ParaLine 
   <String `diabetes) rapporterade 4/26 hypoglykemi '>
  > # end of ParaLine
  <ParaLine 
   <String `(<'>
   <Char HardSpace>
   <String `2,8 mmol/L) och ytterligare 5 hade sym'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tom '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 70Y2'>
    <MCurrPage `1321'>
    <Unique 1073978>
   > # end of Marker
   <String `(70)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. I en annan studie (4 mg x 1 i kom'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `bination med metformin, 24 veckor) notera'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `des hypoglykemi (<'>
   <Char HardSpace>
   <String `3,1 mmol/L) hos 17% av '>
  > # end of ParaLine
  <ParaLine 
   <String `deltagarna '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 73Y2'>
    <MCurrPage `1321'>
    <Unique 1073986>
   > # end of Marker
   <String `(73)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1055060>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `M'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `metformin:trafik'>
    <MCurrPage `1321'>
    <Unique 1058245>
   > # end of Marker
   <String `etformin'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1078828>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Metformin givet i en dos om 500–2'>
   <Char HardSpace>
   <String `000 mg/'>
  > # end of ParaLine
  <ParaLine 
   <String `dag gav lindrig hypoglykemi hos 3,3% av 447 '>
  > # end of ParaLine
  <ParaLine 
   <String `individer. Ingen måttlig eller svår hypogly'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `kemi inträffade '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 89Y2'>
    <MCurrPage `1321'>
    <Unique 1078829>
   > # end of Marker
   <String `(89)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. I en annan studie (n = '>
  > # end of ParaLine
  <ParaLine 
   <String `143 + 146 kontroller) under 24 veckor tog '>
  > # end of ParaLine
  <ParaLine 
   <String `78% maxdos, 2'>
   <Char HardSpace>
   <String `550 mg metformin/dag, med'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `an resterande tog minst 1'>
   <Char HardSpace>
   <String `700 mg/dag. Sym'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tom på hypoglykemi var desamma som i pla'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `cebogruppen (<'>
   <Char HardSpace>
   <String `2%) och ingen hade analys'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `mässigt hypoglykemi '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 90Y2'>
    <MCurrPage `1321'>
    <Unique 1078830>
   > # end of Marker
   <String `(90)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Även i en relativt '>
  > # end of ParaLine
  <ParaLine 
   <TextRectID 154>
   <String `ny studie (n = 140) rapporterades hypoglyke'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `misymtom av ca 1% '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 91Y2'>
    <MCurrPage `1321'>
    <Unique 1078831>
   > # end of Marker
   <String `(91)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1059144>
  <PgfTag `PrepBröd'>
  <Pgf 
   <PgfFIndent  6.0 mm>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `I en översiktsartikel från 1995 om metfor'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `min till typ 2-diabetespatienter sägs att met'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `formin inte orsakar hypoglykemi '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 92Y2'>
    <MCurrPage `1321'>
    <Unique 1074014>
   > # end of Marker
   <String `(92).'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1052945>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `N'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `nateglinid:trafik'>
    <MCurrPage `1321'>
    <Unique 1058250>
   > # end of Marker
   <String `ateglinid'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1067929>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Nateglinid som monoterapi med doserna 30, '>
  > # end of ParaLine
  <ParaLine 
   <String `60, 120 och 180 mg x 3 jämfördes med place'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `bo och man fann hypoglykemi (2,7–3,3 '>
  > # end of ParaLine
  <ParaLine 
   <String `mmol/L) i 3 fall (1,3%) i gruppen som fick '>
  > # end of ParaLine
  <ParaLine 
   <String `120 mg nateglinid '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 93Y2'>
    <MCurrPage `1321'>
    <Unique 1074023>
   > # end of Marker
   <String `(93)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1079722>
  <PgfTag `PrepBröd'>
  <Pgf 
   <PgfFIndent  6.0 mm>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `Nateglinid, metformin, placebo och kom'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `binationen nateglinid + metformin jämför'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `des under 4 veckor och hypoglykemi ('>
   <Font 
    <FTag `'>
    <FPlatformName `W.Symbol.R.400'>
    <FFamily `Symbol'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
   <String `£'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` 3,3 '>
  > # end of ParaLine
  <ParaLine 
   <String `mmol/L) noterades hos <'>
   <Char HardSpace>
   <String `1% i metformin'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `gruppen, 1,7% i nateglinidgruppen och 3,7% '>
  > # end of ParaLine
  <ParaLine 
   <String `i gruppen som fick kombinationsbehandling '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 94Y2'>
    <MCurrPage `1321'>
    <Unique 1079723>
   > # end of Marker
   <String `(94)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1079746>
  <PgfTag `PrepBröd'>
  <Pgf 
   <PgfFIndent  6.0 mm>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `Från en studie med jämförbara gruppstor'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `lekar (n = ca 155) resulterade tillägg av '>
  > # end of ParaLine
  <ParaLine 
   <String `60'>
   <Char HardSpace>
   <String `mg nateglinid x 3 till 1'>
   <Char HardSpace>
   <String `000 mg metformin '>
  > # end of ParaLine
  <ParaLine 
   <String `x 2 i en fördubbling av hypoglykemiepisoder'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `na (3,9% till 8,4%) och ytterligare fördubb'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ling vid 120 mg nateglinid (15,6%) '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 95Y2'>
    <MCurrPage `1321'>
    <Unique 1079747>
   > # end of Marker
   <String `(95)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. En '>
  > # end of ParaLine
  <ParaLine 
   <String `studie av Ristic och medarbetare är svårvär'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `derad eftersom återkommande och svåra hy'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `poglykemier exkluderats '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 96Y2'>
    <MCurrPage `1321'>
    <Unique 1079748>
   > # end of Marker
   <String `(96)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1045496>
  <PgfTag `PrepBröd'>
  <Pgf 
   <PgfFIndent  6.0 mm>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `I Salorantas och medarbetares studie jäm'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `fördes 30, 60 och 120 mg mot placebo. Sym'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tomatisk hypoglykemi noterades hos 5% i '>
  > # end of ParaLine
  <ParaLine 
   <String `placebogruppen medan 12, 11 och 23% drab'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `bades i respektive behandlingsgrupp. Veri'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `fiering visade att majoriteten av dem med '>
  > # end of ParaLine
  <ParaLine 
   <String `symtomatisk hypoglykemi hade ett blodglu'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `kosvärde \>'>
   <Char HardSpace>
   <String `3,3 mmol/L '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 97Y2'>
    <MCurrPage `1321'>
    <Unique 1074053>
   > # end of Marker
   <String `(97)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Bekräftad hypo'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `glykemi ('>
   <Font 
    <FTag `'>
    <FPlatformName `W.Symbol.R.400'>
    <FFamily `Symbol'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
   <String `£'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` 3,3 mmol/L) sågs genomgående i '>
  > # end of ParaLine
  <ParaLine 
   <String `ca 1/4 av de symtomatiska fallen (inklusive '>
  > # end of ParaLine
  <ParaLine 
   <String `placebogruppen) och svår hypoglykemi var '>
  > # end of ParaLine
  <ParaLine 
   <String `sällsynt, men siffran nämns inte. '>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1029614>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `R'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `repaglinid:trafik'>
    <MCurrPage `1321'>
    <Unique 1058255>
   > # end of Marker
   <String `epaglinid'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1045538>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Repaglinid gav färre (2,8%) hypoglykemier '>
  > # end of ParaLine
  <ParaLine 
   <String `(<'>
   <Char HardSpace>
   <String `4,5 mmol/L) än glibenklamid (7,9%) i en '>
  > # end of ParaLine
  <ParaLine 
   <String `studie under Ramadan (6 veckor) '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 98Y2'>
    <MCurrPage `1321'>
    <Unique 1074063>
   > # end of Marker
   <String `(98)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Repa'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `glinid i jämförelse med placebo har rapporte'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `rats ge hypoglykemi hos 17% respektive 3% '>
  > # end of ParaLine
  <ParaLine 
   <String `(3 individer hade ”major hypoglycemic '>
  > # end of ParaLine
  <ParaLine 
   <String `events”) '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 99Y2'>
    <MCurrPage `1321'>
    <Unique 1074071>
   > # end of Marker
   <String `(99)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` och i en annan studie var mot'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `svarande resultat 36% respektive 6% (lind'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `rig till moderat hypoglykemi, en svår hypo'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `glykemi med < 2,5 mmol/L) '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 100Y2'>
    <MCurrPage `1321'>
    <Unique 1074078>
   > # end of Marker
   <String `(100)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1067937>
  <PgfTag `PrepBröd'>
  <Pgf 
   <PgfFIndent  6.0 mm>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <TextRectID 155>
   <String `Patientrapporterade hypoglykemisymtom '>
  > # end of ParaLine
  <ParaLine 
   <String `(ej verifierade) vid typ 2-diabetes låg på en '>
  > # end of ParaLine
  <ParaLine 
   <String `nivå motsvarande placebo i en liten jämfö'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `rande studie (n = 13 + 12) '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 101Y2'>
    <MCurrPage `1322'>
    <Unique 1074085>
   > # end of Marker
   <String `(101)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. I en större '>
  > # end of ParaLine
  <ParaLine 
   <String `24-veckorsstudie med 361 patienter rando'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `miserade till behandling med antingen pla'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `cebo, 1 mg eller 4 mg repaglinid, drabbades '>
  > # end of ParaLine
  <ParaLine 
   <String `11, 27 re'>
   <Char DiscHyphen>
   <String `spektive 35% av någon hypoglyke'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `misk episod. En procent i varje grupp hade '>
  > # end of ParaLine
  <ParaLine 
   <String `erfarit blodglukos <'>
   <Char HardSpace>
   <String `2,5 mmol/L '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 102Y2'>
    <MCurrPage `1322'>
    <Unique 1074092>
   > # end of Marker
   <String `(102).'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1029630>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `R'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `rosiglitazon:trafik'>
    <MCurrPage `1322'>
    <Unique 1058260>
   > # end of Marker
   <String `osiglitazon'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1069544>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Rosiglitazon i kombination med metformin '>
  > # end of ParaLine
  <ParaLine 
   <String `gav 1% hypoglykemier '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 82Y2'>
    <MCurrPage `1322'>
    <Unique 1074099>
   > # end of Marker
   <String `(82)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `, medan ingen '>
  > # end of ParaLine
  <ParaLine 
   <String `”signifikant hypoglykemi” observerades i en '>
  > # end of ParaLine
  <ParaLine 
   <String `studie av Gomez-Perez och medarbetare '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 103Y2'>
    <MCurrPage `1322'>
    <Unique 1074110>
   > # end of Marker
   <String `(103).'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` I en  annan studie sågs lindriga till '>
  > # end of ParaLine
  <ParaLine 
   <String `moderata hypoglykemisymtom hos 2,5% vid '>
  > # end of ParaLine
  <ParaLine 
   <String `doseringen 4 mg x 1 och hos 4,4% vid 8 mg x '>
  > # end of ParaLine
  <ParaLine 
   <String `1 som tillägg till metformin '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 104Y2'>
    <MCurrPage `1322'>
    <Unique 1074117>
   > # end of Marker
   <String `(104)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1029646>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `P'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `pioglitazon:trafik'>
    <MCurrPage `1322'>
    <Unique 1058265>
   > # end of Marker
   <String `ioglitazon'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1079768>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `I en jämförande studie (n = 4 x 320) med pio'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `glitazon som tillägg till metformin sågs hy'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `poglykemisymtom hos 2,2% medan som till'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `lägg till sulfonylurea rapporterades sådana '>
  > # end of ParaLine
  <ParaLine 
   <String `symtom hos 11,3% '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 105Y2'>
    <MCurrPage `1322'>
    <Unique 1079769>
   > # end of Marker
   <String `(105)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Pio'>
   <Char DiscHyphen>
   <String `glitazon som '>
  > # end of ParaLine
  <ParaLine 
   <String `monoterapi (40 veckor) med 15–45 mg/dag '>
  > # end of ParaLine
  <ParaLine 
   <String `gav hypoglykemier hos 4,5% jämfört med '>
  > # end of ParaLine
  <ParaLine 
   <String `gliben'>
   <Char DiscHyphen>
   <String `kla'>
   <Char DiscHyphen>
   <String `mid 24,3% '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 106Y2'>
    <MCurrPage `1322'>
    <Unique 1079770>
   > # end of Marker
   <String `(106)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1079779>
  <PgfTag `PrepBröd'>
  <Pgf 
   <PgfFIndent  6.0 mm>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `I en annan studie när 30 mg pioglitazon '>
  > # end of ParaLine
  <ParaLine 
   <String `gavs som tillägg till metformin till ca 300 in'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `divider sågs inga hypoglykemier '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 107Y2'>
    <MCurrPage `1322'>
    <Unique 1079780>
   > # end of Marker
   <String `(107)'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
   <String `.'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1079782>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `S'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `sitagliptin:trafik'>
    <MCurrPage `1322'>
    <Unique 1079781>
   > # end of Marker
   <String `itagliptin'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1055109>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Se även glipizid ovan. Vid dosering 100 mg x '>
  > # end of ParaLine
  <ParaLine 
   <String `1 i 24 veckor till 467 patienter med typ 2-'>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `diabetes noterades hypoglykemi hos 1,7%, '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `varav 2 individer med svår hypoglykemi (en '>
  > # end of ParaLine
  <ParaLine 
   <String `med missad måltid) '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 89Y2'>
    <MCurrPage `1322'>
    <Unique 1074146>
   > # end of Marker
   <String `(89)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. I en översiktsarti'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `kel konstaterades att sitagliptin hade en hy'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `poglykemifrekvens jämförbar med placebo '>
  > # end of ParaLine
  <ParaLine 
   <String `(ca 1%) '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 108Y2'>
    <MCurrPage `1322'>
    <Unique 1074153>
   > # end of Marker
   <String `(108)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1087568>
  <PgfTag `PrepBröd'>
  <Pgf 
   <PgfFIndent  6.0 mm>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `I en studie med ihopslagna data från 12 '>
  > # end of ParaLine
  <ParaLine 
   <String `dubbelblinda studier (6'>
   <Char HardSpace>
   <String `139 individer) note'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `rades en incidens om 4,9 hypoglykemier/'>
   <Char DiscHyphen>
   <String `100 '>
  > # end of ParaLine
  <ParaLine 
   <String `personår med sitagliptin medan för övriga '>
  > # end of ParaLine
  <ParaLine 
   <String `behandlingar var siffran 11,7. Man anger att '>
  > # end of ParaLine
  <ParaLine 
   <String `frekvensen vid monoterapi är jämförbar med '>
  > # end of ParaLine
  <ParaLine 
   <String `placebo och störst vid samtidig insulinbe'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `handling '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 109Y2'>
    <MCurrPage `1322'>
    <Unique 1087569>
   > # end of Marker
   <String `(109)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1027329>
  <PgfTag `Rub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <TextRectID 155>
   <Font 
    <FTag `Intense Emphasis'>
    <FLocked No>
   > # end of Font
   <String `G04 '>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `– '>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `urologiska medel:trafik'>
    <MCurrPage `1322'>
    <Unique 1058292>
   > # end of Marker
   <String `u'>
   <Font 
    <FTag `Intense Emphasis'>
    <FLocked No>
   > # end of Font
   <String `rologiska medel'>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `Sammanfattning '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1046028>
  <PgfTag `Bröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Instabil urinblåsa behandlas framgångs'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `rikt med antikolinerga läkemedel. Risken '>
  > # end of ParaLine
  <ParaLine 
   <String `för kognitiv påverkan är påtaglig framför '>
  > # end of ParaLine
  <ParaLine 
   <String `allt hos äldre medan barn påverkas i liten '>
  > # end of ParaLine
  <ParaLine 
   <String `omfattning. Några studier om hur dessa lä'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `kemedel påverkar bilkörning finns inte. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1040828>
  <PgfTag `Rub2'>
  <ParaLine 
   <String `Rekommendationer '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1040829>
  <PgfTag `Bröd'>
  <ParaLine 
   <String `Darifenacin förefaller inte ge någon påver'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `kan på kognitiva funktioner trots god för'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `väntad läkemedelseffekt.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1040830>
  <PgfTag `Rub2'>
  <ParaLine 
   <String `Läs vidare'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.700'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1040831>
  <PgfTag `RefTextNr1'>
  <PgfNumString `1.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Font 
    <FTag `'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <String `Preserving cognitive function for patients with '>
  > # end of ParaLine
  <ParaLine 
   <String `overactive bladder: evidence for a differential ef'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `fect with darifenacin '>
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 110Y2'>
    <MCurrPage `1322'>
    <Unique 1074168>
   > # end of Marker
   <String `(110)'>
   <Font 
    <FTag `'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <String `. '>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `(En översiktsartikel '>
  > # end of ParaLine
  <ParaLine 
   <String `från 2008.)'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1040818>
  <PgfTag `Rub2'>
  <ParaLine 
   <String `Enskilda preparat'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1046070>
  <PgfTag `Rub3efterRub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `D'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `darifenacin:trafik'>
    <MCurrPage `1322'>
    <Unique 1058301>
   > # end of Marker
   <String `arifenacin'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1079811>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Darifenacin, 15 mg x 1 långsamt frisatt, på'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `verkade inte kognitiva funktioner utan var '>
  > # end of ParaLine
  <ParaLine 
   <String `jämförbart med placebo '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 111Y2'>
    <MCurrPage `1322'>
    <Unique 1079812>
   > # end of Marker
   <String `(111)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Darifenacin '>
  > # end of ParaLine
  <ParaLine 
   <String `med doseringen 7,5 mg respektive 15 mg x 1 '>
  > # end of ParaLine
  <ParaLine 
   <String `i en vecka till medelålders friska gav ingen '>
  > # end of ParaLine
  <ParaLine 
   <String `påverkan på kognitiva funktioner utan var '>
  > # end of ParaLine
  <ParaLine 
   <String `jämförbart med placebo '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 112Y2'>
    <MCurrPage `1322'>
    <Unique 1079813>
   > # end of Marker
   <String `(112)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Någon påver'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `kan sågs inte heller i en annan studie med '>
  > # end of ParaLine
  <ParaLine 
   <String `äldre '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 113Y2'>
    <MCurrPage `1322'>
    <Unique 1079814>
   > # end of Marker
   <String `(113).'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1027331>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `O'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `oxybutynin:trafik'>
    <MCurrPage `1322'>
    <Unique 1058306>
   > # end of Marker
   <String `xybutynin'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1078849>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Oxybutynin'>
   <Font 
    <FTag `'>
    <FLocked No>
    <FSeparation 1>
    <FColor `White'>
   > # end of Font
   <String `i'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `som en engångsdos (5 och 10 '>
  > # end of ParaLine
  <ParaLine 
   <String `mg) har visat sig ge försämrade kognitiva '>
  > # end of ParaLine
  <ParaLine 
   <String `testresultat i 7 av 15 neuropsykologiska tes'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ter '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 114Y2'>
    <MCurrPage `1322'>
    <Unique 1078850>
   > # end of Marker
   <String `(114)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Långsamt frisatt oxybutynin (20 '>
  > # end of ParaLine
  <ParaLine 
   <String `mg) påverkade kognition, speciellt minnet '>
  > # end of ParaLine
  <ParaLine 
   <String `hos äldre, vid jämförelse mot placebo och da'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `rifenacin (15 mg) '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 111Y2'>
    <MCurrPage `1322'>
    <Unique 1078851>
   > # end of Marker
   <String `(111)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Försökspersonerna i '>
  > # end of ParaLine
  <ParaLine 
   <String `studien var inte medvetna om sin minnespå'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `verkan av oxybutynin.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1027332>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `T'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `tolterodin:trafik'>
    <MCurrPage `1322'>
    <Unique 1058311>
   > # end of Marker
   <String `olterodin'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1077445>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Utöver ett par fallbeskrivningar med min'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `nespåverkan '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 115Y2'>
    <MCurrPage `1322'>
    <Unique 1077446>
   > # end of Marker
   <String `(115)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` och konfusion '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 116Y2'>
    <MCurrPage `1322'>
    <Unique 1077447>
   > # end of Marker
   <String `(116)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` sak'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `nas studier. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1079823>
  <PgfTag `Rub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `M01 – '>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `NSAID:trafik'>
    <MCurrPage `1322'>
    <Unique 1079822>
   > # end of Marker
   <String `NSAID'>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Sammanfattning'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1079824>
  <PgfTag `Bröd'>
  <ParaLine 
   <String `Generellt sett verkar NSAID-preparaten '>
  > # end of ParaLine
  <ParaLine 
   <String `vid engångsdosering inte påverka körför'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `måga eller kognitiva funktioner medan så'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <TextRectID 156>
   <String `väl förbättrade som försämrade testresultat '>
  > # end of ParaLine
  <ParaLine 
   <String `kan anas vid längre tids behandling. Prepa'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ratens trafikvarningstexter anger dock att '>
  > # end of ParaLine
  <ParaLine 
   <String `för enstaka patienter kan allvarligare stör'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ningar inträffa (påverkan på reaktionsför'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `mågan, synrubbningar, dåsighet m'>
   <Char HardSpace>
   <String `m) men '>
  > # end of ParaLine
  <ParaLine 
   <String `detta verkar mer vara uppgifter från bi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `verkningsrapporter än resultat av veten'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `skapliga studier.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1053115>
  <PgfTag `Rub2'>
  <ParaLine 
   <String `Rekommendationer'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1053121>
  <PgfTag `Bröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `De vetenskapliga studierna ger ingen klar '>
  > # end of ParaLine
  <ParaLine 
   <String `vägledning i valet mellan olika NSAID. Läs '>
  > # end of ParaLine
  <ParaLine 
   <String `vidare om de olika substanserna nedan.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1053116>
  <PgfTag `Rub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Enskilda preparat'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1046216>
  <PgfTag `Rub3efterRub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `D'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `diklofenak:trafik'>
    <MCurrPage `1323'>
    <Unique 1058321>
   > # end of Marker
   <String `iklofenak'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1046217>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Diklofenak, 50 mg intramuskulärt, visade '>
  > # end of ParaLine
  <ParaLine 
   <String `inga skillnader mot placebo i psykomotoris'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ka tester vid upprepade mätningar mellan 1 '>
  > # end of ParaLine
  <ParaLine 
   <String `och 8 timmar efter injektion '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 117Y2'>
    <MCurrPage `1323'>
    <Unique 1074231>
   > # end of Marker
   <String `(117)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1046220>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `I'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `ibuprofen:trafik'>
    <MCurrPage `1323'>
    <Unique 1058326>
   > # end of Marker
   <String `buprofen'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1087631>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Ibuprofen 200 mg x 4 i 5 dagar jämfört med '>
  > # end of ParaLine
  <ParaLine 
   <String `placebo till friska män med inducerad mus'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `kelskada gav ingen försämring i psykolog'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `testresultat '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 118Y2'>
    <MCurrPage `1323'>
    <Unique 1087632>
   > # end of Marker
   <String `(118).'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1087633>
  <PgfTag `PrepBröd'>
  <Pgf 
   <PgfFIndent  6.0 mm>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `Goodwin och medarbetare rapporterar om '>
  > # end of ParaLine
  <ParaLine 
   <String `4 äldre patienter i ett kliniskt material vilka '>
  > # end of ParaLine
  <ParaLine 
   <String `erhöll ibuprofen 1,6–3,2 g/dag och som fick '>
  > # end of ParaLine
  <ParaLine 
   <String `en kognitiv påverkan, vilken normaliserades '>
  > # end of ParaLine
  <ParaLine 
   <String `inom 2 veckor efter utsättning '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 119Y2'>
    <MCurrPage `1323'>
    <Unique 1087634>
   > # end of Marker
   <String `(119).'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1027346>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `I'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `indometacin:trafik'>
    <MCurrPage `1323'>
    <Unique 1058331>
   > # end of Marker
   <String `ndometacin'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1079827>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Indometacin 100 mg 2 timmar före körning i '>
  > # end of ParaLine
  <ParaLine 
   <String `avancerad bilsimulator gav ingen påverkan '>
  > # end of ParaLine
  <ParaLine 
   <String `på körförmåga eller reaktionshastighet '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 120Y2'>
    <MCurrPage `1323'>
    <Unique 1079828>
   > # end of Marker
   <String `(120).'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` Indometacin 50 mg x 1 jämfördes bl'>
   <Char HardSpace>
   <String `a '>
  > # end of ParaLine
  <ParaLine 
   <String `mot placebo i ett ”track”-test och neuropsy'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `kologiska tester. Två timmar efter intagen '>
  > # end of ParaLine
  <ParaLine 
   <String `dos under dag 3 sågs en tendens till sänk'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ning av CFT (critical flicker threshold) med'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `an resultaten för uppmärksamhet, reak'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tionsförmåga och koordination var opåver'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `kade '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 121Y2'>
    <MCurrPage `1323'>
    <Unique 1079829>
   > # end of Marker
   <String `(121)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. En individ kunde dock inte '>
  > # end of ParaLine
  <ParaLine 
   <String `genomföra vissa testuppgifter pga yrsel och '>
  > # end of ParaLine
  <ParaLine 
   <String `illamående. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1087696>
  <PgfTag `PrepBröd'>
  <Pgf 
   <PgfFIndent  6.0 mm>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `Indometacin, 25 mg x 3, jämfördes med '>
  > # end of ParaLine
  <ParaLine 
   <String `placebo före, 5 timmar efter första dos och '>
  > # end of ParaLine
  <ParaLine 
   <String `sedan efter 7 dagars medicinering. Neuro'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `psykologiska testresultat visade förbättrade '>
  > # end of ParaLine
  <ParaLine 
   <String `reaktionstider både efter första dosen och ef'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ter 1 vecka. Verbalt minne förbättrades efter '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <TextRectID 156>
   <Font 
    <FTag `'>
    <FDW  -1.0%>
    <FLocked No>
   > # end of Font
   <String `1 vecka i den yngre delgruppen (55–65 år), '>
  > # end of ParaLine
  <ParaLine 
   <String `medan inga skillnader sågs i resultaten från '>
  > # end of ParaLine
  <ParaLine 
   <String `uppmärksamhetstest eller andra tester '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 122Y2'>
    <MCurrPage `1323'>
    <Unique 1087697>
   > # end of Marker
   <String `(122)'>
   <Font 
    <FTag `'>
    <FDW  -1.0%>
    <FLocked No>
   > # end of Font
   <String `.'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1087700>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `N'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `naproxen:trafik'>
    <MCurrPage `1323'>
    <Unique 1087699>
   > # end of Marker
   <String `aproxen'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1046362>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Naproxen 500 mg 2 timmar före körning i '>
  > # end of ParaLine
  <ParaLine 
   <String `avancerad bilsimulator gav ingen påverkan '>
  > # end of ParaLine
  <ParaLine 
   <String `på körförmågan eller reaktionshastigheten '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 120Y2'>
    <MCurrPage `1323'>
    <Unique 1074278>
   > # end of Marker
   <String `(120)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Tre veckor med 750 mg/dag till äldre '>
  > # end of ParaLine
  <ParaLine 
   <String `gav vissa försämringar i resultaten av neu'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ropsykologiska tester, dock inte signifikanta '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 123Y2'>
    <MCurrPage `1323'>
    <Unique 1074285>
   > # end of Marker
   <String `(123).'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` Att försämringar sågs hos några indi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `vider är anmärkningsvärt eftersom omtest'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ning med samma testbatteri efter 3 veckor '>
  > # end of ParaLine
  <ParaLine 
   <String `bör ge förbättringar pga inlärningseffekter '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 124Y2'>
    <MCurrPage `1323'>
    <Unique 1074292>
   > # end of Marker
   <String `(124,'>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 125Y2'>
    <MCurrPage `1323'>
    <Unique 1074297>
   > # end of Marker
   <String `125)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1046363>
  <PgfTag `Rub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `M03 – '>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `muskelrelaxantia:trafik'>
    <MCurrPage `1323'>
    <Unique 1058341>
   > # end of Marker
   <String `muskelrelaxantia'>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Enskilda preparat'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1027353>
  <PgfTag `Rub3efterRub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `B'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `baklofen:trafik'>
    <MCurrPage `1323'>
    <Unique 1058346>
   > # end of Marker
   <String `aklofen'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1030214>
  <PgfTag `Bröd'>
  <ParaLine 
   <String `Inga för bilkörning relevanta studier har '>
  > # end of ParaLine
  <ParaLine 
   <String `kunnat identifieras. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1053156>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `O'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `orfenadrin:trafik'>
    <MCurrPage `1323'>
    <Unique 1058351>
   > # end of Marker
   <String `rfenadrin '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1053167>
  <PgfTag `Bröd'>
  <ParaLine 
   <String `Inga för bilkörning relevanta studier har '>
  > # end of ParaLine
  <ParaLine 
   <String `kunnat identifieras.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1053168>
  <PgfTag `Rub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <Font 
    <FTag `Intense Emphasis'>
    <FLocked No>
   > # end of Font
   <String `N01 '>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `– '>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `anestetika:trafik'>
    <MCurrPage `1323'>
    <Unique 1058356>
   > # end of Marker
   <String `a'>
   <Font 
    <FTag `Intense Emphasis'>
    <FLocked No>
   > # end of Font
   <String `nestetika'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1046442>
  <PgfTag `Bröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <Font 
    <FTag `Intense Emphasis'>
    <FLocked No>
   > # end of Font
   <String `Trafikolyckor finns rapporterade för patien'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ter som kör hem efter anestesi med fällande '>
  > # end of ParaLine
  <ParaLine 
   <String `domar och ersättningsskyldighet (USA) för '>
  > # end of ParaLine
  <ParaLine 
   <String `anestesiologen respektive operatören '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 126Y2'>
    <MCurrPage `1323'>
    <Unique 1074306>
   > # end of Marker
   <String `(126)'>
   <Font 
    <FTag `Intense Emphasis'>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
   > # end of Font
   <String `. '>
  > # end of ParaLine
  <ParaLine 
   <String `Även om körförbud meddelas förekommer '>
  > # end of ParaLine
  <ParaLine 
   <String `det inte sällan att patienten ändå kör. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1046452>
  <PgfTag `BrödIn'>
  <PgfReferenced Yes>
  <ParaLine 
   <Font 
    <FTag `Intense Emphasis'>
    <FLocked No>
   > # end of Font
   <String `I en intervjustudie var andelen körande '>
  > # end of ParaLine
  <ParaLine 
   <String `trots 24-timmars körförbud 5% efter gene'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `rell anestesi och 2,4% efter regional aneste'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `si eller intravenös sedering '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 127Y2'>
    <MCurrPage `1323'>
    <Unique 1074313>
   > # end of Marker
   <String `(127)'>
   <Font 
    <FTag `Intense Emphasis'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
   > # end of Font
   <String `.'>
   <Font 
    <FTag `Intense Emphasis'>
    <FPlatformName `W.NewCenturySchlbk LT Std.R.400'>
    <FFamily `NewCenturySchlbk LT Std'>
    <FPostScriptName `NewCenturySchlbkLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
   <String ` I en stu'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `die körde 73% av bilägarna inom 24 timmar '>
  > # end of ParaLine
  <ParaLine 
   <String `trots rekommendation om att inte köra. Av '>
  > # end of ParaLine
  <ParaLine 
   <String `de 9% som körde hem efter operationen an'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `gav 1/3 att de var trötta, 4/9 hade huvud'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `värk, 1/3 hade yrsel och några hade illamå'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ende och kräkningar '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 128Y2'>
    <MCurrPage `1323'>
    <Unique 1074320>
   > # end of Marker
   <String `(128)'>
   <Font 
    <FTag `Intense Emphasis'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
   > # end of Font
   <String `.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1067985>
  <PgfTag `BrödIn'>
  <PgfReferenced Yes>
  <ParaLine 
   <Font 
    <FTag `Intense Emphasis'>
    <FLocked No>
   > # end of Font
   <String `I en översiktsartikel noterades att risken '>
  > # end of ParaLine
  <ParaLine 
   <String `för postoperativ nedsättning i kognitiva '>
  > # end of ParaLine
  <ParaLine 
   <String `funktioner inte skiljde sig åt mellan gene'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `rell och regional anestesi '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 129Y2'>
    <MCurrPage `1323'>
    <Unique 1074327>
   > # end of Marker
   <String `(129)'>
   <Font 
    <FTag `Intense Emphasis'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
   > # end of Font
   <String `.'>
   <Font 
    <FTag `Intense Emphasis'>
    <FPlatformName `W.NewCenturySchlbk LT Std.R.400'>
    <FFamily `NewCenturySchlbk LT Std'>
    <FPostScriptName `NewCenturySchlbkLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
   <String ` Genom'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `gången visade också att speciellt äldre var '>
  > # end of ParaLine
  <ParaLine 
   <String `känsliga för postoperativ kognitiv dysfunk'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tion, som kunde finnas kvar 1 vecka post'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `operativt hos 26% av patienterna – i vissa '>
  > # end of ParaLine
  <ParaLine 
   <String `fall upp till månader. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1079841>
  <PgfTag `BrödIn'>
  <PgfReferenced Yes>
  <ParaLine 
   <TextRectID 157>
   <Font 
    <FTag `'>
    <FDW  -1.0%>
    <FLocked No>
   > # end of Font
   <String `I en relativt ny studie undersöktes 20 fris'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ka matchade kontroller mot 20 patienter '>
  > # end of ParaLine
  <ParaLine 
   <String `(medelålder 36 vs 44 år) som skulle genomgå '>
  > # end of ParaLine
  <ParaLine 
   <String `artroskopi. Uppmärksamhetsbrister, mikro'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `sömn och förlängda reaktionstider noterades '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `i patientgruppen 2 timmar post'>
   <Char DiscHyphen>
   <String `operativt '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `'>
    <FDW  -1.0%>
    <FLocked No>
   > # end of Font
   <String `men ingen skillnad sågs efter 24 '>
   <Font 
    <FTag `Intense Emphasis'>
    <FDW  0.0%>
    <FLocked No>
   > # end of Font
   <String `timmar '>
  > # end of ParaLine
  <ParaLine 
   <String `jämfört med baseline före ingreppet '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 130Y2'>
    <MCurrPage `1324'>
    <Unique 1079842>
   > # end of Marker
   <String `(130)'>
   <Font 
    <FTag `Intense Emphasis'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
   > # end of Font
   <String `.'>
   <Font 
    <FTag `Intense Emphasis'>
    <FPlatformName `W.NewCenturySchlbk LT Std.R.400'>
    <FFamily `NewCenturySchlbk LT Std'>
    <FPostScriptName `NewCenturySchlbkLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
   <String ` '>
  > # end of ParaLine
  <ParaLine 
   <String `Tolv frivilliga unga testades i en pilotstudie '>
  > # end of ParaLine
  <ParaLine 
   <String `med generell'>
   <Font 
    <FTag `Intense Emphasis'>
    <FLocked No>
    <FSeparation 1>
    <FColor `White'>
   > # end of Font
   <String `l'>
   <Font 
    <FTag `Intense Emphasis'>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
   > # end of Font
   <String ` anestesi (propofol, desfluran '>
  > # end of ParaLine
  <ParaLine 
   <String `och fentanyl '>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `2, 3, 4 och 24 timmar efter'>
   <Font 
    <FTag `Intense Emphasis'>
    <FLocked No>
   > # end of Font
   <String ` '>
  > # end of ParaLine
  <ParaLine 
   <String `anestesislut) samt med alkohol (0,8‰) och '>
  > # end of ParaLine
  <ParaLine 
   <String `utan droger (med motsvarande intervall) '>
  > # end of ParaLine
  <ParaLine 
   <String `avseende simulatorkörning och psykome'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `triska tester. Man såg ingen kvarstående ef'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `fekt av anestesin efter 2 timmar medan al'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `koholen gav en generell försämring vid alla '>
  > # end of ParaLine
  <ParaLine 
   <String `tidpunkterna '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 131Y2'>
    <MCurrPage `1324'>
    <Unique 1079843>
   > # end of Marker
   <String `(131)'>
   <Font 
    <FTag `Intense Emphasis'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
   > # end of Font
   <String `.'>
   <Font 
    <FTag `Intense Emphasis'>
    <FPlatformName `W.NewCenturySchlbk LT Std.R.400'>
    <FFamily `NewCenturySchlbk LT Std'>
    <FPostScriptName `NewCenturySchlbkLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
   <String ` '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1040974>
  <PgfTag `Rub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <Font 
    <FTag `Intense Emphasis'>
    <FLocked No>
   > # end of Font
   <String `Sammanfattning'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1078864>
  <PgfTag `Bröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <Font 
    <FTag `Intense Emphasis'>
    <FLocked No>
   > # end of Font
   <String `Normal rutin efter generell anestesi förefal'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ler, såväl i Sverige som i flera andra länder, '>
  > # end of ParaLine
  <ParaLine 
   <String `v'>
   <Font 
    <FTag `Intense Emphasis'>
    <FDW  -1.0%>
    <FLocked No>
   > # end of Font
   <String `ara att ge körförbud de närmaste 24 tim'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `marna efter anestesislut '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 132Y2'>
    <MCurrPage `1324'>
    <Unique 1078865>
   > # end of Marker
   <String `(132–134)'>
   <Font 
    <FTag `Intense Emphasis'>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
   > # end of Font
   <String `. En sam'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `manställning återfinns i tabell 2 i Ips och '>
  > # end of ParaLine
  <ParaLine 
   <String `medarbetares artikel '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 134Y2'>
    <MCurrPage `1324'>
    <Unique 1078866>
   > # end of Marker
   <String `(134)'>
   <Font 
    <FTag `Intense Emphasis'>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
   > # end of Font
   <String `. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1067996>
  <PgfTag `BrödIn'>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.NewCenturySchlbk LT Std.R.400'>
    <FFamily `NewCenturySchlbk LT Std'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `NewCenturySchlbkLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  9.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  -0.5%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <HyphenMaxLines 6>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `För moderna kortverkande medel förefal'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ler det som att man inte ser någon påverkan '>
  > # end of ParaLine
  <ParaLine 
   <String `efter 6 timmar men tillägg av sederande lä'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `kemedel förlänger definitivt påverkans'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `tiden. Många kör trots givna rekommenda'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tioner om att inte köra: en del kör hem di'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `rekt efter ingreppet.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1040976>
  <PgfTag `Rub2'>
  <ParaLine 
   <Font 
    <FTag `Intense Emphasis'>
    <FLocked No>
   > # end of Font
   <String `Rekommendationer'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1046540>
  <PgfTag `Bröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <Font 
    <FTag `Intense Emphasis'>
    <FLocked No>
   > # end of Font
   <String `Generellt kan sägas att man inte ska köra '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `bil'>
   <Font 
    <FTag `Intense Emphasis'>
    <FLocked No>
   > # end of Font
   <String ` den närmaste tiden efter det att man har '>
  > # end of ParaLine
  <ParaLine 
   <String `fått anestesimedel. Speciellt viktigt är kör'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `förbudet om sederande läkemedel, t'>
   <Char HardSpace>
   <String `ex mi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `dazolam, givits ensamt eller som komplet'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tering till anestesin. Trots att det inte finns '>
  > # end of ParaLine
  <ParaLine 
   <String `bra vetenskapliga belägg för just gränsen '>
  > # end of ParaLine
  <ParaLine 
   <String `24 timmar verkar det ändå vara en rimlig '>
  > # end of ParaLine
  <ParaLine 
   <String `tid för att återhämta sig efter ingreppet och '>
  > # end of ParaLine
  <ParaLine 
   <String `de givna läkemedlen hinner försvinna ur '>
  > # end of ParaLine
  <ParaLine 
   <String `kroppen. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1068036>
  <PgfTag `BrödIn'>
  <ParaLine 
   <String `För propofol ger förslagsvis 6 timmar en '>
  > # end of ParaLine
  <ParaLine 
   <String `god marginal. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1068041>
  <PgfTag `BrödIn'>
  <ParaLine 
   <Font 
    <FTag `Intense Emphasis'>
    <FLocked No>
   > # end of Font
   <String `Om '>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `endast'>
   <Font 
    <FTag `Intense Emphasis'>
    <FLocked No>
   > # end of Font
   <String ` lustgas ges, där det inte finns '>
  > # end of ParaLine
  <ParaLine 
   <String `hållpunkter för negativ körpåverkan, kan '>
  > # end of ParaLine
  <ParaLine 
   <String `man vara mer liberal. Var tydlig gentemot '>
  > # end of ParaLine
  <ParaLine 
   <String `patienten och förklara att hjärnans kapaci'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <TextRectID 157>
   <String `tet är/kan vara påverkad trots att man kän'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ner sig helt ok.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1056327>
  <PgfTag `Rub2'>
  <ParaLine 
   <Font 
    <FTag `Intense Emphasis'>
    <FLocked No>
   > # end of Font
   <String `Läs vidare'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1056328>
  <PgfTag `RefTextNr1'>
  <PgfNumString `1.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Font 
    <FTag `Intense Emphasis'>
    <FLocked No>
   > # end of Font
   <String `Doc, can I drive home? '>
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 135Y2'>
    <MCurrPage `1324'>
    <Unique 1074367>
   > # end of Marker
   <String `(135) '>
   <Font 
    <FTag `Intense Emphasis'>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
   > # end of Font
   <String `(Editorial 2009.)'>
   <Font 
    <FTag `Intense Emphasis'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1056329>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `2.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Font 
    <FTag `Intense Emphasis'>
    <FLocked No>
   > # end of Font
   <String `Nurse-administrated propofol sedation safety '>
  > # end of ParaLine
  <ParaLine 
   <String `further confirmed – but can we really allow our '>
  > # end of ParaLine
  <ParaLine 
   <String `patients to drive afterwards? '>
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 136Y2'>
    <MCurrPage `1324'>
    <Unique 1074374>
   > # end of Marker
   <String `(136)'>
   <Font 
    <FTag `Intense Emphasis'>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
   > # end of Font
   <String ` (Editorial '>
  > # end of ParaLine
  <ParaLine 
   <String `2008.)'>
   <Font 
    <FTag `Intense Emphasis'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1040981>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `3.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Font 
    <FTag `Intense Emphasis'>
    <FLocked No>
   > # end of Font
   <String `Factors affecting recovery and discharge follo'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `wing ambulatory surgery '>
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 132Y2'>
    <MCurrPage `1324'>
    <Unique 1074381>
   > # end of Marker
   <String `(132)'>
   <Font 
    <FTag `Intense Emphasis'>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
   > # end of Font
   <String `. ('>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `En översikts'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `artikel från'>
   <Font 
    <FTag `Intense Emphasis'>
    <FLocked No>
   > # end of Font
   <String ` 2005.)'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1041009>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `4.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Font 
    <FTag `Intense Emphasis'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <String `Recovery and driving after brief anaesthesia. '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 137Y2'>
    <MCurrPage `1324'>
    <Unique 1074388>
   > # end of Marker
   <String `(137)'>
   <Font 
    <FTag `Intense Emphasis'>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
   > # end of Font
   <String `. ('>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `En översiktsartikel från'>
   <Font 
    <FTag `Intense Emphasis'>
    <FLocked No>
   > # end of Font
   <String ` 1981.)'>
   <Font 
    <FTag `Intense Emphasis'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1041024>
  <PgfTag `Rub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Enskilda preparat'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1041016>
  <PgfTag `Rub3efterRub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <Font 
    <FTag `Intense Emphasis'>
    <FLocked No>
   > # end of Font
   <String `D'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `droperidol:trafik'>
    <MCurrPage `1324'>
    <Unique 1058361>
   > # end of Marker
   <String `roperidol'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1051487>
  <PgfTag `PrepBröd'>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.NewCenturySchlbk LT Std.R.400'>
    <FFamily `NewCenturySchlbk LT Std'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `NewCenturySchlbkLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  8.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  -1.0%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <Font 
    <FTag `Intense Emphasis'>
    <FLocked No>
   > # end of Font
   <String `Droperidol, 2,5 mg intramuskulärt, gav för'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `sämrad körförmåga i simulator 30 minuter '>
  > # end of ParaLine
  <ParaLine 
   <String `efter injektion '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 138Y2'>
    <MCurrPage `1324'>
    <Unique 1074399>
   > # end of Marker
   <String `(138)'>
   <Font 
    <FTag `Intense Emphasis'>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
   > # end of Font
   <String `. Fem milligram intra'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `venöst gav påverkan på kognitiva funktioner '>
  > # end of ParaLine
  <ParaLine 
   <String `i minst 10 timmar efter injektion '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 139Y2'>
    <MCurrPage `1324'>
    <Unique 1074406>
   > # end of Marker
   <String `(139)'>
   <Font 
    <FTag `Intense Emphasis'>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
   > # end of Font
   <String ` medan '>
  > # end of ParaLine
  <ParaLine 
   <String `andra hävdar kvarstående effekter '>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `\>'>
   <Char HardSpace>
   <Font 
    <FTag `Intense Emphasis'>
    <FLocked No>
   > # end of Font
   <String `24 tim'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `mar '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 140Y2'>
    <MCurrPage `1324'>
    <Unique 1074413>
   > # end of Marker
   <String `(140,'>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 141Y2'>
    <MCurrPage `1324'>
    <Unique 1074418>
   > # end of Marker
   <String `141)'>
   <Font 
    <FTag `Intense Emphasis'>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
   > # end of Font
   <String ` eller '>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `\>'>
   <Char HardSpace>
   <Font 
    <FTag `Intense Emphasis'>
    <FLocked No>
   > # end of Font
   <String `48 timmar '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 142Y2'>
    <MCurrPage `1324'>
    <Unique 1074424>
   > # end of Marker
   <String `(142).'>
   <Font 
    <FTag `Intense Emphasis'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1051488>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <Font 
    <FTag `Intense Emphasis'>
    <FLocked No>
   > # end of Font
   <String `L'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `lustgas:trafik'>
    <MCurrPage `1324'>
    <Unique 1058366>
   > # end of Marker
   <String `ustgas'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1068063>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <Font 
    <FTag `Intense Emphasis'>
    <FLocked No>
   > # end of Font
   <String `Lustgas, 30%, kan påverka psykomotoriken '>
  > # end of ParaLine
  <ParaLine 
   <String `10–20 minuter efter avslutad behandling '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 143Y2'>
    <MCurrPage `1324'>
    <Unique 1074431>
   > # end of Marker
   <String `(143)'>
   <Font 
    <FTag `Intense Emphasis'>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
   > # end of Font
   <String `. I en studie gav man lustgas till patien'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ter i samband med sigmoideoskopi och '>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `jäm'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `förde med '>
   <Font 
    <FTag `Intense Emphasis'>
    <FLocked No>
   > # end of Font
   <String `matchade kontroller ('>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `n = '>
   <Font 
    <FTag `Intense Emphasis'>
    <FLocked No>
   > # end of Font
   <String `40 + 40). '>
  > # end of ParaLine
  <ParaLine 
   <String `Vid testning av komplex motorisk förmåga '>
  > # end of ParaLine
  <ParaLine 
   <String `fann man inte någon negativ påverkan på '>
  > # end of ParaLine
  <ParaLine 
   <String `kognitionen utan snarast en förbättring '>
  > # end of ParaLine
  <ParaLine 
   <String `mätt ca 10 minuter efter avslutad administ'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `ration av gasen '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 144Y2'>
    <MCurrPage `1324'>
    <Unique 1074438>
   > # end of Marker
   <String `(144).'>
   <Font 
    <FTag `Intense Emphasis'>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
   > # end of Font
   <String ` '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1077511>
  <PgfTag `PrepBröd'>
  <Pgf 
   <PgfFIndent  6.0 mm>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <Font 
    <FTag `Intense Emphasis'>
    <FLocked No>
   > # end of Font
   <String `I en opublicerad studie från TrMC (Trafik'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `medicinskt Centrum, Karolinska Universi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tetssjukhuset i Huddinge) såg man inte hel'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ler någon påverkan på resultaten i ett simul'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tankapacitets- och reaktionstidstest ca 30 '>
  > # end of ParaLine
  <ParaLine 
   <String `minuter efter anestesin vid artroskopi.  '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1046625>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <Font 
    <FTag `Intense Emphasis'>
    <FLocked No>
   > # end of Font
   <String `P'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `propofol:trafik'>
    <MCurrPage `1324'>
    <Unique 1058371>
   > # end of Marker
   <String `ropofol'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1046658>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <Font 
    <FTag `Intense Emphasis'>
    <FLocked No>
   > # end of Font
   <String `Vid test av propofol vid '>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `0,2, 0,4 '>
   <Font 
    <FTag `Intense Emphasis'>
    <FLocked No>
   > # end of Font
   <String `och 0,8 mik'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `rog/L sågs påverkan på kognitiva funktioner '>
  > # end of ParaLine
  <ParaLine 
   <String `vid alla tre nivåerna '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 145Y2'>
    <MCurrPage `1324'>
    <Unique 1074445>
   > # end of Marker
   <String `(145)'>
   <Font 
    <FTag `Intense Emphasis'>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
   > # end of Font
   <String `. Propofol gav 1/2 '>
  > # end of ParaLine
  <ParaLine 
   <String `timme efter administrering kvarstående '>
  > # end of ParaLine
  <ParaLine 
   <String `kognitiva effekter motsvarande inverkan av '>
  > # end of ParaLine
  <ParaLine 
   <String `BAC (blodalkoholkoncentration) 1,1‰ '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 23Y2'>
    <MCurrPage `1324'>
    <Unique 1074452>
   > # end of Marker
   <String `(23)'>
   <Font 
    <FTag `Intense Emphasis'>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
   > # end of Font
   <String `. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1046709>
  <PgfTag `PrepBröd'>
  <Pgf 
   <PgfFIndent  6.0 mm>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <Font 
    <FTag `Intense Emphasis'>
    <FLocked No>
   > # end of Font
   <String `I tester och simulerad körning presterade '>
  > # end of ParaLine
  <ParaLine 
   <String `patienter som fått propofol efter 2 timmar '>
  > # end of ParaLine
  <ParaLine 
   <String `jämförbart (eller bättre) som vid baseline, '>
  > # end of ParaLine
  <ParaLine 
   <TextRectID 158>
   <String `medan patienter som fått midazolam + peti'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `din vid endoskopin fortfarande efter 2 tim'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `mar presterade signifikant sämre än vid '>
  > # end of ParaLine
  <ParaLine 
   <String `baseline '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 146Y2'>
    <MCurrPage `1325'>
    <Unique 1074459>
   > # end of Marker
   <String `(146)'>
   <Font 
    <FTag `Intense Emphasis'>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
   > # end of Font
   <String `. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1046758>
  <PgfTag `PrepBröd'>
  <Pgf 
   <PgfFIndent  6.0 mm>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <Font 
    <FTag `Intense Emphasis'>
    <FLocked No>
   > # end of Font
   <String `I en senare studie gavs propofol alterna'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tivt midazolam eller placebo inför gastrosko'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `pi. Körförmågan testades i bilsimulator före '>
  > # end of ParaLine
  <ParaLine 
   <String `och efter undersökningen. I propofolgruppen '>
  > # end of ParaLine
  <ParaLine 
   <String `hade 97,5% återhämtat sig efter 30 minuter '>
  > # end of ParaLine
  <ParaLine 
   <String `och alla efter 60 minuter medan man i mida'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `zolamgruppen fortfarande hade signifikant '>
  > # end of ParaLine
  <ParaLine 
   <String `sämre värden efter 2 timmar jämfört med '>
  > # end of ParaLine
  <ParaLine 
   <String `baseline '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 147Y2'>
    <MCurrPage `1325'>
    <Unique 1074466>
   > # end of Marker
   <String `(147)'>
   <Font 
    <FTag `Intense Emphasis'>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
   > # end of Font
   <String `. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1046767>
  <PgfTag `PrepBröd'>
  <Pgf 
   <PgfFIndent  6.0 mm>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <Font 
    <FTag `Intense Emphasis'>
    <FLocked No>
   > # end of Font
   <String `I en annan studie undersöktes effekterna '>
  > # end of ParaLine
  <ParaLine 
   <String `av intravenös injektion med propofol (2,4 '>
  > # end of ParaLine
  <ParaLine 
   <String `mg/kg '>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `kroppsvikt'>
   <Font 
    <FTag `Intense Emphasis'>
    <FLocked No>
   > # end of Font
   <String `) inför kolo- eller gastro'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `skopi före, strax efter och efter 1 och 2 tim'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `mar, varvid 4% uppvisade lätt kognitiv ned'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `sättning efter 2 timmar. Omedelbart efter '>
  > # end of ParaLine
  <ParaLine 
   <String `narkosen sågs påtaglig nedsättning av kog'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `nitiva funktioner motsvarande måttligt de'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `menstillstånd. Författaren rekommenderar '>
  > # end of ParaLine
  <ParaLine 
   <String `bilkörning tidigast efter 6 timmar '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 148Y2'>
    <MCurrPage `1325'>
    <Unique 1074478>
   > # end of Marker
   <String `(148)'>
   <Font 
    <FTag `Blue'>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
   > # end of Font
   <String `.'>
   <Font 
    <FTag `Intense Emphasis'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLanguage Swedish>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1027363>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <Font 
    <FTag `Intense Emphasis'>
    <FLocked No>
   > # end of Font
   <String `T'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `tiopental:trafik'>
    <MCurrPage `1325'>
    <Unique 1058376>
   > # end of Marker
   <String `iopental'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1030328>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <Font 
    <FTag `Intense Emphasis'>
    <FLocked No>
   > # end of Font
   <String `Korttila och medarbetare studerade tiopen'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tal och konstaterade att försämrad körför'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `måga i simulator kvarstod i 6 timmar och '>
  > # end of ParaLine
  <ParaLine 
   <String `försämrad reaktionsförmåga i 8 timmar ef'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ter anestesin. Författarna föreslår 24 tim'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `mars körförbud vid tiopentalanestesi '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 149Y2'>
    <MCurrPage `1325'>
    <Unique 1074485>
   > # end of Marker
   <String `(149)'>
   <Font 
    <FTag `Intense Emphasis'>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
   > # end of Font
   <String `. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1027377>
  <PgfTag `Rub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <Font 
    <FTag `Intense Emphasis'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 9>
    <MTypeName `Cross-Ref'>
    <MText `14361: Rub2: N02 – analgetika\x0d '>
    <MCurrPage `1325'>
    <Unique 1082521>
   > # end of Marker
   <String `N02 '>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `–'>
   <Font 
    <FTag `Intense Emphasis'>
    <FLocked No>
   > # end of Font
   <String ` '>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `analgetika:trafik'>
    <MCurrPage `1325'>
    <Unique 1058381>
   > # end of Marker
   <String `analgetika'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1087753>
  <PgfTag `Bröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <Font 
    <FTag `'>
    <FDW  -0.5%>
    <FLocked No>
   > # end of Font
   <String `Smärta i sig har i flera studier visat sig på'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `verka reaktionshastigheten och andra kog'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `nitiva funktioner '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 150Y2'>
    <MCurrPage `1325'>
    <Unique 1087754>
   > # end of Marker
   <String `(150–153)'>
   <Font 
    <FTag `'>
    <FDW  -0.5%>
    <FLocked No>
   > # end of Font
   <String ` varför det är '>
  > # end of ParaLine
  <ParaLine 
   <String `viktigt att behandla smärtan adekvat. Att '>
  > # end of ParaLine
  <ParaLine 
   <String `opioider av olika slag inverkar negativt på '>
  > # end of ParaLine
  <ParaLine 
   <String `kognitiva funktioner och körförmåga har vi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `sats i flera studier och lett till att man van'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ligen avråder från bilkörning. I de få studier '>
  > # end of ParaLine
  <ParaLine 
   <String `som finns där analgetika relateras till före'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `komst av trafikolyckor framskymtar kodein '>
  > # end of ParaLine
  <ParaLine 
   <String `och dextropropoxifen som riskläkemedel. '>
  > # end of ParaLine
  <ParaLine 
   <String `Trafikolyckor med personskador studerades '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `a'>
   <Font 
    <FTag `'>
    <FDW  -0.5%>
    <FLocked No>
   > # end of Font
   <String `v Engeland och medarbetare '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 154Y2'>
    <MCurrPage `1325'>
    <Unique 1087755>
   > # end of Marker
   <String `(154)'>
   <Font 
    <FTag `'>
    <FDW  -0.5%>
    <FLocked No>
   > # end of Font
   <String ` som '>
  > # end of ParaLine
  <ParaLine 
   <String `fann en riskökning på 2,0 (1,7–2,4) med '>
  > # end of ParaLine
  <ParaLine 
   <String `opia'>
   <Char DiscHyphen>
   <String `ter i allmänhet och där äldre (55–69 år) '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `'>
    <FDW  -1.0%>
    <FLocked No>
   > # end of Font
   <String `hade en lägre risk än yngre (18–54 år). Efter'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `som dextropropoxifen avregistrerats kom'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `menteras inte dessa studier. '>
   <Font 
    <FTag `'>
    <FDW  -0.5%>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1046799>
  <PgfTag `Rub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <TextRectID 158>
   <String `Sammanfattning'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1046810>
  <PgfTag `Bröd'>
  <ParaLine 
   <String `Man ser ingen negativ inverkan av analge'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tikamedicinering vid långtidsbehandling '>
  > # end of ParaLine
  <ParaLine 
   <String `men däremot vid intag av engångsdoser, in'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `sättning och dosjusteringar. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1046811>
  <PgfTag `Rub2'>
  <ParaLine 
   <String `Rekommendation'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1079921>
  <PgfTag `Bröd'>
  <ParaLine 
   <String `Stabil underhållsdosering av starka lång'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `samt frisättande (depåberedningar) analge'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tika är vanligtvis inte något hinder för bil'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `körning, men individuell bedömning måste '>
  > # end of ParaLine
  <ParaLine 
   <String `ske med tanke på biverkningar, övrig medi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `cinering och grundsjukdom. I litteraturen '>
  > # end of ParaLine
  <ParaLine 
   <String `föreslås minst 1 veckas stabil dosering och '>
  > # end of ParaLine
  <ParaLine 
   <String `minst 1 dygns körförbud vid extradoser. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1068067>
  <PgfTag `BrödIn'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `En allmän rekommendation efter en en'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `gångsbehandling vid operativa ingrepp är '>
  > # end of ParaLine
  <ParaLine 
   <String `att 1 dygns bilkörningskarens bör vara rim'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `lig.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1068068>
  <PgfTag `Rub2'>
  <ParaLine 
   <String `Läs vidare'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1041146>
  <PgfTag `RefTextNr1'>
  <PgfNumString `1.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Chronic pain and neuropsychological functioning '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 153Y2'>
    <MCurrPage `1325'>
    <Unique 1074509>
   > # end of Marker
   <String `(153)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `.'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1041147>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `2.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `A review of the effects of opioids on psychomo'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tor and cognitive functioning in humans '>
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 155Y2'>
    <MCurrPage `1325'>
    <Unique 1074520>
   > # end of Marker
   <String `(155)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. '>
  > # end of ParaLine
  <ParaLine 
   <String `(En översiktsartikel från 1995.)'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1055201>
  <PgfTag `RefTextNrForts'>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
    <FFamily `Frutiger LT Std 55 Roman'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  7.5 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage USEnglish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLanguage USEnglish>
  > # end of Pgf
  <PgfNumString `3.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Effects of intermediate- and long-term use of '>
  > # end of ParaLine
  <ParaLine 
   <String `opioids on cognition in patients with chronic '>
  > # end of ParaLine
  <ParaLine 
   <String `pain '>
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 156Y2'>
    <MCurrPage `1325'>
    <Unique 1074527>
   > # end of Marker
   <String `(156)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1055202>
  <PgfTag `Rub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Enskilda preparat'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1027380>
  <PgfTag `Rub3efterRub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `A'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `acetylsalicylsyra:trafik'>
    <MCurrPage `1325'>
    <Unique 1058386>
   > # end of Marker
   <String `cetylsalicylsyra'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1079938>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Resultaten av kognitiva tester jämfördes '>
  > # end of ParaLine
  <ParaLine 
   <String `mellan personer som tog (n = 1'>
   <Char HardSpace>
   <String `130) respek'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tive inte tog (n = 3'>
   <Char HardSpace>
   <String `251) acetylsalicylsyra un'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `der de senaste två veckorna'>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <String `.'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` Ingen skillnad '>
  > # end of ParaLine
  <ParaLine 
   <String `noterades '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 157Y2'>
    <MCurrPage `1325'>
    <Unique 1079939>
   > # end of Marker
   <String `(157)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Acetylsalicylsyra jämfört '>
  > # end of ParaLine
  <ParaLine 
   <String `med placebo efter 4 års medicinering visade '>
  > # end of ParaLine
  <ParaLine 
   <String `ingen skillnad i resultaten av kognitiva tes'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ter '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 158Y2'>
    <MCurrPage `1325'>
    <Unique 1079940>
   > # end of Marker
   <String `(158)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1027381>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `B'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `buprenorfin:trafik'>
    <MCurrPage `1325'>
    <Unique 1058391>
   > # end of Marker
   <String `uprenorfin'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1030400>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `På samma sätt som Sabatowski och med'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `arbet'>
   <Char DiscHyphen>
   <String `are '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 159Y2'>
    <MCurrPage `1325'>
    <Unique 1074559>
   > # end of Marker
   <String `(159)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` har Dagtekin och medarbet'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `are visat '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 160Y2'>
    <MCurrPage `1325'>
    <Unique 1074570>
   > # end of Marker
   <String `(160)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` att inte heller stabil långtids'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `behandling med buprenorfinplåster påver'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `kade kognitiva funktioner jämfört med '>
  > # end of ParaLine
  <ParaLine 
   <String `kontroller. Däremot gett som en engångsdos '>
  > # end of ParaLine
  <ParaLine 
   <String `int'>
   <Char DiscHyphen>
   <String `ramuskulärt sågs en påverkan på kogni'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tiva funktioner med maximal effekt efter 4 '>
  > # end of ParaLine
  <ParaLine 
   <String `timmar och kvarstående effekt efter 8 tim'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `mar '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 117Y2'>
    <MCurrPage `1325'>
    <Unique 1074577>
   > # end of Marker
   <String `(117).'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1027382>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <TextRectID 159>
   <String `F'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `fentanyl:trafik'>
    <MCurrPage `1326'>
    <Unique 1058396>
   > # end of Marker
   <String `entanyl'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1078910>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Fentanyl (0,2 mikrog/kg kroppsvikt) har ef'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `fekter på kognitiva funktioner jämförbara '>
  > # end of ParaLine
  <ParaLine 
   <String `med en låg dos alkohol (BAC = 0,3‰) 15 mi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `nuter efter administration och gav en för'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `sämring i 4 av 8 testparametrar mot endast '>
  > # end of ParaLine
  <ParaLine 
   <String `försämring i visuell reaktionstid för alkohol '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 161Y2'>
    <MCurrPage `1326'>
    <Unique 1078911>
   > # end of Marker
   <String `(161)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Mätt efter 1,5 timme efter intravenös '>
  > # end of ParaLine
  <ParaLine 
   <String `administration sågs ingen skillnad jämfört '>
  > # end of ParaLine
  <ParaLine 
   <String `med placebo '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 23Y2'>
    <MCurrPage `1326'>
    <Unique 1078912>
   > # end of Marker
   <String `(23)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. När 100 mikrog fentanyl '>
  > # end of ParaLine
  <ParaLine 
   <String `gavs intravenöst erhölls sämre resultat i tes'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ter än för diazepam som kvarstod efter 2 '>
  > # end of ParaLine
  <ParaLine 
   <String `timmar. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1078931>
  <PgfTag `PrepBröd'>
  <Pgf 
   <PgfFIndent  6.0 mm>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `Kognitiva effekter av långtidsbehandling '>
  > # end of ParaLine
  <ParaLine 
   <String `med fentanylplåster undersöktes i en studie '>
  > # end of ParaLine
  <ParaLine 
   <String `och för 21 smärtpatienter noterades ingen '>
  > # end of ParaLine
  <ParaLine 
   <String `kognitiv påverkan jämfört med 0,5‰ BAC '>
  > # end of ParaLine
  <ParaLine 
   <String `utan fentanylgruppen var helt jämförbar '>
  > # end of ParaLine
  <ParaLine 
   <String `med en kontrollgrupp (friska) '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 159Y2'>
    <MCurrPage `1326'>
    <Unique 1078932>
   > # end of Marker
   <String `(159)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Någon '>
  > # end of ParaLine
  <ParaLine 
   <String `försämring sågs inte heller för fentanyl '>
  > # end of ParaLine
  <ParaLine 
   <String `44'>
   <Char HardSpace>
   <String `mikrog/timme förutom hos några äldre '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 162Y2'>
    <MCurrPage `1326'>
    <Unique 1078933>
   > # end of Marker
   <String `(162)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Med stabil dos (\>'>
   <Char HardSpace>
   <String `12 dagar) med '>
  > # end of ParaLine
  <ParaLine 
   <String `25–400 mikrog/timme var resultaten jämför'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `bara med en kontrollgrupp och påverkan '>
  > # end of ParaLine
  <ParaLine 
   <String `<'>
   <Char HardSpace>
   <String `0,5‰ BAC '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 159Y2'>
    <MCurrPage `1326'>
    <Unique 1078934>
   > # end of Marker
   <String `(159)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1055229>
  <PgfTag `PrepBröd'>
  <Pgf 
   <PgfFIndent  6.0 mm>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `Vid fentanylplåster som tillägg till oxiko'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `don sågs efter 1 månad snarast förbättring'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ar vid simulerad körning '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 163Y2'>
    <MCurrPage `1326'>
    <Unique 1074624>
   > # end of Marker
   <String `(163).'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1055230>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `K'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `kodein:trafik'>
    <MCurrPage `1326'>
    <Unique 1058401>
   > # end of Marker
   <String `odein'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1087768>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Bachs och medarbetare '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 164Y2'>
    <MCurrPage `1326'>
    <Unique 1087767>
   > # end of Marker
   <String `(164)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` visade 2009 att '>
  > # end of ParaLine
  <ParaLine 
   <String `riskökningen för trafikolyckor där föraren '>
  > # end of ParaLine
  <ParaLine 
   <String `fått kodein förskrivet och där preparatet '>
  > # end of ParaLine
  <ParaLine 
   <String `hämtades ut <'>
   <Char HardSpace>
   <String `1 vecka innan trafikolyckan '>
  > # end of ParaLine
  <ParaLine 
   <String `var 1,9 (1,2–'>
   <Char DiscHyphen>
   <String `2,2) gånger, medan risken för '>
  > # end of ParaLine
  <ParaLine 
   <String `tramadol inte var signifikant 1,5 (1,0–1,6). '>
  > # end of ParaLine
  <ParaLine 
   <String `I'>
   <Char HardSpace>
   <String `kodeingruppen förekom blandmedicine'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ring med bl'>
   <Char HardSpace>
   <String `a opioider, bensodiazepiner och '>
  > # end of ParaLine
  <ParaLine 
   <String `sömnmedel och som när dessa uteslöts ledde '>
  > # end of ParaLine
  <ParaLine 
   <String `till en riskökning på 1,3 (1,0–1,6), dock ej '>
  > # end of ParaLine
  <ParaLine 
   <String `signifikant. I högdosgruppen med kodein '>
  > # end of ParaLine
  <ParaLine 
   <String `(som fick \>'>
   <Char HardSpace>
   <String `60 dygnsdoser förskrivet) blev '>
  > # end of ParaLine
  <ParaLine 
   <String `riskökningen 2,9 (2,3–3,6). Dynamisk syn'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `skärpa påverkades negativt vid 90 mg vs '>
  > # end of ParaLine
  <ParaLine 
   <String `placebo, visuomotorisk koordination vid '>
  > # end of ParaLine
  <ParaLine 
   <String `60'>
   <Char HardSpace>
   <String `mg medan ingen påverkan sågs på reak'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tionstider '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 165Y2'>
    <MCurrPage `1326'>
    <Unique 1087769>
   > # end of Marker
   <String `(165)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1079955>
  <PgfTag `PrepBröd'>
  <Pgf 
   <PgfFIndent  6.0 mm>
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.NewCenturySchlbk LT Std.R.400'>
    <FFamily `NewCenturySchlbk LT Std'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `NewCenturySchlbkLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  8.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  -1.0%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <HyphenMaxLines 6>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <Font 
    <FTag `'>
    <FDW  0.0%>
    <FLocked No>
   > # end of Font
   <String `Vid test i körsimulator visade det sig att '>
  > # end of ParaLine
  <ParaLine 
   <String `60 mg inte påverkade körförmågan '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 166Y2'>
    <MCurrPage `1326'>
    <Unique 1079956>
   > # end of Marker
   <String `(166)'>
   <Font 
    <FTag `'>
    <FDW  0.0%>
    <FLocked No>
   > # end of Font
   <String ` och '>
  > # end of ParaLine
  <ParaLine 
   <String `i en senare studie med patienter som tog '>
  > # end of ParaLine
  <ParaLine 
   <String `127–'>
   <Char DiscHyphen>
   <String `270 mg/dag uppvisades samma körför'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `måga som hos patienter utan kodein – 1 re'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `spek'>
   <Char DiscHyphen>
   <String `tive 5 timmar efter senaste dos '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 167Y2'>
    <MCurrPage `1326'>
    <Unique 1079957>
   > # end of Marker
   <String `(167).'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1027384>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <TextRectID 159>
   <String `M'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `metadon:trafik'>
    <MCurrPage `1326'>
    <Unique 1058406>
   > # end of Marker
   <String `etadon'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1030492>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Metadon givet i smärtstillande syfte gav '>
  > # end of ParaLine
  <ParaLine 
   <String `snarast, efter upptitrering och vid steady '>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `state, en förbättring i uppmärksamhet och '>
  > # end of ParaLine
  <ParaLine 
   <String `psykomotorik '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 168Y2'>
    <MCurrPage `1326'>
    <Unique 1074663>
   > # end of Marker
   <String `(168).'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1027385>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `M'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `morfin:trafik'>
    <MCurrPage `1326'>
    <Unique 1058411>
   > # end of Marker
   <String `orfin'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1030507>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Långtidsbehandling med morfinpreparat '>
  > # end of ParaLine
  <ParaLine 
   <String `(långsam frisättning) undersöktes med kog'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `nitiva tester under 1 år med doserna 40–140 '>
  > # end of ParaLine
  <ParaLine 
   <String `mg/dygn vid en 12-månadersuppföljning. '>
  > # end of ParaLine
  <ParaLine 
   <String `Resultaten låg hela tiden inom normalvär'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `desgränserna för de olika testerna och man '>
  > # end of ParaLine
  <ParaLine 
   <String `såg inte heller något samband mellan dos '>
  > # end of ParaLine
  <ParaLine 
   <String `och testresultat '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 169Y2'>
    <MCurrPage `1326'>
    <Unique 1074670>
   > # end of Marker
   <String `(169)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1068178>
  <PgfTag `PrepBröd'>
  <Pgf 
   <PgfFIndent  6.0 mm>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `Två veckors stabil dosering med långsamt '>
  > # end of ParaLine
  <ParaLine 
   <String `frisatt morfin (60–1'>
   <Char HardSpace>
   <String `100 mg/24 timmar) '>
  > # end of ParaLine
  <ParaLine 
   <String `medförde ingen försämring i resultaten av '>
  > # end of ParaLine
  <ParaLine 
   <String `kognitiva tester utom i ett fåtal fall där sam'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tidigt intag av ett neuroleptikum, haloperi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `dol, mot illamående angavs som trolig orsak '>
  > # end of ParaLine
  <ParaLine 
   <String `till nedsättningen '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 170Y2'>
    <MCurrPage `1326'>
    <Unique 1074678>
   > # end of Marker
   <String `(170).'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1047015>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `O'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `oxikodon:trafik'>
    <MCurrPage `1326'>
    <Unique 1058416>
   > # end of Marker
   <String `xikodon'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1068196>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Oxikodon (35 mikrog/24 timmar) gav efter '>
  > # end of ParaLine
  <ParaLine 
   <String `90 dagars behandling ingen försämring eller '>
  > # end of ParaLine
  <ParaLine 
   <String `förbättring av kognitionen på gruppnivå och '>
  > # end of ParaLine
  <ParaLine 
   <String `i de enskilda fall där försämring sågs fanns '>
  > # end of ParaLine
  <ParaLine 
   <String `huvudsakligen äldre '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 162Y2'>
    <MCurrPage `1326'>
    <Unique 1074686>
   > # end of Marker
   <String `(162)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Personer med '>
  > # end of ParaLine
  <ParaLine 
   <String `stabil dosering de senaste 12 dagarna med '>
  > # end of ParaLine
  <ParaLine 
   <String `\>'>
   <Char HardSpace>
   <String `4 veckors behandling (långsamt frisatt oxi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `kodon) presterade som friska kontroller och '>
  > # end of ParaLine
  <ParaLine 
   <String `ingen sämre än motsvarande BAC 0,5‰ '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 171Y2'>
    <MCurrPage `1326'>
    <Unique 1074693>
   > # end of Marker
   <String `(171).'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1027387>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `T'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `tramadol:trafik'>
    <MCurrPage `1326'>
    <Unique 1058421>
   > # end of Marker
   <String `ramadol'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1047056>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Tramadol undersöktes parallellt med kodein '>
  > # end of ParaLine
  <ParaLine 
   <String `varvid man fann en icke signifikant olycks'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `riskökning för tramadol med 1,5 gånger '>
  > # end of ParaLine
  <ParaLine 
   <String `(0,9–2,3), men trenden över tid var uppåtgå'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ende '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 164Y2'>
    <MCurrPage `1326'>
    <Unique 1074701>
   > # end of Marker
   <String `(164)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Tramadol givet som en 20 mg bo'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `lusdos postoperativt jämfördes med 10 mik'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `rog fentanyl varvid signifikant färre med '>
  > # end of ParaLine
  <ParaLine 
   <String `fentanyl kunde fullfölja ett neuropsykolo'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `giskt test än i tramadolgruppen dag 1, men '>
  > # end of ParaLine
  <ParaLine 
   <String `resultatmässigt sågs ingen skillnad bland '>
  > # end of ParaLine
  <ParaLine 
   <String `dem som fullföljde testet '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 172Y2'>
    <MCurrPage `1326'>
    <Unique 1074708>
   > # end of Marker
   <String `(172)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1047061>
  <PgfTag `PrepBröd'>
  <Pgf 
   <PgfFIndent  6.0 mm>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `I övrigt finns inga relevanta studier i Pub'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `Med för tramadol utöver några rättsmedi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `cinska artiklar '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 173Y2'>
    <MCurrPage `1326'>
    <Unique 1074715>
   > # end of Marker
   <String `(173,'>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 174Y2'>
    <MCurrPage `1326'>
    <Unique 1074720>
   > # end of Marker
   <String `174)'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
   <String `.'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` Förhöjd kramprisk '>
  > # end of ParaLine
  <ParaLine 
   <String `har observerats '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 175Y2'>
    <MCurrPage `1326'>
    <Unique 1074726>
   > # end of Marker
   <String `(175)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` och bör beaktas för bil'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `förare speciellt vid tidigare stroke, skallska'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `da eller alkoholmissbruk '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 176Y2'>
    <MCurrPage `1326'>
    <Unique 1074733>
   > # end of Marker
   <String `(176).'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1047079>
  <PgfTag `Rub3'>
  <ParaLine 
   <TextRectID 160>
   <String `Kombinationsbehandling'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1047115>
  <PgfTag `PrepBrödIndrag'>
  <Pgf 
   <PgfFIndent  3.0 mm>
  > # end of Pgf
  <ParaLine 
   <String `Vid kombinationer av analgetika eller till'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `sammans med andra läkemedel av centralt '>
  > # end of ParaLine
  <ParaLine 
   <String `verkande typ är det vetenskapliga underla'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `get osäkert och stor försiktighet är påkallad. '>
  > # end of ParaLine
  <ParaLine 
   <String `För att förstärka den analgetiska effekten '>
  > # end of ParaLine
  <ParaLine 
   <String `kombineras ofta behandlingen med ett an'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `nat ”trafikfarligt” (= har trafikvarningstext) '>
  > # end of ParaLine
  <ParaLine 
   <String `läkemedel.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1047121>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Analgetika med perifera effekter'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1079999>
  <PgfTag `PrepBrödIndrag'>
  <Pgf 
   <PgfFIndent  3.0 mm>
  > # end of Pgf
  <ParaLine 
   <String `Analgetika med perifera effekter förväntas '>
  > # end of ParaLine
  <ParaLine 
   <String `inte ha några effekter på centrala nervsy'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `stemet och har därför inte tagits upp här '>
  > # end of ParaLine
  <ParaLine 
   <String `med undantag för acetylsalicylsyra.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1079982>
  <PgfTag `Rub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <Font 
    <FTag `Intense Emphasis'>
    <FLocked No>
   > # end of Font
   <String `N02C '>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `–'>
   <Font 
    <FTag `Intense Emphasis'>
    <FLocked No>
   > # end of Font
   <String ` '>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `antimigränmedel:trafik'>
    <MCurrPage `1327'>
    <Unique 1079981>
   > # end of Marker
   <String `antimigränmedel'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1079008>
  <PgfTag `Bröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Migränsjukdom befanns vara signifikant '>
  > # end of ParaLine
  <ParaLine 
   <String `associerad med kollisionsolyckor bland fö'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `rare inom det israeliska försvaret '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 177Y2'>
    <MCurrPage `1327'>
    <Unique 1079009>
   > # end of Marker
   <String `(177)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` men '>
  > # end of ParaLine
  <ParaLine 
   <String `någon ytterligare studie har dock inte kun'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `nat återfinnas. Det finns studier som pekar '>
  > # end of ParaLine
  <ParaLine 
   <String `på nedsatt kognition/visuell dysfunktion i '>
  > # end of ParaLine
  <ParaLine 
   <String `perioderna mellan attacker '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 178Y2'>
    <MCurrPage `1327'>
    <Unique 1079010>
   > # end of Marker
   <String `(178–180)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `, spe'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ciellt hos dem med aura '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 181Y2'>
    <MCurrPage `1327'>
    <Unique 1079011>
   > # end of Marker
   <String `(181,'>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 182Y2'>
    <MCurrPage `1327'>
    <Unique 1079012>
   > # end of Marker
   <String `182)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Andra '>
  > # end of ParaLine
  <ParaLine 
   <String `studier har dock inte kunnat påvisa någon '>
  > # end of ParaLine
  <ParaLine 
   <String `nedsatt kognition '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 183Y2'>
    <MCurrPage `1327'>
    <Unique 1079013>
   > # end of Marker
   <String `(183,'>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 184Y2'>
    <MCurrPage `1327'>
    <Unique 1079014>
   > # end of Marker
   <String `184),'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` bl'>
   <Char HardSpace>
   <String `a en studie '>
  > # end of ParaLine
  <ParaLine 
   <String `där man använde ett omfattande testbatte'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ri men på endast yngre som hade haft mi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `grän under en relativt kort tid. Inte heller '>
  > # end of ParaLine
  <ParaLine 
   <String `migränpatienter med en längre sjukdoms'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tid (i medeltal 18 år) uppvisade i en annan '>
  > # end of ParaLine
  <ParaLine 
   <String `studie någon skillnad i kognitiva funktioner '>
  > # end of ParaLine
  <ParaLine 
   <String `jämfört med kontroller '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 185Y2'>
    <MCurrPage `1327'>
    <Unique 1079015>
   > # end of Marker
   <String `(185)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `.  '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1047247>
  <PgfTag `BrödIn'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Trötthet/sömnighet är en vanlig rappor'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `terad biverkning av alla triptanläkemedel '>
  > # end of ParaLine
  <ParaLine 
   <String `och ännu vanligare för ”gruppen övriga” där '>
  > # end of ParaLine
  <ParaLine 
   <String `utöver ergotaminer även opioider, antihis'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `taminer och antiemetika m'>
   <Char HardSpace>
   <String `fl ingick '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 186Y2'>
    <MCurrPage `1327'>
    <Unique 1074787>
   > # end of Marker
   <String `(186)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. '>
  > # end of ParaLine
  <ParaLine 
   <String `Tröttheten kan givetvis påverka körlämp'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ligheten. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1053198>
  <PgfTag `Rub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Sammanfattning'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1068215>
  <PgfTag `Bröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Migränpatienter verkar inte ha någon ned'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `sättning i kognitiva funktioner under an'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `fallsfria perioder. I en placebokontrollerad '>
  > # end of ParaLine
  <ParaLine 
   <String `studie med sumatriptan, zolmitriptan och '>
  > # end of ParaLine
  <ParaLine 
   <String `ergotamin, där även friska ingick med test'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ning av kognitiva funktioner och ”event-'>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `related potentials”, sågs endast marginella '>
  > # end of ParaLine
  <ParaLine 
   <String `läkemedelseffekter utan klinisk relevans. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1053269>
  <PgfTag `BrödIn'>
  <ParaLine 
   <String `Trötthet/somnolens är en inte ovanlig bi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `verkning vid triptanmedicinering.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1053295>
  <PgfTag `Rub2'>
  <ParaLine 
   <TextRectID 160>
   <String `Rekommendationer'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1087786>
  <PgfTag `Bröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Påtaglig trötthet är vanligt förekommande i '>
  > # end of ParaLine
  <ParaLine 
   <String `restitutionsfasen efter ett anfall och inne'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `bär att man inte ska köra bil det närmaste '>
  > # end of ParaLine
  <ParaLine 
   <String `dygnet (dygnen). Valet av läkemedel för be'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `handling i prodromalstadiet eller akutfasen '>
  > # end of ParaLine
  <ParaLine 
   <String `har därför mindre betydelse eftersom läke'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `medelseffekten avklingat när det är dags '>
  > # end of ParaLine
  <ParaLine 
   <String `att köra. Överdosering kan kräva längre tid '>
  > # end of ParaLine
  <ParaLine 
   <String `för eliminering/restitution.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1041229>
  <PgfTag `Rub2'>
  <ParaLine 
   <String `Läs vidare '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1041230>
  <PgfTag `RefTextNr1'>
  <PgfNumString `1.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Font 
    <FTag `'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <String `Triptans and CNS side-effects: pharmacokinetic '>
  > # end of ParaLine
  <ParaLine 
   <String `and metabolic mechanisms '>
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 187Y2'>
    <MCurrPage `1327'>
    <Unique 1074794>
   > # end of Marker
   <String `(187)'>
   <Font 
    <FTag `'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <String `. '>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `(En artikel från '>
  > # end of ParaLine
  <ParaLine 
   <String `2004.)'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1041253>
  <PgfTag `Rub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Enskilda preparat'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1041217>
  <PgfTag `Rub3efterRub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `A'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `almotriptan:trafik'>
    <MCurrPage `1327'>
    <Unique 1058431>
   > # end of Marker
   <String `lmotriptan'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1047361>
  <PgfTag `PrepBröd'>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.NewCenturySchlbk LT Std.R.400'>
    <FFamily `NewCenturySchlbk LT Std'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `NewCenturySchlbkLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  8.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  -1.0%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <HyphenMaxLines 6>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `Almotriptan 12,5 mg har en något lägre före'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `komst av trötthet och somnolens än suma'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `triptan 50 mg och 100 mg enligt en översikts'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `artikel från 2002 '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 188Y2'>
    <MCurrPage `1327'>
    <Unique 1074801>
   > # end of Marker
   <String `(188)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Somnolens drabbade '>
  > # end of ParaLine
  <ParaLine 
   <String `ca 1,6% av patienterna i såväl behandlings'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `grupp (12,5 mg) som placebogrupp medan '>
  > # end of ParaLine
  <ParaLine 
   <String `6,25 mg gav somnolens hos 0,8% '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 189Y2'>
    <MCurrPage `1327'>
    <Unique 1074809>
   > # end of Marker
   <String `(189)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1047332>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `E'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `eletriptan:trafik'>
    <MCurrPage `1327'>
    <Unique 1058436>
   > # end of Marker
   <String `letriptan'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1030699>
  <PgfTag `PrepBröd'>
  <Pgf 
   <HyphenMaxLines 6>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `I en studie rapporterades terapirelaterad '>
  > # end of ParaLine
  <ParaLine 
   <String `somnolens för 1% vid 40 mg och 4% vid '>
  > # end of ParaLine
  <ParaLine 
   <String `80'>
   <Char HardSpace>
   <String `mg jämfört med 2% i placebogruppen '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 190Y2'>
    <MCurrPage `1327'>
    <Unique 1074816>
   > # end of Marker
   <String `(190)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Terapirelaterad trötthet rapportera'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `des för 2 respektive 6% mot 2% för placebo'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `gruppen.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1027409>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `E'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `ergotamin:trafik'>
    <MCurrPage `1327'>
    <Unique 1058441>
   > # end of Marker
   <String `rgotamin'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1068221>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `För 2 mg givet till friska försökspersoner '>
  > # end of ParaLine
  <ParaLine 
   <String `sågs en lätt nedsättning i kognitionen mätt i '>
  > # end of ParaLine
  <ParaLine 
   <String `form av ”Event related potentials” 2 timmar '>
  > # end of ParaLine
  <ParaLine 
   <String `efter intag '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 191Y2'>
    <MCurrPage `1327'>
    <Unique 1074823>
   > # end of Marker
   <String `(191)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Förändringen var liten och '>
  > # end of ParaLine
  <ParaLine 
   <String `bedömdes inte som kliniskt relevant. Ergo'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `taminmissbrukande migränpatienter jäm'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `fördes med migränpatienter utan ergotamin '>
  > # end of ParaLine
  <ParaLine 
   <String `och friska kontroller varvid man efter kor'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `rektion för psykologisk oro (”distress”) inte '>
  > # end of ParaLine
  <ParaLine 
   <String `fann några skillnader i minnesförmåga, '>
  > # end of ParaLine
  <ParaLine 
   <String `mental flexibilitet, processhastighet eller '>
  > # end of ParaLine
  <ParaLine 
   <String `uppmärksamhet '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 192Y2'>
    <MCurrPage `1327'>
    <Unique 1074830>
   > # end of Marker
   <String `(192).'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1047422>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `N'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `naratriptan:trafik'>
    <MCurrPage `1327'>
    <Unique 1058446>
   > # end of Marker
   <String `aratriptan och '>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `zolmitriptan:trafik'>
    <MCurrPage `1327'>
    <Unique 1058451>
   > # end of Marker
   <String `zolmitriptan'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1058461>
  <PgfTag `PrepBröd'>
  <ParaLine 
   <String `Här saknas studier om kognition och trafik'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `säkerhet.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1058462>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <TextRectID 161>
   <String `R'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `rizatriptan:trafik'>
    <MCurrPage `1328'>
    <Unique 1058466>
   > # end of Marker
   <String `izatriptan'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1058463>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Rizatriptan med dosen 10 mg gav väsentli'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `gen likvärdiga resultat som för sumatriptan '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 193Y2'>
    <MCurrPage `1328'>
    <Unique 1074837>
   > # end of Marker
   <String `(193,'>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 194Y2'>
    <MCurrPage `1328'>
    <Unique 1074842>
   > # end of Marker
   <String `194)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1055301>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `S'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `sumatriptan:trafik'>
    <MCurrPage `1328'>
    <Unique 1058471>
   > # end of Marker
   <String `umatriptan'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1049038>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Två timmar efter intag av 100 mg sumatrip'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tan sågs ingen effekt på friska vid Bricken'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `kamps d2-test, se tester s'>
   <Char HardSpace>
   <XRef 
    <XRefName `Page'>
    <XRefSrcText `55866: Rub2: Tester\x0d '>
    <XRefSrcIsElem No>
    <XRefSrcFile `'>
    <XRefLastUpdate  1382866575 931000>
    <XRefSrcElemNonUniqueId `'>
    <XRefAltText `'>
    <XRefApiClient 
     <XRefClientName `'>
     <XRefClientType `'>
    > # end of XRefApiClient
    <Unique 1082479>
   > # end of XRef
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <String `1363'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <XRefEnd >
   <String ` '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 191Y2'>
    <MCurrPage `1328'>
    <Unique 1074848>
   > # end of Marker
   <String `(191)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Sam'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ma dos och testat 3–5 timmar efter intag gav '>
  > # end of ParaLine
  <ParaLine 
   <String `lindrig sedering men något snabbare reak'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tioner vid ordigenkänningstest och något, '>
  > # end of ParaLine
  <ParaLine 
   <String `men ej signifikant, längre enkla reaktionsti'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `der (audiella och visuella), men i övriga tes'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ter sågs ingen skillnad mot placebo '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 193Y2'>
    <MCurrPage `1328'>
    <Unique 1074859>
   > # end of Marker
   <String `(193)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1049039>
  <PgfTag `Rub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `N03 – '>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `antiepileptika:trafik'>
    <MCurrPage `1328'>
    <Unique 1058476>
   > # end of Marker
   <String `antiepileptika'>
   <Font 
    <FTag `Intense Emphasis'>
    <FLocked No>
   > # end of Font
   <String ` '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1080024>
  <PgfTag `Bröd'>
  <Pgf 
   <HyphenMaxLines 6>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `Inga studier finns om hur antiepileptika på'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `verkar körförmågan utan genomgången vi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `sar preparatens inverkan på kognitiva '>
  > # end of ParaLine
  <ParaLine 
   <String `funktioner, som är väl undersökt och i en'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `staka fall i jämförelse med påverkan av al'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `kohol. Majoriteten av studier är dock utför'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `da med unga vanligtvis friska personer, '>
  > # end of ParaLine
  <ParaLine 
   <String `men effekter på barn och äldre har också '>
  > # end of ParaLine
  <ParaLine 
   <String `studerats. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1041386>
  <PgfTag `Rub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Sammanfattning'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1077519>
  <PgfTag `Bröd'>
  <ParaLine 
   <String `Det finns belägg för att fenobarbital har '>
  > # end of ParaLine
  <ParaLine 
   <String `störst inverkan på kognitiva funktioner '>
  > # end of ParaLine
  <ParaLine 
   <String `bland de antiepileptiska läkemedlen, och '>
  > # end of ParaLine
  <ParaLine 
   <String `att topiramat har en sådan påverkan att '>
  > # end of ParaLine
  <ParaLine 
   <String `bilkörning bör avrådas. Fenytoin ger också '>
  > # end of ParaLine
  <ParaLine 
   <String `påverkan på psykomotoriken medan karba'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `mazepin har en något marginell effekt på '>
  > # end of ParaLine
  <ParaLine 
   <String `kognitionen. Valproat tillsammans med vi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `gabatrin, gabapentin och lamotrigin har '>
  > # end of ParaLine
  <ParaLine 
   <String `troligen ingen nämnvärd effekt på körför'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `mågan. Levetiracetam reducerar inte den '>
  > # end of ParaLine
  <ParaLine 
   <String `kognitiva förmågan men kan ge oönskade '>
  > # end of ParaLine
  <ParaLine 
   <String `effekter i form av aggressivitet och impulsi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `vitet samt inte sällan initial trötthet/som'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `nolens vid upptitrering. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1077523>
  <PgfTag `BrödIn'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Data i Tabell 1, s'>
   <Char HardSpace>
   <XRef 
    <XRefName `Page'>
    <XRefSrcText `98249: TabellRubrik_2sp: Tabell 1. Kognitiva effekter av antiepileptiska läkemedel'>
    <XRefSrcIsElem No>
    <XRefSrcFile `'>
    <XRefLastUpdate  1382866575 931000>
    <XRefSrcElemNonUniqueId `'>
    <XRefAltText `'>
    <XRefApiClient 
     <XRefClientName `'>
     <XRefClientType `'>
    > # end of XRefApiClient
    <Unique 1077521>
   > # end of XRef
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <String `1329'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <XRefEnd >
   <String `, är hämtade från '>
  > # end of ParaLine
  <ParaLine 
   <String `en översikt gjord 2002 '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 195Y2'>
    <MCurrPage `1328'>
    <Unique 1077524>
   > # end of Marker
   <String `(195)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` och anpassad '>
  > # end of ParaLine
  <ParaLine 
   <String `för läkemedel på den svenska marknaden. '>
  > # end of ParaLine
  <ParaLine 
   <String `Resultaten skiljer sig något jämfört med en '>
  > # end of ParaLine
  <ParaLine 
   <String `tidig översikt från 1987 där fenytoin bedöm'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `des ha den största påverkan på kognitiva '>
  > # end of ParaLine
  <ParaLine 
   <String `funktioner i jämförelse med fenobarbital, '>
  > # end of ParaLine
  <ParaLine 
   <String `valproat och karbamazepin '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 196Y2'>
    <MCurrPage `1328'>
    <Unique 1077525>
   > # end of Marker
   <String `(196)'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
   <String `.'>
   <XRef 
    <XRefName `Ref'>
    <XRefSrcText `98249: TabellRubrik_2sp: Tabell 1. Kognitiva effekter av antiepileptiska läkemedel'>
    <XRefSrcIsElem No>
    <XRefSrcFile `'>
    <XRefLastUpdate  1382866575 931000>
    <XRefSrcElemNonUniqueId `'>
    <XRefAltText `'>
    <XRefApiClient 
     <XRefClientName `'>
     <XRefClientType `'>
    > # end of XRefApiClient
    <Unique 1089377>
   > # end of XRef
   <Font 
    <FTag `Ref'>
    <FLocked No>
   > # end of Font
   <String ` '>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
   <XRefEnd >
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1047548>
  <PgfTag `Rub2'>
  <ParaLine 
   <TextRectID 161>
   <String `Rekommendationer'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1080032>
  <PgfTag `Bröd'>
  <Pgf 
   <HyphenMaxLines 6>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `Levetiracetam är den substans som i flera '>
  > # end of ParaLine
  <ParaLine 
   <String `studier har visat sig förbättra kognitiva '>
  > # end of ParaLine
  <ParaLine 
   <String `funktioner och borde (ur kognitiv synvin'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `kel) vara att föredra i samband med bilkör'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ning om inte biverkning i form av trötthet '>
  > # end of ParaLine
  <ParaLine 
   <String `eller predisponerande faktorer för beteen'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `depåverkan föreligger. Lamotrigin, gaba'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `pentin och valproat är också alternativ för '>
  > # end of ParaLine
  <ParaLine 
   <String `bilförare och uppvisar ingen eller endast li'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ten påverkan. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1041390>
  <PgfTag `Rub2'>
  <ParaLine 
   <String `Läs vidare'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1041391>
  <PgfTag `RefTextNr1'>
  <PgfNumString `1.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Behavioral and cognitive effects of anti-epileptic '>
  > # end of ParaLine
  <ParaLine 
   <String `drugs '>
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 197Y2'>
    <MCurrPage `1328'>
    <Unique 1074880>
   > # end of Marker
   <String `(197)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. (En översiktsartikel från 2010.)'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1087850>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `2.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Cognitive effects of GABAergic antiepileptic '>
  > # end of ParaLine
  <ParaLine 
   <String `drugs '>
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 198Y2'>
    <MCurrPage `1328'>
    <Unique 1087851>
   > # end of Marker
   <String `(198)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` . (En översiktsartikel från 2010.)'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1087857>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `3.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Cognitive effects of antiepileptic drugs '>
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 199Y2'>
    <MCurrPage `1328'>
    <Unique 1087856>
   > # end of Marker
   <String `(199).'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `(En översiktsartikel från 2008.)'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1087858>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `4.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Font 
    <FTag `'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <String `Behavioural effects of the newer antiepileptic '>
  > # end of ParaLine
  <ParaLine 
   <String `drugs: an update '>
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 200Y2'>
    <MCurrPage `1328'>
    <Unique 1087859>
   > # end of Marker
   <String `(200)'>
   <Font 
    <FTag `'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <String `. '>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `(En översiktsartikel från '>
  > # end of ParaLine
  <ParaLine 
   <String `2004.) '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1041417>
  <PgfTag `Rub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Enskilda preparat'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1041373>
  <PgfTag `Rub3efterRub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `E'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `etosuximid:trafik'>
    <MCurrPage `1328'>
    <Unique 1058481>
   > # end of Marker
   <String `tosuximid'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1047556>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Ingen signifikant skillnad i kognitiva funk'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tioner jämfört med baseline noterades 6 må'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `nader efter insättning av etosuximid '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 201Y2'>
    <MCurrPage `1328'>
    <Unique 1074907>
   > # end of Marker
   <String `(201).'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1047557>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `F'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `felbamat:trafik'>
    <MCurrPage `1328'>
    <Unique 1058486>
   > # end of Marker
   <String `elbamat'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1030825>
  <PgfTag `PrepBröd'>
  <ParaLine 
   <String `Inga studier på människa finns. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1027428>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `F'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `fenobarbital:trafik'>
    <MCurrPage `1328'>
    <Unique 1058491>
   > # end of Marker
   <String `enobarbital'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1079060>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Fenobarbital har en negativ effekt på kogni'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tiva funktioner '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 202Y2'>
    <MCurrPage `1328'>
    <Unique 1079061>
   > # end of Marker
   <String `(202)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` och gav störst påver'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `kan vid jämförelse med fenytoin och valpro'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `at hos friska försökspersoner och med signi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `fikant skillnad mot baseline i flertalet '>
  > # end of ParaLine
  <ParaLine 
   <String `kognitiva tester. Fenobarbital påverkar även '>
  > # end of ParaLine
  <ParaLine 
   <String `inlärningsförmågan '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 203Y2'>
    <MCurrPage `1328'>
    <Unique 1079062>
   > # end of Marker
   <String `(203).'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` Givet till Alzhei'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `merpatienter (AD) och jämfört med AD-kon'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `troller sågs en signifikant försämring i glo'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `bal kognitiv förmåga (MMSE'>
   <FNote 202>
   <String `) jämfört med '>
  > # end of ParaLine
  <ParaLine 
   <String `baseline vid 12 månader, medan kontroll'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `gruppen uppvisade en viss förbättring '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 204Y2'>
    <MCurrPage `1328'>
    <Unique 1079066>
   > # end of Marker
   <String `(204).'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1087906>
  <PgfTag `PrepBröd'>
  <Pgf 
   <PgfFIndent  6.0 mm>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `Vid utsättning av fenobarbital hos barn '>
  > # end of ParaLine
  <ParaLine 
   <String `sågs efter 7 månader en förbättrad kognitiv '>
  > # end of ParaLine
  <ParaLine 
   <String `förmåga jämfört med gruppen som kvarstod '>
  > # end of ParaLine
  <ParaLine 
   <String `på medicineringen '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 205Y2'>
    <MCurrPage `1328'>
    <Unique 1087907>
   > # end of Marker
   <String `(205)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. I ett annat försök '>
  > # end of ParaLine
  <ParaLine 
   <String `att  minska användningen av fenobarbital '>
  > # end of ParaLine
  <ParaLine 
   <String `hos personer boende på institution sågs efter '>
  > # end of ParaLine
  <ParaLine 
   <TextRectID 162>
   <String `4–6 månader en förbättrad kognitiv förmåga '>
  > # end of ParaLine
  <ParaLine 
   <String `hos var fjärde patient, och hos äldre uppvisa'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `des en större andel med förbättring '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 206Y2'>
    <MCurrPage `1329'>
    <Unique 1087908>
   > # end of Marker
   <String `(206).'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` '>
  > # end of ParaLine
  <ParaLine 
   <String `I'>
   <Char HardSpace>
   <String `en tredje studie med utsättning av läke'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `medlet hos barn noterades efter 3 månader '>
  > # end of ParaLine
  <ParaLine 
   <String `ingen signifikant förbättring i IQ, medan '>
  > # end of ParaLine
  <ParaLine 
   <String `P300-mätningar visade förbättringar när fe'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `nobarbital hade satts ut '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 207Y2'>
    <MCurrPage `1329'>
    <Unique 1087909>
   > # end of Marker
   <String `(207)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1068268>
  <PgfTag `PrepBröd'>
  <Pgf 
   <PgfFIndent  6.0 mm>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `I en metaanalys skriver författarna att ett '>
  > # end of ParaLine
  <ParaLine 
   <String `undantag är fenobarbital som har visats ha '>
  > # end of ParaLine
  <ParaLine 
   <String `dramatisk påverkan på kognitionen '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 208Y2'>
    <MCurrPage `1329'>
    <Unique 1074964>
   > # end of Marker
   <String `(208).'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1068275>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `F'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `fenytoin:trafik'>
    <MCurrPage `1329'>
    <Unique 1068273>
   > # end of Marker
   <String `enytoin och '>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `fosfenytoin:trafik'>
    <MCurrPage `1329'>
    <Unique 1068274>
   > # end of Marker
   <String `fosfenytoin'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1068276>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Fenytoin och fosfenytoin har effekter på kog'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `nitiva funktioner i form av långsam psyko'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `motorik '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 209Y2'>
    <MCurrPage `1329'>
    <Unique 1074971>
   > # end of Marker
   <String `(209).'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` Man såg ingen skillnad i in'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tellektuell prestation hos patienter med fe'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `nytoin jämfört med karbamazepin '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 210Y2'>
    <MCurrPage `1329'>
    <Unique 1074978>
   > # end of Marker
   <String `(210,'>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 211Y2'>
    <MCurrPage `1329'>
    <Unique 1074983>
   > # end of Marker
   <String `211)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <String `.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1030920>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `G'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `gabapentin:trafik'>
    <MCurrPage `1329'>
    <Unique 1058506>
   > # end of Marker
   <String `abapentin'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1047729>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Endast en studie finns som visar att gaba'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `pentin inom terapeutisk nivå kan inverka på '>
  > # end of ParaLine
  <ParaLine 
   <String `körningen så att det lett till polisingripande '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 212Y2'>
    <MCurrPage `1329'>
    <Unique 1074989>
   > # end of Marker
   <String `(212)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1047774>
  <PgfTag `PrepBröd'>
  <Pgf 
   <PgfFIndent  6.0 mm>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `I en studie med gabapentin såg man inte '>
  > # end of ParaLine
  <ParaLine 
   <String `någon negativ påverkan på kognitiva funk'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tioner '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 213Y2'>
    <MCurrPage `1329'>
    <Unique 1074996>
   > # end of Marker
   <String `(213)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` och det såg man inte heller i en '>
  > # end of ParaLine
  <ParaLine 
   <String `mindre studie med snabb upptitrering '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 214Y2'>
    <MCurrPage `1329'>
    <Unique 1075003>
   > # end of Marker
   <String `(214).'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` '>
  > # end of ParaLine
  <ParaLine 
   <String `Med 2,4 g gabapentin/dag till friska försöks'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `personer i jämförelse med karbamazepin '>
  > # end of ParaLine
  <ParaLine 
   <String `sågs förbättring mot baseline i 1 av 15 test'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `variabler och viss försämring i 4 variabler. '>
  > # end of ParaLine
  <ParaLine 
   <String `Detta var klart bättre än för karbamazepin '>
  > # end of ParaLine
  <ParaLine 
   <String `som var sämre i 13 av 15 variabler '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 215Y2'>
    <MCurrPage `1329'>
    <Unique 1075010>
   > # end of Marker
   <String `(215)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. I en '>
  > # end of ParaLine
  <ParaLine 
   <String `senare studie undersöktes äldre på motsva'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `rande sätt och man såg en fördel för gaba'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `pentin i 15 av 17 kognitiva testparametrar, '>
  > # end of ParaLine
  <ParaLine 
   <String `men en viss (signifikant) nedsättning sågs '>
  > # end of ParaLine
  <ParaLine 
   <String `för båda preparaten i relation till baseline '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 216Y2'>
    <MCurrPage `1329'>
    <Unique 1075017>
   > # end of Marker
   <String `(216)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Många avbröt dock studien pga bi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `verkningar. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1053370>
  <PgfTag `PrepBröd'>
  <Pgf 
   <PgfFIndent  6.0 mm>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `Vid en annan jämförelse mellan gabapen'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tin och karbamazepin till friska försöksper'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `soner sågs en negativ påverkan av båda sub'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <TextRectID 162>
   <String `stanserna men till fördel för gabapentin. '>
  > # end of ParaLine
  <ParaLine 
   <String `Ingen skillnad sågs för enskilda parametrar '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 217Y2'>
    <MCurrPage `1329'>
    <Unique 1075024>
   > # end of Marker
   <String `(217).'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1080086>
  <PgfTag `PrepBröd'>
  <Pgf 
   <PgfFIndent  6.0 mm>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `Gabapentin som tillägg till annan medici'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `nering visade ingen kognitiv påverkan men '>
  > # end of ParaLine
  <ParaLine 
   <String `en viss sedering sågs vid högsta dosen 2,4 g/'>
  > # end of ParaLine
  <ParaLine 
   <String `dag '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 218Y2'>
    <MCurrPage `1329'>
    <Unique 1080087>
   > # end of Marker
   <String `(218)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` och i studien av Mortimore och '>
  > # end of ParaLine
  <ParaLine 
   <String `med'>
   <Char DiscHyphen>
   <String `arbet'>
   <Char DiscHyphen>
   <String `are sågs förbättrade kognitiva '>
  > # end of ParaLine
  <ParaLine 
   <String `funktioner för gabapentin jämfört med en '>
  > # end of ParaLine
  <ParaLine 
   <String `kontrollgrupp '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 219Y2'>
    <MCurrPage `1329'>
    <Unique 1080088>
   > # end of Marker
   <String `(219).'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `  '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1047862>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `K'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `karbamazepin:trafik'>
    <MCurrPage `1329'>
    <Unique 1058511>
   > # end of Marker
   <String `arbamazepin'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1082491>
  <PgfTag `PrepBröd'>
  <Pgf 
   <HyphenMaxLines 6>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `Karbamazepin och oxkarbazepin, se vidara '>
  > # end of ParaLine
  <ParaLine 
   <String `s'>
   <Char HardSpace>
   <XRef 
    <XRefName `Page'>
    <XRefSrcText `30322: Rub3: Oxkarbazepin'>
    <XRefSrcIsElem No>
    <XRefSrcFile `'>
    <XRefLastUpdate  1382866575 931000>
    <XRefSrcElemNonUniqueId `'>
    <XRefAltText `'>
    <XRefApiClient 
     <XRefClientName `'>
     <XRefClientType `'>
    > # end of XRefApiClient
    <Unique 1082493>
   > # end of XRef
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <String `1330'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <XRefEnd >
   <String ` för oxkarbazepin, är likvärdiga avse'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ende inverkan på kognition och är jämförba'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ra med valproat efter 6 månader '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 220Y2'>
    <MCurrPage `1329'>
    <Unique 1082495>
   > # end of Marker
   <String `(220)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Ing'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `en effekt på kognitiva funktioner av karba'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `mazepin visades av Gallassi och medarbeta'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `re '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 200Y2'>
    <MCurrPage `1329'>
    <Unique 1082496>
   > # end of Marker
   <String `(200)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` medan en annan studie visade min'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `nespåverkan '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 221Y2'>
    <MCurrPage `1329'>
    <Unique 1082497>
   > # end of Marker
   <String `(221)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1077626>
  <PgfTag `PrepBröd'>
  <Pgf 
   <PgfFIndent  6.0 mm>
   <HyphenMaxLines 6>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `I bilkörningstest gav karbamazepin 200 '>
  > # end of ParaLine
  <ParaLine 
   <String `mg x 3 nedsättningar i mätta parametrar '>
  > # end of ParaLine
  <ParaLine 
   <String `med en vinglighet motsvarande 0,5‰ BAC '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 222Y2'>
    <MCurrPage `1329'>
    <Unique 1081852>
   > # end of Marker
   <String `(222).'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` I en långtidsstudie (5 år) visade sig '>
  > # end of ParaLine
  <ParaLine 
   <String `karbamazepin ha mindre av kognitiv påver'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `kan jämfört med fenytoin men framför allt '>
  > # end of ParaLine
  <ParaLine 
   <String `jämfört med fenobarbital '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 223Y2'>
    <MCurrPage `1329'>
    <Unique 1081861>
   > # end of Marker
   <String `(223).'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1058531>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `K'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `klonazepam:trafik'>
    <MCurrPage `1329'>
    <Unique 1058535>
   > # end of Marker
   <String `lonazepam'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1058532>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Klonazepam givet som en engångsdos, 4 mg, '>
  > # end of ParaLine
  <ParaLine 
   <String `till friska försökspersoner gav en negativ på'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `verkan på psykomotoriken under åtminsto'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ne 5 timmar och för några testpersoner be'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tydligt längre '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 224Y2'>
    <MCurrPage `1329'>
    <Unique 1081866>
   > # end of Marker
   <String `(224).'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1027436>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `L'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `lamotrigin:trafik'>
    <MCurrPage `1329'>
    <Unique 1058540>
   > # end of Marker
   <String `amotrigin'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1077649>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Lamotrigin som en engångsdos, 120 respek'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tive 240 mg, till friska försökspersoner gav '>
  > # end of ParaLine
  <ParaLine 
   <String `likvärdigt resultat med placebo avseende '>
  > # end of ParaLine
  <ParaLine 
   <String `ögonrörelser, ”tracking”-test (se under Tes'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ter, s'>
   <Char HardSpace>
   <XRef 
    <XRefName `Page'>
    <XRefSrcText `55866: Rub2: Tester\x0d '>
    <XRefSrcIsElem No>
    <XRefSrcFile `'>
    <XRefLastUpdate  1382866575 931000>
    <XRefSrcElemNonUniqueId `'>
    <XRefAltText `'>
    <XRefApiClient 
     <XRefClientName `'>
     <XRefClientType `'>
    > # end of XRefApiClient
    <Unique 1082501>
   > # end of XRef
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <String `1363'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <XRefEnd >
   <String `) och svajning efter 2–8 timmar '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 225Y2'>
    <MCurrPage `1329'>
    <Unique 1081872>
   > # end of Marker
   <String `(225)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Lamotrigin har som tilläggsterapi inte '>
  > # end of ParaLine
  <ParaLine 
   <String `visat sig påverka kognitiva funktioner '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 226Y2'>
    <MCurrPage `1329'>
    <Unique 1081881>
   > # end of Marker
   <String `(226,'>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 227Y2'>
    <MCurrPage `1329'>
    <Unique 1081886>
   > # end of Marker
   <String `227)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` och har klart mindre påverkan än '>
  > # end of ParaLine
  <ParaLine 
   <TextRectID 163>
   <Font 
    <FTag `'>
    <FDW  -0.5%>
    <FLocked No>
   > # end of Font
   <String `topiramat '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 228Y2'>
    <MCurrPage `1330'>
    <Unique 1081891>
   > # end of Marker
   <String `(228,'>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 229Y2'>
    <MCurrPage `1330'>
    <Unique 1081896>
   > # end of Marker
   <String `229)'>
   <Font 
    <FTag `'>
    <FDW  -0.5%>
    <FLocked No>
   > # end of Font
   <String ` och karbamazepin '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 230Y2'>
    <MCurrPage `1330'>
    <Unique 1081901>
   > # end of Marker
   <String `(230).'>
   <Font 
    <FTag `'>
    <FDW  -0.5%>
    <FLocked No>
   > # end of Font
   <String ` '>
  > # end of ParaLine
  <ParaLine 
   <String `I en av studierna'>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 227Y2'>
    <MCurrPage `1330'>
    <Unique 1081906>
   > # end of Marker
   <String ` '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <String `(227)'>
   <Font 
    <FTag `'>
    <FDW  -0.5%>
    <FLocked No>
   > # end of Font
   <String ` sågs snarast förbätt'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `rade testresultat, dock ej signifikanta. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1077702>
  <PgfTag `PrepBröd'>
  <Pgf 
   <PgfFIndent  6.0 mm>
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.NewCenturySchlbk LT Std.R.400'>
    <FFamily `NewCenturySchlbk LT Std'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `NewCenturySchlbkLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  8.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  -0.5%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `Lamotrigin givet till friska frivilliga män, '>
  > # end of ParaLine
  <ParaLine 
   <String `25 mg x 2 i en dryg vecka, gav förbättrad au'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `diell och visuell enkel reaktionstid jämfört '>
  > # end of ParaLine
  <ParaLine 
   <String `med placebo och valproat '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 231Y2'>
    <MCurrPage `1330'>
    <Unique 1081911>
   > # end of Marker
   <String `(231)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Trots viss på'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `verkan på P300 sågs ingen kognitiv nedsätt'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ning hos friska försökspersoner efter 20 '>
  > # end of ParaLine
  <ParaLine 
   <String `veckor med dosen 300 mg/dag '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 232Y2'>
    <MCurrPage `1330'>
    <Unique 1081916>
   > # end of Marker
   <String `(232)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. I fem '>
  > # end of ParaLine
  <ParaLine 
   <String `and'>
   <Char DiscHyphen>
   <String `ra studier med friska frivilliga sågs inte '>
  > # end of ParaLine
  <ParaLine 
   <String `heller någon negativ påverkan på kognitio'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `nen '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 214Y2'>
    <MCurrPage `1330'>
    <Unique 1077703>
   > # end of Marker
   <String `(214,'>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 225Y2'>
    <MCurrPage `1330'>
    <Unique 1081921>
   > # end of Marker
   <String `225,'>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 230Y2'>
    <MCurrPage `1330'>
    <Unique 1081926>
   > # end of Marker
   <String `230,'>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 233Y2'>
    <MCurrPage `1330'>
    <Unique 1081931>
   > # end of Marker
   <String `233,'>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 234Y2'>
    <MCurrPage `1330'>
    <Unique 1081936>
   > # end of Marker
   <String `234)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Lamotrigin vs '>
  > # end of ParaLine
  <ParaLine 
   <String `placebo som tillägg till annan antiepileptisk '>
  > # end of ParaLine
  <ParaLine 
   <String `medi'>
   <Char DiscHyphen>
   <String `cinering vid partiell epilepsi visade ing'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `en skillnad i kognitiva funktioner '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 235Y2'>
    <MCurrPage `1330'>
    <Unique 1081941>
   > # end of Marker
   <String `(235).'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1077706>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `L'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `levetiracetam:trafik'>
    <MCurrPage `1330'>
    <Unique 1077705>
   > # end of Marker
   <String `evetiracetam'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1079075>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Inga studier med levetiracetam och körför'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `måga finns. Beträffande kognitiva funktio'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ner finns ett flertal studier som påvisar sig'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `nifikanta positiva (= förbättrade) effekter på '>
  > # end of ParaLine
  <ParaLine 
   <String `kognitiva funktioner '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 236Y2'>
    <MCurrPage `1330'>
    <Unique 1081950>
   > # end of Marker
   <String `(236–240).'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` Det finns '>
  > # end of ParaLine
  <ParaLine 
   <String `även studier som visar på en ökad förekomst '>
  > # end of ParaLine
  <ParaLine 
   <String `av aggressivitet samt brist på självkontroll, '>
  > # end of ParaLine
  <ParaLine 
   <String `vilket inte är bra sett ur trafiksäkerhetssyn'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `punkt'>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 241Y2'>
    <MCurrPage `1330'>
    <Unique 1081955>
   > # end of Marker
   <String ` '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <String `(241)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Predisponerande faktorer kan '>
  > # end of ParaLine
  <ParaLine 
   <String `vara olika psykossyndrom och snabb upp'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `titrering '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 242Y2'>
    <MCurrPage `1330'>
    <Unique 1081960>
   > # end of Marker
   <String `(242)'>
   <Font 
    <FTag `Blue'>
    <FDW  -0.5%>
    <FLocked No>
   > # end of Font
   <String `.'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` I en studie sågs psykiatriska '>
  > # end of ParaLine
  <ParaLine 
   <String `och beteendemässiga biverkningar hos 16% '>
  > # end of ParaLine
  <ParaLine 
   <String `av 521 individer jämfört med 1% för gaba'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `pentin och 5% för lamotrigin '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 243Y2'>
    <MCurrPage `1330'>
    <Unique 1081965>
   > # end of Marker
   <String `(243)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Även här '>
  > # end of ParaLine
  <ParaLine 
   <String `var tidigare psykiatriska problem en predis'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ponerande faktor, något som dock inte kunde '>
  > # end of ParaLine
  <ParaLine 
   <String `ses i studien av Hurtado och medarbetare '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 244Y2'>
    <MCurrPage `1330'>
    <Unique 1081970>
   > # end of Marker
   <String `(244)'>
   <Font 
    <FTag `Blue'>
    <FDW  -0.5%>
    <FLocked No>
   > # end of Font
   <String `.'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1077898>
  <PgfTag `PrepBröd'>
  <Pgf 
   <PgfFIndent  6.0 mm>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `Allvarliga uttryck av aggression, våld el'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ler psykos kan ibland ses som biverkningar '>
  > # end of ParaLine
  <ParaLine 
   <String `av levetiracetam '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 245Y2'>
    <MCurrPage `1330'>
    <Unique 1081975>
   > # end of Marker
   <String `(245)'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
   <Font 
    <FTag `Blue'>
    <FPlatformName `W.NewCenturySchlbk LT Std.R.400'>
    <FFamily `NewCenturySchlbk LT Std'>
    <FPostScriptName `NewCenturySchlbkLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FDW  -0.5%>
    <FLanguage USEnglish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
   > # end of Font
   <String `. Trötthet/somnolens '>
  > # end of ParaLine
  <ParaLine 
   <String `är inte en ovanlig biverkning, speciellt vid '>
  > # end of ParaLine
  <ParaLine 
   <String `upptitrering, som måste beaktas.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1077900>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 9>
    <MTypeName `Cross-Ref'>
    <MText `30322: Rub3: Oxkarbazepin'>
    <MCurrPage `1330'>
    <Unique 1082487>
   > # end of Marker
   <String `O'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `oxkarbazepin:trafik'>
    <MCurrPage `1330'>
    <Unique 1077899>
   > # end of Marker
   <String `xkarbazepin'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1077578>
  <PgfTag `PrepBröd'>
  <Pgf 
   <HyphenMaxLines 6>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `Oxkarbazepin har i tre monoterapistudier '>
  > # end of ParaLine
  <ParaLine 
   <String `inte visat någon negativ inverkan på kogni'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tiva funktioner '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 211Y2'>
    <MCurrPage `1330'>
    <Unique 1077568>
   > # end of Marker
   <String `(211,'>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 221Y2'>
    <MCurrPage `1330'>
    <Unique 1081980>
   > # end of Marker
   <String `221,'>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 246Y2'>
    <MCurrPage `1330'>
    <Unique 1081985>
   > # end of Marker
   <String `246).'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` I de två sena'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `re studierna noterades en viss förbättring i '>
  > # end of ParaLine
  <ParaLine 
   <String `kognitiv förmåga.'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1087935>
  <PgfTag `PrepBröd'>
  <Pgf 
   <PgfFIndent  6.0 mm>
   <HyphenMaxLines 6>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `Oxkarbazepin 300 mg x 3 som tillägg till '>
  > # end of ParaLine
  <ParaLine 
   <String `annan anti'>
   <Char DiscHyphen>
   <String `epileptisk medicinering visade ef'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ter 3 veckors behandling ingen inverkan på '>
  > # end of ParaLine
  <ParaLine 
   <String `testresultaten jämfört med placebo '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 247Y2'>
    <MCurrPage `1330'>
    <Unique 1087936>
   > # end of Marker
   <String `(247)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. '>
  > # end of ParaLine
  <ParaLine 
   <String `Sex respektive tolv månader efter insättning '>
  > # end of ParaLine
  <ParaLine 
   <TextRectID 163>
   <String `sågs ingen skillnad i kognitiv funktion jäm'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `fört med baseline '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 201Y2'>
    <MCurrPage `1330'>
    <Unique 1087937>
   > # end of Marker
   <String `(201)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1077572>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `P'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `pregabalin:trafik'>
    <MCurrPage `1330'>
    <Unique 1077571>
   > # end of Marker
   <String `regabalin'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1048330>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Pregabalin, som tillägg vid behandlingsre'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `sistent epilepsi, har visats ge försämrat epi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `sodiskt minne, såväl visuellt som verbalt '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 236Y2'>
    <MCurrPage `1330'>
    <Unique 1081996>
   > # end of Marker
   <String `(236)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. I en studie av Hindmarch och medar'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `betare '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 248Y2'>
    <MCurrPage `1330'>
    <Unique 1075269>
   > # end of Marker
   <String `(248)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` sågs endast en liten men signi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `fikant försämring i ett ”track”-test och CFFT '>
  > # end of ParaLine
  <ParaLine 
   <String `(”critical flicker fusion”-test) men förbättrad '>
  > # end of ParaLine
  <ParaLine 
   <String `bromsreaktionstid. Salinsky och medarbet'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `are '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 249Y2'>
    <MCurrPage `1330'>
    <Unique 1075276>
   > # end of Marker
   <String `(249)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` visade med 600 mg pregabalin/dag '>
  > # end of ParaLine
  <ParaLine 
   <String `efter 12 veckors behandling en signifikant '>
  > # end of ParaLine
  <ParaLine 
   <String `nedgång i resultaten i 3 av 6 kognitiva tes'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ter.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1080104>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `R'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `rufinamid:trafik'>
    <MCurrPage `1330'>
    <Unique 1080103>
   > # end of Marker
   <String `ufinamid'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1080105>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Ingen inverkan på kognitiva funktioner no'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `terades '>
   <Char DiscHyphen>
   <String `efter 3 månaders behandling med '>
  > # end of ParaLine
  <ParaLine 
   <SpclHyphenation Yes>
   <String `upp till 1'>
   <Char HardSpace>
   <String `600 mg rufinamid/dag som till'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `läggsmedicinering '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 250Y2'>
    <MCurrPage `1330'>
    <Unique 1080106>
   > # end of Marker
   <String `(250)'>
   <Font 
    <FTag `Blue'>
    <FDW  -0.5%>
    <FLocked No>
   > # end of Font
   <String `.'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1058571>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `T'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `topiramat:trafik'>
    <MCurrPage `1330'>
    <Unique 1058575>
   > # end of Marker
   <String `opiramat'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1058572>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Inga studier om bilkörning med topiramat '>
  > # end of ParaLine
  <ParaLine 
   <String `finns. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1048392>
  <PgfTag `PrepBröd'>
  <Pgf 
   <PgfFIndent  6.0 mm>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `Topiramat givet till friska försökspersoner '>
  > # end of ParaLine
  <ParaLine 
   <String `(400 mg/dag under 12 veckor) visade påtag'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `liga (\>'>
   <Char HardSpace>
   <String `2 SD) negativa effekter på kognitiva '>
  > # end of ParaLine
  <ParaLine 
   <String `funktioner jämfört med placebo '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 251Y2'>
    <MCurrPage `1330'>
    <Unique 1075291>
   > # end of Marker
   <String `(251).'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` Mot'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `svarande fynd sågs vid 5,7 mg/kg kroppsvikt '>
  > # end of ParaLine
  <ParaLine 
   <String `efter 4 veckor i en annan studie '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 214Y2'>
    <MCurrPage `1330'>
    <Unique 1075298>
   > # end of Marker
   <String `(214)'>
   <Font 
    <FTag `Blue'>
    <FDW  -0.5%>
    <FLocked No>
   > # end of Font
   <String `.'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1068580>
  <PgfTag `PrepBröd'>
  <Pgf 
   <PgfFIndent  6.0 mm>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `I jämförande studier har topiramat större '>
  > # end of ParaLine
  <ParaLine 
   <String `kognitiv påverkan än lamotrigin '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 228Y2'>
    <MCurrPage `1330'>
    <Unique 1082012>
   > # end of Marker
   <String `(228,'>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 229Y2'>
    <MCurrPage `1330'>
    <Unique 1082017>
   > # end of Marker
   <String `229)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` '>
  > # end of ParaLine
  <ParaLine 
   <String `när preparaten gavs som tilläggsterapi till '>
  > # end of ParaLine
  <ParaLine 
   <String `karbamazepin eller fenytoin. I en annan '>
  > # end of ParaLine
  <ParaLine 
   <String `motsvarande jämförelse fann man att topi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ramat hade en inverkan på kognitiva funk'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tioner motsvarande 0,45‰ BAC '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 226Y2'>
    <MCurrPage `1330'>
    <Unique 1082031>
   > # end of Marker
   <String `(226)'>
   <Font 
    <FTag `Blue'>
    <FDW  -0.5%>
    <FLocked No>
   > # end of Font
   <String `.'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` Vid '>
  > # end of ParaLine
  <ParaLine 
   <String `jämförelse med lamotrigin sågs sämre test'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `resultat i 20 av 23 testvariabler '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 252Y2'>
    <MCurrPage `1330'>
    <Unique 1075323>
   > # end of Marker
   <String `(252)'>
   <Font 
    <FTag `Blue'>
    <FDW  -0.5%>
    <FLocked No>
   > # end of Font
   <String `.'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` Skill'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `naden verkade vara mer uttalad om topira'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `mat gavs som tillägg till valproat. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1082052>
  <PgfTag `PrepBröd'>
  <Pgf 
   <PgfFIndent  6.0 mm>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `Påverkan på P300 sågs liksom kognitiva '>
  > # end of ParaLine
  <ParaLine 
   <String `nedsättningar hos friska försökspersoner ef'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ter 20 veckor med 300 mg topiramat/dag '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <String `('>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 232Y2'>
    <MCurrPage `1330'>
    <Unique 1082056>
   > # end of Marker
   <String `232)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Topiramat med dosen 400 mg/dag som '>
  > # end of ParaLine
  <ParaLine 
   <String `tillägg till karbamazepin gav efter 12 veckor  '>
  > # end of ParaLine
  <ParaLine 
   <String `en något större negativ påverkan än tillägg '>
  > # end of ParaLine
  <ParaLine 
   <String `av valproat '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 253Y2'>
    <MCurrPage `1330'>
    <Unique 1082053>
   > # end of Marker
   <String `(253)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1068626>
  <PgfTag `PrepBröd'>
  <Pgf 
   <PgfFIndent  6.0 mm>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `I en översiktsartikel sammanfattar förfat'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tarna att det finns klara kliniska belägg för '>
  > # end of ParaLine
  <ParaLine 
   <String `topiramatinducerad kognitiv påverkan '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 254Y2'>
    <MCurrPage `1330'>
    <Unique 1075344>
   > # end of Marker
   <String `(254)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` '>
  > # end of ParaLine
  <ParaLine 
   <TextRectID 165>
   <String `och i en helt ny studie visas klass II-evidens '>
  > # end of ParaLine
  <ParaLine 
   <String `för en dosberoende kognitiv nedsättning, '>
  > # end of ParaLine
  <ParaLine 
   <String `signifikant vid doser \>'>
   <Char HardSpace>
   <String `192 mg/dag '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 255Y2'>
    <MCurrPage `1331'>
    <Unique 1075351>
   > # end of Marker
   <String `(255)'>
   <Font 
    <FTag `Blue'>
    <FDW  -0.5%>
    <FLocked No>
   > # end of Font
   <String `.'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1048463>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `V'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `valproat:trafik'>
    <MCurrPage `1331'>
    <Unique 1058580>
   > # end of Marker
   <String `alproat'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1031154>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `I en studie med valproat noterades ingen '>
  > # end of ParaLine
  <ParaLine 
   <String `ökad olycksrisk '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 256Y2'>
    <MCurrPage `1331'>
    <Unique 1075358>
   > # end of Marker
   <String `(256)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1079086>
  <PgfTag `PrepBröd'>
  <Pgf 
   <PgfFIndent  6.0 mm>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `Påverkan på kognitiva funktioner är lägre '>
  > # end of ParaLine
  <ParaLine 
   <String `än för andra antiepileptika (huvudsakligen '>
  > # end of ParaLine
  <ParaLine 
   <String `karbamazepin) '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 257Y2'>
    <MCurrPage `1331'>
    <Unique 1079087>
   > # end of Marker
   <String `(257)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` men finns '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 209Y2'>
    <MCurrPage `1331'>
    <Unique 1079088>
   > # end of Marker
   <String `(209,'>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 231Y2'>
    <MCurrPage `1331'>
    <Unique 1082066>
   > # end of Marker
   <String `231)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` '>
  > # end of ParaLine
  <ParaLine 
   <String `och innebär en förbättring när preparatet '>
  > # end of ParaLine
  <ParaLine 
   <String `sätts ut '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 257Y2'>
    <MCurrPage `1331'>
    <Unique 1079089>
   > # end of Marker
   <String `(257)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1079091>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `V'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `vigabatrin:trafik'>
    <MCurrPage `1331'>
    <Unique 1079090>
   > # end of Marker
   <String `igabatrin'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1048504>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Vigabatrin ger lite olika resultat, men två '>
  > # end of ParaLine
  <ParaLine 
   <String `studier visade ingen negativ inverkan på '>
  > # end of ParaLine
  <ParaLine 
   <String `kognitiva funktioner '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 258Y2'>
    <MCurrPage `1331'>
    <Unique 1075396>
   > # end of Marker
   <String `(258,'>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 259Y2'>
    <MCurrPage `1331'>
    <Unique 1075401>
   > # end of Marker
   <String `259)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Vigabatrin '>
  > # end of ParaLine
  <ParaLine 
   <String `som tillägg gav ingen påverkan på kognitiva '>
  > # end of ParaLine
  <ParaLine 
   <String `funktioner i en studie '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 260Y2'>
    <MCurrPage `1331'>
    <Unique 1075407>
   > # end of Marker
   <String `(260)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` medan i en an'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `nan studie hade vigabatrin negativa effekter '>
  > # end of ParaLine
  <ParaLine 
   <String `men av mindre grad än karbamazepin '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 261Y2'>
    <MCurrPage `1331'>
    <Unique 1075414>
   > # end of Marker
   <String `(261).'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1058595>
  <PgfTag `PrepBröd'>
  <Pgf 
   <PgfFIndent  6.0 mm>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `Ur bilkörningssynpunkt finns det skäl att '>
  > # end of ParaLine
  <ParaLine 
   <String `påminna om vigabatrins biverkningsrisk i '>
  > # end of ParaLine
  <ParaLine 
   <String `form av synfältsinskränkningar '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 262Y2'>
    <MCurrPage `1331'>
    <Unique 1075421>
   > # end of Marker
   <String `(262).'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1058596>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Z'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `zonisamid:trafik'>
    <MCurrPage `1331'>
    <Unique 1058600>
   > # end of Marker
   <String `onisamid'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1058597>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Zonisamid med 1 års uppföljning och dose'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ringarna 100, 200, 300 och 400 mg/dag visa'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `de att hälften av gruppen efter ett år klaga'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `de över kognitiv påverkan, något som ses i '>
  > # end of ParaLine
  <ParaLine 
   <String `form av dåliga resultat i kognitiva tester och '>
  > # end of ParaLine
  <ParaLine 
   <String `med störst påverkan vid 400 mg/dag '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 263Y2'>
    <MCurrPage `1331'>
    <Unique 1075428>
   > # end of Marker
   <String `(263).'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1049029>
  <PgfTag `Rub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `N04 – '>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `antiparkinsonmedel:trafik'>
    <MCurrPage `1331'>
    <Unique 1058605>
   > # end of Marker
   <String `antiparkinsonmedel'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1068647>
  <PgfTag `Bröd'>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.NewCenturySchlbk LT Std.R.400'>
    <FFamily `NewCenturySchlbk LT Std'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `NewCenturySchlbkLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  9.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  -1.0%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `Sömnstörningar med påtaglig dagtrötthet är '>
  > # end of ParaLine
  <ParaLine 
   <String `vanligt förekommande vid Parkinsons sjuk'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `dom '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 264Y2'>
    <MCurrPage `1331'>
    <Unique 1075435>
   > # end of Marker
   <String `(264,'>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 265Y2'>
    <MCurrPage `1331'>
    <Unique 1075440>
   > # end of Marker
   <String `265)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` och resulterar i att individen '>
  > # end of ParaLine
  <ParaLine 
   <String `lätt somnar, speciellt i situationer med inak'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tivitet. Dagtröttheten ökar med dopaminerg '>
  > # end of ParaLine
  <ParaLine 
   <String `medicinering '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 266Y2'>
    <MCurrPage `1331'>
    <Unique 1075446>
   > # end of Marker
   <String `(266)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `, troligen pga en viss dos'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `relaterad sederande effekt '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 267Y2'>
    <MCurrPage `1331'>
    <Unique 1075453>
   > # end of Marker
   <String `(267)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` i kombina'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tion med att dopaminerga medel kan störa '>
  > # end of ParaLine
  <ParaLine 
   <String `nattsömnen '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 268Y2'>
    <MCurrPage `1331'>
    <Unique 1075460>
   > # end of Marker
   <String `(268,'>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 269Y2'>
    <MCurrPage `1331'>
    <Unique 1075465>
   > # end of Marker
   <String `269)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` och därmed öka dag'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tröttheten. I en stor tysk studie  (n = 5'>
   <Char HardSpace>
   <String `210 '>
  > # end of ParaLine
  <ParaLine 
   <String `patienter med körkort) framkom att 8% '>
  > # end of ParaLine
  <ParaLine 
   <String `hade erfarit sömnattacker under körning (5-'>
  > # end of ParaLine
  <ParaLine 
   <String `årsperiod) varav en fjärdedel inte föregicks '>
  > # end of ParaLine
  <ParaLine 
   <String `av några varningstecken. I 28% (av de 8 pro'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `centen) resulterade sömnattacken i en kolli'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `sionsolycka '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 270Y2'>
    <MCurrPage `1331'>
    <Unique 1075472>
   > # end of Marker
   <String `(270)'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
   <String `.'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1088058>
  <PgfTag `BrödIn'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `”On-off”-problematik finns inte studerat i '>
  > # end of ParaLine
  <ParaLine 
   <String `sig, men sjukdomens svårighetsgrad, enligt '>
  > # end of ParaLine
  <ParaLine 
   <String `Hoehn and Yahr '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 271Y2'>
    <MCurrPage `1331'>
    <Unique 1088059>
   > # end of Marker
   <String `(271)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `, korrelerar starkt till '>
  > # end of ParaLine
  <ParaLine 
   <TextRectID 165>
   <String `påverkan på körförmågan. Vid körtest på '>
  > # end of ParaLine
  <ParaLine 
   <String `väg blev 100% med stadium 4, '>
   <Font 
    <FTag `'>
    <FDW  -0.5%>
    <FLocked No>
   > # end of Font
   <String `90% i stadi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `um 3 och över 50% i stadium 2 underkända '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 272Y2'>
    <MCurrPage `1331'>
    <Unique 1088060>
   > # end of Marker
   <String `(272)'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FDW  -0.5%>
    <FLocked No>
   > # end of Font
   <String `.'>
   <Font 
    <FTag `'>
    <FDW  -0.5%>
    <FLocked No>
   > # end of Font
   <String ` Av en annan studie framgår att både '>
  > # end of ParaLine
  <ParaLine 
   <String `neurologer och patienter överskattar körför'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `mågan jämfört med resultatet av ett körtest '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 273Y2'>
    <MCurrPage `1331'>
    <Unique 1088061>
   > # end of Marker
   <String `(273)'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FDW  -0.5%>
    <FLocked No>
   > # end of Font
   <String `.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1041500>
  <PgfTag `Rub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Sammanfattning'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1041501>
  <PgfTag `Bröd'>
  <ParaLine 
   <String `Mer eller mindre uttalad dagtrötthet är '>
  > # end of ParaLine
  <ParaLine 
   <String `vanligt förekommande vid Parkinsons sjuk'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `dom liksom förekomst av en progredierande '>
  > # end of ParaLine
  <ParaLine 
   <String `kognitiv funktionsnedsättning gående mot '>
  > # end of ParaLine
  <ParaLine 
   <String `demens. Båda tillstånden har stor betydelse '>
  > # end of ParaLine
  <ParaLine 
   <String `för trafiksäkerheten. Ofta överskuggar rö'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `relseproblematiken de kognitiva problemen '>
  > # end of ParaLine
  <ParaLine 
   <String `vid läkarbesöken, men ur trafiksäkerhets'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `synpunkt är den kognitiva funktionsned'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `sättningen och dagtröttheten ofta viktigare '>
  > # end of ParaLine
  <ParaLine 
   <String `än rörelseproblemen. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1041502>
  <PgfTag `Rub2'>
  <ParaLine 
   <String `Rekommendationer'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1048571>
  <PgfTag `Bröd'>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.NewCenturySchlbk LT Std.R.400'>
    <FFamily `NewCenturySchlbk LT Std'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `NewCenturySchlbkLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  9.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  -0.5%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
  > # end of Pgf
  <ParaLine 
   <String `Vid valet av läkemedel för behandling bör '>
  > # end of ParaLine
  <ParaLine 
   <String `man till bilförare välja sådana som inte har '>
  > # end of ParaLine
  <ParaLine 
   <String `någon (eller så liten som möjligt) sederande '>
  > # end of ParaLine
  <ParaLine 
   <String `effekt och inte med någon antikolinerg kom'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ponent – speciellt inte till äldre. Levodopa '>
  > # end of ParaLine
  <ParaLine 
   <String `förefaller ur bilkörningssynpunkt vara det '>
  > # end of ParaLine
  <ParaLine 
   <String `bästa alternativet, selegilin och tolkapon '>
  > # end of ParaLine
  <ParaLine 
   <String `verkar ha potential att förbättra kognitio'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `nen och rasagilin verkar vara neutralt ur '>
  > # end of ParaLine
  <ParaLine 
   <String `kognitiv synpunkt. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1068697>
  <PgfTag `Rub2'>
  <ParaLine 
   <String `Läs vidare'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1068698>
  <PgfTag `RefTextNr1'>
  <PgfNumString `1.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Font 
    <FTag `'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <String `Driving ability in Parkinson’s Disease: Current sta'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tus of research '>
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 274Y2'>
    <MCurrPage `1331'>
    <Unique 1075500>
   > # end of Marker
   <String `(274)'>
   <Font 
    <FTag `'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <String `. '>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `(En översiktsartikel från '>
  > # end of ParaLine
  <ParaLine 
   <String `2009.)'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1058615>
  <PgfTag `Rub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Enskilda preparat'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1058616>
  <PgfTag `Rub3efterRub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `B'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `bromokriptin:trafik'>
    <MCurrPage `1331'>
    <Unique 1058620>
   > # end of Marker
   <String `romokriptin'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1058617>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Bromokriptin förbättrade arbetsminnet ef'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ter 4 månaders monoterapi '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 275Y2'>
    <MCurrPage `1331'>
    <Unique 1075507>
   > # end of Marker
   <String `(275)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Vid be'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `handling av 66 personer med avancerad Par'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `kinsons sjukdom fick 17 mentala föränd'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ringar och 14 av dessa fick avbryta studien '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 276Y2'>
    <MCurrPage `1331'>
    <Unique 1075514>
   > # end of Marker
   <String `(276)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Bromokriptin givet till patienter med '>
  > # end of ParaLine
  <ParaLine 
   <String `Parkinsons sjukdom som komplement till '>
  > # end of ParaLine
  <ParaLine 
   <String `huvudsakligen levodopa och jämfört med en '>
  > # end of ParaLine
  <ParaLine 
   <String `kontrollgrupp med Parkinsons sjukdom vi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `sade inga skillnader i kognitiv funktion efter '>
  > # end of ParaLine
  <ParaLine 
   <String `6 månaders behandling, varav de 2 sista må'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `naderna var utan dosändring '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 277Y2'>
    <MCurrPage `1331'>
    <Unique 1075521>
   > # end of Marker
   <String `(277).'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1068709>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <TextRectID 166>
   <String `E'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `entakapon:trafik'>
    <MCurrPage `1332'>
    <Unique 1068708>
   > # end of Marker
   <String `ntakapon'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1077909>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Elva procent av en studerad population med '>
  > # end of ParaLine
  <ParaLine 
   <String `222 patienter med Parkinsons sjukdom an'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `gav att de slutade medicinera med entaka'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `pon pga kognitiv försämring, men uppgift '>
  > # end of ParaLine
  <ParaLine 
   <String `saknas om kognitionen förbättrades efter ut'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `sättning '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 278Y2'>
    <MCurrPage `1332'>
    <Unique 1077910>
   > # end of Marker
   <String `(278)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1068738>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `K'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `kabergolin:trafik'>
    <MCurrPage `1332'>
    <Unique 1068737>
   > # end of Marker
   <String `abergolin'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1068733>
  <PgfTag `PrepBröd'>
  <ParaLine 
   <String `Inga relevanta studier har återfunnits i Pub'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `Med.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1027477>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `L'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `levodopa:trafik'>
    <MCurrPage `1332'>
    <Unique 1058635>
   > # end of Marker
   <String `evodopa'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1048614>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Levodopa som överdoserats ledde till vårds'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `lös körning och ett uttalat riskbeteende '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 279Y2'>
    <MCurrPage `1332'>
    <Unique 1075535>
   > # end of Marker
   <String `(279).'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` Vissa positiva förbättringar av kogni'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tiva funktioner kan ses vid levodopabehand'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ling medan antikolinerga läkemedel kan ge '>
  > # end of ParaLine
  <ParaLine 
   <String `försämringar '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 275Y2'>
    <MCurrPage `1332'>
    <Unique 1075546>
   > # end of Marker
   <String `(275).'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1027478>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `P'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `pramipexol:trafik'>
    <MCurrPage `1332'>
    <Unique 1058640>
   > # end of Marker
   <String `ramipexol'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1048621>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Några belägg för att just pramipexol skulle '>
  > # end of ParaLine
  <ParaLine 
   <String `ge plötsligt insomnande bakom ratten finns '>
  > # end of ParaLine
  <ParaLine 
   <String `inte '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 280Y2'>
    <MCurrPage `1332'>
    <Unique 1075553>
   > # end of Marker
   <String `(280)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Däremot noterades en viss sede'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ring och försämrad kognitiv förmåga hos '>
  > # end of ParaLine
  <ParaLine 
   <String `friska försökspersoner med en engångsdos '>
  > # end of ParaLine
  <ParaLine 
   <String `av 0,25 och 0,5 mg pramipexol '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 281Y2'>
    <MCurrPage `1332'>
    <Unique 1075560>
   > # end of Marker
   <String `(281)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1048622>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `R'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `rasagilin:trafik'>
    <MCurrPage `1332'>
    <Unique 1058645>
   > # end of Marker
   <String `asagilin'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1058655>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Rasagilin varken förbättrar eller försämrar '>
  > # end of ParaLine
  <ParaLine 
   <String `kognitiva funktioner hos patienter med Par'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `kinsons sjukdom '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 282Y2'>
    <MCurrPage `1332'>
    <Unique 1075567>
   > # end of Marker
   <String `(282).'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1058656>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `R'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `ropinirol:trafik'>
    <MCurrPage `1332'>
    <Unique 1058660>
   > # end of Marker
   <String `opinirol'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1058657>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Några studier om eventuell kognitiv påver'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `kan av ropinirol finns inte vid sökning i Pub'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `Med. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1068827>
  <PgfTag `PrepBröd'>
  <Pgf 
   <PgfFIndent  6.0 mm>
  > # end of Pgf
  <ParaLine 
   <String `Se allmänt om antiparkinsonmedel ovan. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1027481>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `R'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `rotigotin:trafik'>
    <MCurrPage `1332'>
    <Unique 1058665>
   > # end of Marker
   <String `otigotin'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1058675>
  <PgfTag `PrepBröd'>
  <ParaLine 
   <String `Inga relevanta studier har återfunnits i Pub'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `Med.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1058676>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `S'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `selegilin:trafik'>
    <MCurrPage `1332'>
    <Unique 1058680>
   > # end of Marker
   <String `elegilin'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1058677>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Selegilin verkar i flera studier inte förbättra '>
  > # end of ParaLine
  <ParaLine 
   <String `kognitionen hos individer med kognitiv ned'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `sättning '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 283Y2'>
    <MCurrPage `1332'>
    <Unique 1075574>
   > # end of Marker
   <String `(283–286)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` medan en studie kunde '>
  > # end of ParaLine
  <ParaLine 
   <String `påvisa förbättring i motorisk reaktionsför'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `måga '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 287Y2'>
    <MCurrPage `1332'>
    <Unique 1075581>
   > # end of Marker
   <String `(287)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1055574>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `T'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `tolkapon:trafik'>
    <MCurrPage `1332'>
    <Unique 1058685>
   > # end of Marker
   <String `olkapon'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1048665>
  <PgfTag `PrepBröd'>
  <Pgf 
   <HyphenMaxLines 6>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `Tolkapon verkade förbättra kognitiva funk'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tioner efter 1/2 års uppföljning med medici'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <TextRectID 166>
   <String `nering av patienter med Parkinsons sjuk'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `dom '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 288Y2'>
    <MCurrPage `1332'>
    <Unique 1075588>
   > # end of Marker
   <String `(288)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` och friska försökspersoner '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 289Y2'>
    <MCurrPage `1332'>
    <Unique 1075595>
   > # end of Marker
   <String `(289).'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` '>
  > # end of ParaLine
  <ParaLine 
   <String `Det finns möjligen en skillnad mellan '>
  > # end of ParaLine
  <ParaLine 
   <String `COMT-genotyper där aminosyrakombinatio'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `nerna Val/Val förbättrade, Val/Met inte på'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `verkade och Met/Met försämrade resultaten '>
  > # end of ParaLine
  <ParaLine 
   <String `i vissa neuropsykologiska tester av frontala '>
  > # end of ParaLine
  <ParaLine 
   <String `hjärnfunktioner '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 289Y2'>
    <MCurrPage `1332'>
    <Unique 1075602>
   > # end of Marker
   <String `(289).'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1027494>
  <PgfTag `Rub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `N05A – '>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `neuroleptika:trafik'>
    <MCurrPage `1332'>
    <Unique 1058690>
   > # end of Marker
   <String `neuroleptika'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1041590>
  <PgfTag `Bröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Det finns inga bra studier på hur neurolep'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tika inverkar på körförmågan hos friska '>
  > # end of ParaLine
  <ParaLine 
   <String `personer utan alla studier är gjorda på en'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `bart sjuka, där det inte går att avgöra om '>
  > # end of ParaLine
  <ParaLine 
   <String `den nedsatta körförmågan beror på läke'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `medlet eller grundsjukdomen '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 290Y2'>
    <MCurrPage `1332'>
    <Unique 1075609>
   > # end of Marker
   <String `(290)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Där'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `emot finns det studier på hur kognitiva '>
  > # end of ParaLine
  <ParaLine 
   <String `funktioner hos schizofrenipatienter påver'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `kas av neuroleptika vilket redovisas nedan. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1041605>
  <PgfTag `Rub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Sammanfattning'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1068835>
  <PgfTag `Bröd'>
  <ParaLine 
   <String `Grundsjukdomen i sig innebär ofta nedsätt'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ningar i kognitiva funktioner med betydelse '>
  > # end of ParaLine
  <ParaLine 
   <String `för trafiksäkerheten. Det förefaller finnas '>
  > # end of ParaLine
  <ParaLine 
   <String `en skillnad mellan preparaten avseende ne'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `gativ inverkan på körförmågan, där de '>
  > # end of ParaLine
  <ParaLine 
   <String `klassiska preparaten har en större negativ '>
  > # end of ParaLine
  <ParaLine 
   <String `inverkan än de modernare. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1068840>
  <PgfTag `BrödIn'>
  <ParaLine 
   <String `Långtidsstudier saknas för flertalet sub'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `stanser förutom litium där man i en simula'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `torstudie såg negativ påverkan efter ett års '>
  > # end of ParaLine
  <ParaLine 
   <String `medicinering vid bipolär sjukdom jämfört '>
  > # end of ParaLine
  <ParaLine 
   <String `med en kontrollgrupp, medan behandling '>
  > # end of ParaLine
  <ParaLine 
   <String `av Ménières sjukdom (6 månader) inte visa'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `de någon skillnad mot en kontrollgrupp. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1068852>
  <PgfTag `BrödIn'>
  <ParaLine 
   <String `Det finns en klar risk att patienten kän'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ner sig mycket bättre än vad testresultaten '>
  > # end of ParaLine
  <ParaLine 
   <String `visar, vilket torde innebära en ökad olycks'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `risk i trafiken. Klozapin förefaller ha mind'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `re påverkan på kognitiva funktioner än an'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `dra neuroleptika men dess antikolinerga ef'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `fekter kan ha betydelse för åtminstone '>
  > # end of ParaLine
  <ParaLine 
   <String `äldre patienter.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1068855>
  <PgfTag `Rub2'>
  <ParaLine 
   <String `Rekommendationer'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1077929>
  <PgfTag `Bröd'>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.NewCenturySchlbk LT Std.R.400'>
    <FFamily `NewCenturySchlbk LT Std'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `NewCenturySchlbkLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  9.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.5%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <Font 
    <FTag `'>
    <FDW  -1.5%>
    <FLocked No>
   > # end of Font
   <String `Vid neuroleptikamedicinering bör det ingå '>
  > # end of ParaLine
  <ParaLine 
   <String `någon form av mätning av olika former av re'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `aktionsförmåga och psykomotorisk snabbhet '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `'>
    <FDW  -1.0%>
    <FLocked No>
   > # end of Font
   <String `innan bilkörning medges. Bilkörning är dock '>
  > # end of ParaLine
  <ParaLine 
   <String `inte aktuell förrän tidigast 1 år efter senas'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `te '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `'>
    <FDW  0.0%>
    <FLocked No>
   > # end of Font
   <String `skov av sjukdomen ('>
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `message URL http://www.transportstyrelsen.se/Global/Regler/TSFS_svenska/TSFS%202010-125.pdf'>
    <MCurrPage `1332'>
    <Unique 1077930>
   > # end of Marker
   <String `TSFS 2010:125, 14 kap, '>
  > # end of ParaLine
  <ParaLine 
   <String `3,4 §§'>
   <Font 
    <FTag `'>
    <FDW  0.0%>
    <FLocked No>
   > # end of Font
   <String `) '>
   <Font 
    <FTag `'>
    <FDW  0.0%>
    <FLocked No>
    <FSeparation 4>
    <FColor `Blue'>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 2Y2'>
    <MCurrPage `1332'>
    <Unique 1082108>
   > # end of Marker
   <String `(2)'>
   <Font 
    <FTag `'>
    <FDW  0.0%>
    <FLocked No>
   > # end of Font
   <String `.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1077931>
  <PgfTag `Rub2'>
  <ParaLine 
   <TextRectID 167>
   <String `Läs vidare'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1041610>
  <PgfTag `RefTextNr1'>
  <PgfNumString `1.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Road safety under psychiatric drug targeting '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 291Y2'>
    <MCurrPage `1333'>
    <Unique 1075617>
   > # end of Marker
   <String `(291)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. (En översiktsartikel från 2008.)'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1056525>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `2.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Recent advances in the development of novel '>
  > # end of ParaLine
  <ParaLine 
   <String `pharmacological agents for the treatment of '>
  > # end of ParaLine
  <ParaLine 
   <String `cognitive impairments in schizophrenia '>
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 292Y2'>
    <MCurrPage `1333'>
    <Unique 1075624>
   > # end of Marker
   <String `(292).'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `(En översiktsartikel från 2007.)'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1088115>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `3.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Font 
    <FTag `'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <String `Conventional versus novel antipsychotics: chang'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ing concepts and clinical implications '>
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 293Y2'>
    <MCurrPage `1333'>
    <Unique 1088116>
   > # end of Marker
   <String `(293)'>
   <Font 
    <FTag `'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <String `. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `(En översiktsartikel från 1999.)'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1088117>
  <PgfTag `Rub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Enskilda preparat'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1041597>
  <PgfTag `Rub3efterRub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `F'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `flupentixol:trafik'>
    <MCurrPage `1333'>
    <Unique 1058695>
   > # end of Marker
   <String `lupentixol och '>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `flufenazin:trafik'>
    <MCurrPage `1333'>
    <Unique 1058700>
   > # end of Marker
   <String `flufenazin'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1041592>
  <PgfTag `PrepBröd'>
  <Pgf 
   <HyphenMaxLines 6>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `Flupentixol och flufenazin i depåform gavs '>
  > # end of ParaLine
  <ParaLine 
   <String `till kroniska schizofrenipatienter och jäm'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `fördes med friska kontroller (utan läkeme'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `del) i neuropsykologiska tester och under en'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `kel simulatorkörning. Signifikant nedsätt'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ning sågs i alla mätvariabler för patient'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `gruppen jämfört med kontrollgruppen '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 294Y2'>
    <MCurrPage `1333'>
    <Unique 1075638>
   > # end of Marker
   <String `(294).'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1027498>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `H'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `haloperidol:trafik'>
    <MCurrPage `1333'>
    <Unique 1058705>
   > # end of Marker
   <String `aloperidol'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1080156>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Haloperidol till schizofrenipatienter i dosen '>
  > # end of ParaLine
  <ParaLine 
   <String `30 mg/dag jämfört med friska kontroller '>
  > # end of ParaLine
  <ParaLine 
   <String `utan läkemedel visade en signifikant sänk'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ning av resultaten i tester av enkel upp'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `märksamhet, delad uppmärksamhet och '>
  > # end of ParaLine
  <ParaLine 
   <String `valreaktionstid 25–35 dagar efter insatt be'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `handling '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 295Y2'>
    <MCurrPage `1333'>
    <Unique 1080157>
   > # end of Marker
   <String `(295)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1080158>
  <PgfTag `PrepBröd'>
  <Pgf 
   <PgfFIndent  6.0 mm>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `Vid en jämförelse mellan haloperidol och '>
  > # end of ParaLine
  <ParaLine 
   <String `and'>
   <Char DiscHyphen>
   <String `ra neuroleptika vid utskrivning från '>
  > # end of ParaLine
  <ParaLine 
   <String `sjukhus med ett ART-90-testbatteri sågs en '>
  > # end of ParaLine
  <ParaLine 
   <String `”remarkabel nedsättning i psykomotoriken” '>
  > # end of ParaLine
  <ParaLine 
   <String `i haloperidolgruppen och endast 1/20 (5%) '>
  > # end of ParaLine
  <ParaLine 
   <String `passerade alla subtester utan allvarligare '>
  > # end of ParaLine
  <ParaLine 
   <String `fel mot 7/29 (24%) i ”gruppen övriga” '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 296Y2'>
    <MCurrPage `1333'>
    <Unique 1080159>
   > # end of Marker
   <String `(296,'>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 297Y2'>
    <MCurrPage `1333'>
    <Unique 1080160>
   > # end of Marker
   <String `297)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1027499>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `K'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `klozapin:trafik'>
    <MCurrPage `1333'>
    <Unique 1058710>
   > # end of Marker
   <String `lozapin'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1031921>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Vid jämförelse mellan 10 patienter med klo'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `zapin och 18 patienter med andra neurolep'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tika hade klozapin en trend till bättre resul'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tat i ett deltest RST3 i ART-90-testbatteri '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 298Y2'>
    <MCurrPage `1333'>
    <Unique 1075671>
   > # end of Marker
   <String `(298)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `, något som sedan också har visats i en '>
  > # end of ParaLine
  <ParaLine 
   <String `annan studie '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 299Y2'>
    <MCurrPage `1333'>
    <Unique 1075678>
   > # end of Marker
   <String `(299)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Medlets antikolinerga '>
  > # end of ParaLine
  <ParaLine 
   <String `effekter är ett observandum, speciellt för '>
  > # end of ParaLine
  <ParaLine 
   <String `äldre patienter (”level 3 drug”) '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 20Y2'>
    <MCurrPage `1333'>
    <Unique 1075685>
   > # end of Marker
   <String `(20,'>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 300Y2'>
    <MCurrPage `1333'>
    <Unique 1075690>
   > # end of Marker
   <String `300).'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1027500>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `L'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `litium:trafik'>
    <MCurrPage `1333'>
    <Unique 1058715>
   > # end of Marker
   <String `itium'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1068926>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Litium var föremål för en översiktsartikel '>
  > # end of ParaLine
  <ParaLine 
   <String `1999 '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 301Y2'>
    <MCurrPage `1333'>
    <Unique 1075698>
   > # end of Marker
   <String `(301)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` där huvudsakligen bipolär sjuk'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `dom ingick i studierna. Minnesnedsättning '>
  > # end of ParaLine
  <ParaLine 
   <String `och framför allt långsammare informations'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <TextRectID 167>
   <String `processning var vanliga fynd med relevans '>
  > # end of ParaLine
  <ParaLine 
   <String `för bilkörning men det poängterades att ned'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `sättningarna inte var korrelerade till sede'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ring. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1068931>
  <PgfTag `PrepBröd'>
  <Pgf 
   <PgfFIndent  6.0 mm>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `I en långtidsstudie (6 månader) med liti'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `umbehandling av Ménières sjukdom sågs '>
  > # end of ParaLine
  <ParaLine 
   <String `ingen inverkan på bromsreaktionstid eller '>
  > # end of ParaLine
  <ParaLine 
   <String `andra simulatorvariabler jämfört med place'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `bo '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 302Y2'>
    <MCurrPage `1333'>
    <Unique 1075706>
   > # end of Marker
   <String `(302)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` medan andra långtidsstudier kunde '>
  > # end of ParaLine
  <ParaLine 
   <String `påvisa en mindre förlängning av reaktionsti'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `den och flera misstag '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 303Y2'>
    <MCurrPage `1333'>
    <Unique 1075717>
   > # end of Marker
   <String `(303,'>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 304Y2'>
    <MCurrPage `1333'>
    <Unique 1075722>
   > # end of Marker
   <String `304)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. I en annan '>
  > # end of ParaLine
  <ParaLine 
   <String `studie sågs negativ påverkan på reaktions'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `förmågan vid tvåveckorstestning trots att '>
  > # end of ParaLine
  <ParaLine 
   <String `försökspersonerna kände sig reaktionssnab'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ba '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 305Y2'>
    <MCurrPage `1333'>
    <Unique 1075728>
   > # end of Marker
   <String `(305)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Litium kombinerat med alkohol '>
  > # end of ParaLine
  <ParaLine 
   <String `(0,5‰ BAC) gav en klar försämring av koor'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `dinationsförmågan. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1053492>
  <PgfTag `PrepBröd'>
  <Pgf 
   <PgfFIndent  6.0 mm>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `Även Bramness och medarbetare visade '>
  > # end of ParaLine
  <ParaLine 
   <String `att unga kvinnor insatta på litium hade en 3 '>
  > # end of ParaLine
  <ParaLine 
   <String `gånger (1,3–6,6) ökad olycksrisk '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 256Y2'>
    <MCurrPage `1333'>
    <Unique 1075737>
   > # end of Marker
   <String `(256).'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1027501>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `O'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `olanzapin:trafik'>
    <MCurrPage `1333'>
    <Unique 1058720>
   > # end of Marker
   <String `lanzapin'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1055623>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Det finns inga studier relevanta för bilkör'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ning i PubMed, men medlets antikolinerga '>
  > # end of ParaLine
  <ParaLine 
   <String `effekter är ett observandum, speciellt för '>
  > # end of ParaLine
  <ParaLine 
   <String `äldre patienter '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 20Y2'>
    <MCurrPage `1333'>
    <Unique 1075743>
   > # end of Marker
   <String `(20,'>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 300Y2'>
    <MCurrPage `1333'>
    <Unique 1075748>
   > # end of Marker
   <String `300).'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1055624>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Q'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `quetiapin:trafik'>
    <MCurrPage `1333'>
    <Unique 1058725>
   > # end of Marker
   <String `uetiapin'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1048941>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Quetiapin befanns, jämfört med haloperidol '>
  > # end of ParaLine
  <ParaLine 
   <String `och flupentixol givet till patienter med schi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `zofreni, vara mer gynnsamt ur kognitiv syn'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `vinkel med ca 70% godkända personer i '>
  > # end of ParaLine
  <ParaLine 
   <String `ART-90-testsystemet'>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <String `.'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` Ändå var 30% inte '>
  > # end of ParaLine
  <ParaLine 
   <String `lämpliga för bilkörning '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 306Y2'>
    <MCurrPage `1333'>
    <Unique 1075761>
   > # end of Marker
   <String `(306).'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1027503>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `R'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `risperidon:trafik'>
    <MCurrPage `1333'>
    <Unique 1058730>
   > # end of Marker
   <String `isperidon'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1088106>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Risperidon har jämförts med haloperidol till '>
  > # end of ParaLine
  <ParaLine 
   <String `schizofrenipatienter vid utskrivning och '>
  > # end of ParaLine
  <ParaLine 
   <String `med kontroller '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 297Y2'>
    <MCurrPage `1333'>
    <Unique 1088107>
   > # end of Marker
   <String `(297)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Man såg en kraftig '>
  > # end of ParaLine
  <ParaLine 
   <String `nedsättning i psykomotoriken för båda grup'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `perna jämfört med en kontrollgrupp men till '>
  > # end of ParaLine
  <ParaLine 
   <String `fördel för risperidon där 35% klarade alla '>
  > # end of ParaLine
  <ParaLine 
   <String `deltesterna. Alla i kontrollgruppen blev god'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `kända '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 297Y2'>
    <MCurrPage `1333'>
    <Unique 1088108>
   > # end of Marker
   <String `(297)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. '>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1058751>
  <PgfTag `Rub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <Font 
    <FTag `Intense Emphasis'>
    <FLocked No>
   > # end of Font
   <String `N05B '>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `–'>
   <Font 
    <FTag `Intense Emphasis'>
    <FLocked No>
   > # end of Font
   <String ` '>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `anxiolytika:trafik'>
    <MCurrPage `1333'>
    <Unique 1058755>
   > # end of Marker
   <String `anxiolytika'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1079123>
  <PgfTag `Bröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Bensodiazepiner är de mest frekvent funna '>
  > # end of ParaLine
  <ParaLine 
   <String `substanserna (efter alkohol) hos bilförare '>
  > # end of ParaLine
  <ParaLine 
   <String `som provtagits vid misstanke om rattfylleri. '>
  > # end of ParaLine
  <ParaLine 
   <String `Flera studier visar att bensodiazepinanvän'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `dare är överrepresenterade i trafik'>
   <Char DiscHyphen>
   <String `olyckor '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 154Y2'>
    <MCurrPage `1333'>
    <Unique 1079124>
   > # end of Marker
   <String `(154,'>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 307Y2'>
    <MCurrPage `1333'>
    <Unique 1079125>
   > # end of Marker
   <String `307–312)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` med en riskökning på mellan '>
  > # end of ParaLine
  <ParaLine 
   <TextRectID 168>
   <String `1,5 och 13,5 gånger beroende på typ av läke'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `medel, studiepopulation och -design.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1049110>
  <PgfTag `BrödIn'>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.NewCenturySchlbk LT Std.R.400'>
    <FFamily `NewCenturySchlbk LT Std'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `NewCenturySchlbkLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  9.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  -0.5%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `I en studie om trafikolyckor resulterande '>
  > # end of ParaLine
  <ParaLine 
   <String `i sjukhusinläggning sågs 4 veckor efter re'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ceptuttag en risk på 3,1 gånger med diaze'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `pam och 2,4 gånger med lorazepam medan '>
  > # end of ParaLine
  <ParaLine 
   <String `oxazepam inte hade någon riskökning (1 '>
  > # end of ParaLine
  <ParaLine 
   <String `gång) '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 311Y2'>
    <MCurrPage `1334'>
    <Unique 1075794>
   > # end of Marker
   <String `(311)'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
   <String `.'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` En riskökning på 2,9 gånger för '>
  > # end of ParaLine
  <ParaLine 
   <String `bensodiazepiner under 1,5 års observations'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tid noterades av Engeland och med'>
   <Char DiscHyphen>
   <String `arbet'>
   <Char DiscHyphen>
   <String `are '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 154Y2'>
    <MCurrPage `1334'>
    <Unique 1075805>
   > # end of Marker
   <String `(154)'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
   <String `.'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1049115>
  <PgfTag `BrödIn'>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.NewCenturySchlbk LT Std.R.400'>
    <FFamily `NewCenturySchlbk LT Std'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `NewCenturySchlbkLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  9.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  1.0%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `I en studie av äldre (65 år och äldre) och '>
  > # end of ParaLine
  <ParaLine 
   <String `trafikolyckor fann Ray och medarbetare en '>
  > # end of ParaLine
  <ParaLine 
   <String `ökning av risken för trafikolyckor med per'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `sonskada vid bruk av bensodiazepiner från '>
  > # end of ParaLine
  <ParaLine 
   <String `1,1 gånger (0,5–2,2) för en ekvivalent dos '>
  > # end of ParaLine
  <ParaLine 
   <String `av 4 mg diazepam till 2,4 (1,3–4,4) för en '>
  > # end of ParaLine
  <ParaLine 
   <String `dos ≥ 20 mg '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 307Y2'>
    <MCurrPage `1334'>
    <Unique 1075815>
   > # end of Marker
   <String `(307)'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
   <String `.'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` Samtidigt bruk av två '>
  > # end of ParaLine
  <ParaLine 
   <String `olika bensodiazepiner ökade risken med 5 '>
  > # end of ParaLine
  <ParaLine 
   <String `gånger (1,6–15). Man såg inte heller att '>
  > # end of ParaLine
  <ParaLine 
   <String `risken minskade med tiden som läkemed'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `let togs. Uppfattningen, att en ångestpa'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tient kör bättre med ångestdämpande (lo'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `razepam) än utan, stämmer troligen inte '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 103Y2'>
    <MCurrPage `1334'>
    <Unique 1075825>
   > # end of Marker
   <String `(103,'>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 313Y2'>
    <MCurrPage `1334'>
    <Unique 1075834>
   > # end of Marker
   <String `313)'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
   <String `.'>
   <Font 
    <FTag `'>
    <FDW  0.0%>
    <FLocked No>
   > # end of Font
   <String `  '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1041728>
  <PgfTag `Rub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Sammanfattning'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1080217>
  <PgfTag `Bröd'>
  <ParaLine 
   <String `Endast buspiron har i studier inte visat sig '>
  > # end of ParaLine
  <ParaLine 
   <String `påverka körförmågan. Övriga har en signi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `fikant påverkan även om det finns enstaka '>
  > # end of ParaLine
  <ParaLine 
   <String `individer i studierna som inte påverkades. '>
  > # end of ParaLine
  <ParaLine 
   <String `Viss långsam toleransutveckling ses för '>
  > # end of ParaLine
  <ParaLine 
   <String `bensodiazepiner med minskad men fortfa'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `rande signifikant påverkan efter 1 månads '>
  > # end of ParaLine
  <ParaLine 
   <String `medicinering. Eftersom effekterna på friska '>
  > # end of ParaLine
  <ParaLine 
   <String `försökspersoner och ångestpatienter är lika '>
  > # end of ParaLine
  <ParaLine 
   <String `dras slutsatsen att ångestreduktionen inte '>
  > # end of ParaLine
  <ParaLine 
   <String `påverkar körförmågan till det bättre. Perso'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `nerna var också relativt omedvetna om lä'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `kemedlets faktiska effekter på körförmå'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `gan vid testkörningarna utom i de fall på'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `verkan var av det kraftigare slaget. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1049129>
  <PgfTag `Rub2'>
  <ParaLine 
   <String `Rekommendationer'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.700'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1049156>
  <PgfTag `Bröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Det finns anledning att starkt avråda från '>
  > # end of ParaLine
  <ParaLine 
   <String `bilkörning vid bensodiazepinbruk, möjligen '>
  > # end of ParaLine
  <ParaLine 
   <String `med undantag för oxazepam där man troli'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `gen kan vara något mera liberal efter en '>
  > # end of ParaLine
  <ParaLine 
   <String `tillvänjningsperiod med tanke på Neutels '>
  > # end of ParaLine
  <ParaLine 
   <String `studie '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 311Y2'>
    <MCurrPage `1334'>
    <Unique 1075840>
   > # end of Marker
   <String `(311)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` (se även oxazepam 50 mg till '>
  > # end of ParaLine
  <ParaLine 
   <String `natten under hypnotika). Varje intag av al'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `kohol under medicineringen med bensodia'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `zepiner kan förväntas kraftigt försämra '>
  > # end of ParaLine
  <ParaLine 
   <TextRectID 168>
   <String `körförmågan och det ska patienten varnas '>
  > # end of ParaLine
  <ParaLine 
   <String `för.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1049157>
  <PgfTag `Rub2'>
  <ParaLine 
   <String `Läs vidare'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1056531>
  <PgfTag `RefTextNr1'>
  <PgfNumString `1.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Bensodiazepine use and driving: A meta-analysis '>
  > # end of ParaLine
  <ParaLine 
   <String `(Artikel från 2009) '>
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 314Y2'>
    <MCurrPage `1334'>
    <Unique 1075847>
   > # end of Marker
   <String `(314)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `.'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1088164>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `2.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Font 
    <FTag `'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <String `Impact of psychotropic medications on simulated '>
  > # end of ParaLine
  <ParaLine 
   <String `driving'>
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <String ` '>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 290Y2'>
    <MCurrPage `1334'>
    <Unique 1088165>
   > # end of Marker
   <String `(290)'>
   <Font 
    <FTag `'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <String `. '>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `(Översiktsartikel 2007.)'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1088167>
  <PgfTag `RefTextNr1'>
  <Pgf 
   <PgfNumFormat `R:<n=3\>.\\t'>
  > # end of Pgf
  <PgfNumString `3.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Effects of anxiolytics on driving '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 315Y2'>
    <MCurrPage `1334'>
    <Unique 1088166>
   > # end of Marker
   <String `(315)'>
   <Font 
    <FTag `'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <String `.'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` (Översikts'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `artikel 2009.)'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1078021>
  <PgfTag `Rub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Enskilda preparat'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1049200>
  <PgfTag `Rub3efterRub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `A'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `alprazolam:trafik'>
    <MCurrPage `1334'>
    <Unique 1058760>
   > # end of Marker
   <String `lprazolam'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1079140>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Alprazolam 1 mg i beredning med långsam '>
  > # end of ParaLine
  <ParaLine 
   <String `frisättning (depåberedning) jämfördes med '>
  > # end of ParaLine
  <ParaLine 
   <String `1 mg av ”vanlig” beredning efter en engångs'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `dos till friska försökspersoner '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 316Y2'>
    <MCurrPage `1334'>
    <Unique 1079141>
   > # end of Marker
   <String `(316)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Båda '>
  > # end of ParaLine
  <ParaLine 
   <String `beredningsformerna visade en kraftig inver'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `kan på körförmågan efter 4,5 timmar, med'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `an depåberedningen visade bättre resultat, '>
  > # end of ParaLine
  <ParaLine 
   <String `alla dock sämre än vid BAC 0,5‰. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1055661>
  <PgfTag `PrepBröd'>
  <Pgf 
   <PgfFIndent  6.0 mm>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `Alprazolam 1 mg x 2 till friska kontroller '>
  > # end of ParaLine
  <ParaLine 
   <String `gav signifikanta nedsättningar i kognitiva '>
  > # end of ParaLine
  <ParaLine 
   <String `funktioner efter 3 dagars behandling '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 248Y2'>
    <MCurrPage `1334'>
    <Unique 1075880>
   > # end of Marker
   <String `(248).'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1055662>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `B'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `buspiron:trafik'>
    <MCurrPage `1334'>
    <Unique 1058769>
   > # end of Marker
   <String `uspiron'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1032173>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Buspiron givet 5 mg x 3 under 4 veckors be'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `handling gav ingen inverkan på körförmå'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `gan '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 317Y2'>
    <MCurrPage `1334'>
    <Unique 1075887>
   > # end of Marker
   <String `(317).'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1049295>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `D'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `diazepam:trafik'>
    <MCurrPage `1334'>
    <Unique 1058774>
   > # end of Marker
   <String `iazepam'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1080245>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Effekterna av diazepam, med doserna 5–15 '>
  > # end of ParaLine
  <ParaLine 
   <String `mg/dag till friska försökspersoner, vid mo'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `torvägskörning har undersökts i tre studier '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 313Y2'>
    <MCurrPage `1334'>
    <Unique 1080246>
   > # end of Marker
   <String `(313,'>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 318Y2'>
    <MCurrPage `1334'>
    <Unique 1080247>
   > # end of Marker
   <String `318,'>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 319Y2'>
    <MCurrPage `1334'>
    <Unique 1080248>
   > # end of Marker
   <String `319)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Med en engångsdos och kör'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ning 1 timme efter intag hade 5 mg ingen ef'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `fekt, medan 10 mg hade en effekt motsva'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `rande \>'>
   <Char HardSpace>
   <String `1‰ BAC. I en senare studie med '>
  > # end of ParaLine
  <ParaLine 
   <String `5'>
   <Char HardSpace>
   <String `mg x 3 vid körning 1 timme efter intag av '>
  > # end of ParaLine
  <ParaLine 
   <String `senaste dos sågs en påverkan \>'>
   <Char HardSpace>
   <String `0,5‰ BAC, '>
  > # end of ParaLine
  <ParaLine 
   <String `men självskattning av påverkan skiljde inte '>
  > # end of ParaLine
  <ParaLine 
   <String `från placebo. Undersökning efter 1 veckas '>
  > # end of ParaLine
  <ParaLine 
   <String `medicinering gav en nästan fördubblad ving'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `lighet motsvarande \>'>
   <Char HardSpace>
   <String `1‰ BAC-påverkan '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 313Y2'>
    <MCurrPage `1334'>
    <Unique 1080249>
   > # end of Marker
   <String `(313,'>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 318Y2'>
    <MCurrPage `1334'>
    <Unique 1080250>
   > # end of Marker
   <String `318,'>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 319Y2'>
    <MCurrPage `1334'>
    <Unique 1080251>
   > # end of Marker
   <String `319)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Inte heller nu visade själv'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `skattning någon påverkan jämfört med pla'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `cebo. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1049459>
  <PgfTag `PrepBröd'>
  <Pgf 
   <PgfFIndent  6.0 mm>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `I en studie med ångestpatienter sågs efter '>
  > # end of ParaLine
  <ParaLine 
   <String `1 veckas behandling med 5 mg x 3 en ving'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `lighet motsvarande nästan 1,5‰ BAC som '>
  > # end of ParaLine
  <ParaLine 
   <String `sedan sjönk för att efter 1 månad fortfaran'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `de motsvara \>'>
   <Char HardSpace>
   <String `0,5‰ BAC '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 317Y2'>
    <MCurrPage `1334'>
    <Unique 1075926>
   > # end of Marker
   <String `(317)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Gemensamt '>
  > # end of ParaLine
  <ParaLine 
   <String `var att någon signifikant korrelation mellan '>
  > # end of ParaLine
  <ParaLine 
   <TextRectID 169>
   <String `plasmanivåer och påverkansgrad inte note'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `rades. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1049436>
  <PgfTag `Rub3'>
  <ParaLine 
   <String `Hydroxizin'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1049437>
  <PgfTag `PrepBröd'>
  <ParaLine 
   <String `Se under antihistaminer R06, s'>
   <Char HardSpace>
   <XRef 
    <XRefName `Page'>
    <XRefSrcText `96816: Rub2: R06A – antihistaminer\x0d '>
    <XRefSrcIsElem No>
    <XRefSrcFile `'>
    <XRefLastUpdate  1382866575 931000>
    <XRefSrcElemNonUniqueId `'>
    <XRefAltText `'>
    <XRefApiClient 
     <XRefClientName `'>
     <XRefClientType `'>
    > # end of XRefApiClient
    <Unique 1082510>
   > # end of XRef
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <String `1341'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <XRefEnd >
   <String `.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1049438>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `L'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `lorazepam:trafik'>
    <MCurrPage `1335'>
    <Unique 1058779>
   > # end of Marker
   <String `orazepam'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1049490>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Lorazepam är undersökt i doserna 0,5 mg x '>
  > # end of ParaLine
  <ParaLine 
   <String `3, 1 mg x 3, 1,5 mg x 2 och 2 mg x 2 i 5 studier '>
  > # end of ParaLine
  <ParaLine 
   <String `som alla visade signifikant (≥ 0,8‰ BAC) på'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `verkan efter 1 dags och 8 dagars behandling '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 103Y2'>
    <MCurrPage `1335'>
    <Unique 1075941>
   > # end of Marker
   <String `(103,'>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 313Y2'>
    <MCurrPage `1335'>
    <Unique 1075950>
   > # end of Marker
   <String `313,'>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 320Y2'>
    <MCurrPage `1335'>
    <Unique 1075955>
   > # end of Marker
   <String `320–322)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. I två av studierna ingick '>
  > # end of ParaLine
  <ParaLine 
   <String `ångestpatienter som visade samma påver'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `kansgrad som friska försökspersoner med '>
  > # end of ParaLine
  <ParaLine 
   <String `motsvarande dosering medan ångestnivån '>
  > # end of ParaLine
  <ParaLine 
   <String `mätt med Hamiltons ångestskala reducera'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `des med ca 25%. Dosen 1 mg x 3 gav en på'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `verkan på körförmågan 1 timme efter intag '>
  > # end of ParaLine
  <ParaLine 
   <String `av senaste dos som motsvarade 1,5‰ BAC '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 103Y2'>
    <MCurrPage `1335'>
    <Unique 1075963>
   > # end of Marker
   <String `(103,'>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 313Y2'>
    <MCurrPage `1335'>
    <Unique 1075964>
   > # end of Marker
   <String `313,'>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 320Y2'>
    <MCurrPage `1335'>
    <Unique 1075965>
   > # end of Marker
   <String `320–322).'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1050569>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `O'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `oxazepam:trafik'>
    <MCurrPage `1335'>
    <Unique 1058789>
   > # end of Marker
   <String `xazepam'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1068970>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Oxazepam 10 mg x 3 efter 1 dags intag gav '>
  > # end of ParaLine
  <ParaLine 
   <String `en påverkan motsvarande 0,5–0,8‰ BAC '>
  > # end of ParaLine
  <ParaLine 
   <String `medan självskattning av körkvalitén inte '>
  > # end of ParaLine
  <ParaLine 
   <String `skiljde sig från placebo '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 313Y2'>
    <MCurrPage `1335'>
    <Unique 1075976>
   > # end of Marker
   <String `(313)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1068972>
  <PgfTag `Rub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `N05C – '>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `hypnotika:trafik'>
    <MCurrPage `1335'>
    <Unique 1068971>
   > # end of Marker
   <String `hypnotika'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1088172>
  <PgfTag `Bröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Sömnproblem är inte ovanligt i befolkning'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `en och under 2008 fick ca 750'>
   <Char HardSpace>
   <String `000 personer '>
  > # end of ParaLine
  <ParaLine 
   <String `recept på sömnmedel. Hälften är \>'>
   <Char HardSpace>
   <String `65 år '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 323Y2'>
    <MCurrPage `1335'>
    <Unique 1088173>
   > # end of Marker
   <String `(323)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` och fler än 80% har körkort. Rekom'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `mendationen är att använda kortverkande '>
  > # end of ParaLine
  <ParaLine 
   <String `läkemedel, men om personen tar läkemed'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `let sent på natten efter att ha legat sömnlös '>
  > # end of ParaLine
  <ParaLine 
   <String `är risken påtaglig att han/hon är påverkad '>
  > # end of ParaLine
  <ParaLine 
   <String `dagen efter och det är kanske olämpligt att '>
  > # end of ParaLine
  <ParaLine 
   <String `köra bil eller utföra precisionsarbete.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1041818>
  <PgfTag `Rub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Sammanfattning'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1068975>
  <PgfTag `Bröd'>
  <ParaLine 
   <String `Vid enstaka doser har zopiklon en påverkan '>
  > # end of ParaLine
  <ParaLine 
   <String `även på eftermiddagen dagen efter intag '>
  > # end of ParaLine
  <ParaLine 
   <String `medan zaleplon inte har någon påverkan på '>
  > # end of ParaLine
  <ParaLine 
   <String `förmiddagen efter intag, även om intaget '>
  > # end of ParaLine
  <ParaLine 
   <String `skett vid 4-tiden på natten. Zolpidem intar '>
  > # end of ParaLine
  <ParaLine 
   <String `en mellanställning med påverkan hos vissa '>
  > # end of ParaLine
  <ParaLine 
   <String `på förmiddagen men inte på eftermiddagen.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1041820>
  <PgfTag `Rub2'>
  <ParaLine 
   <String `Rekommendationer'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1041821>
  <PgfTag `Bröd'>
  <ParaLine 
   <String `För bilförare är således zaleplon att föredra '>
  > # end of ParaLine
  <ParaLine 
   <String `eller zolpidem som då ska tas senast vid '>
  > # end of ParaLine
  <ParaLine 
   <String `sänggåendet (före midnatt). Bensodiazepi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ner ska undvikas till bilförare.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1056569>
  <PgfTag `Rub2'>
  <ParaLine 
   <TextRectID 169>
   <String `Läs vidare:'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1056570>
  <PgfTag `RefTextNr1'>
  <PgfNumString `1.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Drugs, driving and traffic safety'>
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <String ` '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 324Y2'>
    <MCurrPage `1335'>
    <Unique 1075990>
   > # end of Marker
   <String `(324).'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1056571>
  <PgfTag `Rub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Enskilda preparat'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1049520>
  <PgfTag `Rub3efterRub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Z'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `zaleplon:trafik'>
    <MCurrPage `1335'>
    <Unique 1058799>
   > # end of Marker
   <String `aleplon'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1049521>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Zaleplon (10 och 20 mg) har visat sig inte på'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `verka körförmågan 10–11 timmar efter in'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tag '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 325Y2'>
    <MCurrPage `1335'>
    <Unique 1075998>
   > # end of Marker
   <String `(325)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` och inte heller 4 timmar efter intag '>
  > # end of ParaLine
  <ParaLine 
   <String `av 20 mg '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 326Y2'>
    <MCurrPage `1335'>
    <Unique 1076005>
   > # end of Marker
   <String `(326)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1027542>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Z'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `zolpidem:trafik'>
    <MCurrPage `1335'>
    <Unique 1058804>
   > # end of Marker
   <String `olpidem'>
   <FNote 203>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1049533>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Zolpidem 10 mg taget vid sänggåendet på'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `verkade inte körningen dagen efter (11 tim'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `mar efter intag och jämfört med 0,5‰ BAC), '>
  > # end of ParaLine
  <ParaLine 
   <String `men en högre dos liksom en dos tagen senare '>
  > # end of ParaLine
  <ParaLine 
   <String `under natten påverkade körförmågan '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 327Y2'>
    <MCurrPage `1335'>
    <Unique 1076013>
   > # end of Marker
   <String `(327,'>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 328Y2'>
    <MCurrPage `1335'>
    <Unique 1076018>
   > # end of Marker
   <String `328)'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
   <String `.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1049534>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Z'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `zopiklon:trafik'>
    <MCurrPage `1335'>
    <Unique 1058809>
   > # end of Marker
   <String `opiklon'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1068978>
  <PgfTag `PrepBröd'>
  <Pgf 
   <HyphenMaxLines 10>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `Zopiklon 7,5 mg taget vid sänggåendet har i '>
  > # end of ParaLine
  <ParaLine 
   <String `nyare studier visat sig ha en påverkan mot'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `svarande 0,5‰ BAC 11 timmar efter intagen '>
  > # end of ParaLine
  <ParaLine 
   <String `dos '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 328Y2'>
    <MCurrPage `1335'>
    <Unique 1076024>
   > # end of Marker
   <String `(328,'>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 329Y2'>
    <MCurrPage `1335'>
    <Unique 1076029>
   > # end of Marker
   <String `329)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Förarna själva kunde vara '>
  > # end of ParaLine
  <ParaLine 
   <String `omedvetna om den påverkan på körförmå'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `gan som sågs av körlärare under körtestet. '>
  > # end of ParaLine
  <ParaLine 
   <String `I'>
   <Char HardSpace>
   <String `3% av försöken avbröts körningen pga tra'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `fikfarlighet och i ett fall (1%) ansåg försöks'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `personen sig för påverkad för att köra. Re'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `sultaten står i bjärt kontrast till tidigare re'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `sultat från 1998 '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 330Y2'>
    <MCurrPage `1335'>
    <Unique 1076036>
   > # end of Marker
   <String `(330,'>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 331Y2'>
    <MCurrPage `1335'>
    <Unique 1076041>
   > # end of Marker
   <String `331).'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` Genom att slå '>
  > # end of ParaLine
  <ParaLine 
   <String `samman data från olika studier kunde Leuf'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `kens '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 329Y2'>
    <MCurrPage `1335'>
    <Unique 1076047>
   > # end of Marker
   <String `(329)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` visa att det inte förelåg någon '>
  > # end of ParaLine
  <ParaLine 
   <String `köns- eller åldersskillnad (upp till 75 år) i '>
  > # end of ParaLine
  <ParaLine 
   <String `påverkan. I en epidemiologisk studie visade '>
  > # end of ParaLine
  <ParaLine 
   <String `det sig att användare av zopiklon hade en '>
  > # end of ParaLine
  <ParaLine 
   <String `olycksrisk'>
   <Char DiscHyphen>
   <String `ökning på 4 gånger '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 309Y2'>
    <MCurrPage `1335'>
    <Unique 1076054>
   > # end of Marker
   <String `(309).'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1069011>
  <PgfTag `PrepBrödIndrag'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Resultaten har under 2009 verifierats i ett '>
  > # end of ParaLine
  <ParaLine 
   <String `avhandlingsarbete av Leufkens '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 329Y2'>
    <MCurrPage `1335'>
    <Unique 1076061>
   > # end of Marker
   <String `(329)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` där '>
  > # end of ParaLine
  <ParaLine 
   <String `han även konstaterade mätbara effekter på '>
  > # end of ParaLine
  <ParaLine 
   <String `kognitiva funktioner i olika neuropsykolo'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `giska tester. Han verifierade också att själv'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `skattning av påverkan inte alls står i paritet '>
  > # end of ParaLine
  <ParaLine 
   <String `med den påverkan som sågs vid körning och '>
  > # end of ParaLine
  <ParaLine 
   <String `i tester (underskattad påverkan).'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1079152>
  <PgfTag `PrepBrödIndrag'>
  <PgfReferenced Yes>
  <ParaLine 
   <TextRectID 170>
   <String `Leufkens visade också att zopiklon har en '>
  > # end of ParaLine
  <ParaLine 
   <String `påverkan på körförmågan hos kroniska an'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `vändare – visserligen mindre än hos friska '>
  > # end of ParaLine
  <ParaLine 
   <String `och hos dem med sporadisk användning – '>
  > # end of ParaLine
  <ParaLine 
   <String `som är signifikant skild från placebo men '>
  > # end of ParaLine
  <ParaLine 
   <String `lägre än vid BAC 0,5‰.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1080258>
  <PgfTag `PrepBrödIndrag'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `”Som vanligt” förekommer det stora indi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `viduella skillnader i känslighet, men mest '>
  > # end of ParaLine
  <ParaLine 
   <String `uttalat för zopiklon jämfört med zaleplon '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 332Y2'>
    <MCurrPage `1336'>
    <Unique 1080259>
   > # end of Marker
   <String `(332)'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
   <String `.'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` Äldre som grupp (upp till 75 år) uppvi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `sade ingen skillnad i påverkan jämfört med '>
  > # end of ParaLine
  <ParaLine 
   <String `yngre.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1080281>
  <PgfTag `Rub3'>
  <ParaLine 
   <String `Mer långverkande medel'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1080282>
  <PgfTag `PrepBrödIndrag'>
  <Pgf 
   <PgfFIndent  3.0 mm>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `Mer långverkande sömnmedel/sederande '>
  > # end of ParaLine
  <ParaLine 
   <String `medel återfinns bland t'>
   <Char HardSpace>
   <String `ex bensodiazepiner'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `na där framför allt nitrazepam, lorazepam, '>
  > # end of ParaLine
  <ParaLine 
   <String `oxazepam och flunitrazepam har studerats. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1040374>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `F'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `flunitrazepam:trafik'>
    <MCurrPage `1336'>
    <Unique 1058814>
   > # end of Marker
   <String `lunitrazepam'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1088260>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Flunitrazepam (2 mg) påverkade körförmå'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `gan både på morgonen och eftermiddagen ef'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ter två behandlingsnätter jämförbart med '>
  > # end of ParaLine
  <ParaLine 
   <String `0,5‰ BAC '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 333Y2'>
    <MCurrPage `1336'>
    <Unique 1088261>
   > # end of Marker
   <String `(333,'>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 334Y2'>
    <MCurrPage `1336'>
    <Unique 1088262>
   > # end of Marker
   <String `334).'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` I såväl en simulator'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `studie som vid ett ”On Road Test” (ORT) på'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `verkades också körningen på morgonen efter '>
  > # end of ParaLine
  <ParaLine 
   <String `intag av 1 eller 2 mg flunitrazepam '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 335Y2'>
    <MCurrPage `1336'>
    <Unique 1088263>
   > # end of Marker
   <String `(335,'>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 336Y2'>
    <MCurrPage `1336'>
    <Unique 1088264>
   > # end of Marker
   <String `336)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Ingen signifikant påverkan sågs '>
  > # end of ParaLine
  <ParaLine 
   <String `emellertid i en tidigare studie '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 337Y2'>
    <MCurrPage `1336'>
    <Unique 1088265>
   > # end of Marker
   <String `(337)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `, men '>
  > # end of ParaLine
  <ParaLine 
   <String `1'>
   <Char HardSpace>
   <String `av 18 fick i den studien avbryta körtestet '>
  > # end of ParaLine
  <ParaLine 
   <String `pga trötthet.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1027550>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `K'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `klometiazol:trafik'>
    <MCurrPage `1336'>
    <Unique 1058819>
   > # end of Marker
   <String `lometiazol och '>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `propiomazin:trafik'>
    <MCurrPage `1336'>
    <Unique 1058824>
   > # end of Marker
   <String `propiomazin'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1032559>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Här finns endast en fallbeskrivning från '>
  > # end of ParaLine
  <ParaLine 
   <String `rättskemiska avdelningen i Linköping med '>
  > # end of ParaLine
  <ParaLine 
   <String `klometiazol '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 338Y2'>
    <MCurrPage `1336'>
    <Unique 1076109>
   > # end of Marker
   <String `(338)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` samt fallbeskrivningar '>
  > # end of ParaLine
  <ParaLine 
   <String `från rättsmedicinska institutet i Köln (med '>
  > # end of ParaLine
  <ParaLine 
   <String `samtidig förekomst av hög alkoholkoncent'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `ration) '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 339Y2'>
    <MCurrPage `1336'>
    <Unique 1076116>
   > # end of Marker
   <String `(339)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Båda substanserna har dock '>
  > # end of ParaLine
  <ParaLine 
   <String `trafikvarningstext i Fass. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1049684>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `M'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `midazolam:trafik'>
    <MCurrPage `1336'>
    <Unique 1058829>
   > # end of Marker
   <String `idazolam'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1058839>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Midazolam 2 mg/70 kg gav 1,5 timme efter '>
  > # end of ParaLine
  <ParaLine 
   <String `administrering kvarstående kognitiva ned'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `sättningar motsvarande påverkan av 1,1‰ '>
  > # end of ParaLine
  <ParaLine 
   <String `BAC '>
   <Font 
    <FTag `'>
    <FLanguage USEnglish>
    <FLocked No>
    <FSeparation 4>
    <FColor `Blue'>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 23Y2'>
    <MCurrPage `1336'>
    <Unique 1076123>
   > # end of Marker
   <String `(23).'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1078025>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `N'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `nitrazepam:trafik'>
    <MCurrPage `1336'>
    <Unique 1078024>
   > # end of Marker
   <String `itrazepam'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1088196>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Nitrazepam 5 mg till natten under 3 dygn '>
  > # end of ParaLine
  <ParaLine 
   <String `påverkade körningen dagen efter men ej '>
  > # end of ParaLine
  <ParaLine 
   <String `dygn 4 '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 340Y2'>
    <MCurrPage `1336'>
    <Unique 1088197>
   > # end of Marker
   <String `(340).'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` Nitrazepam har med 5 mg-'>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `dosering inte påverkat körförmågan '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 334Y2'>
    <MCurrPage `1336'>
    <Unique 1088198>
   > # end of Marker
   <String `(334)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` '>
  > # end of ParaLine
  <ParaLine 
   <String `medan 10 mg till natten efter 2 dygns medi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <TextRectID 170>
   <String `cinering medförde en signifikant skillnad '>
  > # end of ParaLine
  <ParaLine 
   <String `mot placebo '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 341Y2'>
    <MCurrPage `1336'>
    <Unique 1088199>
   > # end of Marker
   <String `(341)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Det är värt att notera att '>
  > # end of ParaLine
  <ParaLine 
   <String `de negativa effekterna var mer uttalade vid '>
  > # end of ParaLine
  <ParaLine 
   <String `eftermiddagskörningarna än på förmidda'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `garna pga aktiva metaboliter. Efter 4 och 10 '>
  > # end of ParaLine
  <ParaLine 
   <String `dagars behandling med 10 mg sågs ingen '>
  > # end of ParaLine
  <ParaLine 
   <String `signifikant skillnad, talande för toleransut'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `veckling. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1027553>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `O'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `oxazepam:trafik'>
    <MCurrPage `1336'>
    <Unique 1058849>
   > # end of Marker
   <String `xazepam'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1032670>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Oxazepam (50 mg till natten) påverkade '>
  > # end of ParaLine
  <ParaLine 
   <String `ORT-resultaten morgonen efter 1 och 2 be'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `handlingsnätter motsvarande 0,5‰ BAC '>
  > # end of ParaLine
  <ParaLine 
   <String `medan eftermiddagskörningen inte var på'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `verkad (bättre än placebo). Vid körning på '>
  > # end of ParaLine
  <ParaLine 
   <String `morgonen i bilsimulator sågs ingen säker'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ställd påverkan (jämfört med 0,5‰ BAC) '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 342Y2'>
    <MCurrPage `1336'>
    <Unique 1082194>
   > # end of Marker
   <String `(342).'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1027554>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `T'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `triazolam:trafik'>
    <MCurrPage `1336'>
    <Unique 1058854>
   > # end of Marker
   <String `riazolam'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1032711>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Triazolam har ännu inte undersökts med '>
  > # end of ParaLine
  <ParaLine 
   <String `ORT-tester medan körning i bilsimulator '>
  > # end of ParaLine
  <ParaLine 
   <String `och på körslinga inte visade någon påverkan '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 340Y2'>
    <MCurrPage `1336'>
    <Unique 1082203>
   > # end of Marker
   <String `(340)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Däremot sågs en ca 3 gånger ökad risk '>
  > # end of ParaLine
  <ParaLine 
   <String `för trafikolyckor med sjukhusinläggning '>
  > # end of ParaLine
  <ParaLine 
   <String `som följd inom 8 veckor efter receptuttag, i '>
  > # end of ParaLine
  <ParaLine 
   <String `paritet med diazepam '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 311Y2'>
    <MCurrPage `1336'>
    <Unique 1076159>
   > # end of Marker
   <String `(311).'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1027564>
  <PgfTag `Rub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <Font 
    <FTag `Intense Emphasis'>
    <FLocked No>
   > # end of Font
   <String `N06A '>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `– '>
   <Font 
    <FTag `Intense Emphasis'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `antidepressiva läkemedel:trafik'>
    <MCurrPage `1336'>
    <Unique 1058859>
   > # end of Marker
   <String `antidepressiva'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1049756>
  <PgfTag `Bröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Förskrivningen av antidepressiva är relate'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `rad till en viss ökning i olycksrisk: 1,4–1,6 '>
  > # end of ParaLine
  <ParaLine 
   <String `gånger beroende på typ av preparat '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 343Y2'>
    <MCurrPage `1336'>
    <Unique 1076166>
   > # end of Marker
   <String `(343)'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
   <String `.'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` '>
  > # end of ParaLine
  <ParaLine 
   <String `Riskökningen för personskada vid olycka '>
  > # end of ParaLine
  <ParaLine 
   <String `uppgick i en annan studie till 2,3 '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 344Y2'>
    <MCurrPage `1336'>
    <Unique 1076173>
   > # end of Marker
   <String `(344)'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
   <String `.'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` Att '>
  > # end of ParaLine
  <ParaLine 
   <String `använda bilen som redskap vid suicid är '>
  > # end of ParaLine
  <ParaLine 
   <String `inte ovanligt och måste finnas med i bedöm'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ningen av en deprimerad patient. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1080301>
  <PgfTag `BrödIn'>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.NewCenturySchlbk LT Std.R.400'>
    <FFamily `NewCenturySchlbk LT Std'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `NewCenturySchlbkLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  9.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  -0.5%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `I en studie av äldres (65 år och äldre) tra'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `fikolyckor med personskador sågs en olycks'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `risk på 2,2 gånger (95% KI 1,3–3,5) för tricy'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `kliska läkemedel. Vid dosering motsvaran'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `de \>'>
   <Char HardSpace>
   <String `125 mg amitriptylin ses en nästan 6 '>
  > # end of ParaLine
  <ParaLine 
   <String `gånger ökning av risken att bli inblandad i '>
  > # end of ParaLine
  <ParaLine 
   <String `en trafikolycka '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 307Y2'>
    <MCurrPage `1336'>
    <Unique 1080302>
   > # end of Marker
   <String `(307)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. '>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1049732>
  <PgfTag `Rub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Sammanfattning'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1049769>
  <PgfTag `Bröd'>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.NewCenturySchlbk LT Std.R.400'>
    <FFamily `NewCenturySchlbk LT Std'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `NewCenturySchlbkLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  9.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  -0.5%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
  > # end of Pgf
  <ParaLine 
   <String `Tricykliska antidepressiva har åtminstone '>
  > # end of ParaLine
  <ParaLine 
   <String `initialt en påverkan på kognitiva funktioner '>
  > # end of ParaLine
  <ParaLine 
   <String `medan SSRI-preparaten och MAO-hämma'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ren moklobemid inte har visat sig ha någon '>
  > # end of ParaLine
  <ParaLine 
   <String `inverkan på körförmågan. Paroxetin 40 mg/'>
  > # end of ParaLine
  <ParaLine 
   <String `dag har dock viss negativ påverkan på kog'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `nitiva funktioner. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1069101>
  <PgfTag `BrödIn'>
  <ParaLine 
   <TextRectID 171>
   <String `Övriga antidepressiva medel har varie'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `rande grad av påverkan och toleransutveck'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ling med undantag för venlafaxin och re'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `boxe'>
   <Char DiscHyphen>
   <String `tin som verkar sakna inverkan på kör'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `förmåga och kognitiva funktioner. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1069102>
  <PgfTag `Rub2'>
  <ParaLine 
   <String `Rekommendationer'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1079171>
  <PgfTag `Bröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Depression i sig innebär en ökad olycksrisk '>
  > # end of ParaLine
  <ParaLine 
   <String `(utöver suicidrisk) och innebär att körför'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `bud bör meddelas patienten tills klar kli'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `nisk effekt av behandlingen har uppnåtts. '>
  > # end of ParaLine
  <ParaLine 
   <String `För bilförare bör något av SSRI-preparaten '>
  > # end of ParaLine
  <ParaLine 
   <String `eller från ”gruppen övriga” användas där '>
  > # end of ParaLine
  <ParaLine 
   <String `man inte har sett några negativa effekter '>
  > # end of ParaLine
  <ParaLine 
   <String `på kognition vid studietidens slut, oftast ef'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ter 1–2 veckor. '>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1053536>
  <PgfTag `Rub2'>
  <ParaLine 
   <String `Läs vidare'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1088268>
  <PgfTag `RefTextNr1'>
  <PgfNumString `1.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Impact of psychotropic medications on simulated '>
  > # end of ParaLine
  <ParaLine 
   <String `driving '>
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 290Y2'>
    <MCurrPage `1337'>
    <Unique 1088269>
   > # end of Marker
   <String `(290)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. (En översiktsartikel från 2007.)'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1088271>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `2.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Drugs, Driving and Traffic Safety '>
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 324Y2'>
    <MCurrPage `1337'>
    <Unique 1088270>
   > # end of Marker
   <String `(324).'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1088272>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `3.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Font 
    <FTag `'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <String `Antidepressants and driver impairment: Empiri'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `cal evidence from a standard on-the-road test '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 345Y2'>
    <MCurrPage `1337'>
    <Unique 1088273>
   > # end of Marker
   <String `(345)'>
   <Font 
    <FTag `'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <String `. '>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `(En översiktsartikel från 2003.)'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1041977>
  <PgfTag `Rub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Enskilda preparat'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1041939>
  <PgfTag `Rub3efterRub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `A'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `amitriptylin:trafik'>
    <MCurrPage `1337'>
    <Unique 1058864>
   > # end of Marker
   <String `mitriptylin'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1049821>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Amitriptylin ger en signifikant försämring '>
  > # end of ParaLine
  <ParaLine 
   <String `av körförmåga och vissa kognitiva tester 4 '>
  > # end of ParaLine
  <ParaLine 
   <String `timmar efter intag av 25 mg jämfört med '>
  > # end of ParaLine
  <ParaLine 
   <String `placebo '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 346Y2'>
    <MCurrPage `1337'>
    <Unique 1076214>
   > # end of Marker
   <String `(346)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Dosen 75 mg/dag gav svår '>
  > # end of ParaLine
  <ParaLine 
   <String `trötthet och nedsatta resultat avseende kör'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `förmåga samt i majoriteten av neuropsyko'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `logiska tester, men nedsättningarna var '>
  > # end of ParaLine
  <ParaLine 
   <String `praktiskt taget borta vid omtestning dag 8 '>
  > # end of ParaLine
  <ParaLine 
   <String `med fortsatt läkemedelsintag '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 347Y2'>
    <MCurrPage `1337'>
    <Unique 1076221>
   > # end of Marker
   <String `(347)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1079218>
  <PgfTag `PrepBröd'>
  <Pgf 
   <PgfFIndent  6.0 mm>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `I en annan studie såg man inte någon så'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `dan toleransutveckling fram till dag 8 vid '>
  > # end of ParaLine
  <ParaLine 
   <String `test av CFF (”Critical Flicker Frequency”, se '>
  > # end of ParaLine
  <ParaLine 
   <String `tester, s'>
   <Char HardSpace>
   <XRef 
    <XRefName `Page'>
    <XRefSrcText `55866: Rub2: Tester\x0d '>
    <XRefSrcIsElem No>
    <XRefSrcFile `'>
    <XRefLastUpdate  1382866575 931000>
    <XRefSrcElemNonUniqueId `'>
    <XRefAltText `'>
    <XRefApiClient 
     <XRefClientName `'>
     <XRefClientType `'>
    > # end of XRefApiClient
    <Unique 1082517>
   > # end of XRef
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <String `1363'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <XRefEnd >
   <String `) '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 348Y2'>
    <MCurrPage `1337'>
    <Unique 1079219>
   > # end of Marker
   <String `(348)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` men väl i ett psykomoto'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `riktest. Femtio milligram som en engångs'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `dos nedsatte kognitiva funktioner '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 349Y2'>
    <MCurrPage `1337'>
    <Unique 1079220>
   > # end of Marker
   <String `(349).'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` Do'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `serna 75–100 mg/dag i 1 vecka har i en stu'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `die visat sig ha kvarstående negativ effekt '>
  > # end of ParaLine
  <ParaLine 
   <String `på koordination öga-hand och CFF '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 350Y2'>
    <MCurrPage `1337'>
    <Unique 1079221>
   > # end of Marker
   <String `(350).'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1049856>
  <PgfTag `PrepBröd'>
  <Pgf 
   <PgfFIndent  6.0 mm>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `Amitriptylin 25 mg till personer med neu'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ropatisk smärta gav dag 1 förlängda reak'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tionstider och vingligare körning på väg '>
  > # end of ParaLine
  <ParaLine 
   <String `(motsvarande 0,5‰ BAC) jämfört med place'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `bo, medan på dag 15 sågs inga skillnader '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 351Y2'>
    <MCurrPage `1337'>
    <Unique 1076249>
   > # end of Marker
   <String `(351).'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1027569>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <TextRectID 171>
   <String `K'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `klomipramin:trafik'>
    <MCurrPage `1337'>
    <Unique 1058878>
   > # end of Marker
   <String `lomipramin'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1049902>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Klomipramin 25–50 mg x 3, givet till depri'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `merade patienter, ingick i en jämförande '>
  > # end of ParaLine
  <ParaLine 
   <String `studie med andra nu avregistrerade läkeme'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `del och placebo '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 352Y2'>
    <MCurrPage `1337'>
    <Unique 1082223>
   > # end of Marker
   <String `(352)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Den ökade snabbheten '>
  > # end of ParaLine
  <ParaLine 
   <String `i reaktionsförmågan som noterades till'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `skrevs förbättringen av de depressiva sym'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tomen '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 352Y2'>
    <MCurrPage `1337'>
    <Unique 1082228>
   > # end of Marker
   <String `(352).'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1049903>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `M'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `maprotilin:trafik'>
    <MCurrPage `1337'>
    <Unique 1058883>
   > # end of Marker
   <String `aprotilin'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1080455>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Maprotilin, 75 mg, försämrade resultatet i '>
  > # end of ParaLine
  <ParaLine 
   <String `CFF och uppvisade en dosberoende effekt '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 353Y2'>
    <MCurrPage `1337'>
    <Unique 1082233>
   > # end of Marker
   <String `(353).'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` I en annan studie var testresultaten '>
  > # end of ParaLine
  <ParaLine 
   <String `normaliserade (= placebo) efter 2 månaders '>
  > # end of ParaLine
  <ParaLine 
   <String `behandling '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 354Y2'>
    <MCurrPage `1337'>
    <Unique 1082238>
   > # end of Marker
   <String `(354)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `.'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1080397>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `N'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `nortriptylin:trafik'>
    <MCurrPage `1337'>
    <Unique 1080396>
   > # end of Marker
   <String `ortriptylin'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1080463>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Nortriptylin har en kraftigt dosberoende se'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `derande effekt som påverkade resultaten '>
  > # end of ParaLine
  <ParaLine 
   <String `från ett uppmärksamhetstest '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 353Y2'>
    <MCurrPage `1337'>
    <Unique 1082243>
   > # end of Marker
   <String `(353).'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1080465>
  <PgfTag `PrepBröd'>
  <Pgf 
   <PgfFIndent  6.0 mm>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `Effekterna av nortriptylin var färre och '>
  > # end of ParaLine
  <ParaLine 
   <String `lindrigare än för amitriptylin i en jämföran'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `de studie med engångsdoser. Reaktionsti'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `derna var fortfarande förlängda efter 5 tim'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `mar vid 12,5 mg och 25 mg'>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 355Y2'>
    <MCurrPage `1337'>
    <Unique 1082248>
   > # end of Marker
   <String ` '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <String `(355).'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1058904>
  <PgfTag `Rub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `SSRI:trafik'>
    <MCurrPage `1337'>
    <Unique 1058903>
   > # end of Marker
   <String `SSRI'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1058905>
  <PgfTag `Rub3efterRub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `C'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `citalopram:trafik'>
    <MCurrPage `1337'>
    <Unique 1058909>
   > # end of Marker
   <String `italopram'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1058906>
  <PgfTag `PrepBröd'>
  <ParaLine 
   <String `Ingen studie med citalopram avseende kör'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `förmåga finns. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1050025>
  <PgfTag `PrepBröd'>
  <Pgf 
   <PgfFIndent  6.0 mm>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `Citalopram 10 mg vs placebo intravenöst '>
  > # end of ParaLine
  <ParaLine 
   <String `gav förbättrat långtidsminne och opåverkad '>
  > # end of ParaLine
  <ParaLine 
   <String `bibehållen uppmärksamhet '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 356Y2'>
    <MCurrPage `1337'>
    <Unique 1082253>
   > # end of Marker
   <String `(356).'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` Inga ne'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `gativa effekter i psykologtestresultat kunde '>
  > # end of ParaLine
  <ParaLine 
   <String `påvisas vid 40 mg i 2 veckor vs placebo hos '>
  > # end of ParaLine
  <ParaLine 
   <String `friska försökspersoner '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 357Y2'>
    <MCurrPage `1337'>
    <Unique 1082258>
   > # end of Marker
   <String `(357).'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1050040>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `E'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `escitalopram:trafik'>
    <MCurrPage `1337'>
    <Unique 1058914>
   > # end of Marker
   <String `scitalopram'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1080327>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Escitalopram 10 mg/dag under 1 vecka och '>
  > # end of ParaLine
  <ParaLine 
   <String `sedan 20 mg/dag visade ingen påverkan på '>
  > # end of ParaLine
  <ParaLine 
   <String `körförmågan jämfört med placebo '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 358Y2'>
    <MCurrPage `1337'>
    <Unique 1082263>
   > # end of Marker
   <String `(358).'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` '>
  > # end of ParaLine
  <ParaLine 
   <String `Inga negativa effekter i psykologtestresultat '>
  > # end of ParaLine
  <ParaLine 
   <String `kunde påvisas vid 40 mg i 2 veckor vs place'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `bo hos friska försökspersoner '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 357Y2'>
    <MCurrPage `1337'>
    <Unique 1082268>
   > # end of Marker
   <String `(357).'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1080340>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `F'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `fluoxetin:trafik'>
    <MCurrPage `1337'>
    <Unique 1080339>
   > # end of Marker
   <String `luoxetin'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1088281>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Fluoxetin 20 mg påverkade inte körförmå'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `gan signifikant dag 1 eller senare (3 veckor). '>
  > # end of ParaLine
  <ParaLine 
   <String `Körförmågan försämrades successivt från '>
  > # end of ParaLine
  <ParaLine 
   <String `dag 1 till 22 men ej signifikant sämre än pla'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `cebo '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 359Y2'>
    <MCurrPage `1337'>
    <Unique 1088282>
   > # end of Marker
   <String `(359)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Däremot sågs en nedsättning av '>
  > # end of ParaLine
  <ParaLine 
   <String `bibehållen uppmärksamhet under hela för'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `söksperioden. Dosen 40 mg visade ingen sig'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <TextRectID 172>
   <String `nifikant skillnad mot placebo i kognitiva '>
  > # end of ParaLine
  <ParaLine 
   <String `funktioner 1,5 och 4 timmar efter intag '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 360Y2'>
    <MCurrPage `1338'>
    <Unique 1088283>
   > # end of Marker
   <String `(360).'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1080331>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `F'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `fluvoxamin:trafik'>
    <MCurrPage `1338'>
    <Unique 1080330>
   > # end of Marker
   <String `luvoxamin'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1080332>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Det finns ingen studie om körförmåga eller '>
  > # end of ParaLine
  <ParaLine 
   <String `placebokontrollerade tester av kognitiva '>
  > # end of ParaLine
  <ParaLine 
   <String `funktioner som passar in i denna samman'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ställning. Preparatet har dock viss antiko'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `linerg effekt '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 20Y2'>
    <MCurrPage `1338'>
    <Unique 1080333>
   > # end of Marker
   <String `(20)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` och bör därmed ha en viss '>
  > # end of ParaLine
  <ParaLine 
   <String `påverkan på kognitionen.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1058930>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `P'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `paroxetin:trafik'>
    <MCurrPage `1338'>
    <Unique 1058934>
   > # end of Marker
   <String `aroxetin'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1058931>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Paroxetin i doseringen 20 respektive 40 mg '>
  > # end of ParaLine
  <ParaLine 
   <String `x 1 påverkade inte körförmågan efter första '>
  > # end of ParaLine
  <ParaLine 
   <String `dosen eller efter 1 veckas medicinering '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 344Y2'>
    <MCurrPage `1338'>
    <Unique 1076348>
   > # end of Marker
   <String `(344)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` '>
  > # end of ParaLine
  <ParaLine 
   <String `eller 4 timmar efter intag av 10 mg '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 346Y2'>
    <MCurrPage `1338'>
    <Unique 1076355>
   > # end of Marker
   <String `(346). '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `Doseringen 20 mg/dag gav i en annan studie '>
  > # end of ParaLine
  <ParaLine 
   <String `ingen påverkan på körförmågan eller neuro'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `psykologiska tester medan 40 mg/dag gav '>
  > # end of ParaLine
  <ParaLine 
   <String `påverkan i ”track”-test, delad uppmärksam'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `het och Sternbergs test '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 347Y2'>
    <MCurrPage `1338'>
    <Unique 1076362>
   > # end of Marker
   <String `(347).'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1027578>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `S'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `sertralin:trafik'>
    <MCurrPage `1338'>
    <Unique 1058939>
   > # end of Marker
   <String `ertralin'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1079310>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `En fallrapport om en trafikolycka visade att '>
  > # end of ParaLine
  <ParaLine 
   <String `den inblandade hade en plasmanivå som var '>
  > # end of ParaLine
  <ParaLine 
   <String `6 gånger normal högkonsumentnivå '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 361Y2'>
    <MCurrPage `1338'>
    <Unique 1079311>
   > # end of Marker
   <String `(361)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. '>
  > # end of ParaLine
  <ParaLine 
   <String `Sertralin som en engångsdos (25, 50, 75 och '>
  > # end of ParaLine
  <ParaLine 
   <String `100 mg) vs placebo gav ingen försämring av '>
  > # end of ParaLine
  <ParaLine 
   <String `testvariablerna eller vid simulerad körning '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 362Y2'>
    <MCurrPage `1338'>
    <Unique 1079312>
   > # end of Marker
   <String `(362)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` utan en förbättring i kritisk flicker-'>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `fusion-test (CFF) noterades '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 349Y2'>
    <MCurrPage `1338'>
    <Unique 1079313>
   > # end of Marker
   <String `(349,'>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 362Y2'>
    <MCurrPage `1338'>
    <Unique 1079314>
   > # end of Marker
   <String `362'>
   <Font 
    <FTag `'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <String `).'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` Do'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `serna 200 och 400 mg resulterade i sänkta '>
  > # end of ParaLine
  <ParaLine 
   <String `resultat avseende minnesfunktion, upp'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `märksamhet och reaktionsförmåga '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 363Y2'>
    <MCurrPage `1338'>
    <Unique 1079315>
   > # end of Marker
   <String `(363).'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` '>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1027580>
  <PgfTag `Rub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `MAO-hämmare:trafik'>
    <MCurrPage `1338'>
    <Unique 1058944>
   > # end of Marker
   <String `MAO-hämmare'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1050102>
  <PgfTag `Rub3efterRub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `M'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `moklobemid:trafik'>
    <MCurrPage `1338'>
    <Unique 1058949>
   > # end of Marker
   <String `oklobemid'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1050119>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Moklobemid, 200 mg x 2, med 8 dagars be'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `handling hade ingen inverkan på psykome'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `triska tester eller körförmåga '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 364Y2'>
    <MCurrPage `1338'>
    <Unique 1076406>
   > # end of Marker
   <String `(364).'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1050167>
  <PgfTag `PrepBröd'>
  <Pgf 
   <PgfFIndent  6.0 mm>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `Ingen inverkan på testresultaten sågs i en '>
  > # end of ParaLine
  <ParaLine 
   <String `studie med doseringen 150 mg x 2 '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 365Y2'>
    <MCurrPage `1338'>
    <Unique 1076413>
   > # end of Marker
   <String `(365)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` och '>
  > # end of ParaLine
  <ParaLine 
   <String `i en studie med 150 mg x 3 '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 366Y2'>
    <MCurrPage `1338'>
    <Unique 1076420>
   > # end of Marker
   <String `(366).'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` Däremot '>
  > # end of ParaLine
  <ParaLine 
   <String `gav 400 mg/dag en förlängd reaktionstid för '>
  > # end of ParaLine
  <ParaLine 
   <String `visuellt stimuli i ”track”-test men ej i and'>
   <Char DiscHyphen>
   <String `ra '>
  > # end of ParaLine
  <ParaLine 
   <String `tester jämfört med amitriptylin, 200 mg/dag, '>
  > # end of ParaLine
  <ParaLine 
   <String `och placebo '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 367Y2'>
    <MCurrPage `1338'>
    <Unique 1076427>
   > # end of Marker
   <String `(367)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1080573>
  <PgfTag `PrepBröd'>
  <Pgf 
   <PgfFIndent  6.0 mm>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `Vid behandling av deprimerade patienter '>
  > # end of ParaLine
  <ParaLine 
   <String `såg Allain och medarbetare med 450 mg/dag '>
  > # end of ParaLine
  <ParaLine 
   <String `som förväntat en förbättring i vissa kogniti'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `va funktioner '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 368Y2'>
    <MCurrPage `1338'>
    <Unique 1080574>
   > # end of Marker
   <String `(368)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. I en annan studie jäm'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `fördes doserna 100 mg x 3 och 200 mg x 3 '>
  > # end of ParaLine
  <ParaLine 
   <TextRectID 172>
   <String `med placebo. Man såg inga signifikanta '>
  > # end of ParaLine
  <ParaLine 
   <String `skillnader i resultaten från de genomförda '>
  > # end of ParaLine
  <ParaLine 
   <String `neuropsykologiska testerna efter 1 vecka. '>
  > # end of ParaLine
  <ParaLine 
   <String `Studien var en dubbelblind, randomiserad, '>
  > # end of ParaLine
  <ParaLine 
   <String `placebokontrollerad studie. De i diagram re'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `dovisade resultaten är dock genomgående '>
  > # end of ParaLine
  <ParaLine 
   <String `bäst för placebo och sämst för 200 mg moklo'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `bemid men med stora standardavvikelser '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 369Y2'>
    <MCurrPage `1338'>
    <Unique 1080575>
   > # end of Marker
   <String `(369).'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1050199>
  <PgfTag `Rub2'>
  <ParaLine 
   <String `Övriga antidepressiva'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1027584>
  <PgfTag `Rub3efterRub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `D'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `duloxetin:trafik'>
    <MCurrPage `1338'>
    <Unique 1058954>
   > # end of Marker
   <String `uloxetin'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1033122>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Duloxetin 60 mg/dag i 24 veckor till depri'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `merade patienter visade visserligen förbätt'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ringar i kognitiva funktioner men inte till '>
  > # end of ParaLine
  <ParaLine 
   <String `samma nivå som hos friska kontroller '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 370Y2'>
    <MCurrPage `1338'>
    <Unique 1076448>
   > # end of Marker
   <String `(370).'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1027585>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `M'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `mianserin:trafik'>
    <MCurrPage `1338'>
    <Unique 1058959>
   > # end of Marker
   <String `ianserin'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1069350>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Mianserin påverkade körförmågan negativt '>
  > # end of ParaLine
  <ParaLine 
   <String `två timmar efter intag (10 mg), jämförbart '>
  > # end of ParaLine
  <ParaLine 
   <String `med 1‰ BAC. Studierna visade att mellan '>
  > # end of ParaLine
  <ParaLine 
   <String `10 och 50% av de testade inte kunde genom'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `föra körtestet dag 1 av behandlingen. Efter '>
  > # end of ParaLine
  <ParaLine 
   <String `1'>
   <Char HardSpace>
   <String `vecka med 10 mg x 3 var påverkan mindre '>
  > # end of ParaLine
  <ParaLine 
   <String `men \>'>
   <Char HardSpace>
   <String `0,5‰ BAC '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 364Y2'>
    <MCurrPage `1338'>
    <Unique 1076456>
   > # end of Marker
   <String `(364,'>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 371Y2'>
    <MCurrPage `1338'>
    <Unique 1076465>
   > # end of Marker
   <String `371).'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` Ramaekers och '>
  > # end of ParaLine
  <ParaLine 
   <String `medarbetare visade också att 30 mg till nat'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ten i 1 vecka gav en viss initial påverkan '>
  > # end of ParaLine
  <ParaLine 
   <String `men mindre än 0,5‰ BAC. Dosen 60 mg till '>
  > # end of ParaLine
  <ParaLine 
   <String `natten gav en initial påverkan men någon '>
  > # end of ParaLine
  <ParaLine 
   <String `sådan sågs inte efter 2 veckor. En viss tole'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ransutveckling sågs fram till dag 16.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1050256>
  <PgfTag `PrepBröd'>
  <Pgf 
   <PgfFIndent  6.0 mm>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `I en studie av O’Hanlon och medarbetare '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 372Y2'>
    <MCurrPage `1338'>
    <Unique 1076471>
   > # end of Marker
   <String `(372)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` med 20 mg mianserin x 3 sågs en signi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `fikant påverkan vid tester även efter 14 da'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `gars medicinering.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1050262>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `M'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `mirtazapin:trafik'>
    <MCurrPage `1338'>
    <Unique 1058964>
   > # end of Marker
   <String `irtazapin'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1080545>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Mirtazapin 30 mg/dag påverkade körförmå'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `gan signifikant dag 2 efter insättning, men '>
  > # end of ParaLine
  <ParaLine 
   <String `dag 9 och 16 sågs ingen signifikant påverkan '>
  > # end of ParaLine
  <ParaLine 
   <String `trots höjning till 45 mg/dag '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 358Y2'>
    <MCurrPage `1338'>
    <Unique 1082308>
   > # end of Marker
   <String `(358)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Med 30 '>
  > # end of ParaLine
  <ParaLine 
   <String `och sedan 60 mg till natten sågs en viss ini'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tial påverkan men någon sådan noterades '>
  > # end of ParaLine
  <ParaLine 
   <String `inte efter 2 veckor. All påverkan var <'>
   <Char HardSpace>
   <String `0,5‰ '>
  > # end of ParaLine
  <ParaLine 
   <String `BAC.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1027587>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `R'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `reboxetin:trafik'>
    <MCurrPage `1338'>
    <Unique 1058969>
   > # end of Marker
   <String `eboxetin'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1079332>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Reboxetin i doserna 0,5, 1 och 4 mg har jäm'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `förts mot placebo och amitriptylin med ett '>
  > # end of ParaLine
  <ParaLine 
   <String `kognitivt testbatteri 1–9 timmar efter intag '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 373Y2'>
    <MCurrPage `1338'>
    <Unique 1079333>
   > # end of Marker
   <String `(373)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Upp till 4 mg gav ingen eller liten ne'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `gativ effekt på kognitiva funktioner. Alkohol '>
  > # end of ParaLine
  <ParaLine 
   <String `hade ingen synergistisk effekt '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 373Y2'>
    <MCurrPage `1338'>
    <Unique 1079334>
   > # end of Marker
   <String `(373)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. '>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1079336>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <TextRectID 173>
   <String `V'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `venlafaxin:trafik'>
    <MCurrPage `1339'>
    <Unique 1079335>
   > # end of Marker
   <String `enlafaxin'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1033275>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Venlafaxin 37,5 mg x 2 i 1 vecka med höjning '>
  > # end of ParaLine
  <ParaLine 
   <String `till maxdosen 75 mg x 2 visade ingen försäm'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `rad körförmåga efter 2 veckors behandling '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 372Y2'>
    <MCurrPage `1339'>
    <Unique 1076499>
   > # end of Marker
   <String `(372).'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1027602>
  <PgfTag `Rub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <Font 
    <FTag `Intense Emphasis'>
    <FLocked No>
   > # end of Font
   <String `N06B '>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `– '>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `centralstimulantia:trafik'>
    <MCurrPage `1339'>
    <Unique 1058979>
   > # end of Marker
   <String `c'>
   <Font 
    <FTag `Intense Emphasis'>
    <FLocked No>
   > # end of Font
   <String `entralstimulerande '>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `medel'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1069363>
  <PgfTag `Bröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Centralstimulantia har huvudsakligen två '>
  > # end of ParaLine
  <ParaLine 
   <String `förskrivningsområden: ADHD och som sti'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `mulantia vid trötthetssyndrom av olika ge'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `nes inklusive vid sömndeprivering. Ibland '>
  > # end of ParaLine
  <ParaLine 
   <String `förskrivs centralstimulantia för att minska '>
  > # end of ParaLine
  <ParaLine 
   <String `sederande effekter av en annan medicine'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ring, t'>
   <Char HardSpace>
   <String `ex neuroleptikamedicinering och lä'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `kemedel som används vid schizofreni. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1050353>
  <PgfTag `BrödIn'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Överskattning av den egna förmågan när '>
  > # end of ParaLine
  <ParaLine 
   <String `centralstimulantia getts har visats i en stu'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `die '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 374Y2'>
    <MCurrPage `1339'>
    <Unique 1076506>
   > # end of Marker
   <String `(374)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` men kunde inte verifieras i en se'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `nare studie av samma författare '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 375Y2'>
    <MCurrPage `1339'>
    <Unique 1076517>
   > # end of Marker
   <String `(375)'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
   <String `.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1043937>
  <PgfTag `Rub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Sammanfattning'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1088320>
  <PgfTag `Bröd'>
  <ParaLine 
   <String `Långsamt frisatt (depåberedning) metylfe'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `nidat har en dokumenterat förbättrande ef'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `fekt på körförmågan vid ADHD även på '>
  > # end of ParaLine
  <ParaLine 
   <String `kvällen och behandlingen kan vara en '>
  > # end of ParaLine
  <ParaLine 
   <String `förut'>
   <Char DiscHyphen>
   <String `sättning för körkortsinnehav. För ung'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `domar som kör bil kvälls- och nattetid bör '>
  > # end of ParaLine
  <ParaLine 
   <String `beredning med långsam frisättning av me'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tylfenidat eller kvällsdos starkt övervägas. '>
  > # end of ParaLine
  <ParaLine 
   <String `När centralstimulantia ges till friska för'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `sökspersoner och även uttröttade ses ofta '>
  > # end of ParaLine
  <ParaLine 
   <String `förbättringar i kognitiva funktioner, men '>
  > # end of ParaLine
  <ParaLine 
   <String `ingen studie har visat hur länge eventuella '>
  > # end of ParaLine
  <ParaLine 
   <String `förbättringar sitter i eller om effekterna av'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tar vid upprepade doseringar. Det kan även '>
  > # end of ParaLine
  <ParaLine 
   <String `finnas risk för att man överskattar sin för'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `måga när centralstimulantia ges i en hög '>
  > # end of ParaLine
  <ParaLine 
   <String `dos (300 mg) till sömndepriverade.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1053620>
  <PgfTag `Rub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Rekommendationer '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1053672>
  <PgfTag `Bröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Långsamt frisatt metylfenidat är bäst do'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `kumenterat när det gäller att ha trafiksä'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `kerhetshöjande effekter vid ADHD med för'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `bättringar av testresultat och körförmåga, '>
  > # end of ParaLine
  <ParaLine 
   <String `medan modafinil ibland har visat sig bättre '>
  > # end of ParaLine
  <ParaLine 
   <String `än placebo, ibland inte men aldrig sämre än '>
  > # end of ParaLine
  <ParaLine 
   <String `placebo.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1042063>
  <PgfTag `Rub2'>
  <ParaLine 
   <String `Läs vidare'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1056663>
  <PgfTag `RefTextNr1'>
  <PgfNumString `1.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `A review of driving risks and impairments associ'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ated with attention-deficit/hyperactivity disorder '>
  > # end of ParaLine
  <ParaLine 
   <String `and the effects of stimulant medication on dri'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <TextRectID 173>
   <String `ving performance '>
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 376Y2'>
    <MCurrPage `1339'>
    <Unique 1076525>
   > # end of Marker
   <String `(376)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. (En översiktsartikel från '>
  > # end of ParaLine
  <ParaLine 
   <String `2007.)'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1042065>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `2.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Font 
    <FTag `'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <String `Modafinil and methylphenidate for neuroen'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `hancement in healthy individuals: A systematic '>
  > # end of ParaLine
  <ParaLine 
   <String `review '>
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 377Y2'>
    <MCurrPage `1339'>
    <Unique 1076532>
   > # end of Marker
   <String `(377)'>
   <Font 
    <FTag `'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <String `. '>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `(En översiktsartikel från 2010.)'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1069386>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `3.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Bedömning av lämplighet vid körkortstillstånd '>
  > # end of ParaLine
  <ParaLine 
   <String `vid neuropsykiatriska funktionsnedsättningar '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 378Y2'>
    <MCurrPage `1339'>
    <Unique 1076539>
   > # end of Marker
   <String `(378)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1069387>
  <PgfTag `Rub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Enskilda preparat'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1042053>
  <PgfTag `Rub3efterRub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `A'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `atomoxetin:trafik'>
    <MCurrPage `1339'>
    <Unique 1058984>
   > # end of Marker
   <String `tomoxetin'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1055880>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Resultaten från en pilotstudie med atomoxe'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tin jämfört med placebo visade ingen signifi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `kant förbättring av körförmågan i simulator '>
  > # end of ParaLine
  <ParaLine 
   <String `efter 3 veckors medicinering '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 379Y2'>
    <MCurrPage `1339'>
    <Unique 1076546>
   > # end of Marker
   <String `(379)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` och inte '>
  > # end of ParaLine
  <ParaLine 
   <String `heller med 80 mg/dag i en jämförande studie '>
  > # end of ParaLine
  <ParaLine 
   <String `med en amfetaminblandning '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 380Y2'>
    <MCurrPage `1339'>
    <Unique 1076553>
   > # end of Marker
   <String `(380)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1055881>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `M'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `metylfenidat:trafik'>
    <MCurrPage `1339'>
    <Unique 1058989>
   > # end of Marker
   <String `etylfenidat'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1069390>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Studier med metylfenidat till ADHD-patien'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ter har visat att körförmågan förbättras '>
  > # end of ParaLine
  <ParaLine 
   <String `jämfört med placebo '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 381Y2'>
    <MCurrPage `1339'>
    <Unique 1076560>
   > # end of Marker
   <String `(381–384).'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` En studie '>
  > # end of ParaLine
  <ParaLine 
   <String `har jämfört långsamt frisatt metylfenidat gi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `vet kl 08.00 med metylfenidat x 3 (kl 8, 12 '>
  > # end of ParaLine
  <ParaLine 
   <String `och 16) och funnit jämförbara förbättringar i '>
  > # end of ParaLine
  <ParaLine 
   <String `resultaten av ett körtest kl 14 och 17 medan '>
  > # end of ParaLine
  <ParaLine 
   <String `beredningen med långsam frisättning behöll '>
  > # end of ParaLine
  <ParaLine 
   <String `förbättringen kl 20 och 23 '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 385Y2'>
    <MCurrPage `1339'>
    <Unique 1076567>
   > # end of Marker
   <String `(385)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1050472>
  <PgfTag `PrepBröd'>
  <Pgf 
   <PgfFIndent  6.0 mm>
  > # end of Pgf
  <ParaLine 
   <String `Få kvinnor har ingått i studierna och ing'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `en studie är gjord med friska kontroller.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1027606>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `M'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `modafinil:trafik'>
    <MCurrPage `1339'>
    <Unique 1058994>
   > # end of Marker
   <String `odafinil'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1079355>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Modafinil givet till friska försökspersoner '>
  > # end of ParaLine
  <ParaLine 
   <String `(placebo, 100 och 200 mg) som en engångs'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `dos gav en blandad bild av resultaten av kog'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `nitiva tester och något samband mellan dos '>
  > # end of ParaLine
  <ParaLine 
   <String `och effekt sågs inte '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 386Y2'>
    <MCurrPage `1339'>
    <Unique 1079356>
   > # end of Marker
   <String `(386)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Exempelvis blev '>
  > # end of ParaLine
  <ParaLine 
   <String `resultatet av testet för sifferrepetition bak'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `länges lika med resultatet för placebo och '>
  > # end of ParaLine
  <ParaLine 
   <String `200 mg modafinil, medan 100 mg gav ett sig'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `nifikant bättre resultat. I en annan studie '>
  > # end of ParaLine
  <ParaLine 
   <String `sågs liknande resultat med förbättringar i '>
  > # end of ParaLine
  <ParaLine 
   <String `vissa test, i andra inte, och befanns vara '>
  > # end of ParaLine
  <ParaLine 
   <String `utan samband med dosen '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 387Y2'>
    <MCurrPage `1339'>
    <Unique 1079357>
   > # end of Marker
   <String `(387).'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1055902>
  <PgfTag `PrepBröd'>
  <Pgf 
   <PgfFIndent  6.0 mm>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `Med engångsdoseringen 4 mg/kg kropps'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `vikt (= ca 300 mg) sågs flera förbättringar i '>
  > # end of ParaLine
  <ParaLine 
   <String `testresultaten '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 375Y2'>
    <MCurrPage `1339'>
    <Unique 1076588>
   > # end of Marker
   <String `(375)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` medan 100 mg och 200 '>
  > # end of ParaLine
  <ParaLine 
   <String `mg i en annan studie inte visade någon skill'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `nad mot placebo '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 388Y2'>
    <MCurrPage `1339'>
    <Unique 1076595>
   > # end of Marker
   <String `(388).'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1050540>
  <PgfTag `PrepBröd'>
  <Pgf 
   <PgfFIndent  6.0 mm>
  > # end of Pgf
  <ParaLine 
   <String `Modafinil har inte testats i verklig trafik '>
  > # end of ParaLine
  <ParaLine 
   <String `eller simulator.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1027617>
  <PgfTag `Rub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <TextRectID 174>
   <Font 
    <FTag `Intense Emphasis'>
    <FLocked No>
   > # end of Font
   <String `N07B '>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `– m'>
   <Font 
    <FTag `Intense Emphasis'>
    <FLocked No>
   > # end of Font
   <String `edel vid '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `behandling av beroendetillstånd'>
   <Font 
    <FTag `Intense Emphasis'>
    <FPlatformName `W.Times New Roman.R.700'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `Sammanfattning'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1042120>
  <PgfTag `Bröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Disulfiram verkar inte ge någon ytterligare '>
  > # end of ParaLine
  <ParaLine 
   <String `försämring av de kognitiva nedsättningar '>
  > # end of ParaLine
  <ParaLine 
   <String `som ofta kan ses hos personer med alkohol'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `beroende.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1042132>
  <PgfTag `Rub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Enskilda preparat'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1042111>
  <PgfTag `Rub3efterRub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `A'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `akamprosat:trafik'>
    <MCurrPage `1340'>
    <Unique 1058999>
   > # end of Marker
   <String `kamprosat och '>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `naltrexon:trafik'>
    <MCurrPage `1340'>
    <Unique 1059004>
   > # end of Marker
   <String `naltrexon'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1055913>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Akamprosat 2 g/dag och naltrexon 50 mg/'>
  > # end of ParaLine
  <ParaLine 
   <String `dag till friska personer gav svårtolkade re'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `sultat om man försöker relatera till baseline-'>
  > # end of ParaLine
  <ParaLine 
   <String `resultaten. Författarna angav dock att det '>
  > # end of ParaLine
  <ParaLine 
   <String `förekommer nedsättningar i olika testresul'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tat, men om det är signifikanta skillnader '>
  > # end of ParaLine
  <ParaLine 
   <String `mot baseline framgår inte. Studien var de'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `signad för att testa eventuell interaktion vid '>
  > # end of ParaLine
  <ParaLine 
   <String `samtidig administrering av preparaten '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 389Y2'>
    <MCurrPage `1340'>
    <Unique 1076602>
   > # end of Marker
   <String `(389)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1055914>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Buprenorfin och metadon'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1040446>
  <PgfTag `PrepBröd'>
  <ParaLine 
   <String `Buprenorfin och metadon är redovisade un'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `der analgetikaavsnittet, s'>
   <Char HardSpace>
   <XRef 
    <XRefName `Page'>
    <XRefSrcText `14361: Rub2: N02 – analgetika\x0d '>
    <XRefSrcIsElem No>
    <XRefSrcFile `'>
    <XRefLastUpdate  1382866575 931000>
    <XRefSrcElemNonUniqueId `'>
    <XRefAltText `'>
    <XRefApiClient 
     <XRefClientName `'>
     <XRefClientType `'>
    > # end of XRefApiClient
    <Unique 1082522>
   > # end of XRef
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <String `1325'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <XRefEnd >
   <String `.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1080609>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `B'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `bupropion:trafik'>
    <MCurrPage `1340'>
    <Unique 1080608>
   > # end of Marker
   <String `upropion'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1080646>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Bupropion är ett antidepressivum men även '>
  > # end of ParaLine
  <ParaLine 
   <String `inregistrerat för behandling av nikotinbero'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ende. Bupropion 150 mg/dag till deprimera'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `de patienter gav förbättring av kognitiva '>
  > # end of ParaLine
  <ParaLine 
   <String `funktioner, men det är oklart om det var lä'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `kemedlet i sig eller en spontan förbättring '>
  > # end of ParaLine
  <ParaLine 
   <String `av depressionen som var orsaken '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 390Y2'>
    <MCurrPage `1340'>
    <Unique 1080647>
   > # end of Marker
   <String `(390).'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1069405>
  <PgfTag `PrepBröd'>
  <Pgf 
   <PgfFIndent  6.0 mm>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `En studie med friska försökspersoner, som '>
  > # end of ParaLine
  <ParaLine 
   <String `gavs 50 mg x 3 i 7 dagar och sedan 100 mg x '>
  > # end of ParaLine
  <ParaLine 
   <String `3 i ytterligare 7 dagar och jämfördes med '>
  > # end of ParaLine
  <ParaLine 
   <String `placebo, visade ingen kognitiv skillnad men '>
  > # end of ParaLine
  <ParaLine 
   <String `en marginell påverkan på kvantitativt EEG '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 391Y2'>
    <MCurrPage `1340'>
    <Unique 1076620>
   > # end of Marker
   <String `(391).'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1027621>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `D'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `disulfiram:trafik'>
    <MCurrPage `1340'>
    <Unique 1059014>
   > # end of Marker
   <String `isulfiram'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1050650>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Tidigare studier har visat att disulfiram gi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `vet vid alkoholberoende eventuellt kan på'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `verka kognitionen (se sammanfattning av '>
  > # end of ParaLine
  <ParaLine 
   <String `Peeke och medarbetare från 1979 '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 392Y2'>
    <MCurrPage `1340'>
    <Unique 1076627>
   > # end of Marker
   <String `(392)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `), och '>
  > # end of ParaLine
  <ParaLine 
   <String `en fallrapport om överdosering har redovi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `sats ge bestående kognitiv nedsättning '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 393Y2'>
    <MCurrPage `1340'>
    <Unique 1076634>
   > # end of Marker
   <String `(393).'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1050717>
  <PgfTag `PrepBröd'>
  <Pgf 
   <PgfFIndent  6.0 mm>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `Disulfiram givet till icke-alkoholister '>
  > # end of ParaLine
  <ParaLine 
   <String `(fångar) och schizofrena patienter, 0,6–1,5 g/'>
  > # end of ParaLine
  <ParaLine 
   <String `dag med ökade doser under 14 dagar, visade '>
  > # end of ParaLine
  <ParaLine 
   <String `att huvudsakligen omedelbart minne var '>
  > # end of ParaLine
  <ParaLine 
   <String `försämrat men även andra testresultat var '>
  > # end of ParaLine
  <ParaLine 
   <TextRectID 174>
   <String `nedsatta och att schizofrenipatienterna upp'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `visade mera av psykotiska symtom '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 394Y2'>
    <MCurrPage `1340'>
    <Unique 1076641>
   > # end of Marker
   <String `(394)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. '>
  > # end of ParaLine
  <ParaLine 
   <String `Vid en mer ”normal” dosering med 0,5 g/dag '>
  > # end of ParaLine
  <ParaLine 
   <String `till 7 friska unga personer sågs snarast i en'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `staka fall något förbättrade testresultat men '>
  > # end of ParaLine
  <ParaLine 
   <String `dock inga signifikanta förändringar '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 392Y2'>
    <MCurrPage `1340'>
    <Unique 1076648>
   > # end of Marker
   <String `(392).'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1059034>
  <PgfTag `PrepBröd'>
  <Pgf 
   <PgfFIndent  6.0 mm>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `I en senare studie av Gilman och medar'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `betare från 1996 jämfördes personer med al'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `koholberoende och \>'>
   <Char HardSpace>
   <String `1 månad sedan senaste '>
  > # end of ParaLine
  <ParaLine 
   <String `alkoholintaget och när de ingick i ett be'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `handlingsprogram (11 med disulfiram och '>
  > # end of ParaLine
  <ParaLine 
   <String `37 utan). Ingen skillnad mellan grupperna '>
  > # end of ParaLine
  <ParaLine 
   <String `sågs i neuropsykologiska testresultat '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 395Y2'>
    <MCurrPage `1340'>
    <Unique 1076656>
   > # end of Marker
   <String `(395).'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1059035>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `V'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `vareniklin:trafik'>
    <MCurrPage `1340'>
    <Unique 1059039>
   > # end of Marker
   <String `areniklin'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1059036>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Vareniklin har av FDA (Food and Drug Ad'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ministration) fått kraftfullare varningstext '>
  > # end of ParaLine
  <ParaLine 
   <String `om psykiatriska problem och trafikolyckor '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 396Y2'>
    <MCurrPage `1340'>
    <Unique 1076663>
   > # end of Marker
   <String `(396).'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1050770>
  <PgfTag `Rub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `R05 – '>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `hostmediciner:trafik'>
    <MCurrPage `1340'>
    <Unique 1059044>
   > # end of Marker
   <String `hostdämpande medel '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Sammanfattning'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1050773>
  <PgfTag `Bröd'>
  <ParaLine 
   <String `Difenhydramin, som tillhör första genera'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tionens antihistaminer, har en påtaglig ef'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `fekt på kognition och körförmåga medan '>
  > # end of ParaLine
  <ParaLine 
   <String `noskapin i simulatorförsök inte gett någon '>
  > # end of ParaLine
  <ParaLine 
   <String `påverkan. Man kan inte utesluta att uppre'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `pade intag dagligen av etylmorfin kan på'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `verka körlämpligheten liksom vid enstaka '>
  > # end of ParaLine
  <ParaLine 
   <String `överdosering (egen klinisk observation).'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1042190>
  <PgfTag `Rub2'>
  <ParaLine 
   <String `Rekommendationer'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1053689>
  <PgfTag `Bröd'>
  <ParaLine 
   <String `För bilförare rekommenderas i första hand '>
  > # end of ParaLine
  <ParaLine 
   <String `alkoholfria läkemedel med sådana substan'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ser, t'>
   <Char HardSpace>
   <String `ex noskapin, som inte påverkar kör'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `förmåga/olycksrisk. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1042310>
  <PgfTag `Rub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Enskilda preparat'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1043954>
  <PgfTag `Rub3efterRub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Difenhydramin'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1050776>
  <PgfTag `PrepBröd'>
  <ParaLine 
   <String `Difenhydramin redovisas under antihista'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `miner, s'>
   <Char HardSpace>
   <XRef 
    <XRefName `Page'>
    <XRefSrcText `96816: Rub2: R06A – antihistaminer\x0d '>
    <XRefSrcIsElem No>
    <XRefSrcFile `'>
    <XRefLastUpdate  1382866575 931000>
    <XRefSrcElemNonUniqueId `'>
    <XRefAltText `'>
    <XRefApiClient 
     <XRefClientName `'>
     <XRefClientType `'>
    > # end of XRefApiClient
    <Unique 1082530>
   > # end of XRef
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <String `1341'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <XRefEnd >
   <String `.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1050777>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `E'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `etylmorfin:trafik'>
    <MCurrPage `1340'>
    <Unique 1059049>
   > # end of Marker
   <String `tylmorfin'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1079360>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Det finns inga studier i PubMed avseende '>
  > # end of ParaLine
  <ParaLine 
   <String `etylmorfin och kognitiv påverkan eller in'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `verkan på bilkörning/resultat av tester i kör'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `simulator. Det finns dock en svensk studie '>
  > # end of ParaLine
  <ParaLine 
   <String `som visar att när drygt 2'>
   <Char HardSpace>
   <String `500 prover från fö'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `rare som misstänkts för rattfylleri analyse'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `rades upptäcktes etylmorfin i 63 fall (2,4%) '>
  > # end of ParaLine
  <ParaLine 
   <String `och i 27 av dessa fall fanns även andra dro'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ger med i bilden. Således fanns det 36 fall '>
  > # end of ParaLine
  <ParaLine 
   <String `med endast etylmorfin (inom terapeutisk ni'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <TextRectID 175>
   <String `vå) som i avsaknad av alkohol eller andra '>
  > # end of ParaLine
  <ParaLine 
   <String `droger skulle kunna vara en indikation på '>
  > # end of ParaLine
  <ParaLine 
   <String `att etylmorfin vid normaldosering skulle '>
  > # end of ParaLine
  <ParaLine 
   <String `kunna påverka körningen så att misstanke '>
  > # end of ParaLine
  <ParaLine 
   <String `om drograttfylleri uppstått '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 397Y2'>
    <MCurrPage `1341'>
    <Unique 1079361>
   > # end of Marker
   <String `(397)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1053698>
  <PgfTag `PrepBröd'>
  <Pgf 
   <PgfFIndent  6.0 mm>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `I en norsk studie över metaboliseringen av '>
  > # end of ParaLine
  <ParaLine 
   <String `etylmorfin fick 10 friska försökspersoner '>
  > # end of ParaLine
  <ParaLine 
   <String `inta 0,88 ml/kg kroppsvikt Cosylan (etyl'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `morfinkombination) som en engångsdos. Sju '>
  > # end of ParaLine
  <ParaLine 
   <String `personer drabbades av yrsel och 2 av söm'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `nighet upp till 60 minuter efter intag '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 398Y2'>
    <MCurrPage `1341'>
    <Unique 1076678>
   > # end of Marker
   <String `(398).'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1027630>
  <PgfTag `Rub3'>
  <ParaLine 
   <String `Kodein'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1033708>
  <PgfTag `PrepBröd'>
  <ParaLine 
   <String `Redovisas under analgetika, s'>
   <Char HardSpace>
   <XRef 
    <XRefName `Page'>
    <XRefSrcText `14361: Rub2: N02 – analgetika\x0d '>
    <XRefSrcIsElem No>
    <XRefSrcFile `'>
    <XRefLastUpdate  1382866575 931000>
    <XRefSrcElemNonUniqueId `'>
    <XRefAltText `'>
    <XRefApiClient 
     <XRefClientName `'>
     <XRefClientType `'>
    > # end of XRefApiClient
    <Unique 1082534>
   > # end of XRef
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <String `1325'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <XRefEnd >
   <String `.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1050979>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `N'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `noskapin:trafik'>
    <MCurrPage `1341'>
    <Unique 1059054>
   > # end of Marker
   <String `oskapin'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1088393>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Noskapin (50 mg, 1+1+2 under 5 timmar) '>
  > # end of ParaLine
  <ParaLine 
   <String `påverkade inte körningen i avancerad bil'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `simulator '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 399Y2'>
    <MCurrPage `1341'>
    <Unique 1088394>
   > # end of Marker
   <String `(399)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Alkohol ingår i Nipaxon (2,2 '>
  > # end of ParaLine
  <ParaLine 
   <String `mg/ml) och Noskapin (2,2 mg/ml).'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1080668>
  <PgfTag `PrepBrödIndrag'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Observera att alkohol ingår i flera andra '>
  > # end of ParaLine
  <ParaLine 
   <String `produkter, t'>
   <Char HardSpace>
   <String `ex Quilla Simplex, Bromhexin '>
  > # end of ParaLine
  <ParaLine 
   <String `(3,6% (v/v), Mollipect och Cocillana-Etyfin '>
  > # end of ParaLine
  <ParaLine 
   <String `(9,6%).'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1079381>
  <PgfTag `Rub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 9>
    <MTypeName `Cross-Ref'>
    <MText `96816: Rub2: R06A – antihistaminer\x0d '>
    <MCurrPage `1341'>
    <Unique 1082509>
   > # end of Marker
   <String `R06A – '>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `antihistaminer:trafik'>
    <MCurrPage `1341'>
    <Unique 1079380>
   > # end of Marker
   <String `antihistaminer'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1088378>
  <PgfTag `Bröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Antihistaminer, främst första generatio'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `nen, är kända för att ha trötthet som bi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `verkning, vilket även lett till att medlen an'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `vänds som sömnmedel. Allergisymtom i sig '>
  > # end of ParaLine
  <ParaLine 
   <String `kan ge störd nattsömn och därmed dagtrött'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `het med sammanhängande trafiksäker'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `hetsrisk '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 400Y2'>
    <MCurrPage `1341'>
    <Unique 1088379>
   > # end of Marker
   <String `(400)'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
   <String `.'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` Antihistaminbruk allmänt '>
  > # end of ParaLine
  <ParaLine 
   <String `har visat sig öka olycksrisken 3 gånger obe'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `'>
    <FDW  -0.5%>
    <FLocked No>
   > # end of Font
   <String `roende av eventuell sömnighet '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 401Y2'>
    <MCurrPage `1341'>
    <Unique 1088380>
   > # end of Marker
   <String `(401)'>
   <Font 
    <FTag `'>
    <FDW  -0.5%>
    <FLocked No>
   > # end of Font
   <String `. Även '>
  > # end of ParaLine
  <ParaLine 
   <String `andra generationens antihistaminer kan ha '>
  > # end of ParaLine
  <ParaLine 
   <String `en viss sederande effekt, speciellt om tera'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `peutisk dosering överskridits '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 402Y2'>
    <MCurrPage `1341'>
    <Unique 1088381>
   > # end of Marker
   <String `(402,'>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 403Y2'>
    <MCurrPage `1341'>
    <Unique 1088382>
   > # end of Marker
   <String `403)'>
   <Font 
    <FTag `'>
    <FDW  -0.5%>
    <FLocked No>
   > # end of Font
   <String `. '>
  > # end of ParaLine
  <ParaLine 
   <String `Viss toleransutveckling kan ses, men efter'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `som läkemedlen i gruppen ofta tas vid behov '>
  > # end of ParaLine
  <ParaLine 
   <String `har resultaten för engångsdoser '>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `mer'>
   <Font 
    <FTag `'>
    <FDW  -0.5%>
    <FLocked No>
   > # end of Font
   <String ` klinisk '>
  > # end of ParaLine
  <ParaLine 
   <String `relevans.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1043960>
  <PgfTag `Rub2'>
  <ParaLine 
   <String `Olycksinblandning'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1051052>
  <PgfTag `Bröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Bland 733 fall av misstänkt påverkan i tra'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `fiken (Ontario 2001–2005) analyserades '>
  > # end of ParaLine
  <ParaLine 
   <String `blodprov varvid man fann 4 fall (av 42 fall) '>
  > # end of ParaLine
  <ParaLine 
   <String `med difenhydramin (en i kombination med '>
  > # end of ParaLine
  <ParaLine 
   <String `alkohol). Övriga 38 var påverkade av andra '>
  > # end of ParaLine
  <ParaLine 
   <String `droger och 691 var påverkade av endast al'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `kohol '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 404Y2'>
    <MCurrPage `1341'>
    <Unique 1076728>
   > # end of Marker
   <String `(404)'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
   <String `.'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1069620>
  <PgfTag `BrödIn'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Bland dödsolyckor i Washington state har '>
  > # end of ParaLine
  <ParaLine 
   <String `andelen som varit påverkad av difenhydra'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <TextRectID 175>
   <String `min ökat från 0,6% 1992/1993 till 2,7% un'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `der 2001/2002 '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 405Y2'>
    <MCurrPage `1341'>
    <Unique 1076735>
   > # end of Marker
   <String `(405)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1051071>
  <PgfTag `Rub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Sammanfattning'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1051074>
  <PgfTag `Bröd'>
  <ParaLine 
   <String `Påverkan på CNS vid behandling med anti'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `histaminer har minskat i takt med att nya '>
  > # end of ParaLine
  <ParaLine 
   <String `substanser har tagits fram. På den svenska '>
  > # end of ParaLine
  <ParaLine 
   <String `marknaden har dessutom flera av de sede'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `rande antihistaminerna avregistrerats men '>
  > # end of ParaLine
  <ParaLine 
   <String `ett fåtal substanser av de tidigare genera'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tionerna finns kvar. Några av studierna an'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tyder att kvinnor är känsligare för antihis'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `taminer men i flertalet av studierna har '>
  > # end of ParaLine
  <ParaLine 
   <String `man testat endast män vilket innebär en '>
  > # end of ParaLine
  <ParaLine 
   <String `viss kvarstående osäkerhet ur bilkörnings'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `synpunkt vad avser kvinnor. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1051112>
  <PgfTag `BrödIn'>
  <ParaLine 
   <String `I studierna fanns det dessutom nästan '>
  > # end of ParaLine
  <ParaLine 
   <String `alltid någon eller några individer där kör'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ningen fick avbrytas därför att trafiklära'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ren bedömde föraren alltför påverkad eller '>
  > # end of ParaLine
  <ParaLine 
   <String `där föraren själv avbröt testet pga känsla '>
  > # end of ParaLine
  <ParaLine 
   <String `av osäker körning. Det innebär att det kan '>
  > # end of ParaLine
  <ParaLine 
   <String `finnas stora individuella variationer vad '>
  > # end of ParaLine
  <ParaLine 
   <String `gäller hur stor CNS-påverkan kan bli. Det'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ta gäller speciellt (även för nyare substan'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ser) när man går utöver rekommenderad '>
  > # end of ParaLine
  <ParaLine 
   <String `dosering.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1042277>
  <PgfTag `Rub2'>
  <ParaLine 
   <String `Rekommendationer'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1051100>
  <PgfTag `Bröd'>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.NewCenturySchlbk LT Std.R.400'>
    <FFamily `NewCenturySchlbk LT Std'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `NewCenturySchlbkLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  9.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  -0.5%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `För aktiva bilförare bör i första hand tredje '>
  > # end of ParaLine
  <ParaLine 
   <String `generationens antihistaminer väljas där '>
  > # end of ParaLine
  <ParaLine 
   <String `fexofenadin är den mest väldokumenterade '>
  > # end of ParaLine
  <ParaLine 
   <String `beträffande avsaknad av påverkan relevant '>
  > # end of ParaLine
  <ParaLine 
   <String `för bilkörning, även om rekommenderad dos '>
  > # end of ParaLine
  <ParaLine 
   <String `överskrids. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1051105>
  <PgfTag `BrödIn'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Av andra generationens antihistaminer '>
  > # end of ParaLine
  <ParaLine 
   <String `är loratadin eller ebastin att föredra efter'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `som cetirizin har mer rapporterade biverk'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ningar i form av trötthet '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 402Y2'>
    <MCurrPage `1341'>
    <Unique 1076742>
   > # end of Marker
   <String `(402)'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
   <String `.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1056709>
  <PgfTag `Rub2'>
  <ParaLine 
   <String `Läs vidare'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1056710>
  <PgfTag `RefTextNr1'>
  <PgfNumString `1.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Drugs, driving and traffic safety '>
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 324Y2'>
    <MCurrPage `1341'>
    <Unique 1076749>
   > # end of Marker
   <String `(324)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1056711>
  <PgfTag `Rub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Enskilda preparat'>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `1:a generationens antihistaminer'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1069446>
  <PgfTag `Rub3efterRub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `D'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `difenhydramin:trafik'>
    <MCurrPage `1341'>
    <Unique 1069445>
   > # end of Marker
   <String `ifenhydramin'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1080697>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Difenhydramin 50 mg gav en kraftig påver'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `kan på resultaten av ett simulatortest (BAC '>
  > # end of ParaLine
  <ParaLine 
   <String `\>'>
   <Char HardSpace>
   <String `1‰) '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 406Y2'>
    <MCurrPage `1341'>
    <Unique 1080698>
   > # end of Marker
   <String `(406)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` och resulterade i sämre psy'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `kometriska testresultat '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 407Y2'>
    <MCurrPage `1341'>
    <Unique 1080699>
   > # end of Marker
   <String `(407).'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` Difenhydra'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `min 50 mg som en engångsdos gav 1,5 timme '>
  > # end of ParaLine
  <ParaLine 
   <String `efter intag signifikant sämre resultat jäm'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `fört med baseline och placebo '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 408Y2'>
    <MCurrPage `1341'>
    <Unique 1080700>
   > # end of Marker
   <String `(408).'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` Dosen '>
  > # end of ParaLine
  <ParaLine 
   <TextRectID 176>
   <String `25 mg gav en signifikant inverkan på psy'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `kometriska tester 6 timmar efter en en'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `gångsdos '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 409Y2'>
    <MCurrPage `1342'>
    <Unique 1080701>
   > # end of Marker
   <String `(409).'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` Difenhydramin givet 50 mg '>
  > # end of ParaLine
  <ParaLine 
   <String `1 x 1 inverkade på körningen 2 respektive 4 '>
  > # end of ParaLine
  <ParaLine 
   <String `timmar efter intag motsvarande BAC '>
  > # end of ParaLine
  <ParaLine 
   <String `\>'>
   <Char HardSpace>
   <String `0,8‰ '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 410Y2'>
    <MCurrPage `1342'>
    <Unique 1080702>
   > # end of Marker
   <String `(410)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` eller BAC \>'>
   <Char HardSpace>
   <String `0,5‰ '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 411Y2'>
    <MCurrPage `1342'>
    <Unique 1080703>
   > # end of Marker
   <String `(411,'>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 412Y2'>
    <MCurrPage `1342'>
    <Unique 1080704>
   > # end of Marker
   <String `412)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` '>
  > # end of ParaLine
  <ParaLine 
   <String `samt även efter 4 dagars medicinering '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 412Y2'>
    <MCurrPage `1342'>
    <Unique 1080705>
   > # end of Marker
   <String `(412)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. '>
  > # end of ParaLine
  <ParaLine 
   <String `Även kognitiva testresultat påverkades ne'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `gativt av difenhydramin '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 404Y2'>
    <MCurrPage `1342'>
    <Unique 1080706>
   > # end of Marker
   <String `(404)'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
   <String `.'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1088521>
  <PgfTag `PrepBröd'>
  <Pgf 
   <PgfFIndent  6.0 mm>
  > # end of Pgf
  <ParaLine 
   <String `I kontrast till påverkad körning sågs i stu'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `dien av Richardson och medarbetare '>
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 413Y2'>
    <MCurrPage `1342'>
    <Unique 1088522>
   > # end of Marker
   <String `(413) '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `att kognitiva testresultat på dag 4 efter ad'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ministrering av 50'>
   <Char HardSpace>
   <String `mg x 2 nådde placebo'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `resultat och talar därmed för en viss tole'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ransutveckling.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1069470>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `D'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `dimenhydrinat:trafik'>
    <MCurrPage `1342'>
    <Unique 1069469>
   > # end of Marker
   <String `imenhydrinat'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1088418>
  <PgfTag `Bröd'>
  <Pgf 
   <PgfAlignment Left>
   <PgfFIndent  3.0 mm>
   <PgfLIndent  3.0 mm>
   <PgfRIndent  3.0 mm>
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.NewCenturySchlbk LT Std.R.400'>
    <FFamily `NewCenturySchlbk LT Std'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `NewCenturySchlbkLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  8.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLeading  2.7 pt>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `Manning och medarbetare '>
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 414Y2'>
    <MCurrPage `1342'>
    <Unique 1088417>
   > # end of Marker
   <String `(414) '>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `undersökte '>
  > # end of ParaLine
  <ParaLine 
   <String `hur dimenhydrinat 100 mg x 3 påverkade '>
  > # end of ParaLine
  <ParaLine 
   <String `kognitiva tester och sömnighet i relation till '>
  > # end of ParaLine
  <ParaLine 
   <String `placebo. Den största påverkan såg man 3 '>
  > # end of ParaLine
  <ParaLine 
   <String `timmar efter första dosen för att efter 11 '>
  > # end of ParaLine
  <ParaLine 
   <String `timmar vara något sämre än placebo. Hu'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `vudsakligen kan förbättringarna hänföras '>
  > # end of ParaLine
  <ParaLine 
   <String `till omtestningseffekter, men en viss tole'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ransutveckling fanns med i bilden. Effekter'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `na efter 3 timmar uppskattades av författar'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `na motsvara en påverkan av alkohol på mel'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `lan 0,4 och 0,6 ‰ BAC. Största effekten på '>
  > # end of ParaLine
  <ParaLine 
   <String `sömnighet (mätt med Stanfords sömnighets'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `skala) sågs vid 7 timmar efter första dosen. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1069479>
  <PgfTag `BrödIn'>
  <Pgf 
   <PgfAlignment Left>
   <PgfFIndent  6.0 mm>
   <PgfLIndent  3.0 mm>
   <PgfRIndent  3.0 mm>
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.NewCenturySchlbk LT Std.R.400'>
    <FFamily `NewCenturySchlbk LT Std'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `NewCenturySchlbkLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  8.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLeading  2.7 pt>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `I en studie jämförde Schneider och medar'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `betare '>
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 415Y2'>
    <MCurrPage `1342'>
    <Unique 1076834>
   > # end of Marker
   <String `(415)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` dimenhydrinat 50 mg som en '>
  > # end of ParaLine
  <ParaLine 
   <String `engångsdos med två andra substanser i en '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `3-fas cross-overstudie. Testresultaten (reak'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tionstid) utvärderades med Wiener Test Sy'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `stem –'>
   <Font 
    <FTag `'>
    <FSize  9.0 pt>
    <FLocked No>
   > # end of Font
   <String ` '>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `före intag, 1,5 och 3 timmar efter in'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tag –'>
   <Font 
    <FTag `'>
    <FSize  9.0 pt>
    <FLocked No>
   > # end of Font
   <String ` '>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `och EEG-mätning (P300-fördröjning). '>
  > # end of ParaLine
  <ParaLine 
   <String `Ingen skillnad i reaktionstider noterades, '>
  > # end of ParaLine
  <ParaLine 
   <String `men avsaknaden av placeboresultat (trä'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ningseffekter) innebär att det i verkligheten '>
  > # end of ParaLine
  <ParaLine 
   <String `troligen föreligger en försämrad reaktions'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tid. En ökad svarslatens på EEG talar för att '>
  > # end of ParaLine
  <ParaLine 
   <String `så är fallet. Ett något utvidgat testbatteri '>
  > # end of ParaLine
  <ParaLine 
   <String `användes senare av Philipova och medarbe'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tare '>
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 416Y2'>
    <MCurrPage `1342'>
    <Unique 1076841>
   > # end of Marker
   <String `(416)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` med samma upplägg av deras stu'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `die men nu även med placebo. Här ser man '>
  > # end of ParaLine
  <ParaLine 
   <String `tydligt inlärningseffekter. EEG-mätning '>
  > # end of ParaLine
  <ParaLine 
   <String `(P300) visade ökad svarslatens. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1069484>
  <PgfTag `BrödIn'>
  <Pgf 
   <PgfAlignment Left>
   <PgfFIndent  6.0 mm>
   <PgfLIndent  3.0 mm>
   <PgfRIndent  3.0 mm>
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.NewCenturySchlbk LT Std.R.400'>
    <FFamily `NewCenturySchlbk LT Std'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `NewCenturySchlbkLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  8.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLeading  2.7 pt>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `2008 rapporterade Kanamaru och med'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `arbet'>
   <Char DiscHyphen>
   <String `are nedsatt kognitiv funktion för di'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `menhydrinat 50 mg i jämförelse med placebo '>
  > # end of ParaLine
  <ParaLine 
   <String `och ca 1,5 timme '>
   <Char DiscHyphen>
   <String `efter intag '>
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 417Y2'>
    <MCurrPage `1342'>
    <Unique 1076848>
   > # end of Marker
   <String `(417)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1053790>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <TextRectID 176>
   <String `H'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `hydroxizin:trafik'>
    <MCurrPage `1342'>
    <Unique 1059074>
   > # end of Marker
   <String `ydroxizin'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1055980>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Hydroxizin 30 mg var mer sederande och '>
  > # end of ParaLine
  <ParaLine 
   <String `gav längre bromsreaktionstider jämfört med '>
  > # end of ParaLine
  <ParaLine 
   <String `placebo och fexofenadin (120 mg) i ett kör'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `test '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 418Y2'>
    <MCurrPage `1342'>
    <Unique 1076856>
   > # end of Marker
   <String `(418)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. En engångsdos med 25 mg hy'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `droxizin jämfördes med cetirizin och placebo '>
  > # end of ParaLine
  <ParaLine 
   <String `varvid man såg en negativ påverkan av hy'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `droxizin på CNS-funktioner mätt med kog'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `nitiva tester '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 419Y2'>
    <MCurrPage `1342'>
    <Unique 1076863>
   > # end of Marker
   <String `(419).'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` Cetirizin gav ingen på'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `verkan (20 mg). '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1027650>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `K'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `klemastin:trafik'>
    <MCurrPage `1342'>
    <Unique 1059079>
   > # end of Marker
   <String `lemastin'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1080737>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Klemastin 2 mg x 2 försämrade körförmågan '>
  > # end of ParaLine
  <ParaLine 
   <String `3 timmar efter intag jämfört med placebo '>
  > # end of ParaLine
  <ParaLine 
   <String `dag 1 och 4 efter påbörjad behandling och ef'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `fekten potentierades av alkohol '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 420Y2'>
    <MCurrPage `1342'>
    <Unique 1080738>
   > # end of Marker
   <String `(420).'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` Två '>
  > # end of ParaLine
  <ParaLine 
   <String `milligram givet som en engångsdos försäm'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `rade körförmågan 4 timmar efter intag mot'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `svarande 0,8‰ BAC '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 421Y2'>
    <MCurrPage `1342'>
    <Unique 1080739>
   > # end of Marker
   <String `(421).'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` På dag 4 efter '>
  > # end of ParaLine
  <ParaLine 
   <String `1'>
   <Char HardSpace>
   <String `mg x 2 med ett något enklare körtest sågs '>
  > # end of ParaLine
  <ParaLine 
   <String `ingen skillnad mot placebo '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 422Y2'>
    <MCurrPage `1342'>
    <Unique 1080740>
   > # end of Marker
   <String `(422)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` och inte '>
  > # end of ParaLine
  <ParaLine 
   <String `heller i en annan studie med 1 mg x 2 i 3 da'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `gar '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 423Y2'>
    <MCurrPage `1342'>
    <Unique 1080741>
   > # end of Marker
   <String `(423).'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1051213>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `P'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `prometazin:trafik'>
    <MCurrPage `1342'>
    <Unique 1059084>
   > # end of Marker
   <String `rometazin'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1055999>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Prometazin 30 mg x 1 i 4 dagar med 8 psy'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `kometriska mätningar dag 1 och 4 gav ett '>
  > # end of ParaLine
  <ParaLine 
   <String `flertal signifikanta försämringar dag 1. ”Cri'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tical Flicker Frequency” (se tester, s'>
   <Char HardSpace>
   <Font 
    <FTag `ÄndringNyText'>
    <FLocked No>
   > # end of Font
   <XRef 
    <XRefName `Page'>
    <XRefSrcText `55866: Rub2: Tester\x0d '>
    <XRefSrcIsElem No>
    <XRefSrcFile `'>
    <XRefLastUpdate  1382866575 931000>
    <XRefSrcElemNonUniqueId `'>
    <XRefAltText `'>
    <XRefApiClient 
     <XRefClientName `'>
     <XRefClientType `'>
    > # end of XRefApiClient
    <Unique 1082538>
   > # end of XRef
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <String `1363'>
   <Font 
    <FTag `ÄndringNyText'>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
   > # end of Font
   <XRefEnd >
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `) '>
  > # end of ParaLine
  <ParaLine 
   <String `påverkades även dag 4. En viss toleransut'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `veckling kan således misstänkas '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 424Y2'>
    <MCurrPage `1342'>
    <Unique 1076899>
   > # end of Marker
   <String `(424)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Tju'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `gofem milligram givet som en engångsdos '>
  > # end of ParaLine
  <ParaLine 
   <String `med mätningar 1, 5, 3 och 6 timmar efter in'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tag gav försämrade psykometriska testvär'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `den i flertalet mätningar '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 425Y2'>
    <MCurrPage `1342'>
    <Unique 1076906>
   > # end of Marker
   <String `(425)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` och liknande '>
  > # end of ParaLine
  <ParaLine 
   <String `resultat finns beskrivna från ett par andra '>
  > # end of ParaLine
  <ParaLine 
   <String `studier '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 426Y2'>
    <MCurrPage `1342'>
    <Unique 1076913>
   > # end of Marker
   <String `(426,'>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 427Y2'>
    <MCurrPage `1342'>
    <Unique 1076918>
   > # end of Marker
   <String `427).'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1051249>
  <PgfTag `Rub2'>
  <ParaLine 
   <String `2:a generationens antihistaminer'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1027654>
  <PgfTag `Rub3efterRub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `C'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `cetirizin:trafik'>
    <MCurrPage `1342'>
    <Unique 1059089>
   > # end of Marker
   <String `etirizin'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1080762>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Cetirizin 5, 10, 20 mg som engångsdoser gav '>
  > # end of ParaLine
  <ParaLine 
   <String `ingen påverkan på resultaten vid test i en '>
  > # end of ParaLine
  <ParaLine 
   <String `körsimulator '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 428Y2'>
    <MCurrPage `1342'>
    <Unique 1080763>
   > # end of Marker
   <String `(428)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` medan vid 1 timmes kör'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `test på väg gav 10 mg påverkan jämförbar '>
  > # end of ParaLine
  <ParaLine 
   <String `med 0,3‰ BAC 3 timmar efter administre'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ring '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 429Y2'>
    <MCurrPage `1342'>
    <Unique 1080764>
   > # end of Marker
   <String `(429)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1079399>
  <PgfTag `PrepBröd'>
  <Pgf 
   <PgfFIndent  6.0 mm>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `I en studie av Volkerts och medarbetare '>
  > # end of ParaLine
  <ParaLine 
   <String `med 10 mg x 1 sågs ingen skillnad mot pla'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `cebo vid en timmes körning på väg dag 1 och '>
  > # end of ParaLine
  <ParaLine 
   <String `4 '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 422Y2'>
    <MCurrPage `1342'>
    <Unique 1079400>
   > # end of Marker
   <String `(422)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Patat och medarbetare kunde inte '>
  > # end of ParaLine
  <ParaLine 
   <String `visa på någon effekt på körning med 10 mg '>
  > # end of ParaLine
  <ParaLine 
   <String `vid steady state, men denna körning varade '>
  > # end of ParaLine
  <ParaLine 
   <String `endast 20 minuter '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 430Y2'>
    <MCurrPage `1342'>
    <Unique 1079401>
   > # end of Marker
   <String `(430)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Efter 10 och 20 mg '>
  > # end of ParaLine
  <ParaLine 
   <TextRectID 177>
   <String `som engångsdoser sågs ingen inverkan på '>
  > # end of ParaLine
  <ParaLine 
   <String `resultaten från psykometriska tester 1, 2, 24 '>
  > # end of ParaLine
  <ParaLine 
   <String `och 36 timmar efter intag '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 419Y2'>
    <MCurrPage `1343'>
    <Unique 1079402>
   > # end of Marker
   <String `(419)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` eller efter 10 '>
  > # end of ParaLine
  <ParaLine 
   <String `mg x 1 under 4 dagar '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 424Y2'>
    <MCurrPage `1343'>
    <Unique 1079403>
   > # end of Marker
   <String `(424)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1080779>
  <PgfTag `PrepBröd'>
  <Pgf 
   <PgfFIndent  6.0 mm>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `Dosen 10 mg x 1 utvärderat 3 timmar ef'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ter intag dag 1 och 4 gav en signifikant säm'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `re körförmåga hos kvinnor men ej hos män '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 431Y2'>
    <MCurrPage `1343'>
    <Unique 1080780>
   > # end of Marker
   <String `(431).'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` Tio milligram givet 3 timmar före kör'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ning visade ingen påverkan jämfört med pla'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `cebo '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 432Y2'>
    <MCurrPage `1343'>
    <Unique 1080781>
   > # end of Marker
   <String `(432).'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` Engångsdoser av 10 och 20 mg '>
  > # end of ParaLine
  <ParaLine 
   <String `påverkade minnessnabbhet och resultat i '>
  > # end of ParaLine
  <ParaLine 
   <String `”tracking”-test negativt '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 433Y2'>
    <MCurrPage `1343'>
    <Unique 1080782>
   > # end of Marker
   <String `(433).'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1051338>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `E'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `ebastin:trafik'>
    <MCurrPage `1343'>
    <Unique 1059094>
   > # end of Marker
   <String `bastin'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1051346>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Ebastin 10, 20 och 30 mg givet x 1 i 5 dagar '>
  > # end of ParaLine
  <ParaLine 
   <String `med körtest dag 1 och 5 gav ingen påverkan '>
  > # end of ParaLine
  <ParaLine 
   <String `på körförmågan jämfört med placebo utöver '>
  > # end of ParaLine
  <ParaLine 
   <String `dosen 30 mg på dag 5 '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 434Y2'>
    <MCurrPage `1343'>
    <Unique 1076989>
   > # end of Marker
   <String `(434,'>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 435Y2'>
    <MCurrPage `1343'>
    <Unique 1076998>
   > # end of Marker
   <String `435).'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` Motsvaran'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `de dosering gav inte heller någon påverkan '>
  > # end of ParaLine
  <ParaLine 
   <String `på resultaten av psykometriska tester '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 436Y2'>
    <MCurrPage `1343'>
    <Unique 1077004>
   > # end of Marker
   <String `(436).'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` '>
  > # end of ParaLine
  <ParaLine 
   <String `Psykometriska tester 5 timmar efter intag '>
  > # end of ParaLine
  <ParaLine 
   <String `av 10 mg som en engångsdos visade ingen in'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `verkan på testresultaten jämfört med place'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `bo '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 437Y2'>
    <MCurrPage `1343'>
    <Unique 1077011>
   > # end of Marker
   <String `(437)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Ingen skillnad sågs med 20 mg som '>
  > # end of ParaLine
  <ParaLine 
   <String `en engångsdos i en pilotstudie där Wiener '>
  > # end of ParaLine
  <ParaLine 
   <String `testsystem användes '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 438Y2'>
    <MCurrPage `1343'>
    <Unique 1077018>
   > # end of Marker
   <String `(438).'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1027656>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `L'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `loratadin:trafik'>
    <MCurrPage `1343'>
    <Unique 1059099>
   > # end of Marker
   <String `oratadin'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1080809>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Loratadin 10 mg/dag med ökad dos till 20 '>
  > # end of ParaLine
  <ParaLine 
   <String `mg/dag visade ingen inverkan på kognitiva '>
  > # end of ParaLine
  <ParaLine 
   <String `funktioner jämfört med placebo vid test efter '>
  > # end of ParaLine
  <ParaLine 
   <String `1–5 dagar '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 439Y2'>
    <MCurrPage `1343'>
    <Unique 1080810>
   > # end of Marker
   <String `(439)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Tio milligram som en en'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `gångsdos gav ingen påverkan på kognitiva '>
  > # end of ParaLine
  <ParaLine 
   <String `tester eller under 1 timmes körning på väg '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 429Y2'>
    <MCurrPage `1343'>
    <Unique 1080811>
   > # end of Marker
   <String `(429)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Fem milligram som en engångsdos gav '>
  > # end of ParaLine
  <ParaLine 
   <String `ingen försämring i neuropsykologiska tester '>
  > # end of ParaLine
  <ParaLine 
   <String `jämfört med baseline eller placebo '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 408Y2'>
    <MCurrPage `1343'>
    <Unique 1080812>
   > # end of Marker
   <String `(408)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` eller '>
  > # end of ParaLine
  <ParaLine 
   <String `efter 4 dagar '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 424Y2'>
    <MCurrPage `1343'>
    <Unique 1080813>
   > # end of Marker
   <String `(424).'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` Vid 10 mg som en en'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `gångsdos och 6 tester under 24 timmar sågs '>
  > # end of ParaLine
  <ParaLine 
   <String `inte heller någon skillnad mot placebo '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 426Y2'>
    <MCurrPage `1343'>
    <Unique 1080814>
   > # end of Marker
   <String `(426).'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1027658>
  <PgfTag `Rub2'>
  <ParaLine 
   <String `3:e generationens antihistaminer'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1027659>
  <PgfTag `Rub3efterRub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `A'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `alimemazin:trafik'>
    <MCurrPage `1343'>
    <Unique 1059104>
   > # end of Marker
   <String `limemazin'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1034087>
  <PgfTag `PrepBröd'>
  <ParaLine 
   <String `Det finns inga studier i PubMed vilka berör '>
  > # end of ParaLine
  <ParaLine 
   <String `bilkörning eller kognitiva funktioner.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1040385>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `C'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `cyproheptadin:trafik'>
    <MCurrPage `1343'>
    <Unique 1059109>
   > # end of Marker
   <String `yproheptadin'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1040386>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Cyproheptadin givet 6 mg x 2 jämfördes med '>
  > # end of ParaLine
  <ParaLine 
   <String `bl'>
   <Char HardSpace>
   <String `a placebo 1 timme respektive 5 timmar ef'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ter 2:a dosen varvid man fann såväl testmäs'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `sigt som i subjektiva skattningar en negativ '>
  > # end of ParaLine
  <ParaLine 
   <String `inverkan av läkemedlet '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 440Y2'>
    <MCurrPage `1343'>
    <Unique 1077064>
   > # end of Marker
   <String `(440)'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1027661>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <TextRectID 177>
   <String `D'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `desloratadin:trafik'>
    <MCurrPage `1343'>
    <Unique 1059114>
   > # end of Marker
   <String `esloratadin'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1069535>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `En engångsdos av 5 mg desloratadin med '>
  > # end of ParaLine
  <ParaLine 
   <String `kognitiv testning 1,5 timme efter intag visa'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `de ingen negativ effekt på testresultaten '>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 408Y2'>
    <MCurrPage `1343'>
    <Unique 1077071>
   > # end of Marker
   <String `(408)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Med samma dos genomfördes ett kör'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `test 2 timmar efter intag utan inverkan på '>
  > # end of ParaLine
  <ParaLine 
   <String `körförmåga eller kognitiva funktioner '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 411Y2'>
    <MCurrPage `1343'>
    <Unique 1077078>
   > # end of Marker
   <String `(411)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. '>
  > # end of ParaLine
  <ParaLine 
   <String `Uthållighet och kognitiva funktioner påver'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `kades inte av desloratadin utan resultaten '>
  > # end of ParaLine
  <ParaLine 
   <String `var jämförbara med placebo '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 408Y2'>
    <MCurrPage `1343'>
    <Unique 1077085>
   > # end of Marker
   <String `(408).'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1027662>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `F'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `fexofenadin:trafik'>
    <MCurrPage `1343'>
    <Unique 1059119>
   > # end of Marker
   <String `exofenadin'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1069538>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Fexofenadin (60 mg x 2, 120 mg x 1, 120 mg '>
  > # end of ParaLine
  <ParaLine 
   <String `x 2 och 240 mg x 1) gav ingen påverkan på '>
  > # end of ParaLine
  <ParaLine 
   <String `körförmågan 3 timmar efter intag dag 1 eller '>
  > # end of ParaLine
  <ParaLine 
   <String `4 efter påbörjad behandling. Det var snarast '>
  > # end of ParaLine
  <ParaLine 
   <String `så, att på dag 4 vid 240 mg x 1 sågs en signi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `fikant förbättring. Ingen interaktion med al'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `kohol sågs '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 420Y2'>
    <MCurrPage `1343'>
    <Unique 1077093>
   > # end of Marker
   <String `(420)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1069541>
  <PgfTag `PrepBröd'>
  <Pgf 
   <PgfFIndent  6.0 mm>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <String `I en simulatorstudie noterades ingen ne'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `gativ inverkan efter intag av fexofenadin 60 '>
  > # end of ParaLine
  <ParaLine 
   <String `mg x 1 '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 406Y2'>
    <MCurrPage `1343'>
    <Unique 1077100>
   > # end of Marker
   <String `(406).'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` Två timmar efter intag av 180 '>
  > # end of ParaLine
  <ParaLine 
   <String `mg sågs ingen skillnad mot placebo i resulta'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ten av psykometriska tester '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 407Y2'>
    <MCurrPage `1343'>
    <Unique 1077107>
   > # end of Marker
   <String `(407).'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` I en stu'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `die gavs 120 mg som en engångsdos och psy'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `kometrisk testning gjordes 1, 3 och 6 timmar '>
  > # end of ParaLine
  <ParaLine 
   <String `efter intag varvid ingen skillnad mot placebo '>
  > # end of ParaLine
  <ParaLine 
   <String `kunde noteras '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 409Y2'>
    <MCurrPage `1343'>
    <Unique 1077114>
   > # end of Marker
   <String `(409).'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` Inte heller sågs någon '>
  > # end of ParaLine
  <ParaLine 
   <String `skillnad mot placebo vid 80, 120 och 180 mg '>
  > # end of ParaLine
  <ParaLine 
   <String `som engångsdoser i test av CFF eller CRT '>
  > # end of ParaLine
  <ParaLine 
   <String `(se tester, s'>
   <Char HardSpace>
   <Font 
    <FTag `ÄndringNyText'>
    <FLocked No>
   > # end of Font
   <XRef 
    <XRefName `Page'>
    <XRefSrcText `55866: Rub2: Tester\x0d '>
    <XRefSrcIsElem No>
    <XRefSrcFile `'>
    <XRefLastUpdate  1382866575 931000>
    <XRefSrcElemNonUniqueId `'>
    <XRefAltText `'>
    <XRefApiClient 
     <XRefClientName `'>
     <XRefClientType `'>
    > # end of XRefApiClient
    <Unique 1082546>
   > # end of XRef
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <String `1363'>
   <Font 
    <FTag `ÄndringNyText'>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
   > # end of Font
   <XRefEnd >
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `) '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 426Y2'>
    <MCurrPage `1343'>
    <Unique 1077121>
   > # end of Marker
   <String `(426)'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `. Vid doserna 60 och '>
  > # end of ParaLine
  <ParaLine 
   <String `120 mg observerades inte heller någon skill'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `nad jämfört med placebo '>
   <Font 
    <FTag `Blue'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink 427Y2'>
    <MCurrPage `1343'>
    <Unique 1077128>
   > # end of Marker
   <String `(427).'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1027663>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `M'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `meklozin:trafik'>
    <MCurrPage `1343'>
    <Unique 1059124>
   > # end of Marker
   <String `eklozin'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054062>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Det finns inga studier i PubMed vilka berör '>
  > # end of ParaLine
  <ParaLine 
   <String `bilkörning eller kognitiva funktioner. Fass '>
  > # end of ParaLine
  <ParaLine 
   <String `har dock trafikvarningstext.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054063>
  <PgfTag `Rub3'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `T'>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `tietylperazin:trafik'>
    <MCurrPage `1343'>
    <Unique 1059129>
   > # end of Marker
   <String `ietylperazin'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1043978>
  <PgfTag `PrepBröd'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Det finns inga studier i PubMed vilka berör '>
  > # end of ParaLine
  <ParaLine 
   <String `bilkörning eller kognitiva funktioner. Fass '>
  > # end of ParaLine
  <ParaLine 
   <String `har dock trafikvarningstext.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1043979>
  <PgfTag `Rub2'>
  <PgfReferenced Yes>
  <ParaLine 
   <Font 
    <FTag `Intense Emphasis'>
    <FLocked No>
   > # end of Font
   <String `Övriga läkemedel och '>
   <Marker 
    <MType 2>
    <MTypeName `Index'>
    <MText `naturläkemedel/växtbaserade läkemedel:trafik'>
    <MCurrPage `1343'>
    <Unique 1059134>
   > # end of Marker
   <String `naturläkemedel'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1051491>
  <PgfTag `Bröd'>
  <ParaLine 
   <String `Läkemedel (och givetvis naturläkemedel) '>
  > # end of ParaLine
  <ParaLine 
   <String `som innehåller etylalkohol (etanol), t'>
   <Char HardSpace>
   <String `ex vis'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `sa multivitaminpreparat och hostmedici'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ner, är givetvis olämpliga att ta i samband '>
  > # end of ParaLine
  <ParaLine 
   <String `med bilkörning av två skäl: Dels för att al'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `koholen i sig inverkar på körförmågan, dels '>
  > # end of ParaLine
  <ParaLine 
   <String `för att alkoholen kan potentiera effekterna '>
  > # end of ParaLine
  <ParaLine 
   <String `av andra läkemedel, speciellt bensodiazepi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <TextRectID 178>
   <String `ner, men även många andra läkemedel. '>
  > # end of ParaLine
  <ParaLine 
   <String `Echinagard orala droppar, som är ett natur'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `läkemedel mot förkylning, innehåller exem'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `pelvis 22% (v/v) etanol, och vitaminprepara'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ten Malvitona innehåller 15,7%, Vitatonin '>
  > # end of ParaLine
  <ParaLine 
   <String `och Beviplex forte 10% (w/v) etanol.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1080835>
  <PgfTag `BrödIn'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Naturläkemedel som är sömngivande, '>
  > # end of ParaLine
  <ParaLine 
   <String `lugnande etc har en potentiell förmåga att '>
  > # end of ParaLine
  <ParaLine 
   <String `kunna påverka kognition och trafiksäker'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `het men studier saknas. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1080841>
  <PgfTag `BrödIn'>
  <ParaLine 
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1080848>
  <PgfTag `BrödIn'>
  <ParaLine 
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1080836>
  <PgfTag `RefRub'>
  <Pgf 
   <PgfPlacement Anywhere>
  > # end of Pgf
  <PgfNumString `Referenser'>
  <ParaLine 
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054143>
  <PgfTag `RefTextNr1'>
  <PgfNumString `1.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 1Y2'>
    <MCurrPage `1344'>
    <Unique 1060709>
   > # end of Marker
   <String `Körkortslagen. SFS1998:488.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1078263>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `2.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 2Y2'>
    <MCurrPage `1344'>
    <Unique 1078262>
   > # end of Marker
   <String `Transportstyrelsens föreskrifter och allmänna råd '>
  > # end of ParaLine
  <ParaLine 
   <String `om medicinska krav för innehav av körkort m'>
   <Char HardSpace>
   <String `m. '>
  > # end of ParaLine
  <ParaLine 
   <String `TSFS 2010:125.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1078265>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `3.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 3Y2'>
    <MCurrPage `1344'>
    <Unique 1078264>
   > # end of Marker
   <String `Luftfartsförordningen. SFS1986:171.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054146>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `4.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 4Y2'>
    <MCurrPage `1344'>
    <Unique 1060728>
   > # end of Marker
   <String `Föreskrifter om hälsoundersökning och hälsotill'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `stånd. BVFS 2000:4.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054147>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `5.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 5Y2'>
    <MCurrPage `1344'>
    <Unique 1060733>
   > # end of Marker
   <String `Läkemedelsverkets föreskrifter om förordnande '>
  > # end of ParaLine
  <ParaLine 
   <String `och utlämnande av läkemedel och teknisk sprit. '>
  > # end of ParaLine
  <ParaLine 
   <String `LVFS 2009:13.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054148>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `6.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 6Y2'>
    <MCurrPage `1344'>
    <Unique 1060738>
   > # end of Marker
   <String `Lag om straff vid vissa trafikbrott. SFS 1951:649.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054149>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `7.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 7Y2'>
    <MCurrPage `1344'>
    <Unique 1060743>
   > # end of Marker
   <String `Beermann B, Liliemark J, Johansson K. Utökad in'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `formation på bipacksedeln och rådgivning ersät'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ter varningstriangeln. Läkartidningen. 2005; '>
  > # end of ParaLine
  <ParaLine 
   <String `102(24–25): 1918–21.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1069632>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `8.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 8Y2'>
    <MCurrPage `1344'>
    <Unique 1069631>
   > # end of Marker
   <String `ICADTS. 100506_ICADTS-list.xls. 2006 [cited 2010 '>
  > # end of ParaLine
  <ParaLine 
   <String `Oct. 25]; Available from: www.icadts.org/reports/'>
  > # end of ParaLine
  <ParaLine 
   <String `medicinaldrugs2.pdf.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054151>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `9.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 9Y2'>
    <MCurrPage `1344'>
    <Unique 1060753>
   > # end of Marker
   <String `ICADTS. Categorization system for medicinal '>
  > # end of ParaLine
  <ParaLine 
   <String `drugs affecting driving performance. 2006 '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `[cited 2010 Oct. 25]; Available from: '>
  > # end of ParaLine
  <ParaLine 
   <String `www.icadts.org/reports/medicinaldrugs1.pdf.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1073386>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `10.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 10Y2'>
    <MCurrPage `1344'>
    <Unique 1073385>
   > # end of Marker
   <String `P'>
   <Font 
    <FTag `'>
    <FDW  -0.5%>
    <FLocked No>
   > # end of Font
   <String `il K, Raes E, VandenNeste T, Goessaert A-S, '>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `Veramme J, Verstraete A. Driving under the Influ'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ence of drugs, alcohol and medicines (DRUID): Re'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `view of existing classification efforts. '>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `2008 Feb. 7 '>
  > # end of ParaLine
  <ParaLine 
   <String `[cited 2010 Oct. 25]; TREN-05-FP6TR-S07.61320-'>
  > # end of ParaLine
  <ParaLine 
   <String `518404-DRUID. Deliverable 4.1.1 Rev. 1.0:[127]. '>
  > # end of ParaLine
  <ParaLine 
   <String `Available from: http://www.bast.de/nn_107548/'>
  > # end of ParaLine
  <ParaLine 
   <String `Druid/EN/deliverales-list/downloads/'>
  > # end of ParaLine
  <ParaLine 
   <String `Deliverable__4__1__1,templateId=raw,proper'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ty=publicationFile.pdf/Deliverable_4_1_1.pdf.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054153>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `11.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 11Y2'>
    <MCurrPage `1344'>
    <Unique 1060767>
   > # end of Marker
   <String `Hilleman D, Miller MA, Parker R, Doering P, Pie'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `per JA. Optimal management of amiodarone '>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `therapy: efficacy and side effects. Pharmacothe'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `rapy. 1998;18(6 Pt 2):138S–45S.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054154>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `12.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 12Y2'>
    <MCurrPage `1344'>
    <Unique 1060772>
   > # end of Marker
   <String `Santaella RM, Fraunfelder FW. Ocular adverse ef'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `fects associated with systemic medications: Re'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <TextRectID 178>
   <String `cognition and management. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Drugs. 2007;67:75–93.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1073382>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `13.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 13Y2'>
    <MCurrPage `1344'>
    <Unique 1073381>
   > # end of Marker
   <String `Verrotti A, Manco R, Matricardi S, Franzoni E, '>
  > # end of ParaLine
  <ParaLine 
   <String `Chiarelli F. Antiepileptic drugs and visual '>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `function. Pediatric Neurology. 2007;36:353–60.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054156>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `14.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 14Y2'>
    <MCurrPage `1344'>
    <Unique 1060782>
   > # end of Marker
   <String `Richa S, Yazbek J-C. Ocular adverse effects of '>
  > # end of ParaLine
  <ParaLine 
   <String `common psychotropic agents: A review. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `CNS Drugs. 2010;24:501–26.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1073403>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `15.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 15Y2'>
    <MCurrPage `1344'>
    <Unique 1073402>
   > # end of Marker
   <String `Gamulescu M-A, Schalke B, Schuierer G, Gabel V-'>
  > # end of ParaLine
  <ParaLine 
   <String `P. Optic neuritis with visual field defect-'>
   <Char DiscHyphen>
   <String `possible '>
  > # end of ParaLine
  <ParaLine 
   <String `ibuprofen-related toxicity. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Ann Pharmacother. 2006;40:571–73.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1069686>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `16.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 16Y2'>
    <MCurrPage `1344'>
    <Unique 1069685>
   > # end of Marker
   <String `Labenz J, Stolte M. [Vision and hearing '>
   <Char DiscHyphen>
   <String `disorders '>
  > # end of ParaLine
  <ParaLine 
   <String `with omeprazole: the facts]. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Leber Magen Darm. 1995;25: 6–8, 11.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054159>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `17.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 17Y2'>
    <MCurrPage `1344'>
    <Unique 1060797>
   > # end of Marker
   <String `Le Quintrec JS, Le Quintrec JL. Drug-induced '>
  > # end of ParaLine
  <ParaLine 
   <String `myo'>
   <Char DiscHyphen>
   <String `pathies. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Baillieres Clin Rheumatol. 1991;5:21–38.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054160>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `18.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 18Y2'>
    <MCurrPage `1344'>
    <Unique 1060802>
   > # end of Marker
   <String `Valiyil R, Christopher-Stine L. Drug-related myo'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `pathies of which the clinician should be aware. '>
  > # end of ParaLine
  <ParaLine 
   <String `Curr Rheumatol Rep. 2010;12:213–20.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054161>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `19.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 19Y2'>
    <MCurrPage `1344'>
    <Unique 1060807>
   > # end of Marker
   <String `Low LF, Anstey KJ, Sachdev P. Use of medications '>
  > # end of ParaLine
  <ParaLine 
   <String `with anticholinergic properties and cognitive '>
  > # end of ParaLine
  <ParaLine 
   <String `function in a young-old community sample. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Int J Geriatr Psychiatry. 2009;24:578–84.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054162>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `20.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 20Y2'>
    <MCurrPage `1344'>
    <Unique 1060812>
   > # end of Marker
   <String `Carnahan RM, Lund BC, Perry PJ, Pollock BG, Culp '>
  > # end of ParaLine
  <ParaLine 
   <String `KR. The anticholinergic drug scale as a '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `measure of drug-related anticholinergic burden: '>
  > # end of ParaLine
  <ParaLine 
   <String `associations with serum anticholinergic '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `activity. J Clin Pharmacol. 2006;46:1481–6.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054163>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `21.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 21Y2'>
    <MCurrPage `1344'>
    <Unique 1060817>
   > # end of Marker
   <String `Ancelin ML, Artero S, Portet F, Dupuy AM, '>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `Touchon J, Ritchie K. Non-degenerative mild cog'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `nitive impairment in elderly people and use of '>
  > # end of ParaLine
  <ParaLine 
   <String `anticholinergic drugs: longitudinal cohort study. '>
  > # end of ParaLine
  <ParaLine 
   <String `BMJ. 2006;332:455–9.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054699>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `22.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 22Y2'>
    <MCurrPage `1344'>
    <Unique 1060826>
   > # end of Marker
   <String `Renneboog B, Musch W, Vandemergel X, Manto '>
  > # end of ParaLine
  <ParaLine 
   <String `MU, Decaux G. Mild chronic hyponatremia is '>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `associated with falls, unsteadiness, and attention '>
  > # end of ParaLine
  <ParaLine 
   <String `deficits. Am J Med. 2006;119:71 e1–8.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054700>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `23.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 23Y2'>
    <MCurrPage `1344'>
    <Unique 1060835>
   > # end of Marker
   <String `Thapar P, Zacny JP, Thompson W, Apfelbaum JL. '>
  > # end of ParaLine
  <ParaLine 
   <String `Using alcohol as a standard to assess the degree '>
  > # end of ParaLine
  <ParaLine 
   <String `of impairment induced by sedative and analgesic '>
  > # end of ParaLine
  <ParaLine 
   <String `drugs used in ambulatory surgery. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Anesthesiology. 1995;82:53–9.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054166>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `24.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 24Y2'>
    <MCurrPage `1344'>
    <Unique 1060840>
   > # end of Marker
   <String `Törnros J, Laurell H. Acute and carry-over effects '>
  > # end of ParaLine
  <ParaLine 
   <String `of brotizolam compared to nitrazepam and pla'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `cebo in monotonous simulated driving. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Pharmacol Toxicol. 1990;67:77–80.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1067589>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `25.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 25Y2'>
    <MCurrPage `1344'>
    <Unique 1067588>
   > # end of Marker
   <String `Parrott AC. Transdermal scopolamine: a review of '>
  > # end of ParaLine
  <ParaLine 
   <String `its effects upon motion sickness, psychological '>
  > # end of ParaLine
  <ParaLine 
   <String `performance, and physiological functioning.'>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String ` '>
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `message URL http://www.ncbi.nlm.nih.gov/pubmed?term=parrott%20ac%20and%20scopolamine%20and%201989'>
    <MCurrPage `1344'>
    <Unique 1067590>
   > # end of Marker
   <String `Aviat Space Environ Med. 1989;60:1–9.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1067592>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `26.\t'>
  <ParaLine 
   <TextRectID 179>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 26Y2'>
    <MCurrPage `1345'>
    <Unique 1067591>
   > # end of Marker
   <String `Spinks A, Wasiak J, Bernath V, and Villanueva E. '>
  > # end of ParaLine
  <ParaLine 
   <String `Scopolamine (hyoscine) for preventing and '>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `treating motion sickness.'>
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <String ` '>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `message URL http://www.ncbi.nlm.nih.gov/pubmed/17636710'>
    <MCurrPage `1345'>
    <Unique 1067593>
   > # end of Marker
   <String `Cochrane Database of '>
  > # end of ParaLine
  <ParaLine 
   <String `Systematic Reviews.'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` 2007. CD002851.pub3.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1088569>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `27.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 27Y2'>
    <MCurrPage `1345'>
    <Unique 1088568>
   > # end of Marker
   <String `Wolf H. Preclinical and clinical pharmacology of '>
  > # end of ParaLine
  <ParaLine 
   <String `the 5-HT3 receptor antagonists. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Scand J Rheumatol Suppl. 2000;11337–45.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1060393>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `28.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 28Y2'>
    <MCurrPage `1345'>
    <Unique 1060857>
   > # end of Marker
   <String `O\qHanlon JF, Vermeeren A, Uiterwijk MM, van '>
  > # end of ParaLine
  <ParaLine 
   <String `Veggel LM, Swijgman HF. Anxiolytics\q effects on '>
  > # end of ParaLine
  <ParaLine 
   <String `the actual driving performance of patients and '>
  > # end of ParaLine
  <ParaLine 
   <String `healthy volunteers in a standardized test. An in'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tegration of three studies. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Neuropsychobiology. 1995;3: 81–8.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1067572>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `29.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 29Y2'>
    <MCurrPage `1345'>
    <Unique 1067571>
   > # end of Marker
   <String `Perez EA, Hesketh P, Sandbach J, Reeves J, Chaw'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `la S, Markman M, et al. Comparison of single-'>
  > # end of ParaLine
  <ParaLine 
   <String `dose oral granisetron versus intravenous ondan'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `setron in the prevention of nausea and vomiting '>
  > # end of ParaLine
  <ParaLine 
   <String `induced by moderately emetogenic chemothera'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `py: a multicenter, double-blind, randomized pa'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `rallel study. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `J Clin Oncol. 1998;16:754–60.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1067580>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `30.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 30Y2'>
    <MCurrPage `1345'>
    <Unique 1067579>
   > # end of Marker
   <String `Chandra P, Hafizi S, Massey-Chase RM, Goodwin '>
  > # end of ParaLine
  <ParaLine 
   <String `GM, Cowen PJ, Harmer CJ. NK1 receptor antago'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `nism and emotional processing in healthy volun'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `teers. J Psychopharmacol. 2010;24:481–7.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1069794>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `31.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 31Y2'>
    <MCurrPage `1345'>
    <Unique 1069793>
   > # end of Marker
   <String `Spinks AB, Wasiak J, Villanueva EV, Bernath V. '>
  > # end of ParaLine
  <ParaLine 
   <String `Scopolamine (hyoscine) for preventing and '>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `treating motion sickness. Cochrane Database Syst '>
  > # end of ParaLine
  <ParaLine 
   <String `Rev. 2007;(3):CD002851.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054174>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `32.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 32Y2'>
    <MCurrPage `1345'>
    <Unique 1060940>
   > # end of Marker
   <String `Nachum Z, Shupak A, Gordon CR. Transdermal '>
  > # end of ParaLine
  <ParaLine 
   <String `scopolamine for prevention of motion sickness : '>
  > # end of ParaLine
  <ParaLine 
   <String `clinical pharmacokinetics and therapeutic appli'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `cations. Clin Pharmacokinet. 2006;45:543–66.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054175>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `33.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 33Y2'>
    <MCurrPage `1345'>
    <Unique 1060948>
   > # end of Marker
   <String `Cox DJ, Kovatchev BP, Gonder-Frederick LA, Sum'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `mers KH, McCall A, Grimm KJ, et al. Relationships '>
  > # end of ParaLine
  <ParaLine 
   <String `between hyperglycemia and cognitive perfor'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `mance among adults with type 1 and type 2 dia'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `betes. Diabetes Care. 2005;28:71–7.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1069806>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `34.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 34Y2'>
    <MCurrPage `1345'>
    <Unique 1069805>
   > # end of Marker
   <String `Cox D, Gonder-Frederick L, McCall A, Kovatchev '>
  > # end of ParaLine
  <ParaLine 
   <String `B, Clarke W. The effects of glucose fluctuation on '>
  > # end of ParaLine
  <ParaLine 
   <String `cognitive function and QOL: the functional costs '>
  > # end of ParaLine
  <ParaLine 
   <String `of hypoglycaemia and hyperglycaemia among '>
  > # end of ParaLine
  <ParaLine 
   <String `adults with type 1 or type 2 diabetes. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Int J Clin Pract Suppl. 2002;(129):20–6.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1069808>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `35.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 35Y2'>
    <MCurrPage `1345'>
    <Unique 1069807>
   > # end of Marker
   <String `Holmes CS, Hayford JT, Gonzalez JL, Weydert JA. '>
  > # end of ParaLine
  <ParaLine 
   <String `A survey of cognitive functioning at '>
   <Char DiscHyphen>
   <String `difference '>
  > # end of ParaLine
  <ParaLine 
   <String `glucose levels in diabetic persons. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `Diabetes Care. 1983;6:180'>
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <String `–'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `5.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1088616>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `36.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 36Y2'>
    <MCurrPage `1345'>
    <Unique 1088615>
   > # end of Marker
   <String `Warren RE and Frier BM. Hypoglycaemia and '>
  > # end of ParaLine
  <ParaLine 
   <String `cognitive function. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `message URL http://www.ncbi.nlm.nih.gov/pubmed/16050942'>
    <MCurrPage `1345'>
    <Unique 1088617>
   > # end of Marker
   <String `Diabetes Obes Metab. 2005;7:493–503.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1088619>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `37.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 37Y2'>
    <MCurrPage `1345'>
    <Unique 1088618>
   > # end of Marker
   <String `Gschwend S, Ryan C, Atchison J, Arslanian S, '>
  > # end of ParaLine
  <ParaLine 
   <String `Becker D. Effects of acute hyperglycemia on men'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <TextRectID 179>
   <String `tal efficiency and counterregulatory hormones in '>
  > # end of ParaLine
  <ParaLine 
   <String `adolescents with insulin-dependent diabetes '>
  > # end of ParaLine
  <ParaLine 
   <String `mellitus. J Pediatr. 1995;126:178–84.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054180>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `38.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 38Y2'>
    <MCurrPage `1345'>
    <Unique 1061013>
   > # end of Marker
   <String `Draelos MT, Jacobson AM, Weinger K, Widom B, '>
  > # end of ParaLine
  <ParaLine 
   <String `Ryan CM, Finkelstein DM, et al. Cognitive func'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `tion in patients with insulin-dependent diabetes '>
  > # end of ParaLine
  <ParaLine 
   <String `mellitus during hyperglycemia and hypoglyce'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `mia. Am J Med. 1995;98:135–44.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054181>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `39.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 39Y2'>
    <MCurrPage `1345'>
    <Unique 1061026>
   > # end of Marker
   <String `Sommerfield AJ, Deary IJ, Frier BM. Acute hyper'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `glycemia alters mood state and impairs cognitive '>
  > # end of ParaLine
  <ParaLine 
   <String `performance in people with type 2 '>
   <Char DiscHyphen>
   <String `diabetes. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Diabetes Care. 2004;27:2335–40.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054182>
  <PgfTag `RefTextNrForts'>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
    <FFamily `Frutiger LT Std 55 Roman'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  7.5 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage UKEnglish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLanguage UKEnglish>
  > # end of Pgf
  <PgfNumString `40.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Font 
    <FTag `'>
    <FLanguage Swedish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 40Y2'>
    <MCurrPage `1345'>
    <Unique 1061039>
   > # end of Marker
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `Cox DJ, Gonder-Frederick L, Clarke W. Driving '>
  > # end of ParaLine
  <ParaLine 
   <String `decrements in type I diabetes during moderate '>
  > # end of ParaLine
  <ParaLine 
   <String `hypoglycemia. Diabetes. 1993;42:239–43.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1078287>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `41.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 41Y2'>
    <MCurrPage `1345'>
    <Unique 1078286>
   > # end of Marker
   <String `Cox D, Clarke W, Gonder-Frederick L, Kovatchev '>
  > # end of ParaLine
  <ParaLine 
   <String `B. Driving mishaps and hypoglycaemia: risk and '>
  > # end of ParaLine
  <ParaLine 
   <String `prevention. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Int J Clin Pract Suppl. 2001; Suppl123:38–42.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1078289>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `42.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 42Y2'>
    <MCurrPage `1345'>
    <Unique 1078288>
   > # end of Marker
   <String `Cox DJ, Gonder-Frederick LA, Kovatchev BP, '>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `Julian DM, Clarke WL. Progressive hypoglyce'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `mia\qs impact on driving simulation performance. '>
  > # end of ParaLine
  <ParaLine 
   <String `Occurrence, awareness and correction. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Diabetes Care. 2000;23:163–70.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1069848>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `43.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 43Y2'>
    <MCurrPage `1345'>
    <Unique 1069847>
   > # end of Marker
   <String `Stork AD, van Haeften TW, Veneman TF. The de'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `cision not to drive during hypoglycemia in pa'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tients with type 1 and type 2 diabetes '>
   <Char DiscHyphen>
   <String `according '>
  > # end of ParaLine
  <ParaLine 
   <String `to hypoglycemia awareness. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Diabetes Care. 2007;30:2822–6.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054186>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `44.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 44Y2'>
    <MCurrPage `1345'>
    <Unique 1061091>
   > # end of Marker
   <String `Veneman TF. Diabetes mellitus and traffic inci'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `dents. Neth J Med. 1996;48:24–8.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054187>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `45.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 45Y2'>
    <MCurrPage `1345'>
    <Unique 1061104>
   > # end of Marker
   <String `Cox DJ, Gonder-Frederick L, Polonsky W, Schlundt '>
  > # end of ParaLine
  <ParaLine 
   <String `D, Kovatchev B, Clarke W. Blood glucose aware'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ness training (BGAT-2): long-term benefits. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Diabetes Care. 2001;24:637–42.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1069866>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `46.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 46Y2'>
    <MCurrPage `1345'>
    <Unique 1069865>
   > # end of Marker
   <String `Evans ML, Pernet A, Lomas J, Jones J, Amiel SA. '>
  > # end of ParaLine
  <ParaLine 
   <String `Delay in onset of awareness of acute hypoglyce'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `mia and of restoration of cognitive perfor'>
   <Char DiscHyphen>
   <String `mance '>
  > # end of ParaLine
  <ParaLine 
   <String `during recovery. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Diabetes Care. 2000;23:893–7.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1069884>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `47.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 47Y2'>
    <MCurrPage `1345'>
    <Unique 1069883>
   > # end of Marker
   <String `Zammitt NN, Warren RE, Deary IJ, Frier BM. De'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `layed recovery of cognitive function follow'>
   <Char DiscHyphen>
   <String `ing '>
  > # end of ParaLine
  <ParaLine 
   <String `hypoglycemia in adults with type 1 diabetes: ef'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `fect of impaired awareness of hypoglycemia. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Diabetes. 2008;57:732–6.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054190>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `48.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 48Y2'>
    <MCurrPage `1345'>
    <Unique 1061143>
   > # end of Marker
   <String `Cox DJ, Ford D, Gonder-Frederick L, Clarke W, '>
  > # end of ParaLine
  <ParaLine 
   <String `Mazze R, Weinger K, et al. Driving mishaps '>
  > # end of ParaLine
  <ParaLine 
   <String `among individuals with type 1 diabetes: a pro'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `spective study. Diabetes Care. 2009;32:2177–80.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1073407>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `49.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 49Y2'>
    <MCurrPage `1345'>
    <Unique 1073406>
   > # end of Marker
   <String `Redelmeier DA, Kenshole AB, Ray JG. Motor ve'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `hicle crashes in diabetic patients with tight glyce'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `mic control: a population-based case control '>
  > # end of ParaLine
  <ParaLine 
   <String `analysis. PLoS Med. 2009;6:e1000192.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1073409>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `50.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <TextRectID 180>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 50Y2'>
    <MCurrPage `1346'>
    <Unique 1073408>
   > # end of Marker
   <String `Hemmelgarn B, Levesque LE, Suissa S. Anti-'>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `diabetic drug use and the risk of motor vehicle '>
  > # end of ParaLine
  <ParaLine 
   <String `crash in the elderly. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Can J Clin Pharmacol. 2006;13:e112–20.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1078293>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `51.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 51Y2'>
    <MCurrPage `1346'>
    <Unique 1078292>
   > # end of Marker
   <String `Belsey J, Krishnarajah G. Glycaemic control and '>
  > # end of ParaLine
  <ParaLine 
   <String `adverse events in patients with type 2 diabetes '>
  > # end of ParaLine
  <ParaLine 
   <String `treated with metformin + sulphonylurea: a meta-'>
  > # end of ParaLine
  <ParaLine 
   <String `analysis. Diabetes Obes Metab. 2008;10 (Suppl '>
  > # end of ParaLine
  <ParaLine 
   <String `1):1–7.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1078295>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `52.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 52Y2'>
    <MCurrPage `1346'>
    <Unique 1078294>
   > # end of Marker
   <String `Vlckova V, Cornelius V, Kasliwal R, Wilton L, Sha'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `kir SA. Hypoglycaemia with oral antidiabetic '>
  > # end of ParaLine
  <ParaLine 
   <String `drugs: results from prescription-event monito'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ring cohorts of rosiglitazone, pioglitazone, '>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `nateglinide and repaglinide. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Drug Saf. 2009;32:409–18.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1069930>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `53.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 53Y2'>
    <MCurrPage `1346'>
    <Unique 1069929>
   > # end of Marker
   <String `Raskin P, Mora PF. Glycaemic control with '>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `liraglutide: the phase 3 trial programme. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Int J Clin Pract Suppl. 2010;64:21–7.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1069948>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `54.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 54Y2'>
    <MCurrPage `1346'>
    <Unique 1069947>
   > # end of Marker
   <String `Peterson GE, Pollom RD. Liraglutide in clinical '>
  > # end of ParaLine
  <ParaLine 
   <String `practice: dosing, safety and efficacy. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Int J Clin Pract Suppl. 2010;64:35–43.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1078307>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `55.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 55Y2'>
    <MCurrPage `1346'>
    <Unique 1078306>
   > # end of Marker
   <String `Stork AD, van Haeften TW, Veneman TF. '>
   <Char DiscHyphen>
   <String `Diabetes '>
  > # end of ParaLine
  <ParaLine 
   <String `and driving: Desired data, research methods and '>
  > # end of ParaLine
  <ParaLine 
   <String `their pitfalls, current knowledge, and future re'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `search. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `message URL http://www.ncbi.nlm.nih.gov/pubmed?term=stork%20ad%20and%20pitfalls%20and%202006'>
    <MCurrPage `1346'>
    <Unique 1078308>
   > # end of Marker
   <String `Diabetes Care. 2006;29:1942–9.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1078310>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `56.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 56Y2'>
    <MCurrPage `1346'>
    <Unique 1078309>
   > # end of Marker
   <String `Holstein A, Egberts EH. Risk of hypoglycaemia '>
  > # end of ParaLine
  <ParaLine 
   <String `with oral antidiabetic agents in patients with '>
  > # end of ParaLine
  <ParaLine 
   <String `Type 2 diabetes. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `message URL http://www.ncbi.nlm.nih.gov/pubmed/14614647'>
    <MCurrPage `1346'>
    <Unique 1078311>
   > # end of Marker
   <String `Exp Clin Endocrinol Diabetes. 2003;111: 405–14.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1073413>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `57.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 57Y2'>
    <MCurrPage `1346'>
    <Unique 1073412>
   > # end of Marker
   <String `Black C, Donnelly P, McIntyre L, Royle P, Shepherd '>
  > # end of ParaLine
  <ParaLine 
   <String `Jonathan J, Thomas S. Meglitinide analogues for '>
  > # end of ParaLine
  <ParaLine 
   <String `type 2 diabetes mellitus. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `message URL http://www.ncbi.nlm.nih.gov/pubmed/17443551'>
    <MCurrPage `1346'>
    <Unique 1073414>
   > # end of Marker
   <String `Cochrane Database of Systematic Reviews.'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` 2007. '>
  > # end of ParaLine
  <ParaLine 
   <String `CD004654.pub2.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1078323>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `58.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 58Y2'>
    <MCurrPage `1346'>
    <Unique 1078322>
   > # end of Marker
   <String `Montanya E, Sesti G. A review of efficacy and '>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `safety data regarding the use of liraglutide, a '>
  > # end of ParaLine
  <ParaLine 
   <String `once-daily human glucagon-like peptide 1 analo'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `gue, in the treatment of type 2 diabetes mellitus. '>
  > # end of ParaLine
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `message URL http://www.ncbi.nlm.nih.gov/pubmed/20109994'>
    <MCurrPage `1346'>
    <Unique 1078324>
   > # end of Marker
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <String `Clin Ther. 2009;31:2472–88.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1078326>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `59.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 59Y2'>
    <MCurrPage `1346'>
    <Unique 1078325>
   > # end of Marker
   <String `Russell-Jones D. The safety and tolerability of '>
  > # end of ParaLine
  <ParaLine 
   <String `GLP-1 receptor agonists in the treatment of type-'>
  > # end of ParaLine
  <ParaLine 
   <String `2 diabetes. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `message URL http://www.ncbi.nlm.nih.gov/pubmed?term=russel-jones%20d%20and%20safety%20and%202010'>
    <MCurrPage `1346'>
    <Unique 1078327>
   > # end of Marker
   <String `Int J Clin Pract. 2010;64:1402–14.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1057023>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `60.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 60Y2'>
    <MCurrPage `1346'>
    <Unique 1061303>
   > # end of Marker
   <String `Blonde L, Russell-Jones D. The safety and '>
   <Char DiscHyphen>
   <String `efficacy '>
  > # end of ParaLine
  <ParaLine 
   <String `of liraglutide with or without oral antidiabetic '>
  > # end of ParaLine
  <ParaLine 
   <String `drug therapy in type 2 diabetes: an overview of '>
  > # end of ParaLine
  <ParaLine 
   <String `the LEAD 1–5 studies. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `message URL http://www.ncbi.nlm.nih.gov/pubmed/19878259'>
    <MCurrPage `1346'>
    <Unique 1057024>
   > # end of Marker
   <String `Diabetes Obes Metab. 2009;11 Suppl. 3:26–34.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1057063>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `61.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 61Y2'>
    <MCurrPage `1346'>
    <Unique 1061316>
   > # end of Marker
   <String `Pinkney J, Fox T, Ranganath L. Selecting GLP-1 '>
  > # end of ParaLine
  <ParaLine 
   <String `agonists in the management of type 2 '>
   <Char DiscHyphen>
   <String `diabetes: '>
  > # end of ParaLine
  <ParaLine 
   <String `differential pharmacology and therapeutic bene'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <TextRectID 180>
   <String `fits of liraglutide and exenatide.'>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String ` '>
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `message URL http://www.ncbi.nlm.nih.gov/pubmed/20856686'>
    <MCurrPage `1346'>
    <Unique 1057064>
   > # end of Marker
   <String `Ther Clin Risk Manag. 2010;6:401–11.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1057065>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `62.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 62Y2'>
    <MCurrPage `1346'>
    <Unique 1061329>
   > # end of Marker
   <String `Cohen V, Teperikidis E, Jellinek SP, Rose J. Acute '>
  > # end of ParaLine
  <ParaLine 
   <String `exenatide (Byetta) poisoning was not '>
   <Char DiscHyphen>
   <String `associated '>
  > # end of ParaLine
  <ParaLine 
   <String `with significant hypoglycemia. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Clin Toxicol (Phila). 2008;46:346–7.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054711>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `63.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 63Y2'>
    <MCurrPage `1346'>
    <Unique 1061342>
   > # end of Marker
   <String `Buse JB, Henry RR, Han J, Kim DD, Fineman MS, '>
  > # end of ParaLine
  <ParaLine 
   <String `Baron AD. Effects of exenatide (exendin-4) on '>
  > # end of ParaLine
  <ParaLine 
   <String `glycemic control over 30 weeks in sulfonylurea-'>
  > # end of ParaLine
  <ParaLine 
   <String `treated patients with type 2 diabetes. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Diabetes Care. 2004;27:2628–35.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054206>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `64.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 64Y2'>
    <MCurrPage `1346'>
    <Unique 1061355>
   > # end of Marker
   <String `Kendall DM, Riddle MC, Rosenstock J, Zhuang D, '>
  > # end of ParaLine
  <ParaLine 
   <String `Kim DD, Fineman MS, et al. Effects of exenatide '>
  > # end of ParaLine
  <ParaLine 
   <String `(exendin-4) on glycemic control over 30 weeks in '>
  > # end of ParaLine
  <ParaLine 
   <String `patients with type 2 diabetes treated with met'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `formin and a sulfonylurea. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Diabetes Care. 2005;28:1083–91.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054207>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `65.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 65Y2'>
    <MCurrPage `1346'>
    <Unique 1061368>
   > # end of Marker
   <String `DeFronzo RA, Ratner RE, Han J, Kim DD, Fineman '>
  > # end of ParaLine
  <ParaLine 
   <String `MS, Baron AD. Effects of exenatide (exendin-4) '>
  > # end of ParaLine
  <ParaLine 
   <String `on glycemic control and weight over 30 weeks in '>
  > # end of ParaLine
  <ParaLine 
   <String `metformin-treated patients with type 2 diabetes. '>
  > # end of ParaLine
  <ParaLine 
   <String `Diabetes Care. 2005;28:1092–100.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1078337>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `66.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 66Y2'>
    <MCurrPage `1346'>
    <Unique 1078336>
   > # end of Marker
   <String `Buysschaert M, Preumont V, Oriot PR, Paris I, Pon'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `chon M, Scarniere D, et al. One-year metabolic '>
  > # end of ParaLine
  <ParaLine 
   <String `outcomes in patients with type 2 diabetes trea'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ted with exenatide in routine practice. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Diabetes Metab. 2010;36:381–8.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1078339>
  <PgfTag `RefTextNrForts'>
  <Pgf 
   <HyphenMaxLines 4>
  > # end of Pgf
  <PgfNumString `67.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 67Y2'>
    <MCurrPage `1346'>
    <Unique 1078338>
   > # end of Marker
   <String `Bergenstal RM, Wysham C, Macconell L, Malloy J, '>
  > # end of ParaLine
  <ParaLine 
   <String `Walsh B, Yan P, et al. Efficacy and safety of exena'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `tide once weekly versus sitagliptin or pioglitazo'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ne as an adjunct to metformin for treatment of '>
  > # end of ParaLine
  <ParaLine 
   <String `type 2 diabetes (DURATION-2): a randomised '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `trial. Lancet. 2010;376:431–9.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054210>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `68.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 68Y2'>
    <MCurrPage `1346'>
    <Unique 1061407>
   > # end of Marker
   <String `Buse JB, Rosenstock J, Sesti G, Schmidt WE, Mon'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tanya E, Brett JH, et al. Liraglutide once a day ver'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `sus exenatide twice a day for type 2 diabetes: a '>
  > # end of ParaLine
  <ParaLine 
   <String `26-week randomised, parallel-group, multinatio'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `nal, open-label trial (LEAD-6). '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Lancet. 2009;374:39–47.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054211>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `69.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 69Y2'>
    <MCurrPage `1346'>
    <Unique 1061420>
   > # end of Marker
   <String `Juhl CB, Hollingdal M, Sturis J, Jakobsen G, Ager'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `so H, Veldhuis J, et al. Bedtime administration of '>
  > # end of ParaLine
  <ParaLine 
   <String `NN2211, a long-acting GLP-1 derivative, substan'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tially reduces fasting and postprandial glycemia '>
  > # end of ParaLine
  <ParaLine 
   <String `in type 2 diabetes. Diabetes. 2002;51:424–9.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054212>
  <PgfTag `RefTextNrForts'>
  <Pgf 
   <HyphenMaxLines 6>
  > # end of Pgf
  <PgfNumString `70.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 70Y2'>
    <MCurrPage `1346'>
    <Unique 1061437>
   > # end of Marker
   <String `Madsbad S, Schmitz O, Ranstam J, Jakobsen G, '>
  > # end of ParaLine
  <ParaLine 
   <String `Matthews DR. Improved glycemic control with no '>
  > # end of ParaLine
  <ParaLine 
   <String `weight increase in patients with type 2 diabetes '>
  > # end of ParaLine
  <ParaLine 
   <String `after once-daily treatment with the long-acting '>
  > # end of ParaLine
  <ParaLine 
   <String `glucagon-like peptide 1 analog liraglutide '>
  > # end of ParaLine
  <ParaLine 
   <String `(NN2211): a 12-week, double-blind, randomized, '>
  > # end of ParaLine
  <ParaLine 
   <String `controlled trial. Diabetes Care. 2004;27:1335–42.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054213>
  <PgfTag `RefTextNrForts'>
  <Pgf 
   <PgfPlacement ColumnTop>
  > # end of Pgf
  <PgfNumString `71.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <TextRectID 181>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 71Y2'>
    <MCurrPage `1347'>
    <Unique 1061450>
   > # end of Marker
   <String `Vilsboll T, Zdravkovic M, Le-Thi T, Krarup T, '>
  > # end of ParaLine
  <ParaLine 
   <String `Schmitz O, Courreges JP, et al. Liraglutide, a long-'>
  > # end of ParaLine
  <ParaLine 
   <String `acting human glucagon-like peptide-1 analog, '>
  > # end of ParaLine
  <ParaLine 
   <String `given as monotherapy significantly improves gly'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `cemic control and lowers body weight without '>
  > # end of ParaLine
  <ParaLine 
   <String `risk of hypoglycemia in patients with type 2 dia'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `betes. Diabetes Care. 2007;30:1608–10.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1073427>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `72.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 72Y2'>
    <MCurrPage `1347'>
    <Unique 1073426>
   > # end of Marker
   <String `Bode BW, Testa MA, Magwire M, Hale PM, Ham'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `mer M, Blonde L, et al. Patient-reported out'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `comes following treatment with the human GLP-'>
  > # end of ParaLine
  <ParaLine 
   <String `1 analogue liraglutide or glimepiride in mono'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `therapy: results from a randomized controlled '>
  > # end of ParaLine
  <ParaLine 
   <String `trial in patients with type 2 diabetes. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Diabetes Obes Metab. 2010;12:604–12.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054215>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `73.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 73Y2'>
    <MCurrPage `1347'>
    <Unique 1061476>
   > # end of Marker
   <String `Nauck M, Frid A, Hermansen K, Shah NS, Tankova '>
  > # end of ParaLine
  <ParaLine 
   <String `T, Mitha IH, et al. Efficacy and safety comparison '>
  > # end of ParaLine
  <ParaLine 
   <String `of liraglutide, glimepiride, and placebo, all in '>
  > # end of ParaLine
  <ParaLine 
   <String `combination with metformin, in type 2 diabetes: '>
  > # end of ParaLine
  <ParaLine 
   <String `the LEAD (liraglutide effect and action in '>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `diabetes)-2 study. Diabetes Care. 2009;32:84–90.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1060399>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `74.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 74Y2'>
    <MCurrPage `1347'>
    <Unique 1061489>
   > # end of Marker
   <String `Marre M, Shaw J, Brandle M, Bebakar WM, '>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `Kamaruddin NA, Strand J, et al. Liraglutide, a '>
  > # end of ParaLine
  <ParaLine 
   <String `once-daily human GLP-1 analogue, added to a '>
  > # end of ParaLine
  <ParaLine 
   <String `sulphonylurea over 26 weeks produces greater '>
  > # end of ParaLine
  <ParaLine 
   <String `improvements in glycaemic and weight control '>
  > # end of ParaLine
  <ParaLine 
   <String `compared with adding rosiglitazone or placebo '>
  > # end of ParaLine
  <ParaLine 
   <String `in subjects with Type 2 diabetes (LEAD-1 SU). '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Diabet Med. 2009;26:268–78.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1060400>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `75.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 75Y2'>
    <MCurrPage `1347'>
    <Unique 1061502>
   > # end of Marker
   <String `Russell-Jones D, Vaag A, Schmitz O, Sethi BK, Lalic '>
  > # end of ParaLine
  <ParaLine 
   <String `N, Antic S, et al. Liraglutide vs insulin glargine '>
  > # end of ParaLine
  <ParaLine 
   <String `and placebo in combination with metformin and '>
  > # end of ParaLine
  <ParaLine 
   <String `sulfonylurea therapy in type 2 diabetes mellitus '>
  > # end of ParaLine
  <ParaLine 
   <String `(LEAD-5 met+SU): a randomised controlled trial. '>
  > # end of ParaLine
  <ParaLine 
   <String `Diabetologia. 2009;52:2046–55.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1070059>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `76.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 76Y2'>
    <MCurrPage `1347'>
    <Unique 1070058>
   > # end of Marker
   <String `Hermansen K, Kolotkin RL, Hammer M, Zdravko'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `vic M, Matthews D. Patient-reported out'>
   <Char DiscHyphen>
   <String `comes in '>
  > # end of ParaLine
  <ParaLine 
   <String `patients with type 2 diabetes treated with lira'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `glutide or glimepiride, both as add-on to metfor'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `min. Prim Care Diabetes. 2010;4:113–7.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1088659>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `77.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 77Y2'>
    <MCurrPage `1347'>
    <Unique 1088658>
   > # end of Marker
   <String `Zinman B, Gerich J, Buse JB, Lewin A, Schwartz S, '>
  > # end of ParaLine
  <ParaLine 
   <String `Raskin P, et al. Efficacy and safety of the human '>
  > # end of ParaLine
  <ParaLine 
   <String `glucagon-like peptide-1 analog liraglutide in '>
  > # end of ParaLine
  <ParaLine 
   <String `combination with metformin and thiazolidinedi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `one in patients with type 2 diabetes (LEAD-4 '>
  > # end of ParaLine
  <ParaLine 
   <String `Met+TZD). Diabetes Care. 2009;32:1224–30.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1070069>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `78.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 78Y2'>
    <MCurrPage `1347'>
    <Unique 1070068>
   > # end of Marker
   <String `Pan C, Yang W, Barona JP, Wang Y, Niggli M, Mo'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `hideen P, et al. Comparison of vildagliptin and '>
  > # end of ParaLine
  <ParaLine 
   <String `acarbose monotherapy in patients with Type 2 di'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `abetes: a 24-week, double-blind, randomized tri'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `al. Diabet Med. 2008;25:435–41.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1070071>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `79.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 79Y2'>
    <MCurrPage `1347'>
    <Unique 1070070>
   > # end of Marker
   <String `Spengler M, Schmitz H, and Landen H. Evaluation '>
  > # end of ParaLine
  <ParaLine 
   <String `of the efficacy and tolerability of acarbose in pa'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tients with diabetes mellitus : a postmarketing '>
  > # end of ParaLine
  <ParaLine 
   <TextRectID 181>
   <String `surveillance study. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Clin Drug Investig. 2005;25:651–9.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1088665>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `80.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 80Y2'>
    <MCurrPage `1347'>
    <Unique 1088664>
   > # end of Marker
   <String `Derosa G, Salvadeo SA, D\qAngelo A, Ferrari I, Me'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `reu R, Palumbo I, et al. Metabolic effect of repa'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `glinide or acarbose when added to a double oral '>
  > # end of ParaLine
  <ParaLine 
   <String `antidiabetic treatment with sulphonylureas and '>
  > # end of ParaLine
  <ParaLine 
   <String `metformin: a double-blind, cross-over, clinical tri'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `al. Curr Med Res Opin. 2009;25:607–15.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054223>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `81.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 81Y2'>
    <MCurrPage `1347'>
    <Unique 1061580>
   > # end of Marker
   <String `Wan Mohamad WB, Tun Fizi A, Ismail RB, Mafau'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `zy M. Efficacy and safety of single versus multiple '>
  > # end of ParaLine
  <ParaLine 
   <String `daily doses of glibenclamide in type 2 diabetes '>
  > # end of ParaLine
  <ParaLine 
   <String `mellitus. Diabetes Res Clin Pract. 2000;49:93–9.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054224>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `82.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 82Y2'>
    <MCurrPage `1347'>
    <Unique 1061593>
   > # end of Marker
   <Font 
    <FTag `'>
    <FDW  -1.0%>
    <FLocked No>
   > # end of Font
   <String `Garber A, Klein E, Bruce S, Sankoh S, Mohideen P. '>
  > # end of ParaLine
  <ParaLine 
   <String `Metformin-glibenclamide versus metformin plus '>
  > # end of ParaLine
  <ParaLine 
   <String `rosiglitazone in patients with type 2 diabetes in'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `a'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `dequately controlled on metformin mono'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `'>
    <FDW  -1.0%>
    <FLocked No>
   > # end of Font
   <Char DiscHyphen>
   <String `therapy. Diabetes Obes Metab. 2006;8:156–63.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054225>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `83.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 83Y2'>
    <MCurrPage `1347'>
    <Unique 1061606>
   > # end of Marker
   <String `Chan TY. Anti-diabetic drugs as a cause of hypo'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `glycaemia among acute medical admissions in '>
  > # end of ParaLine
  <ParaLine 
   <String `Hong Kong and Singapore--relationship to the '>
  > # end of ParaLine
  <ParaLine 
   <String `prescribing patterns in diabetic patients. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Singapore Med J. 1998;39:186–8.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1070136>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `84.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 84Y2'>
    <MCurrPage `1347'>
    <Unique 1070135>
   > # end of Marker
   <String `Holstein A, Plaschke A, Egberts EH. Lower inci'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `dence of severe hypoglycaemia in patients with '>
  > # end of ParaLine
  <ParaLine 
   <String `type 2 diabetes treated with glimepiride versus '>
  > # end of ParaLine
  <ParaLine 
   <String `glibenclamide. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Diabetes Metab Res Rev. 2001;17:467–73.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054717>
  <PgfTag `RefTextNrForts'>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
    <FFamily `Frutiger LT Std 55 Roman'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  7.5 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  -1.0%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
  > # end of Pgf
  <PgfNumString `85.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 85Y2'>
    <MCurrPage `1347'>
    <Unique 1061632>
   > # end of Marker
   <String `Seck T, Nauck M, Sheng D, Sunga S, Davies MJ, '>
  > # end of ParaLine
  <ParaLine 
   <String `Stein PP, et al. Safety and efficacy of treatment '>
  > # end of ParaLine
  <ParaLine 
   <String `with sitagliptin or glipizide in patients with type 2 '>
  > # end of ParaLine
  <ParaLine 
   <String `diabetes inadequately controlled on metformin: '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `a 2-year study. Int J Clin Pract. 2010;64:562–76.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1088671>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `86.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 86Y2'>
    <MCurrPage `1347'>
    <Unique 1088670>
   > # end of Marker
   <String `Nauck MA, Meininger G, Sheng D, Terranella L, '>
  > # end of ParaLine
  <ParaLine 
   <String `Stein PP. Efficacy and safety of the dipeptidyl '>
  > # end of ParaLine
  <ParaLine 
   <String `peptidase-4 inhibitor, sitagliptin, compared with '>
  > # end of ParaLine
  <ParaLine 
   <String `the sulfonylurea, glipizide, in patients with type '>
  > # end of ParaLine
  <ParaLine 
   <String `2 diabetes inadequately controlled on metformin '>
  > # end of ParaLine
  <ParaLine 
   <String `alone: a randomized, double-blind, non-inferio'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `rity trial. Diabetes Obes Metab. 2007;9:194–205.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1073435>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `87.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 87Y2'>
    <MCurrPage `1347'>
    <Unique 1073434>
   > # end of Marker
   <String `Pham DQ, Nogid A, Plakogiannis R. Sitagliptin: a '>
  > # end of ParaLine
  <ParaLine 
   <String `novel agent for the management of type 2 '>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `diabetes mellitus. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Am J Health Syst Pharm. 2008;65:521–31.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054230>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `88.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 88Y2'>
    <MCurrPage `1347'>
    <Unique 1061675>
   > # end of Marker
   <String `Gottschalk M, Danne T, Vlajnic A, Cara JF. Glime'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `piride versus metformin as monotherapy in pedi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `atric patients with type 2 diabetes: a randomized, '>
  > # end of ParaLine
  <ParaLine 
   <String `single-blind comparative study. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Diabetes Care. 2007;30:790–4.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054231>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `89.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 89Y2'>
    <MCurrPage `1347'>
    <Unique 1061688>
   > # end of Marker
   <String `Aschner P, Katzeff HL, Guo H, Sunga S, Williams-'>
  > # end of ParaLine
  <ParaLine 
   <String `Herman D, Kaufman KD, et al. Efficacy and safety '>
  > # end of ParaLine
  <ParaLine 
   <String `of monotherapy of sitagliptin compared with '>
  > # end of ParaLine
  <ParaLine 
   <String `metformin in patients with type 2 diabetes. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Diabetes Obes Metab. 2010;12:252–61.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054232>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `90.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <TextRectID 182>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 90Y2'>
    <MCurrPage `1348'>
    <Unique 1061701>
   > # end of Marker
   <String `DeFronzo RA and Goodman AM. Efficacy of met'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `formin in patients with non-insulin-dependent '>
  > # end of ParaLine
  <ParaLine 
   <String `diabetes mellitus. The Multicenter Metformin '>
  > # end of ParaLine
  <ParaLine 
   <String `Study Group. N Engl J Med. 1995;333:541–9.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054233>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `91.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 91Y2'>
    <MCurrPage `1348'>
    <Unique 1061714>
   > # end of Marker
   <String `Schweizer A, Dejager S, Bosi E. Comparison of vil'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `dagliptin and metformin monotherapy in elderly '>
  > # end of ParaLine
  <ParaLine 
   <String `patients with type 2 diabetes: a 24-week, double-'>
  > # end of ParaLine
  <ParaLine 
   <String `blind, randomized trial. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Diabetes Obes Metab. 2009;1:804–12.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054234>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `92.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 92Y2'>
    <MCurrPage `1348'>
    <Unique 1061727>
   > # end of Marker
   <String `Dunn CJ, Peters DH. Metformin. A review of its '>
  > # end of ParaLine
  <ParaLine 
   <String `pharmacological properties and therapeutic use '>
  > # end of ParaLine
  <ParaLine 
   <String `in non-insulin-dependent diabetes mellitus. '>
  > # end of ParaLine
  <ParaLine 
   <String `Drugs. 1995;49:721–49.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1088693>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `93.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 93Y2'>
    <MCurrPage `1348'>
    <Unique 1088692>
   > # end of Marker
   <String `Hanefeld M, Bouter KP, Dickinson S, Guitard C. '>
  > # end of ParaLine
  <ParaLine 
   <String `Rapid and short-acting mealtime insulin secre'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tion with nateglinide controls both prandial and '>
  > # end of ParaLine
  <ParaLine 
   <String `mean glycemia. Diabetes Care. 2000;23:202–7.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1088696>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `94.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 94Y2'>
    <MCurrPage `1348'>
    <Unique 1088695>
   > # end of Marker
   <String `Horton ES, Clinkingbeard C, Gatlin M, Foley J, '>
  > # end of ParaLine
  <ParaLine 
   <String `Mallows S, Shen S. Nateglinide alone and in com'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `bination with metformin improves glycemic con'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `trol by reducing mealtime glucose levels in type 2 '>
  > # end of ParaLine
  <ParaLine 
   <String `diabetes. Diabetes Care. 2000;23:1660–5.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1088710>
  <PgfTag `RefTextNrForts'>
  <Pgf 
   <HyphenMaxLines 4>
  > # end of Pgf
  <PgfNumString `95.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 95Y2'>
    <MCurrPage `1348'>
    <Unique 1088709>
   > # end of Marker
   <String `Marre M, Van Gaal L, Usadel KH, Ball M, What'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `mough I, Guitard C. Nateglinide improves glycae'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `mic control when added to metformin monothe'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `rapy: results of a randomized trial with type 2 '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `diabetes patients. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Diabetes Obes Metab. 2002;4:177–86.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054238>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `96.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 96Y2'>
    <MCurrPage `1348'>
    <Unique 1061779>
   > # end of Marker
   <String `Ristic S, Collober-Maugeais C, Pecher E, Cressier F. '>
  > # end of ParaLine
  <ParaLine 
   <String `Comparison of nateglinide and gliclazide in com'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `bination with metformin, for treatment of pa'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tients with Type 2 diabetes mellitus inadequately '>
  > # end of ParaLine
  <ParaLine 
   <String `controlled on maximum doses of metformin alo'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ne. Diabet Med. 2006;23:757–62.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054239>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `97.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 97Y2'>
    <MCurrPage `1348'>
    <Unique 1061792>
   > # end of Marker
   <String `Saloranta C, Hershon K, Ball M, Dickinson S, Hol'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `mes D. Efficacy and safety of nateglinide in type '>
  > # end of ParaLine
  <ParaLine 
   <String `2 diabetic patients with modest fasting hypergly'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `cemia. J Clin Endocrinol Metab. 2002;87:4171–6.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054240>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `98.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 98Y2'>
    <MCurrPage `1348'>
    <Unique 1061805>
   > # end of Marker
   <String `Mafauzy M. Repaglinide versus glibenclamide '>
  > # end of ParaLine
  <ParaLine 
   <String `treatment of Type 2 diabetes during Ramadan '>
  > # end of ParaLine
  <ParaLine 
   <String `fasting. Diabetes Res Clin Pract. 2002;58:45–53.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054721>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `99.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 99Y2'>
    <MCurrPage `1348'>
    <Unique 1061818>
   > # end of Marker
   <String `Moses RG, Gomis R, Frandsen KB, Schlienger JL, '>
  > # end of ParaLine
  <ParaLine 
   <String `Dedov I. Flexible meal-related dosing with repag'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `linide facilitates glycemic control in therapy-nai'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ve type 2 diabetes. Diabetes Care. 2001;24:11–5.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054722>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `100.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 100Y2'>
    <MCurrPage `1348'>
    <Unique 1061831>
   > # end of Marker
   <String `Goldberg RB, Einhorn D, Lucas CP, Rendell MS, '>
  > # end of ParaLine
  <ParaLine 
   <String `Damsbo P, Huang WC, et al. A randomized place'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `bo-controlled trial of repaglinide in the treat'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ment of type 2 diabetes. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Diabetes Care. 1998;21:1897–903.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054725>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `101.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 101Y2'>
    <MCurrPage `1348'>
    <Unique 1061844>
   > # end of Marker
   <String `Van Gaal LF, Van Acker KL, De Leeuw IH. '>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `Repaglinide improves blood glucose control in '>
  > # end of ParaLine
  <ParaLine 
   <TextRectID 182>
   <String `sulphonylurea-naive type 2 diabetes. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Diabetes Res Clin Pract. 2001;53:141–8.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054726>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `102.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 102Y2'>
    <MCurrPage `1348'>
    <Unique 1061857>
   > # end of Marker
   <String `Jovanovic L, Dailey G, 3rd, Huang WC, Strange P, '>
  > # end of ParaLine
  <ParaLine 
   <String `Goldstein BJ. Repaglinide in type 2 diabetes: a 24-'>
  > # end of ParaLine
  <ParaLine 
   <String `week, fixed-dose efficacy and safety study. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `J Clin Pharmacol. 2000;40:49–57.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054729>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `103.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 103Y2'>
    <MCurrPage `1348'>
    <Unique 1061870>
   > # end of Marker
   <String `Gomez-Perez FJ, Fanghanel-Salmon G, Antonio '>
  > # end of ParaLine
  <ParaLine 
   <String `Barbosa J, Montes-Villarreal J, Berry RA, Warsi G, '>
  > # end of ParaLine
  <ParaLine 
   <String `et al. Efficacy and safety of rosiglitazone plus '>
  > # end of ParaLine
  <ParaLine 
   <String `metformin in Mexicans with type 2 diabetes. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Diabetes Metab Res Rev. 2002;18:127–34.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1073455>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `104.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 104Y2'>
    <MCurrPage `1348'>
    <Unique 1073454>
   > # end of Marker
   <String `Fonseca V, Rosenstock J, Patwardhan R, Salzman '>
  > # end of ParaLine
  <ParaLine 
   <String `A. Effect of metformin and rosiglitazone combi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `nation therapy in patients with type 2 diabetes '>
  > # end of ParaLine
  <ParaLine 
   <String `mellitus: a randomized controlled trial. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `JAMA. 2000;283:1695–702.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1073457>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `105.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 105Y2'>
    <MCurrPage `1348'>
    <Unique 1073456>
   > # end of Marker
   <String `Charbonnel B, Schernthaner G, Brunetti P, Mat'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `thews DR, Urquhart R, Tan MH, et al. Long-term '>
  > # end of ParaLine
  <ParaLine 
   <String `efficacy and tolerability of add-on pioglitazone '>
  > # end of ParaLine
  <ParaLine 
   <String `therapy to failing monotherapy compared with '>
  > # end of ParaLine
  <ParaLine 
   <String `addition of gliclazide or metformin in patients '>
  > # end of ParaLine
  <ParaLine 
   <String `with type 2 diabetes. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Diabetologia. 2005;48:1093–104.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054248>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `106.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 106Y2'>
    <MCurrPage `1348'>
    <Unique 1061909>
   > # end of Marker
   <String `Jain R, Osei K, Kupfer S, Perez AT, Zhang J. Long-'>
  > # end of ParaLine
  <ParaLine 
   <String `term safety of pioglitazone versus glyburide in '>
  > # end of ParaLine
  <ParaLine 
   <String `patients with recently diagnosed type 2 diabetes '>
  > # end of ParaLine
  <ParaLine 
   <String `mellitus. Pharmacotherapy. 2006;26:1388–95.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054249>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `107.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 107Y2'>
    <MCurrPage `1348'>
    <Unique 1061926>
   > # end of Marker
   <String `Bolli G, Dotta F, Rochotte E, Cohen SE. Efficacy '>
  > # end of ParaLine
  <ParaLine 
   <String `and tolerability of vildagliptin vs. pioglitazone '>
  > # end of ParaLine
  <ParaLine 
   <String `when added to metformin: a 24-week, randomi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `zed, double-blind study. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Diabetes Obes Metab. 2008;10:82–90.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1070338>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `108.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 108Y2'>
    <MCurrPage `1348'>
    <Unique 1070337>
   > # end of Marker
   <String `Lyseng-Williamson KA. Sitagliptin. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Drugs. 2007;67:587–97.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1070340>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `109.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 109Y2'>
    <MCurrPage `1348'>
    <Unique 1070339>
   > # end of Marker
   <String `Williams-Herman D, Engel SS, Round E, Johnson '>
  > # end of ParaLine
  <ParaLine 
   <String `J, Golm GT, Guo H, et al. Safety and tolerability of '>
  > # end of ParaLine
  <ParaLine 
   <String `sitagliptin in clinical studies: a pooled analysis of '>
  > # end of ParaLine
  <ParaLine 
   <String `data from 10,246 patients with type 2 diabetes. '>
  > # end of ParaLine
  <ParaLine 
   <String `BMC Endocr Disord. 2010;10:7.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1057092>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `110.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 110Y2'>
    <MCurrPage `1348'>
    <Unique 1061965>
   > # end of Marker
   <String `Kay GG, Ebinger U. Preserving cognitive func'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `tion for patients with overactive bladder: eviden'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ce for a differential effect with darifenacin. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `message URL http://www.ncbi.nlm.nih.gov/pubmed/18699842'>
    <MCurrPage `1348'>
    <Unique 1057096>
   > # end of Marker
   <String `Int J Clin Pract. 2008;62:1792–800.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1057093>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `111.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 111Y2'>
    <MCurrPage `1348'>
    <Unique 1061978>
   > # end of Marker
   <String `Kay G, Crook T, Rekeda L, Lima R, Ebinger U, '>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `Arguinzoniz M, et al. Differential effects of the '>
  > # end of ParaLine
  <ParaLine 
   <String `antimuscarinic agents darifenacin and oxybuty'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `nin ER on memory in older subjects. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Eur Urol. 2006;50:317–26.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1088755>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `112.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 112Y2'>
    <MCurrPage `1348'>
    <Unique 1088754>
   > # end of Marker
   <String `Kay GG, Wesnes KA. Pharmacodynamic '>
   <Char DiscHyphen>
   <String `effects '>
  > # end of ParaLine
  <ParaLine 
   <String `of darifenacin, a muscarinic M selective receptor '>
  > # end of ParaLine
  <ParaLine 
   <String `antagonist for the treatment of overactive blad'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `der, in healthy volunteers. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `BJU Int. 2005;96:1055–62.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1088761>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `113.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <TextRectID 183>
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 113Y2'>
    <MCurrPage `1349'>
    <Unique 1088760>
   > # end of Marker
   <String `Lipton RB, Kolodner K, Wesnes K. Assessment of '>
  > # end of ParaLine
  <ParaLine 
   <String `cognitive function of the elderly population: ef'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `fects of darifenacin. J Urol. 2005;173:493–8.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1088775>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `114.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 114Y2'>
    <MCurrPage `1349'>
    <Unique 1088774>
   > # end of Marker
   <String `Katz IR, Sands LP, Bilker W, DiFilippo S, Boyce A, '>
  > # end of ParaLine
  <ParaLine 
   <String `D\qAngelo K. Identification of medications that '>
  > # end of ParaLine
  <ParaLine 
   <String `cause cognitive impairment in older people: the '>
  > # end of ParaLine
  <ParaLine 
   <String `case of oxybutynin chloride. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `J Am '>
   <Char DiscHyphen>
   <String `Geriatr Soc. 1998;46:8–13.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1088777>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `115.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 115Y2'>
    <MCurrPage `1349'>
    <Unique 1088776>
   > # end of Marker
   <String `Womack KB, Heilman KM. Tolterodine and me'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `mory: dry but forgetful. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Arch Neurol. 2003;60:771–3.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1070386>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `116.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 116Y2'>
    <MCurrPage `1349'>
    <Unique 1070385>
   > # end of Marker
   <String `Salvatore S, Serati M, Cardozo L, Uccella S, Bolis '>
  > # end of ParaLine
  <ParaLine 
   <String `P. Cognitive dysfunction with tolterodine use. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Am J Obstet Gynecol. 2007;197:e8.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1070388>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `117.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 117Y2'>
    <MCurrPage `1349'>
    <Unique 1070387>
   > # end of Marker
   <String `MacDonald FC, Gough KJ, Nicoll RA, Dow RJ. '>
  > # end of ParaLine
  <ParaLine 
   <String `Psychomotor effects of ketorolac in comparison '>
  > # end of ParaLine
  <ParaLine 
   <String `with buprenorphine and diclofenac. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Br J Clin Pharmacol. 1989;27:453–9.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054260>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `118.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 118Y2'>
    <MCurrPage `1349'>
    <Unique 1062069>
   > # end of Marker
   <String `Allen GJ, Hartl TL, Duffany S, Smith SF, VanHeest '>
  > # end of ParaLine
  <ParaLine 
   <String `JL, Anderson JM, et al. Cognitive and motor func'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `tion after administration of hydrocodone '>
  > # end of ParaLine
  <ParaLine 
   <String `bitartrate plus ibuprofen, ibuprofen alone, or '>
  > # end of ParaLine
  <ParaLine 
   <String `placebo in healthy subjects with exercise-induced '>
  > # end of ParaLine
  <ParaLine 
   <String `muscle damage: a randomized, repeated-dose, '>
  > # end of ParaLine
  <ParaLine 
   <String `placebo-controlled study. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Psychopharmacology (Berl). 2003;166:228–33.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054261>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `119.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 119Y2'>
    <MCurrPage `1349'>
    <Unique 1062082>
   > # end of Marker
   <String `Goodwin JS, Regan M. Cognitive dysfunction '>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `associated with naproxen and ibuprofen in the '>
  > # end of ParaLine
  <ParaLine 
   <String `elderly. Arthritis Rheum. 1982;25:1013–5.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054262>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `120.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 120Y2'>
    <MCurrPage `1349'>
    <Unique 1062095>
   > # end of Marker
   <String `Laurell H, Törnros JE. Inverkan av naproxen och '>
  > # end of ParaLine
  <ParaLine 
   <String `indometacin på prestation i simulerad bilkörning '>
  > # end of ParaLine
  <ParaLine 
   <String `och på reaktionstid. 1989, Linköping: VTI, Statens '>
  > # end of ParaLine
  <ParaLine 
   <String `Väg- och Transportforskningsinstitut Short VTI '>
  > # end of ParaLine
  <ParaLine 
   <String `Notat TF 57–05.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054263>
  <PgfTag `RefTextNrForts'>
  <Pgf 
   <HyphenMaxLines 4>
  > # end of Pgf
  <PgfNumString `121.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 121Y2'>
    <MCurrPage `1349'>
    <Unique 1062108>
   > # end of Marker
   <String `Saarialho-Kere U, Julkunen H, Mattila MJ, Sep'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `pala T. Psychomotor performance of patients '>
  > # end of ParaLine
  <ParaLine 
   <String `with rheumatoid arthritis: cross-over comparison '>
  > # end of ParaLine
  <ParaLine 
   <String `of dextropropoxyphene, dextropropoxy'>
   <Char DiscHyphen>
   <String `phene '>
  > # end of ParaLine
  <ParaLine 
   <String `plus amitriptyline, indomethacin, and placebo. '>
  > # end of ParaLine
  <ParaLine 
   <String `Pharmacol Toxicol. 1988;63:286–92.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1070428>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `122.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 122Y2'>
    <MCurrPage `1349'>
    <Unique 1070427>
   > # end of Marker
   <String `Bruce-Jones PN, Crome P, Kalra L. Indomethacin '>
  > # end of ParaLine
  <ParaLine 
   <String `and cognitive function in healthy elderly volunte'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ers. Br J Clin Pharmacol. 1994;38:45–51.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1088802>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `123.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 123Y2'>
    <MCurrPage `1349'>
    <Unique 1088801>
   > # end of Marker
   <String `Wysenbeek AJ, Klein Z, Nakar S, Mane R. Assess'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ment of cognitive function in elderly patients '>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `treated with naproxen. A prospective study. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Clin Exp Rheumatol. 1988;6:399–400.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1088798>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `124.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 124Y2'>
    <MCurrPage `1349'>
    <Unique 1088797>
   > # end of Marker
   <String `Spikman JM, Timmerman ME, Zomeren van AH, '>
  > # end of ParaLine
  <ParaLine 
   <String `Deelman BG. Recovery versus retest effects in at'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tention after closed head injury. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `J Clin Exp Neuropsychol. 1999;21:585–605.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1070448>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `125.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 125Y2'>
    <MCurrPage `1349'>
    <Unique 1070447>
   > # end of Marker
   <String `Lemay S, Bédard M-A, Rouleau I, Tremblay P-L. '>
  > # end of ParaLine
  <ParaLine 
   <String `Practice effect and test-retest reliability of '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <TextRectID 183>
   <String `attentional and executive tests in middle-aged to '>
  > # end of ParaLine
  <ParaLine 
   <String `elderly subjects. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Clin Neuropsychol. 2004;18:284–302.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054268>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `126.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 126Y2'>
    <MCurrPage `1349'>
    <Unique 1062173>
   > # end of Marker
   <String `Chung F, Assmann N. Car accidents after ambu'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `latory surgery in patients without an escort. '>
  > # end of ParaLine
  <ParaLine 
   <String `Anesth Analg. 2008;106:817–20.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054269>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `127.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 127Y2'>
    <MCurrPage `1349'>
    <Unique 1062186>
   > # end of Marker
   <String `Correa R, Menezes RB, Wong J, Yogendran S, '>
  > # end of ParaLine
  <ParaLine 
   <String `Jenkins K, Chung F. Compliance with postoperati'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ve instructions: a telephone survey of 750 day '>
  > # end of ParaLine
  <ParaLine 
   <String `surgery patients. Anaesthesia. 2001;56:481–4.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1070476>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `128.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 128Y2'>
    <MCurrPage `1349'>
    <Unique 1070475>
   > # end of Marker
   <String `Ogg TW. An assessment of postoperative out'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `patient cases. Br Med J. 1972;4:573–6.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1070478>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `129.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 129Y2'>
    <MCurrPage `1349'>
    <Unique 1070477>
   > # end of Marker
   <String `Wu CL, Hsu W, Richman JM, Raja SN. Postopera'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tive cognitive function as an outcome of regional '>
  > # end of ParaLine
  <ParaLine 
   <String `anesthesia and analgesia. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Reg Anesth Pain Med. 2004;29:257–68.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054272>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `130.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 130Y2'>
    <MCurrPage `1349'>
    <Unique 1062225>
   > # end of Marker
   <String `Chung F, Kayumov L, Sinclair DR, Edward R, Mol'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ler HJ, Shapiro CM. What is the driving perfor'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `mance of ambulatory surgical patients after '>
  > # end of ParaLine
  <ParaLine 
   <String `general anesthesia? '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Anesthesiology. 2005;103:951–6.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1073477>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `131.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 131Y2'>
    <MCurrPage `1349'>
    <Unique 1073476>
   > # end of Marker
   <String `Sinclair DR, Chung F, Smiley A. General anesthe'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `sia does not impair simulator driving skills in vo'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `lunteers in the immediate recovery period – '>
  > # end of ParaLine
  <ParaLine 
   <String `a'>
   <Char HardSpace>
   <String `pilot study. Can J Anaesth. 2003;50:238–45.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054274>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `132.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 132Y2'>
    <MCurrPage `1349'>
    <Unique 1062255>
   > # end of Marker
   <String `Awad IT, Chung F. Factors affecting recovery '>
  > # end of ParaLine
  <ParaLine 
   <String `and discharge following ambulatory surgery. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `message URL http://www.ncbi.nlm.nih.gov/pubmed/16960263'>
    <MCurrPage `1349'>
    <Unique 1057119>
   > # end of Marker
   <String `Can J Anaesth. 2006;53:858–72.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1070514>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `133.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 133Y2'>
    <MCurrPage `1349'>
    <Unique 1070513>
   > # end of Marker
   <String `Rawal N. Postdischarge complications and reha'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `bilitation after ambulatory surgery. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Curr Opin Anaesthesiol. 2008;21:736–42.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054276>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `134.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 134Y2'>
    <MCurrPage `1349'>
    <Unique 1062281>
   > # end of Marker
   <String `Ip HY, Chung F. Escort accompanying discharge '>
  > # end of ParaLine
  <ParaLine 
   <String `after ambulatory surgery: a necessity or a luxury? '>
  > # end of ParaLine
  <ParaLine 
   <String `Curr Opin Anaesthesiol. 2009;22:748–54.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1057148>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `135.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 135Y2'>
    <MCurrPage `1349'>
    <Unique 1062294>
   > # end of Marker
   <String `Vargo JJ. Doc, can I drive home? '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `message URL http://www.ncbi.nlm.nih.gov/pubmed?term=vargo%20jj%20and%20home%20and%202009'>
    <MCurrPage `1349'>
    <Unique 1057158>
   > # end of Marker
   <String `Am J Gastroenterol. 2009;104:1656–7.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1057181>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `136.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 136Y2'>
    <MCurrPage `1349'>
    <Unique 1062307>
   > # end of Marker
   <String `Byrne MF. Nurse-administered propofol seda'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tion safety further confirmed - but can we really '>
  > # end of ParaLine
  <ParaLine 
   <String `allow our patients to drive afterwards? '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `message URL http://www.ncbi.nlm.nih.gov/pubmed?term=byrne%20mf%20and%20safety%20and%202008'>
    <MCurrPage `1349'>
    <Unique 1057188>
   > # end of Marker
   <String `Digestion. 2008;78:187–9.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1057182>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `137.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 137Y2'>
    <MCurrPage `1349'>
    <Unique 1062320>
   > # end of Marker
   <String `Korttila K. Recovery and driving after brief '>
  > # end of ParaLine
  <ParaLine 
   <String `anaesthesia.'>
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <String ` '>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `message URL http://www.ncbi.nlm.nih.gov/pubmed/7025696'>
    <MCurrPage `1349'>
    <Unique 1057205>
   > # end of Marker
   <String `Anaesthesist. 1981;30:377–82.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054280>
  <PgfTag `RefTextNrForts'>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
    <FFamily `Frutiger LT Std 55 Roman'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  7.5 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage UKEnglish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLanguage UKEnglish>
  > # end of Pgf
  <PgfNumString `138.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Font 
    <FTag `'>
    <FLanguage Swedish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 138Y2'>
    <MCurrPage `1349'>
    <Unique 1062333>
   > # end of Marker
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `Fulton J, Popovetsky G, Jacoby JL, Heller MB, '>
  > # end of ParaLine
  <ParaLine 
   <String `Reed J. The effect of IM droperidol on driving '>
  > # end of ParaLine
  <ParaLine 
   <String `performance. J Med Toxicol. 2006;2:93–6.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054281>
  <PgfTag `RefTextNrForts'>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
    <FFamily `Frutiger LT Std 55 Roman'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  7.5 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage UKEnglish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLanguage UKEnglish>
  > # end of Pgf
  <PgfNumString `139.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Font 
    <FTag `'>
    <FLanguage Swedish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 139Y2'>
    <MCurrPage `1349'>
    <Unique 1062346>
   > # end of Marker
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `Korttila K, Linnoila M. Skills related to driving '>
  > # end of ParaLine
  <ParaLine 
   <String `after intravenous diazepam, flunitrazepam or '>
  > # end of ParaLine
  <ParaLine 
   <String `droperidol. Br J Anaesth. 1974;46:961–9.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054282>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `140.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 140Y2'>
    <MCurrPage `1349'>
    <Unique 1062359>
   > # end of Marker
   <String `Brown AS. Neuroleptanalgesia. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Int Anesthesiol Clin. 1969;7:159–75.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054283>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `141.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 141Y2'>
    <MCurrPage `1349'>
    <Unique 1062372>
   > # end of Marker
   <String `Morrison JD. Drugs used in neuroleptanalgesia. '>
  > # end of ParaLine
  <ParaLine 
   <String `Int Anesthesiol Clin. 1969;7:141–57.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1073529>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `142.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <TextRectID 184>
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 142Y2'>
    <MCurrPage `1350'>
    <Unique 1073528>
   > # end of Marker
   <Font 
    <FTag `'>
    <FDW  -1.0%>
    <FLocked No>
   > # end of Font
   <String `Doenicke A, Kugler J, Schellenberger A, Gurtner '>
  > # end of ParaLine
  <ParaLine 
   <String `T. The use of electroencephalography to measure '>
  > # end of ParaLine
  <ParaLine 
   <String `re'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `covery time after intravenous anaesthesia. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Br J Anaesth. 1966;38:580–90.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054285>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `143.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 143Y2'>
    <MCurrPage `1350'>
    <Unique 1062398>
   > # end of Marker
   <String `Korttila K, Ghoneim MM, Jacobs L, Lakes RS. '>
  > # end of ParaLine
  <ParaLine 
   <String `Evaluation of instrumented force platform as a '>
  > # end of ParaLine
  <ParaLine 
   <String `test to measure residual effects of anesthetics. '>
  > # end of ParaLine
  <ParaLine 
   <String `Anesthesiology. 1981;55:625–30.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1070552>
  <PgfTag `RefTextNrForts'>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
    <FFamily `Frutiger LT Std 55 Roman'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  7.5 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage UKEnglish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLanguage UKEnglish>
  > # end of Pgf
  <PgfNumString `144.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Font 
    <FTag `'>
    <FLanguage Swedish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 144Y2'>
    <MCurrPage `1350'>
    <Unique 1070551>
   > # end of Marker
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `Martin JP, Sexton BF, Saunders BP, Atkin WS. In'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `haled patient-administered nitrous oxide/oxygen '>
  > # end of ParaLine
  <ParaLine 
   <String `mixture does not impair driving ability when '>
  > # end of ParaLine
  <ParaLine 
   <String `used as analgesia during screening flexible sig'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `moidoscopy. Gastrointest Endosc. 2000;51:701–3.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1070572>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `145.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 145Y2'>
    <MCurrPage `1350'>
    <Unique 1070571>
   > # end of Marker
   <String `Grant SA, Murdoch J, Millar K, Kenny GN. Blood '>
  > # end of ParaLine
  <ParaLine 
   <String `propofol concentration and psychomotor effects '>
  > # end of ParaLine
  <ParaLine 
   <String `on driving skills. Br J Anaesth. 2000;85:396–400.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1070596>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `146.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 146Y2'>
    <MCurrPage `1350'>
    <Unique 1070595>
   > # end of Marker
   <String `Riphaus A, Gstettenbauer T, Frenz MB, Wehr'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `mann T. Quality of psychomotor recovery after '>
  > # end of ParaLine
  <ParaLine 
   <String `propofol sedation for routine endoscopy: a ran'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `domized and controlled study. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Endoscopy. 2006;38:677–83.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054289>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `147.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 147Y2'>
    <MCurrPage `1350'>
    <Unique 1062450>
   > # end of Marker
   <String `Horiuchi A, Nakayama Y, Katsuyama Y, Ohmori '>
  > # end of ParaLine
  <ParaLine 
   <String `S, Ichise Y, Tanaka N. Safety and driving ability '>
  > # end of ParaLine
  <ParaLine 
   <String `following low-dose propofol sedation. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Digestion. 2008;78:190–4.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054290>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `148.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 148Y2'>
    <MCurrPage `1350'>
    <Unique 1062463>
   > # end of Marker
   <String `Seidl S, Hausmann R, Neisser J, Janisch HD, Betz '>
  > # end of ParaLine
  <ParaLine 
   <String `P. Severity and duration of mental deficiency '>
  > # end of ParaLine
  <ParaLine 
   <String `symptoms after intravenous administration of '>
  > # end of ParaLine
  <ParaLine 
   <String `propofol. Int J Legal Med. 2007;121:281–5.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054291>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `149.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 149Y2'>
    <MCurrPage `1350'>
    <Unique 1062476>
   > # end of Marker
   <String `Korttila K, Linnoila M, Ertama P, Hakkinen S. Re'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `covery and simulated driving after intravenous '>
  > # end of ParaLine
  <ParaLine 
   <String `anesthesia with thiopental, methohexital, propa'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `nidid, or alphadione. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Anesthesiology. 1975;43:291–9.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1070632>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `150.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 150Y2'>
    <MCurrPage `1350'>
    <Unique 1070631>
   > # end of Marker
   <String `Grisart JM, Plaghki LH. Impaired selective atten'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tion in chronic pain patients. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Eur J Pain. 1999;3:325–33.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1080925>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `151.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 151Y2'>
    <MCurrPage `1350'>
    <Unique 1080924>
   > # end of Marker
   <String `Apkarian AV, Sosa Y, Krauss BR, Thomas PS, '>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `Fredrickson BE, Levy RE, et al. Chronic pain '>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `patients are impaired on an emotional decision-'>
  > # end of ParaLine
  <ParaLine 
   <String `making task. Pain. 2004;108:129–36.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1080927>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `152.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 152Y2'>
    <MCurrPage `1350'>
    <Unique 1080926>
   > # end of Marker
   <String `Sjøgren P, Christrup LL, Petersen MA, Højsted J. '>
  > # end of ParaLine
  <ParaLine 
   <String `Neuropsychological assessment of chronic non-'>
  > # end of ParaLine
  <ParaLine 
   <String `malignant pain patients treated in a multidiscipli'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `nary pain centre. Eur J Pain. 2005;9:453–62.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054295>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `153.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 153Y2'>
    <MCurrPage `1350'>
    <Unique 1062528>
   > # end of Marker
   <Char Tab>
   <String `Hart RP, Martelli MF, Zasler ND. Chronic pain '>
  > # end of ParaLine
  <ParaLine 
   <String `and neuropsychological functioning. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `message URL http://www.ncbi.nlm.nih.gov/pubmed?term=hart%20rp%20and%20pain%20and%202000'>
    <MCurrPage `1350'>
    <Unique 1057234>
   > # end of Marker
   <String `Neuropsychol Rev. 2000;10:131–49.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054296>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `154.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 154Y2'>
    <MCurrPage `1350'>
    <Unique 1062541>
   > # end of Marker
   <String `Engeland A, Skurtveit S, Morland J. Risk of road '>
  > # end of ParaLine
  <ParaLine 
   <String `traffic accidents associated with the prescription '>
  > # end of ParaLine
  <ParaLine 
   <String `of drugs: a registry-based cohort study. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Ann Epidemiol. 2007;17:597–602.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1057270>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `155.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <TextRectID 184>
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 155Y2'>
    <MCurrPage `1350'>
    <Unique 1062554>
   > # end of Marker
   <String `Zacny JP. A review of the effects of opioids on '>
  > # end of ParaLine
  <ParaLine 
   <String `psychomotor and cognitive functioning in hu'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `mans. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `message URL http://psycnet.apa.org/index.cfm?fa=buy.optionToBuy&id=1996-10765-001'>
    <MCurrPage `1350'>
    <Unique 1057274>
   > # end of Marker
   <String `Exper Clin Psychopharmacol. 1995;3:432–66.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1057311>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `156.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 156Y2'>
    <MCurrPage `1350'>
    <Unique 1062567>
   > # end of Marker
   <String `Chapman SL, Byas-Smith MG, Reed BA. Effects '>
  > # end of ParaLine
  <ParaLine 
   <String `of intermediate- and long-term use of opioids on '>
  > # end of ParaLine
  <ParaLine 
   <String `cognition in patients with chronic pain. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `message URL http://www.ncbi.nlm.nih.gov/pubmed?term=chapman%20sl%20and%20chronic%20and%202002'>
    <MCurrPage `1350'>
    <Unique 1057315>
   > # end of Marker
   <String `Clin J Pain. 2002;18(4 Suppl):S83–90.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1070676>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `157.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 157Y2'>
    <MCurrPage `1350'>
    <Unique 1070675>
   > # end of Marker
   <String `Grodstein F, Skarupski KA, Bienias JL, Wilson RS, '>
  > # end of ParaLine
  <ParaLine 
   <String `Bennett DA, Evans DA. Anti-inflammatory agents '>
  > # end of ParaLine
  <ParaLine 
   <String `and cognitive decline in a bi-racial population. '>
  > # end of ParaLine
  <ParaLine 
   <String `Neuroepidemiology. 2008;30:45–50.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054300>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `158.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 158Y2'>
    <MCurrPage `1350'>
    <Unique 1062593>
   > # end of Marker
   <String `Kang JH, Cook N, Manson J, Buring JE, '>
  > # end of ParaLine
  <ParaLine 
   <String `Grodstein F. Low dose aspirin and cognitive func'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `tion in the women\qs health study cognitive co'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `hort. BMJ. 2007;334:987.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054301>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `159.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 159Y2'>
    <MCurrPage `1350'>
    <Unique 1062610>
   > # end of Marker
   <String `Sabatowski R, Schwalen S, Rettig K, Herberg '>
  > # end of ParaLine
  <ParaLine 
   <String `KW, Kasper SM, Radbruch L. Driving ability under '>
  > # end of ParaLine
  <ParaLine 
   <String `long-term treatment with transdermal fentanyl. '>
  > # end of ParaLine
  <ParaLine 
   <String `J Pain Symptom Manage. 2003;25:38–47.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1070698>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `160.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 160Y2'>
    <MCurrPage `1350'>
    <Unique 1070697>
   > # end of Marker
   <String `Dagtekin O, Gerbershagen HJ, Wagner W, Petz'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ke F, Radbruch L, Sabatowski R. Assessing cogniti'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ve and psychomotor performance under long-'>
  > # end of ParaLine
  <ParaLine 
   <String `term treatment with transdermal buprenorphine '>
  > # end of ParaLine
  <ParaLine 
   <String `in chronic noncancer pain patients. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Anesth Analg. 2007;105:1442–8.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054303>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `161.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 161Y2'>
    <MCurrPage `1350'>
    <Unique 1062636>
   > # end of Marker
   <String `Schneider U, Bevilacqua C, Jacobs R, Karst M, '>
  > # end of ParaLine
  <ParaLine 
   <String `Dietrich DE, Becker H, et al. Effects of fentanyl '>
  > # end of ParaLine
  <ParaLine 
   <String `and low doses of alcohol on neuropsychological '>
  > # end of ParaLine
  <ParaLine 
   <String `performance in healthy subjects. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Neuropsychobiology. 1999;39:38–43.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054733>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `162.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 162Y2'>
    <MCurrPage `1350'>
    <Unique 1062649>
   > # end of Marker
   <String `Jamison RN, Schein JR, Vallow S, Ascher S, '>
  > # end of ParaLine
  <ParaLine 
   <String `Vorsanger GJ, Katz NP. Neuropsychological ef'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `fects of long-term opioid use in chronic pain pa'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tients. J Pain Symptom Manage. 2003;26:913–21.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1070722>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `163.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 163Y2'>
    <MCurrPage `1350'>
    <Unique 1070721>
   > # end of Marker
   <String `Menefee LA, Frank ED, Crerand C, Jalali S, Park '>
  > # end of ParaLine
  <ParaLine 
   <String `J, Sanschagrin K, et al. The effects of transdermal '>
  > # end of ParaLine
  <ParaLine 
   <String `fentanyl on driving, cognitive performance, and '>
  > # end of ParaLine
  <ParaLine 
   <String `balance in patients with chronic non'>
   <Char DiscHyphen>
   <String `malignant '>
  > # end of ParaLine
  <ParaLine 
   <String `pain conditions. Pain Med. 2004;5:42–9.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054736>
  <PgfTag `RefTextNrForts'>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
    <FFamily `Frutiger LT Std 55 Roman'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  7.5 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage UKEnglish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <HyphenMaxLines 4>
   <PgfLanguage UKEnglish>
  > # end of Pgf
  <PgfNumString `164.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Font 
    <FTag `'>
    <FLanguage Swedish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 164Y2'>
    <MCurrPage `1350'>
    <Unique 1062675>
   > # end of Marker
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `Bachs LC, Engeland A, Morland JG, Skurtveit S. '>
  > # end of ParaLine
  <ParaLine 
   <String `The risk of motor vehicle accidents involving driv'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ers with prescriptions for codeine or tramadol. '>
  > # end of ParaLine
  <ParaLine 
   <String `Clin Pharmacol Ther. 2009;85:596–9.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054307>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `165.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 165Y2'>
    <MCurrPage `1350'>
    <Unique 1062688>
   > # end of Marker
   <String `Bradley CM, Nicholson AN. Effects of a mu-'>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `opioid receptor agonist (codeine phosphate) on '>
  > # end of ParaLine
  <ParaLine 
   <String `visuo-motor coordination and dynamic visual '>
  > # end of ParaLine
  <ParaLine 
   <String `acuity in man. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Br J Clin Pharmacol. 1986;22:507–12.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1070750>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `166.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 166Y2'>
    <MCurrPage `1350'>
    <Unique 1070749>
   > # end of Marker
   <String `Nilsen HK, Landrø NI, Jenssen GD, Dale O. Ef'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `fects of chronic non-malignant pain and a short-'>
  > # end of ParaLine
  <ParaLine 
   <String `acting opioid on performance in a driving simula'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tor. Eur J Pain. 2006;10 (Suppl 1):S179.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1070762>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `167.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <TextRectID 185>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 167Y2'>
    <MCurrPage `1351'>
    <Unique 1070761>
   > # end of Marker
   <String `Nilsen HK, Landrø NI, Kaasa S, Jenssen GD, '>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `Fayers P, Borchgrevink PC. Driving functions in a '>
  > # end of ParaLine
  <ParaLine 
   <String `video simulator in chronic non-malignant pain '>
  > # end of ParaLine
  <ParaLine 
   <String `patients using and not using codeine. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Eur J Pain. 2010;15:409–15.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054310>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `168.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 168Y2'>
    <MCurrPage `1351'>
    <Unique 1062745>
   > # end of Marker
   <String `Haythornthwaite JA, Menefee LA, Quatrano-'>
  > # end of ParaLine
  <ParaLine 
   <String `Piacentini AL, Pappagallo M. Outcome of chronic '>
  > # end of ParaLine
  <ParaLine 
   <String `opioid therapy for non-cancer pain. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `J Pain Symptom Manage. 1998;15:185–94.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054311>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `169.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 169Y2'>
    <MCurrPage `1351'>
    <Unique 1062758>
   > # end of Marker
   <String `Tassain V, Attal N, Fletcher D, Brasseur L, De'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `gieux P, Chauvin M, et al. Long term effects of '>
  > # end of ParaLine
  <ParaLine 
   <String `oral sustained release morphine on neuropsycho'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `logical performance in patients with chronic non-'>
  > # end of ParaLine
  <ParaLine 
   <String `cancer pain. Pain. 2003;104:389–400.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1070788>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `170.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 170Y2'>
    <MCurrPage `1351'>
    <Unique 1070787>
   > # end of Marker
   <String `Vainio A, Ollila J, Matikainen E, Rosenberg P, '>
  > # end of ParaLine
  <ParaLine 
   <String `Kalso E. Driving ability in cancer patients recei'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ving long-term morphine analgesia. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Lancet. 1995;346:667–70.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1070814>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `171.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 171Y2'>
    <MCurrPage `1351'>
    <Unique 1070813>
   > # end of Marker
   <String `Gaertner J, Radbruch L, Giesecke T, Gerbersha'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `gen H, Petzke F, Ostgathe C, et al. Assessing '>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `cognition and psychomotor function under long-'>
  > # end of ParaLine
  <ParaLine 
   <String `term treatment with controlled release '>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `oxycodone in non-cancer pain patients. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Acta Anaesthesiol Scand. 2006;50:664–72.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1070816>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `172.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 172Y2'>
    <MCurrPage `1351'>
    <Unique 1070815>
   > # end of Marker
   <String `Ng KF, Yuen TS, Ng VM. A comparison of post'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `operative cognitive function and pain relief with '>
  > # end of ParaLine
  <ParaLine 
   <String `fentanyl or tramadol patient-controlled analge'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `sia. J Clin Anesth. 2006;18:205–10.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054315>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `173.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 173Y2'>
    <MCurrPage `1351'>
    <Unique 1062810>
   > # end of Marker
   <String `Clarkson JE, Lacy JM, Fligner CL, Thiersch N, '>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `Howard J, Harruff RC, et al. Tramadol (Ultram) '>
  > # end of ParaLine
  <ParaLine 
   <String `concentrations in death investigation and impai'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `red driving cases and their significance. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `J Forensic Sci. 2004;49:1101–5.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1078427>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `174.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 174Y2'>
    <MCurrPage `1351'>
    <Unique 1078426>
   > # end of Marker
   <String `Goeringer KE, Logan BK, Christian GD. Identifi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `cation of tramadol and its metabolites in blood '>
  > # end of ParaLine
  <ParaLine 
   <String `from drug-related deaths and drug-impaired dri'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `vers. J Anal Toxicol. 1997;21:529–37.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1078429>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `175.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 175Y2'>
    <MCurrPage `1351'>
    <Unique 1078428>
   > # end of Marker
   <String `Sjöberg G, Tellerup M, Persson H. Symtom och '>
  > # end of ParaLine
  <ParaLine 
   <String `risker vid överdosering av tramadol. Gynnsam '>
  > # end of ParaLine
  <ParaLine 
   <String `övergång från dextropropoxifen till tramadol vi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `sar analys av 261 fall. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `Läkartidningen. 2010;107:1471–3.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1070830>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `176.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 176Y2'>
    <MCurrPage `1351'>
    <Unique 1070829>
   > # end of Marker
   <String `Gardner JS, Blough D, Drinkard CR, Shatin D, '>
  > # end of ParaLine
  <ParaLine 
   <String `Anderson G, Graham D, et al. Tramadol and sei'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `zures: a surveillance study in a managed care po'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `pulation. Pharmacotherapy. 2000;20:1423–31.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1070848>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `177.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 177Y2'>
    <MCurrPage `1351'>
    <Unique 1070847>
   > # end of Marker
   <String `Lerman Y, Matar M, Lavie B, Danon YL. '>
   <Char DiscHyphen>
   <String `Effect of '>
  > # end of ParaLine
  <ParaLine 
   <String `valvular heart diseases, migraine head'>
   <Char DiscHyphen>
   <String `aches, and '>
  > # end of ParaLine
  <ParaLine 
   <String `perianal diseases on the risk of involve'>
   <Char DiscHyphen>
   <String `ment in '>
  > # end of ParaLine
  <ParaLine 
   <String `motor vehicle crashes. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `J Trauma. 1995;39:1058–62.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1070870>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `178.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <TextRectID 185>
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 178Y2'>
    <MCurrPage `1351'>
    <Unique 1070869>
   > # end of Marker
   <String `Hooker WD, Raskin NH. Neuropsychologic alte'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `rations in classic and common migraine. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Arch Neurol. 1986;43:709–12.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1070872>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `179.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 179Y2'>
    <MCurrPage `1351'>
    <Unique 1070871>
   > # end of Marker
   <String `Coleston DM, Chronicle E, Ruddock KH, Ken'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `nard C. Precortical dysfunction of spatial and '>
  > # end of ParaLine
  <ParaLine 
   <String `temporal visual processing in migraine. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `J Neurol Neurosurg Psychiatry. 1994;57:1208–11.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1078435>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `180.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 180Y2'>
    <MCurrPage `1351'>
    <Unique 1078434>
   > # end of Marker
   <String `Zeitlin C, Oddy M. Cognitive impairment in pa'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tients with severe migraine. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Br J Clin Psychol. 1984;23 (Pt 1):27–35.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1078437>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `181.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 181Y2'>
    <MCurrPage `1351'>
    <Unique 1078436>
   > # end of Marker
   <String `Chronicle E, Mulleners W. Might migraine da'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `mage the brain? Cephalalgia. 1994;14:415–8.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1070908>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `182.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 182Y2'>
    <MCurrPage `1351'>
    <Unique 1070907>
   > # end of Marker
   <String `Chronicle EP, Wilkins AJ, Coleston DM. Thres'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `holds for detection of a target against a back'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ground grating suggest visual dysfunction in '>
  > # end of ParaLine
  <ParaLine 
   <String `migraine with aura but not migraine without au'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ra. Cephalalgia. 1995;15:117–22.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1078441>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `183.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 183Y2'>
    <MCurrPage `1351'>
    <Unique 1078440>
   > # end of Marker
   <String `Wray SH, Mijovic-Prelec D, Kosslyn SM. Visual '>
  > # end of ParaLine
  <ParaLine 
   <String `processing in migraineurs. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Brain. 1995;118 (Pt 1):25–35.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1078453>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `184.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 184Y2'>
    <MCurrPage `1351'>
    <Unique 1078452>
   > # end of Marker
   <String `Burker E, Hannay HJ, Halsey JH. Neuropsycholo'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `gical functioning and personality characteristics '>
  > # end of ParaLine
  <ParaLine 
   <String `of migrainous and nonmigrainous female college '>
  > # end of ParaLine
  <ParaLine 
   <String `students. Neuropsychology. 1989;3:61–73.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1078455>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `185.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 185Y2'>
    <MCurrPage `1351'>
    <Unique 1078454>
   > # end of Marker
   <String `Leijdekkers ML, Passchier J, Goudswaard P, '>
  > # end of ParaLine
  <ParaLine 
   <String `Menges LJ, Orlebeke JF. Migraine patients cogni'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tively impaired? Headache. 1990;30:352–8.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054328>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `186.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 186Y2'>
    <MCurrPage `1351'>
    <Unique 1062983>
   > # end of Marker
   <String `Gallagher RM, Kunkel R. Migraine medication '>
  > # end of ParaLine
  <ParaLine 
   <String `attributes important for patient compliance: con'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `cerns about side effects may delay treatment. '>
  > # end of ParaLine
  <ParaLine 
   <String `Headache. 2003;43:36–43.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054329>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `187.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 187Y2'>
    <MCurrPage `1351'>
    <Unique 1062996>
   > # end of Marker
   <String `Dodick DW, Martin V. Triptans and CNS side-'>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `effects: pharmacokinetic and metabolic mecha'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `nisms.'>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `message URL http://www.ncbi.nlm.nih.gov/pubmed/15154851'>
    <MCurrPage `1351'>
    <Unique 1057336>
   > # end of Marker
   <String ` '>
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <String `Cephalalgia. 2004;24:417–24.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1070988>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `188.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 188Y2'>
    <MCurrPage `1351'>
    <Unique 1070987>
   > # end of Marker
   <String `Keam SJ, Goa KL, Figgitt DP. Almotriptan: a re'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `view of its use in migraine. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Drugs. 2002;62:387–414.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054331>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `189.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 189Y2'>
    <MCurrPage `1351'>
    <Unique 1063022>
   > # end of Marker
   <String `Pascual J, Falk RM, Piessens F, Prusinski A, Doce'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `kal P, Robert M, et al. Consistent efficacy and to'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `lerability of almotriptan in the acute treatment '>
  > # end of ParaLine
  <ParaLine 
   <String `of multiple migraine attacks: results of a large, '>
  > # end of ParaLine
  <ParaLine 
   <String `randomized, double-blind, placebo-controlled '>
  > # end of ParaLine
  <ParaLine 
   <String `study. Cephalalgia. 2000;20:588–96.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054332>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `190.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 190Y2'>
    <MCurrPage `1351'>
    <Unique 1063035>
   > # end of Marker
   <String `Diener HC, Jansen JP, Reches A, Pascual J, Pitei '>
  > # end of ParaLine
  <ParaLine 
   <String `D, Steiner TJ. Efficacy, tolerability and safety of '>
  > # end of ParaLine
  <ParaLine 
   <String `oral eletriptan and ergotamine plus caffeine (Ca'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `fergot) in the acute treatment of migraine: a '>
  > # end of ParaLine
  <ParaLine 
   <String `multicentre, randomised, double-blind, placebo-'>
  > # end of ParaLine
  <ParaLine 
   <String `controlled comparison. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Eur Neurol. 2002;47:99–107.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054333>
  <PgfTag `RefTextNrForts'>
  <Pgf 
   <PgfPlacement ColumnTop>
  > # end of Pgf
  <PgfNumString `191.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <TextRectID 186>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 191Y2'>
    <MCurrPage `1352'>
    <Unique 1063048>
   > # end of Marker
   <String `Evers S, Ruschenschmidt J, Frese A, Rahmann A, '>
  > # end of ParaLine
  <ParaLine 
   <String `Husstedt IW. Impact of antimigraine compounds '>
  > # end of ParaLine
  <ParaLine 
   <String `on cognitive processing: a placebo-'>
   <Char DiscHyphen>
   <String `controlled '>
  > # end of ParaLine
  <ParaLine 
   <String `crossover study. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Headache. 2003;43:1102–8.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1073545>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `192.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Font 
    <FTag `'>
    <FDW  -1.5%>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 192Y2'>
    <MCurrPage `1352'>
    <Unique 1073544>
   > # end of Marker
   <String `Roon KI, Bakker D, van Poelgeest MI, van Buchem'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` '>
  > # end of ParaLine
  <ParaLine 
   <String `MA, Ferrari MD, Middelkoop HA. The influence '>
  > # end of ParaLine
  <ParaLine 
   <String `of ergotamine abuse on psychological and cogni'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tive functioning. Cephalalgia. 2000;20:462–9.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1071056>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `193.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 193Y2'>
    <MCurrPage `1352'>
    <Unique 1071055>
   > # end of Marker
   <String `van der Post J, Schram MT, Schoemaker RC, Pie'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ters MS, Fuseau E, Pereira A, et al. CNS effects of '>
  > # end of ParaLine
  <ParaLine 
   <String `sumatriptan and rizatriptan in healthy female vo'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `lunteers. Cephalalgia. 2002;22:271–81.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1071058>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `194.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 194Y2'>
    <MCurrPage `1352'>
    <Unique 1071057>
   > # end of Marker
   <String `Silberstein SD, Diener HC, McCarroll KA, '>
   <Char DiscHyphen>
   <String `Lines '>
  > # end of ParaLine
  <ParaLine 
   <String `CR. CNS effects of sumatriptan and rizatriptan. '>
  > # end of ParaLine
  <ParaLine 
   <String `Cephalalgia. 2004;24:78; author '>
   <Char DiscHyphen>
   <String `reply 78–9.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054337>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `195.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 195Y2'>
    <MCurrPage `1352'>
    <Unique 1063100>
   > # end of Marker
   <String `Asconape JJ. Some common issues in the use of '>
  > # end of ParaLine
  <ParaLine 
   <String `antiepileptic drugs. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Semin Neurol. 2002;22:27–39.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1078459>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `196.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 196Y2'>
    <MCurrPage `1352'>
    <Unique 1078458>
   > # end of Marker
   <String `Trimble MR. Anticonvulsant drugs and cognitive '>
  > # end of ParaLine
  <ParaLine 
   <String `function: a review of the literature. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Epilepsia. 1987;28(Suppl 3):S37–45.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1078461>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `197.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 197Y2'>
    <MCurrPage `1352'>
    <Unique 1078460>
   > # end of Marker
   <String `Cavanna AE, Ali F, Rickards HE, McCorry D. Be'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `havioral and cognitive effects of anti-epileptic '>
  > # end of ParaLine
  <ParaLine 
   <String `drugs. '>
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `message URL http://www.ncbi.nlm.nih.gov/pubmed/20193640'>
    <MCurrPage `1352'>
    <Unique 1078462>
   > # end of Marker
   <String `Discov Med. 2010;9:138–44.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1057406>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `198.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 198Y2'>
    <MCurrPage `1352'>
    <Unique 1063139>
   > # end of Marker
   <String `Czubak A, Nowakowska E, Burda K, Kus K, '>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `Metelska J. Cognitive effects of GABAergic antie'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `pileptic drugs. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `message URL http://www.ncbi.nlm.nih.gov/pubmed/20193640'>
    <MCurrPage `1352'>
    <Unique 1057415>
   > # end of Marker
   <String `Arzneimittelforschung. 2010;60:1–11.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054341>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `199.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 199Y2'>
    <MCurrPage `1352'>
    <Unique 1063152>
   > # end of Marker
   <String `Park SP, Kwon SH. Cognitive effects of antiepi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `leptic drugs.'>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `message URL http://www.ncbi.nlm.nih.gov/pubmed/19513311'>
    <MCurrPage `1352'>
    <Unique 1057426>
   > # end of Marker
   <String ` '>
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <String `J Clin Neurol. 2008;4:99–106.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1071134>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `200.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 200Y2'>
    <MCurrPage `1352'>
    <Unique 1071133>
   > # end of Marker
   <String `Besag FM. Behavioural effects of the newer '>
  > # end of ParaLine
  <ParaLine 
   <String `antiepileptic drugs: an update. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `message URL http://www.ncbi.nlm.nih.gov/pubmed/14680457'>
    <MCurrPage `1352'>
    <Unique 1071135>
   > # end of Marker
   <String `Expert Opin Drug Saf. 2004;3:1'>
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <String `–'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `8.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1071137>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `201.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 201Y2'>
    <MCurrPage `1352'>
    <Unique 1071136>
   > # end of Marker
   <String `Mandelbaum DE, Burack GD. The effect of sei'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `zure type and medication on cognitive and beha'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `vioral functioning in children with idiopathic '>
  > # end of ParaLine
  <ParaLine 
   <String `epilepsy. Dev Med Child Neurol. 1997;39:731–5.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054344>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `202.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 202Y2'>
    <MCurrPage `1352'>
    <Unique 1063191>
   > # end of Marker
   <String `Meador KJ, Loring DW, Moore EE, Thompson '>
  > # end of ParaLine
  <ParaLine 
   <String `WO, Nichols ME, Oberzan RE, et al. Comparative '>
  > # end of ParaLine
  <ParaLine 
   <String `cognitive effects of phenobarbital, phenytoin, '>
  > # end of ParaLine
  <ParaLine 
   <String `and valproate in healthy adults. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Neurology. 1995;45:1494–9.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054345>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `203.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 203Y2'>
    <MCurrPage `1352'>
    <Unique 1063204>
   > # end of Marker
   <String `Calandre EP, Dominguez-Granados R, Gomez-'>
  > # end of ParaLine
  <ParaLine 
   <String `Rubio M, Molina-Font JA. Cognitive effects of '>
  > # end of ParaLine
  <ParaLine 
   <String `long-term treatment with phenobarbital and val'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `proic acid in school children. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Acta Neurol Scand. 1990;81:504–6.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054346>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `204.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 204Y2'>
    <MCurrPage `1352'>
    <Unique 1063217>
   > # end of Marker
   <String `Cumbo E, Ligori LD. Levetiracetam, lamotrigine, '>
  > # end of ParaLine
  <ParaLine 
   <String `and phenobarbital in patients with epileptic sei'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `zures and Alzheimer\qs disease. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Epilepsy Behav. 2010;17:461–6.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054347>
  <PgfTag `RefTextNrForts'>
  <Pgf 
   <HyphenMaxLines 4>
  > # end of Pgf
  <PgfNumString `205.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <TextRectID 186>
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 205Y2'>
    <MCurrPage `1352'>
    <Unique 1063230>
   > # end of Marker
   <String `Tonekaboni SH, Beyraghi N, Tahbaz HS, Bahrey'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `nian SA, Aghamohammadpoor M. Neurocogniti'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ve effects of phenobarbital discontinuation in '>
  > # end of ParaLine
  <ParaLine 
   <String `epileptic children. Epilepsy Behav. 2006;8:145–8.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054348>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `206.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 206Y2'>
    <MCurrPage `1352'>
    <Unique 1063247>
   > # end of Marker
   <String `Huber B, Bocchicchio M, Hauser I, Horstmann V, '>
  > # end of ParaLine
  <ParaLine 
   <String `Jokeit G, May T, et al. Ambiguous results of an at'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tempt to withdraw barbiturates in epilepsy pa'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tients with intellectual disability. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Seizure. 2009;18(2):109–18.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054349>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `207.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 207Y2'>
    <MCurrPage `1352'>
    <Unique 1063260>
   > # end of Marker
   <String `Chen YJ, Kang WM, So WC. Comparison of '>
  > # end of ParaLine
  <ParaLine 
   <String `antiepileptic drugs on cognitive function in '>
  > # end of ParaLine
  <ParaLine 
   <String `newly diagnosed epileptic children: a psychome'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tric and neurophysiological study. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Epilepsia. 1996;37:81–6.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054350>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `208.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 208Y2'>
    <MCurrPage `1352'>
    <Unique 1063273>
   > # end of Marker
   <String `Meador KJ, Loring DW, Huh K, Gallagher BB, '>
  > # end of ParaLine
  <ParaLine 
   <String `King DW. Comparative cognitive effects of anti'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `convulsants. Neurology. 1990;40(3 Pt 1):391–4.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1078466>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `209.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 209Y2'>
    <MCurrPage `1352'>
    <Unique 1078465>
   > # end of Marker
   <String `Gallassi R, Morreale A, Di Sarro R, Marra M, '>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `Lugaresi E, Baruzzi A. Cognitive effects of anti'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `epileptic drug discontinuation. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Epilepsia. 1992;33(Suppl 6):S41–4.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1078468>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `210.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 210Y2'>
    <MCurrPage `1352'>
    <Unique 1078467>
   > # end of Marker
   <String `Sunmonu TA, Komolafe MA, Ogunrin AO, Ola'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `dimeji BY, Ogunniyi A. Intellectual impairment in '>
  > # end of ParaLine
  <ParaLine 
   <String `patients with epilepsy in Ile-Ife, Nigeria. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Acta Neurol Scand. 2008;118:395–401.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054353>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `211.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 211Y2'>
    <MCurrPage `1352'>
    <Unique 1063312>
   > # end of Marker
   <String `Aikia M, Kalviainen R, Sivenius J, Halonen T, '>
  > # end of ParaLine
  <ParaLine 
   <String `Riekkinen PJ. Cognitive effects of oxcarbazepine '>
  > # end of ParaLine
  <ParaLine 
   <String `and phenytoin monotherapy in newly diagnosed '>
  > # end of ParaLine
  <ParaLine 
   <String `epilepsy: one year follow-up. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Epilepsy Res. 1992;11:199–203.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054354>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `212.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 212Y2'>
    <MCurrPage `1352'>
    <Unique 1063325>
   > # end of Marker
   <String `Peterson BL. Prevalence of gabapentin in im'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `paired driving cases in Washington State in '>
  > # end of ParaLine
  <ParaLine 
   <String `2003–2007. J Anal Toxicol. 2009;33:545–9.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054355>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `213.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 213Y2'>
    <MCurrPage `1352'>
    <Unique 1063342>
   > # end of Marker
   <String `Dodrill CB, Arnett JL, Hayes AG, Garofalo EA, '>
  > # end of ParaLine
  <ParaLine 
   <String `Greeley CA, Greiner MJ, et al. Cognitive abilities '>
  > # end of ParaLine
  <ParaLine 
   <String `and adjustment with gabapentin: results of a '>
  > # end of ParaLine
  <ParaLine 
   <String `multisite study. Epilepsy Res. 1999;35:109–21.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054356>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `214.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 214Y2'>
    <MCurrPage `1352'>
    <Unique 1063355>
   > # end of Marker
   <String `Martin R, Kuzniecky R, Ho S, Hetherington H, '>
  > # end of ParaLine
  <ParaLine 
   <String `Pan J, Sinclair K, et al. Cognitive effects of topira'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `mate, gabapentin, and lamotrigine in healthy '>
  > # end of ParaLine
  <ParaLine 
   <String `young adults. Neurology. 1999;52:321–7.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054357>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `215.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 215Y2'>
    <MCurrPage `1352'>
    <Unique 1063368>
   > # end of Marker
   <String `Meador KJ, Loring DW, Ray PG, Murro AM, King '>
  > # end of ParaLine
  <ParaLine 
   <String `DW, Nichols ME, et al. Differential cognitive ef'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `fects of carbamazepine and gabapentin. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Epilepsia. 1999;40:1279–85.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054358>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `216.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 216Y2'>
    <MCurrPage `1352'>
    <Unique 1063381>
   > # end of Marker
   <String `Martin R, Meador K, Turrentine L, Faught E, Sin'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `clair K, Kuzniecky R, et al. Comparative cognitive '>
  > # end of ParaLine
  <ParaLine 
   <String `effects of carbamazepine and gabapentin in '>
  > # end of ParaLine
  <ParaLine 
   <String `healthy senior adults. Epilepsia. 2001;42:764–71.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1071231>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `217.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 217Y2'>
    <MCurrPage `1352'>
    <Unique 1071230>
   > # end of Marker
   <String `Salinsky MC, Binder LM, Oken BS, Storzbach D, '>
  > # end of ParaLine
  <ParaLine 
   <String `Aron CR, Dodrill CB. Effects of gabapentin and '>
  > # end of ParaLine
  <ParaLine 
   <String `carbamazepine on the EEG and cognition in heal'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `thy volunteers. Epilepsia. 2002;43:482–90.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054360>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `218.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <TextRectID 187>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 218Y2'>
    <MCurrPage `1353'>
    <Unique 1063407>
   > # end of Marker
   <String `Leach JP, Girvan J, Paul A, Brodie MJ. Gabapen'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tin and cognition: a double blind, dose ranging, '>
  > # end of ParaLine
  <ParaLine 
   <String `placebo controlled study in refractory epilepsy. J '>
  > # end of ParaLine
  <ParaLine 
   <String `Neurol Neurosurg Psychiatry. 1997;62:372–6.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054361>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `219.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 219Y2'>
    <MCurrPage `1353'>
    <Unique 1063420>
   > # end of Marker
   <String `Mortimore C, Trimble M, Emmers E. Effects of '>
  > # end of ParaLine
  <ParaLine 
   <String `gabapentin on cognition and quality of life in pa'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tients with epilepsy. Seizure. 1998;7:359–64.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1071239>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `220.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 220Y2'>
    <MCurrPage `1353'>
    <Unique 1071238>
   > # end of Marker
   <String `Donati F, Gobbi G, Campistol J, Rapatz G, '>
  > # end of ParaLine
  <ParaLine 
   <String `Daehler M, Sturm Y, et al. Effects of oxcarbazepi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ne on cognitive function in children and adoles'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `cents with partial seizures.'>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Neurology. 2006;67:679–82.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1077784>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `221.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 221Y2'>
    <MCurrPage `1353'>
    <Unique 1077783>
   > # end of Marker
   <String `Forsythe I, Butler R, Berg I, McGuire R. Cognitive '>
  > # end of ParaLine
  <ParaLine 
   <String `impairment in new cases of epilepsy randomly as'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `signed to carbamazepine, phenytoin and sodium '>
  > # end of ParaLine
  <ParaLine 
   <String `valproate. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Dev Med Child Neurol. 1991;33:524–34.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1077786>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `222.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 222Y2'>
    <MCurrPage `1353'>
    <Unique 1077785>
   > # end of Marker
   <String `Ramaekers G, Lamers J, Verhey F, Muntjewerff '>
  > # end of ParaLine
  <ParaLine 
   <String `D, Mobbs E, Sanders N, et al. A comparative study '>
  > # end of ParaLine
  <ParaLine 
   <String `of the effects of carbamazepine and the NMDA '>
  > # end of ParaLine
  <ParaLine 
   <String `receptor antagonist remacemide on road track'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ing and car-following performance in actual traf'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `fic. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Psychopharmacology (Berl). 2002;159:203–10.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054366>
  <PgfTag `RefTextNrForts'>
  <Pgf 
   <HyphenMaxLines 4>
  > # end of Pgf
  <PgfNumString `223.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 223Y2'>
    <MCurrPage `1353'>
    <Unique 1063485>
   > # end of Marker
   <String `Smith DB, Mattson RH, Cramer JA, Collins JF, '>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `Novelly RA, Craft B. Results of a nationwide Vete'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `rans Administration Cooperative Study compa'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ring the efficacy and toxicity of carbamazepine, '>
  > # end of ParaLine
  <ParaLine 
   <String `phenobarbital, phenytoin, and primidone. Epi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `lepsia. 1987;28(Suppl 3):S50–8.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054367>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `224.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 224Y2'>
    <MCurrPage `1353'>
    <Unique 1063498>
   > # end of Marker
   <String `dos Santos FM, Goncalves JC, Caminha R, da '>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `Silveira GE, Neves CS, Gram KR, et al. Pharmaco'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `kinetic/pharmacodynamic modeling of psycho'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `motor impairment induced by oral clonazepam '>
  > # end of ParaLine
  <ParaLine 
   <String `in healthy volunteers. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Ther Drug Monit. 2009;31:566–74.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054368>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `225.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 225Y2'>
    <MCurrPage `1353'>
    <Unique 1063511>
   > # end of Marker
   <String `Cohen AF, Ashby L, Crowley D, Land G, Peck AW, '>
  > # end of ParaLine
  <ParaLine 
   <String `Miller AA. Lamotrigine (BW430C), a potential an'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ticonvulsant. Effects on the central nervous sys'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tem in comparison with phenytoin and '>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `diazepam. Br J Clin Pharmacol. 1985;20:619–29.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054369>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `226.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 226Y2'>
    <MCurrPage `1353'>
    <Unique 1063524>
   > # end of Marker
   <String `Mills KC, Drazkowski JF, Hammer AE, Caldwell '>
  > # end of ParaLine
  <ParaLine 
   <String `PT, Kustra RP, Blum DE. Relative influences of ad'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `junctive topiramate and adjunctive lamotri'>
   <Char DiscHyphen>
   <String `gine '>
  > # end of ParaLine
  <ParaLine 
   <String `on scanning and the effective field of view. Epi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `lepsy Res. 2008;78:140–6.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1078472>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `227.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 227Y2'>
    <MCurrPage `1353'>
    <Unique 1078471>
   > # end of Marker
   <String `Aldenkamp AP, Mulder OG, Overweg J. Cogniti'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ve effects of lamotrigine as first-line add-on in '>
  > # end of ParaLine
  <ParaLine 
   <String `patients with localization-related (partial) epi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `lepsy. J Epilepsy. 1997;10:117–21.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1078474>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `228.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 228Y2'>
    <MCurrPage `1353'>
    <Unique 1078473>
   > # end of Marker
   <String `Blum D, Meador K, Biton V, Fakhoury T, Shneker '>
  > # end of ParaLine
  <ParaLine 
   <String `B, Chung S, et al. Cognitive effects of lamotri'>
   <Char DiscHyphen>
   <String `gine '>
  > # end of ParaLine
  <ParaLine 
   <TextRectID 187>
   <String `compared with topiramate in patients with epi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `lepsy. Neurology. 2006;67:400–6.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1071324>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `229.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 229Y2'>
    <MCurrPage `1353'>
    <Unique 1071323>
   > # end of Marker
   <String `Meador KJ, Loring DW, Vahle VJ, Ray PG, Werz '>
  > # end of ParaLine
  <ParaLine 
   <String `MA, Fessler AJ, et al. Cognitive and behavioral ef'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `fects of lamotrigine and topiramate in '>
   <Char DiscHyphen>
   <String `healthy '>
  > # end of ParaLine
  <ParaLine 
   <String `volunteers. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Neurology. 2005;64:2108–14.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1071326>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `230.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 230Y2'>
    <MCurrPage `1353'>
    <Unique 1071325>
   > # end of Marker
   <String `Gillham R, Kane K, Bryant-Comstock L, '>
   <Char DiscHyphen>
   <String `Brodie '>
  > # end of ParaLine
  <ParaLine 
   <String `MJ. A double-blind comparison of lamotrigine '>
  > # end of ParaLine
  <ParaLine 
   <String `and carbamazepine in newly diagnosed epi'>
   <Char DiscHyphen>
   <String `lepsy '>
  > # end of ParaLine
  <ParaLine 
   <String `with health-related quality of life as an outcome '>
  > # end of ParaLine
  <ParaLine 
   <String `measure. Seizure. 2000;9:375–9.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054374>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `231.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 231Y2'>
    <MCurrPage `1353'>
    <Unique 1063593>
   > # end of Marker
   <String `Aldenkamp AP, Arends J, Bootsma HP, Diepman '>
  > # end of ParaLine
  <ParaLine 
   <String `L, Hulsman J, Lambrechts D, et al. Randomized '>
  > # end of ParaLine
  <ParaLine 
   <String `double-blind parallel-group study comparing '>
  > # end of ParaLine
  <ParaLine 
   <String `cognitive effects of a low-dose lamotrigine with '>
  > # end of ParaLine
  <ParaLine 
   <String `valproate and placebo in healthy volunteers. Epi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `lepsia. 2002;43:19–26.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054375>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `232.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 232Y2'>
    <MCurrPage `1353'>
    <Unique 1063606>
   > # end of Marker
   <String `Smith ME, Gevins A, McEvoy LK, Meador KJ, Ray '>
  > # end of ParaLine
  <ParaLine 
   <String `PG, Gilliam F. Distinct cognitive neurophysiologic '>
  > # end of ParaLine
  <ParaLine 
   <String `profiles for lamotrigine and topiramate. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Epilepsia. 2006;47:695–703.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1071349>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `233.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 233Y2'>
    <MCurrPage `1353'>
    <Unique 1071348>
   > # end of Marker
   <Font 
    <FTag `'>
    <FDW  -0.5%>
    <FLocked No>
   > # end of Font
   <String `Hamilton MJ, Cohen AF, Yuen AW, Harkin N, '>
  > # end of ParaLine
  <ParaLine 
   <String `Land G, Weatherley BC, et al. Carbamazepine and '>
  > # end of ParaLine
  <ParaLine 
   <String `lamotrigine in healthy volunteers: relevance to '>
  > # end of ParaLine
  <ParaLine 
   <String `early tolerance and clinical trial dosage. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Epilepsia. 1993;34:166–73.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054377>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `234.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 234Y2'>
    <MCurrPage `1353'>
    <Unique 1063632>
   > # end of Marker
   <String `Meador KJ, Loring DW, Ray PG, Murro AM, King '>
  > # end of ParaLine
  <ParaLine 
   <String `DW, Perrine KR, et al. Differential cognitive and '>
  > # end of ParaLine
  <ParaLine 
   <String `behavioral effects of carbamazepine and lamotri'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `gine. Neurology. 2001;56:1177–82.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054378>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `235.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 235Y2'>
    <MCurrPage `1353'>
    <Unique 1063645>
   > # end of Marker
   <String `Smith D, Baker G, Davies G, Dewey M, Chadwick '>
  > # end of ParaLine
  <ParaLine 
   <String `DW. Outcomes of add-on treatment with '>
  > # end of ParaLine
  <ParaLine 
   <String `lamotri'>
   <Char DiscHyphen>
   <String `gine in partial epilepsy. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Epilepsia. 1993;34:312–22.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054379>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `236.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 236Y2'>
    <MCurrPage `1353'>
    <Unique 1063658>
   > # end of Marker
   <String `Ciesielski AS, Samson S, Steinhoff BJ. Neuropsy'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `chological and psychiatric impact of add-on '>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `titration of pregabalin versus levetiracetam: a '>
  > # end of ParaLine
  <ParaLine 
   <String `comparative short-term study. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Epilepsy Behav. 2006;9:424–31.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054380>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `237.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 237Y2'>
    <MCurrPage `1353'>
    <Unique 1063671>
   > # end of Marker
   <String `Zhou B, Zhang Q, Tian L, Xiao J, Stefan H, Zhou '>
  > # end of ParaLine
  <ParaLine 
   <String `D. Effects of levetiracetam as an add-on therapy '>
  > # end of ParaLine
  <ParaLine 
   <String `on cognitive function and quality of life in pa'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tients with refractory partial seizures. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Epilepsy Behav. 2008;12:305–10.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054381>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `238.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 238Y2'>
    <MCurrPage `1353'>
    <Unique 1063684>
   > # end of Marker
   <String `Piazzini A, Chifari R, Canevini MP, Turner K, '>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `Fontana SP, Canger R. Levetiracetam: an improve'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ment of attention and of oral fluency in patients '>
  > # end of ParaLine
  <ParaLine 
   <String `with partial epilepsy. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Epilepsy Res. 2006;68:181–8.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054382>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `239.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 239Y2'>
    <MCurrPage `1353'>
    <Unique 1063697>
   > # end of Marker
   <String `Helmstaedter C, Witt JA. The effects of levetira'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `cetam on cognition: a non-interventional surveil'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `lance study. Epilepsy Behav. 2008;13:642–9.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054383>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `240.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <TextRectID 188>
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 240Y2'>
    <MCurrPage `1354'>
    <Unique 1063710>
   > # end of Marker
   <String `Lopez-Gongora M, Martinez-Domeno A, Garcia '>
  > # end of ParaLine
  <ParaLine 
   <String `C, Escartin A. Effect of levetiracetam on cognitive '>
  > # end of ParaLine
  <ParaLine 
   <String `functions and quality of life: a one-year '>
   <Char DiscHyphen>
   <String `follow-'>
  > # end of ParaLine
  <ParaLine 
   <String `up study. Epileptic Disord. 2008;10:297–305.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1071425>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `241.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 241Y2'>
    <MCurrPage `1354'>
    <Unique 1071424>
   > # end of Marker
   <String `Helmstaedter C, Fritz NE, Kockelmann E, Kosa'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `netzky N, Elger CE. Positive and negative psycho'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tropic effects of levetiracetam. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Epilepsy Behav. 2008;13:535–41.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1071427>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `242.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 242Y2'>
    <MCurrPage `1354'>
    <Unique 1071426>
   > # end of Marker
   <String `White JR, Walczak TS, Leppik IE, Rarick J, Tran T, '>
  > # end of ParaLine
  <ParaLine 
   <String `Beniak TE, et al. Discontinuation of levetiracetam '>
  > # end of ParaLine
  <ParaLine 
   <String `because of behavioral side effects: a case-control '>
  > # end of ParaLine
  <ParaLine 
   <String `study. Neurology. 2003;61:1218–21.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1071437>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `243.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 243Y2'>
    <MCurrPage `1354'>
    <Unique 1071436>
   > # end of Marker
   <String `Weintraub D, Buchsbaum R, Resor SR, Jr, Hirsch '>
  > # end of ParaLine
  <ParaLine 
   <String `LJ. Psychiatric and behavioral side effects of the '>
  > # end of ParaLine
  <ParaLine 
   <String `newer antiepileptic drugs in adults with epi'>
   <Char DiscHyphen>
   <String `lepsy. '>
  > # end of ParaLine
  <ParaLine 
   <String `Epilepsy Behav. 2007;10:105–10.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054387>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `244.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 244Y2'>
    <MCurrPage `1354'>
    <Unique 1063762>
   > # end of Marker
   <String `Hurtado B, Koepp MJ, Sander JW, Thompson PJ. '>
  > # end of ParaLine
  <ParaLine 
   <String `The impact of levetiracetam on challeng'>
   <Char DiscHyphen>
   <String `ing be'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `havior. Epilepsy Behav. 2006;8:588–92.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1071451>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `245.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 245Y2'>
    <MCurrPage `1354'>
    <Unique 1071450>
   > # end of Marker
   <String `Dinkelacker V, Dietl T, Widman G, Lengler U, El'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ger CE. Aggressive behavior of epilepsy patients '>
  > # end of ParaLine
  <ParaLine 
   <String `in the course of levetiracetam add-on therapy: '>
  > # end of ParaLine
  <ParaLine 
   <String `report of 33 mild to severe cases. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Epilepsy Behav. 2003;4:537–47.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1077817>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `246.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 246Y2'>
    <MCurrPage `1354'>
    <Unique 1077816>
   > # end of Marker
   <String `Sabers A, Moller A, Dam M, Smed A, Arlien-So'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `borg P, Buchman J, et al. Cognitive function and '>
  > # end of ParaLine
  <ParaLine 
   <String `anticonvulsant therapy: effect of monotherapy in '>
  > # end of ParaLine
  <ParaLine 
   <String `epilepsy. Acta Neurol Scand. 1995;92:19–27.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1077824>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `247.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 247Y2'>
    <MCurrPage `1354'>
    <Unique 1077832>
   > # end of Marker
   <String `McKee PJ, Blacklaw J, Forrest G, Gillham RA, '>
  > # end of ParaLine
  <ParaLine 
   <String `Walker SM, Connelly D, et al. A double-blind, pla'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `cebo-controlled interaction study between ox'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `carbazepine and carbamazepine, sodium '>
  > # end of ParaLine
  <ParaLine 
   <String `valproate and phenytoin in epileptic patients. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Br J Clin Pharmacol. 1994;37:27–32.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1077819>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `248.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 248Y2'>
    <MCurrPage `1354'>
    <Unique 1077818>
   > # end of Marker
   <String `Hindmarch I, Trick L, Ridout F. A double-blind, '>
  > # end of ParaLine
  <ParaLine 
   <String `placebo- and positive-internal-controlled (alpra'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `zolam) investigation of the cognitive and psycho'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `motor profile of pregabalin in healthy '>
  > # end of ParaLine
  <ParaLine 
   <String `volunteers. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Psychopharmacology (Berl). 2005;183:133–43.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054391>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `249.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 249Y2'>
    <MCurrPage `1354'>
    <Unique 1063814>
   > # end of Marker
   <String `Salinsky M, Storzbach D, Munoz S. Cognitive ef'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `fects of pregabalin in healthy volunteers: a '>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `double-blind, placebo-controlled trial. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Neurology. 2010;74:755–61.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1071485>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `250.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 250Y2'>
    <MCurrPage `1354'>
    <Unique 1071484>
   > # end of Marker
   <String `Aldenkamp AP, Alpherts WC. The effect of the '>
  > # end of ParaLine
  <ParaLine 
   <String `new antiepileptic drug rufinamide on cognitive '>
  > # end of ParaLine
  <ParaLine 
   <String `functions. Epilepsia. 2006;47:1153–9.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1071493>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `251.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 251Y2'>
    <MCurrPage `1354'>
    <Unique 1071492>
   > # end of Marker
   <String `Salinsky MC, Storzbach D, Spencer DC, Oken BS, '>
  > # end of ParaLine
  <ParaLine 
   <String `Landry T, Dodrill CB. Effects of topiramate and '>
  > # end of ParaLine
  <ParaLine 
   <String `gabapentin on cognitive abilities in healthy '>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `volunteers. Neurology. 2005;64:792–8.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054394>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `252.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 252Y2'>
    <MCurrPage `1354'>
    <Unique 1063857>
   > # end of Marker
   <String `Kockelmann E, Elger CE, Helmstaedter C. Cogni'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tive profile of topiramate as compared with la'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <TextRectID 188>
   <String `motrigine in epilepsy patients on antiepileptic '>
  > # end of ParaLine
  <ParaLine 
   <String `drug polytherapy: relationships to blood serum '>
  > # end of ParaLine
  <ParaLine 
   <String `levels and comedication. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Epilepsy Behav. 2004;5:716–21.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054395>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `253.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 253Y2'>
    <MCurrPage `1354'>
    <Unique 1063870>
   > # end of Marker
   <String `Meador KJ, Loring DW, Hulihan JF, Kamin M, '>
  > # end of ParaLine
  <ParaLine 
   <String `Karim R. Differential cognitive and behavioral ef'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `fects of topiramate and valproate. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Neurology. 2003;60:1483–8.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1078478>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `254.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 254Y2'>
    <MCurrPage `1354'>
    <Unique 1078477>
   > # end of Marker
   <String `Aldenkamp AP, De Krom M, Reijs R. Newer '>
  > # end of ParaLine
  <ParaLine 
   <String `antiepileptic drugs and cognitive issues. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Epilepsia. 2003;44(Suppl 4):21–9.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1078480>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `255.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 255Y2'>
    <MCurrPage `1354'>
    <Unique 1078479>
   > # end of Marker
   <String `Loring DW, Williamson DJ, Meador KJ, Wiegand '>
  > # end of ParaLine
  <ParaLine 
   <String `F, Hulihan J. Topiramate dose effects on cogni'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tion: a randomized double-blind study. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Neurology. 2011;76:131–7.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054398>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `256.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 256Y2'>
    <MCurrPage `1354'>
    <Unique 1063909>
   > # end of Marker
   <String `Bramness JG, Skurtveit S, Neutel CI, Morland J, '>
  > # end of ParaLine
  <ParaLine 
   <String `Engeland A. An increased risk of road traffic '>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `accidents after prescriptions of lithium or valpro'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ate? '>
   <Font 
    <FTag `'>
    <FDW  -1.0%>
    <FLocked No>
   > # end of Font
   <String `Pharmacoepidemiol Drug Saf. 2009;18:492–6.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1073561>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `257.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 257Y2'>
    <MCurrPage `1354'>
    <Unique 1073560>
   > # end of Marker
   <String `Hessen E, Lossius MI, Reinvang I, Gjerstad L. In'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `fluence of major antiepileptic drugs on atten'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tion, reaction time, and speed of information '>
  > # end of ParaLine
  <ParaLine 
   <String `processing: results from a randomized, double-'>
  > # end of ParaLine
  <ParaLine 
   <String `blind, placebo-controlled withdrawal study of '>
  > # end of ParaLine
  <ParaLine 
   <String `seizure-free epilepsy patients receiving mono'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `therapy. Epilepsia. 2006;47:2038–45.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1073563>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `258.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 258Y2'>
    <MCurrPage `1354'>
    <Unique 1073562>
   > # end of Marker
   <String `Dodrill CB, Arnett JL, Sommerville KW, Sussman '>
  > # end of ParaLine
  <ParaLine 
   <String `NM. Effects of differing dosages of vigabatrin '>
  > # end of ParaLine
  <ParaLine 
   <String `(Sabril) on cognitive abilities and quality of life in '>
  > # end of ParaLine
  <ParaLine 
   <String `epilepsy. Epilepsia. 1995;36:164–73.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1071555>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `259.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 259Y2'>
    <MCurrPage `1354'>
    <Unique 1071554>
   > # end of Marker
   <String `Dodrill CB, Arnett JL, Sommerville KW, Sussman '>
  > # end of ParaLine
  <ParaLine 
   <String `NM. Evaluation of the effects of vigabatrin on '>
  > # end of ParaLine
  <ParaLine 
   <String `cognitive abilities and quality of life in epilepsy. '>
  > # end of ParaLine
  <ParaLine 
   <String `Neurology. 1993;43:2501–7.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1071557>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `260.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 260Y2'>
    <MCurrPage `1354'>
    <Unique 1071556>
   > # end of Marker
   <String `McGuire AM, Duncan JS, Trimble MR. Effects of '>
  > # end of ParaLine
  <ParaLine 
   <String `vigabatrin on cognitive function and mood when '>
  > # end of ParaLine
  <ParaLine 
   <String `used as add-on therapy in patients with intracta'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ble epilepsy. Epilepsia. 1992;33:128–34.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054403>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `261.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 261Y2'>
    <MCurrPage `1354'>
    <Unique 1063974>
   > # end of Marker
   <String `Kalviainen R, Aikia M, Saukkonen AM, Mer'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `vaala E, Riekkinen PJ, Sr. Vigabatrin vs carbama'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `zepine monotherapy in patients with newly '>
  > # end of ParaLine
  <ParaLine 
   <String `diagnosed epilepsy. A randomized, controlled '>
  > # end of ParaLine
  <ParaLine 
   <String `study. Arch Neurol. 1995;52:989–96.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054404>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `262.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 262Y2'>
    <MCurrPage `1354'>
    <Unique 1063987>
   > # end of Marker
   <String `Frisén L. Vigabatrin-associated loss of vision: '>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `rarebit perimetry illuminates the dose-damage '>
  > # end of ParaLine
  <ParaLine 
   <String `relationship. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Acta Ophthalmol Scand. 2004;82:54–8.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054405>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `263.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 263Y2'>
    <MCurrPage `1354'>
    <Unique 1064000>
   > # end of Marker
   <Char Tab>
   <String `Park SP, Hwang YH, Lee HW, Suh CK, Kwon SH, '>
  > # end of ParaLine
  <ParaLine 
   <String `Lee BI. Long-term cognitive and mood effects of '>
  > # end of ParaLine
  <ParaLine 
   <String `zonisamide monotherapy in epilepsy patients. '>
  > # end of ParaLine
  <ParaLine 
   <String `Epilepsy Behav. 2008;12:102–8.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1071582>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `264.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <TextRectID 189>
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 264Y2'>
    <MCurrPage `1355'>
    <Unique 1071581>
   > # end of Marker
   <Font 
    <FTag `'>
    <FDW  -0.5%>
    <FLocked No>
   > # end of Font
   <String `Homann CN, Suppan K, Homann B, Crevenna R, '>
  > # end of ParaLine
  <ParaLine 
   <String `Ivanic G, Ruzicka E. Driving in Parkinson\qs '>
   <Char DiscHyphen>
   <String `disease '>
  > # end of ParaLine
  <ParaLine 
   <String `– a health hazard? J Neurol. 2003;250:1439–46.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1071600>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `265.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 265Y2'>
    <MCurrPage `1355'>
    <Unique 1071599>
   > # end of Marker
   <String `Kumar S, Bhatia M, Behari M. Excessive daytime '>
  > # end of ParaLine
  <ParaLine 
   <String `sleepiness in Parkinson\qs disease as '>
   <Char DiscHyphen>
   <String `assessed by '>
  > # end of ParaLine
  <ParaLine 
   <String `Epworth Sleepiness Scale (ESS).'>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String ` Sleep Med. 2003;4:339–42.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1071632>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `266.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 266Y2'>
    <MCurrPage `1355'>
    <Unique 1071631>
   > # end of Marker
   <String `Hobson DE, Lang AE, Martin WR, Razmy A, '>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `Rivest J, Fleming J. Excessive daytime sleepiness '>
  > # end of ParaLine
  <ParaLine 
   <String `and sudden-onset sleep in Parkinson dis'>
   <Char DiscHyphen>
   <String `ease: a '>
  > # end of ParaLine
  <ParaLine 
   <String `survey by the Canadian Movement Disorders Gro'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `up. JAMA. 2002;287:455–63.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1071646>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `267.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 267Y2'>
    <MCurrPage `1355'>
    <Unique 1071645>
   > # end of Marker
   <String `Olanow CW, Schapira AH, Roth T. Waking up to '>
  > # end of ParaLine
  <ParaLine 
   <String `sleep episodes in Parkinson\qs disease. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Mov Disord. 2000;15:212–5.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1071648>
  <PgfTag `RefTextNrForts'>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
    <FFamily `Frutiger LT Std 55 Roman'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  7.5 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage UKEnglish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLanguage UKEnglish>
  > # end of Pgf
  <PgfNumString `268.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Font 
    <FTag `'>
    <FLanguage Swedish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 268Y2'>
    <MCurrPage `1355'>
    <Unique 1071647>
   > # end of Marker
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `Kales A, Ansel RD, Markham CH, Scharf MB, Tan '>
  > # end of ParaLine
  <ParaLine 
   <String `TL. Sleep in patients with Parkinson\qs disease and '>
  > # end of ParaLine
  <ParaLine 
   <String `normal subjects prior to and following levo'>
   <Char DiscHyphen>
   <String `dopa '>
  > # end of ParaLine
  <ParaLine 
   <String `administration. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Clin Pharmacol Ther. 1971;12:397–406.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1088861>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `269.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 269Y2'>
    <MCurrPage `1355'>
    <Unique 1088860>
   > # end of Marker
   <String `Nausieda PA, Weiner WJ, Kaplan LR, Weber S, '>
  > # end of ParaLine
  <ParaLine 
   <String `Klawans HL. Sleep disruption in the course of '>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `chronic levodopa therapy: an early feature of the '>
  > # end of ParaLine
  <ParaLine 
   <String `levodopa psychosis. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Clin Neuropharmacol. 1982;5:183–94.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054412>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `270.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 270Y2'>
    <MCurrPage `1355'>
    <Unique 1064091>
   > # end of Marker
   <String `Meindorfner C, Korner Y, Moller JC, Stiasny-'>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `Kolster K, Oertel WH, Kruger HP. Driving in '>
  > # end of ParaLine
  <ParaLine 
   <String `Parkinson\qs disease: mobility, accidents, and sud'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `den onset of sleep at the wheel. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Mov Disord. 2005;20:832–42.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054413>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `271.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 271Y2'>
    <MCurrPage `1355'>
    <Unique 1064104>
   > # end of Marker
   <String `Hoehn MM, Yahr MD. Parkinsonism: onset, pro'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `gression and mortality. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Neurology. 1967;17:427–42.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054414>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `272.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 272Y2'>
    <MCurrPage `1355'>
    <Unique 1064117>
   > # end of Marker
   <String `Zesiewicz TA, Cimino CR, Malek AR, Gardner N, '>
  > # end of ParaLine
  <ParaLine 
   <String `Leaverton PL, Dunne PB, et al. Driving safety in '>
  > # end of ParaLine
  <ParaLine 
   <String `Parkinson\qs disease. Neurology. 2002;59:1787–8.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054415>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `273.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 273Y2'>
    <MCurrPage `1355'>
    <Unique 1064130>
   > # end of Marker
   <String `Heikkila VM, Turkka J, Korpelainen J, Kallanran'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ta T, Summala H. Decreased driving ability in '>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `people with Parkinson\qs disease. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `J Neurol Neurosurg Psychiatry. 1998;64:325–30.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054416>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `274.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 274Y2'>
    <MCurrPage `1355'>
    <Unique 1064143>
   > # end of Marker
   <String `Klimkeit EI, Bradshaw JL, Charlton J, Stolwyk R, '>
  > # end of ParaLine
  <ParaLine 
   <String `Georgiou-Karistianis N. Driving ability in Parkin'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `son\qs disease: current status of research.'>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String ` '>
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `message URL http://www.ncbi.nlm.nih.gov/pubmed?term=klimkeit%20ei%20and%20driving%20and%202009'>
    <MCurrPage `1355'>
    <Unique 1057475>
   > # end of Marker
   <String `Neurosci Biobehav Rev. 2009;33:223–31.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1088897>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `275.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 275Y2'>
    <MCurrPage `1355'>
    <Unique 1088896>
   > # end of Marker
   <String `Cooper JA, Sagar HJ, Doherty SM, Jordan N, '>
  > # end of ParaLine
  <ParaLine 
   <String `Tidswell P, Sullivan EV. Different effects of dopa'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `minergic and anticholinergic therapies on cogni'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tive and motor function in Parkinson\qs disease. '>
  > # end of ParaLine
  <ParaLine 
   <String `A'>
   <Char HardSpace>
   <String `follow-up study of untreated patients. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Brain. 1992;115 ( Pt 6):1701–25.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1078486>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `276.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 276Y2'>
    <MCurrPage `1355'>
    <Unique 1078485>
   > # end of Marker
   <String `Serby M, Angrist B, Lieberman A. Psychiatric ef'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `fects of bromocriptine and lergotrile in Parkinso'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <TextRectID 189>
   <String `nian patients. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `'>
    <FDW  -0.5%>
    <FLocked No>
   > # end of Font
   <String `Adv Biochem Psychopharmacol. 1980;23:287–92.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1071726>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `277.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 277Y2'>
    <MCurrPage `1355'>
    <Unique 1071725>
   > # end of Marker
   <String `Piccirilli M, Piccinin GL, D\qAlessandro P, Finali G, '>
  > # end of ParaLine
  <ParaLine 
   <String `Piccolini C, Scarcella MG, et al. Cognitive perfor'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `mances in parkinsonians before and after bromo'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `criptine therapy. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Acta Neurol (Napoli). 1986;8:167–72.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1071728>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `278.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 278Y2'>
    <MCurrPage `1355'>
    <Unique 1071727>
   > # end of Marker
   <String `Parashos SA, Wielinski CL, Kern JA. Frequency, '>
  > # end of ParaLine
  <ParaLine 
   <String `reasons, and risk factors of entacapone disconti'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `nuation in Parkinson disease. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Clin Neuropharmacol. 2004;27:119–23.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054745>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `279.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 279Y2'>
    <MCurrPage `1355'>
    <Unique 1064212>
   > # end of Marker
   <String `Avanzi M, Baratti M, Cabrini S, Uber E, Brighetti '>
  > # end of ParaLine
  <ParaLine 
   <String `G, Bonfa F. The thrill of reckless driving in pa'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tients with Parkinson\qs disease: an additional be'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `havioural phenomenon in dopamine '>
  > # end of ParaLine
  <ParaLine 
   <String `dysregulation syndrome? '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Parkinsonism Relat Disord. 2008;14:257–8.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1071756>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `280.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 280Y2'>
    <MCurrPage `1355'>
    <Unique 1071755>
   > # end of Marker
   <String `Pal S, Bhattacharya KF, Agapito C, Chaudhuri '>
  > # end of ParaLine
  <ParaLine 
   <String `KR. A study of excessive daytime sleepiness and '>
  > # end of ParaLine
  <ParaLine 
   <String `its clinical significance in three groups of Parkin'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `son\qs disease patients taking pramipexole, caber'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `goline and levodopa mono and combination '>
  > # end of ParaLine
  <ParaLine 
   <String `therapy. J Neural Transm. 2001;108:71–7.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1071780>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `281.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 281Y2'>
    <MCurrPage `1355'>
    <Unique 1071779>
   > # end of Marker
   <String `Hamidovic A, Kang UJ, de Wit H. Effects of low '>
  > # end of ParaLine
  <ParaLine 
   <String `to moderate acute doses of pramipexole on im'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `pulsivity and cognition in healthy volunteers. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `J Clin Psychopharmacol. 2008;28:45–51.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1071782>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `282.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 282Y2'>
    <MCurrPage `1355'>
    <Unique 1071781>
   > # end of Marker
   <String `Elmer L, Schwid S, Eberly S, Goetz C, Fahn S, Kie'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `burtz K, et al. Rasagiline-associated motor impro'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `vement in PD occurs without worsening of '>
  > # end of ParaLine
  <ParaLine 
   <String `cognitive and behavioral symptoms. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `J Neurol Sci. 2006;248:78–83.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1071810>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `283.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 283Y2'>
    <MCurrPage `1355'>
    <Unique 1071809>
   > # end of Marker
   <String `Schifitto G, Zhang J, Evans SR, Sacktor N, Simp'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `son D, Millar LL, et al. A multicenter trial of sele'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `giline transdermal system for HIV-associated '>
  > # end of ParaLine
  <ParaLine 
   <String `cognitive impairment. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Neurology. 2007;69:1314–21.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1078511>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `284.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 284Y2'>
    <MCurrPage `1355'>
    <Unique 1078510>
   > # end of Marker
   <String `Portin R, Rinne UK. The effect of deprenyl (sele'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `giline) on cognition and emotion in parkinsonian '>
  > # end of ParaLine
  <ParaLine 
   <String `patients undergoing long-term levodopa treat'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ment. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Acta Neurol Scand Suppl. 1983;95:135–44.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1078513>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `285.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 285Y2'>
    <MCurrPage `1355'>
    <Unique 1078512>
   > # end of Marker
   <String `Kieburtz K, McDermott M, Como P, Growdon J, '>
  > # end of ParaLine
  <ParaLine 
   <String `Brady J, Carter J, et al. The effect of deprenyl and '>
  > # end of ParaLine
  <ParaLine 
   <String `tocopherol on cognitive performance in early '>
  > # end of ParaLine
  <ParaLine 
   <String `untreated Parkinson\qs disease. Parkinson Study '>
  > # end of ParaLine
  <ParaLine 
   <String `Group. Neurology. 1994;44:1756–9.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1071824>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `286.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 286Y2'>
    <MCurrPage `1355'>
    <Unique 1071823>
   > # end of Marker
   <String `Dalrymple-Alford JC, Jamieson CF, Donaldson '>
  > # end of ParaLine
  <ParaLine 
   <String `IM. Effects of selegiline (deprenyl) on cognition '>
  > # end of ParaLine
  <ParaLine 
   <String `in early Parkinson\qs disease. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Clin Neuropharmacol. 1995;18:348–59.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054752>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `287.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 287Y2'>
    <MCurrPage `1355'>
    <Unique 1064316>
   > # end of Marker
   <String `Lees AJ. Selegiline hydrochloride and cognition. '>
  > # end of ParaLine
  <ParaLine 
   <String `Acta Neurol Scand Suppl. 1991;13691–4.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054753>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `288.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <TextRectID 190>
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 288Y2'>
    <MCurrPage `1356'>
    <Unique 1064329>
   > # end of Marker
   <String `Gasparini M, Fabrizio E, Bonifati V, Meco G. '>
  > # end of ParaLine
  <ParaLine 
   <String `Cognitive improvement during tolcapone treat'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ment in Parkinson\qs disease. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `J Neural Transm. 1997;104:887–94.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1071854>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `289.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 289Y2'>
    <MCurrPage `1356'>
    <Unique 1071853>
   > # end of Marker
   <Char Tab>
   <String `Apud JA, Mattay V, Chen J, Kolachana BS, Calli'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `cott JH, Rasetti R, et al. Tolcapone improves cog'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `nition and cortical information processing in '>
  > # end of ParaLine
  <ParaLine 
   <String `normal human subjects. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Neuropsychopharmacology. 2007;32:1011–20.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1057495>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `290.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 290Y2'>
    <MCurrPage `1356'>
    <Unique 1064355>
   > # end of Marker
   <String `Rapoport MJ, Banina MC. Impact of psychotro'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `pic medications on simulated driving: a critical re'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `view. '>
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `message URL http://www.ncbi.nlm.nih.gov/pubmed/17521229'>
    <MCurrPage `1356'>
    <Unique 1057502>
   > # end of Marker
   <String `CNS Drugs. 2007;21:503–19.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1057496>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `291.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 291Y2'>
    <MCurrPage `1356'>
    <Unique 1064368>
   > # end of Marker
   <String `Brunnauer A, Laux G. [Road safety under psychi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `atric drug targeting]. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `message URL http://www.ncbi.nlm.nih.gov/pubmed/18512188'>
    <MCurrPage `1356'>
    <Unique 1057525>
   > # end of Marker
   <String `Fortschr Neurol Psychiatr. 2008;76:366–77.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1071880>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `292.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 292Y2'>
    <MCurrPage `1356'>
    <Unique 1071879>
   > # end of Marker
   <String `Buchanan RW, Freedman R, Javitt DC, Abi-Darg'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ham A, Lieberman JA. Recent advances in the de'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `velopment of novel pharmacological agents for '>
  > # end of ParaLine
  <ParaLine 
   <String `the treatment of cognitive impairments in schi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `zophrenia. '>
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `message URL http://www.ncbi.nlm.nih.gov/pubmed/17641146'>
    <MCurrPage `1356'>
    <Unique 1071881>
   > # end of Marker
   <String `Schizophr Bull. 2007;33:1120–30.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1071883>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `293.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 293Y2'>
    <MCurrPage `1356'>
    <Unique 1071882>
   > # end of Marker
   <String `Remington G, Chong SA. Conventional versus '>
  > # end of ParaLine
  <ParaLine 
   <String `novel antipsychotics: changing concepts and '>
  > # end of ParaLine
  <ParaLine 
   <String `clinical implications. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `message URL http://www.ncbi.nlm.nih.gov/pubmed/10586534'>
    <MCurrPage `1356'>
    <Unique 1071884>
   > # end of Marker
   <String `J Psychiatry Neurosci. 1999;24:431–41.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054436>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `294.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 294Y2'>
    <MCurrPage `1356'>
    <Unique 1064407>
   > # end of Marker
   <String `Wylie KR, Thompson DJ, Wildgust HJ. Effects of '>
  > # end of ParaLine
  <ParaLine 
   <String `depot neuroleptics on driving performance in '>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `chronic schizophrenic patients. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `J Neurol Neurosurg Psychiatry. 1993;56:910–3.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1071906>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `295.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 295Y2'>
    <MCurrPage `1356'>
    <Unique 1071905>
   > # end of Marker
   <String `Gerhard U, Hobi V. Cognitive-psychomotor '>
  > # end of ParaLine
  <ParaLine 
   <String `func'>
   <Char DiscHyphen>
   <String `tions with regard to fitness for driving of '>
  > # end of ParaLine
  <ParaLine 
   <String `psychiatric patients treated with neuroleptics '>
  > # end of ParaLine
  <ParaLine 
   <String `and antidepressants. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Neuropsychobiology. 1984;12:39–47.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1071934>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `296.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 296Y2'>
    <MCurrPage `1356'>
    <Unique 1071933>
   > # end of Marker
   <String `Kagerer S, Winter C, Moller HJ, Soyka M. Effects '>
  > # end of ParaLine
  <ParaLine 
   <String `of haloperidol and atypical neuroleptics on '>
  > # end of ParaLine
  <ParaLine 
   <String `psycho'>
   <Char DiscHyphen>
   <String `motor performance and driving ability in '>
  > # end of ParaLine
  <ParaLine 
   <String `schizophrenic patients. Results from an experi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `mental study. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Neuropsychobiology. 2003;47:212–8.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054439>
  <PgfTag `RefTextNrForts'>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
    <FFamily `Frutiger LT Std 55 Roman'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  7.5 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage UKEnglish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLanguage UKEnglish>
  > # end of Pgf
  <PgfNumString `297.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Font 
    <FTag `'>
    <FLanguage Swedish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 297Y2'>
    <MCurrPage `1356'>
    <Unique 1064446>
   > # end of Marker
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `Soyka M, Winter C, Kagerer S, Brunnauer M, '>
  > # end of ParaLine
  <ParaLine 
   <String `Laux G, Moller HJ. Effects of haloperidol and ris'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `peridone on psychomotor performance relevant '>
  > # end of ParaLine
  <ParaLine 
   <String `to driving ability in schizophrenic patients com'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `pared to healthy controls. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `J Psychiatr Res. 2005;39:101–8.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054440>
  <PgfTag `RefTextNrForts'>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
    <FFamily `Frutiger LT Std 55 Roman'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  7.5 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage UKEnglish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLanguage UKEnglish>
  > # end of Pgf
  <PgfNumString `298.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Font 
    <FTag `'>
    <FLanguage Swedish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 298Y2'>
    <MCurrPage `1356'>
    <Unique 1064463>
   > # end of Marker
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `Grabe HJ, Wolf T, Gratz S, Laux G. The influence '>
  > # end of ParaLine
  <ParaLine 
   <String `of clozapine and typical neuroleptics on informa'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tion processing of the central nervous system un'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `der clinical conditions in schizophre'>
   <Char DiscHyphen>
   <String `nic disorders: '>
  > # end of ParaLine
  <ParaLine 
   <String `implications for fitness to drive. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Neuropsychobiology. 1999;40:196–201.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1071974>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `299.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 299Y2'>
    <MCurrPage `1356'>
    <Unique 1071973>
   > # end of Marker
   <String `Brunnauer A, Laux G, Geiger E, Moller HJ. The '>
  > # end of ParaLine
  <ParaLine 
   <String `impact of antipsychotics on psychomotor perfor'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <TextRectID 190>
   <String `mance with regards to car driving skills. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `J Clin Psychopharmacol. 2004;24:155–60.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1072010>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `300.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 300Y2'>
    <MCurrPage `1356'>
    <Unique 1072009>
   > # end of Marker
   <String `Chew ML, Mulsant BH, Pollock BG, Lehman ME, '>
  > # end of ParaLine
  <ParaLine 
   <String `Greenspan A, Mahmoud RA, et al. Anticholiner'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `gic activity of 107 medications commonly used by '>
  > # end of ParaLine
  <ParaLine 
   <String `older adults. J Am Geriatr Soc. 2008;56:1333–41.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1072028>
  <PgfTag `RefTextNrForts'>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
    <FFamily `Frutiger LT Std 55 Roman'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  7.5 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  -1.5%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
  > # end of Pgf
  <PgfNumString `301.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 301Y2'>
    <MCurrPage `1356'>
    <Unique 1072027>
   > # end of Marker
   <String `Honig A, Arts BM, Ponds RW, Riedel WJ. Lithium '>
  > # end of ParaLine
  <ParaLine 
   <String `induced cognitive side-effects in bipolar disorder: a '>
  > # end of ParaLine
  <ParaLine 
   <String `qualitative analysis and implications for daily prac'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tice. Int Clin Psychopharmacol. 1999;14:167–71.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1072030>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `302.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 302Y2'>
    <MCurrPage `1356'>
    <Unique 1072029>
   > # end of Marker
   <String `Bech P, Thomsen J, Rafaelsen OJ. Long-term '>
  > # end of ParaLine
  <ParaLine 
   <String `lithium treatment: effect on simulated driving '>
  > # end of ParaLine
  <ParaLine 
   <String `and other psychological tests. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Eur J Clin Pharmacol. 1976;10:331–5.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054445>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `303.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 303Y2'>
    <MCurrPage `1356'>
    <Unique 1064528>
   > # end of Marker
   <String `Hatcher S, Sims R, Thompson D. The effects of '>
  > # end of ParaLine
  <ParaLine 
   <String `chronic lithium treatment on psychomotor per'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `formance related to driving. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Br J Psychiatry. 1990;157:275–8.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1078517>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `304.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 304Y2'>
    <MCurrPage `1356'>
    <Unique 1078516>
   > # end of Marker
   <String `Jauhar P. Psychomotor performance of patients '>
  > # end of ParaLine
  <ParaLine 
   <String `on maintenance lithium therapy. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Hum Psycho'>
   <Char DiscHyphen>
   <String `pharmacol. 1993;8:141–4.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1078519>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `305.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 305Y2'>
    <MCurrPage `1356'>
    <Unique 1078518>
   > # end of Marker
   <String `Linnoila M, Saario I, Maki M. Effect of treatment '>
  > # end of ParaLine
  <ParaLine 
   <String `with diazepam or lithium and alcohol on psycho'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `motor skills related to driving. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Eur J Clin Pharmacol. 1974;7:337–42.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1072106>
  <PgfTag `RefTextNrForts'>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
    <FFamily `Frutiger LT Std 55 Roman'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  7.5 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  -0.5%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
  > # end of Pgf
  <PgfNumString `306.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 306Y2'>
    <MCurrPage `1356'>
    <Unique 1072105>
   > # end of Marker
   <String `Brunnauer A, Laux G, Zwick S. Driving simulator '>
  > # end of ParaLine
  <ParaLine 
   <String `performance and psychomotor functions of schi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `zophrenic patients treated with antipsychotics. '>
  > # end of ParaLine
  <ParaLine 
   <String `Eur Arch Psychiatry Clin Neurosci. 2009;259:483–9.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054449>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `307.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 307Y2'>
    <MCurrPage `1356'>
    <Unique 1064580>
   > # end of Marker
   <String `Ray WA, Fought RL, Decker MD. Psychoactive '>
  > # end of ParaLine
  <ParaLine 
   <String `drugs and the risk of injurious motor vehicle cras'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `hes in elderly drivers. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Am J Epidemiol. 1992;136:873–83.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054450>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `308.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 308Y2'>
    <MCurrPage `1356'>
    <Unique 1064593>
   > # end of Marker
   <String `Hemmelgarn B, Suissa S, Huang A, Boivin JF, '>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `Pinard G. Benzodiazepine use and the risk of mo'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tor vehicle crash in the elderly. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `JAMA. 1997;278:27–31.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1072132>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `309.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 309Y2'>
    <MCurrPage `1356'>
    <Unique 1072131>
   > # end of Marker
   <String `Barbone F, McMahon AD, Davey PG, Morris AD, '>
  > # end of ParaLine
  <ParaLine 
   <String `Reid IC, McDevitt DG, et al. Association of road-'>
  > # end of ParaLine
  <ParaLine 
   <String `traffic accidents with benzodiazepine use. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Lancet. 1998;352:1331–6.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1078541>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `310.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 310Y2'>
    <MCurrPage `1356'>
    <Unique 1078540>
   > # end of Marker
   <String `Neutel CI. Risk of traffic accident injury after a '>
  > # end of ParaLine
  <ParaLine 
   <String `prescription for a benzodiazepine. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Ann Epidemiol. 1995;5:239–44.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1078547>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `311.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 311Y2'>
    <MCurrPage `1356'>
    <Unique 1078546>
   > # end of Marker
   <String `Neutel I. Benzodiazepine-related traffic acci'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `dents in young and elderly drivers. Hum Psycho'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `pharmakol Clin Exp. 1998;13:S115–S23.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1078549>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `312.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 312Y2'>
    <MCurrPage `1356'>
    <Unique 1078548>
   > # end of Marker
   <String `Mura P, Kintz P, Ludes B, Gaulier JM, Marquet P, '>
  > # end of ParaLine
  <ParaLine 
   <String `Martin-Dupont S, et al. Comparison of the preva'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `lence of alcohol, cannabis and other drugs bet'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ween 900 injured drivers and 900 control '>
  > # end of ParaLine
  <ParaLine 
   <String `subjects: results of a French collaborative study. '>
  > # end of ParaLine
  <ParaLine 
   <String `Forensic Sci Int. 2003;133:79–85.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054761>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `313.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <TextRectID 191>
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 313Y2'>
    <MCurrPage `1357'>
    <Unique 1064658>
   > # end of Marker
   <String `Brookhuis KA, Borgman AE. The effects of some '>
  > # end of ParaLine
  <ParaLine 
   <String `anxiolytics on driving performance. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `J Drugther Res. 1988;13:228–31.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1057637>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `314.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 314Y2'>
    <MCurrPage `1357'>
    <Unique 1064671>
   > # end of Marker
   <String `Rapoport MJ, Lanctot KL, Streiner DL, Bedard '>
  > # end of ParaLine
  <ParaLine 
   <String `M, Vingilis E, Murray B, et al. Benzodiazepine use '>
  > # end of ParaLine
  <ParaLine 
   <String `and driving: a meta-analysis. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `message URL http://www.ncbi.nlm.nih.gov/pubmed/19389334'>
    <MCurrPage `1357'>
    <Unique 1057638>
   > # end of Marker
   <String `J Clin Psychiatry. 2009;70:663–73.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1057674>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `315.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 315Y2'>
    <MCurrPage `1357'>
    <Unique 1064684>
   > # end of Marker
   <String `Vermeeren A, Leufkens TRM, Verster JC. '>
   <Char DiscHyphen>
   <String `Effects '>
  > # end of ParaLine
  <ParaLine 
   <String `of anxiolytics on driving. JC Verster, et al. Editors. '>
  > # end of ParaLine
  <ParaLine 
   <String `In: Drugs, Driving and Trafic Safety. '>
   <Char DiscHyphen>
   <String `Basel, Boston, '>
  > # end of ParaLine
  <ParaLine 
   <String `Berlin: Birkhäuser Verlag AG; 2009. s'>
   <Char HardSpace>
   <String `289'>
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <String `–'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `305.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1072186>
  <PgfTag `RefTextNrForts'>
  <Pgf 
   <HyphenMaxLines 4>
  > # end of Pgf
  <PgfNumString `316.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 316Y2'>
    <MCurrPage `1357'>
    <Unique 1072185>
   > # end of Marker
   <String `Leufkens TR, Vermeeren A, Smink BE, van '>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `Ruitenbeek P, Ramaekers JG. Cognitive, psycho'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `motor and actual driving performance in healthy '>
  > # end of ParaLine
  <ParaLine 
   <String `volunteers after immediate and extended release '>
  > # end of ParaLine
  <ParaLine 
   <String `formulations of alprazolam 1 mg. Psychopharma'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `cology (Berl). 2007;191:951–9.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1072210>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `317.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 317Y2'>
    <MCurrPage `1357'>
    <Unique 1072209>
   > # end of Marker
   <String `van Laar MW, Volkerts ER, van Willigenburg AP. '>
  > # end of ParaLine
  <ParaLine 
   <String `Therapeutic effects and effects on actual driving '>
  > # end of ParaLine
  <ParaLine 
   <String `performance of chronically administered buspi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `rone and diazepam in anxious outpatients. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `J Clin Psychopharmacol. 1992;12:86–95.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054460>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `318.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 318Y2'>
    <MCurrPage `1357'>
    <Unique 1064723>
   > # end of Marker
   <String `O\qHanlon JF, Haak TW, Blaauw GJ, Riemersma '>
  > # end of ParaLine
  <ParaLine 
   <String `JB. Diazepam impairs lateral position control in '>
  > # end of ParaLine
  <ParaLine 
   <String `highway driving. Science. 1982;217:79–81.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1073575>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `319.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 319Y2'>
    <MCurrPage `1357'>
    <Unique 1073574>
   > # end of Marker
   <String `Brookhuis KA, Borgman AE, Roos EPM, DeVries '>
  > # end of ParaLine
  <ParaLine 
   <String `G, Brookhuis J. The effects of clorazepate 5 mg, '>
  > # end of ParaLine
  <ParaLine 
   <String `oxazepam 10 mg, and lorazepam 0.5 mg on '>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `aspects of driving and driving related skills. 1987, '>
  > # end of ParaLine
  <ParaLine 
   <String `Groningen: Traffic Research Centre, University of '>
  > # end of ParaLine
  <ParaLine 
   <String `Groningen Short. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054787>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `320.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 320Y2'>
    <MCurrPage `1357'>
    <Unique 1064749>
   > # end of Marker
   <String `Volkerts ER, Brookhuis KA, O\qHanlon JF. The ef'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `fects of treatment with buspirone, diazepam, '>
  > # end of ParaLine
  <ParaLine 
   <String `and lorazsepam on driving performance in real '>
  > # end of ParaLine
  <ParaLine 
   <String `traffic. In: International Congress on Alcohol, '>
  > # end of ParaLine
  <ParaLine 
   <String `Drugs and Traffic safety, T86., P.C. Noordzij and R. '>
  > # end of ParaLine
  <ParaLine 
   <String `Roszbach, Editors. 1987, Excerpta Medica: Am'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `sterdam.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054783>
  <PgfTag `RefTextNrForts'>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
    <FFamily `Frutiger LT Std 55 Roman'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  7.5 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage UKEnglish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <HyphenMaxLines 4>
   <PgfLanguage UKEnglish>
  > # end of Pgf
  <PgfNumString `321.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Font 
    <FTag `'>
    <FLanguage Swedish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 321Y2'>
    <MCurrPage `1357'>
    <Unique 1064766>
   > # end of Marker
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `van Laar M, Volkerts E, Verbaten M. Subchronic '>
  > # end of ParaLine
  <ParaLine 
   <String `effects of the GABA-agonist lorazepam and the '>
  > # end of ParaLine
  <ParaLine 
   <String `5-HT2A/2C antagonist ritanserin on driving per'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `formance, slow wave sleep and daytime sleepi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ness in healthy volunteers. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Psychopharmacology (Berl). 2001;154:189–97.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1073579>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `322.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 322Y2'>
    <MCurrPage `1357'>
    <Unique 1073578>
   > # end of Marker
   <String `Vermeeren A, Swijgman HF, O\qHanlon JF. Acute '>
  > # end of ParaLine
  <ParaLine 
   <String `and subchronic effects of alpidem, lorazepam, '>
  > # end of ParaLine
  <ParaLine 
   <String `and placebo on anxiety, psychometric test perfor'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `mance and actual driving in anxious patients. '>
  > # end of ParaLine
  <ParaLine 
   <String `1994, Maastricht: Institute for Human Psycho'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `pharmacology IGVG 93–29.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054465>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `323.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 323Y2'>
    <MCurrPage `1357'>
    <Unique 1064792>
   > # end of Marker
   <String `Behandling av sömnbesvär hos vuxna. En syste'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `matisk litteraturöversikt. Rapport 199. 2010, '>
  > # end of ParaLine
  <ParaLine 
   <String `Stockholm: SBU. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1057774>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `324.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <TextRectID 191>
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 324Y2'>
    <MCurrPage `1357'>
    <Unique 1064805>
   > # end of Marker
   <String `Verster JC, Pandi-Perumal SR, Ramaekers JG, '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `de Gier JJ. Drugs, Driving and Trafic Safety. Basel, '>
  > # end of ParaLine
  <ParaLine 
   <String `Boston, Berlin: Birkhäuser Verlag AG; 2009; s 559.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1088999>
  <PgfTag `RefTextNrForts'>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
    <FFamily `Frutiger LT Std 55 Roman'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  7.5 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage UKEnglish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLanguage UKEnglish>
  > # end of Pgf
  <PgfNumString `325.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Font 
    <FTag `'>
    <FLanguage Swedish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 325Y2'>
    <MCurrPage `1357'>
    <Unique 1088998>
   > # end of Marker
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `Vermeeren A, Riedel WJ, van Boxtel MP, Dar'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `wish M, Paty I, Patat A. Differential residual ef'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `fects of zaleplon and zopiclone on actual driving: '>
  > # end of ParaLine
  <ParaLine 
   <String `a comparison with a low dose of alcohol. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Sleep. 2002;25:224–31.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1089003>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `326.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 326Y2'>
    <MCurrPage `1357'>
    <Unique 1089002>
   > # end of Marker
   <String `Vermeeren A, Danjou PE, O\qHanlon JF. Residual '>
  > # end of ParaLine
  <ParaLine 
   <String `effects of evening and middle-of-the-night admi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `nistration of zaleplon 10 and 20 mg on memory '>
  > # end of ParaLine
  <ParaLine 
   <String `and actual driving performance. '>
   <Char DiscHyphen>
   <String `Hum Psychop'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `harmacol Clin Exp. 1998;13(S2):S98–107.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1078561>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `327.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 327Y2'>
    <MCurrPage `1357'>
    <Unique 1078560>
   > # end of Marker
   <String `Verster JC, Volkerts ER, Schreuder AH, Eijken EJ, '>
  > # end of ParaLine
  <ParaLine 
   <String `van Heuckelum JH, Veldhuijzen DS, et al. Residu'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `al effects of middle-of-the-night administration '>
  > # end of ParaLine
  <ParaLine 
   <String `of zaleplon and zolpidem on driving ability, me'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `mory functions, and psychomotor performance. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `J Clin Psychopharmacol. 2002;22:576–83.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054470>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `328.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 328Y2'>
    <MCurrPage `1357'>
    <Unique 1064857>
   > # end of Marker
   <String `Leufkens TR, Lund JS, Vermeeren A. '>
   <Char DiscHyphen>
   <String `Highway '>
  > # end of ParaLine
  <ParaLine 
   <String `driving performance and cognitive functioning '>
  > # end of ParaLine
  <ParaLine 
   <String `the morning after bedtime and middle-of-the-'>
  > # end of ParaLine
  <ParaLine 
   <String `night use of gaboxadol, zopiclone and zolpidem. '>
  > # end of ParaLine
  <ParaLine 
   <String `J Sleep Res. 2009;18:387–96.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054471>
  <PgfTag `RefTextNrForts'>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
    <FFamily `Frutiger LT Std 55 Roman'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  7.5 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage UKEnglish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLanguage UKEnglish>
  > # end of Pgf
  <PgfNumString `329.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Font 
    <FTag `'>
    <FLanguage Swedish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 329Y2'>
    <MCurrPage `1357'>
    <Unique 1064870>
   > # end of Marker
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `Leufkens TRM. Hypnotics and anxiolytics. Field '>
  > # end of ParaLine
  <ParaLine 
   <String `and laboratory measures of drug safety in dri'>
   <Char DiscHyphen>
   <String `ving '>
  > # end of ParaLine
  <ParaLine 
   <String `performance and cognitive functions. In: Neu'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ropsychology and Psychopharmacology. 2009. '>
  > # end of ParaLine
  <ParaLine 
   <String `University of Maastricht: Maastricht. s'>
   <Char HardSpace>
   <String `216.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1089015>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `330.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 330Y2'>
    <MCurrPage `1357'>
    <Unique 1089014>
   > # end of Marker
   <String `Nicholson AN. Residual sequelae of zopiclone. '>
  > # end of ParaLine
  <ParaLine 
   <String `Rev Contemp Pharmacother. 1998;9:123–9.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1089017>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `331.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 331Y2'>
    <MCurrPage `1357'>
    <Unique 1089016>
   > # end of Marker
   <String `Noble S, Langtry HD, Lamb HM. Zopiclone. An '>
  > # end of ParaLine
  <ParaLine 
   <String `update of its pharmacology, clinical efficacy and '>
  > # end of ParaLine
  <ParaLine 
   <String `tolerability in the treatment of insomnia. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Drugs. 1998;55:277–302.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1072276>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `332.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 332Y2'>
    <MCurrPage `1357'>
    <Unique 1072275>
   > # end of Marker
   <String `Verster JC, Veldhuijzen DS, Volkerts ER. Residual '>
  > # end of ParaLine
  <ParaLine 
   <String `effects of sleep medication on driving ability. '>
  > # end of ParaLine
  <ParaLine 
   <String `Sleep Med Rev. 2004;8:309–25.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1072300>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `333.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 333Y2'>
    <MCurrPage `1357'>
    <Unique 1072299>
   > # end of Marker
   <String `O\qHanlon JF. Driving performance under the in'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `fluence of drugs: rationale for, and application '>
  > # end of ParaLine
  <ParaLine 
   <String `of, a new test. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Br J Clin Pharmacol. 1984;18 Suppl 112: 1S–29S.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1072302>
  <PgfTag `RefTextNrForts'>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
    <FFamily `Frutiger LT Std 55 Roman'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  7.5 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage UKEnglish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLanguage UKEnglish>
  > # end of Pgf
  <PgfNumString `334.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Font 
    <FTag `'>
    <FLanguage Swedish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 334Y2'>
    <MCurrPage `1357'>
    <Unique 1072301>
   > # end of Marker
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `Volkerts ER, Louwerens JW, Gloerich ABM, et al.  '>
  > # end of ParaLine
  <ParaLine 
   <String `Zopiclone\qs residual effect upon actual driving '>
  > # end of ParaLine
  <ParaLine 
   <String `performance versus those of nitrazepam and flu'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `nitrazepam. 1985. Haren: Traffic Research Centre, '>
  > # end of ParaLine
  <ParaLine 
   <String `University of Groningen, The Netherlands Short '>
  > # end of ParaLine
  <ParaLine 
   <String `VK 84–10.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054477>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `335.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 335Y2'>
    <MCurrPage `1357'>
    <Unique 1064952>
   > # end of Marker
   <String `Bocca ML, Le Doze F, Etard O, Pottier M, L\qHoste '>
  > # end of ParaLine
  <ParaLine 
   <String `J, Denise P. Residual effect of zolpidem 10 mg and '>
  > # end of ParaLine
  <ParaLine 
   <String `zopiclone 7.5 mg versus flunitrazepam 1 mg and '>
  > # end of ParaLine
  <ParaLine 
   <String `placebo on driving performance and ocular sac'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `cades. '>
   <Font 
    <FTag `'>
    <FDW  -2.0%>
    <FLocked No>
   > # end of Font
   <String `Psychopharmacology (Berl). 1999;143:373–9.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1072330>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `336.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <TextRectID 192>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 336Y2'>
    <MCurrPage `1358'>
    <Unique 1072329>
   > # end of Marker
   <String `Schmidt U, Brendemuhl D, Ruther E. Aspects of '>
  > # end of ParaLine
  <ParaLine 
   <String `driving after hypnotic therapy with particular re'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ference to temazepam. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Acta Psychiatr Scand Suppl. 1986;332:112–8.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1072332>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `337.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 337Y2'>
    <MCurrPage `1358'>
    <Unique 1072331>
   > # end of Marker
   <String `Vermeeren A, O\qHanlon JF, DeClerk AC, et al.  '>
  > # end of ParaLine
  <ParaLine 
   <String `Acute effects of zolpidem and flunitrazepam on '>
  > # end of ParaLine
  <ParaLine 
   <String `sleep, memory and driving performance, compa'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `red to those of partial sleep deprivation and pla'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `cebo. Acta Therapeutica. 1995;2147–64.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054790>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `338.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 338Y2'>
    <MCurrPage `1358'>
    <Unique 1064991>
   > # end of Marker
   <String `Jones AW. Driving under the influence of chlor'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `methiazole. Forensic Sci Int. 2005;153:213–7.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1078615>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `339.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 339Y2'>
    <MCurrPage `1358'>
    <Unique 1078614>
   > # end of Marker
   <String `Iffland R. [Therapeutic concentrations of chlor'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `methiazol in blood and their detection '>
   <Char DiscHyphen>
   <String `(author\qs '>
  > # end of ParaLine
  <ParaLine 
   <String `transl)]. Z Rechtsmed. 1977;80:27–33.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1078619>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `340.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 340Y2'>
    <MCurrPage `1358'>
    <Unique 1078618>
   > # end of Marker
   <String `Laurell H, Törnros J. The carry-over effects of '>
  > # end of ParaLine
  <ParaLine 
   <String `tria'>
   <Char DiscHyphen>
   <String `zolam compared with nitrazepam and place'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `bo in acute emergency driving situations and in '>
  > # end of ParaLine
  <ParaLine 
   <String `monotonous simulated driving. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Acta Pharmacol Toxicol (Copenh). 1986;58:182–6.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1078628>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `341.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 341Y2'>
    <MCurrPage `1358'>
    <Unique 1078627>
   > # end of Marker
   <String `O\qHanlon JF, Volkerts ER. Hypnotics and actual '>
  > # end of ParaLine
  <ParaLine 
   <String `driving performance. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Acta Psychiatr Scand Suppl. 1986;332:95–104.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1089088>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `342.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 342Y2'>
    <MCurrPage `1358'>
    <Unique 1089087>
   > # end of Marker
   <String `Volkerts ER, van Laar MW, van Willigenburg '>
  > # end of ParaLine
  <ParaLine 
   <String `AAP, Plomp TA, Maes RAA. A comparative study '>
  > # end of ParaLine
  <ParaLine 
   <String `of on-the-road and simulated driving performan'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ce after nocturnal treatment with lormetazepam '>
  > # end of ParaLine
  <ParaLine 
   <String `1 mg and oxazepam 50 mg. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Hum Psychopharmacol. 1992;7:297–309.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1078164>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `343.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 343Y2'>
    <MCurrPage `1358'>
    <Unique 1078163>
   > # end of Marker
   <String `Bramness JG, Skurtveit S, Neutel CI, Morland J, '>
  > # end of ParaLine
  <ParaLine 
   <String `Engeland A. Minor increase in risk of road '>
   <Char DiscHyphen>
   <String `traffic '>
  > # end of ParaLine
  <ParaLine 
   <String `accidents after prescriptions of antidepressants: '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `a study of population registry data in Norway. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `J Clin Psychiatry. 2008;69:1099–103.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1072395>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `344.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 344Y2'>
    <MCurrPage `1358'>
    <Unique 1072394>
   > # end of Marker
   <String `Leveille SG, Buchner DM, Koepsell TD, McClos'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `key LW, Wolf ME, Wagner EH. Psychoactive med'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ications and injurious motor vehicle collisions '>
  > # end of ParaLine
  <ParaLine 
   <String `involving older drivers. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Epidemiology. 1994;5:591–8.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1072397>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `345.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 345Y2'>
    <MCurrPage `1358'>
    <Unique 1072396>
   > # end of Marker
   <String `Ramaekers JG. Antidepressants and driver im'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `pairment: empirical evidence from a standard on-'>
  > # end of ParaLine
  <ParaLine 
   <String `the-road test. '>
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `message URL http://www.ncbi.nlm.nih.gov/pubmed/12590619'>
    <MCurrPage `1358'>
    <Unique 1072398>
   > # end of Marker
   <String `J Clin Psychiatry. 2003;64:20–9.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1072416>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `346.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 346Y2'>
    <MCurrPage `1358'>
    <Unique 1072415>
   > # end of Marker
   <String `Iwamoto K, Takahashi M, Nakamura Y, Kawa'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `mura Y, Ishihara R, Uchiyama Y, et al. The effects '>
  > # end of ParaLine
  <ParaLine 
   <String `of acute treatment with paroxetine, amitriptyli'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ne, and placebo on driving performance and cog'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `nitive function in healthy Japanese subjects: a '>
  > # end of ParaLine
  <ParaLine 
   <String `double-blind crossover trial. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Hum Psychopharmacol. 2008;23:399–407.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1089129>
  <PgfTag `RefTextNrForts'>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
    <FFamily `Frutiger LT Std 55 Roman'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  7.5 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage UKEnglish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <HyphenMaxLines 4>
   <PgfLanguage UKEnglish>
  > # end of Pgf
  <PgfNumString `347.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Font 
    <FTag `'>
    <FLanguage Swedish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 347Y2'>
    <MCurrPage `1358'>
    <Unique 1089128>
   > # end of Marker
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `Robbe HW, O\qHanlon JF. Acute and subchronic '>
  > # end of ParaLine
  <ParaLine 
   <String `effects of paroxetine 20 and 40 mg on actual driv'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ing, psychomotor performance and subjective '>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `assessments in healthy volunteers. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Eur Neuropsychopharmacol. 1995;5:35–42.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1089131>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `348.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <TextRectID 192>
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 348Y2'>
    <MCurrPage `1358'>
    <Unique 1089130>
   > # end of Marker
   <String `Seppäla T, Strömberg C, Bergman I. Effects of '>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `zimeldine, mianserin and amitriptyline on psy'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `chomotor skills and their interaction with etha'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `nol a placebo controlled cross-over study. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Eur J Clin Pharmacol. 1984;27:181–9.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1080900>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `349.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 349Y2'>
    <MCurrPage `1358'>
    <Unique 1080899>
   > # end of Marker
   <String `Mattila MJ, Saarialho-Kere U, Mattila M. Acute '>
  > # end of ParaLine
  <ParaLine 
   <String `effects of sertraline, amitriptyline, and placebo '>
  > # end of ParaLine
  <ParaLine 
   <String `on the psychomotor performance of healthy sub'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `jects over 50 years of age. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `J Clin '>
   <Char DiscHyphen>
   <String `Psychiatry. 1988;49(Suppl 8):52–8.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1080902>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `350.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 350Y2'>
    <MCurrPage `1358'>
    <Unique 1080901>
   > # end of Marker
   <String `Seppäla T. Psychomotor skills during acute and '>
  > # end of ParaLine
  <ParaLine 
   <String `two-week treatment with mianserin (ORG GB 94) '>
  > # end of ParaLine
  <ParaLine 
   <String `and amitriptyline, and their combined effects '>
  > # end of ParaLine
  <ParaLine 
   <String `with alcohol. Ann Clin Res. 1977;9:66–72.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1072452>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `351.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 351Y2'>
    <MCurrPage `1358'>
    <Unique 1072451>
   > # end of Marker
   <String `Veldhuijzen DS, van Wijck AJ, Wille F, Verster JC, '>
  > # end of ParaLine
  <ParaLine 
   <String `Kenemans JL, Kalkman CJ, et al. Effect of chronic '>
  > # end of ParaLine
  <ParaLine 
   <String `nonmalignant pain on highway driving perfor'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `mance. Pain. 2006;122:28–35.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1072454>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `352.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 352Y2'>
    <MCurrPage `1358'>
    <Unique 1072453>
   > # end of Marker
   <Char Tab>
   <String `Seppala T, Linnoila M, Mattila MJ. Psychomotor '>
  > # end of ParaLine
  <ParaLine 
   <String `skills in depressed out-patients treated with L-'>
  > # end of ParaLine
  <ParaLine 
   <String `tryptophan, doxepin, or chlorimipramine. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Ann Clin Res. 1978;10:214–21.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054497>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `353.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 353Y2'>
    <MCurrPage `1358'>
    <Unique 1065216>
   > # end of Marker
   <String `Amado-Boccara I, Gougoulis N, Poirier-Littre '>
  > # end of ParaLine
  <ParaLine 
   <String `MF, Galinowski A, Loo H. [Effects of anti'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `depressants on cognitive functions. Review of the '>
  > # end of ParaLine
  <ParaLine 
   <String `literature]. Encephale. 1994;20:65–77.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054498>
  <PgfTag `RefTextNrForts'>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
    <FFamily `Frutiger LT Std 55 Roman'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  7.5 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage UKEnglish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLanguage UKEnglish>
  > # end of Pgf
  <PgfNumString `354.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Font 
    <FTag `'>
    <FLanguage Swedish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 354Y2'>
    <MCurrPage `1358'>
    <Unique 1065229>
   > # end of Marker
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <Char Tab>
   <String `Hobi V, Gastpar M, Gastpar G, Gilsdorf U, '>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `Kielholz P, Schwarz E. Driving ability of '>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `depressive patients under antidepressants. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `J Int Med Res. 1982;10:65–81.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054499>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `355.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 355Y2'>
    <MCurrPage `1358'>
    <Unique 1065242>
   > # end of Marker
   <String `Bye C, Clubley M, Peck AW. Drowsiness, impai'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `red performance and tricyclic antidepressants '>
  > # end of ParaLine
  <ParaLine 
   <String `drugs. Br J Clin Pharmacol. 1978;6:155–62.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1072492>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `356.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 356Y2'>
    <MCurrPage `1358'>
    <Unique 1072491>
   > # end of Marker
   <String `Harmer CJ, Bhagwagar Z, Cowen PJ, Goodwin '>
  > # end of ParaLine
  <ParaLine 
   <String `GM. Acute administration of citalopram facilita'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tes memory consolidation in healthy '>
   <Char DiscHyphen>
   <String `volunteers. '>
  > # end of ParaLine
  <ParaLine 
   <String `Psychopharmacology (Berl). 2002;163:106–10.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1072506>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `357.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 357Y2'>
    <MCurrPage `1358'>
    <Unique 1072505>
   > # end of Marker
   <Char Tab>
   <String `Paul MA, Gray GW, Love RJ, Lange M. SSRI ef'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `fects on pyschomotor performance: assessment '>
  > # end of ParaLine
  <ParaLine 
   <String `of citalopram and escitalopram on normal sub'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `jects. Aviat Space Environ Med. 2007;78:693–7.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1072508>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `358.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 358Y2'>
    <MCurrPage `1358'>
    <Unique 1072507>
   > # end of Marker
   <String `Wingen M, Bothmer J, Langer S, Ramaekers JG. '>
  > # end of ParaLine
  <ParaLine 
   <String `Actual driving performance and psychomotor '>
  > # end of ParaLine
  <ParaLine 
   <String `function in healthy subjects after acute and '>
  > # end of ParaLine
  <ParaLine 
   <String `subchronic treatment with escitalopram, mirta'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `zapine, and placebo: a crossover trial. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `J Clin Psychiatry. 2005;66:436–43.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1080495>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `359.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 359Y2'>
    <MCurrPage `1358'>
    <Unique 1081421>
   > # end of Marker
   <String `Ramaekers JG, Muntjewerff ND, O\qHanlon JF. '>
  > # end of ParaLine
  <ParaLine 
   <String `A'>
   <Char HardSpace>
   <String `comparative study of acute and subchronic ef'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `fects of dothiepin, fluoxetine and placebo on '>
  > # end of ParaLine
  <ParaLine 
   <String `psychomotor and actual driving performance. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Br J Clin Pharmacol. 1995;39:397–404.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1080497>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `360.\t'>
  <ParaLine 
   <TextRectID 193>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 360Y2'>
    <MCurrPage `1359'>
    <Unique 1080496>
   > # end of Marker
   <String `Hindmarch I. Three antidepressants (amitriptyli'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ne, dothiepin, fluoxetine), with and without al'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `cohol, compared with placebo on tests of '>
  > # end of ParaLine
  <ParaLine 
   <String `psychomotor ability related to car driving. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Hum Psychopharmacol. 1987;2:177–83.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054503>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `361.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 361Y2'>
    <MCurrPage `1359'>
    <Unique 1065294>
   > # end of Marker
   <String `Rohrig TP, Goodson LJ. A sertraline-intoxicated '>
  > # end of ParaLine
  <ParaLine 
   <String `driver. J Anal Toxicol. 2004;28:689–91.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1072543>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `362.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 362Y2'>
    <MCurrPage `1359'>
    <Unique 1072542>
   > # end of Marker
   <String `Hindmarch I, Bhatti JZ. Psychopharmacological '>
  > # end of ParaLine
  <ParaLine 
   <String `effects of sertraline in normal, healthy '>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `volunteers. Eur J Clin Pharmacol. 1988;35:221–3.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1078656>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `363.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 363Y2'>
    <MCurrPage `1359'>
    <Unique 1078655>
   > # end of Marker
   <String `Saletu B, Grünberger J. Drug profiling by com'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `puted electroencephalography and brain maps, '>
  > # end of ParaLine
  <ParaLine 
   <String `with special consideration of sertraline and its '>
  > # end of ParaLine
  <ParaLine 
   <String `psychometric effects. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `J Clin Psychiatry. 1988;49(Suppl):59–71.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1078662>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `364.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 364Y2'>
    <MCurrPage `1359'>
    <Unique 1078661>
   > # end of Marker
   <String `Ramaekers JG, Swijgman HF, O\qHanlon JF. Ef'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `fects of moclobemide and mianserin on high'>
   <Char DiscHyphen>
   <String `way '>
  > # end of ParaLine
  <ParaLine 
   <String `driving, psychometric performance and subjecti'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ve parameters, relative to placebo. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `'>
    <FDW  -1.5%>
    <FLocked No>
   > # end of Font
   <String `Psychopharmacology (Berl). 1992;106(Suppl)S62–7.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1078664>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `365.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 365Y2'>
    <MCurrPage `1359'>
    <Unique 1078663>
   > # end of Marker
   <String `Siepmann M, Handel J, Mueck-Weymann M, '>
  > # end of ParaLine
  <ParaLine 
   <String `Kirch W. The effects of moclobemide on autono'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `mic and cognitive functions in healthy volunte'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ers. Pharmacopsychiatry. 2004;37:81–7.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1089187>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `366.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 366Y2'>
    <MCurrPage `1359'>
    <Unique 1089186>
   > # end of Marker
   <String `Dingemanse J, Berlin I, Payan C, Thiede HM, '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Puech AJ. Comparative investigation of the effect '>
  > # end of ParaLine
  <ParaLine 
   <String `of moclobemide and toloxatone on monoamine '>
  > # end of ParaLine
  <ParaLine 
   <String `oxidase activity and psychometric performance in '>
  > # end of ParaLine
  <ParaLine 
   <String `healthy subjects. Psycho'>
   <Char DiscHyphen>
   <String `pharmacology (Berl). '>
  > # end of ParaLine
  <ParaLine 
   <String `1992;106(Suppl):S68–70.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1072603>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `367.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 367Y2'>
    <MCurrPage `1359'>
    <Unique 1072602>
   > # end of Marker
   <String `Fairweather DB, Kerr JS, Hindmarch I. The ef'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `fects of moclobemide on psychomotor perfor'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `mance and cognitive function. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Int Clin Psycho'>
   <Char DiscHyphen>
   <String `pharmacol. 1993;8:43–7.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1072627>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `368.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 368Y2'>
    <MCurrPage `1359'>
    <Unique 1072626>
   > # end of Marker
   <String `Allain H, Lieury A, Brunet-Bourgin F, Mirabaud '>
  > # end of ParaLine
  <ParaLine 
   <String `C, Trebon P, Le Coz F, et al. Antidepressants and '>
  > # end of ParaLine
  <ParaLine 
   <String `cognition: comparative effects of moclobemide, '>
  > # end of ParaLine
  <ParaLine 
   <String `viloxazine and maprotiline. Psychopharmacology '>
  > # end of ParaLine
  <ParaLine 
   <String `(Berl). 1992;106(Suppl):S56–61.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1072629>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `369.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 369Y2'>
    <MCurrPage `1359'>
    <Unique 1072628>
   > # end of Marker
   <String `Haring C, Baier D, Herberg KW. Verkehrstüch'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tigkeit unter moclobemid. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Munch Med Wochenschr. 1995;137:217–31.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1072649>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `370.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 370Y2'>
    <MCurrPage `1359'>
    <Unique 1072648>
   > # end of Marker
   <String `Herrera-Guzman I, Herrera-Abarca JE, Gudayol-'>
  > # end of ParaLine
  <ParaLine 
   <String `Ferre E, Herrera-Guzman D, Gomez-Carbajal L, '>
  > # end of ParaLine
  <ParaLine 
   <String `Pena-Olvira M, et al. Effects of selective serotonin '>
  > # end of ParaLine
  <ParaLine 
   <String `reuptake and dual serotonergic-noradre'>
   <Char DiscHyphen>
   <String `nergic '>
  > # end of ParaLine
  <ParaLine 
   <String `reuptake treatments on attention and executive '>
  > # end of ParaLine
  <ParaLine 
   <String `functions in patients with major depressive disor'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `der. Psychiatry Res. 2010;177:323–9.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1072665>
  <PgfTag `RefTextNrForts'>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
    <FFamily `Frutiger LT Std 55 Roman'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  7.5 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage UKEnglish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLanguage UKEnglish>
  > # end of Pgf
  <PgfNumString `371.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Font 
    <FTag `'>
    <FLanguage Swedish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 371Y2'>
    <MCurrPage `1359'>
    <Unique 1072664>
   > # end of Marker
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `Ramaekers JG, Muntjewerff ND, vanVeggel '>
  > # end of ParaLine
  <ParaLine 
   <String `LMA, Uiterwijk MM, O\qHanlon JF. Effects of '>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `nocturnal doses of mirtazapine and mianserin on '>
  > # end of ParaLine
  <ParaLine 
   <String `sleep and on daytime psychomotor and '>
   <Char DiscHyphen>
   <String `driving '>
  > # end of ParaLine
  <ParaLine 
   <TextRectID 193>
   <String `performance in young, healthy volunteers. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Hum Psychopharmacol Clin Exp. '>
  > # end of ParaLine
  <ParaLine 
   <String `1998;13:S87–S97.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1072671>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `372.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 372Y2'>
    <MCurrPage `1359'>
    <Unique 1072670>
   > # end of Marker
   <String `O\qHanlon JF, Robbe HW, Vermeeren A, van '>
  > # end of ParaLine
  <ParaLine 
   <String `Leeuwen C, Danjou PE. Venlafaxine\qs effects on '>
  > # end of ParaLine
  <ParaLine 
   <String `healthy volunteers\q driving, psychomotor, and vi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `gilance performance during 15-day fixed and in'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `cremental dosing regimens. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `J Clin Psychopharmacol. 1998;18:212–21.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1072691>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `373.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 373Y2'>
    <MCurrPage `1359'>
    <Unique 1072690>
   > # end of Marker
   <String `Kerr JS, Powell J, Hindmarch I. The effects of re'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `boxetine and amitriptyline, with and without al'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `cohol on cognitive function and psychomotor '>
  > # end of ParaLine
  <ParaLine 
   <String `performance.'>
   <Font 
    <FTag `'>
    <FDW  -1.5%>
    <FLocked No>
   > # end of Font
   <String ` Br J Clin Pharmacol. 1996;42:239–41.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054516>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `374.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 374Y2'>
    <MCurrPage `1359'>
    <Unique 1065467>
   > # end of Marker
   <String `Baranski JV, Pigeau RA, Angus RG. On the ability '>
  > # end of ParaLine
  <ParaLine 
   <String `to self-monitor cognitive performance during '>
  > # end of ParaLine
  <ParaLine 
   <String `sleep deprivation: a calibration study. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `J Sleep Res. 1994;3:36–44.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054517>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `375.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 375Y2'>
    <MCurrPage `1359'>
    <Unique 1065480>
   > # end of Marker
   <String `Baranski JV, Pigeau R, Dinich P, Jacobs I. '>
   <Char DiscHyphen>
   <String `Effects '>
  > # end of ParaLine
  <ParaLine 
   <String `of modafinil on cognitive and meta-'>
   <Char DiscHyphen>
   <String `cognitive '>
  > # end of ParaLine
  <ParaLine 
   <String `performance. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Hum Psychopharmacol. 2004;19:323–32.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054518>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `376.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 376Y2'>
    <MCurrPage `1359'>
    <Unique 1065493>
   > # end of Marker
   <String `Barkley RA, Cox D. A review of driving risks and '>
  > # end of ParaLine
  <ParaLine 
   <String `impairments associated with attention-deficit/'>
  > # end of ParaLine
  <ParaLine 
   <String `hyperactivity disorder and the effects of stimu'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `lant medication on driving performance. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `message URL http://www.ncbi.nlm.nih.gov/pubmed/17303170'>
    <MCurrPage `1359'>
    <Unique 1057836>
   > # end of Marker
   <String `J Safety Res. 2007;38:113–28.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054519>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `377.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 377Y2'>
    <MCurrPage `1359'>
    <Unique 1065506>
   > # end of Marker
   <String `Repantis D, Schlattmann P, Laisney O, '>
   <Char DiscHyphen>
   <String `Heuser I. '>
  > # end of ParaLine
  <ParaLine 
   <String `Modafinil and methylphenidate for neuroenhan'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `cement in healthy individuals: A systematic re'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `view. '>
   <Font 
    <FTag `Blue'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `message URL http://www.ncbi.nlm.nih.gov/pubmed?term=repantis%20d%20and%20modafinil%20and%202010'>
    <MCurrPage `1359'>
    <Unique 1057847>
   > # end of Marker
   <String `Pharmacol Res. 2010;62:187–206.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1073601>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `378.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 378Y2'>
    <MCurrPage `1359'>
    <Unique 1073600>
   > # end of Marker
   <String `Johansson K, Malmberg K, Alfredsson J, Ras'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `musson P, Bergman I, Ginsberg Y, et al. Bedöm'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ning av lämplighet vid körkortstillstånd vid '>
  > # end of ParaLine
  <ParaLine 
   <String `neuropsykiatriska funktionsnedsättningar. 2:a '>
  > # end of ParaLine
  <ParaLine 
   <String `utgåvan.Täby: Novartis Sverige AB. 2009. '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1072728>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `379.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 379Y2'>
    <MCurrPage `1359'>
    <Unique 1072727>
   > # end of Marker
   <String `Barkley RA, Anderson DL, Kruesi M. A pilot stu'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `dy of the effects of atomoxetine on driving per'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `formance in adults with ADHD. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `J Atten '>
   <Char DiscHyphen>
   <String `Disord. 2007;10:306–16.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1072753>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `380.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 380Y2'>
    <MCurrPage `1359'>
    <Unique 1072752>
   > # end of Marker
   <String `Kay GG, Michaels MA, Pakull B. Simulated dri'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ving changes in young adults with ADHD recei'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ving mixed amphetamine salts extended release '>
  > # end of ParaLine
  <ParaLine 
   <String `and atomoxetine. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `J Atten Disord. 2009;12:316–29.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1072777>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `381.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 381Y2'>
    <MCurrPage `1359'>
    <Unique 1072776>
   > # end of Marker
   <String `Verster JC, Bekker EM, de Roos M, Minova A, '>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `Eijken EJ, Kooij JJ, et al. Methylphenidate signifi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `cantly improves driving performance of adults '>
  > # end of ParaLine
  <ParaLine 
   <String `with attention-deficit hyperactivity disorder: '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `a randomized crossover trial. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `J Psychopharmacol. 2008;22:230–7.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1072791>
  <PgfTag `RefTextNrForts'>
  <Pgf 
   <PgfPlacement ColumnTop>
  > # end of Pgf
  <PgfNumString `382.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <TextRectID 194>
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 382Y2'>
    <MCurrPage `1360'>
    <Unique 1072790>
   > # end of Marker
   <String `Cox DJ, Merkel RL, Moore M, Thorndike F, Mul'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ler C, Kovatchev B. Relative benefits of stimulant '>
  > # end of ParaLine
  <ParaLine 
   <String `therapy with OROS methylphenidate versus mix'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ed amphetamine salts extended re'>
   <Char DiscHyphen>
   <String `lease in impro'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ving the driving performance of adole'>
   <Char DiscHyphen>
   <String `scent '>
  > # end of ParaLine
  <ParaLine 
   <String `drivers with attention-deficit/hyper'>
   <Char DiscHyphen>
   <String `activity disor'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `der. Pediatrics. 2006;118:e704–10.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1072793>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `383.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 383Y2'>
    <MCurrPage `1360'>
    <Unique 1072792>
   > # end of Marker
   <String `Barkley RA, Murphy KR, O\qConnell T, Connor DF. '>
  > # end of ParaLine
  <ParaLine 
   <String `Effects of two doses of methylphenidate on '>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `simulator driving performance in adults with '>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `attention deficit hyperactivity disorder. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `J Safety Res. 2005;36:121–31.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1072815>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `384.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 384Y2'>
    <MCurrPage `1360'>
    <Unique 1072814>
   > # end of Marker
   <String `Cox DJ, Humphrey JW, Merkel RL, Penberthy JK, '>
  > # end of ParaLine
  <ParaLine 
   <String `Kovatchev B. Controlled-release methylphenida'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `te improves attention during on-road driving by '>
  > # end of ParaLine
  <ParaLine 
   <String `adolescents with attention-deficit/hyperactivity '>
  > # end of ParaLine
  <ParaLine 
   <String `disorder. J Am Board Fam Pract. 2004;17:235–9.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1072827>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `385.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 385Y2'>
    <MCurrPage `1360'>
    <Unique 1072826>
   > # end of Marker
   <String `Cox DJ, Merkel RL, Penberthy JK, Kovatchev B, '>
  > # end of ParaLine
  <ParaLine 
   <String `Hankin CS. Impact of methylphenidate delivery '>
  > # end of ParaLine
  <ParaLine 
   <String `profiles on driving performance of adolescents '>
  > # end of ParaLine
  <ParaLine 
   <String `with attention-deficit/hyperactivity disorder: a '>
  > # end of ParaLine
  <ParaLine 
   <String `pilot study. J Am Acad Child Adolesc Psychiatry. '>
  > # end of ParaLine
  <ParaLine 
   <String `2004;43:269–75.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1072843>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `386.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 386Y2'>
    <MCurrPage `1360'>
    <Unique 1072842>
   > # end of Marker
   <String `Randall DC, Viswanath A, Bharania P, Elsabagh '>
  > # end of ParaLine
  <ParaLine 
   <String `SM, Hartley DE, Shneerson JM, et al. Does moda'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `finil enhance cognitive performance in young vo'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `lunteers who are not sleep-deprived? '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `J Clin Psychopharmacol. 2005;25:175–9.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1072845>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `387.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 387Y2'>
    <MCurrPage `1360'>
    <Unique 1072844>
   > # end of Marker
   <String `Turner DC, Robbins TW, Clark L, Aron AR, '>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `Dowson J, Sahakian BJ. Cognitive enhancing ef'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `fects of modafinil in healthy volunteers. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Psychopharmacology (Berl). 2003;165:260–9.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054530>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `388.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 388Y2'>
    <MCurrPage `1360'>
    <Unique 1065653>
   > # end of Marker
   <String `Randall DC, Shneerson JM, Plaha KK, File SE. '>
  > # end of ParaLine
  <ParaLine 
   <String `Modafinil affects mood, but not cognitive func'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `tion, in healthy young volunteers. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Hum '>
   <Char DiscHyphen>
   <String `Psychopharmacol. 2003;18:163–73.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1072895>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `389.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 389Y2'>
    <MCurrPage `1360'>
    <Unique 1072894>
   > # end of Marker
   <String `Mason BJ, Goodman AM, Dixon RM, Hameed '>
  > # end of ParaLine
  <ParaLine 
   <String `MH, Hulot T, Wesnes K, et al. A pharmacokinetic '>
  > # end of ParaLine
  <ParaLine 
   <String `and pharmacodynamic drug interaction study of '>
  > # end of ParaLine
  <ParaLine 
   <String `acamprosate and naltrexone. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Neuropsycho'>
   <Char DiscHyphen>
   <String `pharmacology. 2002;27:596–606.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1072885>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `390.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 390Y2'>
    <MCurrPage `1360'>
    <Unique 1072884>
   > # end of Marker
   <String `Herrera-Guzman I, Gudayol-Ferre E, Lira-Man'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `dujano J, Herrera-Abarca J, Herrera-Guzman D, '>
  > # end of ParaLine
  <ParaLine 
   <String `Montoya-Perez K, et al. Cognitive predictors of '>
  > # end of ParaLine
  <ParaLine 
   <String `treatment response to bupropion and cognitive '>
  > # end of ParaLine
  <ParaLine 
   <String `effects of bupropion in patients with major de'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `pressive disorder. Psychiatry Res. 2008;160:72–82.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054817>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `391.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 391Y2'>
    <MCurrPage `1360'>
    <Unique 1065692>
   > # end of Marker
   <String `Siepmann M, Werner K, Schindler C, Oertel R, '>
  > # end of ParaLine
  <ParaLine 
   <String `Kirch W. The effects of bupropion on cognitive '>
  > # end of ParaLine
  <ParaLine 
   <String `functions in healthy subjects. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Psychopharmacology (Berl). 2005;182:597–8.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1072927>
  <PgfTag `RefTextNrForts'>
  <Pgf 
   <PgfPlacement ColumnTop>
  > # end of Pgf
  <PgfNumString `392.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <TextRectID 194>
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 392Y2'>
    <MCurrPage `1360'>
    <Unique 1072926>
   > # end of Marker
   <String `Peeke SC, Prael AR, Herning RI, Rogers W, Beno'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `witz NL, Jones RT. Effect of disulfiram on cogni'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tion, subjective response, and cortical-event-'>
  > # end of ParaLine
  <ParaLine 
   <String `related potentials in nonalcoholic subjects. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Alcohol Clin Exp Res. 1979;3:223–9.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1072947>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `393.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 393Y2'>
    <MCurrPage `1360'>
    <Unique 1072946>
   > # end of Marker
   <String `Ryan TV, Sciara AD, Barth JT. Chronic neuropsy'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `chological impairment resulting from disulfiram '>
  > # end of ParaLine
  <ParaLine 
   <String `overdose. J Stud Alcohol. 1993;54:389–92.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1072949>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `394.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 394Y2'>
    <MCurrPage `1360'>
    <Unique 1072948>
   > # end of Marker
   <String `Heath RG, Nesselhof W, Bishop MP, Meyers LW. '>
  > # end of ParaLine
  <ParaLine 
   <String `Behavioral and metabolic changes assiciated '>
  > # end of ParaLine
  <ParaLine 
   <String `with administration of tetraethylthiuram disulfi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `de (Antabus). Dis Nerv Syst. 1950;26:99–105.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054537>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `395.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 395Y2'>
    <MCurrPage `1360'>
    <Unique 1065744>
   > # end of Marker
   <Font 
    <FTag `'>
    <FDW  -0.5%>
    <FLocked No>
   > # end of Font
   <String `Gilman S, Adams KM, Johnson-Greene D, Koep'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `pe RA, Junck L, Kluin KJ, et al. Effects of disulfiram '>
  > # end of ParaLine
  <ParaLine 
   <String `on positron emission tomography and neuropsy'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `chological studies in severe chronic alcoholism. '>
  > # end of ParaLine
  <ParaLine 
   <String `Alcohol Clin Exp Res. 1996;20:1456–61.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1072964>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `396.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 396Y2'>
    <MCurrPage `1360'>
    <Unique 1072963>
   > # end of Marker
   <String `Kuehn BM. Varenicline gets stronger warnings '>
  > # end of ParaLine
  <ParaLine 
   <String `about psychiatric problems, vehicle crashes. '>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `JAMA. 2009;302:834.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1072990>
  <PgfTag `RefTextNrForts'>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
    <FFamily `Frutiger LT Std 55 Roman'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  7.5 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage UKEnglish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLanguage UKEnglish>
  > # end of Pgf
  <PgfNumString `397.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Font 
    <FTag `'>
    <FLanguage Swedish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 397Y2'>
    <MCurrPage `1360'>
    <Unique 1072989>
   > # end of Marker
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `Jones AW, Holmgren A, Kugelberg FC. Driving '>
  > # end of ParaLine
  <ParaLine 
   <String `under the influence of opiates: concentration re'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `lationships between morphine, codeine, 6-acetyl '>
  > # end of ParaLine
  <ParaLine 
   <String `morphine, and ethyl morphine in blood. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `J Anal Toxicol. 2008;32:265–72.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1073002>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `398.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 398Y2'>
    <MCurrPage `1360'>
    <Unique 1073001>
   > # end of Marker
   <String `Aasmundstad TA, Xu BQ, Johansson I, Ripel A, '>
  > # end of ParaLine
  <ParaLine 
   <String `Bjorneboe A, Christophersen AS, et al. Biotrans'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `formation and pharmacokinetics of ethylmor'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `phine after a single oral dose. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Br J Clin Pharmacol. 1995;39:611–20.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054541>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `399.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 399Y2'>
    <MCurrPage `1360'>
    <Unique 1065796>
   > # end of Marker
   <String `Laurell H, Törnros JE. Effekt på simulerad bilkör'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ning av hostmediciner i kombination med alko'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `hol. 1989. Linköping: VTI - Statens Väg- och '>
  > # end of ParaLine
  <ParaLine 
   <String `Trafikforskningsinstitut. TF 57–04.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054542>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `400.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 400Y2'>
    <MCurrPage `1360'>
    <Unique 1065809>
   > # end of Marker
   <String `Kakumanu S, Glass C, Craig T. Poor sleep and '>
  > # end of ParaLine
  <ParaLine 
   <String `daytime somnolence in allergic rhinitis: signifi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `cance of nasal congestion.'>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Am J Respir Med. 2002;1:195–200.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054543>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `401.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 401Y2'>
    <MCurrPage `1360'>
    <Unique 1065822>
   > # end of Marker
   <String `Howard ME, Desai AV, Grunstein RR, Hukins C, '>
  > # end of ParaLine
  <ParaLine 
   <String `Armstrong JG, Joffe D, et al. Sleepiness, sleep-di'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `sordered breathing, and accident risk factors in '>
  > # end of ParaLine
  <ParaLine 
   <String `commercial vehicle drivers. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Am J Respir Crit Care Med. 2004;170:1014–21.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054544>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `402.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 402Y2'>
    <MCurrPage `1360'>
    <Unique 1065835>
   > # end of Marker
   <String `Mann RD, Pearce GL, Dunn N, Shakir S. '>
   <Char DiscHyphen>
   <String `Sedation '>
  > # end of ParaLine
  <ParaLine 
   <String `with ”non-sedating” antihistamines: four '>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `prescription-event monitoring studies in general '>
  > # end of ParaLine
  <ParaLine 
   <String `practice. BMJ. 2000;320:1184–6.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054545>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `403.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 403Y2'>
    <MCurrPage `1360'>
    <Unique 1065848>
   > # end of Marker
   <String `Casale TB, Blaiss MS, Gelfand E, Gilmore T, '>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `Harvey PD, Hindmarch I, et al. First do no harm: '>
  > # end of ParaLine
  <ParaLine 
   <String `managing antihistamine impairment in patients '>
  > # end of ParaLine
  <ParaLine 
   <String `with allergic rhinitis. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `J Allergy Clin Immunol. 2003;111:S835–42.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1073044>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `404.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <TextRectID 195>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 404Y2'>
    <MCurrPage `1361'>
    <Unique 1073043>
   > # end of Marker
   <String `Palmentier JP, Warren R, Gorczynski LY. '>
   <Char DiscHyphen>
   <String `Alcohol '>
  > # end of ParaLine
  <ParaLine 
   <String `and drugs in suspected impaired drivers in Onta'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `rio from 2001 to 2005. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `J Forensic Leg Med. 2009;16:444–8.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1073046>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `405.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 405Y2'>
    <MCurrPage `1361'>
    <Unique 1073045>
   > # end of Marker
   <String `Schwilke EW, Sampaio dos Santos MI, '>
   <Char DiscHyphen>
   <String `Logan BK. '>
  > # end of ParaLine
  <ParaLine 
   <String `Changing patterns of drug and alcohol use in fa'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tally injured drivers in Washington State. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `J Forensic Sci. 2006;51:1191–8.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1073617>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `406.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 406Y2'>
    <MCurrPage `1361'>
    <Unique 1073616>
   > # end of Marker
   <String `Weiler JM, Bloomfield JR, Woodworth GG, '>
  > # end of ParaLine
  <ParaLine 
   <String `Grant AR, Layton TA, Brown TL, et al. Effects of '>
  > # end of ParaLine
  <ParaLine 
   <String `fexofenadine, diphenhydramine, and alcohol on '>
  > # end of ParaLine
  <ParaLine 
   <String `driving performance. A randomized, placebo-'>
  > # end of ParaLine
  <ParaLine 
   <String `controlled trial in the Iowa driving simulator. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Ann Intern Med. 2000;132:354–63.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1073619>
  <PgfTag `RefTextNrForts'>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
    <FFamily `Frutiger LT Std 55 Roman'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  7.5 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage UKEnglish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLanguage UKEnglish>
  > # end of Pgf
  <PgfNumString `407.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Font 
    <FTag `'>
    <FLanguage Swedish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 407Y2'>
    <MCurrPage `1361'>
    <Unique 1073618>
   > # end of Marker
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `Mansfield L, Mendoza C, Flores J, Meeves SG. '>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `Effects of fexofenadine, diphenhydramine, and '>
  > # end of ParaLine
  <ParaLine 
   <String `placebo on performance of the test of variables '>
  > # end of ParaLine
  <ParaLine 
   <String `of attention (TOVA). '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Ann Allergy Asthma Immunol. 2003;90:554–9.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054550>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `408.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 408Y2'>
    <MCurrPage `1361'>
    <Unique 1065917>
   > # end of Marker
   <String `Wilken JA, Kane RL, Ellis AK, Rafeiro E, Briscoe '>
  > # end of ParaLine
  <ParaLine 
   <String `MP, Sullivan CL, et al. A comparison of the effect '>
  > # end of ParaLine
  <ParaLine 
   <String `of diphenhydramine and desloratadine on vigi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `lance and cognitive function during treatment of '>
  > # end of ParaLine
  <ParaLine 
   <String `ragweed-induced allergic rhinitis. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Ann Allergy Asthma Immunol. 2003;91:375–85.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1073074>
  <PgfTag `RefTextNrForts'>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
    <FFamily `Frutiger LT Std 55 Roman'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  7.5 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  -2.0%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
  > # end of Pgf
  <PgfNumString `409.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 409Y2'>
    <MCurrPage `1361'>
    <Unique 1073073>
   > # end of Marker
   <String `Gupta S, Kapoor B, Gillani Z, Kapoor V, Gupta BM. '>
  > # end of ParaLine
  <ParaLine 
   <String `Effects of fexofenadine, cetirizine and diphen'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `hydramine on psychomotor performance in adult '>
  > # end of ParaLine
  <ParaLine 
   <String `healthy volunteer. JK Science. 2004;6:201–5.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1073092>
  <PgfTag `RefTextNrForts'>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
    <FFamily `Frutiger LT Std 55 Roman'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  7.5 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage UKEnglish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLanguage UKEnglish>
  > # end of Pgf
  <PgfNumString `410.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Font 
    <FTag `'>
    <FLanguage Swedish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 410Y2'>
    <MCurrPage `1361'>
    <Unique 1073091>
   > # end of Marker
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `Ramaekers JG, O\qHanlon JF. Acrivastine, terfen'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `adine and diphenhydramine effects on '>
   <Char DiscHyphen>
   <String `driving '>
  > # end of ParaLine
  <ParaLine 
   <String `performance as a function of dose and time after '>
  > # end of ParaLine
  <ParaLine 
   <String `dosing. Eur J Clin Pharmacol. 1994;47:261–6.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1073108>
  <PgfTag `RefTextNrForts'>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
    <FFamily `Frutiger LT Std 55 Roman'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  7.5 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage UKEnglish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLanguage UKEnglish>
  > # end of Pgf
  <PgfNumString `411.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Font 
    <FTag `'>
    <FLanguage Swedish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 411Y2'>
    <MCurrPage `1361'>
    <Unique 1073107>
   > # end of Marker
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `Vuurman EF, Rikken GH, Muntjewerff ND, de '>
  > # end of ParaLine
  <ParaLine 
   <String `Halleux F, Ramaekers JG. Effects of desloratadine, '>
  > # end of ParaLine
  <ParaLine 
   <String `diphenhydramine, and placebo on driving per'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `formance and psychomotor performance meas'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `urements. Eur J Clin Pharmacol. 2004;60:307–13.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1073104>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `412.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 412Y2'>
    <MCurrPage `1361'>
    <Unique 1073103>
   > # end of Marker
   <Font 
    <FTag `'>
    <FDW  -0.5%>
    <FLocked No>
   > # end of Font
   <String `Verster JC, de Weert AM, Bijtjes SI, Aarab M, van '>
  > # end of ParaLine
  <ParaLine 
   <String `Oosterwijck AW, Eijken EJ, et al. Driving ability af'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ter acute and sub-chronic administration of levo'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `cetirizine and diphenhydramine: a randomized, '>
  > # end of ParaLine
  <ParaLine 
   <String `double-blind, placebo-controlled '>
   <Char DiscHyphen>
   <String `trial. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Psychopharmacology (Berl). 2003;169:84–90.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054555>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `413.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 413Y2'>
    <MCurrPage `1361'>
    <Unique 1065982>
   > # end of Marker
   <String `Richardson GS, Roehrs TA, Rosenthal L, Kosho'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `rek G, Roth T. Tolerance to daytime sedative '>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `effects of H1 antihistamines. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `J Clin Psychopharmacol. 2002;22:511'>
   <Font 
    <FTag `'>
    <FDW  -0.5%>
    <FLocked No>
   > # end of Font
   <String `–'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `5.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1073147>
  <PgfTag `RefTextNrForts'>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
    <FFamily `Frutiger LT Std 55 Roman'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  7.5 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage UKEnglish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLanguage UKEnglish>
  > # end of Pgf
  <PgfNumString `414.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Font 
    <FTag `'>
    <FLanguage Swedish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 414Y2'>
    <MCurrPage `1361'>
    <Unique 1073146>
   > # end of Marker
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `Manning C, Scandale L, Manning E, Gengo F. '>
  > # end of ParaLine
  <ParaLine 
   <String `Central nervous system effects of meclizine and '>
  > # end of ParaLine
  <ParaLine 
   <String `dimenhydrinate: evidence of acute tolerance to '>
  > # end of ParaLine
  <ParaLine 
   <String `antihistamines. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `J Clin Pharmacol. 1992;32:996–1002.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054557>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `415.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <TextRectID 195>
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 415Y2'>
    <MCurrPage `1361'>
    <Unique 1066008>
   > # end of Marker
   <String `Schneider D, Kiessling B, Wieczorek M, Bognar-'>
  > # end of ParaLine
  <ParaLine 
   <String `Steinberg I, Schneider L, Claussen CF. Influence of '>
  > # end of ParaLine
  <ParaLine 
   <String `3 antivertiginous medications on the vigi'>
   <Char DiscHyphen>
   <String `lance of '>
  > # end of ParaLine
  <ParaLine 
   <String `healthy volunteers. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Int J Clin Pharmacol Ther. 2003;41:171–81.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054558>
  <PgfTag `RefTextNrForts'>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
    <FFamily `Frutiger LT Std 55 Roman'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  7.5 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage UKEnglish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLanguage UKEnglish>
  > # end of Pgf
  <PgfNumString `416.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Font 
    <FTag `'>
    <FLanguage Swedish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 416Y2'>
    <MCurrPage `1361'>
    <Unique 1066021>
   > # end of Marker
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `Philipova D, Tzenova B, Iwanowitsch A, Bognar-'>
  > # end of ParaLine
  <ParaLine 
   <String `Steinberg I. Influence of an antivertiginous com'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `bination preparation of cinnarizine and '>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `dimenhydrinate on event-related potentials, re'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `action time and psychomotor performance – a '>
  > # end of ParaLine
  <ParaLine 
   <String `randomized, double-blind, 3-way crossover study '>
  > # end of ParaLine
  <ParaLine 
   <String `in healthy volunteers. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Int J Clin Pharmacol Ther. 2004;42:218–31.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054559>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `417.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 417Y2'>
    <MCurrPage `1361'>
    <Unique 1066034>
   > # end of Marker
   <String `Kanamaru Y, Kikukawa A, Miyamoto Y, '>
   <Char DiscHyphen>
   <String `Hirafuji '>
  > # end of ParaLine
  <ParaLine 
   <String `M. Dimenhydrinate effect on cerebral oxygen '>
  > # end of ParaLine
  <ParaLine 
   <String `status and salivary chromogranin-A during cogni'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tive tasks. Prog Neuropsychopharmacol Biol Psy'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `chiatry. 2008;32:107–15.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054560>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `418.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 418Y2'>
    <MCurrPage `1361'>
    <Unique 1066047>
   > # end of Marker
   <String `Tashiro M, Horikawa E, Mochizuki H, Sakurada '>
  > # end of ParaLine
  <ParaLine 
   <String `Y, Kato M, Inokuchi T, et al. Effects of fexofenadi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ne and hydroxyzine on brake reaction time '>
  > # end of ParaLine
  <ParaLine 
   <String `during car-driving with cellular phone use. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Hum Psychopharmacol. 2005;20:501–9.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1073635>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `419.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 419Y2'>
    <MCurrPage `1361'>
    <Unique 1073634>
   > # end of Marker
   <String `Gengo FM, Dabronzo J, Yurchak A, Love S, Mil'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ler JK. The relative antihistaminic and psychomo'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tor effects of hydroxyzine and cetirizine. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Clin Pharmacol Ther. 1987;42:265–72.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1073637>
  <PgfTag `RefTextNrForts'>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
    <FFamily `Frutiger LT Std 55 Roman'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  7.5 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage UKEnglish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLanguage UKEnglish>
  > # end of Pgf
  <PgfNumString `420.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Font 
    <FTag `'>
    <FLanguage Swedish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 420Y2'>
    <MCurrPage `1361'>
    <Unique 1073636>
   > # end of Marker
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `Vermeeren A, O\qHanlon JF. Fexofenadine\qs '>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `effects, alone and with alcohol, on actual driving '>
  > # end of ParaLine
  <ParaLine 
   <String `and psychomotor performance. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `J Allergy Clin Immunol. 1998;101:306–11.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1073641>
  <PgfTag `RefTextNrForts'>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
    <FFamily `Frutiger LT Std 55 Roman'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  7.5 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage UKEnglish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLanguage UKEnglish>
  > # end of Pgf
  <PgfNumString `421.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Font 
    <FTag `'>
    <FLanguage Swedish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 421Y2'>
    <MCurrPage `1361'>
    <Unique 1073640>
   > # end of Marker
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `Vuurman EF, Uiterwijk MM, Rosenzweig P, '>
  > # end of ParaLine
  <ParaLine 
   <String `O\qHanlon JF. Effects of mizolastine and clema'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `stine on actual driving and psychomotor perfor'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `mance in healthy volunteers. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Eur J Clin Pharmacol. 1994;47:253–9.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1078683>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `422.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 422Y2'>
    <MCurrPage `1361'>
    <Unique 1078682>
   > # end of Marker
   <String `Volkerts ER, van Willigenburg AAP, van Laar '>
  > # end of ParaLine
  <ParaLine 
   <String `MW, Maes RAA. Does cetirizine belong to the '>
  > # end of ParaLine
  <ParaLine 
   <String `new generation of antihistamines? An investiga'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tion into its acute and subcronic effects on high'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `way driving, psychometric test perfor'>
   <Char DiscHyphen>
   <String `mance and '>
  > # end of ParaLine
  <ParaLine 
   <String `daytime sleepiness. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Hum Psychopharmacol. 1992;7:227–38.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1078685>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `423.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 423Y2'>
    <MCurrPage `1361'>
    <Unique 1078684>
   > # end of Marker
   <String `Hindmarch I. The effects of the sub-chronic ad'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ministration of an anti-histamine, clemastine, on '>
  > # end of ParaLine
  <ParaLine 
   <String `tests of car driving ability and psychomotor per'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `formance. Curr Med Res Opin. 1976;4:197–206.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054566>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `424.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 424Y2'>
    <MCurrPage `1361'>
    <Unique 1066125>
   > # end of Marker
   <String `Hindmarch I, Johnson S, Meadows R, Kirkpatrick '>
  > # end of ParaLine
  <ParaLine 
   <String `T, Shamsi Z. The acute and sub-chronic effects of '>
  > # end of ParaLine
  <ParaLine 
   <String `levocetirizine, cetirizine, loratadine, promethazi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ne and placebo on cognitive function, psychomo'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tor performance, and weal and flare. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Curr Med Res Opin. 2001;17:241–55.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054567>
  <PgfTag `RefTextNrForts'>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
    <FFamily `Frutiger LT Std 55 Roman'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  7.5 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage UKEnglish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLanguage UKEnglish>
  > # end of Pgf
  <PgfNumString `425.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <TextRectID 196>
   <Char Tab>
   <Font 
    <FTag `'>
    <FLanguage Swedish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 425Y2'>
    <MCurrPage `1362'>
    <Unique 1066138>
   > # end of Marker
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `Shamsi Z, Kimber S, Hindmarch I. An investiga'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tion into the effects of cetirizine on cognitive '>
  > # end of ParaLine
  <ParaLine 
   <String `function and psychomotor performance in '>
  > # end of ParaLine
  <ParaLine 
   <String `healthy volunteers. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Eur J Clin Pharmacol. 2001;56:865–71.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054568>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `426.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 426Y2'>
    <MCurrPage `1362'>
    <Unique 1066151>
   > # end of Marker
   <String `Hindmarch I, Shamsi Z, Stanley N, Fairweather '>
  > # end of ParaLine
  <ParaLine 
   <String `DB. A double-blind, placebo-controlled investi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `gation of the effects of fexofenadine, loratadine '>
  > # end of ParaLine
  <ParaLine 
   <String `and promethazine on cognitive and psychomo'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tor function. Br J Clin Pharmacol. 1999;48:200–6.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054569>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `427.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 427Y2'>
    <MCurrPage `1362'>
    <Unique 1066164>
   > # end of Marker
   <String `Ridout F, Hindmarch I. The effects of acute doses '>
  > # end of ParaLine
  <ParaLine 
   <String `of fexofenadine, promethazine, and placebo on '>
  > # end of ParaLine
  <ParaLine 
   <String `cognitive and psychomotor function in healthy '>
  > # end of ParaLine
  <ParaLine 
   <String `Japanese volunteers. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Ann Allergy Asthma Immunol. 2003;90:404–10.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1066205>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `428.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 428Y2'>
    <MCurrPage `1362'>
    <Unique 1066204>
   > # end of Marker
   <String `Gengo FM, Gabos C, Mechtler L. Quantitative '>
  > # end of ParaLine
  <ParaLine 
   <String `effects of cetirizine and diphenhydramine on '>
  > # end of ParaLine
  <ParaLine 
   <String `mental performance measured using an automo'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `bile driving simulator. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Ann Allergy. 1990;64:520–6.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1073271>
  <PgfTag `RefTextNrForts'>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
    <FFamily `Frutiger LT Std 55 Roman'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  7.5 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage UKEnglish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLanguage UKEnglish>
  > # end of Pgf
  <PgfNumString `429.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Font 
    <FTag `'>
    <FLanguage Swedish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 429Y2'>
    <MCurrPage `1362'>
    <Unique 1073270>
   > # end of Marker
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `Ramaekers JG, Uiterwijk MM, O\qHanlon JF. '>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `Effects of loratadine and cetirizine on actual '>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `driving and psychometric test performance, and '>
  > # end of ParaLine
  <ParaLine 
   <String `EEG during driving. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Eur J Clin Pharmacol. 1992;42:363–9.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054572>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `430.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 430Y2'>
    <MCurrPage `1362'>
    <Unique 1066225>
   > # end of Marker
   <String `Patat A, Stubbs D, Dunmore C, Ulliac N, Sexton '>
  > # end of ParaLine
  <ParaLine 
   <String `B, Zieleniuk I, et al. Lack of interaction between '>
  > # end of ParaLine
  <ParaLine 
   <String `two antihistamines, mizolastine and cetirizine, '>
  > # end of ParaLine
  <ParaLine 
   <String `and ethanol in psychomotor and driving perfor'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `mance in healthy subjects. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Eur J Clin Pharmacol. 1995;48:143–50.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1073289>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `431.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 431Y2'>
    <MCurrPage `1362'>
    <Unique 1073288>
   > # end of Marker
   <String `Vermeeren A, Ramaekers JG, O\qHanlon JF. '>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `Effects of emedastine and cetirizine, alone and '>
  > # end of ParaLine
  <ParaLine 
   <String `with alcohol, on actual driving of males and '>
  > # end of ParaLine
  <ParaLine 
   <String `females. J Psychopharmacol. 2002;16:57–64.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1073301>
  <PgfTag `RefTextNrForts'>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
    <FFamily `Frutiger LT Std 55 Roman'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  7.5 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage UKEnglish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLanguage UKEnglish>
  > # end of Pgf
  <PgfNumString `432.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Font 
    <FTag `'>
    <FLanguage Swedish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 432Y2'>
    <MCurrPage `1362'>
    <Unique 1073300>
   > # end of Marker
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `Theunissen EL, Vermeeren A, van Oers AC, van '>
  > # end of ParaLine
  <ParaLine 
   <String `Maris I, Ramaekers JG. A dose-ranging study of '>
  > # end of ParaLine
  <ParaLine 
   <String `the effects of mequitazine on actual driving, '>
  > # end of ParaLine
  <ParaLine 
   <String `memory and psychomotor performance as com'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `pared to dexchlorpheniramine, cetirizine and '>
  > # end of ParaLine
  <ParaLine 
   <String `placebo. Clin Exp Allergy. 2004;34:250–8.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1073323>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `433.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 433Y2'>
    <MCurrPage `1362'>
    <Unique 1073322>
   > # end of Marker
   <String `van Ruitenbeek P, Vermeeren A, Riedel WJ. His'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tamine H1 receptor antagonist cetirizine impairs '>
  > # end of ParaLine
  <ParaLine 
   <String `working memory processing speed, but not epi'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `sodic memory. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Br J Pharmacol. 2010;161:456–66.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1073333>
  <PgfTag `RefTextNrForts'>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
    <FFamily `Frutiger LT Std 55 Roman'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  7.5 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage UKEnglish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLanguage UKEnglish>
  > # end of Pgf
  <PgfNumString `434.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Font 
    <FTag `'>
    <FLanguage Swedish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 434Y2'>
    <MCurrPage `1362'>
    <Unique 1073332>
   > # end of Marker
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `Brookhuis KA, De Vries G, De Waard D. Acute '>
  > # end of ParaLine
  <ParaLine 
   <String `and subchronic effects of the H1-histamine re'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ceptor antagonist ebastine in 10, 20 and 30 mg '>
  > # end of ParaLine
  <ParaLine 
   <String `dose, and triprolidine 10 mg on car driving per'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `formance. Br J Clin Pharmacol. 1993;36:67–70.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1073335>
  <PgfTag `RefTextNrForts'>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
    <FFamily `Frutiger LT Std 55 Roman'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  7.5 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage UKEnglish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLanguage UKEnglish>
  > # end of Pgf
  <PgfNumString `435.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Font 
    <FTag `'>
    <FLanguage Swedish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 435Y2'>
    <MCurrPage `1362'>
    <Unique 1073334>
   > # end of Marker
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `O\qHanlon JF, Ramaekers JG. Antihistamine ef'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `fects on actual driving performance in a stan'>
   <Char DiscHyphen>
   <String `dard '>
  > # end of ParaLine
  <ParaLine 
   <TextRectID 196>
   <String `test: a summary of Dutch experience, 1989–94. '>
  > # end of ParaLine
  <ParaLine 
   <String `Allergy. 1995;50:234–42.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054578>
  <PgfTag `RefTextNrForts'>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
    <FFamily `Frutiger LT Std 55 Roman'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  7.5 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage UKEnglish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLanguage UKEnglish>
  > # end of Pgf
  <PgfNumString `436.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Font 
    <FTag `'>
    <FLanguage Swedish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 436Y2'>
    <MCurrPage `1362'>
    <Unique 1066303>
   > # end of Marker
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `Hindmarch, Shamsi Z. The effects of single and '>
  > # end of ParaLine
  <ParaLine 
   <String `repeated administration of ebastine on cogni'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tion and psychomotor performance in compari'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `son to triprolidine and placebo in healthy '>
  > # end of ParaLine
  <ParaLine 
   <String `volunteers. Curr Med Res Opin. 2001;17:273–81.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1089210>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `437.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 437Y2'>
    <MCurrPage `1362'>
    <Unique 1089209>
   > # end of Marker
   <String `Tagawa M, Kano M, Okamura N, Higuchi M, '>
  > # end of ParaLine
  <ParaLine 
   <String `Matsuda M, Mizuki Y, et al. Differential cognitive '>
  > # end of ParaLine
  <ParaLine 
   <String `effects of ebastine and (+)-chlorpheniramine in '>
  > # end of ParaLine
  <ParaLine 
   <String `healthy subjects: correlation between cognitive '>
  > # end of ParaLine
  <ParaLine 
   <String `impairment and plasma drug concentration. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Br J Clin Pharmacol. 2002;53:296–304.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1073347>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `438.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 438Y2'>
    <MCurrPage `1362'>
    <Unique 1073346>
   > # end of Marker
   <String `Magerl M, Schmolke J, Metz M, Zuberbier T, Sie'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `benhaar F, Maurer M. Prevention of signs and '>
  > # end of ParaLine
  <ParaLine 
   <String `symptoms of dermographic urticaria by single-'>
  > # end of ParaLine
  <ParaLine 
   <String `dose ebastine 20 mg. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Clin Exp Dermatol. 2009;34:e137–40.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1073645>
  <PgfTag `RefTextNrForts'>
  <PgfNumString `439.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 439Y2'>
    <MCurrPage `1362'>
    <Unique 1073644>
   > # end of Marker
   <String `Kay GG, Berman B, Mockoviak SH, Morris CE, '>
  > # end of ParaLine
  <ParaLine 
   <String `Reeves D, Starbuck V, et al. Initial and steady-sta'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `te effects of diphenhydramine and lorata'>
   <Char DiscHyphen>
   <String `dine on '>
  > # end of ParaLine
  <ParaLine 
   <String `sedation, cognition, mood, and psychomotor '>
  > # end of ParaLine
  <ParaLine 
   <String `performance. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Arch Intern Med. 1997;157:2350–6.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054829>
  <PgfTag `RefTextNrForts'>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
    <FFamily `Frutiger LT Std 55 Roman'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  7.5 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage UKEnglish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLanguage UKEnglish>
  > # end of Pgf
  <PgfNumString `440.\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <Char Tab>
   <Font 
    <FTag `'>
    <FLanguage Swedish>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `newlink 440Y2'>
    <MCurrPage `1362'>
    <Unique 1066359>
   > # end of Marker
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `Hakkou F, Jaouen C, Iraki L. A comparative study '>
  > # end of ParaLine
  <ParaLine 
   <String `of cyproheptadine and DL carnitine on psycho'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `motor performance and memory in healthy '>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `volunteers. '>
   <Char HardReturn>
  > # end of ParaLine
  <ParaLine 
   <String `Fundam Clin Pharmacol. 1990;4:191–200.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1089429>
  <PgfTag `FaktaText'>
  <Pgf 
   <PgfBotSeparator `Tunn_Tjock'>
  > # end of Pgf
  <ParaLine 
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1028117>
  <PgfTag `Rub1'>
  <PgfReferenced Yes>
  <ParaLine 
   <Marker 
    <MType 9>
    <MTypeName `Cross-Ref'>
    <MText `63239: Rub1: Appendix\x0d '>
    <MCurrPage `1362'>
    <Unique 1082461>
   > # end of Marker
   <String `Appendix'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1028119>
  <PgfTag `Rub2efterRub1'>
  <ParaLine 
   <String `Förkortningar'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1028120>
  <PgfTag `BrödPunkt'>
  <PgfNumString `•\t'>
  <ParaLine 
   <String `ATC – ATC-systemet är fastställt av '>
  > # end of ParaLine
  <ParaLine 
   <String `WHO och betyder ”systemet för anato'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `misk, terapeutisk och kemisk klassifice'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ring av läkemedel”. ATC-systemet är ett '>
  > # end of ParaLine
  <ParaLine 
   <String `farmakologiskt ”alfabet” som berättar '>
  > # end of ParaLine
  <ParaLine 
   <String `om vilken farmakologisk effekt ett läke'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `medel utövar. '>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.700'>
    <FFamily `Times New Roman'>
    <FWeight `Bold'>
    <FEncoding `FrameRoman'>
    <FSize  12.0 pt>
    <FUnderlining FSingle>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1028121>
  <PgfTag `BrödPunkt'>
  <PgfNumString `•\t'>
  <ParaLine 
   <String `BAC – Blodalkoholkoncentration'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1028122>
  <PgfTag `BrödPunkt'>
  <PgfNumString `•\t'>
  <ParaLine 
   <String `BVFS – Banverkets författningssamling'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1028123>
  <PgfTag `BrödPunkt'>
  <PgfNumString `•\t'>
  <ParaLine 
   <String `BGAT – Blood Glucose Awareness '>
  > # end of ParaLine
  <ParaLine 
   <String `Training'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1028125>
  <PgfTag `BrödPunkt'>
  <PgfNumString `•\t'>
  <ParaLine 
   <String `DRUID – Driving under the influence of '>
  > # end of ParaLine
  <ParaLine 
   <String `drugs, alcohol and medicines. EU-pro'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `jekt.'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1028126>
  <PgfTag `BrödPunkt'>
  <PgfNumString `•\t'>
  <ParaLine 
   <TextRectID 197>
   <String `ERP – Event Related Potentials – EEG-'>
  > # end of ParaLine
  <ParaLine 
   <String `reaktion på visuella eller audiella sti'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `muli '>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1028127>
  <PgfTag `BrödPunkt'>
  <PgfNumString `•\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `FDA – Food and Drug Administration – '>
  > # end of ParaLine
  <ParaLine 
   <String `USA:s motsvarighet till Läkemedelsver'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ket'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1043991>
  <PgfTag `BrödPunkt'>
  <PgfNumString `•\t'>
  <ParaLine 
   <String `GLP1 – Glukagonliknande peptid 1'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1043992>
  <PgfTag `BrödPunkt'>
  <PgfNumString `•\t'>
  <ParaLine 
   <String `HbA'>
   <Font 
    <FTag `'>
    <FPosition FSubscript>
    <FLocked No>
   > # end of Font
   <String `1c'>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String ` – Ett protein som speglar blod'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `sockerläget under en längre period'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1028130>
  <PgfTag `BrödPunkt'>
  <PgfNumString `•\t'>
  <ParaLine 
   <String `ICADS – The International Council on '>
  > # end of ParaLine
  <ParaLine 
   <String `Alcohol & Drug Safety'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1028133>
  <PgfTag `BrödPunkt'>
  <PgfNumString `•\t'>
  <ParaLine 
   <String `LEAD – Liraglutide Effect and Action in '>
  > # end of ParaLine
  <ParaLine 
   <String `Diabetes'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1028134>
  <PgfTag `BrödPunkt'>
  <PgfNumString `•\t'>
  <ParaLine 
   <String `NSAID – Non-steroidal anti-inflamma'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tory drug'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
   <String `s'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1028135>
  <PgfTag `BrödPunkt'>
  <PgfNumString `•\t'>
  <ParaLine 
   <String `LSFS – Luftfartsstyrelsens författ'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ningssamling'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1028136>
  <PgfTag `BrödPunkt'>
  <PgfNumString `•\t'>
  <ParaLine 
   <String `LVFS – Läkemedelsverkets författ'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ningssamling'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1028137>
  <PgfTag `BrödPunkt'>
  <PgfNumString `•\t'>
  <ParaLine 
   <String `P300 – se ERP, reaktion vid audiellt '>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `stimuli'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1028139>
  <PgfTag `BrödPunkt'>
  <PgfNumString `•\t'>
  <ParaLine 
   <String `PubMed – PubMed is a free database '>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `accessing primarily the MEDLINE '>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `database of citations and abstracts on '>
  > # end of ParaLine
  <ParaLine 
   <String `life sciences and biomedical topics '>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1028140>
  <PgfTag `BrödPunkt'>
  <PgfNumString `•\t'>
  <ParaLine 
   <String `SFS – Svensk författningssamling'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1028141>
  <PgfTag `BrödPunkt'>
  <PgfNumString `•\t'>
  <ParaLine 
   <String `SSRI – Selektiva serotoninåterupptags'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `hämmare'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1028142>
  <PgfTag `BrödPunkt'>
  <PgfNumString `•\t'>
  <ParaLine 
   <String `SU – Sulfonylurea, en grupp perorala '>
  > # end of ParaLine
  <ParaLine 
   <String `antidiabetika'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1028143>
  <PgfTag `BrödPunkt'>
  <PgfNumString `•\t'>
  <ParaLine 
   <String `TBL – Trafikbrottslagen'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1028144>
  <PgfTag `BrödPunktSista'>
  <PgfNumString `•\t'>
  <ParaLine 
   <String `TSFS – Transportstyrelsens författ'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ningssamling'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1028146>
  <PgfTag `Rub2'>
  <Pgf 
   <PgfPlacement ColumnTop>
  > # end of Pgf
  <PgfReferenced Yes>
  <ParaLine 
   <TextRectID 197>
   <Marker 
    <MType 9>
    <MTypeName `Cross-Ref'>
    <MText `55866: Rub2: Tester\x0d '>
    <MCurrPage `1363'>
    <Unique 1082474>
   > # end of Marker
   <String `Tester'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1089256>
  <PgfTag `BrödPunkt'>
  <PgfNumString `•\t'>
  <ParaLine 
   <Font 
    <FTag `'>
    <FLanguage USEnglish>
    <FLocked No>
   > # end of Font
   <String `ART90 – Act and React Testsystem. '>
   <Font 
    <FTag `'>
    <FLocked No>
   > # end of Font
   <String `An'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `vänds framför allt i Tyskland och Öster'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `rike'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1089260>
  <PgfTag `BrödPunkt'>
  <PgfNumString `•\t'>
  <ParaLine 
   <String `Brickenkamps d2-test mäter koncentra'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tion, uppmärksamhet och processhas'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `tighet'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1089261>
  <PgfTag `BrödPunkt'>
  <PgfNumString `•\t'>
  <ParaLine 
   <String `CFF – Critical Flicker Frequency – frek'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `vensen där ett blinkande ljus uppfattas '>
  > # end of ParaLine
  <ParaLine 
   <String `som konstant. Testet kallas ibland '>
  > # end of ParaLine
  <ParaLine 
   <String `CFFT (Critical Flicker Fusion Test).'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1054134>
  <PgfTag `BrödPunkt'>
  <PgfNumString `•\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `CRT – Conditioned Reaction Time – '>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `Reaktionstid mätt när man först ska '>
  > # end of ParaLine
  <ParaLine 
   <Char DiscHyphen>
   <String `bedöma om givet villkor är uppfyllt. (Ex'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `empelvis ska man reagera på ett visst '>
  > # end of ParaLine
  <ParaLine 
   <String `stimulus, men om en grön lampa lyser i '>
  > # end of ParaLine
  <ParaLine 
   <String `ett visst hörn ska man inte reagera alls.)'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1089216>
  <PgfTag `BrödPunkt'>
  <PgfNumString `•\t'>
  <ParaLine 
   <String `MMSE – Svensk variant heter MMT '>
  > # end of ParaLine
  <ParaLine 
   <String `(Mini-mental test) av Folstein och med'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `arbetare'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1089217>
  <PgfTag `BrödPunkt'>
  <PgfNumString `•\t'>
  <ParaLine 
   <String `Sternbergs test – Ett sifferminnestest'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1028153>
  <PgfTag `BrödPunkt'>
  <PgfNumString `•\t'>
  <ParaLine 
   <String `Track test – Med ratt eller joystick följer '>
  > # end of ParaLine
  <ParaLine 
   <String `man en krokig linje på en dataskärm – '>
  > # end of ParaLine
  <ParaLine 
   <String `avvikelserna (storlek och duration) re'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `gistreras'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1028154>
  <PgfTag `BrödPunkt'>
  <PgfNumString `•\t'>
  <PgfReferenced Yes>
  <ParaLine 
   <String `Wiener Test System (WTS) – En sam'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `ling av datoriserade intelligens- och kog'>
   <Char SoftHyphen>
  > # end of ParaLine
  <ParaLine 
   <String `nitiva test'>
   <Font 
    <FTag `'>
    <FPlatformName `W.Times New Roman.R.400'>
    <FFamily `Times New Roman'>
    <FEncoding `FrameRoman'>
    <FLocked No>
   > # end of Font
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1086103>
  <Pgf 
   <PgfTag `Footer'>
   <PgfAlignment LeftRight>
   <PgfLIndent  0.0 mm>
   <PgfRunInDefaultPunct `. '>
   <PgfSpBefore  0.0 pt>
   <PgfBlockSize 1>
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
    <FFamily `Frutiger LT Std 55 Roman'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  7.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage UKEnglish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLeading  2.0 pt>
   <PgfAutoNum No>
   <PgfNumTabs 2>
   <TabStop 
    <TSX  67.0 mm>
    <TSType Center>
    <TSLeaderStr ` '>
   > # end of TabStop
   <TabStop 
    <TSX  134.0 mm>
    <TSType Right>
    <TSLeaderStr ` '>
   > # end of TabStop
   <PgfPDFStructureLevel 0>
   <PgfLanguage UKEnglish>
  > # end of Pgf
  <ParaLine 
   <TextRectID 57>
   <String `Läkemedelsverket'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1086104>
  <ParaLine 
   <String `Läkemedelsboken 2014'>
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <TFTag `A'>
 <TFAutoConnect Yes>
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1086105>
  <Pgf 
   <PgfTag `Body'>
   <PgfUseNextTag Yes>
   <PgfNextTag `KapRub'>
   <PgfAlignment Right>
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
    <FFamily `Frutiger LT Std 45 Light'>
    <FVar `Regular'>
    <FWeight `Bold'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Bold'>
    <FEncoding `FrameRoman'>
    <FSize  7.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLeading  1.7 pt>
   <PgfNumTabs 0>
   <PgfPDFStructureLevel 0>
   <PgfLanguage Swedish>
  > # end of Pgf
  <ParaLine 
   <TextRectID 58>
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1086135>
  <ParaLine 
   <TextRectID 63>
   <Variable 
    <VariableName `Avsnittsnamn'>
    <Unique 1086133>
   > # end of Variable
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1086139>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
    <FFamily `Frutiger LT Std 55 Roman'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  7.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
  > # end of Pgf
  <ParaLine 
   <Variable 
    <VariableName `Kapitelnamn'>
    <Unique 1086137>
   > # end of Variable
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1086143>
  <Pgf 
   <PgfTag `Header'>
   <PgfUseNextTag No>
   <PgfNextTag `'>
   <PgfAlignment Left>
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
    <FFamily `Frutiger LT Std 45 Light'>
    <FVar `Regular'>
    <FWeight `Bold'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Bold'>
    <FEncoding `FrameRoman'>
    <FSize  14.5 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  -4.0%>
    <FStretch  100.0%>
    <FLanguage UKEnglish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLeading  3.0 pt>
   <PgfNumTabs 2>
   <TabStop 
    <TSX  67.0 mm>
    <TSType Center>
    <TSLeaderStr ` '>
   > # end of TabStop
   <TabStop 
    <TSX  134.0 mm>
    <TSType Right>
    <TSLeaderStr ` '>
   > # end of TabStop
   <PgfPDFStructureLevel 0>
   <PgfLanguage UKEnglish>
  > # end of Pgf
  <ParaLine 
   <TextRectID 64>
   <Variable 
    <VariableName `Current Page #'>
    <Unique 1086141>
   > # end of Variable
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1086144>
  <Pgf 
   <PgfTag `Footer'>
   <PgfAlignment Right>
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
    <FFamily `Frutiger LT Std 55 Roman'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  7.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage UKEnglish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLeading  2.0 pt>
   <PgfPDFStructureLevel 0>
  > # end of Pgf
  <ParaLine 
   <TextRectID 65>
   <String `Läkemedelsverket'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1086145>
  <ParaLine 
   <String `Läkemedelsboken 2014'>
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <TFTag `A'>
 <TFAutoConnect Yes>
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1086146>
  <Pgf 
   <PgfTag `Body'>
   <PgfUseNextTag Yes>
   <PgfNextTag `KapRub'>
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
    <FFamily `Frutiger LT Std 45 Light'>
    <FVar `Regular'>
    <FWeight `Bold'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Bold'>
    <FEncoding `FrameRoman'>
    <FSize  7.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLeading  1.7 pt>
   <PgfNumTabs 0>
   <PgfPDFStructureLevel 0>
   <PgfLanguage Swedish>
  > # end of Pgf
  <ParaLine 
   <TextRectID 66>
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1086109>
  <Pgf 
   <PgfAlignment Left>
  > # end of Pgf
  <ParaLine 
   <TextRectID 59>
   <Variable 
    <VariableName `Avsnittsnamn'>
    <Unique 1086107>
   > # end of Variable
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1086113>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
    <FFamily `Frutiger LT Std 55 Roman'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  7.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
  > # end of Pgf
  <ParaLine 
   <Variable 
    <VariableName `Kapitelnamn'>
    <Unique 1086111>
   > # end of Variable
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1086170>
  <Pgf 
   <PgfTag `Header'>
   <PgfUseNextTag No>
   <PgfNextTag `'>
   <PgfAlignment Right>
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
    <FFamily `Frutiger LT Std 45 Light'>
    <FVar `Regular'>
    <FWeight `Bold'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Bold'>
    <FEncoding `FrameRoman'>
    <FSize  14.5 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  -4.0%>
    <FStretch  100.0%>
    <FLanguage UKEnglish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLeading  3.0 pt>
   <PgfNumTabs 2>
   <TabStop 
    <TSX  67.0 mm>
    <TSType Center>
    <TSLeaderStr ` '>
   > # end of TabStop
   <TabStop 
    <TSX  134.0 mm>
    <TSType Right>
    <TSLeaderStr ` '>
   > # end of TabStop
   <PgfPDFStructureLevel 0>
   <PgfLanguage UKEnglish>
  > # end of Pgf
  <ParaLine 
   <TextRectID 70>
   <Variable 
    <VariableName `Current Page #'>
    <Unique 1086168>
   > # end of Variable
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1086171>
  <Pgf 
   <PgfTag `Footer'>
   <PgfAlignment LeftRight>
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
    <FFamily `Frutiger LT Std 55 Roman'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  7.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage UKEnglish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLeading  2.0 pt>
   <PgfPDFStructureLevel 0>
  > # end of Pgf
  <ParaLine 
   <TextRectID 71>
   <String `Läkemedelsverket'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1086172>
  <ParaLine 
   <String `Läkemedelsboken 2014'>
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <TFTag `A'>
 <TFAutoConnect Yes>
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1086173>
  <Pgf 
   <PgfTag `Body'>
   <PgfUseNextTag Yes>
   <PgfNextTag `KapRub'>
   <PgfAlignment Right>
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
    <FFamily `Frutiger LT Std 45 Light'>
    <FVar `Regular'>
    <FWeight `Bold'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Bold'>
    <FEncoding `FrameRoman'>
    <FSize  7.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLeading  1.7 pt>
   <PgfNumTabs 0>
   <PgfPDFStructureLevel 0>
   <PgfLanguage Swedish>
  > # end of Pgf
  <ParaLine 
   <TextRectID 72>
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1086177>
  <Pgf 
   <PgfAlignment Left>
  > # end of Pgf
  <ParaLine 
   <TextRectID 73>
   <Variable 
    <VariableName `Avsnittsnamn'>
    <Unique 1086175>
   > # end of Variable
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1086181>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
    <FFamily `Frutiger LT Std 55 Roman'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  7.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
  > # end of Pgf
  <ParaLine 
   <Variable 
    <VariableName `Kapitelnamn'>
    <Unique 1086179>
   > # end of Variable
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1086205>
  <Pgf 
   <PgfAlignment Right>
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
    <FFamily `Frutiger LT Std 45 Light'>
    <FVar `Regular'>
    <FWeight `Bold'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Bold'>
    <FEncoding `FrameRoman'>
    <FSize  7.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
  > # end of Pgf
  <ParaLine 
   <TextRectID 77>
   <Variable 
    <VariableName `Avsnittsnamn'>
    <Unique 1086203>
   > # end of Variable
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1086209>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
    <FFamily `Frutiger LT Std 55 Roman'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  7.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
  > # end of Pgf
  <ParaLine 
   <Variable 
    <VariableName `Kapitelnamn'>
    <Unique 1086207>
   > # end of Variable
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <TFTag `A'>
 <TFAutoConnect Yes>
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1086210>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
    <FFamily `Frutiger LT Std 45 Light'>
    <FVar `Regular'>
    <FWeight `Bold'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Bold'>
    <FEncoding `FrameRoman'>
    <FSize  7.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
  > # end of Pgf
  <ParaLine 
   <TextRectID 78>
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1086214>
  <Pgf 
   <PgfTag `Header'>
   <PgfUseNextTag No>
   <PgfNextTag `'>
   <PgfAlignment Left>
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
    <FFamily `Frutiger LT Std 45 Light'>
    <FVar `Regular'>
    <FWeight `Bold'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Bold'>
    <FEncoding `FrameRoman'>
    <FSize  14.5 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  -4.0%>
    <FStretch  100.0%>
    <FLanguage UKEnglish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLeading  3.0 pt>
   <PgfNumTabs 2>
   <TabStop 
    <TSX  67.0 mm>
    <TSType Center>
    <TSLeaderStr ` '>
   > # end of TabStop
   <TabStop 
    <TSX  134.0 mm>
    <TSType Right>
    <TSLeaderStr ` '>
   > # end of TabStop
   <PgfPDFStructureLevel 0>
   <PgfLanguage UKEnglish>
  > # end of Pgf
  <ParaLine 
   <TextRectID 79>
   <Variable 
    <VariableName `Current Page #'>
    <Unique 1086212>
   > # end of Variable
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1086215>
  <Pgf 
   <PgfTag `Footer'>
   <PgfAlignment Right>
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
    <FFamily `Frutiger LT Std 55 Roman'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  7.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage UKEnglish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLeading  2.0 pt>
   <PgfPDFStructureLevel 0>
  > # end of Pgf
  <ParaLine 
   <TextRectID 80>
   <String `Läkemedelsverket'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1086216>
  <ParaLine 
   <String `Läkemedelsboken 2014'>
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <TFTag `A'>
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1086241>
  <Pgf 
   <PgfTag `Body'>
   <PgfUseNextTag Yes>
   <PgfNextTag `KapRub'>
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
    <FFamily `Frutiger LT Std 45 Light'>
    <FVar `Regular'>
    <FWeight `Bold'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Bold'>
    <FEncoding `FrameRoman'>
    <FSize  7.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLeading  1.7 pt>
   <PgfNumTabs 0>
   <PgfPDFStructureLevel 0>
   <PgfLanguage Swedish>
  > # end of Pgf
  <ParaLine 
   <TextRectID 84>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1086242>
  <PgfTag `KapRub'>
  <ParaLine 
   <TextRectID 85>
   <String `KapRub'>
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1086246>
  <Pgf 
   <PgfTag `Header'>
   <PgfUseNextTag No>
   <PgfNextTag `'>
   <PgfAlignment Right>
   <PgfPlacement Anywhere>
   <PgfRunInDefaultPunct `. '>
   <PgfSpAfter  0.0 pt>
   <PgfBlockSize 1>
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
    <FFamily `Frutiger LT Std 55 Roman'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  7.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLeading  1.0 pt>
   <PgfNumTabs 2>
   <TabStop 
    <TSX  67.0 mm>
    <TSType Center>
    <TSLeaderStr ` '>
   > # end of TabStop
   <TabStop 
    <TSX  134.0 mm>
    <TSType Right>
    <TSLeaderStr ` '>
   > # end of TabStop
   <PgfAcrobatLevel 0>
   <PgfPDFStructureLevel 0>
  > # end of Pgf
  <ParaLine 
   <TextRectID 86>
   <Variable 
    <VariableName `Kapitelnamn'>
    <Unique 1086244>
   > # end of Variable
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1086250>
  <Pgf 
   <PgfAlignment Left>
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
    <FFamily `Frutiger LT Std 45 Light'>
    <FVar `Regular'>
    <FWeight `Bold'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Bold'>
    <FEncoding `FrameRoman'>
    <FSize  14.5 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  -4.0%>
    <FStretch  100.0%>
    <FLanguage UKEnglish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLeading  3.0 pt>
   <PgfLanguage UKEnglish>
  > # end of Pgf
  <ParaLine 
   <TextRectID 88>
   <Variable 
    <VariableName `Current Page #'>
    <Unique 1086248>
   > # end of Variable
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1086251>
  <Pgf 
   <PgfTag `Footer'>
   <PgfAlignment Right>
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
    <FFamily `Frutiger LT Std 55 Roman'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  7.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage UKEnglish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLeading  2.0 pt>
   <PgfPDFStructureLevel 0>
  > # end of Pgf
  <ParaLine 
   <TextRectID 89>
   <String `Läkemedelsverket'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1086252>
  <ParaLine 
   <String `Läkemedelsboken 2014'>
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1086277>
  <Pgf 
   <PgfTag `Header'>
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
    <FFamily `Frutiger LT Std 45 Light'>
    <FVar `Regular'>
    <FWeight `Bold'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Bold'>
    <FEncoding `FrameRoman'>
    <FSize  14.5 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  -4.0%>
    <FStretch  100.0%>
    <FLanguage UKEnglish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLeading  3.0 pt>
   <PgfPDFStructureLevel 0>
  > # end of Pgf
  <ParaLine 
   <TextRectID 107>
   <Variable 
    <VariableName `Current Page #'>
    <Unique 1086275>
   > # end of Variable
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1086278>
  <Pgf 
   <PgfTag `Footer'>
   <PgfAlignment LeftRight>
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
    <FFamily `Frutiger LT Std 55 Roman'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  7.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage UKEnglish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLeading  2.0 pt>
   <PgfPDFStructureLevel 0>
  > # end of Pgf
  <ParaLine 
   <TextRectID 108>
   <String `Läkemedelsverket'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1086279>
  <ParaLine 
   <String `Läkemedelsboken 2014'>
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <TFTag `A'>
 <TFAutoConnect Yes>
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1086280>
  <Pgf 
   <PgfTag `Body'>
   <PgfUseNextTag Yes>
   <PgfNextTag `KapRub'>
   <PgfAlignment Right>
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
    <FFamily `Frutiger LT Std 45 Light'>
    <FVar `Regular'>
    <FWeight `Bold'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Bold'>
    <FEncoding `FrameRoman'>
    <FSize  7.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLeading  1.7 pt>
   <PgfNumTabs 0>
   <PgfPDFStructureLevel 0>
   <PgfLanguage Swedish>
  > # end of Pgf
  <ParaLine 
   <TextRectID 109>
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1086284>
  <Pgf 
   <PgfAlignment Left>
  > # end of Pgf
  <ParaLine 
   <TextRectID 110>
   <Variable 
    <VariableName `Avsnittsnamn'>
    <Unique 1086282>
   > # end of Variable
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1086288>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
    <FFamily `Frutiger LT Std 55 Roman'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  7.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
  > # end of Pgf
  <ParaLine 
   <Variable 
    <VariableName `Kapitelnamn'>
    <Unique 1086286>
   > # end of Variable
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1086311>
  <Pgf 
   <PgfAlignment Right>
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
    <FFamily `Frutiger LT Std 45 Light'>
    <FVar `Regular'>
    <FWeight `Bold'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Bold'>
    <FEncoding `FrameRoman'>
    <FSize  7.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
  > # end of Pgf
  <ParaLine 
   <TextRectID 114>
   <Variable 
    <VariableName `Avsnittsnamn'>
    <Unique 1086309>
   > # end of Variable
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1086315>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
    <FFamily `Frutiger LT Std 55 Roman'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  7.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
  > # end of Pgf
  <ParaLine 
   <Variable 
    <VariableName `Kapitelnamn'>
    <Unique 1086313>
   > # end of Variable
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <TFTag `A'>
 <TFAutoConnect Yes>
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1086316>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
    <FFamily `Frutiger LT Std 45 Light'>
    <FVar `Regular'>
    <FWeight `Bold'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Bold'>
    <FEncoding `FrameRoman'>
    <FSize  7.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
  > # end of Pgf
  <ParaLine 
   <TextRectID 115>
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1086320>
  <Pgf 
   <PgfTag `Header'>
   <PgfUseNextTag No>
   <PgfNextTag `'>
   <PgfAlignment Left>
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
    <FFamily `Frutiger LT Std 45 Light'>
    <FVar `Regular'>
    <FWeight `Bold'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Bold'>
    <FEncoding `FrameRoman'>
    <FSize  14.5 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  -4.0%>
    <FStretch  100.0%>
    <FLanguage UKEnglish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLeading  3.0 pt>
   <PgfNumTabs 2>
   <TabStop 
    <TSX  67.0 mm>
    <TSType Center>
    <TSLeaderStr ` '>
   > # end of TabStop
   <TabStop 
    <TSX  134.0 mm>
    <TSType Right>
    <TSLeaderStr ` '>
   > # end of TabStop
   <PgfPDFStructureLevel 0>
   <PgfLanguage UKEnglish>
  > # end of Pgf
  <ParaLine 
   <TextRectID 116>
   <Variable 
    <VariableName `Current Page #'>
    <Unique 1086318>
   > # end of Variable
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1086321>
  <Pgf 
   <PgfTag `Footer'>
   <PgfAlignment Right>
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
    <FFamily `Frutiger LT Std 55 Roman'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  7.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage UKEnglish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLeading  2.0 pt>
   <PgfPDFStructureLevel 0>
  > # end of Pgf
  <ParaLine 
   <TextRectID 117>
   <String `Läkemedelsverket'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1086322>
  <ParaLine 
   <String `Läkemedelsboken 2014'>
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1014940>
  <Pgf 
   <PgfTag `Header'>
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
    <FFamily `Frutiger LT Std 45 Light'>
    <FVar `Regular'>
    <FWeight `Bold'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Bold'>
    <FEncoding `FrameRoman'>
    <FSize  20.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  -4.0%>
    <FStretch  93.0%>
    <FLanguage UKEnglish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLeading  4.0 pt>
   <PgfPDFStructureLevel 0>
  > # end of Pgf
  <ParaLine 
   <TextRectID 93>
   <Variable 
    <VariableName `Current Page #'>
    <Unique 1014938>
   > # end of Variable
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1014941>
  <Pgf 
   <PgfTag `Footer'>
   <PgfAlignment LeftRight>
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
    <FFamily `Frutiger LT Std 55 Roman'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  7.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage UKEnglish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLeading  2.0 pt>
   <PgfPDFStructureLevel 0>
  > # end of Pgf
  <ParaLine 
   <TextRectID 94>
   <String `Läkemedelsverket'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1014942>
  <ParaLine 
   <String `Läkemedelsboken 2014'>
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <TFTag `A'>
 <TFAutoConnect Yes>
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1014943>
  <Pgf 
   <PgfTag `Body'>
   <PgfUseNextTag Yes>
   <PgfNextTag `KapRub'>
   <PgfAlignment Right>
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
    <FFamily `Frutiger LT Std 45 Light'>
    <FVar `Regular'>
    <FWeight `Bold'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Bold'>
    <FEncoding `FrameRoman'>
    <FSize  7.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLeading  1.7 pt>
   <PgfNumTabs 0>
   <PgfPDFStructureLevel 0>
   <PgfLanguage Swedish>
  > # end of Pgf
  <ParaLine 
   <TextRectID 95>
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1014947>
  <Pgf 
   <PgfAlignment Left>
  > # end of Pgf
  <ParaLine 
   <TextRectID 96>
   <Variable 
    <VariableName `Avsnittsnamn'>
    <Unique 1014945>
   > # end of Variable
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1014951>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
    <FFamily `Frutiger LT Std 55 Roman'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  7.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
  > # end of Pgf
  <ParaLine 
   <Variable 
    <VariableName `Kapitelnamn'>
    <Unique 1014949>
   > # end of Variable
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1086395>
  <Pgf 
   <PgfAlignment Center>
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
    <FFamily `Frutiger LT Std 45 Light'>
    <FVar `Regular'>
    <FWeight `Bold'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Bold'>
    <FEncoding `FrameRoman'>
    <FSize  2.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLeading  0.0 pt>
  > # end of Pgf
  <ParaLine 
   <TextRectID 121>
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1086396>
  <Pgf 
   <PgfAlignment Right>
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
    <FFamily `Frutiger LT Std 45 Light'>
    <FVar `Regular'>
    <FWeight `Bold'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Bold'>
    <FEncoding `FrameRoman'>
    <FSize  7.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLeading  1.7 pt>
  > # end of Pgf
  <ParaLine 
   <TextRectID 124>
   <String `1'>
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <TFTag `HTML'>
 <TFAutoConnect Yes>
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1086940>
  <ParaLine 
   <TextRectID 132>
   <ATbl 2>
   <ATbl 3>
   <ATbl 4>
   <ATbl 5>
   <ATbl 6>
   <ATbl 7>
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <TFTag `A'>
 <TFAutoConnect Yes>
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1014970>
  <PgfTag `Bröd'>
  <ParaLine 
   <TextRectID 101>
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1014974>
  <Pgf 
   <PgfTag `Header'>
   <PgfUseNextTag No>
   <PgfNextTag `'>
   <PgfAlignment Left>
   <PgfRunInDefaultPunct `. '>
   <PgfBlockSize 1>
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
    <FFamily `Frutiger LT Std 45 Light'>
    <FVar `Regular'>
    <FWeight `Bold'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Bold'>
    <FEncoding `FrameRoman'>
    <FSize  20.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  -4.0%>
    <FStretch  93.0%>
    <FLanguage UKEnglish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLeading  4.0 pt>
   <PgfNumTabs 2>
   <TabStop 
    <TSX  67.0 mm>
    <TSType Center>
    <TSLeaderStr ` '>
   > # end of TabStop
   <TabStop 
    <TSX  134.0 mm>
    <TSType Right>
    <TSLeaderStr ` '>
   > # end of TabStop
   <HyphenMaxLines 2>
   <PgfPDFStructureLevel 0>
   <PgfLanguage UKEnglish>
  > # end of Pgf
  <ParaLine 
   <TextRectID 102>
   <Variable 
    <VariableName `Current Page #'>
    <Unique 1014972>
   > # end of Variable
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1014975>
  <Pgf 
   <PgfTag `Footer'>
   <PgfAlignment Right>
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
    <FFamily `Frutiger LT Std 55 Roman'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  7.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage UKEnglish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLeading  2.0 pt>
   <PgfPDFStructureLevel 0>
  > # end of Pgf
  <ParaLine 
   <TextRectID 103>
   <String `Läkemedelsverket'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1014976>
  <ParaLine 
   <String `Läkemedelsboken 2014'>
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <TFTag `Headings'>
 <TFAutoConnect Yes>
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1087013>
  <Pgf 
   <PgfTag `Body'>
   <PgfUseNextTag Yes>
   <PgfNextTag `KapRub'>
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
    <FFamily `Frutiger LT Std 45 Light'>
    <FVar `Regular'>
    <FWeight `Bold'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Bold'>
    <FEncoding `FrameRoman'>
    <FSize  7.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLeading  1.7 pt>
   <PgfNumTabs 0>
   <PgfPDFStructureLevel 0>
   <PgfLanguage Swedish>
  > # end of Pgf
  <ParaLine 
   <TextRectID 144>
   <ATbl 8>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1087014>
  <ParaLine 
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1086397>
  <Pgf 
   <PgfAlignment Center>
  > # end of Pgf
  <ParaLine 
   <TextRectID 126>
   <String `1'>
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1086000>
  <Pgf 
   <PgfTag `Header'>
   <PgfUseNextTag No>
   <PgfNextTag `'>
   <PgfAlignment Right>
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
    <FFamily `Frutiger LT Std 45 Light'>
    <FVar `Regular'>
    <FWeight `Bold'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Bold'>
    <FEncoding `FrameRoman'>
    <FSize  14.5 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  -4.0%>
    <FStretch  100.0%>
    <FLanguage UKEnglish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLeading  3.0 pt>
   <PgfNumTabs 2>
   <TabStop 
    <TSX  67.0 mm>
    <TSType Center>
    <TSLeaderStr ` '>
   > # end of TabStop
   <TabStop 
    <TSX  134.0 mm>
    <TSType Right>
    <TSLeaderStr ` '>
   > # end of TabStop
   <PgfPDFStructureLevel 0>
   <PgfLanguage UKEnglish>
  > # end of Pgf
  <ParaLine 
   <TextRectID 34>
   <Variable 
    <VariableName `Current Page #'>
    <Unique 1085998>
   > # end of Variable
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1086001>
  <Pgf 
   <PgfTag `Footer'>
   <PgfAlignment LeftRight>
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
    <FFamily `Frutiger LT Std 55 Roman'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  7.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage UKEnglish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLeading  2.0 pt>
   <PgfPDFStructureLevel 0>
  > # end of Pgf
  <ParaLine 
   <TextRectID 35>
   <String `Läkemedelsverket'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1086002>
  <ParaLine 
   <String `Läkemedelsboken 2014'>
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1086006>
  <Pgf 
   <PgfTag `Body'>
   <PgfUseNextTag Yes>
   <PgfNextTag `KapRub'>
   <PgfAlignment Left>
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
    <FFamily `Frutiger LT Std 45 Light'>
    <FVar `Regular'>
    <FWeight `Bold'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Bold'>
    <FEncoding `FrameRoman'>
    <FSize  7.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLeading  1.7 pt>
   <PgfNumTabs 0>
   <PgfPDFStructureLevel 0>
   <PgfLanguage Swedish>
  > # end of Pgf
  <ParaLine 
   <TextRectID 36>
   <Variable 
    <VariableName `Avsnittsnamn'>
    <Unique 1086004>
   > # end of Variable
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1086010>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
    <FFamily `Frutiger LT Std 55 Roman'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  7.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
  > # end of Pgf
  <ParaLine 
   <Variable 
    <VariableName `Kapitelnamn'>
    <Unique 1086008>
   > # end of Variable
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <TFTag `A'>
 <TFAutoConnect Yes>
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1086011>
  <Pgf 
   <PgfAlignment Right>
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
    <FFamily `Frutiger LT Std 45 Light'>
    <FVar `Regular'>
    <FWeight `Bold'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Bold'>
    <FEncoding `FrameRoman'>
    <FSize  7.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
  > # end of Pgf
  <ParaLine 
   <TextRectID 37>
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1086400>
  <Pgf 
   <PgfUseNextTag No>
   <PgfNextTag `'>
   <PgfAlignment LeftRight>
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
    <FFamily `Frutiger LT Std 45 Light'>
    <FVar `Regular'>
    <FWeight `Bold'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Bold'>
    <FEncoding `FrameRoman'>
    <FSize  7.5 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLeading  2.0 pt>
  > # end of Pgf
  <ParaLine 
   <TextRectID 127>
   <AFrame 1>
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1086944>
  <Pgf 
   <PgfUseNextTag Yes>
   <PgfNextTag `KapRub'>
   <PgfAlignment Center>
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
    <FFamily `Frutiger LT Std 45 Light'>
    <FVar `Regular'>
    <FWeight `Bold'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Bold'>
    <FEncoding `FrameRoman'>
    <FSize  20.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLeading  0.0 pt>
  > # end of Pgf
  <ParaLine 
   <TextRectID 134>
   <ATbl 10>
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1086948>
  <ParaLine 
   <TextRectID 135>
   <ATbl 11>
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1031352>
  <PgfTag `Bröd'>
  <ParaLine 
   <TextRectID 164>
   <ATbl 9>
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1085890>
  <Pgf 
   <PgfTag `Header'>
   <PgfUseNextTag No>
   <PgfNextTag `'>
   <PgfAlignment Right>
   <PgfRunInDefaultPunct `. '>
   <PgfBlockSize 1>
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
    <FFamily `Frutiger LT Std 45 Light'>
    <FVar `Regular'>
    <FWeight `Bold'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Bold'>
    <FEncoding `FrameRoman'>
    <FSize  14.5 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  -4.0%>
    <FStretch  100.0%>
    <FLanguage UKEnglish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLeading  3.0 pt>
   <PgfNumTabs 2>
   <TabStop 
    <TSX  67.0 mm>
    <TSType Center>
    <TSLeaderStr ` '>
   > # end of TabStop
   <TabStop 
    <TSX  134.0 mm>
    <TSType Right>
    <TSLeaderStr ` '>
   > # end of TabStop
   <HyphenMaxLines 2>
   <PgfPDFStructureLevel 0>
   <PgfLanguage UKEnglish>
  > # end of Pgf
  <ParaLine 
   <TextRectID 12>
   <Variable 
    <VariableName `Current Page #'>
    <Unique 1085888>
   > # end of Variable
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <TFTag `A'>
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1085959>
  <PgfTag `KapRub'>
  <ParaLine 
   <TextRectID 26>
   <String `KapRub'>
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1085963>
  <Pgf 
   <PgfTag `Header'>
   <PgfUseNextTag No>
   <PgfNextTag `'>
   <PgfAlignment Left>
   <PgfPlacement Anywhere>
   <PgfRunInDefaultPunct `. '>
   <PgfSpAfter  0.0 pt>
   <PgfBlockSize 1>
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
    <FFamily `Frutiger LT Std 45 Light'>
    <FVar `Regular'>
    <FWeight `Bold'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Bold'>
    <FEncoding `FrameRoman'>
    <FSize  14.5 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  -4.0%>
    <FStretch  100.0%>
    <FLanguage UKEnglish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLeading  3.0 pt>
   <PgfNumTabs 2>
   <TabStop 
    <TSX  67.0 mm>
    <TSType Center>
    <TSLeaderStr ` '>
   > # end of TabStop
   <TabStop 
    <TSX  134.0 mm>
    <TSType Right>
    <TSLeaderStr ` '>
   > # end of TabStop
   <PgfAcrobatLevel 0>
   <PgfPDFStructureLevel 0>
   <PgfLanguage UKEnglish>
  > # end of Pgf
  <ParaLine 
   <TextRectID 28>
   <Variable 
    <VariableName `Current Page #'>
    <Unique 1085961>
   > # end of Variable
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1085964>
  <Pgf 
   <PgfTag `Footer'>
   <PgfAlignment Right>
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
    <FFamily `Frutiger LT Std 55 Roman'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  7.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage UKEnglish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLeading  2.0 pt>
   <PgfPDFStructureLevel 0>
  > # end of Pgf
  <ParaLine 
   <TextRectID 29>
   <String `Läkemedelsverket'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1085965>
  <ParaLine 
   <String `Läkemedelsboken 2014'>
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1085969>
  <Pgf 
   <PgfTag `Body'>
   <PgfUseNextTag Yes>
   <PgfNextTag `KapRub'>
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
    <FFamily `Frutiger LT Std 45 Light'>
    <FVar `Regular'>
    <FWeight `Bold'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Bold'>
    <FEncoding `FrameRoman'>
    <FSize  7.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLeading  1.7 pt>
   <PgfNumTabs 0>
   <PgfPDFStructureLevel 0>
   <PgfLanguage Swedish>
  > # end of Pgf
  <ParaLine 
   <TextRectID 30>
   <Variable 
    <VariableName `Avsnittsnamn'>
    <Unique 1085967>
   > # end of Variable
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1085973>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
    <FFamily `Frutiger LT Std 55 Roman'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  7.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
  > # end of Pgf
  <ParaLine 
   <Variable 
    <VariableName `Kapitelnamn'>
    <Unique 1085971>
   > # end of Variable
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1085891>
  <Pgf 
   <PgfTag `Footer'>
   <PgfUseNextTag No>
   <PgfNextTag `'>
   <PgfAlignment LeftRight>
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
    <FFamily `Frutiger LT Std 55 Roman'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  7.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage UKEnglish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLeading  2.0 pt>
   <PgfNumTabs 2>
   <TabStop 
    <TSX  67.0 mm>
    <TSType Center>
    <TSLeaderStr ` '>
   > # end of TabStop
   <TabStop 
    <TSX  134.0 mm>
    <TSType Right>
    <TSLeaderStr ` '>
   > # end of TabStop
   <PgfPDFStructureLevel 0>
   <PgfLanguage UKEnglish>
  > # end of Pgf
  <ParaLine 
   <TextRectID 13>
   <String `Läkemedelsverket'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1085892>
  <ParaLine 
   <String `Läkemedelsboken 2014'>
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <TFTag `A'>
 <TFAutoConnect Yes>
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1085893>
  <Pgf 
   <PgfTag `Body'>
   <PgfUseNextTag Yes>
   <PgfNextTag `KapRub'>
   <PgfAlignment Right>
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
    <FFamily `Frutiger LT Std 45 Light'>
    <FVar `Regular'>
    <FWeight `Bold'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Bold'>
    <FEncoding `FrameRoman'>
    <FSize  7.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLeading  1.7 pt>
   <PgfNumTabs 0>
   <PgfPDFStructureLevel 0>
   <PgfLanguage Swedish>
  > # end of Pgf
  <ParaLine 
   <TextRectID 14>
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1085897>
  <Pgf 
   <PgfAlignment Left>
  > # end of Pgf
  <ParaLine 
   <TextRectID 15>
   <Variable 
    <VariableName `Avsnittsnamn'>
    <Unique 1085895>
   > # end of Variable
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1085901>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
    <FFamily `Frutiger LT Std 55 Roman'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  7.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
  > # end of Pgf
  <ParaLine 
   <Variable 
    <VariableName `Kapitelnamn'>
    <Unique 1085899>
   > # end of Variable
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1085903>
  <Pgf 
   <PgfUseNextTag No>
   <PgfNextTag `'>
   <PgfAlignment Right>
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
    <FFamily `Frutiger LT Std 45 Light'>
    <FVar `Regular'>
    <FWeight `Bold'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Bold'>
    <FEncoding `FrameRoman'>
    <FSize  9.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 4>
    <FColor `Blue'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLeading  2.0 pt>
  > # end of Pgf
  <ParaLine 
   <TextRectID 16>
   <Font 
    <FTag `LänkSidhuvud'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink LB2013IX.fm:firstpage'>
    <MCurrPage `Left'>
    <Unique 1085902>
   > # end of Marker
   <String `Sökord'>
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1085905>
  <Pgf 
   <PgfAlignment Center>
  > # end of Pgf
  <ParaLine 
   <TextRectID 18>
   <Font 
    <FTag `LänkSidhuvud'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink LB2013TOC.fm:firstpage'>
    <MCurrPage `Left'>
    <Unique 1085904>
   > # end of Marker
   <String `Innehåll'>
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1085925>
  <Pgf 
   <PgfUseNextTag Yes>
   <PgfNextTag `KapRub'>
   <PgfAlignment Right>
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
    <FFamily `Frutiger LT Std 45 Light'>
    <FVar `Regular'>
    <FWeight `Bold'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Bold'>
    <FEncoding `FrameRoman'>
    <FSize  7.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLeading  1.7 pt>
  > # end of Pgf
  <ParaLine 
   <TextRectID 19>
   <Variable 
    <VariableName `Avsnittsnamn'>
    <Unique 1085923>
   > # end of Variable
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1085929>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
    <FFamily `Frutiger LT Std 55 Roman'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  7.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
  > # end of Pgf
  <ParaLine 
   <Variable 
    <VariableName `Kapitelnamn'>
    <Unique 1085927>
   > # end of Variable
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <TFTag `A'>
 <TFAutoConnect Yes>
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1085930>
  <Pgf 
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
    <FFamily `Frutiger LT Std 45 Light'>
    <FVar `Regular'>
    <FWeight `Bold'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Bold'>
    <FEncoding `FrameRoman'>
    <FSize  7.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
  > # end of Pgf
  <ParaLine 
   <TextRectID 20>
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1085934>
  <Pgf 
   <PgfTag `Header'>
   <PgfUseNextTag No>
   <PgfNextTag `'>
   <PgfAlignment Left>
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
    <FFamily `Frutiger LT Std 45 Light'>
    <FVar `Regular'>
    <FWeight `Bold'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Bold'>
    <FEncoding `FrameRoman'>
    <FSize  14.5 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  -4.0%>
    <FStretch  100.0%>
    <FLanguage UKEnglish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLeading  3.0 pt>
   <PgfNumTabs 2>
   <TabStop 
    <TSX  67.0 mm>
    <TSType Center>
    <TSLeaderStr ` '>
   > # end of TabStop
   <TabStop 
    <TSX  134.0 mm>
    <TSType Right>
    <TSLeaderStr ` '>
   > # end of TabStop
   <PgfPDFStructureLevel 0>
   <PgfLanguage UKEnglish>
  > # end of Pgf
  <ParaLine 
   <TextRectID 21>
   <Variable 
    <VariableName `Current Page #'>
    <Unique 1085932>
   > # end of Variable
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1085935>
  <Pgf 
   <PgfTag `Footer'>
   <PgfAlignment Right>
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 55 Roman.R.400'>
    <FFamily `Frutiger LT Std 55 Roman'>
    <FVar `Regular'>
    <FWeight `Regular'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Roman'>
    <FEncoding `FrameRoman'>
    <FSize  7.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage UKEnglish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLeading  2.0 pt>
   <PgfPDFStructureLevel 0>
  > # end of Pgf
  <ParaLine 
   <TextRectID 22>
   <String `Läkemedelsverket'>
  > # end of ParaLine
 > # end of Para
 <Para 
  <Unique 1085936>
  <ParaLine 
   <String `Läkemedelsboken 2014'>
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1085938>
  <Pgf 
   <PgfTag `Body'>
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
    <FFamily `Frutiger LT Std 45 Light'>
    <FVar `Regular'>
    <FWeight `Bold'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Bold'>
    <FEncoding `FrameRoman'>
    <FSize  9.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 4>
    <FColor `Blue'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfNumTabs 0>
   <PgfPDFStructureLevel 0>
   <PgfLanguage Swedish>
  > # end of Pgf
  <ParaLine 
   <TextRectID 23>
   <Font 
    <FTag `LänkSidhuvud'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink LB2013IX.fm:firstpage'>
    <MCurrPage `Right'>
    <Unique 1085937>
   > # end of Marker
   <String `Sökord'>
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1085940>
  <Pgf 
   <PgfAlignment Center>
  > # end of Pgf
  <ParaLine 
   <TextRectID 25>
   <Font 
    <FTag `LänkSidhuvud'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink LB2013TOC.fm:firstpage'>
    <MCurrPage `Right'>
    <Unique 1085939>
   > # end of Marker
   <String `Innehåll'>
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1085975>
  <Pgf 
   <PgfAlignment Right>
  > # end of Pgf
  <ParaLine 
   <TextRectID 31>
   <Font 
    <FTag `LänkSidhuvud'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink LB2013IX.fm:firstpage'>
    <MCurrPage `Första kapitelsida höger'>
    <Unique 1085974>
   > # end of Marker
   <String `Sökord'>
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1085977>
  <Pgf 
   <PgfAlignment Center>
  > # end of Pgf
  <ParaLine 
   <TextRectID 33>
   <Font 
    <FTag `LänkSidhuvud'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink LB2013TOC.fm:firstpage'>
    <MCurrPage `Första kapitelsida höger'>
    <Unique 1085976>
   > # end of Marker
   <String `Innehåll'>
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1086013>
  <Pgf 
   <PgfAlignment Right>
  > # end of Pgf
  <ParaLine 
   <TextRectID 39>
   <Font 
    <FTag `LänkSidhuvud'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink LB2013IX.fm:firstpage'>
    <MCurrPage `Första kapitelsida vänster'>
    <Unique 1086012>
   > # end of Marker
   <String `Sökord'>
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1086015>
  <Pgf 
   <PgfAlignment Center>
  > # end of Pgf
  <ParaLine 
   <TextRectID 41>
   <Font 
    <FTag `LänkSidhuvud'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink LB2013TOC.fm:firstpage'>
    <MCurrPage `Första kapitelsida vänster'>
    <Unique 1086014>
   > # end of Marker
   <String `Innehåll'>
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1086048>
  <Pgf 
   <PgfAlignment Right>
  > # end of Pgf
  <ParaLine 
   <TextRectID 46>
   <Font 
    <FTag `LänkSidhuvud'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink LB2013IX.fm:firstpage'>
    <MCurrPage `Left utan linje'>
    <Unique 1086047>
   > # end of Marker
   <String `Sökord'>
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1086050>
  <Pgf 
   <PgfAlignment Center>
  > # end of Pgf
  <ParaLine 
   <TextRectID 48>
   <Font 
    <FTag `LänkSidhuvud'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink LB2013TOC.fm:firstpage'>
    <MCurrPage `Left utan linje'>
    <Unique 1086049>
   > # end of Marker
   <String `Innehåll'>
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1086082>
  <Pgf 
   <PgfAlignment Right>
  > # end of Pgf
  <ParaLine 
   <TextRectID 53>
   <Font 
    <FTag `LänkSidhuvud'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink LB2013IX.fm:firstpage'>
    <MCurrPage `Right utan linje'>
    <Unique 1086081>
   > # end of Marker
   <String `Sökord'>
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1086084>
  <Pgf 
   <PgfAlignment Center>
  > # end of Pgf
  <ParaLine 
   <TextRectID 55>
   <Font 
    <FTag `LänkSidhuvud'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink LB2013TOC.fm:firstpage'>
    <MCurrPage `Right utan linje'>
    <Unique 1086083>
   > # end of Marker
   <String `Innehåll'>
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1086115>
  <Pgf 
   <PgfAlignment Right>
  > # end of Pgf
  <ParaLine 
   <TextRectID 60>
   <Font 
    <FTag `LänkSidhuvud'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink LB2013IX.fm:firstpage'>
    <MCurrPage `Left liggande'>
    <Unique 1086114>
   > # end of Marker
   <String `Sökord'>
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1086117>
  <Pgf 
   <PgfAlignment Center>
  > # end of Pgf
  <ParaLine 
   <TextRectID 62>
   <Font 
    <FTag `LänkSidhuvud'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink LB2013TOC.fm:firstpage'>
    <MCurrPage `Left liggande'>
    <Unique 1086116>
   > # end of Marker
   <String `Innehåll'>
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1086148>
  <Pgf 
   <PgfAlignment Right>
  > # end of Pgf
  <ParaLine 
   <TextRectID 67>
   <Font 
    <FTag `LänkSidhuvud'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink LB2013IX.fm:firstpage'>
    <MCurrPage `Right liggande'>
    <Unique 1086147>
   > # end of Marker
   <String `Sökord'>
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1086150>
  <Pgf 
   <PgfAlignment Center>
  > # end of Pgf
  <ParaLine 
   <TextRectID 69>
   <Font 
    <FTag `LänkSidhuvud'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink LB2013TOC.fm:firstpage'>
    <MCurrPage `Right liggande'>
    <Unique 1086149>
   > # end of Marker
   <String `Innehåll'>
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1086183>
  <Pgf 
   <PgfAlignment Right>
  > # end of Pgf
  <ParaLine 
   <TextRectID 74>
   <Font 
    <FTag `LänkSidhuvud'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink LB2013IX.fm:firstpage'>
    <MCurrPage `Left preparat'>
    <Unique 1086182>
   > # end of Marker
   <String `Sökord'>
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1086185>
  <Pgf 
   <PgfAlignment Center>
  > # end of Pgf
  <ParaLine 
   <TextRectID 76>
   <Font 
    <FTag `LänkSidhuvud'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink LB2013TOC.fm:firstpage'>
    <MCurrPage `Left preparat'>
    <Unique 1086184>
   > # end of Marker
   <String `Innehåll'>
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1086218>
  <Pgf 
   <PgfAlignment Right>
  > # end of Pgf
  <ParaLine 
   <TextRectID 81>
   <Font 
    <FTag `LänkSidhuvud'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink LB2013IX.fm:firstpage'>
    <MCurrPage `Right preparat'>
    <Unique 1086217>
   > # end of Marker
   <String `Sökord'>
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1086220>
  <Pgf 
   <PgfAlignment Center>
  > # end of Pgf
  <ParaLine 
   <TextRectID 83>
   <Font 
    <FTag `LänkSidhuvud'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink LB2013TOC.fm:firstpage'>
    <MCurrPage `Right preparat'>
    <Unique 1086219>
   > # end of Marker
   <String `Innehåll'>
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1086254>
  <Pgf 
   <PgfAlignment Right>
  > # end of Pgf
  <ParaLine 
   <TextRectID 90>
   <Font 
    <FTag `LänkSidhuvud'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink LB2013IX.fm:firstpage'>
    <MCurrPage `Första_Avsnitt'>
    <Unique 1086253>
   > # end of Marker
   <String `Sökord'>
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1086256>
  <Pgf 
   <PgfAlignment Center>
  > # end of Pgf
  <ParaLine 
   <TextRectID 92>
   <Font 
    <FTag `LänkSidhuvud'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink LB2013TOC.fm:firstpage'>
    <MCurrPage `Första_Avsnitt'>
    <Unique 1086255>
   > # end of Marker
   <String `Innehåll'>
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1086290>
  <Pgf 
   <PgfAlignment Right>
  > # end of Pgf
  <ParaLine 
   <TextRectID 111>
   <Font 
    <FTag `LänkSidhuvud'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink LB2013IX.fm:firstpage'>
    <MCurrPage `Left preparat utan linje'>
    <Unique 1086289>
   > # end of Marker
   <String `Sökord'>
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1086292>
  <Pgf 
   <PgfAlignment Center>
  > # end of Pgf
  <ParaLine 
   <TextRectID 113>
   <Font 
    <FTag `LänkSidhuvud'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink LB2013TOC.fm:firstpage'>
    <MCurrPage `Left preparat utan linje'>
    <Unique 1086291>
   > # end of Marker
   <String `Innehåll'>
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1086324>
  <Pgf 
   <PgfAlignment Right>
  > # end of Pgf
  <ParaLine 
   <TextRectID 118>
   <Font 
    <FTag `LänkSidhuvud'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink LB2013IX.fm:firstpage'>
    <MCurrPage `Right preaparat utan linje'>
    <Unique 1086323>
   > # end of Marker
   <String `Sökord'>
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1086326>
  <Pgf 
   <PgfAlignment Center>
  > # end of Pgf
  <ParaLine 
   <TextRectID 120>
   <Font 
    <FTag `LänkSidhuvud'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink LB2013TOC.fm:firstpage'>
    <MCurrPage `Right preaparat utan linje'>
    <Unique 1086325>
   > # end of Marker
   <String `Innehåll'>
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1086949>
  <Pgf 
   <PgfUseNextTag Yes>
   <PgfNextTag `KapRub'>
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
    <FFamily `Frutiger LT Std 45 Light'>
    <FVar `Regular'>
    <FWeight `Bold'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Bold'>
    <FEncoding `FrameRoman'>
    <FSize  7.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 0>
    <FColor `Black'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLeading  1.7 pt>
  > # end of Pgf
  <ParaLine 
   <TextRectID 138>
   <String `1'>
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1086950>
  <ParaLine 
   <TextRectID 141>
   <String `1'>
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1026848>
  <Pgf 
   <PgfUseNextTag No>
   <PgfNextTag `'>
   <PgfAlignment Right>
   <PgfFont 
    <FTag `'>
    <FPlatformName `W.Frutiger LT Std 45 Light.R.700'>
    <FFamily `Frutiger LT Std 45 Light'>
    <FVar `Regular'>
    <FWeight `Bold'>
    <FAngle `Regular'>
    <FPostScriptName `FrutigerLTStd-Bold'>
    <FEncoding `FrameRoman'>
    <FSize  9.0 pt>
    <FUnderlining FNoUnderlining>
    <FOverline No>
    <FStrike No>
    <FChangeBar No>
    <FOutline No>
    <FShadow No>
    <FPairKern Yes>
    <FTsume No>
    <FCase FAsTyped>
    <FPosition FNormal>
    <FDX  0.0%>
    <FDY  0.0%>
    <FDW  0.0%>
    <FStretch  100.0%>
    <FLanguage Swedish>
    <FLocked No>
    <FSeparation 4>
    <FColor `Blue'>
    <FBackgroundColor NoColor>
   > # end of PgfFont
   <PgfLeading  2.0 pt>
  > # end of Pgf
  <ParaLine 
   <TextRectID 97>
   <Font 
    <FTag `LänkSidhuvud'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink LB2013IX.fm:firstpage'>
    <MCurrPage `Left preaparat utan linje'>
    <Unique 1026847>
   > # end of Marker
   <String `Sökord'>
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1026850>
  <Pgf 
   <PgfAlignment Center>
  > # end of Pgf
  <ParaLine 
   <TextRectID 99>
   <Font 
    <FTag `LänkSidhuvud'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink LB2013TOC.fm:firstpage'>
    <MCurrPage `Left preaparat utan linje'>
    <Unique 1026849>
   > # end of Marker
   <String `Innehåll'>
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1026858>
  <Pgf 
   <PgfAlignment Right>
  > # end of Pgf
  <ParaLine 
   <TextRectID 104>
   <Font 
    <FTag `LänkSidhuvud'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink LB2013IX.fm:firstpage'>
    <MCurrPage `Right preparat utan linje'>
    <Unique 1026857>
   > # end of Marker
   <String `Sökord'>
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
<TextFlow 
 <Notes 
 > # end of Notes
 <Para 
  <Unique 1026860>
  <Pgf 
   <PgfAlignment Center>
  > # end of Pgf
  <ParaLine 
   <TextRectID 106>
   <Font 
    <FTag `LänkSidhuvud'>
    <FLocked No>
   > # end of Font
   <Marker 
    <MType 8>
    <MTypeName `Hypertext'>
    <MText `gotolink LB2013TOC.fm:firstpage'>
    <MCurrPage `Right preparat utan linje'>
    <Unique 1026859>
   > # end of Marker
   <String `Innehåll'>
  > # end of ParaLine
 > # end of Para
> # end of TextFlow
# End of MIFFile
